Citrus Sinensis ID: 003264

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-----
Protein Sequence
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Secondary Structure (PSIPRED)
cccccEEEEHHHHHHHHHccccccccccccccccccccEEEccccEEEEEEcccccccccEEEEEEcccccEEEEEEcccccccccccEEEEEccccEEEEEccccEEEEEcccccccccEEEEEEcccEEEEEccccccccccEEEEEccccccccccccEEEEEcccccEEEEEEcccccccccccEEEEEEEccccEEEEEEccEEEEEEccccccEEEcccccccccEEcEEEEcccEEEEEEEEccccEEEEEEEcccccEEEEEEEcccccEEEEEEEcccccccccccccccccccccccccccccccEEccccccccccccEEcccccccccccEEEcccccccccccEEEEccccHHHHHHHHHcccccccccccccccccccEEEcccccccccccccccccccccccccccccccccEEEEEEEEEEcccccHHHEEEEEEEEcccccccccccccccHHHHHHccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHccccccEEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccccccccccccEEEcccccccccccEEEEEcccccHHHHcccccEEccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHEEEEcccccccccccHHHHHHHHccccccccccccccEEEEEcccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEEEEEEccHHHHccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEccccEEEEEEccccccccccEEEEEccccEEEEEEccccEEEEccccccccccEEEEEccccEEEEEccccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEcccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccEEccccccccccccccccccccccccccccEEcccccccccccEEEEccccccccccEEEcccccHHHHHHHHHHcccEEEEEEEEccccccEEEEEEccHHHHHHHcccccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHccccHHcccEEEEccccccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEEccHHccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccHHHHcHHHcccccHHHHHHHHHHHHHHHccccccccccHEEEEEEcccccccccccccEEEEEcccccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLslatdtitpatligdgeklvsssqifelgffspgkskykYLGIWYKQVPDTVVWVAnrnspivdsnavltignngnlvllnqtdgiiwssnlsrevknpvaqlldtgnlvlrekfssntsegsylwqsfdcpsdtlligmnmgwdlktgreryltswrtaddpspgnftfRLEIRVLPhlciyngsvklsctgpwnglafgadptntsylfrpiveqkEDEIIYRYESYSSRILMMLkinpsgdvQRLIWHEMSTGWqvfftapnnfcqlygycgansvcsvddtancecLKGFKLKLqnnqtwprecvrshssdcitrerfikfddiklpylvdvslnesmnlkECEAEclknctcrayanskvtgggsgclmwfGDLIDIRkitgynngqpiyvrvpdsepgdkkLLWIFVILVLpaallpgffIFCRWRRKHKEKETTMESSQDLLKFDIYMSvatrtnepsegdgdakgtrrdsvlpcfsLASVSAATENFSMQcklgeggfgpvykgkllngQEVAVKRLssqsgqglkEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYeympnkslnfflfdpsrthllgwQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASnilldsdmnpkisdfgmarmfcgdelqgntkrvvgtygymspeyaldglfsvksDVFSFGVLLLETLTskrntgvydiesfnLLGHAWnlwkdnrayellspalqHEASYQMLNRYITVALLCVQekaadrptmSKVVSMITnehatlpypkqsafsyarrgekisflpssrvseacsvngvtlslispr
Flexible Loop (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSwrtaddpspgnFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFrpiveqkedEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLklqnnqtwprecvrshssdcitrerfikfddiklPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKekettmessqdllKFDIYMSVATrtnepsegdgdakgtrrDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITnehatlpypkqsafSYARRGEKISflpssrvseacsvngvtlslispr
Low Complexity Region (SEG)
MGNPPffftfscfvfLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Disordered region (IsUnstruct)
*****FFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRR**************LLKFDIYMSV*********************VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK***********EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD*****KVVSMITNEHATLPY*****F*Y********************V**V********
Disordered Region (DISOPRED)
***PPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLS*****PVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEK**************I***********************DSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFS************************VTLSLISPR
Disordered Region (DISEMBL)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKH*********SQDLLKFDIYMSVATR**************RRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Disordered Region (DISPRO)
**NPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEP***********RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR***************CSVNGVTLSLISP*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	835	2.2.26 [Sep-21-2011]
Q9S972	847	Receptor-like serine/thre	yes	no	0.953	0.939	0.453	0.0
O81905	850	Receptor-like serine/thre	no	no	0.955	0.938	0.453	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.952	0.943	0.441	0.0
O81832	783	G-type lectin S-receptor-	no	no	0.893	0.952	0.443	0.0
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.938	0.941	0.423	1e-179
O81906	849	G-type lectin S-receptor-	no	no	0.967	0.951	0.411	1e-179
Q09092	857	Putative serine/threonine	N/A	no	0.972	0.947	0.413	1e-175
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.942	0.931	0.411	1e-174
P0DH86	853	G-type lectin S-receptor-	no	no	0.940	0.920	0.419	1e-172
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.947	0.939	0.405	1e-168

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/832 (45%), Positives = 510/832 (61%), Gaps = 36/832 (4%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSP 82
           AT+++T    I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR++P
Sbjct: 32  ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNP 87

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNT 140
           +  SN  L I +N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN VLR+  S N 
Sbjct: 88  LSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNN 144

Query: 141 SEGSYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLP 199
               +LWQSFD P+DTLL  M MGWD K+G   R L SW+T DDPS G+F+ +L     P
Sbjct: 145 KPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFP 204

Query: 200 HLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMM 257
              IYN       +GPW G  F + P      Y+     E  + +++Y Y    + I  +
Sbjct: 205 EFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSI 263

Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKL 317
           L ++ +G +QRL W E +  W+  + +P + C  Y  CG    C  + +  C C+KGF+ 
Sbjct: 264 LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP 323

Query: 318 KLQNNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
              N Q   R+    CVR     C  R+ F++   ++LP   + S+++ + LKECE  CL
Sbjct: 324 --MNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381

Query: 374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIF 433
           K C C A+AN+ +  GGSGC++W G L DIR       GQ +YVRV   +  DK++    
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKK 439

Query: 434 VI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGD 489
           +I   + +   LL  F IF  W+RK K   T      DL++  D  M+   + +      
Sbjct: 440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-- 497

Query: 490 GDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS 548
             +K  + D + LP     +++ AT NFS   KLG+GGFG VYKG LL+G+E+AVKRLS 
Sbjct: 498 --SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query: 549 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 608
            S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD +R+ 
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F  
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN 727
           +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+     N
Sbjct: 676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query: 728 LLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           LLG  W  WK+ +  E++ P    AL  E     + R I + LLCVQE+A DRP MS V+
Sbjct: 736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query: 784 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
            M+ +E   +P PK+  F   R   ++    S++  + C+VN VTLS+I  R
Sbjct: 796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/841 (45%), Positives = 513/841 (60%), Gaps = 43/841 (5%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
           +S  T + + +  I     +VS   +FELGFF PG     YLGIWYK +   T VWVANR
Sbjct: 27  ISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANR 86

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKFS 137
           ++P+  S   L I ++ NLV+L+Q+D  +WS+NL+  +V++P VA+LLD GN VLR+  S
Sbjct: 87  DTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD--S 143

Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
            N++    LWQSFD P+DTLL  M +GWD KTG  R++ SW++ DDPS G+F+F+LE   
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203

Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRIL 255
            P + ++N   ++  +GPWNG+ F   P      Y+       KE E+ Y +    S + 
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDVY 262

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
             L I+ SG +QR  W E +  W  F+ AP + C  Y  CG    C  + +  C C+KGF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322

Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
           K +  N Q W        CVR     C   + F++   +KLP     S++  + +KECE 
Sbjct: 323 KPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQ 380

Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLL 430
           +CL++C C A+AN+ + G GSGC+ W G+L DIR       GQ +YVR+  ++  DK+  
Sbjct: 381 KCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRNR 438

Query: 431 WIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQ----DLLKFDIYMSVAT 480
              +I   + +   LL  F IF  W+RK K     ET +   Q    DLL  ++ +S  +
Sbjct: 439 SAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVIS--S 496

Query: 481 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 540
           R +   E + D      D  LP      V+ AT NFS   KLG+GGFG VYKGKLL+GQE
Sbjct: 497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550

Query: 541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
           +AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+  
Sbjct: 551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610

Query: 601 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660
           LFD SR   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDF
Sbjct: 611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670

Query: 661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 720
           GMAR+F  DE + NT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++SKRN G 
Sbjct: 671 GMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGF 730

Query: 721 YDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS----YQMLNRYITVALLCVQEKAAD 775
           Y+ +   NLLG  W  WK+ +  E++ P +   +S    +++L R I + LLCVQE+A D
Sbjct: 731 YNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAED 789

Query: 776 RPTMSKVVSMITNEHATLPYPKQSAFSYAR-RGEKISFLPSSRVSEACSVNGVTLSLISP 834
           RPTMS V+ M+ +E  T+P PK   +   R   +  S     R  E+ +VN +T+S++  
Sbjct: 790 RPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDA 849

Query: 835 R 835
           R
Sbjct: 850 R 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/839 (44%), Positives = 501/839 (59%), Gaps = 44/839 (5%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANR 79
           +S  T + T +  I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR
Sbjct: 25  VSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANR 84

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFS 137
           ++P+  SN  L I  N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN +LR+   
Sbjct: 85  DNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD--- 140

Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
              S    LWQSFD P+DTLL  M +GWD KTG  R L SW+T DDPS G F+ +LE   
Sbjct: 141 ---SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSE 197

Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRIL 255
            P   I +    L  +GPWNG+ F + P      Y+       KE E+ Y Y    + + 
Sbjct: 198 FPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLY 256

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
             L +N +G +QRL W E +  W+  + +P + C  Y  CG    C  +   NC C+KGF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316

Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
           K    N Q W        C+R     C  R+ F +   +KLP      ++  + LK C+ 
Sbjct: 317 KP--VNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374

Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLL 430
            CL++C C A+AN+ +  GGSGC++W  +++D+R       GQ +YVR+  +E  DK++ 
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRIK 432

Query: 431 WIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTME------SSQDLLKFDIYMSVATR 481
              +I   + +   LL  F IF  W+RK K   T          SQD L  D+ +S    
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492

Query: 482 TNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV 541
           T++  + +                L +++ AT NFS   KLG+GGFG VYKG+LL+G+E+
Sbjct: 493 TSKEKKSEYLELPLL--------ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544

Query: 542 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL 601
           AVKRLS  S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  L
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604

Query: 602 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
           FD +R+  L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664

Query: 662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY 721
           MAR+F  +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724

Query: 722 DI-ESFNLLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADR 776
           +     NLLG  W  WK+    E++ P    +L  +     + R I + LLCVQE+A DR
Sbjct: 725 NSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDR 784

Query: 777 PTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
           P MS V+ M+ +E   +P PK+  F   R   +     S++  + C+VN +TLS+I  R
Sbjct: 785 PVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  638 bits (1646), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/835 (44%), Positives = 490/835 (58%), Gaps = 89/835 (10%)

Query: 20  LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
           LL+ ATD +     + DG+ +VS    FE+GFFSPG S+ +YLGIWYK++   TVVWVAN
Sbjct: 19  LLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVAN 78

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNL-----SREVKNPVAQLLDTGNLVLR 133
           R+SP+ D +  L +  NG+L L N  + IIWSS+         ++NP+ Q+LDTGNLV+R
Sbjct: 79  RDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138

Query: 134 EKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRL 193
               ++  +  Y+WQS D P D  L GM  G +  TG  R+LTSWR  DDPS GN+T ++
Sbjct: 139 ----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKM 194

Query: 194 EIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEIIYRYESY 250
           +   +P   +   SV +  TGPWNGL F   P    N  Y +  +    E+E+ Y Y+  
Sbjct: 195 DPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVF--TEEEVYYTYKLE 252

Query: 251 SSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCE 310
           +  +L  +++NP+G +QR  W +    W  + +A  + C  Y  CG+   C+++++  C 
Sbjct: 253 NPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACR 312

Query: 311 CLKGFKLKLQNNQT---WPRECVRSHSSDCITRER-FIKFDDIKLPYLVDVSLNESMNLK 366
           CLKGF  K         W   CVR    DC   E  F+K   +KLP       +++M+L 
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372

Query: 367 ECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NGQPIYVRVPDSEPG 425
           EC+  CL+NCTC AY+   +  GG GC++WFGDLIDIR+   YN NGQ +YV        
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE---YNENGQDLYV-------- 421

Query: 426 DKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEP 485
                                      R    E ET    S           V++R  E 
Sbjct: 422 ---------------------------RLASSEIETLQRESS---------RVSSRKQE- 444

Query: 486 SEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR 545
                       D  LP   L +VS AT  FS   KLG+GGFGPVYKG L  GQEVAVKR
Sbjct: 445 ----------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKR 494

Query: 546 LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 605
           LS  S QG++EFKNE+ LIAKLQHRNLV+++G CV++ E++LIYEY PNKSL+ F+FD  
Sbjct: 495 LSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKE 554

Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
           R   L W  RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+LLDSDMN KISDFG+AR 
Sbjct: 555 RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLART 614

Query: 666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE- 724
             GDE + NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+LE ++ +RN G  + E 
Sbjct: 615 LGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEH 674

Query: 725 SFNLLGHAWNLWKDNRAYELLSPALQHEAS-YQMLNRYITVALLCVQEKAADRPTMSKVV 783
             NLLGHAW  + +++AYE++  A+    +    + R I + LLCVQ+   DRP MS VV
Sbjct: 675 KLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVV 734

Query: 784 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVS---EACSVNGVTLSLISPR 835
            M+++E   L  P+Q  F   R     + L S  VS   E  S N  T+S+I PR
Sbjct: 735 LMLSSEMLLLD-PRQPGFFNER-----NLLFSDTVSINLEIPSNNFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  630 bits (1626), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 358/846 (42%), Positives = 495/846 (58%), Gaps = 62/846 (7%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNS 81
           ++ DTI     + DGE ++S+ + F  GFFS G S+ +Y+GIWY Q+   T+VWVANR+ 
Sbjct: 17  ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76

Query: 82  PIVDSNAVLTIGNNGNLVLL---NQTDGIIWSSNLSREVKNP--VAQLLDTGNLVLREKF 136
           PI D++ ++   N GNL +    N+T+ +IWS+N+S  +  P  VA L D GNLVL +  
Sbjct: 77  PINDTSGMVKFSNRGNLSVYASDNETE-LIWSTNVSDSMLEPTLVATLSDLGNLVLFDPV 135

Query: 137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
           +     G   W+SFD P+DT L  M +G+  K G +R LTSW++  DP  G+   R+E R
Sbjct: 136 T-----GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERR 190

Query: 197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPTN-TSYLFRPIVEQKEDEIIYRYESYSSRIL 255
             P L +Y G       G W G  +   P     Y+F       EDE+ + Y    + ++
Sbjct: 191 GFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVI 250

Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSV--DDTANCECLK 313
               +N +G + R  W      W  F++ P   C  Y +CG N  C      T  C CL 
Sbjct: 251 TRTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLP 310

Query: 314 GFKLKLQNNQTWPRE-CVRSHSSDCITRER---------FIKFDDIKLPYLVDVSLNESM 363
           GF+ K       PR   +R  S  C  ++R         F+K   +K+P   D S++ ++
Sbjct: 311 GFEPKF------PRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNI 364

Query: 364 NLKECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
            LKEC+  CLKNC+C AYA++  +   G  GCL W G ++D R  T  N+GQ  Y+RV  
Sbjct: 365 TLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDAR--TYLNSGQDFYIRVDK 422

Query: 422 SE---------PGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF 472
            E          G +++L I + L+  A +L    +FC  R + K       S+      
Sbjct: 423 EELARWNRNGLSGKRRVLLILISLI-AAVMLLTVILFCVVRERRKSNRHRSSSAN----- 476

Query: 473 DIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYK 532
             +  V    +E    + D     R+  LP F L ++ AAT NFS Q KLG GGFGPVYK
Sbjct: 477 --FAPVPFDFDESFRFEQDKA---RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYK 531

Query: 533 GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
           G L N  E+AVKRLS  SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE  EK+L+YEY+
Sbjct: 532 GVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYL 591

Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
           PNKSL++F+F   +   L W  R++I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLDS+
Sbjct: 592 PNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSE 651

Query: 653 MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           M PKISDFGMAR+F G++++G T RVVGT+GYM+PEYA++G FS+KSDV+SFGVL+LE +
Sbjct: 652 MIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEII 711

Query: 713 TSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA-SYQMLNRYITVALLCVQE 771
           T K+N+  ++ ES NL+GH W+LW++  A E++   +  E    + + + I + LLCVQE
Sbjct: 712 TGKKNSAFHE-ESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQE 770

Query: 772 KAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR--GEKISFLPSSRVSEACSVNGVTL 829
            A+DR  MS VV M+ +    LP PK  AF+ ARR  GE  + L         SVN VT 
Sbjct: 771 NASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKG---QTGISVNDVTF 827

Query: 830 SLISPR 835
           S I  R
Sbjct: 828 SDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  628 bits (1620), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 353/857 (41%), Positives = 510/857 (59%), Gaps = 49/857 (5%)

Query: 10  FSCFVFLLGSLLSLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWY 66
            S F++      S+A +TI     + DG   + LVS  + FELGFFSPG S +++LGIWY
Sbjct: 11  LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70

Query: 67  KQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVA 122
             + D  VVWVANR +PI D + VL I N+GNLVLL+  +  +WSSN+        N V 
Sbjct: 71  GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130

Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTAD 182
            + DTGN VL E     T     +W+SF+ P+DT L  M +  + +TG      SWR+  
Sbjct: 131 SIHDTGNFVLSE-----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSET 185

Query: 183 DPSPGNFTFRLEIRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQ 238
           DPSPGN++  ++    P + ++ G+  +   +G WN   F   P     T+YL+   +  
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSS 245

Query: 239 KEDE---IIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYC 295
             DE   + + Y      +L+  K+  +G  + L W+E    W  F + P++ C  Y  C
Sbjct: 246 PPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRC 305

Query: 296 GANSVCSVDDTAN-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDI 349
           G   +C +  +   C C+ G++     N  W R C R     C     +  + F+    +
Sbjct: 306 GKFGICDMKGSNGICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSV 363

Query: 350 KLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGY 409
           KLP   ++  +  ++ ++C   CL+NC+C AY+      GG GC++W  DL+D+++    
Sbjct: 364 KLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFEA- 417

Query: 410 NNGQPIYVRVPDSEPGDKKLLWIFVIL-VLPAALLPGFFIFCRWRRKHKEKETTMESSQD 468
             G  +++R+ DSE G+ +   I VI+ VL   +L G F    WR K K+  +     ++
Sbjct: 418 -GGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKN 476

Query: 469 LLKFDIYMSVATRTNEPSEG---------DGDAKGTRRDSVLPCFSLASVSAATENFSMQ 519
                + ++  T++ E +           +G A  T   S LP FSL +++ AT +F  +
Sbjct: 477 T-DTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNT---SELPVFSLNAIAIATNDFCKE 532

Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
            +LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            E  EK+L+YEYMPNKSL+FFLFD ++  L+ W+ R  IIEGIA+GLLYLH+ SRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           RDLK SN+LLD++MNPKISDFGMAR+F G++ + NT RVVGTYGYMSPEYA++GLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712

Query: 700 DVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLN 759
           DV+SFGVLLLE ++ KRNT +   E  +L+G+AW L+   R+ EL+ P ++   S +   
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772

Query: 760 RYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGE-KISFLPSSRV 818
           R I VA+LCVQ+ AA+RP M+ V+ M+ ++ ATL  P+Q  F+  RR    ++F   S  
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832

Query: 819 SEACSVNGVTLSLISPR 835
               S N +T +++  R
Sbjct: 833 QYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  615 bits (1585), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 356/861 (41%), Positives = 512/861 (59%), Gaps = 49/861 (5%)

Query: 6   FFFTFSCFVFLLGSLLSLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLG 63
           F   F   + L+   LS+  +T+  T +  I   + LVS   IFE+GFF    S++ YLG
Sbjct: 15  FLLVFVVMI-LIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTN-SRW-YLG 71

Query: 64  IWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR--EVKNP 120
           +WYK+V D T VWVANR++P+ ++   L I  N NLVLL+ ++  +W +NL+R  E    
Sbjct: 72  MWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPV 130

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VA+LL  GN V+R+  SSN     YLWQSFD P+DTLL  M +G++LKTG  R+LTSWR+
Sbjct: 131 VAELLANGNFVMRD--SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQ 238
           +DDPS GNF+++LE + LP   +   +  +  +GPWNG+ F   P +   SY+    +E 
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIEN 248

Query: 239 KEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAP-NNFCQLYGYCGA 297
            E E+ Y +   ++     L +   G  QRL W+     W  F+++P +  C  Y  CG 
Sbjct: 249 NE-EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGP 307

Query: 298 NSVCSVDDTANCECLKGFK---LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
            + C V+ +  C C++GF    ++  + + W   C+R     C + + F +   +KLP  
Sbjct: 308 YAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPET 366

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRK-ITGYNNGQ 413
              +++ S+ +KEC+  C+ +C C A+AN+ +  GGSGC++W   L DIR   T   +GQ
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQ 426

Query: 414 PIYVRVPDSEPGDKKLLWIFVI-LVLPAALLPGFFIFCRWRRKHKEKETT------MESS 466
            +YVR+  ++   K+     +I L +  ++L    +FC W+RK K  + +       + +
Sbjct: 427 DLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRN 486

Query: 467 QDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGG 526
           Q+L   ++ +S         E  G+ K    +  LP   + +V  ATENFS   KLG+GG
Sbjct: 487 QNLPMNEMVLS------SKREFSGEYKFEELE--LPLIEMETVVKATENFSSCNKLGQGG 538

Query: 527 FGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586
           FG VYKG+LL+G+E+AVKRLS  S QG  EF NE+ LIA+LQH NLV+++GCC+E  EK+
Sbjct: 539 FGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKM 598

Query: 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
           LIYEY+ N SL+ +LF  +R   L W  R  I  G+A+GLLYLHQ SR RIIHRDLK SN
Sbjct: 599 LIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSN 658

Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           ILLD +M PKISDFGMAR+F  DE + NT +VVGTYGYMSPEYA+ G+FS KSDVFSFGV
Sbjct: 659 ILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGV 718

Query: 707 LLLETLTSKRNTGVYDIESFN-LLGHAWNLWKDNRAYELLSPALQHEASY-------QML 758
           ++LE ++ K+N G Y+++  N LL + W+ WK+ RA E++ P +    S        Q +
Sbjct: 719 IVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEV 778

Query: 759 NRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSR- 817
            + I + LLCVQE A  RP MS VV M  +E   +P PK   +   R   ++   PSS  
Sbjct: 779 LKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELD--PSSSW 836

Query: 818 ---VSEACSVNGVTLSLISPR 835
               +E+ +VN  T S+I  R
Sbjct: 837 QCDENESWTVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  611 bits (1575), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 350/850 (41%), Positives = 500/850 (58%), Gaps = 63/850 (7%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNSP 82
           + +TI  +  + DG+ + S  + F  GFFS G SK +Y+GIWY QV + T+VWVANR+ P
Sbjct: 21  SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGI--IWSSNLSREVKNP--VAQLLDTGNLVLREKFSS 138
           I D++ ++     GNL +    +G   IWS+++   ++ P  VA+L D GNLVL +  + 
Sbjct: 81  INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVT- 139

Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
               G   W+SF+ P++TLL  M  G+  ++G +R +TSWR+  DP  GN T+R+E R  
Sbjct: 140 ----GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGF 195

Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTS-YLFRPIVEQKEDEIIYRYESYSSRILMM 257
           P + +Y G      TG W G  +   P  T+ ++F        DE+   Y    + +   
Sbjct: 196 PQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTR 255

Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTAN--CECLKGF 315
           + +N +G +QR  W+     W  F++AP + C +Y +CG N  C    T    C CL G+
Sbjct: 256 MVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGY 315

Query: 316 KLKLQNNQTWPRECVRSHSSDCITR----------ERFIKFDDIKLPYLVDVSLNESMNL 365
           + K       PR+     +SD  TR          E F K   +K+P    V+++ ++ L
Sbjct: 316 EPKT------PRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITL 369

Query: 366 KECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE 423
           KECE  CLKNC+C AYA++  +   G  GCL W G+++D R  T  ++GQ  Y+RV  SE
Sbjct: 370 KECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTR--TYLSSGQDFYLRVDKSE 427

Query: 424 ---------PGDKKLLWIFVILV-LPAALLPGFFIFCRWRRKHKEKETTMESSQDLL--K 471
                     G K+L+ I + L+ +   LL  F  + R RR+  +     ++        
Sbjct: 428 LARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSS 487

Query: 472 FDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 531
           FD+  S      E            R   LP F L++++ AT NF+ Q KLG GGFGPVY
Sbjct: 488 FDLEDSFILEELEDKS---------RSRELPLFELSTIATATNNFAFQNKLGAGGFGPVY 538

Query: 532 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
           KG L NG E+AVKRLS  SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE  EK+L+YEY
Sbjct: 539 KGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEY 598

Query: 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
           +PNKSL++F+F   +   L W  R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD+
Sbjct: 599 LPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDN 658

Query: 652 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLET 711
           +M PKI+DFG+AR+F G++++G+T RVVGTYGYMSPEYA+DG FS+KSDV+SFGVL+LE 
Sbjct: 659 EMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEI 718

Query: 712 LTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQ 770
           +T KRN+  Y+ ES NL+ H W+ W++  A E++   +  E   +  + + + + LLCVQ
Sbjct: 719 ITGKRNSAFYE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQ 777

Query: 771 EKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR-----GEKISFLPSSRVSEACSVN 825
           E ++DRP MS VV M+ +    LP PK  AF+  RR     G      PS   S   ++N
Sbjct: 778 ENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSS--TIN 835

Query: 826 GVTLSLISPR 835
            VTL+ +  R
Sbjct: 836 DVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  606 bits (1562), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 358/854 (41%), Positives = 509/854 (59%), Gaps = 69/854 (8%)

Query: 21  LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
           +S+ T + T +  I   + +VS   +FELGFF      + YLGIWYK++   T VWVANR
Sbjct: 30  ISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDSW-YLGIWYKKISQRTYVWVANR 88

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP-VAQLLDTGNLVLREKFSS 138
           ++P+ +   +L I +N NLV+L+ +D  +WS+NL+  V++  VA+LLD GN VLR    +
Sbjct: 89  DTPLSNPIGILKI-SNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKIN 147

Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
            + E  +LWQSFD P+DTLL  M +G D K G  R++TSW+++ DPS G+F F+LE   L
Sbjct: 148 ESDE--FLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGL 205

Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVE-QKEDEIIYRYE------SYS 251
           P    +   +++  +GPW+GL F             I+E Q+ D+IIY +       +Y+
Sbjct: 206 PEFFGFTSFLEVYRSGPWDGLRFSG-----------ILEMQQWDDIIYNFTENREEVAYT 254

Query: 252 SRI-----LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDT 306
            R+        L IN  G ++  +W      W +F+  P + C LYG CG  + C +  +
Sbjct: 255 FRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTS 314

Query: 307 ANCECLKGFKLKLQNNQTWPR-----ECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
             C C+KGF  +  + Q W        C R     C   +RF +  ++K+P      +++
Sbjct: 315 PTCNCIKGF--QPLSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDK 371

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
            + LKECE +C  +C C AYANS +  GGSGC++W G+  DIR      +GQ ++VR+  
Sbjct: 372 RIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAA--DGQDLFVRLAA 429

Query: 422 SEPGDKKLLWIFVILVLPAA---LLPGFFIFCRWRRKHKEKETTM------ESSQDLLKF 472
           +E G+++ +   +I ++      L+  F I+C W++K K    T       +  Q+L+  
Sbjct: 430 AEFGERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIIT 489

Query: 473 D-IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 531
           + + MS   R     E          D  LP     +V  ATENFS    LG GGFG VY
Sbjct: 490 NGVVMSSGRRLLGEEE----------DLELPLTEFETVVMATENFSDSNILGRGGFGIVY 539

Query: 532 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
           KG+LL+GQE+AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CC+   EKILIYEY
Sbjct: 540 KGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEY 599

Query: 592 MPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + N SL+  LF+ ++ ++ L WQTR  II GIA+GLLYLHQ SR +IIHRDLKASN+LLD
Sbjct: 600 LENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLD 659

Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            +M PKISDFGMAR+F  DE + NT++VVGTYGYMSPEYA++G+FSVKSDVFSFGVL+LE
Sbjct: 660 KNMTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLE 719

Query: 711 TLTSKRNTGVYDI-ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLN------RYIT 763
            ++ KRN G ++  +  NLLG+ W  WK+ +  E++   +   +S   L       R I 
Sbjct: 720 IVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQ 779

Query: 764 VALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSS--RVSEA 821
           + LLCVQE+A DRP MS VV M+ +E   +P PK+  +   R     +   SS  R SE+
Sbjct: 780 IGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSES 839

Query: 822 CSVNGVTLSLISPR 835
            +VN +T+S+I+ R
Sbjct: 840 LTVNQITVSVINAR 853

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  594 bits (1531), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 341/841 (40%), Positives = 488/841 (58%), Gaps = 50/841 (5%)

Query: 21  LSLATDTITPATLIGDGEK--LVSSSQIFELGFFSPGKS--KYKYLGIWYKQVP-DTVVW 75
           L    D IT ++ I D E   L+  S IF  GFF+P  S  + +Y+GIWY+++P  TVVW
Sbjct: 26  LCFGEDRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVW 85

Query: 76  VANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVA---QLLDTGNLVL 132
           VAN++SPI D++ V++I  +GNL + +  + ++WS+N+S  V  P A   QL+D+GNL+L
Sbjct: 86  VANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVA-PNATWVQLMDSGNLML 144

Query: 133 REKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFR 192
           ++    N + G  LW+SF  P D+ +  M +G D +TG    LTSW + DDPS GN+T  
Sbjct: 145 QD----NRNNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAG 200

Query: 193 LEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSS 252
           +     P L I+  +V    +GPWNG  F   P   S LF        D       SY++
Sbjct: 201 IAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYAN 260

Query: 253 RILM-MLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCEC 311
              M    ++P G + +  W      W++    P   C  YG CG    C   +   C+C
Sbjct: 261 DSFMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKC 320

Query: 312 LKGFKLKLQ---NNQTWPRECVRSHSSDCITRER-------------FIKFDDIKLPYLV 355
           +KGF  K     N   W   C+R     C  R+R             F+K   +K+P   
Sbjct: 321 VKGFVPKNNTEWNGGNWSNGCMRKAPLQC-ERQRNVSNGGGGGKADGFLKLQKMKVPISA 379

Query: 356 DVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPI 415
           + S     + + C   CL NC+C AYA  +    G GC++W GDL+D++   G  +G  +
Sbjct: 380 ERS---EASEQVCPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG--SGIDL 430

Query: 416 YVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIY 475
           ++RV  SE      L + +   +   +L          RK+K++    +     L F   
Sbjct: 431 FIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFK-R 489

Query: 476 MSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKL 535
           M   T  NE +      K       LP F    ++ +T++FS++ KLG+GGFGPVYKGKL
Sbjct: 490 MEALTSDNESASNQIKLKE------LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKL 543

Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
             GQE+AVKRLS +SGQGL+E  NE+++I+KLQHRNLV+L+GCC+E  E++L+YEYMP K
Sbjct: 544 PEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKK 603

Query: 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655
           SL+ +LFDP +  +L W+TR  I+EGI +GLLYLH+ SRL+IIHRDLKASNILLD ++NP
Sbjct: 604 SLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNP 663

Query: 656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           KISDFG+AR+F  +E + NT+RVVGTYGYMSPEYA++G FS KSDVFS GV+ LE ++ +
Sbjct: 664 KISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGR 723

Query: 716 RNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA 774
           RN+  +  E + NLL +AW LW D  A  L  PA+  +   + + + + + LLCVQE A 
Sbjct: 724 RNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVAN 783

Query: 775 DRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISP 834
           DRP +S V+ M+T E+ +L  PKQ AF   RRG   +   S + S+  S+N V+L+ ++ 
Sbjct: 784 DRPNVSNVIWMLTTENMSLADPKQPAF-IVRRGASEA-ESSDQSSQKVSINDVSLTAVTG 841

Query: 835 R 835
           R
Sbjct: 842 R 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	835
224115098	802	predicted protein [Populus trichocarpa]	0.949	0.988	0.502	0.0
359493711	1081	PREDICTED: G-type lectin S-receptor-like	0.925	0.715	0.490	0.0
224122858	831	predicted protein [Populus trichocarpa]	0.967	0.972	0.481	0.0
255587572	822	S-locus-specific glycoprotein S6 precurs	0.955	0.970	0.478	0.0
359496546	866	PREDICTED: receptor-like serine/threonin	0.976	0.941	0.467	0.0
255555127	834	S-locus-specific glycoprotein S6 precurs	0.970	0.971	0.458	0.0
147799241	818	hypothetical protein VITISV_027305 [Viti	0.914	0.933	0.481	0.0
359493740	2422	PREDICTED: uncharacterized protein LOC10	0.943	0.325	0.469	0.0
224115136	843	predicted protein [Populus trichocarpa]	0.958	0.948	0.455	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.952	0.979	0.455	0.0

>gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa]

 Score =  793 bits (2049), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/844 (50%), Positives = 551/844 (65%), Gaps = 51/844 (6%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           M + PFF  FS         LS + D ITP   + DG+ L+S SQ FELGFFSPG SKY+
Sbjct: 1   MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60

Query: 61  YLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           Y+GIWYK+ P+TVVWVANRN+P+ D   VLTI N GNLVLL+Q   IIWSSN S  +  P
Sbjct: 61  YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VAQLLD+GNLV+R+  SS  +E SY WQSFD PSDTLL GM +GW+LKTG+ERYL +WR+
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTE-SYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKE 240
             DPSPG+FT+RL+I  LP L I  GSVK   +GPWNG+ FG  P   + +F PI+ + E
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239

Query: 241 DEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
           DEI Y Y   ++ +   L +N SG V+RL+ +  ++GW   ++ P + C+ YG CGAN +
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299

Query: 301 CSVDDTANCECLKGFK------LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
           C    +  CECLKGFK      L +QN     R+C    + DC + E F+K   +KLP L
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYG-SRKCETRLTLDCQSGEGFLKLPGVKLPDL 358

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGG--SGCLMWFGDLIDIRKITGYNNG 412
           ++  LNESMNLKECEAEC KNC+C A+A + ++GGG  SGCLMWFG+LIDIR+ +G   G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418

Query: 413 QPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF 472
           Q I++RVP SE                           R  ++ K  +T + +S   L  
Sbjct: 419 QDIHIRVPASE-----------------------LEMARSSKRKKMLKTALVASMSAL-L 454

Query: 473 DIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYK 532
            I++S   R  E  E              P F L +++ AT NF+    +G GGFG VYK
Sbjct: 455 GIFVSGMDRRKEGMEA-------------PLFDLDTIATATNNFAPDSIIGAGGFGSVYK 501

Query: 533 GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
           GKLL GQE+AVK+LS  SGQG++EF+NE++LIAKLQHRNLV L+G C+ + E++LIYEYM
Sbjct: 502 GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYM 561

Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
           PNKSL++F+FD  R+ LLGW+ R  II GIA+GLLYLHQ S+L+I+HRDLK SN+LLDS+
Sbjct: 562 PNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSN 621

Query: 653 MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           + PKISDFG+AR+   D  +  T+RV+GTYGYM+PEYA+DG FSVKSDVFS GVLLLE +
Sbjct: 622 LIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLEII 681

Query: 713 TSKRNTG-VYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQE 771
           + K+N G V+     +LLGHAW +W + RA EL+   L+  +    L R I V LLCVQ+
Sbjct: 682 SGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGLEDTSGKSQLLRCIQVGLLCVQK 741

Query: 772 KAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSL 831
              DRP MS VV M+ NE A LP PKQ  F +  RG       +SR  ++ S N   +++
Sbjct: 742 LPEDRPVMSTVVFMLANEGAVLPQPKQPGF-FIERGSVSE--ATSRNEDSYSTNEANITI 798

Query: 832 ISPR 835
           +  R
Sbjct: 799 LEAR 802

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  760 bits (1962), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/824 (49%), Positives = 525/824 (63%), Gaps = 51/824 (6%)

Query: 25   TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
             D+I     I D E LVSS Q FELGFFSPG SK +YLGIWYK  P T VWVANRN+PI 
Sbjct: 296  ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355

Query: 85   DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            DS  VLTI NNG LVLLNQ+  +IWS NLSR  +NPVAQLL+TGNLVLR+   SN +  S
Sbjct: 356  DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413

Query: 145  YLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIY 204
            Y+WQSFD PSDT+L GM +GW+LKTG +R LTSW+++DDPS G+F++  +I VLP+L + 
Sbjct: 414  YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473

Query: 205  NGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSG 264
             GS K+  +GPWNGL F       + +++ +     DE+   YES +++I+  L +N SG
Sbjct: 474  VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533

Query: 265  DVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQT 324
             +QRL+  + S+ W   ++ P+  C+ YG+CGAN +C +     CECL GF  K Q  + 
Sbjct: 534  FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQ--EE 591

Query: 325  W-----PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCR 379
            W        C R    DC   E F+K   +KLP L+D  +   ++L+EC+  CL NC+C 
Sbjct: 592  WDMFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCT 651

Query: 380  AYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPG------DKKLLWIF 433
            AYA +   G G GCLMW GDLIDIR++T   + + IY+R+  SE G       KKL+ I 
Sbjct: 652  AYAYTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIIL 710

Query: 434  VILVLPAALLPGF-FIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDA 492
            VI      L  G  F F  W+++      TM + Q+                        
Sbjct: 711  VISTFSGILTLGLSFWFRFWKKR------TMGTDQE------------------------ 740

Query: 493  KGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ 552
               + +  LP F L +++ AT NFS   K+G GGFG VYKG L  G  VAVKRLS  S Q
Sbjct: 741  -SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQ 799

Query: 553  GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
            G++EFKNE +LIAKLQH+NLVRL+GCC++  E+IL+YEYMPNKSL++F+FD +R  LL W
Sbjct: 800  GVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAW 859

Query: 613  QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
              R +I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+F  +E++
Sbjct: 860  DKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEME 919

Query: 673  GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV-YDIESFNLLGH 731
              TKR+VGTYGYMSPEY +DG FS+K DVFSFGVLLLE ++ ++N G  +     NLLGH
Sbjct: 920  TRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLGH 979

Query: 732  AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 791
            AW LW+ NRA EL+   L+       + R I V LLCVQ   ADRP MS V+ M+ NE A
Sbjct: 980  AWLLWEQNRALELMDACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNEGA 1039

Query: 792  TLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
            TLP PK   F +  R    +   S ++ E  S N VT+S++  R
Sbjct: 1040 TLPQPKHPGF-FTERSSVDTDTMSGKI-ELHSENAVTISMLKGR 1081

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/851 (48%), Positives = 536/851 (62%), Gaps = 43/851 (5%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           MG     F  S   FL  S+ S A ++I     + DG+ LVSS   FELGFFSPG S+ +
Sbjct: 8   MGGQTILFLLSIVFFL--SIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNR 65

Query: 61  YLGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKN 119
           Y+GIWYK++   TVVWVANRN+P+ DS+ +L   ++GNL  +N T+G IWSSN+SR   N
Sbjct: 66  YMGIWYKKISSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAIN 125

Query: 120 PVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWR 179
           PVAQLLDTGNLV+R +  ++    ++LWQSFD P D+ L GM  G    TG  RYLTSW+
Sbjct: 126 PVAQLLDTGNLVVRAE--NDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWK 183

Query: 180 TADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGAD---PTNTSYLFRPIV 236
           +  DPS G +T +L+   LP   +  GSV    +GPWNGL F        N  Y F  + 
Sbjct: 184 SPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVF 243

Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
            Q  +EI Y+Y+  +S +L  + ++P G +QR  W + +  W ++ TA  + C  +  CG
Sbjct: 244 NQ--EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCG 301

Query: 297 ANSVCSVDDTANCECLKGFKLKLQNNQT---WPRECVRSHSSDCITRERFIKFDDIKLPY 353
           A+ VC+++++  C+CLK F+ K     T   W + CVR    DC   E FIK+  IK+P 
Sbjct: 302 AHGVCNINNSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NG 412
                 N+++NL+ECE  CLKNC+C AYAN  V  GGSGC++WFGDLIDIR+   YN NG
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ---YNENG 418

Query: 413 QPIYVRV-------PDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMES 465
           Q IY+R+       P    G K++  I + + L A  L    +F R+ RK+K+++ T E 
Sbjct: 419 QDIYIRIAASVIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478

Query: 466 SQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEG 525
           +           V T      E D   +    D  LP F LA+++ AT  FS+  KLG+G
Sbjct: 479 N-----------VVTN----PEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQG 523

Query: 526 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585
           GFGPVYKG L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+L+GCC+E  E+
Sbjct: 524 GFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEER 583

Query: 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 645
           +LIYEYMPNKSL+ F+FD  R  LL W  R  II GIA+GLLYLHQ SRLRIIHRDLKAS
Sbjct: 584 MLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKAS 643

Query: 646 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 705
           NILLD +MNPKISDFGMAR F GDE   NT R+VGTYGYMSPEYA+DGLFSVKSDVFSFG
Sbjct: 644 NILLDYEMNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFG 703

Query: 706 VLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV 764
           VL+LE ++ ++N G    E   NLLGHAW L K+ R  +L+  ++        + R I V
Sbjct: 704 VLVLEIVSGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEV 763

Query: 765 ALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSV 824
           ALLCVQ+   DRP MS VV M++++   LP PK+  F   R     S   S+   E  SV
Sbjct: 764 ALLCVQKSPEDRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDS--SSTIKHEISSV 820

Query: 825 NGVTLSLISPR 835
           N +T +L+  R
Sbjct: 821 NELTSTLLEAR 831

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  719 bits (1857), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/825 (47%), Positives = 516/825 (62%), Gaps = 27/825 (3%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSPIV 84
           +T+ P   + DGE L+S+   FELGFFS G S+ +YLGIWYK++P  TVVWV NR  P  
Sbjct: 10  ETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNREVPSF 69

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
           D+  VL +   G ++L N T GIIWSSN SR  KNPV QLLD+GNL++++   +N    +
Sbjct: 70  DNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNGNNPD--N 127

Query: 145 YLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIY 204
            +WQSFD P +TLL  M +GW+L  G  RYLTSW++ DDP+ GNF+  +++R  P L + 
Sbjct: 128 IVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMK 187

Query: 205 NGSVKLSCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPS 263
            G      +GPWNGL F   P  N + +F       + EI Y YE  ++ ++  L ++  
Sbjct: 188 KGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEK 247

Query: 264 GDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQ 323
           G ++R  W + +  W +FF+ P + C  Y  CGA + C+++    C CL+GF  K   + 
Sbjct: 248 GALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFVPKSPTDW 307

Query: 324 T---WPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRA 380
           +   W   CVR     C T + F K   +KLP      ++ SM+LKECE  CL+NC+C A
Sbjct: 308 SASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLA 367

Query: 381 YANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGD-----KKLLWIFVI 435
           YANS + G  SGCL+WF  LID+RK T    GQ +Y+R+  SE        K++  I   
Sbjct: 368 YANSDIRG--SGCLLWFDHLIDMRKFT--EGGQDLYIRIAASELAKGKSHGKRVAIIVSC 423

Query: 436 LVLPAALLP-GFFIFCRWRRKH---KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGD 491
           L++   +   G  ++ R R+++   +     +  S   + F I   +A  T   + GD  
Sbjct: 424 LIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIENYGD-- 481

Query: 492 AKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG 551
             G + D+ L  F L ++  AT NFS   KLGEGGFGPVYKG LL+GQE+AVKRLS  SG
Sbjct: 482 -NGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSG 540

Query: 552 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG 611
           QG KEFKNE++LIA+LQHRNLV+L+GCC+   EK+LIYEYMPNKSL+ F+FD  R+ LL 
Sbjct: 541 QGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLD 600

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           W    +II GIA+GLLYLHQ SRLRIIHRDLKASNILLD DMNPKISDFG+AR F  D+ 
Sbjct: 601 WHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQN 660

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLG 730
             NTKRVVGTYGYMSPEYA+DGLFSVKSDVFSFGVL+LE ++ KRN G   ++ S NLLG
Sbjct: 661 AANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLG 720

Query: 731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 790
           HAW LW + RA EL     Q E S   + R I V LLCVQ    DRP MS VV M+ +E 
Sbjct: 721 HAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLGSE- 779

Query: 791 ATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
           ++LP PKQ  F Y  R +      S+      S N ++ +LI PR
Sbjct: 780 SSLPQPKQPGF-YTER-DPFEADSSTSKERVWSRNEISSTLIEPR 822

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  719 bits (1855), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/843 (46%), Positives = 533/843 (63%), Gaps = 28/843 (3%)

Query: 12  CFVFL-LGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP 70
           CF FL L  ++ ++ DTIT    I +G+ LVS+   FELGFFSPG SK+ Y+GIWYK +P
Sbjct: 33  CFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGDFELGFFSPGDSKW-YVGIWYKNIP 91

Query: 71  -DTVVWVANRNSPIV--DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDT 127
            + VVWVANR++PI+   S +V+ IG+ GN+V++++   + WS+N S  V NPVAQLLDT
Sbjct: 92  KERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDEDLHVFWSTNESTAV-NPVAQLLDT 150

Query: 128 GNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPG 187
           GNLV+RE   ++    +YLWQSFD  +DTLL GM +GWD KTG  RYLTSW++ +DPS G
Sbjct: 151 GNLVVREDKDADPE--NYLWQSFDYLTDTLLPGMKLGWDQKTGSNRYLTSWKSKEDPSSG 208

Query: 188 NFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADP-TNTSYLFRPIVEQKEDEIIYR 246
           +++F+L+ R  P + I+N   K   +GPWNG+ F   P   +S +F    E  +D   Y 
Sbjct: 209 DYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGVPEMKSSSVFTFDFEWNQDGAYYS 268

Query: 247 YESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDT 306
           YE  +  I   L ++ +G +QR  W E    W +++ AP + C  Y  CG   +C  + +
Sbjct: 269 YELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLYWFAPKDQCDDYRECGPYGICDTNSS 328

Query: 307 ANCECLKGFKLKLQNNQTW-----PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
             C+C +GF+ K  N Q W        C R    DC   + F+    +KLP      +++
Sbjct: 329 PVCKCPRGFEPK--NPQAWNLRDGSDGCSRKTEFDCNNGDGFLALKRMKLPETGSSFVDK 386

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
           SM+LK+CE  C KNC+C  YAN ++T    GC++W  DL+D+R+      GQ +Y+RV  
Sbjct: 387 SMSLKDCEMTCRKNCSCTGYANPEITSD-KGCIIWTTDLLDMREYAEGEGGQDLYIRVAA 445

Query: 422 SEPGDK-------KLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDI 474
           SE G +       K++ +  I V  A LL G  I   W+RK  +       S+  L    
Sbjct: 446 SELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYLWKRKKMKIIVAHIVSKPGLSERS 505

Query: 475 YMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 534
           +  +      PS+ D   +    +  LP F   ++  AT NFS   KLG+GGFG VYKG 
Sbjct: 506 HDYILNEAVIPSKRDYTDEVKTDELELPLFDFGTIVLATNNFSDTNKLGQGGFGCVYKGM 565

Query: 535 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594
           LL G+E+AVKRL+  SGQG++EF NE+ LIA+LQHRNLV+L+GCCVE  EK+LIYEYM N
Sbjct: 566 LLEGEEIAVKRLAKNSGQGIEEFMNEVRLIARLQHRNLVQLLGCCVEMEEKMLIYEYMQN 625

Query: 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
           +SL+  LFD  ++ LL W  R  II G+A+GLLYLHQ SR RIIHRDLKASN+LLD +MN
Sbjct: 626 RSLDSILFDEKKSSLLDWGRRFNIICGVARGLLYLHQDSRFRIIHRDLKASNVLLDGEMN 685

Query: 655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS 714
           PKISDFGMAR+F  D+ + NTKRVVGTYGYMSPEYA+DGLFSVKSDVFSFGVL+LE ++ 
Sbjct: 686 PKISDFGMARIFGRDQTEANTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLVLEIISG 745

Query: 715 KRNTGVYDI-ESFNLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEK 772
           K+N G Y + +  NLLGHAW LW++ +  EL+  ++    A Y +L R I V LLCVQE 
Sbjct: 746 KKNRGFYHLNDEHNLLGHAWRLWREGKGLELMDSSVSESCAPYDVL-RCIQVGLLCVQEH 804

Query: 773 AADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLI 832
           A DRP MS VV M+++E ATLP PK   F   R+  +     SS+  E  +VN VT++++
Sbjct: 805 AEDRPVMSSVVLMLSSETATLPLPKNPGFCLGRKLVETD-SSSSKQEETFTVNQVTVTVM 863

Query: 833 SPR 835
             R
Sbjct: 864 DAR 866

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/847 (45%), Positives = 538/847 (63%), Gaps = 37/847 (4%)

Query: 3   NPPF-FFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKY 61
           NP F FFTF  F        S ++DT+T    + +G+ L+S+ Q FELGFF+PG SK  Y
Sbjct: 11  NPIFLFFTFLSF---YAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWY 67

Query: 62  LGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           +GIWYK + D T VWVANR++P+ +S+ +  I N  ++VL +Q + +IWSSN  +   NP
Sbjct: 68  VGIWYKNISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSNQIK-ATNP 125

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           V QLLDTG+LVLRE   +N     YLWQSFD P+DTLL  M +GWDL     RYL+SW++
Sbjct: 126 VMQLLDTGDLVLREANVNN----QYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKS 181

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQ 238
            DDP  G+++F+L+    P + ++N   K+  +GPWNGL F   P      Y+    V  
Sbjct: 182 KDDPGAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFV-T 240

Query: 239 KEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGAN 298
            + E+ Y +   S+     L +  SG++QR  W      W  F+ AP + C  Y  CG  
Sbjct: 241 NQSEVFYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPY 300

Query: 299 SVCSVDDTANCECLKGFKLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPY 353
            +C  + +  C+C++GF+ K  N Q W        CVR     C+  ++F+   +IKLP 
Sbjct: 301 GICDSNASPVCKCMRGFEPK--NLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPE 357

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQ 413
                ++  ++LK CE  CL+NC+C AYANS ++ GG+GC++WFG+L+D+R+ T    GQ
Sbjct: 358 SSTSFVDRIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYT-EGGGQ 416

Query: 414 PIYVRVPDSEPGDKKLLWIFVI--LVLPAALLPGFFIFCRWRRK--HKEKETTMESSQDL 469
            +YVR+  S+ GD K +   +I   V    LL G      W+R+   KE++   E SQ+L
Sbjct: 417 DLYVRLAASDIGDGKNVAALIIGISVGIGTLLLGLAACFIWKRRSVRKEQKGVQERSQNL 476

Query: 470 LKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGP 529
           L  ++ +S        S+ D   +  + +  LP F   +++ AT+NFS + KLG+GGFG 
Sbjct: 477 LLNEVVIS--------SKRDYSGEKDKDELELPLFDFGTIATATDNFSDENKLGQGGFGC 528

Query: 530 VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589
           VYKG+L+ GQ VAVKRLS  S QG++EFKNE+ LIA+LQHRNLVRL+GCC+E  EK+LIY
Sbjct: 529 VYKGRLVEGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIY 588

Query: 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
           EYM ++SL+  +F+ ++  LL WQ R  I+ GIA+GLLY+HQ SR RIIHRDLKASNILL
Sbjct: 589 EYMEHRSLDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILL 648

Query: 650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL 709
           D + NPKISDFGMAR+F GD+ + +TKRVVGTYGYMSPEYA+DG FSVKSDVFSFGVL+L
Sbjct: 649 DGEWNPKISDFGMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVL 708

Query: 710 ETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLC 768
           E ++  +N G Y   S  NLLGHAW LWK+ +  E+L  ++    S   + R I V LLC
Sbjct: 709 EIVSGNKNRGFYHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVLRCIQVGLLC 768

Query: 769 VQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVT 828
           VQE+A DRPTMS VV M+++E+AT+P+PK   F   R   +     S +  E+ +VN VT
Sbjct: 769 VQERAEDRPTMSSVVLMLSSENATMPHPKTPGFCLGRNPFETD-SSSGKQDESYTVNQVT 827

Query: 829 LSLISPR 835
           ++++  R
Sbjct: 828 VTMLDAR 834

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera]

 Score =  714 bits (1844), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/819 (48%), Positives = 518/819 (63%), Gaps = 55/819 (6%)

Query: 10  FSCFVFLLGSLLSL-----ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGI 64
           F+  VFL   ++S+     A D+IT    I DGE ++S+   FELGF   G SK +YLGI
Sbjct: 4   FTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGI 63

Query: 65  WYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQ 123
           WYK+V P TVVWVANR  P+ DS+  L + + G+LV+LN ++G+IWSSN SR  +NP AQ
Sbjct: 64  WYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQ 123

Query: 124 LLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADD 183
           LLD+GNLV+  K  +++   ++LWQSFD P DTLL GM  G +  TG +RYL+SW++ DD
Sbjct: 124 LLDSGNLVI--KSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDD 181

Query: 184 PSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT-------NTSYLFRPIV 236
           PS G+FT+ L+    P L + +GS  +  +GPWNG+ F   P        N S++F    
Sbjct: 182 PSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVF---- 237

Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
              E E+ + Y+  +S +L  L +NP+G+VQRLIW   +  W V+ TA  + C  Y  CG
Sbjct: 238 --NEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCG 295

Query: 297 ANSVCSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPY 353
           A S C++  +  C C+KGF  K     +   W   CVR  S DC   + F K+  +KLP 
Sbjct: 296 AYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPD 355

Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQ 413
             +   NESMNLKEC + C +NC+C AY NS + GGGSGCL+WFGDLIDI++ T   NGQ
Sbjct: 356 TRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFT--ENGQ 413

Query: 414 PIYVRVPDSE----PGDKKLLWIFVILVLPAALLPGFFIFCRW--RRKHKEKETTMESSQ 467
             Y+R+  SE        K  W+ V  V  A ++    +   +  +++ K K TT  +++
Sbjct: 414 DFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNE 473

Query: 468 DLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGF 527
                         TNE  E          D  LP F L ++  AT NFS   KLGEGGF
Sbjct: 474 -----------GAETNERQE----------DLELPLFXLDTILNATHNFSRNNKLGEGGF 512

Query: 528 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587
           GPVYKG L +G+E+AVKRLS +S QGL EFKNE++ I+KLQHRNLV+L+GCC+   EK+L
Sbjct: 513 GPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKML 572

Query: 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647
           IYEYMPNKSLNFF+FD  ++ +L W  R  II GIA+GLLYLHQ SRLRIIHRDLKA N+
Sbjct: 573 IYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNV 632

Query: 648 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
           LLD++MNP+ISDFGMAR F G+E    TKRVVGTYGYMSPEYA+DG++SVKSDVFSFGVL
Sbjct: 633 LLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVL 692

Query: 708 LLETLTSKRNTGV-YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVAL 766
            LE ++ KRN G  +     NLLGHAW L+ +    EL+  ++ +  +   + R + V L
Sbjct: 693 XLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGL 752

Query: 767 LCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR 805
           LCVQ    DRP MS VV M+++E A LP PK+  F   R
Sbjct: 753 LCVQRHPDDRPNMSSVVLMLSSEGA-LPQPKEPGFFTER 790

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera]

 Score =  713 bits (1841), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/827 (46%), Positives = 518/827 (62%), Gaps = 39/827 (4%)

Query: 10  FSCFVFLLGSL-LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQ 68
           F+  V +   L +S+A DT+T   +I DGE + S+   FELGFFSP  S+ +Y+GIWYK+
Sbjct: 4   FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63

Query: 69  VPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDT 127
           V   TVVWVANR  P+  S+ +L + + G LV+LN T+  IWSSN SR  +NP AQLLD+
Sbjct: 64  VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123

Query: 128 GNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPG 187
           GNLV++    S++   ++LWQSFD P +TLL GM  G +  TG +RYL+SW+T DDPS G
Sbjct: 124 GNLVMKNGNDSDSE--NFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIG 181

Query: 188 NFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEII 244
           NFT+RL+    P L + NGS     +GPWNGL F   P    N+ Y +  I   KE    
Sbjct: 182 NFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKE--TY 239

Query: 245 YRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD 304
           Y +E  +S ++  L ++P G  QR  W + ++ W ++ +A  + C  Y  CG   +C ++
Sbjct: 240 YTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEIN 299

Query: 305 DTANCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
            +  CEC+KGF+ K Q+N     W   CVRS    C     F+K+  +KLP   +   NE
Sbjct: 300 RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNE 359

Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
           SMNLKEC + CL NC+C AY NS + GGGSGCL+WFGDLIDIR+ T   NGQ  Y+R+  
Sbjct: 360 SMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYT--ENGQDFYIRMAK 417

Query: 422 SEPGDKKLLWIFVILVLPAALLPGFFIFCRW------------RRKHKEKETTMESSQDL 469
           SE G   L   ++ ++    +    +  C +            +RK     T       L
Sbjct: 418 SELG-MSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIIL 476

Query: 470 LKFDIYMSVATRTNEPSEGDG-----DAKGT-----RRDSVLPCFSLASVSAATENFSMQ 519
           L   + + V  +     +G+      + KG        D  LP F L ++  AT+NFS  
Sbjct: 477 LSLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATDNFSND 536

Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
            KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE+  I+KLQHRNLV+L+GCC
Sbjct: 537 NKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCC 596

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
           +   EK+LIYEYMPNKSL+FF+FD  ++ +L W  R  II GIA+GLLYLHQ SRLRIIH
Sbjct: 597 IHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIH 656

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           RDLKA N+LLD++MNP+ISDFGMAR F G+E +  TKRVVGTYGYMSPEYA+DG++S+KS
Sbjct: 657 RDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKS 716

Query: 700 DVFSFGVLLLETLTSKRNTGV-YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQML 758
           DVFSFGVL+LE +T KRN G  +   + NLLGHAW L+ + +  EL+  ++    +   +
Sbjct: 717 DVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEV 776

Query: 759 NRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR 805
            R + V LLCVQ    DRP+MS VV M+++E A L  PK+  F   R
Sbjct: 777 LRALNVGLLCVQRSPDDRPSMSSVVLMLSSESA-LHQPKEPGFFTER 822

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa]

 Score =  713 bits (1840), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/862 (45%), Positives = 527/862 (61%), Gaps = 62/862 (7%)

Query: 13  FVFLLGSLL------SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWY 66
           FVF++  LL      S A D+I+P+  + DG+ LVS    FELGFFSPG SK  YLGIWY
Sbjct: 5   FVFIITKLLLFLFKFSTALDSISPSEFMIDGKTLVSEKGTFELGFFSPGISKKSYLGIWY 64

Query: 67  KQVP-DTVVWVANRNSPIVDSNAVLTIGNNGNLVLL-NQTDGIIWSSNLSREVKNPVAQL 124
           K +P  T+VWVANR +PI DS+ +L + N  ++VLL N T+ ++WSSN +++  +P+ QL
Sbjct: 65  KNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPILQL 124

Query: 125 LDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDP 184
           LD+GNLVLR+K   N      LWQSFD P DT+L GM +GWDL+ G +  L+SW+++DDP
Sbjct: 125 LDSGNLVLRDK---NDGRSGLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDP 181

Query: 185 SPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKED 241
           SPG+FT  +E    P +  + GS K   +GPWNG+ F        N  + F  +    E 
Sbjct: 182 SPGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEV 241

Query: 242 EIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVC 301
             I+  +S S+ I  ++  + + D Q   W+E +  W +  + P + C  YG CGAN+ C
Sbjct: 242 YYIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANC 301

Query: 302 SVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVS 358
             +    C+CL+ FK K     N   W + CVR+   DC   + FIKFD +KLP      
Sbjct: 302 IFNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSW 361

Query: 359 LNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVR 418
           +N+ MNLKEC+A+CL NC+C AY+N  + GGGSGC  WFGDL+DIR + G   GQ +Y+R
Sbjct: 362 VNKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPG--GGQELYIR 419

Query: 419 VPDSEPGDKKL---LWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIY 475
           +  SE GD++    + I  I      L+ G         K K K     SS+        
Sbjct: 420 MHASEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSE-------- 471

Query: 476 MSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKL 535
                RT    + D +  G + D  LP F+ ++++ AT NFS+  KLGEGGFGPVY+GKL
Sbjct: 472 -----RTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKL 526

Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
            +G E+AVKRLS  SGQG  EFKNE++LI KLQHRNLV+L+GCC ++ EK+LIYEYMPN+
Sbjct: 527 EDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNR 586

Query: 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655
           SL+FF+FD ++  LL W  R  II GIA+GLLYLHQ SRLRIIHRDLKASN+LLD  MNP
Sbjct: 587 SLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNP 646

Query: 656 KISDFGMARMFCGDELQGNTKRVVGT---------------------YGYMSPEYALDGL 694
           KISDFG+ARMF  D+ +G+T RV                         GYM+PEYA DGL
Sbjct: 647 KISDFGLARMFVADQTEGDTSRVTSDSLASSNIPILPLCILTLNASCSGYMAPEYATDGL 706

Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           FSVKSDVFSFGVLLLE ++ K++ G Y  +  +L+GH W LW + +A EL+        +
Sbjct: 707 FSVKSDVFSFGVLLLEIISGKKSKGFYHPD-HSLIGHTWRLWNEGKASELIDALGDESCN 765

Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAF-SYARRGEKISFL 813
              + R + ++LLCVQ    DRP+M+ VV M+  + A LP PK+ AF +Y   GE  S  
Sbjct: 766 PSEVLRCVHISLLCVQHHPDDRPSMASVVWMLGGDSA-LPKPKEPAFLNYRAPGESSS-- 822

Query: 814 PSSRVSEACSVNGVTLSLISPR 835
            SS    + S N +T+S+  PR
Sbjct: 823 -SSSKVGSSSTNEITVSVFEPR 843

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  712 bits (1837), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/852 (45%), Positives = 518/852 (60%), Gaps = 57/852 (6%)

Query: 1   MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
           MG     F +S F  +L   +S A D +     + DGE LVS+   FELGFF+P  S  +
Sbjct: 1   MGVVDVIFVYSLFFSILK--ISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSR 58

Query: 61  YLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
           YLG+WYK+ P TVVWVANR  PI +    L + + G LVLLN T+ I+WSSN S  V+NP
Sbjct: 59  YLGLWYKKSPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNP 118

Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
           VAQLLD+GNLV+R+   ++    ++LWQSFD P DTLL GM +G +L TG   +L+SW+ 
Sbjct: 119 VAQLLDSGNLVVRD--GNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKG 176

Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVE 237
            ++P+PG FT  ++++  P L +   +  +   G WNG  F   P    +  Y F  +  
Sbjct: 177 KENPAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFN 236

Query: 238 QKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGA 297
           +  +E+ +++E  +S +   L + PSG VQ   W   +  W VF TA  + C+ Y  CGA
Sbjct: 237 R--NEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGA 294

Query: 298 NSVCSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
           N+ C  + +  C+CL GF  K     N+Q W   C+R    DC  ++ F  +  +KLP  
Sbjct: 295 NARCDSNSSPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDT 354

Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQP 414
                ++S +L ECE  C++NC+C AYAN    G GSGCL WFGDLID R++     GQ 
Sbjct: 355 SSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLA--EGGQD 412

Query: 415 IYVRVPDSEPG------DKKLLWIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTMES 465
           IY+R+  S+ G       KK     VI   ++L +++L    +FC  RRKH++     + 
Sbjct: 413 IYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDR 472

Query: 466 SQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEG 525
            ++ ++                             LP   L ++  AT+NFS   KLGEG
Sbjct: 473 KEEEME-----------------------------LPMLDLTTIEHATDNFSSSKKLGEG 503

Query: 526 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585
           GFG VYKG+L+ GQE+AVKRLS  SGQGL EFKNE++LIAKLQHRNLV+L+GCC+ + EK
Sbjct: 504 GFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEK 563

Query: 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 645
           +LIYEYMPN+SL+ F+FDP+R   L W  R  II+GIA+GLLYLHQ SRLRIIHRD+KAS
Sbjct: 564 MLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKAS 623

Query: 646 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 705
           NILLD+++NPKISDFG+ARMF GD+ + NTKRVVGTYGYMSPEYALDG FSVKSDVFSFG
Sbjct: 624 NILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFG 683

Query: 706 VLLLETLTSKRNTGVY--DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT 763
           VL+LE ++ K+N G    D    NLLGHAW LW +    EL+        +     R I 
Sbjct: 684 VLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIH 743

Query: 764 VALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACS 823
           VALLCVQ++  DRP MS VV M+ +E+  LP PKQ  F       +     SS   ++ S
Sbjct: 744 VALLCVQQRPEDRPNMSSVVLMLGSENP-LPQPKQPGFFMGSNPPEKD--TSSNKHQSHS 800

Query: 824 VNGVTLSLISPR 835
            N VT++L+  R
Sbjct: 801 ANEVTVTLLQAR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	835
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.953	0.939	0.453	3.7e-183
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.955	0.938	0.453	5.4e-182
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.431	0.459	0.536	1.9e-179
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.954	0.945	0.444	6.3e-179
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.408	0.418	0.559	4.4e-167
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.956	0.941	0.419	1.4e-165
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.942	0.948	0.404	2.5e-152
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.955	0.947	0.402	1.1e-151
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.391	0.406	0.534	4.6e-150
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.925	0.911	0.416	1.3e-148

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1777 (630.6 bits), Expect = 3.7e-183, P = 3.7e-183
 Identities = 377/832 (45%), Positives = 510/832 (61%)

Query:    24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSP 82
             AT+++T    I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVANR++P
Sbjct:    32 ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNP 87

Query:    83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNT 140
             +  SN  L I +N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN VLR+  S N 
Sbjct:    88 LSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNN 144

Query:   141 SEGSYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLP 199
                 +LWQSFD P+DTLL  M MGWD K+G   R L SW+T DDPS G+F+ +L     P
Sbjct:   145 KPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFP 204

Query:   200 HLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMM 257
                IYN       +GPW G  F + P      Y+     E  + +++Y Y    + I  +
Sbjct:   205 EFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSI 263

Query:   258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKL 317
             L ++ +G +QRL W E +  W+  + +P + C  Y  CG    C  + +  C C+KGF+ 
Sbjct:   264 LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP 323

Query:   318 KLQNNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
                N Q   R+    CVR     C  R+ F++   ++LP   + S+++ + LKECE  CL
Sbjct:   324 --MNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381

Query:   374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIF 433
             K C C A+AN+ +  GGSGC++W G L DIR       GQ +YVRV   +  DK++    
Sbjct:   382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKK 439

Query:   434 VI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGD 489
             +I   + +   LL  F IF  W+RK K   T      DL++  D  M+   + +      
Sbjct:   440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-- 497

Query:   490 GDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS 548
               +K  + D + LP     +++ AT NFS   KLG+GGFG VYKG LL+G+E+AVKRLS 
Sbjct:   498 --SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query:   549 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 608
              S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD +R+ 
Sbjct:   556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query:   609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
              L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F  
Sbjct:   616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query:   669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFN 727
             +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+     N
Sbjct:   676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query:   728 LLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
             LLG  W  WK+ +  E++ P    AL  E     + R I + LLCVQE+A DRP MS V+
Sbjct:   736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query:   784 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
              M+ +E   +P PK+  F   R   ++    S++  + C+VN VTLS+I  R
Sbjct:   796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1766 (626.7 bits), Expect = 5.4e-182, P = 5.4e-182
 Identities = 381/841 (45%), Positives = 517/841 (61%)

Query:    22 SLATDTITPAT--LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVAN 78
             S++ +T++ +    I     +VS   +FELGFF PG     YLGIWYK +   T VWVAN
Sbjct:    26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85

Query:    79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKF 136
             R++P+  S   L I ++ NLV+L+Q+D  +WS+NL+  +V++P VA+LLD GN VLR+  
Sbjct:    86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-- 142

Query:   137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
             S N++    LWQSFD P+DTLL  M +GWD KTG  R++ SW++ DDPS G+F+F+LE  
Sbjct:   143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query:   197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRI 254
               P + ++N   ++  +GPWNG+ F   P      Y+       KE E+ Y +    S +
Sbjct:   203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query:   255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
                L I+ SG +QR  W E +  W  F+ AP + C  Y  CG    C  + +  C C+KG
Sbjct:   262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query:   315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
             FK +  N Q W  R+    CVR     C   + F++   +KLP     S++  + +KECE
Sbjct:   322 FKPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECE 379

Query:   370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKL 429
              +CL++C C A+AN+ + G GSGC+ W G+L DIR       GQ +YVR+  ++  DK+ 
Sbjct:   380 QKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRN 437

Query:   430 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQDLLKFDIYMS---VAT 480
                 +I   + +   LL  F IF  W+RK K     ET +   Q L   D+ M+   +++
Sbjct:   438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQ-LRSRDLLMNEVVISS 496

Query:   481 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 540
             R +   E + D      D  LP      V+ AT NFS   KLG+GGFG VYKGKLL+GQE
Sbjct:   497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550

Query:   541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
             +AVKRLS  S QG  EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+  
Sbjct:   551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610

Query:   601 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660
             LFD SR   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDF
Sbjct:   611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670

Query:   661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 720
             GMAR+F  DE + NT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++SKRN G 
Sbjct:   671 GMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGF 730

Query:   721 YDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS----YQMLNRYITVALLCVQEKAAD 775
             Y+ +   NLLG  W  WK+ +  E++ P +   +S    +++L R I + LLCVQE+A D
Sbjct:   731 YNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAED 789

Query:   776 RPTMSKVVSMITNEHATLPYPKQSAFSYARRG-EKISFLPSSRVSEACSVNGVTLSLISP 834
             RPTMS V+ M+ +E  T+P PK   +   R   +  S     R  E+ +VN +T+S++  
Sbjct:   790 RPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDA 849

Query:   835 R 835
             R
Sbjct:   850 R 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 927 (331.4 bits), Expect = 1.9e-179, Sum P(2) = 1.9e-179
 Identities = 198/369 (53%), Positives = 254/369 (68%)

Query:   473 DIYMSVATRTNEPSEGDGDAKGTRR----DSVLPCFSLASVSAATENFSMQCKLGEGGFG 528
             D+Y+ +A+   E  + +     +R+    D  LP   L +VS AT  FS   KLG+GGFG
Sbjct:   418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477

Query:   529 PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588
             PVYKG L  GQEVAVKRLS  S QG++EFKNE+ LIAKLQHRNLV+++G CV++ E++LI
Sbjct:   478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537

Query:   589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
             YEY PNKSL+ F+FD  R   L W  RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+L
Sbjct:   538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597

Query:   649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             LDSDMN KISDFG+AR   GDE + NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+
Sbjct:   598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657

Query:   709 LETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEAS-YQMLNRYITVAL 766
             LE ++ +RN G  + E   NLLGHAW  + +++AYE++  A+    +    + R I + L
Sbjct:   658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGL 717

Query:   767 LCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNG 826
             LCVQ+   DRP MS VV M+++E   L  P+Q  F +  R    S   S  + E  S N 
Sbjct:   718 LCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPGF-FNERNLLFSDTVSINL-EIPSNNF 774

Query:   827 VTLSLISPR 835
              T+S+I PR
Sbjct:   775 QTMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1737 (616.5 bits), Expect = 6.3e-179, P = 6.3e-179
 Identities = 372/837 (44%), Positives = 509/837 (60%)

Query:    22 SLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
             S++ +T+  T +  I   + ++S SQIFELGFF+P  S   YLGIWYK +P  T VWVAN
Sbjct:    24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query:    79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKF 136
             R++P+  SN  L I  N NLV+ +Q+D  +WS+N++  +V++PVA +LLD GN +LR+  
Sbjct:    84 RDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD-- 140

Query:   137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
                 S    LWQSFD P+DTLL  M +GWD KTG  R L SW+T DDPS G F+ +LE  
Sbjct:   141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196

Query:   197 VLPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRI 254
               P   I +    L  +GPWNG+ F + P      Y+       KE E+ Y Y    + +
Sbjct:   197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNL 255

Query:   255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
                L +N +G +QRL W E +  W+  + +P + C  Y  CG    C  +   NC C+KG
Sbjct:   256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315

Query:   315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
             FK    N Q W  R+    C+R     C  R+ F +   +KLP      ++  + LK C+
Sbjct:   316 FKPV--NEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCK 373

Query:   370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKL 429
               CL++C C A+AN+ +  GGSGC++W  +++D+R       GQ +YVR+  +E  DK++
Sbjct:   374 ERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRI 431

Query:   430 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMS--VATRTN 483
                 +I   + +   LL  F IF  W+RK K   T    + D ++  D  ++  V +R  
Sbjct:   432 KNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRG 491

Query:   484 EPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAV 543
               S+   + K    +  LP   L +++ AT NFS   KLG+GGFG VYKG+LL+G+E+AV
Sbjct:   492 YTSK---EKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546

Query:   544 KRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 603
             KRLS  S QG  EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+  LFD
Sbjct:   547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606

Query:   604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
              +R+  L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMA
Sbjct:   607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666

Query:   664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI 723
             R+F  +E + NT+RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVLLLE ++ KRN G Y+ 
Sbjct:   667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726

Query:   724 E-SFNLLGHAWNLWKDNRAYELLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPT 778
                 NLLG  W  WK+    E++ P    +L  +     + R I + LLCVQE+A DRP 
Sbjct:   727 NRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPV 786

Query:   779 MSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
             MS V+ M+ +E   +P PK+  F   R   +     S++  + C+VN +TLS+I  R
Sbjct:   787 MSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 950 (339.5 bits), Expect = 4.4e-167, Sum P(2) = 4.4e-167
 Identities = 197/352 (55%), Positives = 251/352 (71%)

Query:   488 GDGDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL 546
             G+   KG   + + LP F   ++S AT++FS    LG GGFGPVYKGKL +GQE+AVKRL
Sbjct:   471 GENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRL 530

Query:   547 SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR 606
             S+ SGQG++EFKNE+ LIAKLQHRNLVRL+GCC++  E +LIYEYMPNKSL+FF+FD  R
Sbjct:   531 SANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERR 590

Query:   607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
             +  L W+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD+DMNPKISDFG+A+ F
Sbjct:   591 STELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSF 650

Query:   667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-S 725
              GD+ + +T RVVGTYGYM PEYA+DG FSVKSDVFSFGVL+LE +T K N G    +  
Sbjct:   651 GGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHD 710

Query:   726 FNLLGHAWNLWKDNRAYELLSPALQHEASY--QMLNRYITVALLCVQEKAADRPTMSKVV 783
              NLLGH W +W ++R  E+       E S   ++L R I VALLCVQ+K  DRPTM+ VV
Sbjct:   711 LNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVL-RCIHVALLCVQQKPEDRPTMASVV 769

Query:   784 SMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
              M  ++ ++LP+P Q  F   R    IS   S R     S N V+++++  R
Sbjct:   770 LMFGSD-SSLPHPTQPGFFTNRNVPDISSSLSLR-----SQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1611 (572.2 bits), Expect = 1.4e-165, P = 1.4e-165
 Identities = 353/842 (41%), Positives = 507/842 (60%)

Query:    22 SLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVA 77
             S+A +TI     + DG   + LVS  + FELGFFSPG S +++LGIWY  + D  VVWVA
Sbjct:    23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82

Query:    78 NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVAQLLDTGNLVLRE 134
             NR +PI D + VL I N+GNLVLL+  +  +WSSN+        N V  + DTGN VL E
Sbjct:    83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSE 142

Query:   135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
                  T     +W+SF+ P+DT L  M +  + +TG      SWR+  DPSPGN++  ++
Sbjct:   143 -----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVD 197

Query:   195 IRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQKEDE---IIYRY 247
                 P + ++ G+  +   +G WN   F   P     T+YL+   +    DE   + + Y
Sbjct:   198 PSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTY 257

Query:   248 ESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTA 307
                   +L+  K+  +G  + L W+E    W  F + P++ C  Y  CG   +C +  + 
Sbjct:   258 VPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSN 317

Query:   308 N-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDIKLPYLVDVSLNE 361
               C C+ G++     N  W R C R     C     +  + F+    +KLP   ++  + 
Sbjct:   318 GICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDF-EIPEHN 374

Query:   362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
              ++ ++C   CL+NC+C AY  S V  GG GC++W  DL+D+++      G  +++R+ D
Sbjct:   375 LVDPEDCRERCLRNCSCNAY--SLV--GGIGCMIWNQDLVDLQQFEA--GGSSLHIRLAD 428

Query:   422 SEPGDKKLLWIFVIL-VLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVAT 480
             SE G+ +   I VI+ VL   +L G F    WR K K+  +     ++     + ++  T
Sbjct:   429 SEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNT-DTSVVVADLT 487

Query:   481 RTNEPSE---GDGDA--KGTR-RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 534
             ++ E +    G  D   +G     S LP FSL +++ AT +F  + +LG GGFGPVYKG 
Sbjct:   488 KSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGV 547

Query:   535 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594
             L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC E  EK+L+YEYMPN
Sbjct:   548 LEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPN 607

Query:   595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
             KSL+FFLFD ++  L+ W+ R  IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MN
Sbjct:   608 KSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMN 667

Query:   655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS 714
             PKISDFGMAR+F G++ + NT RVVGTYGYMSPEYA++GLFSVKSDV+SFGVLLLE ++ 
Sbjct:   668 PKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSG 727

Query:   715 KRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA 774
             KRNT +   E  +L+G+AW L+   R+ EL+ P ++   S +   R I VA+LCVQ+ AA
Sbjct:   728 KRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAA 787

Query:   775 DRPTMSKVVSMITNEHATLPYPKQSAFSYARRGE-KISFLPSSRVSEACSVNGVTLSLIS 833
             +RP M+ V+ M+ ++ ATL  P+Q  F+  RR    ++F   S      S N +T +++ 
Sbjct:   788 ERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVL 847

Query:   834 PR 835
              R
Sbjct:   848 GR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1486 (528.2 bits), Expect = 2.5e-152, P = 2.5e-152
 Identities = 340/841 (40%), Positives = 492/841 (58%)

Query:    21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANR 79
             L LATD IT ++   D E +VS+   F  GFFSP  S  +Y GIW+  +P  TVVWVAN 
Sbjct:    18 LCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANS 77

Query:    80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVK-NPV-AQLLDTGNLVLREKFS 137
             NSPI DS+ +++I   GNLV+++    + WS+N+   V  N   A+LL+TGNLVL    +
Sbjct:    78 NSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLG--T 135

Query:   138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
             +NT +   LW+SF+ P +  L  M++  D KTGR   L SW++  DPSPG ++  L    
Sbjct:   136 TNTGD-EILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLP 194

Query:   198 LPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSY---LFRPIVEQKEDEIIYRYESYSSRI 254
              P L ++   + +  +GPWNG  F   P N  Y   LF   +       +    SY+   
Sbjct:   195 FPELVVWKDDLLMWRSGPWNGQYFIGLP-NMDYRINLFELTLSSDNRGSVSM--SYAGNT 251

Query:   255 LMM-LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD--DTANCEC 311
             L+    ++  G V +  W+     W+ +   P+  C  Y  CG  + C  +   T  C C
Sbjct:   252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311

Query:   312 LKGFKLKLQ---NNQTWPRECVRSHSSDCITRER---------FIKFDDIKLPYLVDVSL 359
             ++GFK +     NN  W + CVR     C +R+          F++   +K+P+    S 
Sbjct:   312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRS- 370

Query:   360 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRV 419
                 N ++C   CLKNC+C AY+  +    G GCL+W G+L+D+++ +G   G   Y+R+
Sbjct:   371 --GANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSG--TGVVFYIRL 422

Query:   420 PDSE--PGDKKLLWIFVILVLPAALLPGFFIFCRWR-RKHKEKETTMESSQDLLKFDIYM 476
              DSE      + + I V L++ A L  G  +   W+  KH+EK        + ++     
Sbjct:   423 ADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERME----- 477

Query:   477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL 536
               A  +N+            +   LP F    ++ AT NFS+  KLG+GGFG VYKG+L 
Sbjct:   478 --ALSSNDVG---AILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQ 532

Query:   537 NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596
              G ++AVKRLS  SGQG++EF NE+++I+KLQHRNLVRL+G C+E  E++L+YE+MP   
Sbjct:   533 EGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENC 592

Query:   597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656
             L+ +LFDP +  LL W+TR  II+GI +GL+YLH+ SRL+IIHRDLKASNILLD ++NPK
Sbjct:   593 LDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPK 652

Query:   657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
             ISDFG+AR+F G+E + +T RVVGTYGYM+PEYA+ GLFS KSDVFS GV+LLE ++ +R
Sbjct:   653 ISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRR 712

Query:   717 NTGVY-DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD 775
             N+  Y D ++ NL  +AW LW       L+ P +  E     + R + V LLCVQ+ A D
Sbjct:   713 NSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHAND 772

Query:   776 RPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEA-CSVNGVTLSLISP 834
             RP+++ V+ M+++E++ LP PKQ AF   RRG   S + SS  S+   S+N V+L+ I+ 
Sbjct:   773 RPSVATVIWMLSSENSNLPEPKQPAF-IPRRGT--SEVESSGQSDPRASINNVSLTKITG 829

Query:   835 R 835
             R
Sbjct:   830 R 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1480 (526.0 bits), Expect = 1.1e-151, P = 1.1e-151
 Identities = 340/844 (40%), Positives = 485/844 (57%)

Query:    17 LGSLLSLAT-DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQV-PDTVV 74
             L S +S +T ++ T    I +G+ L+S  + FELGFF+P  S  +Y+GIWYK + P TVV
Sbjct:    20 LCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVV 79

Query:    75 WVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLRE 134
             WVANR  P++D    L I ++GNLV++N  +  IWS+N+  E  N VA L  TG+LVL  
Sbjct:    80 WVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL-- 137

Query:   135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
                S++    + W+SF+ P+DT L GM +  +   G  R    W++  DPSPG ++  ++
Sbjct:   138 --CSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGID 195

Query:   195 IRVLPHLCIYNGSVKLSCTGPWNGLAFGADP-----TNTSYLFRPIVEQKEDEIIY-RYE 248
                   + I+ G  +   +GPWN   F   P     TN  Y F+       D  +Y  Y 
Sbjct:   196 PVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYV 255

Query:   249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD---D 305
             +  S   +   I P G  ++  W++    W +    P+  C+ Y  CG  SVC      D
Sbjct:   256 ASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFD 315

Query:   306 TANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCIT------RERFIKFDDIKLPYLVD 356
             +  C C+ GF+   Q   NN+ +   C R    +C         + F     IK+P    
Sbjct:   316 SGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGS 375

Query:   357 VSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIY 416
             V L+   N + C+  C ++C+C+AYA   V G   GC++W  DLID+        G  I 
Sbjct:   376 VVLHN--NSETCKDVCARDCSCKAYA--LVVG--IGCMIWTRDLIDMEHFE--RGGNSIN 427

Query:   417 VRVPDSEPGDKK---LLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD 473
             +R+  S+ G  K    LWI V  V+ A LL G  I+  W+ K K  +  +   +D+   D
Sbjct:   428 IRLAGSKLGGGKENSTLWIIVFSVIGAFLL-GLCIWILWKFK-KSLKAFLWKKKDITVSD 485

Query:   474 IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG 533
             I  +    ++      GD   T  D  LP FS  SV++AT +F+ + KLG+GGFG VYKG
Sbjct:   486 IIENRDYSSSPIKVLVGDQVDTP-D--LPIFSFDSVASATGDFAEENKLGQGGFGTVYKG 542

Query:   534 KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593
                 G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRL+GCC+E  EK+L+YEYMP
Sbjct:   543 NFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMP 602

Query:   594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653
             NKSL+ FLFD S+   L W+ R ++I GIA+GLLYLH+ SRL+IIHRDLKASNILLD++M
Sbjct:   603 NKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEM 662

Query:   654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             NPKISDFGMAR+F   +   NT RVVGTYGYM+PEYA++G+FS KSDV+SFGVL+LE ++
Sbjct:   663 NPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVS 722

Query:   714 SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKA 773
              ++N      +  +L+G+AW+LW   +  E++ P ++         R I V +LC Q+  
Sbjct:   723 GRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSV 782

Query:   774 ADRPTMSKVVSMITNEHATLPYPKQSAF-SYARRGE-KISFLPSSRVSEACSVNGVTLSL 831
               RP M  V+ M+ ++ + LP P+Q  F S+   G+ +++F       +  SVN VT + 
Sbjct:   783 IHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNF----DGHDVASVNDVTFTT 838

Query:   832 ISPR 835
             I  R
Sbjct:   839 IVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 4.6e-150, Sum P(2) = 4.6e-150
 Identities = 180/337 (53%), Positives = 238/337 (70%)

Query:   501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE 560
             L  F + ++  AT NFS+  KLG+GGFG VYKGKL +G+E+AVKRLSS SGQG +EF NE
Sbjct:   476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535

Query:   561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKII 619
             ++LI+KLQHRNLVR++GCC+E+ EK+LIYE+M NKSL+ FLFD SR  L + W  R  II
Sbjct:   536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFD-SRKRLEIDWPKRFDII 594

Query:   620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             +GIA+GLLYLH  SRLR+IHRDLK SNILLD  MNPKISDFG+ARM+ G E Q NT+RVV
Sbjct:   595 QGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV 654

Query:   680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV-YDIESFNLLGHAWNLWKD 738
             GT GYMSPEYA  G+FS KSD++SFGVL+LE ++ ++ +   Y +E   L+ +AW  W +
Sbjct:   655 GTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSE 714

Query:   739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQ 798
              R  +LL   L        + R I + LLCVQ + ADRP   ++++M+T   + LP PKQ
Sbjct:   715 YRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPKQ 773

Query:   799 SAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
               F++  R ++      S  ++  +VNG+T S+I  R
Sbjct:   774 PTFAFHTRDDE------SLSNDLITVNGMTQSVILGR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
 Identities = 359/862 (41%), Positives = 493/862 (57%)

Query:    25 TDTITPATLIGDGEKLVSSSQ-IFELGFFSPGKSK--YKYLGIWYKQV-PDTVVWVANRN 80
             TDT+     +     LVSS + +FE GFF+P   +   +YLGIWY  + P TVVWVANR 
Sbjct:    25 TDTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSRQYLGIWYHSISPRTVVWVANRV 84

Query:    81 SPIVDSNAVLTIGNNGNLVLLNQT--DG-----IIWSSNLSREVKNP----VAQLLDTGN 129
             +P   ++  LT+   G+L +L+ T  +G     ++WSSN +     P     A L DTG+
Sbjct:    85 APATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSSNTTSRA-GPRGGYSAVLQDTGS 143

Query:   130 LVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL--KTGRERYL-TSWRTADDPSP 186
             L +R       SE   LW SF  P+DT+L GM +      +  +ER L TSW +  DPSP
Sbjct:   144 LEVR-------SEDGVLWDSFWHPTDTILSGMRITLQAPGRGPKERMLFTSWASETDPSP 196

Query:   187 GNFTFRLEIRVLPHLCIY-NGSVKLSCTGPWNGLAFGADPTNTSYL--FRPIVEQKEDEI 243
             G +   L+        I+ +G+V    +G WNG+ F   P    Y   F P +    D +
Sbjct:   197 GRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPWRPLYRSGFTPAI----DPV 252

Query:   244 IYRYESYSSR--ILMMLKINPSG-DVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
             +  Y +Y++    L    + P+G D+  ++  + S  W++ +  P+N C+ Y  CG N+ 
Sbjct:   253 LGNYYTYTATNTSLQRFVVLPNGTDICYMV-RKSSQDWELVWYQPSNECEYYATCGPNAK 311

Query:   301 C--SVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRER---FIKFDDIKLP 352
             C  S D  A C CLKGF  KLQ   N   W + C+RS    C T +    F+   +IK P
Sbjct:   312 CTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWP 371

Query:   353 YLVDVSLNESMNLKE--CEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKI-TGY 409
                D S   S    E  C   CL NC+C AY  +  TG    CL W  +LID+ ++ TG 
Sbjct:   372 ---DFSYWVSTVGDEPGCRTVCLNNCSCGAYVYTATTG----CLAWGNELIDMHELQTG- 423

Query:   410 NNGQPIYVRVPDSEPGDKKLLW-------IFVILVLPAALLPGF--------FIFCRWRR 454
                  + +++P SE      +W         V+ VL A LL  +         +   WR 
Sbjct:   424 --AYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRS 481

Query:   455 KHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATE 514
             +H    ++ +S Q+    DI  S+  R ++  E DG      +   L  +SL  +  AT 
Sbjct:   482 RH----SSTQSQQNSAMLDISQSI--RFDDDVE-DG------KSHELKVYSLDRIRTATS 528

Query:   515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
             NFS   KLGEGGFGPVY G L  G+EVAVKRL   SGQGL+EFKNE++LIAKLQHRNLVR
Sbjct:   529 NFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVR 588

Query:   575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
             L+GCC+ + EKIL+YEYMPNKSL+ FLF+P +  LL W+ R  IIEGIA+GLLYLH+ SR
Sbjct:   589 LLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSR 648

Query:   635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
             LR++HRDLKASNILLD+DM PKISDFGMARMF GD+ Q NT RVVGT+GYMSPEYA++G+
Sbjct:   649 LRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGI 708

Query:   695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRAYELLSPALQHEA 753
             FSVKSDV+ FGVL+LE +T KR    +  E S N+ G+AW  W ++ A EL+ P ++   
Sbjct:   709 FSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASC 768

Query:   754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFL 813
             S + + R I +ALLCVQ+ A +RP +  V+ M++N+ ++LP P+        RG +I   
Sbjct:   769 SVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLML--RGREIESS 826

Query:   814 PSSRVSEACSVNGVTLSLISPR 835
              SS    + S+  VT++ +  R
Sbjct:   827 KSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S972	SD16_ARATH	2, ., 7, ., 1, 1, ., 1	0.4531	0.9532	0.9397	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	835
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-55
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-55
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-45
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	1e-39
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	9e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-31
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-29
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-28
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-27
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-26
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-26
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-25
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-25
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-22
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-20
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-18
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	1e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-08
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	8e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	7e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (489), Expect = 1e-55
 Identities = 97/281 (34%), Positives = 137/281 (48%), Gaps = 35/281 (12%)

Query: 517 SMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 570
           ++  KLGEG FG VYKG L         EVAVK L    S Q ++EF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+G C E+   +++ EYMP   L  +L   +R   L     +     IA+G+ YL 
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSP 687
                  IHRDL A N L+  ++  KISDFG++R    D    +  +V G      +M+P
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173

Query: 688 EYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 745
           E   +G F+ KSDV+SFGVLL E  TL  +   G+ + E    L          + Y L 
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK---------KGYRLP 224

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            P       Y+       + L C  E   DRPT S++V ++
Sbjct: 225 KPPNCPPELYK-------LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  191 bits (488), Expect = 1e-55
 Identities = 95/282 (33%), Positives = 131/282 (46%), Gaps = 38/282 (13%)

Query: 517 SMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 570
           ++  KLGEG FG VYKGKL         EVAVK L    S Q ++EF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+G C E+    ++ EYM    L  +L        L     +     IA+G+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSP 687
                  IHRDL A N L+  ++  KISDFG++R    D    +  R  G      +M+P
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWNLWKDNRAYEL 744
           E   +G F+ KSDV+SFGVLL E  T     G      + +  +L +   L    R   L
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLEY---LKNGYR---L 222

Query: 745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             P       Y        + L C  E   DRPT S++V ++
Sbjct: 223 PQPPNCPPELYD-------LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  183 bits (468), Expect = 1e-52
 Identities = 99/281 (35%), Positives = 137/281 (48%), Gaps = 34/281 (12%)

Query: 521 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 575
           KLGEG FG VYKGKL        EVAVK L    S +  K+F  E  ++ KL H N+VRL
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           +G C E+    L+ EYM    L  +L      F       L  +  +     IA+G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYGYMSPE 688
                 + +HRDL A N L+  D+  KISDFG++R ++  D  +  T   +    +M+PE
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177

Query: 689 YALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
              DG+F+ KSDV+SFGVLL E  TL +    G+ + E    L       K  R   L  
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------KGYR---LPK 228

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
           P    +  Y+++       L C Q    DRPT S++V  + 
Sbjct: 229 PEYCPDELYELM-------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 5e-51
 Identities = 75/193 (38%), Positives = 106/193 (54%), Gaps = 11/193 (5%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
           LGEGGFG VY  +    G++VA+K +  +    L E    E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            ++    L+ EY    SL   L +      L     ++I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 640 RDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSV 697
           RDLK  NILLDSD    K++DFG++++   D+    T   VGT  YM+PE  L  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173

Query: 698 KSDVFSFGVLLLE 710
           KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (454), Expect = 9e-51
 Identities = 92/283 (32%), Positives = 134/283 (47%), Gaps = 37/283 (13%)

Query: 516 FSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH 569
             +  KLGEG FG VYKG L         +VAVK L   +  +  +EF  E  ++ KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL+G C +     ++ EYMP   L  FL        L  +  +++   IA+G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRVVGTYGYMS 686
                   +HRDL A N L+  ++  KISDFG++R    D+    +G  K  +    +M+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWNLWKDNRAYE 743
           PE   DG F+ KSDV+SFGVLL E  T     G      + +  +L       +D   Y 
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLELL----EDG--YR 222

Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L  P    +  Y+++       L C      DRPT S++V  +
Sbjct: 223 LPRPENCPDELYELM-------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (421), Expect = 3e-46
 Identities = 76/200 (38%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLG G FG VYK K    G+ VAVK L   S+  +  +  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
              ++    L+ EY     L  +L         L      KI   I +GL YLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-F 695
           IIHRDLK  NILLD +   KI+DFG+A+     +   +    VGT  YM+PE  L G  +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 696 SVKSDVFSFGVLLLETLTSK 715
             K DV+S GV+L E LT K
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (416), Expect = 1e-45
 Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
           + +  KLGEG FG VY  +    G+ VA+K +  +  +  +E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           RL     ++ +  L+ EY     L   L                Q        I   L Y
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      I+HRDLK  NILLD D + K++DFG+AR     E        VGT  YM+PE
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S GV+L E LT K
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  141 bits (358), Expect = 1e-39
 Identities = 55/121 (45%), Positives = 74/121 (61%), Gaps = 7/121 (5%)

Query: 33  LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
            +  G+ LVSS  +FELGFF        Y  I YK    TVVWVANR++P   S+  LT+
Sbjct: 3   PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61

Query: 93  GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152
            ++GNLV+ + +  ++WSSN +R   N V  LLD GNLVL +      S+G++LWQSFD 
Sbjct: 62  QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD------SDGNFLWQSFDY 115

Query: 153 P 153
           P
Sbjct: 116 P 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  140 bits (356), Expect = 2e-39
 Identities = 54/116 (46%), Positives = 70/116 (60%), Gaps = 7/116 (6%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
             TVVWVANR +P+ DS+  L + ++GNLVL +    ++WSSN S +    VA L D GN
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60

Query: 130 LVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185
           LVL        + G  LWQSFD P+DTLL G   G ++  G  R LTSW++  DPS
Sbjct: 61  LVLY------DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 3e-38
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 520 CKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
             LG G FG VY       G+ +AVK   LS  S + L+  + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 577 GCCVEQGEK-ILIY-EYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           G   ++ +  + I+ EY+   SL      F             Q        I +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAYL 117

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H      I+HRD+K +NIL+DSD   K++DFG A+     E    T  V GT  +M+PE 
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
                +   +D++S G  ++E  T K 
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  130 bits (330), Expect = 9e-36
 Identities = 52/119 (43%), Positives = 73/119 (61%), Gaps = 8/119 (6%)

Query: 33  LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
            +  G+ LVS + +FELGFF+    +  Y  I YK    TVVWVANR++P V  +  LT+
Sbjct: 3   TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60

Query: 93  GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD 151
            ++GNLVL +    ++WSSN +    N V  LLD GNLV+ +      S+G++LWQSFD
Sbjct: 61  QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSFD 113

Length = 114

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 3e-35
 Identities = 77/207 (37%), Positives = 106/207 (51%), Gaps = 14/207 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+ G      +VAVK L   +    + F  E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64

Query: 574 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +L   C  + E I I  EYM   SL  FL       L      V +   IA+G+ YL   
Sbjct: 65  QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---QGNTKRVVGTYGYMSPEY 689
                IHRDL A NIL+  ++  KI+DFG+AR+   DE    +G    +  T    +PE 
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
           A  G F++KSDV+SFG+LL E +T  R
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  134 bits (340), Expect = 4e-35
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 521 KLGEGGFGPVYKGKLLN-----GQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           +LGEG FG V   +        G++VAVK L+ S   Q   +F+ E+ ++  L H N+V+
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 575 LMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
             G C + G +   LI EY+P+ SL  +L        +  +  +     I +G+ YL   
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEYA 690
              R IHRDL A NIL++S+   KISDFG+A++   D+             + Y +PE  
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
               FS  SDV+SFGV L E  T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 1e-34
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 11/204 (5%)

Query: 515 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G G FG VYKG  L  G  VA+K++S +    + LK    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+ +G         +I EY  N SL   +    +            +  + QGL YLH+
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                +IHRD+KA+NIL   D   K++DFG+A           +  VVGT  +M+PE   
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172

Query: 692 DGLFSVKSDVFSFGVLLLETLTSK 715
               S  SD++S G  ++E LT  
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  132 bits (333), Expect = 2e-34
 Identities = 84/274 (30%), Positives = 132/274 (48%), Gaps = 38/274 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E F+++ KLG G FG V++G   N   VA+K L S      ++F+ E+  + +L+H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDP-----SRTHLL--GWQTRVKIIEGIAQGL 626
            L   C       +I E M   SL  FL  P         L+    Q        +A+G+
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            YL +      IHRDL A NIL+  D+  K++DFG+AR+   D    + K++   Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYEL 744
           PE A  G FS KSDV+SFG+LL E  T  +    G+ + E ++ +            Y +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---------TAGYRM 223

Query: 745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPT 778
             PA   +  Y+++       L C   +  DRP+
Sbjct: 224 PCPAKCPQEIYKIM-------LECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+G+GGFG VYK +    G+EVA+K +  +S +  ++  NE+ ++ K +H N+V+  G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
           +++ E  ++ E+    SL   L   S    L       + + + +GL YLH      IIH
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           RD+KA+NILL SD   K+ DFG++              +VGT  +M+PE      +  K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 700 DVFSFGVLLLE 710
           D++S G+  +E
Sbjct: 179 DIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (322), Expect = 9e-33
 Identities = 71/214 (33%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 522 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVR 574
           LGEG FG V+ G+  + +       VAVK L   +    ++ F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQTRVKIIEGIA 623
             G C E    I+++EYM +  LN FL              S    L     ++I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-- 681
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R    D    +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 682 --YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
               +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (311), Expect = 2e-31
 Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 50/282 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 571
            +      LG+G  G VYK +    G+  A+K++      +  K+   E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IA 623
           +V+  G   ++GE  ++ EYM   SL   L           +   KI E         I 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQIL 109

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +GL YLH   +  IIHRD+K SN+L++S    KI+DFG+++    +         VGT  
Sbjct: 110 KGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVT 165

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE 743
           YMSPE      +S  +D++S G+ LLE        G +                     E
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECA-----LGKFPFLPPGQPSFF----------E 210

Query: 744 LL-------SPALQHEASYQMLNRYITVALLCVQEKAADRPT 778
           L+        P+L  E        +I+    C+Q+    RP+
Sbjct: 211 LMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (317), Expect = 2e-31
 Identities = 79/301 (26%), Positives = 124/301 (41%), Gaps = 20/301 (6%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-R 570
           ++ +  KLGEG FG VY  +  + + VA+K L+ +     + ++ F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L     ++G   L+ EY+   SL   L    R   L     + I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 631 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGD----ELQGNTKRVVGTYGYM 685
                 IIHRD+K  NILLD D    K+ DFG+A++         +       VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 686 SPEYALDGLF---SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
           +PE  L       S  SD++S G+ L E LT          ++ +       +       
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIIL-ELPT 232

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFS 802
             L+  L       +      +    + +   +R + S  +S     H  L     S   
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292

Query: 803 Y 803
            
Sbjct: 293 K 293

Length = 384

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  123 bits (311), Expect = 3e-31
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 25/210 (11%)

Query: 522 LGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           LGEG FG VYKG+L   N +     VA+K L  +   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLF-------------DPSRTHLLGWQTRVKIIEG 621
           L+G C ++    +++EY+ +  L+ FL              D +    L     + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVG 680
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R ++  D  +  +K ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
              +M PE  L G F+ +SD++SFGV+L E
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 85/275 (30%), Positives = 119/275 (43%), Gaps = 39/275 (14%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           LG G FG V+ GK     +VA+K +   +     +F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641
           Q    ++ EYM N  L  +L    R   LG +  + +   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 642 LKASNILLDSDMNPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           L A N L+  D   K+SDFG+AR    D+      TK  V    +  PE      FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182

Query: 700 DVFSFGVLLLETLT-------SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
           DV+SFGVL+ E  +          N+ V +  S                Y L  P L   
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS--------------AGYRLYRPKLAPT 228

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
             Y ++         C  EK  DRP   K++S +T
Sbjct: 229 EVYTIMY-------SCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  122 bits (309), Expect = 6e-31
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 33/203 (16%)

Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           K+GEG  G VYK      G+EVA+K  RL  Q+ + +    NE++++   +H N+V    
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA-------QGLLYL 629
             +   E  ++ EYM   SL         T ++  Q  V++ E  IA       QGL YL
Sbjct: 83  SYLVGDELWVVMEYMDGGSL---------TDII-TQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSP 687
           H      +IHRD+K+ NILL  D + K++DFG    F     +  +KR  VVGT  +M+P
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 688 EYALDGLFSVKSDVFSFGVLLLE 710
           E      +  K D++S G++ +E
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  120 bits (301), Expect = 3e-30
 Identities = 76/266 (28%), Positives = 132/266 (49%), Gaps = 27/266 (10%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  L  ++VA+K +  +     ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           E+    L++E+M +  L+ +L   ++      +T + +   + +G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSDV+SFGVL+ E  +  +    Y+  S     ++  +   N  + L  P L  ++ Y++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTP--YENRS-----NSEVVETINAGFRLYKPRLASQSVYEL 233

Query: 758 LNRYITVALLCVQEKAADRPTMSKVV 783
           +         C +E+  DRP+ S ++
Sbjct: 234 MQH-------CWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  119 bits (301), Expect = 5e-30
 Identities = 84/299 (28%), Positives = 126/299 (42%), Gaps = 45/299 (15%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKGKL--LNG----QEVAVKRL-SSQSGQGLKEFKNEMM 562
               ++ ++   LG G FG VY+G     +G     +VAVK L  S S Q   +F  E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKI 618
           +++K  H+N+VRL+G   E+  + ++ E M    L  FL +    P R   L  +  +  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNT 675
              +A+G  YL +      IHRD+ A N LL         KI+DFGMAR           
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL-------TSKRNTGVYDIESFNL 728
            R +    +M PE  LDG+F+ K+DV+SFGVLL E           + N  V +  +   
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT--- 235

Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
                          L  P       Y+++         C Q    DRP  + ++  I 
Sbjct: 236 -----------GGGRLDPPKGCPGPVYRIMTD-------CWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  118 bits (297), Expect = 1e-29
 Identities = 91/269 (33%), Positives = 129/269 (47%), Gaps = 29/269 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  KLG G FG V+ G      +VA+K L   S    + F  E  L+ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  P     L     + +   IA+G+ ++    
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE--- 119

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R   IHRDL+A+NIL+   +  KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 176

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E         NL    R Y +  P  
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ------NL---ERGYRMPRPDN 227

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPT 778
             E  Y+++         C +EK  +RPT
Sbjct: 228 CPEELYELMRL-------CWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 1e-29
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           ++G+G FG VY  +   +G+   +K   LS+ S +  ++  NE+ ++ KL H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 578 CCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 632
              E+G+  ++ EY     L+  +                 +I++   Q    L YLH  
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF----PEEQILDWFVQLCLALKYLH-- 120

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           SR +I+HRD+K  NI L S+   K+ DFG++++         T  VVGT  Y+SPE   +
Sbjct: 121 SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQN 177

Query: 693 GLFSVKSDVFSFGVLLLETLTSKR 716
             ++ KSD++S G +L E  T K 
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 2e-29
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQH 569
           +    ++GEG +G VYK +    G+ VA+K++  ++    KE        E+ L+ KL+H
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57

Query: 570 RNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 621
            N+VRL        +G   +++EYM +  L   L  P           VK  E       
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE----------VKFTESQIKCYM 106

Query: 622 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + +GL YLH      I+HRD+K SNIL+++D   K++DFG+AR +        T RV+
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 680 GTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
            T  Y  PE  L    +  + D++S G +L E    K
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 522 LGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG            VA+K L  ++  +  KE  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLH 630
           +G C+    ++ LI + MP   L  ++ +        +LL W  +      IA+G+ YL 
Sbjct: 75  LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +    R++HRDL A N+L+ +  + KI+DFG+A++   DE + + +       +M+ E  
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
           L  +++ KSDV+S+GV + E +T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 6e-29
 Identities = 86/281 (30%), Positives = 120/281 (42%), Gaps = 43/281 (15%)

Query: 522 LGEGGFGPVYKGKLL--NGQE--VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           LG G FG V KG  L  +G+E  VAVK L       G KEF  E  ++A+L H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIAQGLLYLHQYS 633
           G C  +   +L+ E  P   L  +L          L     +V      A G+ YL    
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-- 113

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARM--FCGDELQGNT--KRVVGTYGYMSPEY 689
               +HRDL A N+LL +    KISDFGM+R      D  +  T  +  +  Y   +PE 
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169

Query: 690 ALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
              G FS KSDV+S+GV L E  +  +K    +   E   +L              L  P
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---------GERLPRP 220

Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               +  Y ++         C + +  DRPT S++ S    
Sbjct: 221 EECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  116 bits (291), Expect = 8e-29
 Identities = 75/210 (35%), Positives = 108/210 (51%), Gaps = 22/210 (10%)

Query: 522 LGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLV 573
           LG G FG VY+G   +          VAVK L   +  Q  KEF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           +L+G C+    + +I E M    L  +L D         LL  +  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 630 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYG 683
            Q   +  IHRDL A N L+     D+D   KI DFG+AR ++  D  +   + ++    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +M+PE  LDG F+ +SDV+SFGVL+ E LT
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG V  G    GQ+VAVK L   S    + F  E  ++  L+H NLV+L+G  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641
                ++ EYM   SL  +L    R  ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 642 LKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDGLFSVKS 699
           L A N+L+  D+  K+SDFG+A+    +  QG      G     + +PE   +  FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180

Query: 700 DVFSFGVLLLETLTSKRN 717
           DV+SFG+LL E  +  R 
Sbjct: 181 DVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 3e-28
 Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 32/267 (11%)

Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           +  KLG G FG V++G   N   VAVK L   +    K+F  E  ++ KL+H  L++L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 578 CCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
            C    E I I  E M   SL  +L   +   L      + +   +A G+ YL   +   
Sbjct: 69  VCT-LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN--- 123

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDG 693
            IHRDL A N+L+  +   K++DFG+AR+   D  +       G      + +PE AL  
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179

Query: 694 LFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            FS+KSDV+SFG+LL E +T  R    G+ + E          L + ++ Y +  P    
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---------LQQVDQGYRMPCPPGCP 230

Query: 752 EASYQMLNRYITVALLCVQEKAADRPT 778
           +  Y ++       L C +E   DRPT
Sbjct: 231 KELYDIM-------LDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  112 bits (281), Expect = 1e-27
 Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 35/273 (12%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYL--HQYSRLR 636
           +Q    ++ EYM N  L  +L    R H   +Q    +++ + + +G+ YL   Q+    
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESKQF---- 121

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDG 693
            IHRDL A N L+D     K+SDFG++R    DE   +    VG+     +  PE  L  
Sbjct: 122 -IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYS 176

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS KSDV++FGVL+ E  +  +         +    ++  + K ++   L  P L  E 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK-------MPYERFNNSETVEKVSQGLRLYRPHLASEK 229

Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            Y ++         C  EKA +RPT  +++S I
Sbjct: 230 VYAIMYS-------CWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 24/265 (9%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
           K+G+G FG VYKG L    EVAVK   S     LK  F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
           V++    ++ E +P  SL  FL        L  +  +++    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPEYALDGLFSV 697
           RDL A N L+  +   KISDFGM+R   G    +    K++     + +PE    G ++ 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174

Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           +SDV+S+G+LL ET +            +  + +     +    Y + +P L  E  Y++
Sbjct: 175 ESDVWSYGILLWETFS-------LGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRL 227

Query: 758 LNRYITVALLCVQEKAADRPTMSKV 782
           +         C      +RP+ S++
Sbjct: 228 ML-------QCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (279), Expect = 5e-27
 Identities = 79/205 (38%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 518 MQCKLGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRN 571
               LGEG FG V  Y     N   G+ VAVK L  + GQ     +K E+ ++  L H N
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 572 LVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           +V+  GCC EQG K   LI EY+P  SL  +L  P   H L     +   + I +G+ YL
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PK--HKLNLAQLLLFAQQICEGMAYL 123

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-CGDELQGNTKRVVGTYGYMSPE 688
           H       IHRDL A N+LLD+D   KI DFG+A+    G E     +       + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT 713
              +  FS  SDV+SFGV L E LT
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 85/287 (29%), Positives = 138/287 (48%), Gaps = 42/287 (14%)

Query: 522 LGEGGFGPVYKGKL----LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V +G+L     +  +VAVK  +L   +   ++EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 576 MGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHL----LGWQTRVKIIEGIAQG 625
           +G C E          ++I  +M +  L+ FL   SR       L  QT +K +  IA G
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL-QGNTKRVVGTYG 683
           + YL   S    IHRDL A N +L  DM   ++DFG+++ ++ GD   QG   ++     
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 180

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRA 741
           +++ E   D +++ KSDV++FGV + E  T  +    GV + E ++ L H       NR 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------NR- 233

Query: 742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             L  P    +  Y ++         C +    DRPT +K+  ++ N
Sbjct: 234 --LKQPEDCLDELYDLMYS-------CWRADPKDRPTFTKLREVLEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  109 bits (274), Expect = 2e-26
 Identities = 83/284 (29%), Positives = 121/284 (42%), Gaps = 38/284 (13%)

Query: 522 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVR 574
           LG G FG V+  K    +E      V VK L     +    EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           L+G C E     +I EY     L  FL       +  +   L  + +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMS 686
           L   S  R +HRDL A N L+ S    K+S   +++     E     N    +    +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---WLA 186

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYEL 744
           PE   +  FS KSDV+SFGVL+ E  T       G+ D E  N L             EL
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------AGKLEL 238

Query: 745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             P       Y+++ R       C      DRP+ S++VS +  
Sbjct: 239 PVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  109 bits (274), Expect = 3e-26
 Identities = 84/288 (29%), Positives = 128/288 (44%), Gaps = 43/288 (14%)

Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRL-SSQSGQGLKEFKNEMM 562
           KLGEG FG V+  +    Q+                 VAVK L    S    ++F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 614
           ++++L   N+ RL+G C       +I EYM N  LN FL             +  L + T
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 671
            + +   IA G+ YL     L  +HRDL   N L+  +   KI+DFGM+R ++  D   +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 731
           QG   R      +M+ E  L G F+ KSDV++FGV L E LT  R      +    ++ +
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245

Query: 732 AWNLWKDNRAYELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPT 778
           A + ++D+     L  P    +  Y+++         C +    DRPT
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLE-------CWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 26/205 (12%)

Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V +G+L L G++   VA+K L + S    + +F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 634
           G   +    ++I EYM N SL+ FL    R +         V ++ GIA G+ YL   S 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASGMKYL---SE 124

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 688
           +  +HRDL A NIL++S++  K+SDFG++R         +++    T G      + +PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPIRWTAPE 178

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT 713
                 F+  SDV+SFG+++ E ++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 71/204 (34%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKR-----LSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+G FG VY    ++ G+E+AVK+      S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 576 MGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQY 632
            GC +   E + I+ EYMP  S+     D  + +  L    TR K    I +G+ YLH  
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTR-KYTRQILEGVEYLH-- 121

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYMSPEYAL 691
               I+HRD+K +NIL DS  N K+ DFG ++        G   K V GT  +MSPE   
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 692 DGLFSVKSDVFSFGVLLLETLTSK 715
              +  K+DV+S G  ++E LT K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  108 bits (272), Expect = 4e-26
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 33/210 (15%)

Query: 522 LGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 577 GCCVEQGEK--ILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           G C   G +   L+ EY+P  SL  +L       D  +  L   Q        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG----- 683
           L      R +HRDL   NIL++S+   KI DFG+ ++   D+        V   G     
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESPIF 176

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +PE   +  FSV SDV+SFGV+L E  T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-26
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 57/300 (19%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLK-EFKNEMMLIAK 566
           E  ++  +LG+G FG VY+G             VA+K ++  +    + EF NE  ++ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYM-------------PNKSLNFFLFDPSRTHLLGWQ 613
               ++VRL+G        +++ E M             P    N  L  P+    +   
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQ 672
                   IA G+ YL      + +HRDL A N ++  D+  KI DFGM R ++  D  +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176

Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLG 730
              K ++    +M+PE   DG+F+ KSDV+SFGV+L E  TL  +   G+ + E    + 
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235

Query: 731 HAWNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +L       ++  EL+                     +C Q     RPT  ++VS +
Sbjct: 236 DGGHLDLPENCPDKLLELMR--------------------MCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  107 bits (270), Expect = 5e-26
 Identities = 89/276 (32%), Positives = 116/276 (42%), Gaps = 32/276 (11%)

Query: 521 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
           KLG+G FG V +G+          VAVK L S      + +F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG---WQTRVKIIEGIAQGLLYLHQY 632
            G  V     +++ E  P  SL   L   +  H L        V+I    A G+ YL   
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYMSPEYA 690
              R IHRDL A NILL SD   KI DFG+ R      D         V  + + +PE  
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
               FS  SDV+ FGV L E  T       Y  E +  L  +  L K ++  E L    +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLE---R 222

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            EA  Q       V L C     ADRPT + +   +
Sbjct: 223 PEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  107 bits (268), Expect = 6e-26
 Identities = 89/280 (31%), Positives = 141/280 (50%), Gaps = 31/280 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 572
           E+  +  KLG+G FG V+ G      +VA+K L  + G  + E F  E  ++ KL+H  L
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V L     E+   I + E+M   SL  FL +    +L   Q  V +   IA G+ Y+   
Sbjct: 64  VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 690
            R+  IHRDL+A+NIL+  ++  KI+DFG+AR+   +E    T R    +   + +PE A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 175

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
           L G F++KSDV+SFG+LL E +T  R    G+ + E          L +  R Y +  P 
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---------LEQVERGYRMPCPQ 226

Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
              E+ ++++        LC ++   +RPT   + S + +
Sbjct: 227 GCPESLHELMK-------LCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  107 bits (268), Expect = 1e-25
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 31/216 (14%)

Query: 522 LGEGGFGPVYKGK---LLNGQE---VAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVR 574
           +G+G FG V++ +   LL  +    VAVK L  + S     +F+ E  L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------------LGWQTR 615
           L+G C       L++EYM    LN FL   S                       L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGN 674
           + I + +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R ++  D  + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
               +    +M PE      ++ +SDV+++GV+L E
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWE 224

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (265), Expect = 2e-25
 Identities = 85/277 (30%), Positives = 132/277 (47%), Gaps = 28/277 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL     ++    +I EYM   SL  FL       +L     +     IA+G+ Y+    
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 177

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  +    G+ + +  + L          R Y +     
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---------QRGYRMPRMEN 228

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             +  Y ++         C +EKA +RPT   + S++
Sbjct: 229 CPDELYDIMK-------TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (266), Expect = 2e-25
 Identities = 72/218 (33%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 518 MQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQH++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----------------LLGWQTR 615
           +VR  G C E    ++++EYM +  LN FL    R+H                 L     
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFL----RSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           + I   IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +     
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            R +    +M PE  L   F+ +SD++SFGV+L E  T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  106 bits (267), Expect = 2e-25
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 35/295 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL 567
           +  ++   L EG FG ++ G L++      +EV VK +   + +  +     E  L+  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 568 QHRNLVRLMGCCVEQGEK-ILIYEYMPNKSLNFFLFDPS-----RTHLLGWQTRVKIIEG 621
            H+N++ ++  C+E GE   ++Y YM   +L  FL             L  Q  V +   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE--LQGNTKRV 678
           IA G+ YLH   +  +IH+D+ A N ++D ++  KI+D  ++R +F  D   L  N  R 
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 738
           V    +M+ E  ++  +S  SDV+SFGVLL E L +   T   +I+ F +        KD
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEM----AAYLKD 234

Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              Y L  P           +    V   C      +RP+ S++V  +T+ HA L
Sbjct: 235 --GYRLAQP-------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  105 bits (264), Expect = 2e-25
 Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 29/269 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 65  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P  
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPE 227

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPT 778
             E+ + ++         C +++  +RPT
Sbjct: 228 CPESLHDLM-------CQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (264), Expect = 2e-25
 Identities = 82/267 (30%), Positives = 132/267 (49%), Gaps = 36/267 (13%)

Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLS----SQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VY+G  L +G   AVK +S     Q+GQ  +K+ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 576 MGCCVEQGEKILIY-EYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +G    + + + I+ E +P  SL   L  +      ++   TR      I  GL YLH  
Sbjct: 68  LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
            R   +HRD+K +NIL+D++   K++DFGMA+           K   G+  +M+PE    
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 693 -GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            G + + +D++S G  +LE  T K      +  +         ++K  R+ EL  P +  
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--------VFKIGRSKEL--PPIPD 225

Query: 752 EASYQMLNRYITVALLCVQEKAADRPT 778
             S +  + +I   L C+Q   + RPT
Sbjct: 226 HLSDEAKD-FI---LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (265), Expect = 2e-25
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E F +  KLGEG +G VYK      GQ VA+K +  +    L+E   E+ ++ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+  G   +  +  ++ EY    S++  +   ++T  L  +    I+    +GL YLH  
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHS- 117

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
              + IHRD+KA NILL+ +   K++DFG++        + NT  V+GT  +M+PE   +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173

Query: 693 GLFSVKSDVFSFGVLLLE 710
             ++ K+D++S G+  +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  106 bits (266), Expect = 4e-25
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 46/295 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +  ++   LGEG FG V K + +          VAVK L    + + L +  +EM ++  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHL--LGW 612
           + +H+N++ L+G C ++G   ++ EY  + +L  FL            D  R     L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL 671
           +  V     +A+G+ +L      + IHRDL A N+L+  D   KI+DFG+AR +   D  
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 672 QGNTK-RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 728
           +  T  R+     +M+PE   D +++ +SDV+SFGVLL E  TL      G+   E F L
Sbjct: 189 RKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           L            Y +  P    +  Y ++         C  E  + RPT  ++V
Sbjct: 247 L---------KEGYRMEKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 4e-25
 Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)

Query: 515 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
           +F +  K+G+G FG V+K  +  + +  A+K+  LS  + +  +E  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---LGWQTRVKIIEGIAQGLLY 628
           ++R     +++G+  ++ EY  N  L+  L       L     W+  ++I+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH     +I+HRD+K+ N+ LD+  N KI D G+A++   +    NT  +VGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
              D  ++ KSDV++ GV+L E  T K
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  105 bits (264), Expect = 5e-25
 Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 43/297 (14%)

Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 562
           KLGEG FG V+  +    ++                 VAVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 614
           ++++L+  N++RL+  C+      +I EYM N  LN FL         + +    + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 671
            + +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFGM+R ++ GD   +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 731
           QG   R V    +MS E  L G F+  SDV++FGV L E LT  +      +    ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Query: 732 AWNLWKD-NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
               ++D  R   L  PAL  ++ Y+++       L C +  A +RP+  ++ + + 
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (262), Expect = 6e-25
 Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 20/197 (10%)

Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLM 576
           +LG G  G V K      G+ +AVK +  +        K  +    ++ K     +V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           G     G+  +  EYM   SL+  L          +LG     KI   + +GL YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           + +IIHRD+K SNIL++S    K+ DFG++            K  VGT  YM+PE     
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGN 174

Query: 694 LFSVKSDVFSFGVLLLE 710
            +SVKSD++S G+ L+E
Sbjct: 175 DYSVKSDIWSLGLSLIE 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  104 bits (260), Expect = 9e-25
 Identities = 82/273 (30%), Positives = 121/273 (44%), Gaps = 33/273 (12%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V+ GK     +VA+K ++ +     ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    ++ E+M N  L  +L    R   L     + + + + +G+ YL + S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPEYALDGL 694
           DL A N L+ S    K+SDFGM R    DE          + G      +  PE      
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177

Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           +S KSDV+SFGVL+ E  T     G    E  +       + +  R Y    P L     
Sbjct: 178 YSSKSDVWSFGVLMWEVFTE----GKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTV 230

Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
           Y+       V   C  EK   RPT ++++  IT
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (260), Expect = 1e-24
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 517 SMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +M+ KLG G +G VY+G        VAVK L   +   ++EF  E  ++ +++H NLV+L
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C  +    +I E+M   +L  +L + +R   +     + +   I+  + YL + +  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALDG 693
             IHRDL A N L+  +   K++DFG++R+  GD        K  +    + +PE     
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180

Query: 694 LFSVKSDVFSFGVLLLETLT 713
            FS+KSDV++FGVLL E  T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  105 bits (262), Expect = 1e-24
 Identities = 88/308 (28%), Positives = 145/308 (47%), Gaps = 57/308 (18%)

Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 562
           KLGEG FG V+  +++N Q+                 VAVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL------------ 610
           ++++L+  N++RL+G CV++    +I EYM N  LN FL   S  HL             
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 611 -------GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
                   + + + +   IA G+ YL   S L  +HRDL   N L+  ++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 664 R-MFCGD--ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV 720
           R ++ GD   +QG   R V    +M+ E  L G F+  SDV++FGV L E L   +    
Sbjct: 186 RNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 721 YDIESFNLLGHAWNLWKDN-RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM 779
            ++    ++ +A   ++D  R   L  P    +  Y+++       L C      +RP+ 
Sbjct: 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSF 295

Query: 780 SKVVSMIT 787
           S + + +T
Sbjct: 296 SDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (259), Expect = 1e-24
 Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
             E+  +  KLG G FG V+ G      +VAVK L   +    + F  E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           LV+L     E+   I + EYM   SL  FL D      L     V +   +A G+ Y+  
Sbjct: 63  LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEY 689
             R+  IHRDL+++NIL+   +  KI+DFG+AR+   +E    T R    +   + +PE 
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEA 174

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
           AL G F++KSDV+SFG+LL E +T  R
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +  + G+  A+K L  +     KE      E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 578 CCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
              +  EK+ L+ EY P   L   L     F   R      +        I   L YLH 
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE--------IVLALEYLH- 110

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
              L II+RDLK  NILLD+D + K++DFG+A+    +  + NT    GT  Y++PE  L
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              +    D +S GVLL E LT
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (255), Expect = 4e-24
 Identities = 72/196 (36%), Positives = 105/196 (53%), Gaps = 13/196 (6%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
            +GEG FG V +G+   GQ+VAVK +        + F  E  ++ KL H+NLVRL+G  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
             G  I++ E M   +L  FL    R  L+     ++    +A+G+ YL      +++HR
Sbjct: 70  HNGLYIVM-ELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124

Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A NIL+  D   K+SDFG+AR+  G     N+K  V    + +PE      FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKSD 179

Query: 701 VFSFGVLLLETLTSKR 716
           V+S+GVLL E  +  R
Sbjct: 180 VWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (255), Expect = 7e-24
 Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 53/229 (23%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 574
           +GEG F  V   K     +E A+K L  +  Q +KE K      E  ++ +L  H  +++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 575 LMGCCVEQGEKILIYEYMPN----------KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           L     ++     + EY PN           SL+              +        I  
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-------------KCTRFYAAEILL 113

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------ 678
            L YLH      IIHRDLK  NILLD DM+ KI+DFG A++   +    + K        
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 679 ------------VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
                       VGT  Y+SPE   +      SD+++ G ++ + LT K
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  102 bits (254), Expect = 8e-24
 Identities = 73/216 (33%), Positives = 114/216 (52%), Gaps = 29/216 (13%)

Query: 521 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
           +LGE  FG VYKG L         Q VA+K L  ++   L+E FK+E M+ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 620
            L+G   ++    +I+ Y  +  L+ FL            D  +T    L     V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 677
            IA G+ +L   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            +    +MSPE  + G FS+ SD++S+GV+L E  +
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 2e-23
 Identities = 80/280 (28%), Positives = 140/280 (50%), Gaps = 43/280 (15%)

Query: 522 LGEGGFGPVYKG--KLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM 576
           +G G FG V++G  K+   +EVAV   + + G   K+   F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           G   +    ++I EYM N +L+ +L D     S   L+G      ++ GIA G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMS 686
           S +  +HRDL A NIL++S++  K+SDFG++R+     L+ + +    T G      + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTA 178

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+SFG+++ E ++       +D+ +  ++         N  + L +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-YWDMSNHEVMKAI------NDGFRLPA 231

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+  A RP    +V+++
Sbjct: 232 PMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (251), Expect = 2e-23
 Identities = 72/220 (32%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 521 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-----------------LLGWQTRVK 617
             G C +    I+++EYM +  LN FL    R H                  LG    + 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFL----RAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R    D    +  R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR 180

Query: 678 VVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           V G       +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  100 bits (250), Expect = 2e-23
 Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 35/223 (15%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           N  ++ +LGEG FG V+  +  N    Q+   VAVK L   S    K+F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--------------LLGWQT 614
           H ++V+  G CVE    I+++EYM +  LN FL    R H               L    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL----RAHGPDAVLMAEGNRPAELTQSQ 121

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
            + I + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTD 174

Query: 675 TKRVVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             RV G       +M PE  +   F+ +SDV+S GV+L E  T
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 49/277 (17%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           LG G F   Y+ + +  G  +AVK+++      S+  + ++  + E+ L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           ++G   E     L  E+M   S++  L  +   +  ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 633 SRLRIIHRDLKASNILLDSD-MNPKISDFGMA-RMFC----GDELQGNTKRVVGTYGYMS 686
              +IIHRD+K +N+L+DS     +I+DFG A R+        E QG   +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY---- 742
           PE      +    DV+S G +++E  T+K         +     H   ++K   A     
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIASATTAPS 231

Query: 743 --ELLSPALQHEASYQMLNRYITVALLCVQEKAADRP 777
             E LSP L+             V L C++ +  DRP
Sbjct: 232 IPEHLSPGLR------------DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 86/278 (30%), Positives = 138/278 (49%), Gaps = 37/278 (13%)

Query: 522 LGEGGFGPVYKGKLL--NGQEV--AVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G+G FG VY G L+  +GQ++  AVK L+  +  + +++F  E +++    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 577 GCCV-EQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+   +       L+G+  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
               + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D++SF++  +   L +  R   LL P 
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY---LLQGRR---LLQPE 225

Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +  Y+       V L C   K   RPT S++VS I
Sbjct: 226 YCPDPLYE-------VMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 5e-23
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 28/207 (13%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL-SSQSGQGLKEFKN---EMMLIAKLQHRNLVRL 575
           KLGEG +G VYK +    G+ VA+K++      +G+        E+ L+ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63

Query: 576 MGCCVEQGEKI-LIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           +        K+ L++EY     K           P+    + +Q        + +GL Y 
Sbjct: 64  LDVIH-TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H +   RI+HRDLK  NIL++ D   K++DFG+AR F G  L+  T  VV T  Y +PE 
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEI 169

Query: 690 AL-DGLFSVKSDVFSFGVLLLETLTSK 715
            L    +S   D++S G +  E +T K
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGL-KEFKNEMMLIAKLQHRN 571
           E      +LGEG  G V K +L N   + A+K +++     L K+   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 572 LVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLY 628
           +V+  G  ++       +  EY    SL+        R   +G +   KI E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH     +IIHRD+K SNILL      K+ DFG++    G+ +        GT  YM+PE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPE 173

Query: 689 YALDGLFSVKSDVFSFGVLLLE 710
                 +S+ SDV+S G+ LLE
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.4 bits (245), Expect = 9e-23
 Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 32/214 (14%)

Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQG-------LKEFKNEMMLIAKLQHRN 571
           +G G FG VY G    +G+ +AVK+  L S S          L     E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVK-IIEGIAQG 625
           +V+ +G  ++     +  EY+P  S+     N+  F+         +T V+  +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---------ETLVRNFVRQILKG 118

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKR--VVGT 681
           L YLH  +R  IIHRD+K +NIL+D+    KISDFG+++    + L    N  R  + G+
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             +M+PE      ++ K+D++S G L++E LT K
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 99.4 bits (247), Expect = 9e-23
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)

Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 696 SVKSDVFSFGVLLLETLT 713
           + +SDV+S+GV + E +T
Sbjct: 189 THQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN-----EMMLIAKLQ 568
            +    KLGEG +  VYK +    G+ VA+K++     +  K+  N     E+ L+ +L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMP--------NKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           H N++ L+     +    L++E+M         +KS+   +  P+        T      
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMT------ 111

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
              +GL YLH      I+HRDLK +N+L+ SD   K++DFG+AR F G   +  T +VV 
Sbjct: 112 --LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV- 164

Query: 681 TYGYMSPEYALDGLFSVKS-----DVFSFGVLLLETL 712
           T  Y +PE     LF  +      D++S G +  E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 522 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G +G VY  + L+ Q  +A+K +  +  + ++    E+ L + L+HRN+V+ +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 581 EQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
           E G   +  E +P  SL+  L   + P + +    QT +   + I +GL YLH     +I
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHD---NQI 129

Query: 638 IHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-- 694
           +HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G   
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +   +D++S G  ++E  T K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
            N S    LG G FG V +       K     +VAVK L   +    +E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIE 620
           L  H N+V L+G C   G  ++I EY     L  FL     +      LL +  +V    
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV---- 150

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKR 677
             A+G+ +L   +    IHRDL A N+LL      KI DFG+AR    D    ++GN + 
Sbjct: 151 --AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNL 735
            V    +M+PE   + +++ +SDV+S+G+LL E  +L S    G+     F      + L
Sbjct: 206 PVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKL 256

Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K+   Y +  P       Y ++         C       RPT  ++V +I
Sbjct: 257 IKE--GYRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 97.7 bits (243), Expect = 3e-22
 Identities = 73/221 (33%), Positives = 110/221 (49%), Gaps = 34/221 (15%)

Query: 521 KLGEGGFGPVYKGKLLNGQE---------------VAVKRLSSQSGQGLK-EFKNEMMLI 564
           KLGEG FG V+  +     E               VAVK L +   +  + +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHL-----LGWQTR 615
           ++L++ N++RL+G CV      +I EYM N  LN FL     + + TH      +     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQ 672
           + +   IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R ++ GD   +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G   R V    +M+ E  L G F+  SDV++FGV L E  T
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 13/204 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 574 RLMGCCVEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +L+G  VE+ G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +    +HRDL A N+L+  D   K+SDFG+ +       Q   K  V    + +PE   +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173

Query: 693 GLFSVKSDVFSFGVLLLETLTSKR 716
             FS KSDV+SFG+LL E  +  R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 89.3 bits (222), Expect = 7e-22
 Identities = 29/67 (43%), Positives = 44/67 (65%), Gaps = 1/67 (1%)

Query: 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMW 396
           C   + F++  ++KLP      ++ S+ LKECE  CL NC+C AYA + +  GGSGCL+W
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59

Query: 397 FGDLIDI 403
            G+L+D+
Sbjct: 60  TGELVDM 66

Length = 66

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQHRNLVRLMG 577
           K+GEG +G VYK +  L G+ VA+K++  +            E+ L+ +L H N+++L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 636
               +G+  L++E+M   +  + L    +  L   ++ +K  +  + QGL + H +    
Sbjct: 66  VFRHKGDLYLVFEFM--DTDLYKLIKDRQRGLP--ESLIKSYLYQLLQGLAFCHSH---G 118

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLF 695
           I+HRDLK  N+L++++   K++DFG+AR F            V T  Y +PE  L D  +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 696 SVKSDVFSFGVLLLETLT 713
           S   D++S G +  E L+
Sbjct: 177 STPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.5 bits (237), Expect = 1e-21
 Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 35/282 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 630
           +L    V +    +I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 65  KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 688
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 173

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLS 746
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L   + + +     E L 
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL- 232

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                            + + C + +  +RPT   + S++ +
Sbjct: 233 ---------------YNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 65/308 (21%)

Query: 515 NFSMQCKLGEGGFGPVYKG-----KLLNG-QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL 567
           N  +   LGEG FG V K      K   G   VAVK L   +    L++  +E  L+ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----------------------FDPS 605
            H ++++L G C + G  +LI EY    SL  FL                       +P 
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 606 RTHL-------LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658
              L         WQ        I++G+ YL   + ++++HRDL A N+L+      KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN- 717
           DFG++R    ++      +      +M+ E   D +++ +SDV+SFGVLL E +T   N 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 718 -TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR 776
             G+     FNLL            Y +  P    E  Y ++       L C +++   R
Sbjct: 230 YPGIAPERLFNLL---------KTGYRMERPENCSEEMYNLM-------LTCWKQEPDKR 273

Query: 777 PTMSKVVS 784
           PT + +  
Sbjct: 274 PTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 22/275 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           +++ +   +G G    VY    L N ++VA+KR+   +    + E + E+  +++  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+     V   E  L+  Y+   SL   +        L       +++ + +GL YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSPEY 689
             +   IHRD+KA NILL  D + KI+DFG++      GD  +   K  VGT  +M+PE 
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 690 ALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSP 747
                 +  K+D++SFG+  +E  T       Y  ++   L      L  D        P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-----LQND-------PP 225

Query: 748 ALQHEASYQMLNR-YITVALLCVQEKAADRPTMSK 781
           +L+  A Y+  ++ +  +  LC+Q+  + RPT  +
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 18/203 (8%)

Query: 522 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 631
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYA 690
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  + +   + +PE  
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
           +   F + SDV+SFGV L E LT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 15/201 (7%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 576
           K+GEG +G VYK +  L G+ VA+K  RL ++  +G+      E+ L+ +L H N+VRL+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64

Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
              V    K+ L++E++ +  L  ++ D S    L        +  + QG+ Y H +   
Sbjct: 65  DV-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-L 694
           R++HRDLK  N+L+D +   K++DFG+AR F G  ++  T  VV T  Y +PE  L    
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQ 176

Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +S   D++S G +  E +  +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLI 564
             NF ++ K+G+G F  VYK   LL+G+ VA+K++       +      LKE      L+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGI 622
            +L H N+++ +   +E  E  ++ E      L+  +  F   +  L+  +T  K    +
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQL 115

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L ++H     RI+HRD+K +N+ + +    K+ D G+ R F       ++   VGT 
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTP 170

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            YMSPE   +  ++ KSD++S G LL E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 51/284 (17%)

Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G+L L G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLLYLHQYSR 634
           G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ YL   S 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---SD 124

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 688
           +  +HRDL A NIL++S++  K+SDFG++R+     L+ + +    T G      + +PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAY 742
                 F+  SDV+S+G+++ E ++       Y    +      W +   +        Y
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAIEEGY 226

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            L +P     A +Q++       L C Q+   +RP   ++VS++
Sbjct: 227 RLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 12/200 (6%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           K+GEG +G VYKG+    GQ VA+K  RL S+          E+ L+ +LQH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 636
             +++    LI+E++      +    P   ++      VK  +  I QG+L+ H     R
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD--AELVKSYLYQILQGILFCH---SRR 121

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LF 695
           ++HRDLK  N+L+D+    K++DFG+AR F G  ++  T  VV T  Y +PE  L    +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179

Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S   D++S G +  E  T K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 26/272 (9%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
           +F +  KLG+G +G VYK K L + Q  A+K   L S S +  ++  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLH 630
           ++      ++  +  ++ EY P   L+  +    +   L+  Q   +I   + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +    +I+HRDLK++NILL ++   KI D G++++      +   K  +GT  YM+PE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVW 173

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
               +S KSD++S G LL E  T         ++            K  R      P + 
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--------KVQRGK---YPPIP 222

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
              S  + N         +Q K   RP   K+
Sbjct: 223 PIYSQDLQN----FIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 15/203 (7%)

Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+G FG VY       G+ L  ++V     S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GC  ++ EK L    EYMP  S+   L   +   L    TR K    I +G+ YLH   
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALD 692
              I+HRD+K +NIL DS  N K+ DFG ++      + G   R V GT  +MSPE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +  K+DV+S G  ++E LT K
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 41/280 (14%)

Query: 522 LGEGGFGPVYKGKLLNGQ---EVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           LGEG FG V +G+L       +VAVK  +++  +   +++F +E + + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 577 GCCVEQGEK------ILIYEYMPNKSLNFFLFDPSR----THLLGWQTRVKIIEGIAQGL 626
           G C++  E       ++I  +M +  L+ FL   SR       L  Q  VK +  IA G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDEL-QGNTKRVVGTYGY 684
            YL   S    IHRDL A N +L+ +MN  ++DFG++ +++ GD   QG   ++     +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKW 180

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAY 742
           ++ E   D +++ KSDV+SFGV + E  T  +    GV + E ++ L         NR  
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG------NR-- 232

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
            L  P    +  Y +++        C      DRP+   +
Sbjct: 233 -LKQPPDCLDGLYSLMSS-------CWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 15/198 (7%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G  G V K K +  G  +A K +   +   + K+   E+ ++ + +   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 580 VEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
           + +    +  E+M   SL+       P    +LG     KI   + +GL YL  Y+  RI
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125

Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 697
           +HRD+K SNIL++S    K+ DFG++    G+ +       VGT  YMSPE    G ++V
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181

Query: 698 KSDVFSFGVLLLETLTSK 715
           KSDV+S G+ ++E    K
Sbjct: 182 KSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 37/217 (17%)

Query: 522 LGEGGFGPVYKG-KLLNGQEVAVK----------RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           +G+G +G VY    +  G+ +AVK          R  S+    +K  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 571 NLVRLMGCCVEQGEKIL-IY-EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
           N+V+ +G   E  E+ L I+ EY+P  S+   L     F+         Q          
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--------L 118

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGT 681
           +GL YLH      I+HRDLKA N+L+D+D   KISDFG+++    D++  N     + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173

Query: 682 YGYMSPEY-ALDGL-FSVKSDVFSFGVLLLETLTSKR 716
             +M+PE        +S K D++S G ++LE    +R
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G FG V+KG L +   VAVK       Q LK +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           ++    ++ E +P    +F  F   +   L  +  VK     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N L+  +   KISDFGM+R         +  + +    + +PE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 701 VFSFGVLLLETLT 713
           V+S+G+LL ET +
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 26/205 (12%)

Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG V+KG  +   +     VA+K +  +SG Q  +E  + M+ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           +G C   G  + L+ +  P  SL   +       DP R  LL W  +      IA+G+ Y
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQ------IAKGMYY 124

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           L ++   R++HR+L A NILL SD   +I+DFG+A +   D+ +           +M+ E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT 713
             L G ++ +SDV+S+GV + E ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 93.1 bits (231), Expect = 2e-20
 Identities = 77/245 (31%), Positives = 119/245 (48%), Gaps = 30/245 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE--------VAVKRLSSQ-SGQGLKEFKNEMMLI 564
           +   +   LGEG FG V + +     +        VAVK L    + + L +  +EM L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTH--LL 610
             + +H+N++ L+G C ++G   +I EY    +L  FL           FD ++     L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
            ++  V     +A+G+ YL   SR R IHRDL A N+L+  D   KI+DFG+AR     +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 728
               T        +M+PE   D +++ +SDV+SFG+L+ E  TL      G+   E F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 729 L--GH 731
           L  GH
Sbjct: 249 LREGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 87.0 bits (216), Expect = 2e-20
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 3/108 (2%)

Query: 213 TGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLI 270
           +GPWNG+ F   P     SY      E  E E+ Y Y   ++ I   L ++  G ++R  
Sbjct: 3   SGPWNGIRFSGIPEMQKLSYYVYNFTENNE-EVYYTYRMTNNSIYSRLTLSSEGSLERFT 61

Query: 271 WHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLK 318
           W   S  W +F++AP + C +YG CG    C V+ +  C C+KGF  K
Sbjct: 62  WIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPK 109

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 39/268 (14%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++G G FG VY  + +   + VA+K++S    QS +  ++   E+  + +L+H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYLHQYSR 634
           GC + +    L+ EY    +      D    H    Q      I  G  QGL YLH + R
Sbjct: 82  GCYLREHTAWLVMEYCLGSAS-----DILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
              IHRD+KA NILL      K++DFG A +        N+   VGT  +M+PE  L   
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMD 187

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQ 750
           +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP L 
Sbjct: 188 EGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------DSPTLS 235

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPT 778
                     ++     C+Q+   DRP+
Sbjct: 236 SNDWSDYFRNFVD---SCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 521 KLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRLMG 577
           K+G G FG VY    L+  E+ AVK +  Q      +KE  +EM ++  L+H NLV+  G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 578 CCVEQGEKILIY-EYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
             V + EK+ I+ EY    +L   L                 RV  ++ + +GL YLH +
Sbjct: 67  VEVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHV------IRVYTLQ-LLEGLAYLHSH 118

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF------CGDELQGNTKRVVGTYGYMS 686
               I+HRD+K +NI LD +   K+ DFG A          G+E+Q     + GT  YM+
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMA 171

Query: 687 PEYALDGLFSVK---SDVFSFGVLLLETLTSKR 716
           PE    G        +D++S G ++LE  T KR
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)

Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVR 574
           +LGE  FG +YKG L      + Q VA+K L    + Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--------------VKIIE 620
           L+G   ++    +++EY+    L+ FL   S    +G  +               + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVV 679
            IA G+ YL  +     +H+DL A NIL+   ++ KISD G++R ++  D  +   K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
               +M PE  + G FS  SD++SFGV+L E  +
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           NF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173

Query: 692 DG-LFSVKSDVFSFGVLLLETLTSK 715
               +S   D++S G +  E +T +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 27/193 (13%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL---SSQSG---QGLKEFKNEMM 562
            +   ++ +  KLGEG FG VYK  ++  G+ VA+K++   + + G     L+E K    
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQT 614
           ++ KL+H N+V L+   VE+ +K         ++  YM +  L+  L +P    L   ++
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLT--ES 115

Query: 615 RVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
           ++K  +  + +G+ YLH+     I+HRD+KA+NIL+D+    KI+DFG+AR + G     
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 674 NTKRVVGTYGYMS 686
                 GT  Y +
Sbjct: 173 KGGGGGGTRKYTN 185

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 90.6 bits (225), Expect = 6e-20
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 29/204 (14%)

Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KRL  + G+ +    NE  ++ K+  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                 + +  L+   M    L + +       F  +R      Q        I  GL +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LHQ    RI++RDLK  N+LLD   N +ISD G+A    G       K   GT GYM+PE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPE 164

Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
                ++    D F+ G  L E +
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 30/237 (12%)

Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++P++     L ++  V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 8e-20
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 20/206 (9%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL---KEFKN---EMMLIAKLQHRNLVRL 575
           LG+G +G VY G    GQ +AVK++   +   L   KE++    E+ L+  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C++     +  E++P  S++  L  F P    +    T+ +I++G+A    YLH   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN----TKRVVGTYGYMSPEY 689
              ++HRD+K +N++L  +   K+ DFG AR      L G      K + GT  +M+PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSK 715
             +  +  KSD++S G  + E  T K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.4 bits (224), Expect = 9e-20
 Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 54/295 (18%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-QH 569
           +   Q  +GEG FG V K ++       + A+KR+   + +   ++F  E+ ++ KL  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 616
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179

Query: 677 RVVGTYG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 732
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Query: 733 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 240 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 521 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            +G+G FG V K      GK+L  +E+    ++ +  Q L    +E+ ++ +L+H N+VR
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63

Query: 575 LMGCCV-EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRV---KIIEGIAQGLLYL 629
                +    + + I  EY     L   +    +         +    I   + Q LL L
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-----KYIEEEFIWRILTQLLLAL 118

Query: 630 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           +           ++HRDLK +NI LD++ N K+ DFG+A++   D      K  VGT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYY 176

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLE 710
           MSPE      +  KSD++S G L+ E
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)

Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG------LKEFKNEMMLIAKLQHRNLV 573
           ++GEG  G V+K K    G+ VA+K+++ +  +G      L+E K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+         +L+ EYMP+  L+  L D  R  L   Q +   +  + +G+ Y+H   
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
              I+HRDLK +N+L+ +D   KI+DFG+AR+F  +E +  + + V T  Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)

Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V +G+L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           G   +    ++I E+M N +L+ FL      F      L+G      ++ GIA G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVG------MLRGIAAGMKYL- 122

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSP 687
             S +  +HRDL A NIL++S++  K+SDFG++R    D         +G      + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      F+  SDV+S+G+++ E ++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 61/198 (30%), Positives = 109/198 (55%), Gaps = 17/198 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +V+L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
              G+  ++ E+ P  +++  + +  R  L   Q +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYAL-----D 692
           RDLKA N+LL  D + K++DFG++       ++   +R   +GT  +M+PE  +     D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 693 GLFSVKSDVFSFGVLLLE 710
             +  K+D++S G+ L+E
Sbjct: 190 TPYDYKADIWSLGITLIE 207

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 15/210 (7%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKLQ 568
           N+ +   LG+G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 569 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           H  +V+  GC  +  E+ L    E+MP  S+   L   S   L    TR K    I +G+
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYM 685
            YLH      I+HRD+K +NIL DS  N K+ DFG ++      L G   K V GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           SPE      +  K+D++S G  ++E LT K
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 17/206 (8%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + + +  +LG+G FG VYK +    G   A K +  +S + L++F  E+ ++++ +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V L      + +  ++ E+    +L+  + +  R  L   Q R  +   + + L +LH 
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRY-VCRQMLEALNFLHS 121

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
           +   ++IHRDLKA NILL  D + K++DFG++       LQ   KR   +GT  +M+PE 
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN-KSTLQ---KRDTFIGTPYWMAPEV 174

Query: 690 AL-----DGLFSVKSDVFSFGVLLLE 710
                  D  +  K+D++S G+ L+E
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.0 bits (220), Expect = 4e-19
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 35/266 (13%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH ++   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHSHN--- 135

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DG 693
           +IHRD+KA NILL      K+ DFG A       +       VGT  +M+PE  L   +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQHE 752
            +  K DV+S G+  +E   ++R   ++++ + + L H A N           SPALQ  
Sbjct: 190 QYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESPALQSG 237

Query: 753 ASYQMLNRYITVALLCVQEKAADRPT 778
              +    ++     C+Q+   DRPT
Sbjct: 238 HWSEYFRNFVDS---CLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 4e-19
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)

Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 571
           F+   ++G G FG VY  + +   EV A+K++S    QS +  ++   E+  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
            +   GC + +    L+ EY    + +  L +  +  L   +    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           ++   +IHRD+KA NILL      K++DFG A +             VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194

Query: 692 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
              +G +  K DV+S G+  +E   ++R   ++++ + + L H       N      SP 
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHI----AQNE-----SPT 243

Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           LQ          ++     C+Q+   DRPT  +++  +
Sbjct: 244 LQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 26/234 (11%)

Query: 516 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           F++   LG+G FG V + +L     + Q+VAVK L +   S   ++EF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 570 RNLVRLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKII 619
            N+++L+G  +    K      ++I  +M +  L+ FL   SR       L  QT V+ +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDEL-QGNTKR 677
             IA G+ YL   S    IHRDL A N +L+ +M   ++DFG+++ ++ GD   QG   +
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLL 729
           +     +++ E   D +++  SDV++FGV + E +T  +    GV + E +N L
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
            N+ +   LG G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 568 QHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQ 624
           +H  +V+  GC  +  EK L    EYMP  S+     D  + +  L      +    I Q
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 683
           G+ YLH      I+HRD+K +NIL DS  N K+ DFG ++      + G   K V GT  
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           +MSPE      +  K+DV+S    ++E LT K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 19/217 (8%)

Query: 512 ATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLI 564
           A E  +M  +LG+G FG VY+G      K      VA+K ++ + S +   EF NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 565 AKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLF----DPSRTHLLGWQTRVKII 619
            +    ++VRL+G  V QG+  L I E M    L  +L     +     +    +  K+I
Sbjct: 64  KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 620 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +    +MSPE   DG+F+  SDV+SFGV+L E  T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 516 FSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLV 573
           F++   +G+G FG VYK       Q VA+K +   ++   +++ + E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +  G  ++  +  +I EY    S      D  +   L       I+  +  GL YLH+  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYMSPEYA 690
               IHRD+KA+NILL  + + K++DFG++      +L     +    VGT  +M+PE  
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
               +  K+D++S G+  +E   
Sbjct: 171 KQSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 77/258 (29%), Positives = 126/258 (48%), Gaps = 34/258 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKG---KLLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-Q 568
           E+   +  +GEG FG V +    K       A+K L   + +   ++F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTR 615
           H N++ L+G C  +G   +  EY P  +L  FL        DP+  + H     L  Q  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           ++    +A G+ YL   S  + IHRDL A N+L+  ++  KI+DFG++R   G+E+    
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173

Query: 676 KRVVGTYG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGH 731
           K+ +G     +M+ E     +++ KSDV+SFGVLL E  +L      G+   E +  L  
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233

Query: 732 AWNLWK----DNRAYELL 745
            + + K    D+  YEL+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQHR 570
           +F +   +G+G FG V   +  + +++ A+K ++ Q       ++   NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 571 NLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 624
            LV L     +  E + L+ + +    L + L     F          Q +  I E I  
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-------QVKFWICE-IVL 111

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L YLH      IIHRD+K  NILLD   +  I+DF +A     D     T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
           M+PE      +SV  D +S GV   E L  KR
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.0 bits (215), Expect = 2e-18
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 20/202 (9%)

Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 631
           +G C+    + LI + MP   L  ++ +        +LL W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               R++HRDL A N+L+ +  + KI+DFG+A++   DE + + +       +M+ E  L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
             +++ +SDV+S+GV + E +T
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMGC 578
           +G G FG V+  +    Q++ + +          E    +NE  ++  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
            +E    +++ EY P  +L  ++       LL   T   I+    Q LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123

Query: 639 HRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEYALDGLF 695
           HRDLK  NILLD   M  KI DFG+++      L   +K   VVGT  Y+SPE      +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK-----ILSSKSKAYTVVGTPCYISPELCEGKPY 178

Query: 696 SVKSDVFSFGVLLLETLTSKR 716
           + KSD+++ G +L E  + KR
Sbjct: 179 NQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 68/270 (25%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 522 LGEGGFGP--VYK----GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+G FG   +Y+      L+  +EV + RLS +     ++  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               ++    ++  EY    +L +      +  L   +  +  +  I   + Y+H+    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            I+HRD+K  NI L      K+ DFG++++  G E     + VVGT  YMSPE      +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSM-AETVVGTPYYMSPELCQGVKY 178

Query: 696 SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY 755
           + KSD+++ G +L E LT KR       ++ N L     + + N    +         S 
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV------SVYSS 227

Query: 756 QMLNRYITVALLCVQEKAADRPTMSKVVSM 785
           ++    I++    +Q+    RPT  +V+  
Sbjct: 228 EL----ISLVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 86.2 bits (213), Expect = 3e-18
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 51/300 (17%)

Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 252

Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 253 --KEGHRMDKPANCTNELYMMMRD-------CWHAIPSHRPTFKQLVEDLDRILTLTTNE 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 36/224 (16%)

Query: 516 FSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRL--SSQSGQGLKEFK-NEMMLIAKLQH 569
           + ++  +G G +G VYK K  N   G+E A+K+     +   G+ +    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 570 RNLVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLF--DPSRTHL-------LGWQTRVKI 618
            N+V L+   +E  +K   L+++Y  +       F     R  +       L WQ     
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQG- 673
              I  G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+F    L+  
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPL 169

Query: 674 -NTKRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            +   VV T  Y +PE  L      K+ D+++ G +  E LT +
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 5e-18
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L    + + L +  +EM ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSR--THLLGWQTRVKI 618
           ++ L+G C + G   ++ EY    +L  +L           FD  +     L ++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                +M+PE   D +++ +SDV+SFGVLL E  T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 515 NFSMQCKLGEGGFGPVY--KGKLLNGQEVAVK-RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + +  K+GEG FG +Y  K K  +   V  +  L+    +  +  K E++L+AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-------NFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           +V       E G   ++ EY     L          LF  S   +L W  +      I+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           GL ++H     +I+HRD+K+ NI L  + M  K+ DFG+AR    ++        VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPY 167

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           Y+SPE   +  ++ K+D++S G +L E  T K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 23/203 (11%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGC 578
           ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
           C ++    ++ E +  +  +F  F  +    L  +  ++++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM--------SPEYA 690
           HRDL A N L+      KISDFGM+R    +E  G    V  + G M        +PE  
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDG----VYASTGGMKQIPVKWTAPEAL 168

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
             G +S +SDV+SFG+LL E  +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 78.2 bits (193), Expect = 1e-17
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 326 PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSK 385
           P  C    S+D      F+K  D+KLP     ++  +++L+EC   CL NC+C AYA + 
Sbjct: 2   PLNCGGDGSTD-----GFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAYNN 54

Query: 386 VTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVP 420
              G  GCL+W G L ++R     + G  +Y+R+ 
Sbjct: 55  ---GSGGCLLWNGLLNNLRS--LSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GKL   +++  KRL  +  +G +    E  ++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL---------FDPSRTHLLGWQTRVKIIEGIAQGL 626
                 + +  L+   M    L + +         F   R      Q        I  GL
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISGL 110

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            +LHQ    RII+RDLK  N+LLD+D N +ISD G+A      + Q  TK   GT G+M+
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMA 165

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           PE      +    D F+ GV L E + ++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 16/200 (8%)

Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + L+ + MP   L     D  R +   +G Q  +     IA+G+ YL +  
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
            +R++HRDL A N+L+ S  + KI+DFG+AR+   DE + +         +M+ E  L  
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 694 LFSVKSDVFSFGVLLLETLT 713
            F+ +SDV+S+GV + E +T
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 29/218 (13%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRN 571
           F +  ++GEG +G VYK +    G+ VA+K++   + + G  +   + E+ ++ +L HRN
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 572 LVRLMGCCV----------EQGEKILIYEYMPNKSLNFF---LFDPSRTHLLGWQTRVKI 618
           +V L               ++G   L++EYM +  +      L   S  H+         
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSF 121

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
           ++ + +GL Y H+ + L   HRD+K SNILL++    K++DFG+AR++  +E +  T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 679 VGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
           + T  Y  PE  L +  +    DV+S G +L E  T K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 33/212 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E++ +  ++G G +G VYK + +  G+ VA+K +  + G   +  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA-------QG 625
           V   G  + + +  ++ EY    SL   ++  +R  L   Q        IA       +G
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQ--------IAYVCRETLKG 113

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT--KR--VVGT 681
           L YLH+      IHRD+K +NILL  D + K++DFG++           T  KR   +GT
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGT 164

Query: 682 YGYMSPEYA---LDGLFSVKSDVFSFGVLLLE 710
             +M+PE A     G +  K D+++ G+  +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 20/207 (9%)

Query: 521 KLGEGGFGPVYKGKLLN--GQEVAVKRL---SSQSGQGLKEFKNEMML--IAKLQHRNLV 573
           ++GEG +G V+K + L   G+ VA+KR+   + + G  L   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 574 RLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           RL   C       + +  L++E++ ++ L  +L D      +  +T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   ++   D++S G +  E    K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 1e-17
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +  G  G  YKGK + NG +  VK ++  +     E  +    + KLQH N+V+L+G C 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753

Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
            +    LI+EY+  K+L+  L +      L W+ R KI  GIA+ L +LH      ++  
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           +L    I++D    P +    +  + C D     TK  + +  Y++PE       + KSD
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISS-AYVAPETRETKDITEKSD 860

Query: 701 VFSFGVLLLETLTSKRNTGVYDIES 725
           ++ FG++L+E LT K      D E 
Sbjct: 861 IYGFGLILIELLTGKSPA---DAEF 882

Length = 968

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 27/213 (12%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           NF    KLGEG +  VYKG+    G+ VA+K   L ++ G      + E+ L+ +L+H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGIA 623
           +VRL      + + +L++EYM +K L  ++         DP+      +Q        + 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LL 110

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +G+ + H+    R++HRDLK  N+L++     K++DFG+AR F G  +   +  VV T  
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLW 165

Query: 684 YMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 715
           Y +P+  L    +S   D++S G ++ E +T +
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 35/271 (12%)

Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++G G FG VY     +  E VAVK++S    Q+ +  ++   E+  + +L+H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           GC +++    L+ EY    + +  L +  +  L   +    I  G  QGL YLH ++   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHSHN--- 141

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DG 693
           +IHRD+KA NILL      K++DFG A               VGT  +M+PE  L   +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSPALQHE 752
            +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP LQ  
Sbjct: 196 QYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------DSPTLQSN 243

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
                   ++     C+Q+   +RP  ++++
Sbjct: 244 EWTDSFRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 70/290 (24%), Positives = 126/290 (43%), Gaps = 38/290 (13%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHR 570
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 622
           N+++     +E  E  ++ E      L+  +          P +T    W+  V++   +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV---WKYFVQLCSAL 119

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            YMSPE   +  ++ KSD++S G LL E    +              G   NL+   +  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS----------PFYGDKMNLYSLCKKI 220

Query: 743 ELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 791
           E    P L  +   + L + +    +C+      RP ++ V  +    HA
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHR 570
           NF ++ K+G G F  VY+   LL+ + VA+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 622
           N+++ +   +E  E  ++ E      L+  +          P RT    W+  V++   +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV---WKYFVQLCSAV 119

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            YMSPE   +  ++ KSD++S G LL E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 30/208 (14%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC- 578
           +GEG +G VYK +    GQ VA+K +        +E K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 579 -----CVEQGEKILIYEYMPNKS----LNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 627
                     +  L+ E     S    +        R     + +     I+    +GL 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLA 127

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           YLH+    ++IHRD+K  NILL  +   K+ DFG++     D   G     +GT  +M+P
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAP 182

Query: 688 E-----YALDGLFSVKSDVFSFGVLLLE 710
           E        D  +  +SDV+S G+  +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 38/252 (15%)

Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR 574
           +GEG FG V K      G  ++     +K  +S+     ++F  E+ ++ KL  H N++ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTRVKIIEG 621
           L+G C  +G   L  EY P+ +L  FL        DP+    +     L  Q  +     
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K+ +G 
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 172

Query: 682 YG--YMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWK 737
               +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   + L K
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 738 ----DNRAYELL 745
               D+  Y+L+
Sbjct: 233 PLNCDDEVYDLM 244

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 521 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR----NLV 573
           +LG G FG V KG  K+   Q +VA+K L +++    K  ++EMM  A++ H+     +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           R++G C E    +L+ E      LN FL    +   +     V+++  ++ G+ YL   +
Sbjct: 59  RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               +HRDL A N+LL +    KISDFG+++    D+      R  G +   + +PE   
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171

Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS +SDV+S+G+ + E  +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 19/200 (9%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQH---RNLVRLM 576
           +G G +G VY+GK +  G+ VA+K ++  +    + + + E+ L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G  ++     +I EY    S+   +    +   +  +    II  +   L Y+H+     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV--VGTYGYMSPEYALDG- 693
           +IHRD+KA+NIL+ +  N K+ DFG+A +      Q ++KR   VGT  +M+PE   +G 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 694 LFSVKSDVFSFGVLLLETLT 713
            +  K+D++S G+ + E  T
Sbjct: 178 YYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
           K+GEG +G VYK +  +  + +A+K++   Q  +G+      E+ L+ ++QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 578 CCVEQGEKILIYEYMP---NKSLNF---FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
               +    L++EY+     K ++    F  +P       +Q    I+ GIA    Y H 
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120

Query: 632 YSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +   R++HRDLK  N+L+D   N  K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175

Query: 691 LDGL-FSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +  K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 512 ATENFSMQCKLGEGGFGPVYKG---KLLNGQ---EVAVKRLS-SQSGQGLKEFKNEMMLI 564
           + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVK 617
                 ++VRL+G   +    +++ E M +  L  +L        +         Q  ++
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTK 676
           +   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R ++  D  +   K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            ++     M+PE   DG+F+  SD++SFGV+L E  +
Sbjct: 181 GLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 30/206 (14%)

Query: 525 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           G +G V+   K   G   A+K +          + +   E  ++++ Q   +V+L     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62

Query: 581 EQGEK--ILIYEYMPN---KSL--NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            QG+K   L+ EY+P     SL  N    D               I  I   L YLH   
Sbjct: 63  -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLHSNG 113

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARM-FCGDELQGN-----TKRVVGTYGYMSP 687
              IIHRDLK  NIL+DS+ + K++DFG++++     ++  N      KR+VGT  Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E  L    S   D +S G +L E L 
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN---------------- 559
           + +Q +LG+G FG VY           VK   + + + LK  K                 
Sbjct: 2   YILQQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51

Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E  L++KL H  +V+     +E+    +I EY   + L+  L +   T     + +V   
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--C 109

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
           E   Q LL +H   + RI+HRDLKA NI L +++  KI DFG++R+  G      T    
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FT 166

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           GT  YMSPE      +  KSD++S G +L E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 8e-17
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 19/200 (9%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQ---HRNLVRL 575
           +GEG +G VYK + L  G+ VA+K++    S +G+      E+ L+ +L+   H N+VRL
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 576 MGCC-VEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           +  C   + ++     L++E++ ++ L  +L    +  L     +  ++  + +G+ +LH
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   RI+HRDLK  NIL+ SD   KI+DFG+AR++     +     VV T  Y +PE  
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178

Query: 691 LDGLFSVKSDVFSFGVLLLE 710
           L   ++   D++S G +  E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
                  K+GEG  G V        G++VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK------IIEGIAQGL 626
           V +    +   E  ++ E++   +L         T ++   TR+       +   + + L
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGAL---------TDIVT-HTRMNEEQIATVCLAVLKAL 128

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGY 684
            +LH      +IHRD+K+ +ILL SD   K+SDFG    FC    +   +R  +VGT  +
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYW 181

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLE 710
           M+PE      +  + D++S G++++E
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 36/216 (16%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIAK 566
           + +  +LG+G FG VY  +    G+ VA+K++        K+F +        E+  + K
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53

Query: 567 LQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 624
           L  H N+V+L     E  E   ++EYM     N +     R      ++ ++ II  I Q
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV----VG 680
           GL ++H   +    HRDLK  N+L+      KI+DFG+AR     E++  ++      V 
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIR--SRPPYTDYVS 160

Query: 681 TYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
           T  Y +PE  L    +S   D+++ G ++ E  T +
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G G +G V        G++VA+K+LS   QS    K    E+ L+  + H N++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 579 CVEQGEKILIYEYMPNKSLNFF-------------LFDPSRTHLLGWQTRVKIIEGIAQG 625
                       + P  SL  F             L +  +   L       ++  I +G
Sbjct: 83  ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L Y+H      IIHRDLK SNI ++ D   KI DFG+AR    DE+ G     V T  Y 
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182

Query: 686 SPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
           +PE  L+ +   ++ D++S G ++ E LT K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ---HRNLVR 574
           ++G G +G VYK +   +G  VA+K +  Q+ + GL      E+ L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 575 LMGCC----VEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           LM  C     ++  K+ L++E++ ++ L  +L D      L  +T   ++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSK 715
            L   ++   D++S G +  E    K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 16/210 (7%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMM 562
           ++ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q  Q  KE   NE++
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++ + +H N+V  +   +   E  ++ EY+   SL   +   + T +   Q    +    
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQI-AAVCREC 124

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVG 680
            Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VG
Sbjct: 125 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVG 177

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  +M+PE      +  K D++S G++ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 570
             + +   +GEG +G V K +    G+ VA+K+   S+  + +K+    E+ ++ +L+H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 625
           N+V L      +G   L++EY+    L           P       WQ        + Q 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV----VGT 681
           + Y H      IIHRD+K  NIL+      K+ DFG AR      L+          V T
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVAT 164

Query: 682 YGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
             Y +PE  + D  +    DV++ G ++ E L 
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
           E F+   ++G+G FG VYKG     +EV A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKS-LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           + R  G  ++  +  +I EY+   S L+     P     +       I+  I +GL YLH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
                R IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173

Query: 691 LDGLFSVKSDVFSFGVLLLE 710
               +  K+D++S G+  +E
Sbjct: 174 KQSAYDFKADIWSLGITAIE 193

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.2 bits (197), Expect = 3e-16
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q     +   NE+++
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 14/193 (7%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+GEG  G V   +   +G++VAVK +  +  Q  +   NE++++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
           +   E  ++ E++   +L   +   S+T L   Q    + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQI-ATVCESVLQALCYLHSQG---VIH 140

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFSV 697
           RD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT  +M+PE      +  
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 698 KSDVFSFGVLLLE 710
           + D++S G++++E
Sbjct: 197 EVDIWSLGIMVIE 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 5e-16
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 126

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 25/202 (12%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           +LG+G FG VYK +    G   A K + ++S + L+++  E+ ++A   H N+V+L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
             +    ++ E+    +++  + +  R  L   Q RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL-- 691
           RDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 692 ---DGLFSVKSDVFSFGVLLLE 710
              D  +  K+DV+S G+ L+E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQS--GQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
           LG GGFG V   K+ +     A+K +  +     G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              ++    ++ EY     L   L D  R     +  R   I  +     YLH      I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLH---NRGI 114

Query: 638 IHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
           I+RDLK  N+LLDS+   K+ DFG A+ +  G      T    GT  Y++PE  L+  + 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYD 170

Query: 697 VKSDVFSFGVLLLETLTSK 715
              D +S G+LL E LT +
Sbjct: 171 FSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 6e-16
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 14/211 (6%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           ++ S+    + ++   K+G+G  G V+    +  GQEVA+K+++ Q     +   NE+++
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + +L++ N+V  +   +   E  ++ EY+   SL     D      +       +     
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECL 125

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ N+LL  D + K++DFG    FC       +KR  +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 23/204 (11%)

Query: 521 KLGEGGFGPVYKG--KLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 573
           +LG G FG V KG  K+   ++ VAVK L + +       K+E++  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           R++G C E    +L+ E      LN FL    +   +  +   +++  ++ G+ YL + +
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEY 689
               +HRDL A N+LL +    KISDFG+++    DE     + + K  V  Y   +PE 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169

Query: 690 ALDGLFSVKSDVFSFGVLLLETLT 713
                FS KSDV+SFGVL+ E  +
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 38/220 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSG---QGLKEFKNEMMLIAK 566
           + +    ++ EG +G VY+ +    G+ VA+K+L     + G     L+E  N ++   K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60

Query: 567 LQHRNLVRL----MGCCVEQGEKILIY---EYMPN--KSLNFFLFDPSRTHLLGWQTRVK 617
           LQH N+V +    +G  +++     IY   EY+ +  KSL     +  +   L  Q+ VK
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSL----METMKQPFL--QSEVK 109

Query: 618 -IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
            ++  +  G+ +LH      I+HRDLK SN+LL++    KI DFG+AR + G  L+  T+
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQ 165

Query: 677 RVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
            VV T  Y +PE  L    +S   D++S G +  E LT K
Sbjct: 166 LVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 521 KLGEGGFGPVYKG--KLLNGQE--VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
            +GEG FG VY+G       ++  VAVK   + +   ++E F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G   E    I + E  P   L  +L      + L   + +     ++  L YL      
Sbjct: 73  IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
           R +HRD+ A N+L+ S    K+ DFG++R +  DE      +      +M+PE      F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 696 SVKSDVFSFGVLLLETL 712
           +  SDV+ FGV + E L
Sbjct: 186 TSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 37/166 (22%)

Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN-------FFLFDPSRTHLLGW 612
           E+ ++  + H N+V+        GE  ++ E+M   SL         FL D +R      
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR------ 175

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
               +I+ GIA    YLH   R  I+HRD+K SN+L++S  N KI+DFG++R+       
Sbjct: 176 ----QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 673 GNTKRVVGTYGYMSPEY--------ALDGLFSVKSDVFSFGVLLLE 710
            N+   VGT  YMSPE         A DG      D++S GV +LE
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILE 265

Length = 353

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 22/199 (11%)

Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLSSQS-GQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 578 CCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                 +  L++EY       +F       DP       +Q        + +GL + H +
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               ++HRDLK  N+L++ +   K++DFG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 173

Query: 693 G-LFSVKSDVFSFGVLLLE 710
             L+S   D++S G +  E
Sbjct: 174 AKLYSTSIDMWSAGCIFAE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV 580
           +G G +G VYKG+ +   ++A  ++   +G   +E K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 581 EQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           ++       +  L+ E+    S+   L   ++ + L  +    I   I +GL +LHQ+  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
            ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT  +M+PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 692 --DGLFSVKSDVFSFGVLLLE 710
             D  +  KSD++S G+  +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 60/191 (31%), Positives = 91/191 (47%), Gaps = 33/191 (17%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQG-----LKEFKNEMMLIAKLQHRNLV 573
           K+G+G FG V+K +     Q VA+K+ L     +G     L+E K    ++  L+H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW--QTRVK--------IIEGIA 623
            L+  C  +        Y   K   + +F+     L G      VK        +++ + 
Sbjct: 75  NLIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC---GDELQGNTKRVVG 680
            GL Y+H   R +I+HRD+KA+NIL+  D   K++DFG+AR F      +    T RVV 
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185

Query: 681 TYGYMSPEYAL 691
           T  Y  PE  L
Sbjct: 186 TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 18/203 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++GEG +G VY+ +   +G+ VA+K++   + + G  +   + E+ L+  L+H N+V L 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 577 GCCV-EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYS 633
              V +  + I L+ EY   + L   L +         +++VK ++  + +GL YLH+  
Sbjct: 73  EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFS---ESQVKCLMLQLLRGLQYLHENF 128

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
              IIHRDLK SN+LL      KI+DFG+AR + G   +  T +VV T  Y +PE  L  
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGC 183

Query: 694 LFSVKS-DVFSFGVLLLETLTSK 715
                + D+++ G +L E L  K
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQH-RNLVRLM 576
            +LG G +G V K + +  G  +AVKR+ +  + Q  K    ++ +  +       V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 577 GCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQTRVKIIEGIAQGLLYLH 630
           G    +G+  +  E M + SL+ F   ++D   T    +LG     KI   I + L YLH
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH 120

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMSPEY 689
             S+L +IHRD+K SN+L++ +   K+ DFG++    G  +    K +  G   YM+PE 
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173

Query: 690 ALDGL-----FSVKSDVFSFGVLLLETLTSK 715
            ++       + VKSDV+S G+ ++E  T +
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 27/286 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 570
           E +     +GEG +G V K K    GQ VA+K+ L S+  + +K+    E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           NLV L+     +    L++E++ +  L+     P   + L      K +  I +G+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            ++   IIHRD+K  NIL+      K+ DFG AR              V T  Y +PE  
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELL 172

Query: 691 L-DGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESF--------NLLGHAWNLWKDNR 740
           + D  +    D+++ G L+ E LT +    G  DI+          NL+     +++ N 
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 741 AYELLS-PALQH----EASYQMLNRY-ITVALLCVQEKAADRPTMS 780
            +  +  P ++     E  +  L+   + +A  C++    DRP+ S
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 16/191 (8%)

Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G  G VYK   LL  + +AVK +       L K+  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
             +    +  E+M   SL+ +   P   H+LG     +I   + +GL YL     L+I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE--HVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           RD+K SN+L+++    K+ DFG++       +    K  VGT  YM+PE      + + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 700 DVFSFGVLLLE 710
           DV+S G+  +E
Sbjct: 175 DVWSLGISFME 185

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 522 LGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQH-RNLVRLM 576
           +G G FG V K  +L+   G  +AVKR+ S    +  K    ++ ++ +      +V+  
Sbjct: 12  IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 577 GCCVEQGEKILIYEYMPNKSLNF--FLFDPSRTHL----LGWQTRVKIIEGIAQGLLYLH 630
           G    +G+  +  E M      F  ++++  ++ +    LG     KI     + L YL 
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLK 124

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPE- 688
           +   L+IIHRD+K SNILLD + N K+ DFG+     G  +    K R  G   YM+PE 
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAGCRPYMAPER 178

Query: 689 ---YALDGLFSVKSDVFSFGVLLLETLTSK 715
               A DG + V+SDV+S G+ L E  T K
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 12/199 (6%)

Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 576
            K+GEG +G V+K +    GQ VA+K+ + S+    +K+    E+ ++ +L+H NLV L+
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
                + +  L++EY  +  LN           +      KII    Q + + H+++   
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLF 695
            IHRD+K  NIL+      K+ DFG AR+  G     +    V T  Y +PE  + D  +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178

Query: 696 SVKSDVFSFGVLLLETLTS 714
               DV++ G +  E LT 
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 29/234 (12%)

Query: 488 GDGDAKGTRRD---SVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK 544
            D  A  +  D    ++P    A    A+  +++   L  G  G V+      GQ   V 
Sbjct: 37  DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95

Query: 545 RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
               Q G  L E     ML+  + H +++R+    V      ++   +P+ S + + +  
Sbjct: 96  LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLT 148

Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
            R+  L     + I + I +GL YLH     RIIHRD+K  NI ++      I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Query: 665 ------MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
                  F G         + GT    +PE      ++ K+D++S G++L E L
Sbjct: 206 FPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E+F +  ++G G +G VYK + +N G+  A+K +  + G+     + E++++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           V   G  + + +  +  E+    SL   + +  P     + + +R  +     QGL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
              +   +HRD+K +NILL  + + K++DFG++            K  +GT  +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 691 L---DGLFSVKSDVFSFGVLLLE 710
                G ++   D+++ G+  +E
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
           E F+   K+G+G FG V+KG     Q+V A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLH 630
           + +  G  ++  +  +I EY+   S    L +P        +T++  I+  I +GL YLH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLD----ETQIATILREILKGLDYLH 118

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
              +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173

Query: 691 LDGLFSVKSDVFSFGVLLLE 710
               +  K+D++S G+  +E
Sbjct: 174 KQSAYDSKADIWSLGITAIE 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 33/208 (15%)

Query: 522 LGEGGFGPVYKG--KLLNGQE--VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           LG G FG + +G  KL + +E  VA+  L +  S +  + F  E + + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 634
           G        +++ EYM N +L+ FL    R H   L     + ++ G+A G+ YL   S 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS-------- 686
           +  +H+ L A  +L++SD+  KIS F           +    +    Y  MS        
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWA 175

Query: 687 -PEYALDGLFSVKSDVFSFGVLLLETLT 713
            PE      FS  SDV+SFG+++ E ++
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 61/226 (26%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 571
           +G G +G V        G++VA+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 572 LVRLM-----GCCVEQGEKILIYEYMP--------------NKSLNFFLFDPSRTHLLGW 612
           ++ L+         +  +  ++ E M               +  + +FL+      +L  
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-----QIL-- 113

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
                      +GL YLH      +IHRDLK SNIL++S+ + KI DFG+AR    DE +
Sbjct: 114 -----------RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 673 GN--TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
               T+ VV T  Y +PE  L    ++   D++S G +  E LT K
Sbjct: 160 KGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)

Query: 522 LGEGGFGPVYK-------GKLLNGQEVAVKRLS-----SQSGQGLKEFKNEMMLIAK-LQ 568
           LG G FG VYK         LL  +E+ V   +      +  + + +  +E+ +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 627
           H N+VR     +E     ++ + +    L               + R+  I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYM 685
           YLH+  R  I+HRDL  +NI+L  D    I+DFG+A+     + Q  +K   VVGT  Y 
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 745
            PE   +  +  K+DV++FG +L +  T       Y   S N+L  A  +      YE L
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFY---STNMLSLATKIV--EAVYEPL 233

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
              +  E    ++         C+   A  RP + +V +MI++
Sbjct: 234 PEGMYSEDVTDVITS-------CLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 521 KLGEGGFGPVYKGKLL----NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           K+GEG FG   K  L+    +G++  +K +  S  S +  +E + E+ +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
                 E G   ++ +Y     L +   +  R  L       +I++   Q  L L     
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQICLALKHVHD 119

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDG 693
            +I+HRD+K+ NI L  D   K+ DFG+AR+     EL    +  +GT  Y+SPE   + 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICENR 176

Query: 694 LFSVKSDVFSFGVLLLETLTSK 715
            ++ KSD+++ G +L E  T K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 34/162 (20%)

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
           +V   G     GE  +  E+M   SL+  L    R   ++LG     KI   + +GL YL
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYL 115

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARMFCGDELQGNTKRVVGT 681
            +  + +I+HRD+K SNIL++S    K+ DFG        MA  F            VGT
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGT 161

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI 723
             YMSPE      ++V+SD++S G+ L+E        G Y I
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMA-----IGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
           E F+   ++G+G FG V+KG     Q+V A+K +  +  +  +++ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           + +  G  ++  +  +I EY+   S      D  R           +++ I +GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 692 DGLFSVKSDVFSFGVLLLE 710
              +  K+D++S G+  +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVA---VKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++G G FG V  G+   G   A   VK L +S +      F  E+    +L H N+++ +
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRV--KIIEGIAQGLLYLHQYS 633
           G C+E    +L+ E+ P   L  +L   +R  +    Q  V  ++   +A GLL+LHQ  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG---DELQGNTKRVVGTYGYMSPEYA 690
               IH DL   N  L +D++ KI D+G+A        D         V    +++PE  
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAV-PLRWLAPELV 174

Query: 691 L---DGLFSVK----SDVFSFGVLLLETLT 713
                 L        S+++S GV + E  T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 633
                 +    L+   M    L F ++        G++    +     I  GL  LHQ  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQE- 121

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             RI++RDLK  NILLD   + +ISD G+A      +     K  VGT GYM+PE   + 
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE 176

Query: 694 LFSVKSDVFSFGVLLLETLTSK 715
            ++   D ++ G LL E +  +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)

Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFK---NEMMLIAKLQHRN 571
           F +  ++G+GG+G V+  K  +  E VA+KR+       L E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRVKIIEGIAQGLLYLH 630
           LV+L+    +     L  EY+P       L   +   +L     R  + E     +  LH
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH 118

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               L  IHRDLK  N L+D+  + K++DFG+++      +      VVG+  YM+PE  
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVL 170

Query: 691 LDGLFSVKSDVFSFGVLLLETLT 713
               +    D +S G +L E L 
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 575
            K+GEG F  V K +    G+  A+K +  +  + L++  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 576 MGCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +    ++  G   L++E M    +N +     R   L  +     +  + + L ++H   
Sbjct: 64  IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-D 692
           R  I HRD+K  NIL+  D   K++DFG  R       +      + T  Y +PE  L D
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTD 173

Query: 693 GLFSVKSDVFSFGVLLLETLT 713
           G +  K D+++ G +  E L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            ++ +  ++G G +G VYK   L  G+  AVK +  + G      + E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           V   G  + + +  +  EY    SL   + +  P     + +  R  +     QGL YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
              ++   HRD+K +NILL  + + K++DFG+A            K  +GT  +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 691 L---DGLFSVKSDVFSFGVLLLE 710
               +G ++   D+++ G+  +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H N++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK-----------IIEGIAQG 625
                       + P +SL  F      THL+G      VK           +I  I +G
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G     V T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184

Query: 686 SPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 15/195 (7%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V   +     +  A+K LS      LK+     NE  ++  ++H  LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     L+ EY+P   L F     S         R    + +   L YLH    L I
Sbjct: 69  SFQDDSNLYLVMEYVPGGEL-FSHLRKSG-RFPEPVARFYAAQ-VVLALEYLHS---LDI 122

Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 697
           ++RDLK  N+LLDSD   KI+DFG A+      ++G T  + GT  Y++PE  L   +  
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177

Query: 698 KSDVFSFGVLLLETL 712
             D ++ G+L+ E L
Sbjct: 178 AVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.8 bits (181), Expect = 1e-13
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 21/165 (12%)

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           Q LL +H      +IHRD+K++NILL S+   K+ DFG ++M+         +   GT  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNR 740
           Y++PE      +S K+D+FS GVLL E LT KR     ++E      L G          
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--------- 261

Query: 741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 785
            Y+ L P++  E       + I  ALL    K   RP+ SK+++M
Sbjct: 262 -YDPLPPSISPEM------QEIVTALLSSDPKR--RPSSSKLLNM 297

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   + +  KR+  + G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 633
                 +    L+   M    L F +++       G++    +     I  GL  LH+ +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHREN 122

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               ++RDLK  NILLD   + +ISD G+A ++  G+ ++G     VGT GYM+PE   +
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNN 175

Query: 693 GLFSVKSDVFSFGVLLLETL 712
             +++  D +  G L+ E +
Sbjct: 176 QRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V K +      +  ++L     +     +   E+ ++ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
           +V   G     GE  +  E+M   SL+  L +  R    +LG     K+   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 690 ALDGLFSVKSDVFSFGVLLLE 710
                +SV+SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 16/196 (8%)

Query: 521 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+GEG  G V    +   G++VAVK++  +  Q  +   NE++++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
           +   E  ++ E++   +L   +     TH  +  +    +   + + L YLH      +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140

Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 696
           HRD+K+ +ILL SD   K+SDFG    FC    +   KR  +VGT  +M+PE      + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 697 VKSDVFSFGVLLLETL 712
            + D++S G++++E +
Sbjct: 197 TEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 31/208 (14%)

Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                 +    L+   M    L F +       FD  R      +        I  GL  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSP 687
           LH   R RI++RDLK  NILLD   + +ISD G+A  +  G+ ++G     VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSK 715
           E   +  ++   D +  G L+ E +  K
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 20/192 (10%)

Query: 538 GQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM--GCCVEQGEKILIYEYM 592
           G EVA+K L + + +   +   F+ E  L A+L H N+V L+  G     G    ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--- 649
           P ++L   L   +    L      +++  +   L   H      I+HRDLK  NI++   
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 650 DSDMNPKISDFGMARMFCG----DELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSF 704
               + K+ DFG+  +  G    D      T  V+GT  Y +PE       +  SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 705 GVLLLETLTSKR 716
           G++ LE LT +R
Sbjct: 176 GLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 33/207 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
             + +  KLG+G +G V+K       + VA+K++     ++   Q  + F+ E+M + +L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQEL 63

Query: 568 -QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
             H N+V+L+     + +K   L++EYM    L+  +    R ++L    +  I+  + +
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLLK 118

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-----VV 679
            L Y+H  S   +IHRDLK SNILL+SD   K++DFG+AR     EL+ N +       V
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS--ELEENPENPVLTDYV 173

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGV 706
            T  Y +PE  L       S  ++ GV
Sbjct: 174 ATRWYRAPEILL------GSTRYTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVV 679
           IA GL +LH      II+RDLK  N++LD++ + KI+DFGM +  +F G      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           GT  Y++PE      +    D ++FGVLL E L
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 87/337 (25%), Positives = 132/337 (39%), Gaps = 89/337 (26%)

Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K  + + VAVK L  + G    E+K  M    +LI    H N
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72

Query: 572 LVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL------FDPSRTHLL-------------- 610
           +V L+G C + G  ++ I EY    +L+ +L      F P R                  
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 611 -------------GWQT--RVKIIEGIAQG-------------LLYLHQYSR-------L 635
                        G+     +  +E   +G             + Y  Q +R        
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEYALDG 693
           + IHRDL A NILL  +   KI DFG+AR    D   ++    R+     +M+PE   D 
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250

Query: 694 LFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
           +++ +SDV+SFGVLL E  +L +    GV   E F          +      + +P    
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--------CRRLKEGTRMRAPEYAT 302

Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
              Y ++       L C      DRPT S++V ++ +
Sbjct: 303 PEIYSIM-------LDCWHNNPEDRPTFSELVEILGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 24/172 (13%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 678
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR    D    ++GN +  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 738
           V    +M+PE   D +++V+SDV+S+G+LL E  +  ++   Y             +  +
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--YP-----------GILVN 321

Query: 739 NRAYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
           ++ Y+++    Q     +     Y ++  +C   +  +RPT S++  +I  +
Sbjct: 322 SKFYKMVKRGYQMSRPDFAPPEIY-SIMKMCWNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 511 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK--NEMMLIAKL 567
           AAT   +++ KLGEG +  VYKG   +NGQ VA+K +S ++ +G+  F    E  L+  L
Sbjct: 3   AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N+V L      +     ++EYM      + +  P   H   +  R+ + + + +GL 
Sbjct: 61  KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH--PYNVRLFMFQ-LLRGLA 117

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           Y+H      I+HRDLK  N+L+      K++DFG+AR       Q  +  VV T  Y  P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPP 172

Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           +  L    +S   D++  G + +E L
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVV 679
           I  GL +LH+     II+RDLK  N+LLDS+ + KI+DFGM +  +  G      T    
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           GT  Y++PE      +    D ++ GVLL E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN----- 559
             +V   T  +     +G G FG V   +  L GQ VA+K++       +K F       
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54

Query: 560 ----EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
               E+ L+  L+H N++ L    +   E I     +    L+  L     +  L  Q  
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
              +  I +GL Y+H      ++HRDLK SNIL++ + + KI DFG+AR+    ++ G  
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTG-- 164

Query: 676 KRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
              V T  Y +PE  L    + V+ D++S G +  E L  K
Sbjct: 165 --YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 31/205 (15%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 576
           LG+G FG V   +L    E  A+K L         + +  M+    L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 577 GCCVEQGEKILIY--EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             C  Q ++ L +  EY+    L F +     FD +R      +        I  GL +L
Sbjct: 63  --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQFL 112

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSP 687
           H+     II+RDLK  N+LLD D + KI+DFGM    C + + G  K     GT  Y++P
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGM----CKENMNGEGKASTFCGTPDYIAP 165

Query: 688 EYALDGLFSVKSDVFSFGVLLLETL 712
           E      ++   D +SFGVLL E L
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 56/250 (22%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG------------------LKEFKNEMM 562
           LGEG +G V K    L G+ VA+K++                         L+E K    
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKII 619
           ++ +++H N++ L+   VE     L+ + M +   K ++       +  L   Q +  I+
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-IL 125

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN----- 674
             I  GL  LH++     +HRDL  +NI ++S    KI+DFG+AR +             
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 675 --------TKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKR-NTGVYDIE 724
                   T +VV T  Y +PE  +    +    D++S G +  E LT K    G  +I+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241

Query: 725 S----FNLLG 730
                F LLG
Sbjct: 242 QLGRIFELLG 251

Length = 335

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 22/202 (10%)

Query: 522 LGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLK-----EFKNEMMLIAKLQHRNL 572
           LG+G FG V+  + +     GQ  A+K L   +   LK       K E  ++A++ H  +
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQ 631
           V+L      +G+  LI +++    L    F      ++  +  VK  +  +A  L +LH 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
              L II+RDLK  NILLD + + K++DFG+++     E +       GT  YM+PE   
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171

Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
               +  +D +SFGVL+ E LT
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 18/195 (9%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+GEG  G V    +  +G+ VAVK++  +  Q  +   NE++++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQYSRLRII 638
           +   E  ++ E++   +L   +     TH    + ++  +   + + L  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGD---ELQGNTKRVVGTYGYMSPEYALDGLF 695
           HRD+K+ +ILL  D   K+SDFG    FC     E+    K +VGT  +M+PE      +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVP-RRKSLVGTPYWMAPELISRLPY 193

Query: 696 SVKSDVFSFGVLLLE 710
             + D++S G++++E
Sbjct: 194 GPEVDIWSLGIMVIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKL 567
             +     +GEG +G V        G +VA+K++S    Q      L+E K    ++ + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60

Query: 568 QHRNLVRLMGC----CVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           +H N++ ++        E    + ++ E M        L+   +T  L        +  I
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV---V 679
            +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+AR+   D    +T  +   V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170

Query: 680 GTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            T  Y +PE  L+     K+ D++S G +L E L+++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 22/154 (14%)

Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
            KLGEG +  VYKG+  L GQ VA+K  RL  + G      + E  L+  L+H N+V L 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
                +    L++EY+ +  L  ++             L  +Q        + +GL Y H
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
           Q    R++HRDLK  N+L+      K++DFG+AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 51/148 (34%), Positives = 76/148 (51%), Gaps = 12/148 (8%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLGEG +  VYKGK  +NG+ VA+K  RL  + G      + E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
               +    L++EY+      +    P   H       VK+ +  + +GL Y+HQ     
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLFLFQLLRGLSYIHQRY--- 123

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMAR 664
           I+HRDLK  N+L+      K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 29/204 (14%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 576
           LG+G FG V+  +L    Q  A+K L         + +  M+    L    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            C  +  E +  + EY+    L F +     FD  R      +        I  GL +LH
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFLH 113

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPE 688
                 I++RDLK  NILLD+D + KI+DFGM    C + + G+ K     GT  Y++PE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAKTCTFCGTPDYIAPE 166

Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
             L   ++   D +SFGVLL E L
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLGEG +  VYKG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
               +    L++EY+ +K L  +L D    + +        +  + +GL Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL-F 695
           +HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++  G +  E  T +
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           L+++      F +   +G G +G VYKG+ +   ++A  ++   +    +E K E+ ++ 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 566 KL-QHRNLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
           K   HRN+    G  +++       +  L+ E+    S+   L   ++ + L       I
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              I +GL +LH +   ++IHRD+K  N+LL  +   K+ DFG++     D   G     
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181

Query: 679 VGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLE 710
           +GT  +M+PE        D  +  +SD++S G+  +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           ++      +G G FG V+  +  ++    A+K ++      LK+     NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             ++RL     +Q    ++ EY+P   L  +L +  R       T +     I   L YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H      I++RDLK  NILLD + + K++DFG A+     +L+  T  + GT  Y++PE 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169

Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                 +   D ++ G+L+ E L
Sbjct: 170 IQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 579 CVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-----LHQ 631
            +   ++   L+++Y  +   +   F  +       +  V++  G+ + LLY     +H 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 632 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQ--GNTKRVVGTYGY 684
                ++HRDLK +NIL+  +  P     KI+D G AR+F    L+   +   VV T+ Y
Sbjct: 124 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWY 181

Query: 685 MSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            +PE  L      K+ D+++ G +  E LTS+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 +    L+   M    L F +++       G+  +  I    A+    L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYA-AELCCGLEDLQRE 121

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           RI++RDLK  NILLD   + +ISD G+A ++  G+ ++G     VGT GYM+PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 695 FSVKSDVFSFGVLLLETL 712
           ++   D +  G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 521 KLGEGGFGPVYKGKL---LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           ++G G FG V  G++       +V VK L  S S Q   +F  E      LQH NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLYLHQYSR 634
           G C E    +L+ E+ P   L  +L    +  L+        ++   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
              IH DL   N LL +D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 8/196 (4%)

Query: 522 LGEGGFG-PVYKGKLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           +GEG FG  +    + + Q+ A+K +   +S   +++ + E +L+AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
              G   ++ EY     L   +    R  L    T ++    +  G+ ++H+    R++H
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS 699
           RD+K+ NI L  +   K+ DFG AR+         T   VGT  Y+ PE   +  ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181

Query: 700 DVFSFGVLLLETLTSK 715
           D++S G +L E  T K
Sbjct: 182 DIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E ++   ++G G +G V        G++VA+K+LS   QS    K    E+ L+  +QH 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGI 622
           N++ L+          +  +   +    F+L  P           H L       ++  +
Sbjct: 75  NVIGLLDVFTSA----VSGDEFQD----FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
             GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T 
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178

Query: 683 GYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            Y +PE  L+ +   ++ D++S G ++ E LT K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 48/129 (37%), Positives = 66/129 (51%), Gaps = 9/129 (6%)

Query: 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
           LI +Y+    L   L+   R H    + RV I E I   L +LHQ   L II+RD+K  N
Sbjct: 82  LILDYVNGGELFTHLY--QREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLEN 135

Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--DGLFSVKSDVFSF 704
           ILLDS+ +  ++DFG+++ F  +E +       GT  YM+PE      G      D +S 
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194

Query: 705 GVLLLETLT 713
           GVL  E LT
Sbjct: 195 GVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KRL  +SG+ +   + E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 632
                 +    L+   M    L + +++     L       ++I   AQ   G+L+LH  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSAQITCGILHLHS- 113

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
             + I++RD+K  N+LLD   N ++SD G+A      +      +  GT GYM+PE   +
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKE 168

Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +S   D F+ G  + E +  +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRN-LVRLM 576
           K+GEG +G VYK +    G+ VA+K+       +G+      E+ L+  L     +VRL+
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 577 GCCVEQGE----KILIY---EYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 627
              VE  E    K  +Y   EY+ +  L  F+    R     L  +T    +  + +G+ 
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           + H++    ++HRDLK  N+L+D      KI+D G+ R F    ++  T  +V T  Y +
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRA 179

Query: 687 PEYALDGL-FSVKSDVFSFGVLLLETLT 713
           PE  L    +S   D++S G +  E   
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
           +V   G     GE  +  E+M   SL+  L    R    +LG     K+   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 690 ALDGLFSVKSDVFSFGVLLLE 710
                +SV+SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 29/204 (14%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           LG+G FG V   +L  +G+  AVK L      Q          + +L     H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            CC +  +++  + E++    L F +     FD +R      +        I   L++LH
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPE 688
                 II+RDLK  N+LLD + + K++DFGM    C + +     T    GT  Y++PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGM----CKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
              + L+    D ++ GVLL E L
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 32/147 (21%)

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           LM  C+++     I   +P               +LG     K+   I + L YL +  +
Sbjct: 95  LMSTCLDK-LLKRIQGPIPE-------------DILG-----KMTVAIVKALHYLKE--K 133

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALD- 692
             +IHRD+K SNILLD+  N K+ DFG++ R+    + +  T R  G   YM+PE  +D 
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPE-RIDP 188

Query: 693 ----GLFSVKSDVFSFGVLLLETLTSK 715
                 + +++DV+S G+ L+E  T +
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 32/175 (18%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 678
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR    D     +G+ +  
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
           +    +M+PE   D +++ +SDV+SFGVLL E  +L +    GV   E F          
Sbjct: 240 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRL 290

Query: 737 KDN---RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           KD    RA E  +P +              + L C Q    +RPT S +V ++ +
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 521 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
           +LG+G +G VYK      G  +  +E+ ++   S+  Q + E    + ++ K     +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIME----LDILHKAVSPYIVD 63

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
             G    +G   +  EYM   SL+        T  +      +I   + +GL +L +   
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY----- 689
             IIHRD+K +N+L++ +   K+ DFG++    G+ +    K  +G   YM+PE      
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 690 -ALDGLFSVKSDVFSFGVLLLE 710
              +  ++V+SDV+S G+ +LE
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 4e-11
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  ++H N++ L+
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 577 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                   +E   ++ +   +    LN  +    +   L  +    +I  + +GL Y+H 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                IIHRDLK SN+ ++ D   +I DFG+AR    DE+ G     V T  Y +PE  L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188

Query: 692 DGL-FSVKSDVFSFGVLLLETLTSK 715
           + + ++   D++S G ++ E L  K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 10/192 (5%)

Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
           +GEG +G V K +    +E VA+K+   S+  + +KE    E+ ++  L+  N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
              +G+  L++EY+    L      P+           K+   I Q +  +H   +  I+
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVK 698
           HRD+K  N+L+  +   K+ DFG AR    +    N    V T  Y SPE  L   +   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 699 SDVFSFGVLLLE 710
            D++S G +L E
Sbjct: 182 VDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +G GGFG VY       GK+   + +  KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           M       +K+  I + M    L++ L   S+  +            I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--NR 116

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
             +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT+GYM+PE    G+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGV 171

Query: 695 -FSVKSDVFSFGVLLLETL 712
            +   +D FS G +L + L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 14/211 (6%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G+G +G V   +   +G++  +K+L+ +  S +  K  + E  L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 579 CVEQGEKILIYEYM---PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
              +GE  L+Y  M       L +      +  LL     V+    IA  L YLH+    
Sbjct: 68  W--EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            I+HRDLK  N+ L      K+ D G+AR+        +T  ++GT  YMSPE   +  +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179

Query: 696 SVKSDVFSFGVLLLETLTSKRNTGVYDIESF 726
           + KSDV++ G  + E  T K      D+ S 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.9 bits (158), Expect = 6e-11
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 26/170 (15%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 678
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN +  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
           V    +M+PE   + +++ +SDV+S+G+LL E  +L S    G+     F      + + 
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMI 330

Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           K+   Y +LSP       Y ++         C       RPT  ++V +I
Sbjct: 331 KE--GYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 32/187 (17%)

Query: 538 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
           G  VAVK+LS   Q+    K    E++L+  + H+N++ L+              + P K
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93

Query: 596 SLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643
           SL  F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK
Sbjct: 94  SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150

Query: 644 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFS 703
            SNI++ SD   KI DFG+AR  C + +   T  VV  Y Y +PE  L   +    D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWS 207

Query: 704 FGVLLLE 710
            G ++ E
Sbjct: 208 VGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 32/230 (13%)

Query: 538 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------MGCCVEQG 583
            + VAVK++     Q +K    E+ +I +L H N+V++              +G   E  
Sbjct: 30  DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 584 EKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
              ++ EYM       L           L  +Q        + +GL Y+H  +   ++HR
Sbjct: 90  SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138

Query: 641 DLKASNILLDS-DMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGLFSVK 698
           DLK +N+ +++ D+  KI DFG+AR+       +G     + T  Y SP   L      K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198

Query: 699 S-DVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           + D+++ G +  E LT K    G +++E   L+  +  + ++    ELL+
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)

Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLV 573
           LG+GG+G V++ + + G +     A+K L      ++ +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L+      G+  LI EY+    L   L    R  +    T    +  I+  L +LHQ  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPEYAL 691
              II+RDLK  NILLD+  + K++DFG+    C + +     T    GT  YM+PE  +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
                   D +S G L+ + LT
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 12/148 (8%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLGEG +  V+KG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
                    L++EY+ +K L  ++ D      +     VKI +  I +GL Y H   R +
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH---RRK 124

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMAR 664
           ++HRDLK  N+L++     K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 30/209 (14%)

Query: 517 SMQCKLGE----GGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHR 570
            +   +G+         + K K      VAVK+  L S S + LK  + E++   +LQH 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL-GWQTRV--KIIEGIAQGLL 627
           N++  +   +   E  ++   M   S    L    +TH   G        I++ +   L 
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 683
           Y+H       IHR +KAS+ILL  D    +S    +         G  +RVV  +     
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK---HGKRQRVVHDFPKSSV 169

Query: 684 ----YMSPEYALDGL--FSVKSDVFSFGV 706
               ++SPE     L  ++ KSD++S G+
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 579 CVEQGEK--ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEG----IAQGLLYLHQ 631
            +   ++   L+++Y  +   +   F   S+ +    Q    +++     I  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 632 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQ--GNTKRVVGTYGY 684
                ++HRDLK +NIL+  +  P     KI+D G AR+F    L+   +   VV T+ Y
Sbjct: 127 N---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWY 181

Query: 685 MSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            +PE  L      K+ D+++ G +  E LTS+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.4 bits (157), Expect = 7e-11
 Identities = 57/195 (29%), Positives = 82/195 (42%), Gaps = 48/195 (24%)

Query: 538 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
           GQ VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P K
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88

Query: 596 SLNFF--------------------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           SL  F                      D  R   L +Q           G+ +LH     
Sbjct: 89  SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAG-- 138

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +
Sbjct: 139 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGY 194

Query: 696 SVKSDVFSFGVLLLE 710
               D++S G ++ E
Sbjct: 195 KENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 566
           NF +   LG G +G V+  + ++G +     A+K L      Q  +  +  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 567 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQ 624
           ++    +  +    +   K+ LI +Y+    L   L    R      +  V+I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE++       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172

Query: 685 MSPEYAL--DGLFSVKSDVFSFGVLLLETLT 713
           M+P+     DG      D +S GVL+ E LT
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 49/230 (21%)

Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ-SGQGL--KEFKNEMMLIAKLQHRNLVRLM 576
            +G+GG G VY     +  + VA+K++    S   L  K F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG--WQ-----------TRVK----II 619
             C   G+   +Y  MP      ++   +   LL   WQ           T V     I 
Sbjct: 69  SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE-----LQGN 674
             I   + Y+H  S+  ++HRDLK  NILL       I D+G A     +E     +  +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 675 TK-----------RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            +           ++VGT  YM+PE  L    S  +D+++ GV+L + LT
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 37/211 (17%)

Query: 522 LGEGGFGPV-YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G G +G V        G +VA+K+L    QS    K    E+ L+  ++H N++ L+  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 579 CVEQGEKILIYEYMPNKSLN----FFLFDPSRTHLLG--------WQTRVK-IIEGIAQG 625
                       + P+ SL+    F+L  P     LG         + R++ ++  + +G
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y 
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYR 182

Query: 686 SPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           +PE  L+ + ++   D++S G ++ E LT K
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 7/96 (7%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           I +GL YLH      I+HRD+K  N+L++S+   KI DFG+AR+   DE +  T+ VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 682 YGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSK 715
           Y Y +PE  L G   ++   D++S G +  E L  +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 29/204 (14%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
           LG+G FG V   +L    EV A+K L         +    M    +L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            CC +  +++  + EY+    L F +     FD  R+     +        +   L++LH
Sbjct: 63  -CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE--------VTLALMFLH 113

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPE 688
           ++    +I+RDLK  NILLD++ + K++DFGM    C + +     T    GT  Y++PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGM----CKEGILNGVTTTTFCGTPDYIAPE 166

Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
              +  +    D ++ GVL+ E +
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 60/224 (26%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 571
           +G G +G V   K     ++VA+K+++         F N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 572 LVRL----MGCCVEQGEKI-LIYEYM---------PNKSLN-----FFLFDPSRTHLLGW 612
           ++ +         E    + ++YE M          +++L+     +FL+          
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
                    + +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+AR        
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-D 163

Query: 673 GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
             T+ VV T  Y +PE  L+   ++   DV+S G +  E L  K
Sbjct: 164 FMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 29/223 (13%)

Query: 506 LASVSAATENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
           L S+   T+ + +   +G+G +G VYK     +G   AVK L   S    +E + E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72

Query: 565 AKL-QHRNLVRLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK- 617
             L  H N+V+  G   +      G+  L+ E     S+   +       LL    R+  
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 618 -----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
                I+ G   GL +LH     RIIHRD+K +NILL ++   K+ DFG++       L+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 673 GNTKRVVGTYGYMSPEY-----ALDGLFSVKSDVFSFGVLLLE 710
            NT   VGT  +M+PE        D  +  + DV+S G+  +E
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
           +G+G FG V   K   +G+  AVK L  ++    KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +  +K+  + +Y+    L FF     R      + R    E IA  L YLH    L
Sbjct: 63  -YSFQTADKLYFVLDYVNGGEL-FFHLQRER-SFPEPRARFYAAE-IASALGYLHS---L 115

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYGYMSPEYALDG 693
            II+RDLK  NILLDS  +  ++DFG+    C + ++ +  T    GT  Y++PE     
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGL----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 694 LFSVKSDVFSFGVLLLETL 712
            +    D +  G +L E L
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 63/225 (28%)

Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLV 573
            +G G +G V       +G++VA+K++           + L+E K    ++   +H N++
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67

Query: 574 --------------------RLMGCCVEQGEKILIYEYMP--NKSLNFFLFDPSRTHLLG 611
                                LM   +      +I+   P   + + +FL+         
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMESDLHH----IIHSDQPLTEEHIRYFLYQ-------- 115

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG--D 669
                     + +GL Y+H  +   +IHRDLK SN+L++ D   +I DFGMAR       
Sbjct: 116 ----------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 670 ELQGNTKRVVGTYGYMSPE--YALDGLFSVKSDVFSFGVLLLETL 712
           E +      V T  Y +PE   +L   ++   D++S G +  E L
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           IA GL +LH      II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.5 bits (149), Expect = 5e-10
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 17/198 (8%)

Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
           LG+G FG V   +L   G+  AVK L         + +  M+   ++A       +  + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 578 CCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           C  +  E +  + E++    L F + D  R  L  ++      E I  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSKG--- 116

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV--GTYGYMSPEYALDGL 694
           II+RDLK  N++LD D + KI+DFGM    C + + G+ +     GT  Y++PE      
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM----CKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 695 FSVKSDVFSFGVLLLETL 712
           ++   D +SFGVLL E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +G GGFG VY       GK+   + +  KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           M       +K+  I + M    L++ L   S+  +   +        I  GL ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
             +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT+GYM+PE    G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGT 171

Query: 695 -FSVKSDVFSFGVLLLETL 712
            +   +D FS G +L + L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 57/207 (27%), Positives = 84/207 (40%), Gaps = 34/207 (16%)

Query: 522 LGEGGFGPV----YKGKLLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRN 571
           LG G FG V    YK     G+  A+K L      +    + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLL 627
           LV L  C   +     + EY     L   +    F   R               +  GL 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--------VVLGLQ 115

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVVGTYGYM 685
           YLH+    +I++RDLK  N+LLD++   KI+DFG+ +  M  GD     T    GT  ++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPEFL 168

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETL 712
           +PE   +  ++   D +  GVL+ E L
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 57/173 (32%), Positives = 88/173 (50%), Gaps = 28/173 (16%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTKRV 678
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR    D     +G+ +  
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNL 735
           +    +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +
Sbjct: 245 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 302 ----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLGEG +  V+KG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
               +    L++EY+ +  L  +L +      L     VKI +  + +GL Y H   + +
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCH---KRK 123

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL- 694
           I+HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +S   D++  G +L E  T +
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
           +G+G FG V   K   +G   AVK L  ++    KE  + M    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSR 634
               +  EK+  + +Y+    L FF     R  L   + R +     +A  + YLH    
Sbjct: 63  -YSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFL---EPRARFYAAEVASAIGYLHS--- 114

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           L II+RDLK  NILLDS  +  ++DFG+ +   G E +  T    GT  Y++PE      
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 695 FSVKSDVFSFGVLLLETL 712
           +    D +  G +L E L
Sbjct: 173 YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           I+ GL +LH   R  II+RDLK  N++LDS+ + KI+DFGM +    D +   T+   GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE      +    D +++GVLL E L  +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 23/197 (11%)

Query: 525 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQHRNLVRLMGCC 579
           G FG VY   K   G   A+K L         +  N      +++ + +   + +L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIEGIAQGLLYLHQYSRLR 636
             +    L+ EY+            S    LG        + I  +  G+  LHQ     
Sbjct: 67  QSKDYLYLVMEYLNGGDCA------SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--- 117

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
           IIHRD+K  N+L+D   + K++DFG++R   G E     K+ VGT  Y++PE  L     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPETILGVGDD 171

Query: 697 VKSDVFSFGVLLLETLT 713
             SD +S G ++ E L 
Sbjct: 172 KMSDWWSLGCVIFEFLF 188

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A G+ +L   +    +HRDL A N+L+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA 741
             +M+PE   + L++  SDV+SFG+LL E  T     G        +    +N  K  R 
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT----LGGTPYPELPMNEQFYNAIK--RG 358

Query: 742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           Y +  PA   +  Y+++ +       C +EK   RP  S++V ++ +
Sbjct: 359 YRMAKPAHASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGD 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 566
           NF +   LG G +G V+  + + G +     A+K L      Q  + ++  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           + Q   LV L      + +  LI +Y+    +   L+   R +    + R    E I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGE-IILA 117

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L +LH   +L I++RD+K  NILLDS+ +  ++DFG+++ F  +E +  T    GT  YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173

Query: 686 SPEYALDGLFSVKS-DVFSFGVLLLETLT 713
           +PE         K+ D +S G+L+ E LT
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVV 679
           I  GL Y+H  +   ++HRDLK  N+L+++D   KI DFG+AR F  +  E  G     V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 680 GTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            T  Y +PE  L      K+ DV+S G +L E L  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 522 LGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           +G+G +G V+K     NG + AVK L        +E + E  ++  L  H N+V+  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 580 ----VEQGEKI-LIYEYMPNKSLN----FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
               V+ G+++ L+ E     S+      FL    R   +       I+     GL +LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLH 141

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY- 689
                + IHRD+K +NILL ++   K+ DFG++       L+ NT   VGT  +M+PE  
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI 196

Query: 690 ----ALDGLFSVKSDVFSFGVLLLE 710
                LD  +  + DV+S G+  +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 72/250 (28%), Positives = 110/250 (44%), Gaps = 27/250 (10%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
           +G+G FG V   +    ++  AVK L  ++    KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSRL 635
                  +   + +Y+    L F+     R  L   + R +     IA  L YLH    L
Sbjct: 63  FSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIASALGYLHS---L 115

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            I++RDLK  NILLDS  +  ++DFG+ +     E  G T    GT  Y++PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 696 SVKSDVFSFGVLLLETLTS-----KRNTG-VYDIESFNLLGHAWNLWKD--NRAYELLSP 747
               D +  G +L E L        RNT  +YD    N+L     L  +  N A  LL  
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKPNITNSARHLLEG 229

Query: 748 ALQHEASYQM 757
            LQ + + ++
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 1e-08
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 32/183 (17%)

Query: 542 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE---YMPNKSLN 598
           A  R + Q        +NE++ + +L H N++++        E+IL  E   YM  +  +
Sbjct: 202 AGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYD 246

Query: 599 F----FLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
           F    F++D +   +   L  QTR  I++ +   + Y+H     ++IHRD+K  NI L+ 
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302

Query: 652 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLE 710
           D    + DFG A  F   E +      VGT    SPE  A DG   + +D++S G++LL+
Sbjct: 303 DGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLD 360

Query: 711 TLT 713
            L+
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 573
           ++G G FG V   ++     VA   VK L + +    KE +NE +        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKE-QNEFLQQGDPYRILQHPNIL 58

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
           + +G CVE    +L++EY     L  +L         S+  LL      ++   IA G+ 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMS 686
           ++H   +   +H DL   N  L SD+  K+ D+G+    +  D ++    + V    +++
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLA 169

Query: 687 PEYAL---DGLFSVK----SDVFSFGVLLLE 710
           PE       GL + +    S+V++ GV L E
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWE 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 15/197 (7%)

Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
           +G+G FG V   K  L+G+  AVK L  +     KE K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRL 635
               +  EK+       N    FF     R+     + R +     IA  L YLH    +
Sbjct: 63  -YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLHS---I 115

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            I++RDLK  NILLDS  +  ++DFG+ +   G      T    GT  Y++PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 696 SVKSDVFSFGVLLLETL 712
               D +  G +L E L
Sbjct: 174 DNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 549 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 608
           ++  G K    E+ ++  + HR ++ L+        K  +   MP    + F +   R+ 
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180

Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            L  +  + I   + + L YLH      IIHRD+K  NI LD   N  + DFG A   C 
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA---CK 234

Query: 669 DELQGNTKRVVGTYGYM---SPEY-ALDGLFSVKSDVFSFGVLLLETLTSKR 716
            +   +T +  G  G +   SPE  ALD  +  K+D++S G++L E      
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 42/220 (19%)

Query: 514 ENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 562
           E+F +   +G G FG V           Y  KLL+  E+ +KR  S        F  E  
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF------FWEERD 95

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFD---PSRTHLLGWQTRVK 617
           ++A      +V+L      Q +K L  + EYMP   L   + +   P +     W  R  
Sbjct: 96  IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFY 147

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTK 676
             E +   L  +H       IHRD+K  N+LLD   + K++DFG   +M     ++ +T 
Sbjct: 148 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT- 202

Query: 677 RVVGTYGYMSPEYAL----DGLFSVKSDVFSFGVLLLETL 712
             VGT  Y+SPE       DG +  + D +S GV L E L
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 58/189 (30%), Positives = 87/189 (46%), Gaps = 28/189 (14%)

Query: 539 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 50  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156

Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213

Query: 707 LLLETLTSK 715
           ++ E +   
Sbjct: 214 IMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 55/231 (23%)

Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V+  +  +  +V A+K L      +  Q     + E  ++A      +V+L 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVKLY 67

Query: 577 GCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------IAQGLLY 628
                Q E+ L  + EYMP   L            +    R  +         IA+ +L 
Sbjct: 68  --YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVLA 113

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA--------RMFCGDELQGNTKR--- 677
           L    +L  IHRD+K  NIL+D+D + K++DFG+         R +  ++      R   
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 678 ----------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
                            VGT  Y++PE      + ++ D +S GV+L E L
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 16/204 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQ--EVAVKRLSSQSGQGLKEFK---NEMMLIAKLQ 568
           E+F+    LG G FG V      N     VA+KR         K+     +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H   V L G   ++    L+ E++       FL    R     +   V      AQ +L 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYA-AQIVLI 143

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
                 L I++RDLK  N+LLD D   K++DFG A++     +   T  + GT  Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198

Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
             L+      +D ++ G+ + E L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 539 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 43  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92

Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 93  EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149

Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 206

Query: 707 LLLETLTSK 715
           ++ E +  K
Sbjct: 207 IMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 570
           +F M   LG G FG V   K    G+  A+K L  +    +K+ ++   E  ++ +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ------ 624
            +V +M    ++     + E++    L    F    THL   +   +    +A+      
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGEL----F----THL---RKAGRFPNDVAKFYHAEL 127

Query: 625 --GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
                YLH      II+RDLK  N+LLD+  + K++DFG A+     ++   T  + GT 
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTP 179

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
            Y++PE           D ++ GVLL E +
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   D+ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             Y++PE  L   ++   D ++ GVLL E LT
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +    +HRDL A N+LL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             +M+PE   D L++  SDV+S+G+LL E  +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 22/203 (10%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +   +G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
               +     + EY+    L F L     F   RT   G +        I   L YLH  
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLHSG 114

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
              +I++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLED 169

Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           IA+ +L L    +  I++RDLK  NILLD+  +  + DFG+++    D    NT    GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159

Query: 682 YGYMSPEYALDGL-FSVKSDVFSFGVLLLE 710
             Y++PE  LD   ++   D +S GVL+ E
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H  LV L  C   +     + EY+    L F +    +  L     R    E I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMS 686
           LH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT  Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCGTPNYIA 164

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           PE      +    D ++ GVL+ E +  +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 49.9 bits (119), Expect = 8e-08
 Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 8/83 (9%)

Query: 339 TRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMW- 396
           + + F++  + KLP    + ++   +L+EC ++CL  NC+CR++  +    G  GCL+W 
Sbjct: 2   SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWS 57

Query: 397 FGDLIDIRKITGYNNGQPIYVRV 419
              L D R     + G  +Y ++
Sbjct: 58  ESSLGDARL--FPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 2/159 (1%)

Query: 558 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 617
           ++E+  +A   H  +V+         + +LI EY     LN  +    + HL   +  V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           ++    Q +L L +    +++HRDLK++NI L      K+ DFG ++ +           
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
             GT  Y++PE      +S K+D++S GV+L E LT  R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 522 LGEGGFGPVYKGKLLN---------GQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRN 571
           LG+G F  +YKG L           GQEV+V   +     +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           LV+L G CV   E I++ EY+    L+ FL        L W+  V   + +A  L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119

Query: 632 YSRLRIIHRDLKASNILL---DSDMNP----KISDFGMAR-MFCGDELQGNTKRVVGTYG 683
               +++H ++   NIL+     +       K+SD G+   +   +E             
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 684 YMSPEYALDGLFSVKS--DVFSFGVLLLE 710
           +++PE   +G  S+    D +SFG  LLE
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE 198

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-GNT-KRVV 679
           I   L YLH      +++RDLK  N++LD D + KI+DFG+    C + +  G T K   
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           GT  Y++PE   D  +    D +  GV++ E +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 12/146 (8%)

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           LV L  C        L+ EY+    L F +    +  L     R    E I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHE 114

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--MFCGDELQGNTKRVVGTYGYMSPEY 689
                II+RDLK  N+LLD+D + K++D+GM +  +  GD     T    GT  Y++PE 
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSK 715
                +    D ++ GVL+ E +  +
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 21/158 (13%)

Query: 522 LGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           LG+G F  ++KG          L+  EV +K L        + F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
              G CV   E I++ EY+   SL+ +L      +L+    ++++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 634 RLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 663
              + H ++ A N+LL         NP   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           I   L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE   D  +    D +  GV++ E +  +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 13/98 (13%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 679
           I+  L +LH+     II+RDLK  N+LLD++ + K++D+GM    C + ++    T    
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM----CKEGIRPGDTTSTFC 157

Query: 680 GTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y++PE     D  FSV  D ++ GVL+ E +  +
Sbjct: 158 GTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           I   L YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGT 159

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE   D  +    D +  GV++ E +  +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 49/216 (22%)

Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGC- 578
           +G G FG VY+   ++  E VA+K++         ++KN E++++  L H N++ L    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128

Query: 579 ---CVEQGEKIL----IYEYMP-------------NKSLNFFLFDPSRTHLLGWQTRVKI 618
              C ++ EK +    + E++P             N +L  FL       L  +Q     
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-----VKLYSYQ----- 178

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKR 677
              + + L Y+H  S+  I HRDLK  N+L+D + +  K+ DFG A+     +    +  
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVS 229

Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
            + +  Y +PE  L    ++   D++S G ++ E +
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 16/100 (16%)

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM---------FCG----DELQ 672
           L YLH Y    I+HRDLK  N+L+ S  + K++DFG++++         + G    D  +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
              K+V GT  Y++PE  L   +    D ++ G++L E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 36/97 (37%), Positives = 47/97 (48%), Gaps = 10/97 (10%)

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGNTKRVVGTY 682
           + L Y+H  +   + HRDLK  NIL ++D   KI DFG+AR  F            V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 683 GYMSPEYALDGLFSVKS----DVFSFGVLLLETLTSK 715
            Y +PE  L G F  K     D++S G +  E LT K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 13/146 (8%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCC 579
            L  G    VY       ++  +K   S+     +E +  ++ +   +    V +++   
Sbjct: 5   LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
              G   L+ E++  ++L+              + +  I E +A+ L  LHQ   L + H
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 640 RDLKASNILLDSDMNPKISDFGMARM 665
            DL   NIL+D      I D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQ 568
           E++ +   +G G FG V   +  + Q+V   +L S+  + +K      F  E  ++A   
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF-EMIKRSDSAFFWEERDIMAFAN 101

Query: 569 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKIIEGIA 623
              +V+L   C  Q +K L  + EYMP   L   + +   P +     W          A
Sbjct: 102 SPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----A 149

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           + +L L     + +IHRD+K  N+LLD   + K++DFG   M   +         VGT  
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPD 208

Query: 684 YMSPEY----ALDGLFSVKSDVFSFGVLLLETL 712
           Y+SPE       DG +  + D +S GV L E L
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVG 680
           IA+ +L +H   +L  +HRD+K  N+LLD + + +++DFG   +M     +Q +    VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165

Query: 681 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 712
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E F +   +  G FG VY G K  N +  AVK +         +  N+ M+      R+ 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57

Query: 573 VRLMGC--CV------EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIE 620
           + L      V      +    + L+ EY+    +   L      H+ G+   +  VK I 
Sbjct: 58  LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
            +A  L YLH++    IIHRDLK  N+L+ ++ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVG 680
           +A+ +L +    +L  +HRD+K  N+LLD + + +++DFG   R+     +Q N    VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165

Query: 681 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 712
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 4e-06
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 46/231 (19%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 575
           K+G G FG V+  K    QE    +  + S +GLKE +   ++I      +L+H+N+VR 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 576 MGCCVEQGEKIL--IYEYMPNKSLN------FFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +   + +  + L  + E+     L+      + +F     H +     V I   +   L 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITRQLLHALA 132

Query: 628 YLHQY----SRLRIIHRDLKASNILLDSDMN-----------------PKISDFGMARMF 666
           Y H      +  R++HRDLK  NI L + +                   KI DFG+++  
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSV--KSDVFSFGVLLLETLTSK 715
               ++      VGT  Y SPE  L    S   KSD+++ G ++ E  + K
Sbjct: 193 ---GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 7/97 (7%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+ +L +H   ++  +HRD+K  N+L+D   + K++DFG A     +++  N+K  VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGT 166

Query: 682 YGYMSPEY--ALDG----LFSVKSDVFSFGVLLLETL 712
             Y++PE    ++G     + V+ D +S GV+  E +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 36/127 (28%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM------------ARMFCGD 669
           IA+ +L +    +L  IHRD+K  N+LLD+  + K+SDFG+             R+    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 670 ----------------ELQGNTKR--------VVGTYGYMSPEYALDGLFSVKSDVFSFG 705
                                 KR         VGT  Y++PE  L   ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 706 VLLLETL 712
           V++ E L
Sbjct: 227 VIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 43/196 (21%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 530 VYKGKLLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK- 585
           +YKG   N +EV ++            +   +NE+  + ++   N++++ G  ++  +  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 586 ---ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL 642
               LI EY     L   L    +   L ++T++ +     +GL  L++Y+     +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 643 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS---VKS 699
            + + L+  +   KI   G+ ++     L     + V    Y S +   D +FS   +K 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203

Query: 700 DVFSFGVLLLETLTSK 715
           D++S GV+L E  T K
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 37/139 (26%), Positives = 57/139 (41%), Gaps = 45/139 (32%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--------------- 666
           IA+  L +    ++  IHRD+K  NIL+D D + K++DFG+   F               
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Query: 667 ------------------CGDELQGNTKR------------VVGTYGYMSPEYALDGLFS 696
                             CGD L+   +R            +VGT  Y++PE  L   ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226

Query: 697 VKSDVFSFGVLLLETLTSK 715
              D +S GV+L E L  +
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 30/214 (14%)

Query: 514 ENFSMQCKLGEGGFG-----------PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 562
           E++ +   +G G FG            VY  KLL+  E+ +KR  S        F  E  
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEERD 95

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++A      +V+L     +     ++ EYMP   L   +   S   +     R       
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYT---- 148

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E        VGT 
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTP 207

Query: 683 GYMSPEY----ALDGLFSVKSDVFSFGVLLLETL 712
            Y+SPE       DG +  + D +S GV L E L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 59/260 (22%), Positives = 96/260 (36%), Gaps = 79/260 (30%)

Query: 514 ENFSMQCKLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--- 569
           E+F     +G+G FG V    K   G+  A+K L           K+EM    +L H   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKA 50

Query: 570 -RNL---------VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
            R++         V L     +     LI E++P   L         T L+ + T  + +
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDV 102

Query: 620 EG--IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-------------R 664
               +A+ +L +    +L  IHRD+K  NIL+D   + K+SDFG++             +
Sbjct: 103 TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 665 MFCGDELQ-GNTKR-------------------------------VVGTYGYMSPEYALD 692
           +  G   +     R                                VGT  Y++PE  L 
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 693 GLFSVKSDVFSFGVLLLETL 712
             +  + D +S G ++ E L
Sbjct: 223 QGYGQECDWWSLGAIMFECL 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 44/216 (20%)

Query: 522 LGEGGFGPVYKGKL---------LNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
           LG G    +Y G L             E  +K +      S     L  F+   M+  ++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMM-RQV 61

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H+++V L G CV   E I++ E++    L+ F+   S      W  + K+ + +A  L 
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119

Query: 628 YLHQYSRLRIIHRDLKASNILL-----DSDMNP--KISDFG-----MARMFCGDELQGNT 675
           YL       ++H ++   NILL     D +  P  K+SD G     ++R  C + +    
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP--- 173

Query: 676 KRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLE 710
                   +++PE   D    S+ +D +SFG  L E
Sbjct: 174 --------WIAPECVEDSKNLSIAADKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 65/248 (26%)

Query: 522 LGEGGFGPV-YKGKLLNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V    K+      A+K L  +       +   K E  ++A+  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
              ++     + +Y+P   +   L     F                   IA+    +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELTCAVESV 117

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-------------------------- 666
            ++  IHRD+K  NIL+D D + K++DFG+   F                          
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 667 -------CGDELQGNTKR------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
                  CGD L+   +R            +VGT  Y++PE  L   ++   D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 708 LLETLTSK 715
           L E L  +
Sbjct: 238 LYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 8/154 (5%)

Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E  ++  + H ++++L G         LI   +P    + + +  ++ ++      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A  F  D          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           GT    +PE      +    D++S G++L E  T
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 40.8 bits (96), Expect = 7e-05
 Identities = 16/48 (33%), Positives = 25/48 (52%)

Query: 788 NEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLISPR 835
           +E   +P PKQ  F   R   +     S++  E+ +VN VT+S+I  R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)

Query: 538 GQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
           G  V V+   L + + + LK  +NE++L    +H N++             +I  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 596 SLNFFL--FDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
           S N  L  + P      L+G      I+ G  +GL YLHQ      IHR++KAS+IL+  
Sbjct: 85  SANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILISG 136

Query: 652 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY----------MSPEYALDGL--FSVKS 699
           D    +S  G++ ++    L  N ++    Y +          +SPE     L  ++VKS
Sbjct: 137 DGLVSLS--GLSHLYS---LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191

Query: 700 DVFSFGVLLLETLTSK 715
           D++S G+   E  T +
Sbjct: 192 DIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 40/233 (17%)

Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           +  +T+ F +   LGEG FG V +      +E    ++     +  ++ K E+  + K++
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTR---------VKI 618
             +         ++   + I  Y  N++ +  +  P     LL W  +          +I
Sbjct: 184 QADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNP-------------KISDFGM 662
           I      L Y H  + L ++H DLK  NIL+   D+ ++P             +I D G 
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
               C DE    T  +V T  Y SPE  L   +   +D++S G ++ E  T K
Sbjct: 295 ----CCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVG 680
           +A+ ++ +    +L  +HRD+K  NIL+D + + +++DFG       D  +Q +    VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 165

Query: 681 TYGYMSPEY--ALD---GLFSVKSDVFSFGVLLLETL 712
           T  Y+SPE   A++   G +  + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 4e-04
 Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 23/153 (15%)

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEGIAQGLL 627
           + N ++L          +LI +Y+ +  L    FD  +    L      KII  + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMF----CGDELQGNTKRVVGTY 682
            LH++    IIH D+K  N+L D   +   + D+G+ ++     C D          GT 
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----------GTL 170

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            Y SPE      + V  D ++ GVL  E LT K
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 9e-04
 Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 33/124 (26%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-----------------R 664
           IA+ +L +    +L  IHRD+K  N+LLDS  + K+SDFG+                   
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 665 MFCGDELQG-NTKR---------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           +      Q  N+KR                VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 709 LETL 712
            E L
Sbjct: 227 YEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 32/132 (24%), Positives = 51/132 (38%), Gaps = 41/132 (31%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA------------------ 663
           IA+    +    ++  IHRD+K  NIL+D D + K++DFG+                   
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 664 ---RMFCGDELQGNTKR--------------------VVGTYGYMSPEYALDGLFSVKSD 700
               M   +E     +                     +VGT  Y++PE  L   ++   D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226

Query: 701 VFSFGVLLLETL 712
            +S GV+L E L
Sbjct: 227 WWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 8/88 (9%)

Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +      GK  N   VAVK L + +    +E   +E+ +++ L QH+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL 601
            L+G C   G  ++I EY     L  FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 33/124 (26%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA------------RMFCGD 669
           IA+ +L +    +L  IHRD+K  N+LLD+  + K+SDFG+             R    +
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 670 -----ELQG-NTKR---------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
                  Q  N+KR                VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 709 LETL 712
            E L
Sbjct: 227 YEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 21/157 (13%)

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEG 621
           L++++ H +L  + G CV   E I++ E++ +  L+  L    +  + + W  ++ + + 
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAW--KITVAQQ 125

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNIL-----LDSDMNP--KISDFGMARMFCGDELQGN 674
           +A  L YL   +   ++H ++ A NIL     L    +P  K+SD G++  F     +  
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREER 180

Query: 675 TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLE 710
            +R+     +++PE    G   S  +D +SFG  LLE
Sbjct: 181 VERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	835
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.7
smart00090	237	RIO RIO-like kinase.	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.09
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.74
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.46
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.42
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.39
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.38
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.31
PRK09902	216	hypothetical protein; Provisional	98.28
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.26
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.26
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	98.24
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.23
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.14
PF01636	239	APH: Phosphotransferase enzyme family This family	98.13
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.02
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.97
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.9
PLN02876	822	acyl-CoA dehydrogenase	97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.73
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.73
PRK10593	297	hypothetical protein; Provisional	97.72
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.62
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.55
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.54
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.49
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.44
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.3
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.03
PRK05231	319	homoserine kinase; Provisional	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.96
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.91
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.87
PLN02236	344	choline kinase	96.78
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	96.76
PLN02756	418	S-methyl-5-thioribose kinase	96.37
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.27
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.1
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.05
KOG2270	520	consensus Serine/threonine protein kinase involved	95.88
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.79

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=449.58  Aligned_cols=288  Identities=44%  Similarity=0.724  Sum_probs=253.7

Q ss_pred             CCCcccHHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEE
Q 003264          500 VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC  579 (835)
Q Consensus       500 ~l~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  579 (835)
                      ....|++.++..+|++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999998765433156699999999999999999999999


Q ss_pred             EecC-eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          580 VEQG-EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       580 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                      .+.+ +.+|||||+++|+|.++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999876544 88999999999999999999999988899999999999999999999999


Q ss_pred             ccCccccccCCCcccccccc-ccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC-cccccccccchhhh
Q 003264          659 DFGMARMFCGDELQGNTKRV-VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLLGHAWNLW  736 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~  736 (835)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .....+..|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111112 89999999999999999999999999999999999998887544 34445788888899


Q ss_pred             ccccchhccCcccc-chhHH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          737 KDNRAYELLSPALQ-HEASY-QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       737 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ....+.+++|+.+. ..... ....++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999999987 44443 68888999999999999999999999999996653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=396.23  Aligned_cols=261  Identities=32%  Similarity=0.502  Sum_probs=215.7

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-eEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  590 (835)
                      .++.+.+.||+|+||+||+|.+.....||||++.....  ...++|.+|+.+|.+++|||||+|+|+|.+.. ..++|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            34555667999999999999996555599999976532  22669999999999999999999999999988 7999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccccCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGD  669 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~  669 (835)
                      |+++|+|..+++.. +...+++..+++++.+||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999764 46779999999999999999999999873  99999999999999998 9999999999876432


Q ss_pred             CccccccccccccceeCceeec--CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL--DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .  .......||..|||||++.  ...|+.|+|||||||+||||+||+.||......+.              ...+...
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--------------~~~v~~~  261 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--------------ASAVVVG  261 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--------------HHHHHhc
Confidence            2  2333478999999999999  56999999999999999999999999986543111              1111112


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      ..+...+..+...+..++.+||+.||+.||++.|++.+|+.+....
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            2233333346678889999999999999999999999998775433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-45  Score=374.33  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=209.4

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-eEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  590 (835)
                      .+.+.++.||+|..|+|||++++. ++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.... ...|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            355667899999999999999865 788999999544 4556788999999999999999999999999999 5999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ||.+|+|++++..   .+.+++...-+|+.++++||.|||+..  +||||||||+||||+..|++||+|||.++.+.+. 
T Consensus       159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999943   356899999999999999999999632  4999999999999999999999999999987544 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         .....+||..|||||.+.+..|+.++||||||++++|+++|+.|+...........+..         ..+++ ...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll---------~~Iv~-~pp  299 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL---------CAIVD-EPP  299 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH---------HHHhc-CCC
Confidence               34567899999999999999999999999999999999999999876421111111100         01111 011


Q ss_pred             chhHH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASY-QMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +..+. .++.++.+++..||++||.+||++.|+++.
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22233 478889999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-45  Score=391.77  Aligned_cols=257  Identities=33%  Similarity=0.485  Sum_probs=218.1

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .+.+++++.||+|-||.||.|.++....||||.++.. ....+.|.+|+.+|++|+|+|||+|+++|..++.++||||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            3456778999999999999999988889999999764 334578889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      +.|+|.++|.+ .....+...+.+.++.||++||+||++++   +|||||.++||||+++..+||+|||||+...++.+.
T Consensus       284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            99999999965 34566889999999999999999999998   999999999999999999999999999955444432


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+...               ++.+.++...+-
T Consensus       360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~GyRl  423 (468)
T KOG0197|consen  360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGYRL  423 (468)
T ss_pred             -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccCcC
Confidence             2333445789999999999999999999999999999999 77776654422               223334444444


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ..+..++..+.+|+..||..+|++|||++.+...|+.+.
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            455567778889999999999999999999999998763

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-44  Score=406.24  Aligned_cols=262  Identities=29%  Similarity=0.450  Sum_probs=223.3

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      ..+....+.||+|.||+||+|+..      +...||||.++..... ..++|++|++++..++|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            456677889999999999999853      2457999999877555 789999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          586 ILIYEYMPNKSLNFFLFDPS-------R----THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      ++|+|||..|+|.+||....       .    ...++..+.+.|+.|||.||+||-+++   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999995321       1    234888999999999999999999987   999999999999999999


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccch
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  733 (835)
                      |||+||||+|.+...++........-+++|||||.+..++|+.+||||||||+|||+++ |+.|+.....++.      .
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------I  715 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------I  715 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------H
Confidence            99999999999988887776656667899999999999999999999999999999999 8888775543321      1


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      ..++.+++         -..+..++.++.+|+..||+.+|.+||+++||-..|+...+.
T Consensus       716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            12222222         335566778899999999999999999999999999887443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=364.92  Aligned_cols=201  Identities=30%  Similarity=0.518  Sum_probs=181.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..+|.+.++||+|+||+||+|+++. +.+||||.+...  .....+.+..|+.+|+.++|||||+|++++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            3678999999999999999999854 889999998765  5566778899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC------CCeEecccCcc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD------MNPKISDFGMA  663 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla  663 (835)
                      |||.+|+|.+|+..   .+.+++..+..++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999953   347899999999999999999999998   9999999999999764      45899999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      +.+....   .....+|++-|||||++...+|+.|+|+||+|+||||+++|+.||....
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9875432   3345789999999999999999999999999999999999999998544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-43  Score=382.53  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=212.8

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..|...+.||+|||+.||+++. ..|+.||+|++.+.   .....+.+.+||++.+.|+|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998 67999999999764   3445678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      |+|++++|..+++   +.+.+++.++..++.||+.||.|||+++   |||||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999984   5678999999999999999999999998   999999999999999999999999999987543


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  ......+||+.|+|||++....++..+||||+|||||-||.|++||+..+... +....          ..+     
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----------~~~-----  234 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----------LNE-----  234 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH----------hcC-----
Confidence            2  34456899999999999999999999999999999999999999998654221 11100          000     


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        -..+...+....+||.++|+.+|.+||++++|+..
T Consensus       235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              11222445667889999999999999999999954

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=358.90  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=205.6

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh-------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++...       ......++|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3467888999999999999999874 599999999976521       12334579999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC---CCeEeccc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDF  660 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DF  660 (835)
                      ..||||||+++|.|.+.+..   .+.+.+..-..+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999998843   455777888899999999999999998   9999999999999765   67999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCC---CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |+|+...   ....+...+||+.|.|||++..+.   +..++|+||+||+||-+++|.+||...-....     ..+++.
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQIL  395 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHh
Confidence            9999864   233456789999999999998764   33478999999999999999999975332210     011111


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .++.      ...+....+..++..++|.+||..||++||++.|+++.
T Consensus       396 ~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 KGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            1111      01123445677889999999999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-43  Score=347.16  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEee-EEEecCe-EEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG-CCVEQGE-KILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV  588 (835)
                      .+|+++++||+|.||+|||++. .+|..||.|.+.-.  +....+....|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            5689999999999999999985 57999999988633  4556778899999999999999999998 4555555 8999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS-RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ||||..|+|..++... +..+.+++..+++++.|++.||.++|+.- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999653 34567999999999999999999999832 134999999999999999999999999999998


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .....  .....+||+.||+||.+.+..|+.||||||+||++|||+.-++||...+     +......+ ...+      
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~~KI-~qgd------  244 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLCKKI-EQGD------  244 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHHHHH-HcCC------
Confidence            54432  2345799999999999999999999999999999999999999997542     21111111 1111      


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                        ..+-....++..+.+||..|+..||+.||+...+++.+..
T Consensus       245 --~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 --YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              1111225677889999999999999999997666666544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-42  Score=341.35  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      +.|+.+.++|+|+||.|||++.++ |+.||||++....+  ...+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            468888999999999999999876 99999999976533  345567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ||+..-|+++-   .....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.+|.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            99998887765   23456889999999999999999999998   99999999999999999999999999999863  


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCC-ccccc--------ccccchhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFN--------LLGHAWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~--------~~~~~~~~~~~~~  740 (835)
                      ....-+.++.|.+|.|||.+.+ ..|...+||||+||++.||++|.+-|...+ .++..        +......++....
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            2233455788999999999988 689999999999999999999999987654 33221        1111111222111


Q ss_pred             -chh--ccCccccch---hHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 -AYE--LLSPALQHE---ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 -~~~--~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ..-  +..+.-...   .-+..+..+++++..|++.||.+|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             111  111111111   11234557899999999999999999999884

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=377.54  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=218.3

Q ss_pred             cCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ....+.++||.|.||+|++|+++-    ...||||.++.. .+....+|+.|+.||.+++||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456678899999999999999853    347999999876 456778999999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      .|||++|+|+.||...  .+.+.+.+...++++||.||.||.+.+   +|||||.++||||+.+..+||+||||++.+.+
T Consensus       709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999654  355899999999999999999999988   99999999999999999999999999998755


Q ss_pred             CCccc-cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          669 DELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       669 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      +.... .+..-.-+.+|.|||.+...+++.+||||||||+|||.++ |.+|+=.+.               ++++...++
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------------NQdVIkaIe  848 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------------NQDVIKAIE  848 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------------hHHHHHHHH
Confidence            44211 1111223679999999999999999999999999999877 888854322               223334444


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ...+-..+.+++..|.+|++.|||+|..+||.+.+|+.+|+++..
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            555556677888999999999999999999999999999987643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=350.24  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|+++++||+|+||+||.++.++ ++.+|+|++++..   ....+..++|..+|.+++||.||+++..|.+.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999998765 8899999997652   33567789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||+.||.|..+|   ++...+++..+.-++..|+.||.|||+++   ||||||||+|||||.+|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999   35567899999999999999999999998   99999999999999999999999999996533


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+...+     .......+         
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----~~~I~~~k---------  241 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----YDKILKGK---------  241 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----HHHHhcCc---------
Confidence            3  2334458999999999999999999999999999999999999999986552211     00000000         


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                       ....+.-......+++...++.+|++|.
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             0111122345677899999999999995

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-41  Score=391.46  Aligned_cols=261  Identities=30%  Similarity=0.498  Sum_probs=219.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC--Cc----EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN--GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++.++.+.||+|.||.||+|...+  |.    .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4567788999999999999998644  43    4999999765 567788999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      +|++|||++|+|..||.+.+    +...+...+.+.++.+||+|+.|||+++   +|||||.++|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997642    2456888999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhcccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      ||+.+...++........-+..|||||.+.++.++.|+|||||||+|||++| |..|+...+..+.  ...   ....+ 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~---~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLD---VLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHH---HHhCC-
Confidence            9998777776665555556789999999999999999999999999999999 7788875442211  110   00111 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                               +-+.+..++..+.+|+..||+.+|++||++..+++.+..+..
T Consensus       922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                     233455566788899999999999999999999998877643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=358.04  Aligned_cols=266  Identities=28%  Similarity=0.443  Sum_probs=219.2

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..+...+.++||+|-||+|.++....+..||||+++... .....+|.+|+++|.+|+|||||+|+|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            446778889999999999999999888999999998764 4456899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+|+..+.-.. +.....++|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+...+
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999996543222 455677889999999999999988   9999999999999999999999999999888777


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh--CCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      +.......+-+++|||||.+..++++.++|||+||+++||+++  ...|+.....++.  .+........+..      .
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~------~  763 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGR------Q  763 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCc------c
Confidence            7777777788999999999999999999999999999999866  5677765443321  1111111111111      1


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .....+.-++..+.+++..||..+.++||+++++...|.+.
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11123344567788999999999999999999999988764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=342.81  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=217.1

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|++.+.||.|.-++||+|+. +.+..||||++.-.. ....+.+++|+..|+.++||||++++..|..+..+++||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            347899999999999999999986 458999999997543 334789999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      .||.+|++.++++..- ...+++..+..|++++++||.|||+++   .||||||+.||||+.+|.+||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999996542 334889999999999999999999998   999999999999999999999999988766443


Q ss_pred             Ccc-cc-ccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          670 ELQ-GN-TKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       670 ~~~-~~-~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ... .. ....+||++|||||++..  ..|+.|+||||||++..||++|..||..+....+.+....      +....+.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq------n~pp~~~  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ------NDPPTLL  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc------CCCCCcc
Confidence            321 11 156789999999999654  4699999999999999999999999998775543332211      1111122


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+..+....+...+.+++..|++.||++|||++++++.
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            2233444555666789999999999999999999999853

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=347.71  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=205.8

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC--eEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~  589 (835)
                      ..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3568888999999999999999865 8999999987654334677899999999999999999999855544  689999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~  668 (835)
                      ||+++|+|.+++.+...  .+++..+.+++.||++||+|||+++   ||||||||+||||+. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999955432  6999999999999999999999988   999999999999999 79999999999987653


Q ss_pred             -CCccccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCC-Ccccccccccchhhhccccchhcc
Q 003264          669 -DELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                       ...........||+.|||||++.++. ...++|||||||++.||+||++||... +...     .   +.      .+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-----~---~~------~ig  236 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-----A---LL------LIG  236 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-----H---HH------HHh
Confidence             12223344578999999999999643 345999999999999999999999863 1110     0   00      000


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .....+..+...+....+++..|++.+|++|||++++++..-
T Consensus       237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            000111334445667888999999999999999999998753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=356.61  Aligned_cols=269  Identities=28%  Similarity=0.458  Sum_probs=216.5

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      ..+.+...+++.+.+.||+|+||+||+|++.  ..||||+++..  ..+..+.|++|+..+++-+|.||+-+.|+|....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3455556677888999999999999999984  36999999754  4557889999999999999999999999999887


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      . .||+.+|++.+|..+|+..+  ..+...+.++|++||++||.|||.++   |||||||..||++.+++.|||+||||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence            7 99999999999999996543  56888899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      ..-..-..........|...|||||++..   .+|+.++||||||+++|||++|..|+.....++.        +|..++
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------ifmVGr  607 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------IFMVGR  607 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------EEEecc
Confidence            65332222222334567889999999865   4699999999999999999999999984333332        122222


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      -+-..|..   .....+.+++.+|+..||..++++||.+.+|+.+|+.+...+
T Consensus       608 G~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 GYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            21111111   223455677888999999999999999999999998874433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-39  Score=359.37  Aligned_cols=261  Identities=28%  Similarity=0.397  Sum_probs=205.0

Q ss_pred             hcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC-
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG-  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-  583 (835)
                      .++|++.++||+|+||.||+|.+      ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            47899999999999999999974      225689999987543 33456789999999999 8999999999887654 


Q ss_pred             eEEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  606 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  606 (835)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999998854211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccce
Q 003264          607 --THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY  684 (835)
Q Consensus       607 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  684 (835)
                        ...+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134778889999999999999999987   999999999999999999999999999865433222222334567889


Q ss_pred             eCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHH
Q 003264          685 MSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  763 (835)
Q Consensus       685 ~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  763 (835)
                      +|||++.+..++.++|||||||+||||++ |..||........ ..    .....+..     .    ..+...+..+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~----~~~~~~~~-----~----~~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC----QRLKDGTR-----M----RAPENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH----HHHhcCCC-----C----CCCCCCCHHHHH
Confidence            99999999999999999999999999997 9999875432110 00    00111100     0    011223456889


Q ss_pred             HHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          764 VALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       764 li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ++.+||+.+|++||++.|++++|+.+.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=350.96  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=210.9

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ....+|...+.||+|+|++|++|+..+ +++||||++.+.   .+...+.+..|-.+|.+| .||.|++|+..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345789999999999999999998755 899999998764   233345577889999999 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      |+|+||+++|+|.++|.+   .+.+++.....++.+|+.||+|||++|   ||||||||+|||||.|+++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999953   467899999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcc---------ccc--cccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          666 FCGDELQ---------GNT--KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       666 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      +.+....         ...  ...+||..|.+||++.+...+..+|+|+||||||+|+.|.+||...+.-  ....    
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFq----  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQ----  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHH----
Confidence            8553221         122  4589999999999999999999999999999999999999999864421  1110    


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                              ++++  +.-+.+..+++...+|+.+.|-.||.+|++..||.+.
T Consensus       298 --------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 --------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                    0100  1112333444677889999999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=345.77  Aligned_cols=267  Identities=24%  Similarity=0.351  Sum_probs=207.3

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  586 (835)
                      ..+.|+.+++||+|.||.||||++ .+|+.||+|++....  +.......+||.+|++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346799999999999999999986 458999999987553  34456678899999999999999999999887  6899


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ||+|||++ +|.-++..  ..-.+++.++..++.||+.||+|+|+++   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999987 45555522  2345889999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCC-ccccccccc-----chhhhccc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLLGH-----AWNLWKDN  739 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~-----~~~~~~~~  739 (835)
                      ....... .+..+-|.+|.|||.+.+. .|+.++|+||.||||.||+.|++.+.... .++.+..-.     ....|...
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            6554433 3445679999999999886 79999999999999999999999988654 232221100     01112211


Q ss_pred             cch--hccCcccc-----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 RAY--ELLSPALQ-----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 ~~~--~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.  ..+.+...     .+.-..+....++|+..+|..||.+|.|+.++++.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111  11111111     11123345667889999999999999999999864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=352.03  Aligned_cols=245  Identities=29%  Similarity=0.440  Sum_probs=206.4

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      .++-||+|+.|.||+|++ .++.||||+++...       ..+|+-|++|+||||+.|.|+|.....++||||||+.|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            457899999999999999 56899999986543       3478889999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      ...|+   ....+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||-++.....   .....
T Consensus       200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            99994   3456788889999999999999999987   999999999999999999999999999987433   34456


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      +.||..|||||++.+.+.++|+|||||||||||||||..|+...+....        +|..+      ...+.-..+..+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------IwGVG------sNsL~LpvPstc  336 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IWGVG------SNSLHLPVPSTC  336 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EEecc------CCcccccCcccC
Confidence            8999999999999999999999999999999999999999875442211        11111      112223344556


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      +.-+.-|+.+||+..|.+||++++++..|+-..+++
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            677888999999999999999999999997665444

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=356.54  Aligned_cols=264  Identities=29%  Similarity=0.391  Sum_probs=212.6

Q ss_pred             hhcCCccccccccCCcccEEEEEecC--C--cE-EEEEEecC---cChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN--G--QE-VAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      ..++..+.++||+|+||.||+|++..  +  .. ||||..+.   .......+|.+|+++|++++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34566677999999999999998754  2  23 89999875   34667889999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      .+++|||+|.||+|+++|.+..  ..++..+++.++.+.|.||+|||+++   +|||||.++|+|+..++.+||+||||+
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence            9999999999999999995432  36899999999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccch
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      +.-.  .+........-+..|+|||.+....|+.++|||||||++||+++ |..|+........  .    .        
T Consensus       310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--~----~--------  373 (474)
T KOG0194|consen  310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--K----A--------  373 (474)
T ss_pred             cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--H----H--------
Confidence            7642  12222222356789999999999999999999999999999999 7778765432110  0    0        


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCC
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  796 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p  796 (835)
                      .+.....+...+...+..+..++.+|+..+|++||+|.++.+.|+.+......+
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            000111122222244556677888999999999999999999999886665554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.7e-39  Score=316.18  Aligned_cols=275  Identities=24%  Similarity=0.374  Sum_probs=210.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChh--hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|..+++||+|.||.||+|++. .|+.||||+++.....  -.....+|++.|+.++|+||+.|+++|.+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999974 5999999999755322  23456889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++ .+|...+++  +...+...++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 478888854  4557889999999999999999999998   9999999999999999999999999999885443


Q ss_pred             ccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCC-ccccccc--------ccchhhhccc-
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLL--------GHAWNLWKDN-  739 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~--------~~~~~~~~~~-  739 (835)
                      ...  ...+-|.+|.|||.+.+. .|+...|+||.|||+.||+-|.+-+.... .++....        ...|..+..- 
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            222  223789999999999875 69999999999999999999988776543 3332111        1112111110 


Q ss_pred             ---cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 003264          740 ---RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS  799 (835)
Q Consensus       740 ---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~  799 (835)
                         .......+.+.. .-.......++++..++..||.+|++++|++++= .. ..+|.|..+
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf-~~~P~pt~~  293 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YF-KSLPLPTPP  293 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch-hh-hcCCCCCCh
Confidence               111111111111 2234456679999999999999999999999772 11 334555443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=346.56  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=208.3

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHH--HHHHHHHHHhcC-CCceeeEeeEEEecC-eEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLMGCCVEQG-EKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~  586 (835)
                      ..++|.++++||.|.||.||+|+-. .+..||||+++..-.. +++  -.+|++.|++|+ |||||+|.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3478999999999999999999864 4889999999765332 222  367999999998 999999999999988 999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +|||||+. +|.+++++  +.+.+++.++..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.+
T Consensus        87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999965 78888855  4778999999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCccccccccccccceeCceeec-CCCCCccccchhHHHHHHHHHhCCCCCCCCCc-cccc----cc-ccchhhhccc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN----LL-GHAWNLWKDN  739 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~----~~-~~~~~~~~~~  739 (835)
                      ....   .-+.++.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|.+.++ ++..    .+ ...+..|.++
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            4432   345578999999999875 46799999999999999999999988876552 2210    01 0111111111


Q ss_pred             -cchh---ccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 -RAYE---LLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 -~~~~---~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ....   +.-|...    ...-...+.+..+++.+|++.||.+|||++|.+++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             1111   1111111    12223467788999999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=348.70  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=210.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ..|...++||+|.-|.||.++.. .++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            56778889999999999999864 58899999998766666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+.+    ....+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999999998    3345899999999999999999999998   99999999999999999999999999988754433 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       .....+||+.|||||++....|++|.||||||++++||+-|.+|+-..+.-.      +..++...     -.|.+  .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~n-----g~P~l--k  490 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATN-----GTPKL--K  490 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhc-----CCCCc--C
Confidence             4456799999999999999999999999999999999999999986422110      00011111     11111  2


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+...+..+.+++.+||+.|+++||++.|+|+.
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            344566788999999999999999999999975

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-38  Score=341.97  Aligned_cols=264  Identities=29%  Similarity=0.463  Sum_probs=203.8

Q ss_pred             cCCccccccccCCcccEEEEEecC-----------------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRL  575 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  575 (835)
                      ++|++.++||+|+||.||++.+.+                 +..||||.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578999999999999999997532                 3369999987643 3445679999999999999999999


Q ss_pred             eeEEEecCeEEEEEEecCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEE
Q 003264          576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPS----------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH  639 (835)
Q Consensus       576 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  639 (835)
                      ++++.+....++||||+++|+|.+++....                ....+++..+.+++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999884321                1134678899999999999999999988   999


Q ss_pred             ecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhC--CCC
Q 003264          640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS--KRN  717 (835)
Q Consensus       640 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG--~~p  717 (835)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999876443332223344567899999999988999999999999999999974  456


Q ss_pred             CCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          718 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      +.......  ..............      ......+..++..+.+++.+||+.+|++||++.||.+.|++
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ--VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH--HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            65433211  11111111100000      00000112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=338.21  Aligned_cols=270  Identities=26%  Similarity=0.386  Sum_probs=207.1

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHh--cCCCceeeEeeEEEecC----eEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG----EKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~l  587 (835)
                      +..++.++||+|+||.||||++. ++.||||++...   ..+.|++|-++...  ++|+||++++++-....    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            45667789999999999999994 599999999654   44667777666664  58999999999887666    8999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~------~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      |+||.+.|+|.++|    ....++|....+|+..+++||+|||+      +.+++|+|||||++||||..|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    45679999999999999999999996      346789999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCCccccccccc--c-
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FS-----VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH--A-  732 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--~-  732 (835)
                      +|..+............+||.+|||||++.+.. +.     .+.||||+|.|||||++...-......+.+.+.-.  . 
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999998777677777789999999999987642 22     36899999999999999765443212222111100  0 


Q ss_pred             ----hhhhccccchhccCccccc-hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          733 ----WNLWKDNRAYELLSPALQH-EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       733 ----~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                          ...++.-.+.+...|.++. -.....+..+.+.+..||..||+.|.|+.=+.+.+.++..
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                0000000111111222211 0112446778899999999999999999999999988743

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-39  Score=344.94  Aligned_cols=247  Identities=26%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|.+.+.||+|.||.||||+-+. .+.||+|.+.+.  .+...+.+++|++++++++|||||.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            578999999999999999998754 789999999765  34567889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+.+ +|..+|.   ....++++.+..++.+++.||.|||+++   |+|||+||+|||++..+.+|++|||+|+....+ 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 9999993   4567999999999999999999999987   999999999999999999999999999976432 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       ......+.||+.|||||...++.|+..+|.||+||||||+++|++||-....-  .+..   .+        +-||.. 
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~--~Lv~---~I--------~~d~v~-  218 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT--QLVK---SI--------LKDPVK-  218 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH--HHHH---HH--------hcCCCC-
Confidence             23345678999999999999999999999999999999999999998542211  1110   00        011111 


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        .+...+..+..++...++.||.+|.+-.+++..
T Consensus       219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             --CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence              233667778899999999999999999998854

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=339.28  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=211.9

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..|+..++||+|.||.||||.+.. ++.||+|++.-. .+...+++++|+.+|..++|+||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            457777999999999999999854 889999999754 455678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      |.+|++.+.|.   ....+.+..+.-++++++.||.|||+++   .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999983   3344578888889999999999999998   99999999999999999999999999988755443


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      ..  ...+||+.|||||++....|+.|+||||||++.+||++|.+|+........               .-++....++
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------lflIpk~~PP  229 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------LFLIPKSAPP  229 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------------EEeccCCCCC
Confidence            32  568999999999999988999999999999999999999999876543222               1122222333


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....++..+.+++..||..+|+.||++.++++.
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            3344677789999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.6e-38  Score=351.23  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             hcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.++||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35799999999999999999974      235689999987542 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR----------------------------------------------------------  606 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  606 (835)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          607 --------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       607 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                                    ...+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124778899999999999999999987   999999999999999999999999999876433222


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.. ..    ..+....  ...      
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~----~~~~~~~--~~~------  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FY----KMIKEGY--RML------  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HH----HHHHhCc--cCC------
Confidence            22223345678999999999999999999999999999998 8888764332110 00    0111110  000      


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                       .+...+..+.+++.+|++.+|++||++.||+++|+.
T Consensus       338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence             111123467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.3e-38  Score=335.68  Aligned_cols=244  Identities=19%  Similarity=0.300  Sum_probs=197.8

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChh---hHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeEEEEEEec
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYM  592 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~E~~  592 (835)
                      ..||+|+++.||+|+. +|+.||||++......   ..+.|.+|+.+|.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 6899999998754322   25778899999999999999999999987    34688999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++|+|.+++..   ...+++....+++.+++.||.|||+. +   ++||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999954   34588999999999999999999984 5   7899999999999999999999999998653221 


Q ss_pred             cccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                          ....++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ...   .....     ..+  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~~~---i~~~~-----~~~--  241 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--YDL---IINKN-----NSL--  241 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--HHH---HHhcC-----CCC--
Confidence                22457889999999976  6899999999999999999999999975432211  100   00000     001  


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        ..+...+..+.+++.+||+.+|++||+++|+++.|+..
T Consensus       242 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              11123455788999999999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.4e-38  Score=351.07  Aligned_cols=260  Identities=28%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+|+..      ++..||||++.... ....+.+.+|+.+++.+ +|+||+++++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            468999999999999999998742      24579999997543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCC-----------------------------------------------------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPS-----------------------------------------------------------  605 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  605 (835)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999884321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          606 --------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       606 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                              ....+++..+.+++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    0124678889999999999999999987   99999999999999999999999999986533222112222


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  756 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  756 (835)
                      ..++..|||||++.+..++.++|||||||++|||++ |+.||........ ..    .....         ......+..
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~---------~~~~~~~~~  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKR---------GYQMSRPDF  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHc---------ccCccCCCC
Confidence            345678999999999999999999999999999997 9999865332110 00    00000         000011111


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          757 MLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+..+.+++.+||+.+|++||++.+|+++|+++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            245688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=315.39  Aligned_cols=237  Identities=26%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|+.++.||.|+||.|.+++.+. |..+|+|++++..-   ...+...+|..+|+.+.||+++++++.+.+.+.++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            3689999999999999999999865 78899999987642   3456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||.++|.|..+|+   +.+.+++..+..++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+... 
T Consensus       123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            99999999999994   4456899999999999999999999998   9999999999999999999999999999763 


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                          ..+-..+||+.|+|||++....|..++|.|||||++|||+.|.+||......  .+.+            .++.. 
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--~iY~------------KI~~~-  256 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--QIYE------------KILEG-  256 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--HHHH------------HHHhC-
Confidence                3356689999999999999999999999999999999999999999754421  1110            00100 


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADR  776 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~R  776 (835)
                       .-..+.-+...+.+|+...++.|-.+|
T Consensus       257 -~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 -KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             112445566778889999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-38  Score=345.70  Aligned_cols=247  Identities=27%  Similarity=0.362  Sum_probs=209.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .-|++.+.||.|+-|.|-.|++. .|+.+|||++.+.   .......+.+|+.+|+.+.||||+++++++++..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45889999999999999999974 5999999999765   2334566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|.|.+++.   +.+.+++.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||||..-.+ 
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999984   4567999999999999999999999998   99999999999999999999999999976322 


Q ss_pred             CccccccccccccceeCceeecCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                        .......+|.+.|.|||++.+..|. .++||||.|||||.||+|+.||+..+...  ++..+    +          .
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LLlKV----~----------~  226 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LLLKV----Q----------R  226 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HHHHH----H----------c
Confidence              2334567999999999999999884 78999999999999999999998544322  11111    0          0


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+.+...+.+..+|+.+|+..||+.|.|++||++.
T Consensus       227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1122345566778899999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=341.14  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=204.9

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc----Ch-hhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  584 (835)
                      ...+|.+.+.||+|.||+|+.|+.. .++.||||++...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4578999999999999999999864 5899999977653    12 33556778999999998 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCcc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA  663 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla  663 (835)
                      .++||||+.+|+|.+++.+   ...+.+.++.++++||+.|++|||+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456888999999999999999999998   9999999999999999 99999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      ....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+....  ..   . +...  
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--~~---k-i~~~--  238 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--YR---K-IRKG--  238 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--HH---H-HhcC--
Confidence            8763  2233445678999999999999977 86 789999999999999999999986332111  00   0 0000  


Q ss_pred             hhccCccccchhHHHH-HHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          742 YELLSPALQHEASYQM-LNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                       +.       ..+... +..+..++.+|++.+|.+|+++.+++
T Consensus       239 -~~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 -EF-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -Cc-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             00       111122 56788899999999999999999999

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=329.24  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=202.3

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--------------hhhHHHHHHHHHHHHhcCCCceeeEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------------GQGLKEFKNEMMLIAKLQHRNLVRLM  576 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l~  576 (835)
                      ..++|++.+.||+|.||.|-+|+.. +++.||||++.+..              ....+..++||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3578999999999999999999874 58999999986431              11346889999999999999999999


Q ss_pred             eEEEec--CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          577 GCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       577 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      .+..+.  +.+|||+|||..|.+...-   .....+.+.++.++++++..||+|||.++   ||||||||+|+||+++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence            998754  5899999999999875432   12223899999999999999999999998   999999999999999999


Q ss_pred             eEecccCccccccCCC---ccccccccccccceeCceeecCCC----CCccccchhHHHHHHHHHhCCCCCCCCCccccc
Q 003264          655 PKISDFGMARMFCGDE---LQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  727 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~  727 (835)
                      +||+|||.+..+....   ........+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.....-  .
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--~  326 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--E  326 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--H
Confidence            9999999998763332   112233478999999999987743    356789999999999999999998642211  0


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      +.            ..++...+......++.+.+.+||.++|++||++|.+..+|....
T Consensus       327 l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 LF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            10            112222333333345677889999999999999999999987653

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-37  Score=332.63  Aligned_cols=257  Identities=29%  Similarity=0.482  Sum_probs=208.4

Q ss_pred             cCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578899999999999999998643      2579999987543 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          587 LIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ++|||+++++|.+++.....             ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854211             145788999999999999999999988   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........  .   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~---  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--I---  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H---
Confidence            999999999986644333233334456889999999998999999999999999999998 9999865332211  0   


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                       ..+..         ......+..++..+.+|+.+||+.+|++||+++||++.|++
T Consensus       237 -~~i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 -EMIRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             01111         11111233456788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=325.27  Aligned_cols=271  Identities=25%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHH--hcCCCceeeEeeEEEecC----eE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA--KLQHRNLVRLMGCCVEQG----EK  585 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~----~~  585 (835)
                      ..++..+.+.||+|.||+||+|++ .|+.||||++...++..   +.+|.++..  .|+|+||+.+++.-..+.    ++
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            457889999999999999999999 68999999998765543   445666655  459999999998866543    78


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      +||.+|.++|+|.+||.    ...++....++++..+|.||+|||.     ++++.|.|||||++||||+.++.+.|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999993    4678999999999999999999994     67899999999999999999999999999


Q ss_pred             CccccccCC--CccccccccccccceeCceeecCCC----C-C-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccc
Q 003264          661 GMARMFCGD--ELQGNTKRVVGTYGYMSPEYALDGL----F-S-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       661 Gla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~  732 (835)
                      |||......  .........+||.+|||||++.+.-    + + ..+||||||+|+||++.....-+....-+..+.+.+
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999876443  2334456679999999999986532    2 1 358999999999999874322111111111111111


Q ss_pred             hhhhccccch-----hccCcccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          733 WNLWKDNRAY-----ELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       733 ~~~~~~~~~~-----~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ......++..     +.+.|.+. .-.+.+.+..+.+++..||..+|.-|-++--+.+.|.++.
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            1111111111     11222221 2244567888999999999999999999999999988763

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-37  Score=332.44  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=205.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++++.||+|+||.||+++-++ |..+|+|++++..   ....+.++.|-.+|...++|.||+|+..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45899999999999999999998765 8999999998764   3456678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||++||++..+|   .+...|++..+..++.+++-|++.||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999   45678999999999999999999999998   9999999999999999999999999995431


Q ss_pred             C----------------------CCccc-----cc------------------cccccccceeCceeecCCCCCccccch
Q 003264          668 G----------------------DELQG-----NT------------------KRVVGTYGYMSPEYALDGLFSVKSDVF  702 (835)
Q Consensus       668 ~----------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~s~ksDVw  702 (835)
                      .                      .+...     ..                  ...+||+.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      00010     00                  124799999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCcccc--cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC--
Q 003264          703 SFGVLLLETLTSKRNTGVYDIESF--NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT--  778 (835)
Q Consensus       703 SlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs--  778 (835)
                      |||||+||||.|.+||........  .+..|..              .+..........+..+||.+|+. ||++|..  
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            999999999999999986553321  1222111              11111112233667889999999 9999975  


Q ss_pred             -HHHHHHH
Q 003264          779 -MSKVVSM  785 (835)
Q Consensus       779 -~~evl~~  785 (835)
                       ++||.+.
T Consensus       438 G~~EIK~H  445 (550)
T KOG0605|consen  438 GAEEIKKH  445 (550)
T ss_pred             cHHHHhcC
Confidence             6666544

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-37  Score=328.83  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             hcCCccccccccCCcccEEEEEec----CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357899999999999999999763    35689999987653 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998542  346889999999999999999999988   9999999999999999999999999876532


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .... .......++..|+|||.+.+..++.++|||||||++||+++ |..||........  ..    .....       
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~----~~~~~-------  224 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IK----AVEDG-------  224 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHHCC-------
Confidence            2111 11112345678999999999999999999999999999775 9999865432210  00    00000       


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        .....+..++..+.+++.+||+.+|++||+++++++.|+..
T Consensus       225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              00111223456688899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-37  Score=345.64  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=206.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  584 (835)
                      .++|++.++||+|+||.||+|+...      +..||||++.... ....+.+.+|++++++++ ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4789999999999999999998532      3479999997543 334567999999999995 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCC-----------------------------------------------------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPS-----------------------------------------------------------  605 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  605 (835)
                      .+|||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875321                                                           


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC
Q 003264          606 ----------------------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       606 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~  651 (835)
                                                        ....+++..+.+++.||++||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                              0124778888999999999999999987   999999999999999


Q ss_pred             CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccc
Q 003264          652 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLG  730 (835)
Q Consensus       652 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~  730 (835)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.........   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence            99999999999987643332222233456788999999999999999999999999999997 88888643221110   


Q ss_pred             cchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        .......         .....+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       350 --~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 --YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              0000000         00111223456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=339.48  Aligned_cols=271  Identities=21%  Similarity=0.317  Sum_probs=220.0

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      ....++|.++++||+|+||+|+++..+. ++.+|||.+++..   ....+..+.|..++... +||.+++|+.+|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3455899999999999999999999865 7889999998763   45567788898888887 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      +++||||+.||++..+.    +...+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999954333    4567999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .-..  ....+.+.+||+.|||||++.+..|+..+|.|||||+||||+.|..||...+.+..                  
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------  576 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------  576 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------
Confidence            6432  23356778999999999999999999999999999999999999999987664421                  


Q ss_pred             cCcccc--chhHHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH---h-----hc-ccCCCCCCCCCcccccccC
Q 003264          745 LSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTM----SKVVSM---I-----TN-EHATLPYPKQSAFSYARRG  807 (835)
Q Consensus       745 ~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~---L-----~~-~~~~l~~p~~~~~~~~~~~  807 (835)
                      +|..+.  ..++.-.+.+.+.|+.+++..+|++|..+    .+.+..   +     +. ..+.+++|..|....++..
T Consensus       577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~  654 (694)
T KOG0694|consen  577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV  654 (694)
T ss_pred             HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence            111111  12344456677889999999999999877    443322   1     11 2356677777766555553

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.2e-37  Score=336.63  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+++.. .+..||+|.+... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            378999999999999999999986 4788999998754 33445679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||+++.+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999843   345889999999999999999999853  4999999999999999999999999999765322 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-cccc-ch-------hhhc-c--
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGH-AW-------NLWK-D--  738 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~-~~-------~~~~-~--  738 (835)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...+..... .... ..       .... .  
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               223356899999999999999999999999999999999999998654321110 0000 00       0000 0  


Q ss_pred             ----------------ccchhccC----ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 ----------------NRAYELLS----PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ----------------~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                      ....++.+    ..........+...+.+++.+||+.||++||+++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            00000000    000000111245678999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-38  Score=331.72  Aligned_cols=251  Identities=35%  Similarity=0.544  Sum_probs=196.1

Q ss_pred             ccccccccCCcccEEEEEec-----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          517 SMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++.. .....+.|.+|++.+++++||||++++|++.+.+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35678999999999999986     2568999999654 34457899999999999999999999999998888999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.++|... ....+++..+..++.||++||+|||+++   ++|+||+++|||++.++.+||+|||+++......
T Consensus        82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999654 2356899999999999999999999987   9999999999999999999999999998763333


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .............|+|||.+....++.++||||||+++|||++ |+.|+.......  +..   .. ....         
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~---~~-~~~~---------  222 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIE---KL-KQGQ---------  222 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHH---HH-HTTE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc---cc-cccc---------
Confidence            3333344557789999999999999999999999999999999 678876543221  110   00 1110         


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      ....+..++..+.+++..||+.+|++||++.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1111222345678899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.6e-37  Score=329.09  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=207.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|.+.+.||+|+||.||+|+..+      ++.||||.+...... ..+.+.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568899999999999999998643      478999999765443 567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          586 ILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      ++||||+++++|.+++....           ....+++..+..++.||+.||+|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985421           2345788999999999999999999988   999999999999999999


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccch
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  733 (835)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...+.+..  ..   
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~--~~---  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--IE---  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HH---
Confidence            99999999986543332222233446788999999999999999999999999999998 9999865432211  10   


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                       ......         ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       236 -~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 -CITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             000110         01111234466889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.3e-37  Score=330.91  Aligned_cols=261  Identities=28%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             cCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|+.++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999753      345699999877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          588 IYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      ||||+++++|.+++....             ....+++..+++++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1234889999999999999999999988   999999999999999999


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccch
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  733 (835)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  .    
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~----  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--I----  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----
Confidence            99999999976543332222334456789999999999999999999999999999999 9999865432211  0    


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      ..........         ....++..+.+++.+|++.+|++||++.+|+++|+++.+.
T Consensus       236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            0111111110         1112345688999999999999999999999999988543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-37  Score=323.72  Aligned_cols=256  Identities=29%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|++|.||+|...+++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46799999999999999999998778899999986543 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 345889999999999999999999987   999999999999999999999999999876422211


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......+..|+|||.+.+..++.++||||||++++||++ |+.|+.......  ...    .....         ...
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~---------~~~  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ----QVDQG---------YRM  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcC---------CCC
Confidence             1112233468999999999999999999999999999999 888886433111  000    00000         000


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            11123346788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-37  Score=326.63  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=212.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ...+|++.++||+|+||.||+|+..+++.+|+|.+..........+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44679999999999999999999988999999999876665677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.+.. ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996542 345789999999999999999999987   99999999999999999999999999987643221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                      .  .....++..|+|||.+.+..++.++||||||++++||++ |+.|+........  ..             .+.....
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~-------------~~~~~~~  222 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YD-------------QITAGYR  222 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HH-------------HHHhCCc
Confidence            1  113345778999999998899999999999999999998 8888865432111  00             0001111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ...+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            112233456788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=339.67  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+|+... ++.||||++....   ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            468999999999999999999864 8899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   346889999999999999999999988   99999999999999999999999999986532 


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.....  .   ......   ..+....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~---~i~~~~---~~~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--E---NLKYWK---ETLQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--H---HHHhcc---ccccCCC
Confidence                233457899999999999999999999999999999999999998754422110  0   000000   0000000


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+..+.+++.+|++.+|++||++.|+++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            011112345677889999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-37  Score=329.25  Aligned_cols=252  Identities=24%  Similarity=0.301  Sum_probs=201.1

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999874 58999999986432   2234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998887543 2335889999999999999999999988   9999999999999999999999999998653221


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  .......        ..  ...
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~--------~~--~~~  221 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRR--------VK--EDQ  221 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHH--------hh--ccc
Confidence               12335689999999999999999999999999999999999999975432110  0000000        00  001


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                      ...+...+..+.+|+.+||+.+|++||+     ++++++.
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            1122234567788999999999999997     7787763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.3e-37  Score=329.02  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=203.8

Q ss_pred             hhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      .+++|++.+.||+|+||.||+|.+.      .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24679999986432 2345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      .++||||+++++|.+++.....       ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234678889999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhh
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      +|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+..  ..    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~--~~----~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--LR----FV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HH
Confidence            99999986543332222222345788999999999999999999999999999999 6788764332111  00    00


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ......         ..+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            001000         011123456788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-37  Score=324.22  Aligned_cols=257  Identities=29%  Similarity=0.448  Sum_probs=206.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|++..    ...||||.+.... .....+|.+|+.++.+++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578999999999999999998743    3579999987543 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++...  ...+++..+.+++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999998542  236889999999999999999999987   9999999999999999999999999998774


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    .....       
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~----~~~~~-------  224 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IK----AVEDG-------  224 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HH----HHHcC-------
Confidence            2222222223345678999999999999999999999999999998 9988864332110  00    00000       


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        .....+...+..+.+++.+|++.+|++||+++||++.|+.+
T Consensus       225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              00011122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=336.89  Aligned_cols=263  Identities=27%  Similarity=0.419  Sum_probs=223.3

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      ...+....+.++.++||-|-||.||.|.++. .-.||||.++.. .-..++|++|+.+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444555677888999999999999999865 668999999764 34578999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      |||+|||.+|+|.+||.+-. ...++....+.++.||+.||+||..++   +|||||.++|+||.++..+||+||||++.
T Consensus       339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999996543 334677788999999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      +..+.+... ....-++.|.|||-+....++.|+|||+|||+||||.| |..|+...+.               .+++++
T Consensus       415 MtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------------SqVY~L  478 (1157)
T KOG4278|consen  415 MTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYGL  478 (1157)
T ss_pred             hcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------HHHHHH
Confidence            876654432 22334779999999999999999999999999999998 6777765331               234555


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      +....+-+.+..++..+.+|+++||+.+|.+||++.|+-+.++.+.
T Consensus       479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            5666666667778889999999999999999999999999887543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.2e-37  Score=324.16  Aligned_cols=255  Identities=30%  Similarity=0.439  Sum_probs=206.9

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46799999999999999999998888899999986533 34578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998543 2345788899999999999999999987   999999999999999999999999999876432211


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......++..|+|||++....++.++||||||+++|||++ |+.|+........  ...    ....     ...    
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~----~~~~-----~~~----  223 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--MSA----LQRG-----YRM----  223 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--HHH----HHcC-----CCC----
Confidence             1222345778999999988899999999999999999998 8999865332211  000    0000     000    


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ......+..+.+++.+|++.+|++||++++++++|++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111234567889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-36  Score=326.89  Aligned_cols=267  Identities=30%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             CccccccccCCcccEEEEEe-----cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  587 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  587 (835)
                      |++.+.||+|+||+||+++.     .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     347789999987543 33457788999999999999999999988764  35789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++..    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    34899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ..... .......++..|+|||.+.+..++.++||||||++++||++|..|+........................+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            32211 11122345667999999988899999999999999999999999976433221111111111111111112222


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .......+...+..+.+++.+|++.+|++||++++++++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            2222222333456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.8e-37  Score=328.73  Aligned_cols=264  Identities=21%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.+.||+|+||.||+++... ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            468999999999999999999864 7889999986542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++++.+..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999988776542   2345889999999999999999999987   9999999999999999999999999998763322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-cccc--------hhh-hcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGHA--------WNL-WKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~--------~~~-~~~~~  740 (835)
                       ........|+..|+|||++.+..++.++|||||||++|||++|+.||...+...... ....        ... .....
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence             112234568999999999999899999999999999999999999997543211100 0000        000 00000


Q ss_pred             chhccCcccc------chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSPALQ------HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......+...      .......+..+.+++.+|++.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      1111224567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-36  Score=327.09  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=204.6

Q ss_pred             cCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|++.++||+|+||.||+|+.     ..++.||+|.+... ......++.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5688899999999999999985     24578999998754 33445778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          588 IYEYMPNKSLNFFLFDPS--------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ||||+++++|.+++....              ....+++.....++.|++.||+|||+++   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999984321              1234788899999999999999999988   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..|+.......  ...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VIE--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence            999999999987644333223333456778999999988899999999999999999998 888875432110  000  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                        .......         ...+..+...+.+++.+|++.+|++||++.+|++.|..
T Consensus       238 --~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --MVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              0000000         01112234567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.9e-37  Score=329.49  Aligned_cols=261  Identities=29%  Similarity=0.443  Sum_probs=209.5

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|.+.+.||+|+||.||+++..      ++..+|+|.+........+.+.+|++++.+++||||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            367899999999999999999852      24568999997766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          587 LIYEYMPNKSLNFFLFDPS----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                      +||||+++++|.+++....          ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985321          2235899999999999999999999987   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhh
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNL  735 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  735 (835)
                      |+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    .
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--~~----~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IE----C  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----H
Confidence            999999986543322222233445778999999998999999999999999999998 8888764332110  00    0


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .......     ..    +..++..+.+++.+|++.+|.+||++.|+++.|+++..
T Consensus       235 i~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVL-----QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            0111100     01    11233568899999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.4e-37  Score=334.33  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .+|++.+.||+|+||.||+|++.. ++    .||||++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            579999999999999999998643 33    48999987543 34567899999999999999999999998765 5779


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |+||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998542  345788999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  .    .......  ... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~--~~~-  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S----SILEKGE--RLP-  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--H----HHHhCCC--CCC-
Confidence            3332222222344678999999999999999999999999999998 9999865332211  0    0001000  000 


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                            .+..+...+.+++.+||+.+|++||++.+++..|...
T Consensus       232 ------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         232 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  1112334578899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-37  Score=311.70  Aligned_cols=279  Identities=24%  Similarity=0.302  Sum_probs=208.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChh--hHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  587 (835)
                      .++|+.+++|++|.||.||+|+++. ++.||+|+++-..+.  -.-.-.+||.+|.+++|||||.+..+..-  -+..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3678999999999999999999854 788999999754321  12235789999999999999999888764  357999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |||||++ +|..++....  ..+...++.-++.|+++|++|||.+.   |+|||||++|+|+...|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 6777775433  56888899999999999999999987   9999999999999999999999999999874


Q ss_pred             CCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCc-cccc----ccc----cchhhhc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFN----LLG----HAWNLWK  737 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~----~~~----~~~~~~~  737 (835)
                      ..  ....+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-+..... ++.+    ++.    ..|....
T Consensus       229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            33  3345567889999999999885 699999999999999999999998876542 2221    111    1111111


Q ss_pred             ccc------chhccCccccchhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcc
Q 003264          738 DNR------AYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAF  801 (835)
Q Consensus       738 ~~~------~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~  801 (835)
                      .-.      .....-..++..+... ....-.+++...+..||.+|.|++|.++.  ....+.|.|..|.+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSM  375 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhh
Confidence            110      0001111111221111 34556789999999999999999998865  23355566655543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.4e-37  Score=336.17  Aligned_cols=245  Identities=23%  Similarity=0.270  Sum_probs=200.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67999999999999999999985 48899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998843   345788999999999999999999988   999999999999999999999999999865322


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..    .......   .     
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~----~~i~~~~---~-----  232 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--IY----EKILAGR---L-----  232 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--HH----HHHhcCC---c-----
Confidence                 223578999999999999999999999999999999999999986433111  00    0000110   0     


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                        ..+......+.+++.+||+.||++||+     ++++++.
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              011113356788999999999999996     6777644

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-36  Score=322.03  Aligned_cols=252  Identities=30%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.+.||+|+||.||+++..++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468889999999999999999988889999988643 2334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988542  235889999999999999999999988   999999999999999999999999999865332211 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+...+...  ....   .....   ....+.    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~---i~~~~---~~~~~~----  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEM---ISRGF---RLYRPK----  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH---HHCCC---CCCCCC----
Confidence            1122345678999999998899999999999999999999 888886543211  1110   00000   011111    


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                         .....+.+++.+||+.+|++||++.|+++.|.
T Consensus       225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               12346789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=348.58  Aligned_cols=260  Identities=25%  Similarity=0.326  Sum_probs=213.4

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecCC-cEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeE-EEe-----
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC-CVE-----  581 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~-----  581 (835)
                      .....++++.+.|.+|||+.||.|++..+ .+||+|++-..++...+..++|+.+|++|+ |+|||.+++. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34567899999999999999999998776 999999998778899999999999999996 9999999993 322     


Q ss_pred             -cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          582 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       582 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                       .-+++|.||||++|.|-+++....... |.+.++++|+.++++|+++||... ++|||||||-+||||..+++.|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence             137899999999999999996543333 999999999999999999999985 78999999999999999999999999


Q ss_pred             CccccccCCCcccc-------ccccccccceeCceee---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc
Q 003264          661 GMARMFCGDELQGN-------TKRVVGTYGYMSPEYA---LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  730 (835)
Q Consensus       661 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~  730 (835)
                      |.|...........       .-....|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+....-      
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            99965322221110       1123468999999976   5678999999999999999999999999853211      


Q ss_pred             cchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                                  .+++-...-.....++.++.+||..||+.+|++||++-+|+..+..+
T Consensus       265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                        11112222223356788999999999999999999999999988765

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=318.97  Aligned_cols=267  Identities=25%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecC--cChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-----cC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-----QG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~  583 (835)
                      ....|...+.||+|+||.|+.+... +|+.||||++..  ......++..+|+++|+.++|+||+.+++++.-     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666789999999999999875 489999999973  345567788999999999999999999998875     35


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..|+|+|+| ..+|...++   ....+....+..++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            789999999 678888883   3344899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCC-cccccccccchhh------
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLLGHAWNL------  735 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~------  735 (835)
                      +...........+..+.|.+|.|||++.. ..|+...||||.||||.||++|++-|.+.+ .++..+.......      
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            98755433444567889999999998755 579999999999999999999999988766 3333222111111      


Q ss_pred             --hccccchhccC--ccccc----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 --WKDNRAYELLS--PALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 --~~~~~~~~~~~--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        +..+.+...+.  |...+    ..-+......++|+.+||..||.+|+|++|.++.
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              11111111110  00000    0111234567899999999999999999999865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=332.25  Aligned_cols=245  Identities=22%  Similarity=0.241  Sum_probs=200.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999985 48899999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999843   345889999999999999999999988   999999999999999999999999999865322


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.||........  ..   .. ....         
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~---~i-~~~~---------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--YE---KI-LAGK---------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-HhCC---------
Confidence                 2235689999999999999999999999999999999999999875332110  00   00 0000         


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                       ...+......+.+++.+|++.||.+||+     ++|+++.
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             0111122456788999999999999995     7777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-36  Score=319.17  Aligned_cols=248  Identities=26%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999975 58899999876543 34457799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++..  ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999843  2345789999999999999999999987   99999999999999999999999999876432211111112


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  756 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  756 (835)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+........               ...+........+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---------------REAIEQGVRLPCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---------------HHHHHcCCCCCCccc
Confidence            233567999999999999999999999999999998 8888764332110               000000111111223


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          757 MLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+..+.+++.+|++.+|++||++.|++++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3557889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=377.08  Aligned_cols=261  Identities=25%  Similarity=0.428  Sum_probs=209.3

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ...|...+.||+|+||.||+|+. .+++.||||++......    ..+|++.+++++|||||+++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999997 46899999998654322    23568899999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++|+|.+++.      .++|..+.+++.||++||+|||+.+.++|+||||||+||+++.++.+++. ||........  
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999983      27899999999999999999997666679999999999999999988875 6655433211  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                          ....++..|||||++.+..++.++|||||||++|||++|+.|+............++............+++.+..
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence                1236789999999999999999999999999999999999998543332233333433333333344455555533


Q ss_pred             --hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          752 --EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       752 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                        ....++..++.+++.+|++.+|++||+|+||++.|+...
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence              234456678889999999999999999999999998763

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=335.06  Aligned_cols=260  Identities=28%  Similarity=0.431  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec-C
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ-G  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  583 (835)
                      .++|++.+.||+|+||.||+|+..      .++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999642      24789999987543 33456788899999999 899999999988754 5


Q ss_pred             eEEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  606 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  606 (835)
                      ..++++||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999998843211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccccccccccccee
Q 003264          607 -THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM  685 (835)
Q Consensus       607 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  685 (835)
                       ...+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125789999999999999999999987   9999999999999999999999999998764333222233445678899


Q ss_pred             CceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHH
Q 003264          686 SPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV  764 (835)
Q Consensus       686 aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l  764 (835)
                      |||++.+..++.++|||||||+|+||++ |..|+........ +    ........         ....+......+.++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~~~~l  308 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEGT---------RMRAPEYATPEIYSI  308 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhccC---------CCCCCccCCHHHHHH
Confidence            9999999999999999999999999998 9998864221110 0    00001100         001112234568899


Q ss_pred             HHhccccCCCCCCCHHHHHHHhhcc
Q 003264          765 ALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       765 i~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +.+|++.+|++||++.|++++|+.+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.1e-37  Score=335.01  Aligned_cols=242  Identities=22%  Similarity=0.266  Sum_probs=196.5

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 58899999987532   234566788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  675 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  675 (835)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99988843   346889999999999999999999998   999999999999999999999999998753221  1223


Q ss_pred             cccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHH
Q 003264          676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  755 (835)
Q Consensus       676 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  755 (835)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      +.    ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~----~~~~~------~~----~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME------EI----RFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HH----HHHcC------CC----CCCC
Confidence            345799999999999999999999999999999999999999865332111  00    00000      00    1112


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          756 QMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       756 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .....+.+++.+||+.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            3445678899999999999999     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=349.74  Aligned_cols=253  Identities=19%  Similarity=0.219  Sum_probs=204.9

Q ss_pred             cCCccccccccCCcccEEEEEecC--CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..|.+.+.||+|+||.||++....  ++.||+|.+..........+++|+.+++.++|||||++++++.+.+..+|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            348999999999999999997643  578899987655555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++|+|.+++... .....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999887542 23346888999999999999999999987   9999999999999999999999999998765433


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.|+...+...  ...   .... ..    ..    
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~---~~~~-~~----~~----  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQ---QVLY-GK----YD----  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHHh-CC----CC----
Confidence            2233345679999999999999999999999999999999999999986433211  000   0000 00    00    


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             111223456888999999999999999999874

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-36  Score=325.70  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=209.5

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  584 (835)
                      ..++|++.+.||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999999765     688999998754 33446778999999999999999999998876 467


Q ss_pred             EEEEEEecCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  659 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  659 (835)
                      .++++||+++++|.+++......     ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998543222     46889999999999999999999987   99999999999999999999999


Q ss_pred             cCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhcc
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKD  738 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  738 (835)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+...+..  .+...    ...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAY----LKD  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHc
Confidence            999986644332222223456778999999998899999999999999999999 99998653321  11110    001


Q ss_pred             ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       739 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .  ...       .....++..+.+++.+|++.+|++||++.|+++.|+.+.+
T Consensus       235 ~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 G--YRL-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C--CCC-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0  000       0111234567899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=321.09  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             CccccccccCCcccEEEEEecC----CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe-----
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  584 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  584 (835)
                      |++.+.||+|+||.||+|++..    +..||||+++..  .....+.+.+|+..++.++||||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998743    367999998753  23445789999999999999999999999876654     


Q ss_pred             -EEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          585 -KILIYEYMPNKSLNFFLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       585 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999885432   2346889999999999999999999987   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      |+++................+..|+|||.+....++.++||||||+++|||++ |..|+.......  ....   . ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~---~-~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDY---L-RHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---H-HcC
Confidence            99987644433222223345678999999988899999999999999999999 888876433211  1110   0 000


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .         ....+..++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0         0111223456788999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-36  Score=325.81  Aligned_cols=257  Identities=28%  Similarity=0.457  Sum_probs=204.6

Q ss_pred             CCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      +|++.+.||+|+||.||+|+...      ...+|+|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47888999999999999998632      3578999886543 3345778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCe
Q 003264          588 IYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  646 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  646 (835)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999874321                     1235788999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccc
Q 003264          647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  725 (835)
Q Consensus       647 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~  725 (835)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.....+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543322222223345778999999988899999999999999999998 998886433221


Q ss_pred             ccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .      +....         .......+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       238 ~------~~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 L------FNLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             H------HHHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            1      01111         1111111223345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-36  Score=326.64  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcccEEEEEecC------CcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .+|++.++||+|+||.||+|+...      ++.||||++..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457888999999999999998642      47899999975533 33567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          587 LIYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      +++||+++++|.+++...             .....+++..+.+++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998421             11235788899999999999999999987   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+.......  ...  
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~--  237 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIE--  237 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence            999999999887643332222233456789999999998899999999999999999998 777876433211  110  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                        ......         ....+..++..+.+++..|++.+|++||++++|++.|+.
T Consensus       238 --~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 --MIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              000110         011122345668889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.9e-36  Score=335.91  Aligned_cols=248  Identities=26%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|+..++||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56778899999999999999875 58999999986543 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|....       ...+..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999986432       3457788899999999999999988   9999999999999999999999999998764221 


Q ss_pred             cccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          672 QGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                       .......||..|+|||++..     ...+.++|||||||++|||++|+.||............  ....          
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~~----------  289 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM--CAIC----------  289 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--HHHh----------
Confidence             11234578999999998743     23456899999999999999999998733221110000  0000          


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..............+.+++.+||+.+|++||++.|+++.
T Consensus       290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000011122345668899999999999999999999975

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-36  Score=321.09  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=206.1

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .+|++.++||+|+||.||+|...+ ++.||+|++... ....+++.+|++++.+++|+||+++++++.+....++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            468888999999999999998754 889999998653 334577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998543 2345889999999999999999999987   999999999999999999999999999876432221


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......+..|+|||.+.+..++.++||||||+++|||++ |..|+...+.+..      .....         .....
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~---------~~~~~  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLE---------KGYRM  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHH---------CCCCC
Confidence             1112234668999999999999999999999999999998 8888765332211      00000         01111


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11223346688899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-37  Score=332.48  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=213.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe-EEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-KILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~  589 (835)
                      ++|..++++|+|+||.++..+.+. ++.+++|.+.-.  .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            678999999999999999998754 778999988543  34445578899999999999999999999999998 99999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      +|++||+|.+.+.+.+ ...++++.+.+++.||+.|+.|||+++   |+|||||+.||+++.++.+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 567899999999999999999999877   999999999999999999999999999988654


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .  .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+....     ..          .+.+..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~----------ki~~~~  222 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----IL----------KINRGL  222 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HH----------HHhhcc
Confidence            4  234457899999999999999999999999999999999999999986553211     00          011111


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ....+..++..+..++..|++.+|+.||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233455567788899999999999999999999976

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-36  Score=324.10  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57999999999999999999875 48899999986442 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 88887743  2345788999999999999999999988   9999999999999999999999999997643221 


Q ss_pred             cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-----ccchhhhcc----cc
Q 003264          672 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-----GHAWNLWKD----NR  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-----~~~~~~~~~----~~  740 (835)
                       .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ...     ......|..    ..
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             12233467899999998865 5689999999999999999999999875442211 000     000000100    01


Q ss_pred             chhccCccccch----hHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSPALQHE----ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......+.....    ........+.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111111100    01122356789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-36  Score=326.70  Aligned_cols=260  Identities=28%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+... ......++.+|+.++.++ +|+||+++++++.+++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            44679999999999999999998642      367999998754 334456788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          584 EKILIYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      ..+++|||+++|+|..++...             .....+++..+++++.||+.||+|||+.+   |+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998532             22346889999999999999999999987   99999999999999


Q ss_pred             CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccccc
Q 003264          651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  729 (835)
Q Consensus       651 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  729 (835)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+..   
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence            999999999999987644332222223345678999999999999999999999999999998 8888764332111   


Q ss_pred             ccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         .......         .....+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       244 ---~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 ---FKLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ---HHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence               0000000         01111223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-37  Score=314.29  Aligned_cols=247  Identities=22%  Similarity=0.369  Sum_probs=208.6

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+++.   ++++.-.+++|+++|..|+||||+.++.+|+..+..+||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46899999999999999999986 56999999998754   566778899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||..+|.|.+|+   .+...+++.++..+++||..|+.|+|.++   ++|||||.+|||||.++++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999   34567999999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ....++|.+-|.+||++.+..| .+..|-|||||+||-|+.|..||+..+....  .   . .+..+.   ...|
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--v---r-QIs~Ga---YrEP  273 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--V---R-QISRGA---YREP  273 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--H---H-Hhhccc---ccCC
Confidence            33   3356799999999999999988 4789999999999999999999987653211  0   0 011111   1111


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .        .+....-||+|||-.+|++|.|+.+|...
T Consensus       274 ~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 E--------TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             C--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1        12234568999999999999999999876

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-36  Score=337.16  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=196.8

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|++++.||+|+||+||+|+.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999875 47899999986532   3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999843   345888999999999999999999988   9999999999999999999999999986431100


Q ss_pred             c---------------------------------------------cccccccccccceeCceeecCCCCCccccchhHH
Q 003264          671 L---------------------------------------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG  705 (835)
Q Consensus       671 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG  705 (835)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHh--ccccCCCCCCCHHHHH
Q 003264          706 VLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALL--CVQEKAADRPTMSKVV  783 (835)
Q Consensus       706 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl  783 (835)
                      |++|||++|+.||..........     ..........       ..........+.+++.+  |+..+|..||++.|++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~~-------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQL-----KVINWENTLH-------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHH-----HHHccccccC-------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            99999999999997544221100     0000000000       00011123456677766  5566777799999998


Q ss_pred             HH
Q 003264          784 SM  785 (835)
Q Consensus       784 ~~  785 (835)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.2e-36  Score=328.88  Aligned_cols=264  Identities=26%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||.||++++. ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999986 4788999988654 33445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999843   345788999999999999999999753  3999999999999999999999999999765322 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-cc------cchhhh----c-c
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LG------HAWNLW----K-D  738 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~------~~~~~~----~-~  738 (835)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... ..      ......    . .
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               1223568999999999998899999999999999999999999987543221100 00      000000    0 0


Q ss_pred             cc--------------chhccCcccc---ch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 NR--------------AYELLSPALQ---HE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ~~--------------~~~~~~~~l~---~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..              ...+.+....   .. ....+...+.+++.+||+.||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            00              0000000000   00 001134568899999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.1e-36  Score=322.87  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|++.+.||+|+||+||+|++.. ++    .|++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            578889999999999999998743 43    47888875443 234567888999999999999999999875 456789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998542  345889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........      ...+.....  ...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~--~~~  232 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGER--LAQ  232 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCc--CCC
Confidence            4332223334567789999999999999999999999999999998 9999865332111      011111110  011


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      +..       +...+.+++.+|+..+|++||++.|+++.|..+.
T Consensus       233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            111       2245677899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-36  Score=319.41  Aligned_cols=252  Identities=30%  Similarity=0.443  Sum_probs=203.0

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.+.||+|+||.||+|+..++..+|||.+.... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            5688999999999999999998777789999987533 334678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998542  235889999999999999999999987   999999999999999999999999999865433211 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+....++.++||||||+++|||++ |..|+........  ..   .......          ..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~---~~~~~~~----------~~  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VE---KVSQGLR----------LY  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH---HHhcCCC----------CC
Confidence            1122345678999999988889999999999999999998 9999865432211  00   0000000          00


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+......+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01113467788999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=349.35  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=206.6

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC---
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG---  583 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---  583 (835)
                      ....++|++.+.||+|+||+||+++.. +++.||||++...  .......+.+|+..+..++|+||++++..+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999864 5899999998643  3445677889999999999999999988776433   


Q ss_pred             -----eEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          584 -----EKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       584 -----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                           ..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 367999999999999998543 23356889999999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   ....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--~~---~~~~  259 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--MH---KTLA  259 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HHhc
Confidence            999999876443333333456799999999999999999999999999999999999999875332110  00   0000


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .    ..     ...+......+.+++.+||+.+|++||++.++++.
T Consensus       260 -~----~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 -G----RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -C----CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             0    00     01122344568889999999999999999999864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-36  Score=330.10  Aligned_cols=242  Identities=22%  Similarity=0.263  Sum_probs=196.3

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+++.. +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 4889999998753   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  675 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  675 (835)
                      +|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99888843   346889999999999999999999988   999999999999999999999999998753221  1122


Q ss_pred             cccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHH
Q 003264          676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  755 (835)
Q Consensus       676 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  755 (835)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      ..    ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~----~~~~~------~~----~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME------DI----KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HH----HhccC------Cc----cCCC
Confidence            345789999999999999999999999999999999999999865432211  00    00000      00    1112


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          756 QMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       756 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .....+.+++.+|++.+|++||     ++.|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2345678899999999999997     88888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-36  Score=323.95  Aligned_cols=264  Identities=28%  Similarity=0.431  Sum_probs=206.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-----------------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceee
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVR  574 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~  574 (835)
                      .++|++.++||+|+||.||+++..+                 +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999998643                 2458999987553 345678999999999999999999


Q ss_pred             EeeEEEecCeEEEEEEecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCe
Q 003264          575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  646 (835)
Q Consensus       575 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  646 (835)
                      +++++..+...++++||+++++|..++....        ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985432        1235889999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh--CCCCCCCCCcc
Q 003264          647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIE  724 (835)
Q Consensus       647 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~  724 (835)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999987644433333344556789999999988899999999999999999998  56676543321


Q ss_pred             cccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          725 SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .  ........+......      .....+..++..+.+++.+|++.+|++||++.||++.|+
T Consensus       241 ~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  111111111110000      001111223457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-36  Score=322.57  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=204.3

Q ss_pred             hhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      .+++|++.+.||+|+||.||+|.+..      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35779999999999999999998753      5679999886543 3445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEe
Q 003264          585 KILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKI  657 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl  657 (835)
                      .++||||+++++|.+++....    ....+++..+++++.||++||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999985432    1235889999999999999999999987   99999999999998765   5999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhh
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      +|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||.....+..  ..    . 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~----~-  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--ME----F-  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----H-
Confidence            99999987643332222222334568999999999999999999999999999997 8888875432211  00    0 


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                              +........+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       234 --------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 --------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    0000011112233467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.8e-36  Score=329.13  Aligned_cols=242  Identities=22%  Similarity=0.266  Sum_probs=195.4

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+++.. +|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 5899999998753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  675 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  675 (835)
                      +|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888843   346889999999999999999999988   9999999999999999999999999987532211  122


Q ss_pred             cccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHH
Q 003264          676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASY  755 (835)
Q Consensus       676 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  755 (835)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      ...    .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~----~~~~~------~~~----~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILME------EIR----FPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHhcC------CCC----CCC
Confidence            345689999999999999999999999999999999999999875432211  00    00000      000    112


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          756 QMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       756 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .....+.+++.+|++.+|++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            2345678899999999999998     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.5e-36  Score=317.83  Aligned_cols=259  Identities=22%  Similarity=0.373  Sum_probs=208.2

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999875 5889999987542   2344567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++++|.+++.... ....+++..+..++.||++||+|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998874322 2345788999999999999999999987   99999999999999999999999999887543


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.............    ..     ...   
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----~~-----~~~---  224 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IE-----QCD---  224 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH----Hh-----cCC---
Confidence            221  1223467889999999988889999999999999999999999985432221111110    00     000   


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ............+.+++.+||+.+|++||++.||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11111223456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=330.38  Aligned_cols=241  Identities=20%  Similarity=0.262  Sum_probs=193.5

Q ss_pred             cccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||.||+++..+ ++.||+|++...   .......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999754 789999998643   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999843   345889999999999999999999988   9999999999999999999999999997542221  22334


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  .   ......         .  ...+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~---~~~~~~---------~--~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM--Y---RKILQE---------P--LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH--H---HHHHcC---------C--CCCCCcC
Confidence            5789999999999999999999999999999999999999875332110  0   000000         0  0111233


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      ...+.+++.+||+.+|++||++..+.+.|
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            45678899999999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.8e-36  Score=327.32  Aligned_cols=241  Identities=25%  Similarity=0.338  Sum_probs=190.7

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+|+... ++.||||.++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999754 7889999987532   23345556677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988843   345889999999999999999999987   9999999999999999999999999997643222  22


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .. ...      .+    ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~---~i-~~~------~~----~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FD---SI-LND------RP----HFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-HcC------CC----CCC
Confidence            3345789999999999999999999999999999999999999875442211  00   00 000      01    111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMS-KVVS  784 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  784 (835)
                      ......+.+++.+||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            22345577899999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.2e-36  Score=320.17  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=199.7

Q ss_pred             CccccccccCCcccEEEEEecCC-c--EEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------Ce
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNG-Q--EVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GE  584 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  584 (835)
                      |.+.++||+|+||.||+|+.... +  .||+|.++..  .....+.+.+|+.++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999997553 2  6899988653  344567889999999999999999999987543      24


Q ss_pred             EEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          585 KILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      .++++||+++|+|..++...   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432   12345889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhcccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      +++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......  +..    ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYD----YLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HHHcCC
Confidence            9987644332222233346778999999999999999999999999999999 788886432211  111    111111


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..         ..+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00         01112345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-36  Score=322.79  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=205.4

Q ss_pred             cCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|.+.++||+|+||.||+++..      ++..+|+|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            57888899999999999999742      356899999887766677889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          588 IYEYMPNKSLNFFLFDPSR------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      +|||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999854321            135789999999999999999999988   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |.+|+........  ..   .
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~---~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE---C  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HH---H
Confidence            9999999976543322222223345788999999999999999999999999999998 8888754332110  00   0


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      . ...         .....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       237 ~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 I-TQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-HcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0 000         000111123456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=298.78  Aligned_cols=266  Identities=22%  Similarity=0.228  Sum_probs=212.7

Q ss_pred             HhhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----e
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----E  584 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~  584 (835)
                      ...++|++.++||+|||+-||.++. .+++.+|+|++.-...++.+..++|++..++++||||++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            3458999999999999999999984 458899999998777778899999999999999999999999877544     4


Q ss_pred             EEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          585 KILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      .||+++|...|+|.+.+...+ +...+++.+.+.|+.+|.+||++||+.. +++.||||||.|||+.+++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence            899999999999999986543 3447999999999999999999999976 57999999999999999999999999998


Q ss_pred             ccccCCCcc-------ccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch
Q 003264          664 RMFCGDELQ-------GNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       664 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~  733 (835)
                      ....-....       ........|..|.|||.+.-   ...++++|||||||+||+|+.|..||+..-.....+. .  
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-L--  253 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-L--  253 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-E--
Confidence            754211100       01122356899999998854   4678999999999999999999999975332111111 0  


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                               ....+.+.-.....+++.+.+++.+|++.||.+||+..+++..++.+
T Consensus       254 ---------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 ---------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     11111111112223678899999999999999999999999998775

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-36  Score=321.71  Aligned_cols=271  Identities=27%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             cCCccccccccCCcccEEEEEec-----CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  586 (835)
                      ++|++.+.||+|+||.||+++..     +++.||||++........+.+.+|++++.+++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57889999999999999999742     4789999999876666678899999999999999999999987543  4688


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  245889999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCccc-cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh-hhccccchhc
Q 003264          667 CGDELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN-LWKDNRAYEL  744 (835)
Q Consensus       667 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  744 (835)
                      ....... ......++..|+|||.+.+..++.++||||||++++||++|..++................ ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4322111 1112234456999999998899999999999999999999887654322111000000000 0000000011


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +............+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111111223345688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=327.17  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=213.8

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC---Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN---GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      ....+..++.++||.|-||.||+|...+   |+  .||||.-+.. .....+.|+.|+.+|+.++|||||+|+|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3344566677899999999999998632   33  5899988764 45567889999999999999999999999976 4


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++|||.++.|.|..||..  +...++......++.||..||+|||+..   +|||||..+|||+.+..-+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            78999999999999999954  4456888899999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccch
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      +.+..+.+.... ...-+..|||||.+.-..++.++|||.|||.+||+++ |..||..-....               +.
T Consensus       539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI  602 (974)
T KOG4257|consen  539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VI  602 (974)
T ss_pred             hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eE
Confidence            998776655544 3456789999999999999999999999999999987 889987533221               11


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      -.+...-+...++.++..|..++.+||..+|.+||.+.|+...|+.+
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            11222223345566778889999999999999999999999887654

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=321.43  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=206.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4689999999999999999998643      3689999986543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          586 ILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                      ++||||+++++|.+++....       ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999985432       1234788999999999999999999987   9999999999999999999999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhc
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...+....  ..    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~----~~~  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LK----FVI  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HH----HHh
Confidence            9999987654433223333456789999999988899999999999999999998 8888864332211  00    011


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ....         ...+...+..+.+++.+|++.+|++||++.++++.|+
T Consensus       236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1100         0111223567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-36  Score=325.67  Aligned_cols=264  Identities=25%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999986 588999999875432 234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++ ++|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 567666643  2345788999999999999999999988   9999999999999999999999999987542211


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc-------hhhhcccc--
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-------WNLWKDNR--  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~~~--  740 (835)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+....       ...+....  
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12233567899999998865 4588999999999999999999999975432111100000       00000000  


Q ss_pred             ------chhccCc-cccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 ------AYELLSP-ALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ------~~~~~~~-~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                            ......+ .+... ........+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                  0000000 00000 00012345778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=317.39  Aligned_cols=252  Identities=30%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .+|++.+.||+|+||.||+++...+..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4688999999999999999998777889999986432 234578889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999998542  236889999999999999999999988   999999999999999999999999999865322211 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  ..   .. .     ....    ..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~---~~-~-----~~~~----~~  221 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VE---SV-S-----AGYR----LY  221 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HH---HH-H-----cCCc----CC
Confidence            1112234568999999999999999999999999999999 7888864332110  00   00 0     0000    01


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            11124557889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.1e-36  Score=322.30  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=194.6

Q ss_pred             cCCccccccccCCcccEEEEEec--CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhc---CCCceeeEeeEEEe-----
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE-----  581 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----  581 (835)
                      ++|++.+.||+|+||.||+|+..  +++.||||++....  ......+.+|+.++.++   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47899999999999999999873  36789999886432  22234566777777766   69999999999863     


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999997 5888887543 2335789999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc--cccccc----hhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLGHA----WNL  735 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~----~~~  735 (835)
                      +++.....   .......|+..|+|||.+.+..++.++|||||||++|||++|++||........  .+....    ...
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99865332   223345689999999999989999999999999999999999999875432111  000000    000


Q ss_pred             hccc--cchhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          736 WKDN--RAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       736 ~~~~--~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +...  .......+..   ...........+.+++.+|++.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000  0000000000   00111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-36  Score=333.18  Aligned_cols=246  Identities=22%  Similarity=0.263  Sum_probs=200.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC--CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|+...  +..||+|++...   .....+.+.+|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3679999999999999999998644  368999998643   22345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999843   345889999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .     ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..   .. .....      
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~---~i-~~~~~------  245 (340)
T PTZ00426        183 T-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--YQ---KI-LEGII------  245 (340)
T ss_pred             C-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--HH---HH-hcCCC------
Confidence            2     12345789999999999998999999999999999999999999875332110  00   00 00000      


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                          ..+......+.+++.+|++.+|++|+     +++|+++.
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                01112234567899999999999995     88988765

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-36  Score=324.12  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcccEEEEEecC---------------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEee
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN---------------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      ++|++.++||+|+||.||+++...               ...||||.+... .....+.|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            589999999999999999987632               235899998754 3344567999999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          578 CCVEQGEKILIYEYMPNKSLNFFLFDPS---------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       578 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ++......++||||+++++|.+++....         ....+++..++.++.|+++||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999984321         1124688899999999999999999988   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh--CCCCCCCCCcccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIESF  726 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~  726 (835)
                      ++.++.+||+|||+++.+.............++..|+|||++....++.++||||||++++||++  +..|+.....+..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222233445778999999998999999999999999999998  4456554322110


Q ss_pred             cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                        .......+....      .......+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       242 --~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 --IENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              000000000000      00000011123457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-36  Score=336.15  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  584 (835)
                      .++|.+.++||+|+||.||+|++.      .++.||||++.... ....+.+.+|+++|.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457888999999999999999863      24689999997543 333457889999999997 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR----------------------------------------------------------  606 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  606 (835)
                      .++|+||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999854211                                                          


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE
Q 003264          607 -------------------------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  649 (835)
Q Consensus       607 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl  649 (835)
                                                           ...+++..+.+++.||+.||+|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                 124667788999999999999999887   9999999999999


Q ss_pred             cCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccc
Q 003264          650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  728 (835)
Q Consensus       650 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~  728 (835)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........  
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence            9999999999999986533222112223456789999999998899999999999999999998 8888764331110  


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         .......+         .....+......+.+++.+||+.+|++||+++||++.|+.+
T Consensus       351 ---~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 ---FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ---HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               00000000         00111122346788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=333.54  Aligned_cols=253  Identities=28%  Similarity=0.361  Sum_probs=212.0

Q ss_pred             cCCccccccccCCcccEEEEEecC--Cc--EEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--GQ--EVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++..+.++||+|.||.|++|.+..  |+  .||||.+...... ....|++|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            456677899999999999998754  44  5899999866443 67899999999999999999999999988 788999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +|.++.|+|.+.|.+ .....+.......++.|||.||.||.+++   +|||||..+|+||-....+||+||||.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999977 45567888999999999999999999987   99999999999999999999999999998865


Q ss_pred             CCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          669 DELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       669 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .+.. .......-+..|+|||.+....++.++|||+|||+||||+| |..||......               .+.+.+|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------------qIL~~iD  329 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------------QILKNID  329 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---------------HHHHhcc
Confidence            5432 33334455789999999999999999999999999999999 66787653311               2233344


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      ..-+-..+..+++++.+++..||..+|++||++..|++.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3334445667889999999999999999999999998443

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-36  Score=322.69  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=204.6

Q ss_pred             hhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ..++|++.++||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45789999999999999999997532      4589999986443 2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      .++||||+++|+|.+++.....       .....+..+.+++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999954221       234567788999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhh
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      +|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |..|+.....+..  ...   ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~--~~~---~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKF---VM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH---HH
Confidence            99999986543332222223345678999999999999999999999999999999 6778764332211  000   00


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      . ...         ...+......+.+++.+|++.+|++||++.++++.|...
T Consensus       236 ~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 D-GGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             c-CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            0 000         001112345788999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-36  Score=308.88  Aligned_cols=267  Identities=25%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecC-----
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQG-----  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~-----  583 (835)
                      ...|..+++||+|.||+||+|+.. +|+.||+|++....+  .......+|+.++++++|+| ||+|++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            356778889999999999999974 588999999875533  23455688999999999999 999999999877     


Q ss_pred             -eEEEEEEecCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          584 -EKILIYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       584 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                       ..++|+||++ .+|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             7889999994 5788888543221 45677889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-----ccc----cc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-----NLL----GH  731 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-----~~~----~~  731 (835)
                      +|+.+.-.  .......++|.+|.|||++.+. .|+...||||+|||+.||+++++-|........     .++    +.
T Consensus       166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99975321  2224456789999999999887 799999999999999999998887776543211     001    11


Q ss_pred             chhhhccccchhccCccc--cchhHHH---HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 AWNLWKDNRAYELLSPAL--QHEASYQ---MLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l--~~~~~~~---~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .|+....-..+...-+..  .......   ......+++.+|++.+|.+|.|++.++++
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111110111000000  1111111   12467899999999999999999999986

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-36  Score=331.09  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----eEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  586 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  586 (835)
                      +|++.++||+|+||.||+|+.. +++.||||++...  ......++.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999975 5899999998643  2234467889999999999999999999886432     479


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||++ ++|.+++.   ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 67888774   2345889999999999999999999998   999999999999999999999999999865


Q ss_pred             cCCCc-cccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc----cc----chh
Q 003264          667 CGDEL-QGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH----AWN  734 (835)
Q Consensus       667 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~----~~----~~~  734 (835)
                      ..... ........||..|+|||++.+  ..++.++|||||||++|||++|+.||...+.... ...    ..    ...
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 112234578999999998865  6789999999999999999999999875432110 000    00    000


Q ss_pred             hhccccchhc---cCccccchhH---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYEL---LSPALQHEAS---YQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~~---~~~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+......+.   +.+.......   ......+.+++.+|++.+|++||+++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000   0000000000   1123457889999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-35  Score=315.45  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||.||+|++.+...||+|++.... ...+++.+|+.++.+++||||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35799999999999999999998777789999987533 23467899999999999999999999874 45679999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999998543 2345789999999999999999999987   999999999999999999999999999866433221


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......++..|+|||++.+..++.++||||||+++|||++ |..|+........  ..    .....         ...
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~----~~~~~---------~~~  222 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG---------YRM  222 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HH----HHhcC---------CCC
Confidence             1123346778999999988899999999999999999999 7778764332110  00    00000         001


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ......+..+.+++.+|++.+|++||++.+++++|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            11223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=335.56  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=203.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999986 58999999987532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   56889999999999999999999987   999999999999999999999999999865433


Q ss_pred             C---------------------------ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          670 E---------------------------LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       670 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      .                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0112234578999999999999999999999999999999999999987544


Q ss_pred             cccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 003264          723 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVSM  785 (835)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  785 (835)
                      ....     .........  .+..+.     .......+.+++..|++ +|++||+ ++|+++.
T Consensus       235 ~~~~-----~~~i~~~~~--~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQET-----YNKIINWKE--SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH-----HHHHhccCC--cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2111     000000000  000000     01135667889999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-35  Score=316.05  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++. .+++.||||.+...   .....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688999999999999999996 46899999987643   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++++|.+++... .....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999988   99999999999999999999999999876533


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+......         .......+.
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~  227 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDYPP  227 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------hhhcCCCCC
Confidence            221  122346888999999999889999999999999999999999998643322111110         000111111


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .   ........+.+++.+|++.+|++||+|.+|+++++.+.
T Consensus       228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1   11234567889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.2e-36  Score=326.76  Aligned_cols=245  Identities=24%  Similarity=0.346  Sum_probs=193.9

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHH---HhcCCCceeeEeeEEEecCeEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      |++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+.++   ++++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999875 48899999987532   22345566676655   566899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|..++.    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    245899999999999999999999988   99999999999999999999999999875322


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+....  ..   .. ....      ..
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~---~i-~~~~------~~  219 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FD---SI-VNDE------VR  219 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-HhCC------CC
Confidence            1  1223346789999999999999999999999999999999999999875432211  00   00 0000      00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                          .+......+.+++.+||+.+|++||     ++.++++.
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                1112345678899999999999999     46666553

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.6e-36  Score=324.00  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=206.8

Q ss_pred             hhcCCccccccccCCcccEEEEEec--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      ..++|++.+.||+|+||.||+++..        ++..||+|.+... .....+++.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3578899999999999999999742        2457999998654 234567889999999999 89999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ....++||||+++|+|.+++.....             ...+++..+..++.||++||+|||+++   ++||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999864321             235788899999999999999999988   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~  727 (835)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........ 
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence            99999999999999987644332222333456678999999998899999999999999999998 7777754331111 


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       .    .......         ....+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       249 -~----~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         249 -F----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             -H----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence             0    0011110         0011123456688899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.7e-36  Score=324.89  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC--------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      .++|.+.+.||+|+||.||+++...        ...+|+|.+... ......++.+|+.++.++ +||||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3679999999999999999997532        357999999754 234556788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  649 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl  649 (835)
                      ...++||||+++|+|.+++.....             ...+++.++++++.||+.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999954321             235888999999999999999999987   9999999999999


Q ss_pred             cCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccc
Q 003264          650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  728 (835)
Q Consensus       650 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~  728 (835)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+..  
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~--  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence            9999999999999976533222222222234568999999999899999999999999999998 8888754332110  


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..    .....         .....+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus       252 ~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         252 FK----LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HH----HHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            00    00000         01111223346778899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-35  Score=314.85  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357899999999999999999988888999999875432 3467899999999999999999999875 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999998543 2345789999999999999999999987   999999999999999999999999999865432211


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......++..|+|||.+....++.++||||||+++|||++ |..|+...+...  ....    +.         .....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~----~~---------~~~~~  222 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQ----VE---------RGYRM  222 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----HH---------cCCCC
Confidence             1122345678999999988899999999999999999999 888886433111  1100    00         00111


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ..+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122344568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=335.51  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=199.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.++||+|+||+||+++.. +++.||||++....   ......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999985 48899999996532   234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   345899999999999999999999998   999999999999999999999999998765321


Q ss_pred             Cccc------------------------------------cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh
Q 003264          670 ELQG------------------------------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT  713 (835)
Q Consensus       670 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt  713 (835)
                      ....                                    ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 003264          714 SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKVVSM  785 (835)
Q Consensus       714 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  785 (835)
                      |..||...+....  .   ............  +     ........+.+++.+|+. +|.+|++   +.|+++.
T Consensus       235 G~~Pf~~~~~~~~--~---~~i~~~~~~~~~--~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQET--Y---RKIINWKETLQF--P-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHH--H---HHHHcCCCccCC--C-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999975432111  0   000000000000  0     001234456788888986 9999998   8888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-35  Score=312.59  Aligned_cols=260  Identities=24%  Similarity=0.389  Sum_probs=209.6

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999986 6899999988642   2334678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++++|..++.+. .....+++..+..++.++++||+|||+.+   |+|+||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 23445889999999999999999999987   99999999999999999999999999876533


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.............    ....        .
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~--------~  224 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEKC--------D  224 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----hhcC--------C
Confidence            221  1223467889999999998899999999999999999999999986433211111000    0000        0


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ............+.+++.+|++.+|++||++.+|+++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            001111244567889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-35  Score=321.05  Aligned_cols=263  Identities=28%  Similarity=0.441  Sum_probs=202.5

Q ss_pred             cCCccccccccCCcccEEEEEec-----------------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-----------------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRL  575 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  575 (835)
                      ++|++.++||+|+||.||+++..                 +...||+|++... .....+++.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998532                 2346899998754 33456789999999999999999999


Q ss_pred             eeEEEecCeEEEEEEecCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeE
Q 003264          576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSR--------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  647 (835)
Q Consensus       576 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  647 (835)
                      ++++.+.+..++||||+++++|.+++.....        ...+++..+..++.||+.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999854321        134778899999999999999999988   99999999999


Q ss_pred             EEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh--CCCCCCCCCccc
Q 003264          648 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT--SKRNTGVYDIES  725 (835)
Q Consensus       648 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~  725 (835)
                      |++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222223345678999999888899999999999999999998  667765433211


Q ss_pred             ccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .  ............ ....     ...+..++..+.+++.+||+.+|++||++.||++.|+
T Consensus       242 ~--~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V--IENTGEFFRDQG-RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H--HHHHHHHHhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1  100000000000 0000     0111223467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-37  Score=296.38  Aligned_cols=249  Identities=27%  Similarity=0.349  Sum_probs=209.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|.||.||.|+.+. +-.||+|++.+.   ..+..+++++|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4789999999999999999999755 678999998654   233457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||.++|+|...|.+. +...+++.....++.|+|.||.|+|..+   +|||||||+|+|++..+.+||+|||-+.... 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999643 4456888999999999999999999987   9999999999999999999999999986532 


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                         .......+||..|.+||...+..++..+|+|++|++.||++.|.+||.....+.         ..+.-...++..  
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------tYkrI~k~~~~~--  241 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------TYKRIRKVDLKF--  241 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------HHHHHHHccccC--
Confidence               334456899999999999999999999999999999999999999998544111         111111112222  


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           +...+....++|.+|+..+|.+|....|+++.
T Consensus       242 -----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 -----PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 23455677889999999999999999999864

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.9e-36  Score=322.75  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-C--cEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+|+..+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998754 3  35789988743 334567789999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          589 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      +||+++++|.+++....             ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1235888999999999999999999987   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..||........  ..    
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--~~----  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--YE----  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----
Confidence            99999998642111   11111223567999999998899999999999999999998 9999865432210  00    


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .         +........+..+...+.+++.+|++.+|.+||+++++++.|+.+..
T Consensus       230 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         230 K---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             H---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0         00011111112244567899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-36  Score=335.99  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      +|++++.||+|+||.||+++... ++.||||++....   ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            68999999999999999999754 8899999986532   2234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999843   345788899999999999999999988   9999999999999999999999999975331000


Q ss_pred             -----------------------------------------ccccccccccccceeCceeecCCCCCccccchhHHHHHH
Q 003264          671 -----------------------------------------LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL  709 (835)
Q Consensus       671 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~  709 (835)
                                                               .........||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000011346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 003264          710 ETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP---TMSKVVSM  785 (835)
Q Consensus       710 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~  785 (835)
                      ||++|+.||...........     ..........  +     ........+.+++.+|+ .+|++|+   ++.|+++.
T Consensus       236 ell~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLK-----VINWETTLHI--P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHH-----HhccCccccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999975442211000     0000000000  0     01122345566777765 4999999   88888865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-35  Score=318.70  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCc----EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|++.++||+|+||+||+|+.. +++    .||+|.+... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            367899999999999999999853 344    4899998654 33456778999999999999999999999875 4577


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +++||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  345889999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+........  ..    ......     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~-----  228 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI--PD----LLEKGE-----  228 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HHHCCC-----
Confidence            43322212222345678999999999999999999999999999998 8888764332111  00    011110     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          ....+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                0011122345678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-35  Score=314.10  Aligned_cols=247  Identities=27%  Similarity=0.381  Sum_probs=195.8

Q ss_pred             ccccCCcccEEEEEec---CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          521 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +||+|+||.||+|.+.   +++.+|+|+++...  ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   47889999986443  334678999999999999999999999875 45778999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc-c
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-N  674 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  674 (835)
                      +|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   345889999999999999999999987   9999999999999999999999999998764332211 1


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.......  ...    ......         ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~i~~~~---------~~~~  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQ----MIESGE---------RMEC  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHCCC---------CCCC
Confidence            122234678999999988889999999999999999998 999987543211  110    111110         1111


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +...+..+.+++.+|++.+|++||++.+|.+.|++.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            223446688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-36  Score=327.34  Aligned_cols=242  Identities=25%  Similarity=0.319  Sum_probs=194.3

Q ss_pred             cccccCCcccEEEEEec----CCcEEEEEEecCcC----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++||+|+||.||+++..    .++.||||++....    ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999853    47899999986431    23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..   ...+.+..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999998843   345788889999999999999999988   9999999999999999999999999987542221 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+....     ...... ..          .
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-----~~~~~~-~~----------~  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-----IDKILK-GK----------L  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----HHHHHc-CC----------C
Confidence             122345789999999999998999999999999999999999999875432110     000000 00          0


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      ..+......+.+++.+|++.+|++||     ++.++++.
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            11122345678899999999999999     78887763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-35  Score=331.71  Aligned_cols=259  Identities=19%  Similarity=0.208  Sum_probs=196.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..+|++.++||+|+||.||++++. .++.||||....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            368999999999999999999975 488999997532      3467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +. ++|..++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 678777743   345789999999999999999999987   9999999999999999999999999997542211 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-----cccccchhhh---------c
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-----NLLGHAWNLW---------K  737 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-----~~~~~~~~~~---------~  737 (835)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-..+....     ..........         .
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            1122345799999999999999999999999999999999999987643221000     0000000000         0


Q ss_pred             c-ccchhc---------cCcccc--chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 D-NRAYEL---------LSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~-~~~~~~---------~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      . ....+.         ..+...  ..........+.+++.+||+.||++|||++|+++.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0 000000         000000  01112345678899999999999999999999964

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=319.05  Aligned_cols=271  Identities=26%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             cCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      +.|++.+.||+|+||.||+++.     ..++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     247889999987543 34456799999999999999999999998875  568


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998432  235899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      +...... .......++..|+|||.+.+..++.++||||||++++||++++.|.........................+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433211 112234567789999999888999999999999999999998765432110000000000000000000000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +...........++..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000001111223456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-35  Score=322.22  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+++..      .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            367999999999999999999742      24579999987543 34456789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+++   |+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999985432 234899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      .+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+........ ..    ......    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~----~~~~~~----  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY----KLIKEG----  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH----HHHHcC----
Confidence            6643322112223345778999999999999999999999999999998 8888764332110 00    000000    


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                           .....+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus       261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 00001112245688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.4e-36  Score=331.54  Aligned_cols=203  Identities=24%  Similarity=0.330  Sum_probs=175.4

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+++... ++.||||++....   ......+++|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            478999999999999999998754 8899999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   346899999999999999999999988   999999999999999999999999999764321


Q ss_pred             Ccc---------------------------------ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCC
Q 003264          670 ELQ---------------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  716 (835)
Q Consensus       670 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~  716 (835)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 003264          717 NTGVYD  722 (835)
Q Consensus       717 p~~~~~  722 (835)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-35  Score=325.27  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=205.2

Q ss_pred             cCCccccccccCCcccEEEEEecC--------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      .+|++.+.||+|+||.||+++...        ...||+|.+... .....+++.+|+.++.++ +||||+++++++.+..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            578999999999999999997521        236899988754 334567899999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      ..++++||+++|+|.+++....             ....+++..++.++.||++||+|||+++   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999985422             1235788999999999999999999987   99999999999999


Q ss_pred             CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccccc
Q 003264          651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  729 (835)
Q Consensus       651 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  729 (835)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...+.+..  .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--F  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--H
Confidence            999999999999986543322222222344568999999999999999999999999999998 7888764332211  0


Q ss_pred             ccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                          ......         ...+.+......+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus       247 ----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 ----KLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                000000         011111233456888999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-35  Score=319.97  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=204.4

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+++..      ++..||+|++.... .....++.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999863      36789999987543 34457799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCe
Q 003264          586 ILIYEYMPNKSLNFFLFDPS-------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  646 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  646 (835)
                      ++|+||+++++|.+++....                   ....+++..++.++.||+.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788899999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccc
Q 003264          647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  725 (835)
Q Consensus       647 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~  725 (835)
                      |+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999886543322222222344678999999998999999999999999999998 777875433211


Q ss_pred             ccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      .  ..    ........         ..+...+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus       241 ~--~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V--IY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H--HH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            0  00    00111100         0112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-35  Score=324.36  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=193.5

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCC-CceeeEeeEEEecCeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~  589 (835)
                      +|++.+.||+|+||.||+|+... ++.||||++...   .....+.+..|+.++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58899999999999999998764 789999998753   23345678889999999966 56888999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988843   345789999999999999999999987   999999999999999999999999998753211


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... .      ..  
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~---~i~~-~------~~--  218 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQ---SIME-H------NV--  218 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH---HHHc-C------CC--
Confidence              1123345789999999999999999999999999999999999999875432211  00   0000 0      00  


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                        ..+......+.+++.+|++.+|++|++.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1111234567889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-36  Score=330.10  Aligned_cols=253  Identities=20%  Similarity=0.283  Sum_probs=201.2

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+++.. +++.||||+++...   ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999875 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998542  246889999999999999999999988   999999999999999999999999999876433


Q ss_pred             CccccccccccccceeCceeec------CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........     ............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRFLK  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCccC
Confidence            221 223356899999999986      45678999999999999999999999875432110     001111111011


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..       ........+.+++..|++ +|++||++.++++.
T Consensus       230 ~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 FP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            10       111234567789999998 99999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=308.79  Aligned_cols=255  Identities=21%  Similarity=0.253  Sum_probs=210.8

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|+++++||+|.-|+||++++.+ +..+|+|++.+..   .....+.+.|-+||+.++||.++.|++.++.++..+||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3678899999999999999999876 5889999997653   34456778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||||+||+|..++++ +..+.+++..+..++..++-||+|||-.|   ||.|||||+||||.++|++-|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999988854 35567999999999999999999999998   99999999999999999999999998854311


Q ss_pred             C----------------------------------C--------------------ccccccccccccceeCceeecCCC
Q 003264          669 D----------------------------------E--------------------LQGNTKRVVGTYGYMSPEYALDGL  694 (835)
Q Consensus       669 ~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~  694 (835)
                      .                                  .                    ........+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                  0                    001123468999999999999999


Q ss_pred             CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCC
Q 003264          695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAA  774 (835)
Q Consensus       695 ~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~  774 (835)
                      ++.++|.|+|||+||||+.|..||...+.+..              ...++...+........+..+.+||+..|.+||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999998664432              1122222222222225667789999999999999


Q ss_pred             CCCC----HHHHHHH
Q 003264          775 DRPT----MSKVVSM  785 (835)
Q Consensus       775 ~RPs----~~evl~~  785 (835)
                      +|..    +.||.+.
T Consensus       378 kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhccccchHHhhcC
Confidence            9998    8888764

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-35  Score=318.68  Aligned_cols=271  Identities=28%  Similarity=0.404  Sum_probs=207.5

Q ss_pred             cCCccccccccCCcccEEEEEec-----CCcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  585 (835)
                      +.|++.+.||+|+||.||+++..     .++.||||.+...... ..+.|.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            56788899999999999999853     3678999999765443 56789999999999999999999999887  5578


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999542  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ....... .......++..|+|||.+....++.++||||||++++||++|+.|+........................+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532211 112223456679999999888999999999999999999999988754332211111000000000011111


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +........+..+...+.+++.+|++.+|++||++.||+++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111112223446788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-35  Score=313.88  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+++|+.++.+++||||+++++++......++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57999999999999999999974 58899999987655455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+....  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence            99999998843   345789999999999999999999987   9999999999999999999999999998653221  


Q ss_pred             ccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          673 GNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .......++..|+|||.+.   ...++.++||||||++++||++|+.|+.......... ..     ...   ....+..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~-----~~~---~~~~~~~  231 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LM-----SKS---NFQPPKL  231 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-ee-----ecC---CCCCCCC
Confidence            1122346788999999874   3457889999999999999999999985432111100 00     000   0000111


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      .  .....+..+.+++.+|++.+|++||+++++++.|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1123446788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.8e-36  Score=334.60  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=194.0

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|+++++||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++++++||||+++++.+.++...++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999875 47899999986542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999843   345788999999999999999999988   9999999999999999999999999975431100


Q ss_pred             c---------------------------------------------cccccccccccceeCceeecCCCCCccccchhHH
Q 003264          671 L---------------------------------------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG  705 (835)
Q Consensus       671 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG  705 (835)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 003264          706 VLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKV  782 (835)
Q Consensus       706 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev  782 (835)
                      |+||||++|+.||...+......     ......       ..+...........+.+++.+++ .+|++|++   +.|+
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~-----~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQM-----KVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHH-----HHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            99999999999997543211100     000000       00000011122344566676665 49999997   7777


Q ss_pred             HH
Q 003264          783 VS  784 (835)
Q Consensus       783 l~  784 (835)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            65

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-35  Score=312.97  Aligned_cols=254  Identities=31%  Similarity=0.449  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46799999999999999999998889999999987543 34567899999999999999999999864 56789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999885432 346889999999999999999999987   999999999999999999999999999876422211


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......++..|+|||.+....++.++||||||++++||++ |+.||...+....  ..    .....         ...
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~---------~~~  222 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQ----NLERG---------YRM  222 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HH----HHHcC---------CCC
Confidence             1122345678999999998899999999999999999999 9999865432111  00    00000         000


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ..+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1112234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-35  Score=322.43  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=204.7

Q ss_pred             cCCccccccccCCcccEEEEEec--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      ++|.+.++||+|+||.||+++..        ....||+|.+... ......++.+|+.++.++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            67889999999999999999752        2457999998754 334567789999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      ..++||||+++|+|.+++....             ....+++..+.+++.||+.||.|||+++   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999985432             1245889999999999999999999987   99999999999999


Q ss_pred             CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccccc
Q 003264          651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  729 (835)
Q Consensus       651 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  729 (835)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........  .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--F  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence            999999999999986643222222222234567999999998999999999999999999999 8888764332111  0


Q ss_pred             ccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .    .......         ...+......+.+++.+|++.+|++||++.|+++.|..+.
T Consensus       247 ~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         247 K----LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             H----HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            0    0011100         0111223456778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-35  Score=328.16  Aligned_cols=261  Identities=27%  Similarity=0.401  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec-C
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ-G  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  583 (835)
                      .++|++.+.||+|+||.||+|+.      ..++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            36899999999999999999974      246789999997543 33456788999999999 789999999988654 4


Q ss_pred             eEEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSR---------------------------------------------------------  606 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  606 (835)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccc
Q 003264          607 -------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV  679 (835)
Q Consensus       607 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  679 (835)
                             ...+++..+.+++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999987   9999999999999999999999999998653332222222334


Q ss_pred             cccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHH
Q 003264          680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQML  758 (835)
Q Consensus       680 gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  758 (835)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+........ ..    ........         ...+....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~----~~~~~~~~---------~~~~~~~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGTR---------MRAPDYTT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH----HHHhccCC---------CCCCCCCC
Confidence            5678999999999999999999999999999997 8888764322110 00    00001100         00011123


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          759 NRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       759 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ..+.+++..|++.+|++||++.||++.|+.+.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            45788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.2e-36  Score=333.46  Aligned_cols=254  Identities=21%  Similarity=0.261  Sum_probs=201.0

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++.++||+|+||.||+++.. +++.||||++...   .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999975 4889999998643   22334567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998843    34788889999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCccccccccccccceeCceeecCC----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+....     ............
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~~~  267 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKNSLT  267 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCCcCC
Confidence            3221 122345799999999988653    478999999999999999999999875432110     000111000000


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                      .       ......+..+.+++..|++.+|.+  ||++.|+++.
T Consensus       268 ~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 F-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0       111123466788999999999987  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-35  Score=315.01  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             cCCccccccccCCcccEEEEEecC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..|++.+.||+|+||.||+|++.. +   ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998753 3   36999998754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  345889999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCccccccc-cc--cccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          669 DELQGNTKR-VV--GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       669 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......... ..  .+..|+|||.+....++.++||||||+++|||++ |..|+...+...  .....    ..     .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i----~~-----~  227 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAI----EQ-----D  227 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHH----Hc-----C
Confidence            222111111 11  2457999999999999999999999999999886 999986433211  11100    00     0


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          .....+...+..+.+++..|++.+|++||++.+++++|+..
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00011123345678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-35  Score=313.82  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|+..+.||+|+||.||+|++.. +   ..+|||.+... .....+++.+|++++.+++|+||+++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578888999999999999998753 3   37999998754 33446778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998542  345889999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCcccc-ccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ....... ......+..|+|||++....++.++||||||+++|||++ |+.|+.......  ..    ..+...      
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~----~~i~~~------  226 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VM----KAINDG------  226 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH----HHHhcC------
Confidence            3221111 111223467999999998899999999999999999997 999986433211  00    000000      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         ............+.+++.+|++.+|++||++.+|++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               01111122345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-36  Score=333.78  Aligned_cols=253  Identities=22%  Similarity=0.270  Sum_probs=196.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.++||+|+||.||+++.. +++.||||++...   .....+.+++|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999875 5889999998643   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999843   345788999999999999999999998   999999999999999999999999999643211


Q ss_pred             Ccc------------c---------------------------------cccccccccceeCceeecCCCCCccccchhH
Q 003264          670 ELQ------------G---------------------------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSF  704 (835)
Q Consensus       670 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSl  704 (835)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCC---CCHHH
Q 003264          705 GVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR---PTMSK  781 (835)
Q Consensus       705 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~e  781 (835)
                      ||++|||++|+.||........  ..   ..........+  +.     .......+.+++.+|++ +|.+|   +++.|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--~~---~i~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHET--YR---KIINWRETLYF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHH--HH---HHHccCCccCC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999865432111  00   00000000000  00     01123557789999997 66665   59999


Q ss_pred             HHHH
Q 003264          782 VVSM  785 (835)
Q Consensus       782 vl~~  785 (835)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.3e-36  Score=328.44  Aligned_cols=242  Identities=22%  Similarity=0.254  Sum_probs=194.8

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+++.. +++.||+|++...   ......++.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999874 5889999998753   2234567788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      +|..++..   ...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99988843   3468899999999999999999997 56   9999999999999999999999999987542221  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+...  .    .....      ...    .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~--~----~i~~~------~~~----~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--E----LILME------EIR----FP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH--H----HHhcC------CCC----CC
Confidence            23456899999999999999999999999999999999999998654322110  0    00000      000    11


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      ......+.+++.+|++.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12345678899999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.3e-35  Score=324.48  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=197.7

Q ss_pred             CCccccccccCCcccEEEEEec----CCcEEEEEEecCc----ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      +|++.+.||+|+||.||+++..    .++.||+|++.+.    .....+.+.+|+.++.++ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999999763    4789999998643    223346688899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998843   345889999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      +..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......... ........       .
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~-------~  225 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL-------K  225 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh-------c
Confidence            533221 122345789999999998765 4789999999999999999999998643321110 00000000       0


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .++.+    +......+.+++.+|++.||++||     +++++++.
T Consensus       226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11111    122345678899999999999999     67777754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=311.45  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+|... ++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467899999999999999999874 78999999976543 5678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985432 236899999999999999999999988   99999999999999999999999999987632211 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                          ....+..|+|||.+....++.++||||||++++||++ |..|+........  ...    ....         ...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~----~~~~---------~~~  218 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPH----VEKG---------YRM  218 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHH----HhcC---------CCC
Confidence                2334678999999988899999999999999999997 9988864432111  000    0000         011


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ..+...+..+.+++.+|++.+|++||+++|++++|++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1122335678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.1e-35  Score=310.29  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|++|.||+++.. +++.|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999875 4889999998643  344567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998643 2356889999999999999999999987   99999999999999999999999999987643221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||++.+..++.++||||||++++||++|+.|+...+....  ..   .. .     +    ....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~-~-----~----~~~~  219 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--IL---KI-I-----R----GVFP  219 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-H-----c----CCCC
Confidence              12334678899999999999999999999999999999999999875442110  00   00 0     0    0011


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-35  Score=309.26  Aligned_cols=247  Identities=27%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChh
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN  598 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~  598 (835)
                      ++||+|+||.||+|...+++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998888999999987653 333457889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccccccc
Q 003264          599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV  678 (835)
Q Consensus       599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  678 (835)
                      +++...  ...+.+..+..++.|++++|.|||+.+   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            988532  245789999999999999999999987   999999999999999999999999999764322211 11223


Q ss_pred             ccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       679 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      .++..|+|||++....++.++||||||+++|||++ |..|+........  ..    .....         .....+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~----~~~~~---------~~~~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--RE----QVEKG---------YRMSCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHHcC---------CCCCCCCCC
Confidence            44678999999998899999999999999999998 8888864332111  00    00000         000111223


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-35  Score=323.28  Aligned_cols=247  Identities=21%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++... ++.||+|++...   .....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999754 789999998753   233456678899988877 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999888743   346889999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc---cccccchhhhccccchhccCccccc
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||........   ....+.........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence            2345789999999999999999999999999999999999999864321111   00000111111100          0


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPT------MSKVVS  784 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  784 (835)
                      ..+......+.+++.+||+.||++||+      +.++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            112233456788999999999999998      456653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=310.87  Aligned_cols=250  Identities=36%  Similarity=0.516  Sum_probs=204.4

Q ss_pred             cccccCCcccEEEEEecC----CcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||++....    +..|++|.+...... ..+.+.+|++.+..++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998754    788999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          595 KSLNFFLFDPSR------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       595 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ++|.+++.....      ...+++..+..++.|+++||+|||+++   ++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      367899999999999999999999987   99999999999999999999999999987754


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...........++..|+|||.+....++.++||||||++++||++ |..|+........  ..    ....         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~~~~---------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LE----YLRK---------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHHc---------
Confidence            432233344567889999999988899999999999999999999 5888875432111  00    0000         


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ......+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0011112233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-35  Score=310.64  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=195.1

Q ss_pred             ccccCCcccEEEEEec---CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCC
Q 003264          521 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      .||+|+||.||+|++.   .+..||+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   35579999987653 334567999999999999999999999875 457899999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc-ccc
Q 003264          597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-GNT  675 (835)
Q Consensus       597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~  675 (835)
                      |.+++..  ....+++..+++++.||++||+|||+++   ++||||||+|||++.++.+||+|||+++.+...... ...
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999853  2346899999999999999999999987   999999999999999999999999999865332211 111


Q ss_pred             cccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       676 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      ....++..|+|||.+....++.++||||||+++|||++ |..|+........  .    ......         .....+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~---------~~~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--M----SFIEQG---------KRLDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--H----HHHHCC---------CCCCCC
Confidence            12233578999999988889999999999999999996 9999865432111  0    000110         111112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23356778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=311.02  Aligned_cols=252  Identities=28%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|++.+.||+|++|.||++... ++++||+|.+....     ....+.+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999874 48999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998843   345788999999999999999999988   9999999999999999999999999997653


Q ss_pred             CCCcccc-ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...+....     .....         .
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~---------~  221 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIA---------T  221 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HHHHh---------c
Confidence            2211111 1234578899999999999999999999999999999999999864321110     00000         0


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .......+......+.+++.+|++.+|++||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000111222344567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-35  Score=320.59  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=201.0

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+|++.. +.  .+|+|.+... .....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            578899999999999999998743 43  4688887653 334557889999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          589 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      |||+++++|.+++....             ....+++..++.++.||++||+|||+++   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999985432             1235789999999999999999999987   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++....   .........+..|+|||++....++.++||||||++++||++ |..||...+....  ...   
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~---  235 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEK---  235 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HHH---
Confidence            9999999864211   111111234668999999988889999999999999999998 9999864332211  000   


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       ...         ......+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       236 -~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         236 -LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -Hhc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             000         000011112345678899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.4e-35  Score=313.22  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+|++. +++.||+|++... .....+++.+|+.++.+++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46888899999999999999874 5889999998654 334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|..+.       .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996543       3678888999999999999999988   999999999999999999999999999765322  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc-cchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG-HAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~  750 (835)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||............ .........     ..+.+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC-
Confidence              123357899999999999999999999999999999999999998653321111000 000000000     00111 


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ........+.+++.+|++.+|++||+++|+++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              111234567889999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-35  Score=321.70  Aligned_cols=242  Identities=24%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++... ++.||||++....   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998864 7899999987532   33456678899999888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988843   346899999999999999999999988   9999999999999999999999999987532111  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+....  .    .......      .    ..+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~----~~i~~~~------~----~~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--F----QSILEDE------V----RYP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--H----HHHHcCC------C----CCC
Confidence            2335689999999999999999999999999999999999999875432211  0    0000000      0    011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTM-----SKVVSM  785 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  785 (835)
                      ......+.+++.+||+.+|++||++     .++++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1234567889999999999999999     887753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-35  Score=330.45  Aligned_cols=255  Identities=20%  Similarity=0.251  Sum_probs=199.4

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ...++|++.+.||+|+||.||+++... ++.||+|.+.+.   .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            345789999999999999999999864 789999998642   2233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999843    34788899999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCC----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ..... .......||+.|+|||++...    .++.++|||||||+||||++|+.||...+....     ...........
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~~~i~~~~~~~  266 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----YSKIMDHKNSL  266 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCccc
Confidence            32221 122346799999999998654    378899999999999999999999975432110     00111111000


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                      ..       ......+..+.+++..|++.++.+  ||++.|+++.
T Consensus       267 ~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00       111223456677888898755543  8899999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-36  Score=311.14  Aligned_cols=261  Identities=23%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----eEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l  587 (835)
                      -.|+..+++|+|+||.||+|++.+ ++.||||+.-....    .--+|+.+|++++|||||+|+-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            357778999999999999999865 68999999865432    1236899999999999999999887543     3468


Q ss_pred             EEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCcccc
Q 003264          588 IYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARM  665 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~  665 (835)
                      ||||+|. +|.+.++.. ..+..++...+.-+..||.+||+|||+.+   |+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 566666432 23455778888899999999999999987   9999999999999976 9999999999998


Q ss_pred             ccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCc-ccccccccchhhhccccc--
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLLGHAWNLWKDNRA--  741 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~--  741 (835)
                      +..++.   ......|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+. ++......+......+++  
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            755443   3456779999999999885 799999999999999999999999887542 221111000000000000  


Q ss_pred             -----hhccCccccc-----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 -----YELLSPALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 -----~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           .+...|.+..     -.......+..+++.++++.+|.+|.++.|++..
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 0111111111     1223345678899999999999999999999865

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.2e-35  Score=312.79  Aligned_cols=256  Identities=27%  Similarity=0.441  Sum_probs=203.5

Q ss_pred             cCCccccccccCCcccEEEEEecC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+|++.+.||+|+||.||+|++..    +..+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            578899999999999999998642    3479999986543 33456889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998542  345789999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCccc-cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          669 DELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       669 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ..... ......++..|+|||.+.+..++.++||||||++++|+++ |..|+........  ...    ....  ..   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~~----~~~~--~~---  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKA----IEEG--YR---  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HHH----HhCC--Cc---
Confidence            22111 1111223568999999998899999999999999999886 9999865432211  000    0000  00   


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          ...+...+..+.+++.+|++.+|++||+|.++++.|+.+
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                011122345678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-35  Score=308.32  Aligned_cols=248  Identities=29%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChh
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN  598 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~  598 (835)
                      ++||+|+||.||++.+.+++.||+|++..... ...+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987799999999876543 35678999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccccccc
Q 003264          599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV  678 (835)
Q Consensus       599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  678 (835)
                      +++...  ...+++..+..++.+++.+|+|||+++   ++||||||+||+++.++.+||+|||+++..............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  235788999999999999999999988   999999999999999999999999999865322222221223


Q ss_pred             ccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       679 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..+..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    ...         .......+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~----~~~---------~~~~~~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RE----RIE---------SGYRMPAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HH----HHh---------cCCCCCCCccC
Confidence            34667999999988899999999999999999999 7888764332110  00    000         00001112233


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      +..+.+++.+|++.+|++||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.3e-35  Score=315.12  Aligned_cols=247  Identities=25%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             cccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||+||+++.. +++.||||.+....   ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 58899999986532   22346678899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccccc
Q 003264          598 NFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK  676 (835)
Q Consensus       598 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  676 (835)
                      ..++... .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887542 23456899999999999999999999988   99999999999999999999999999976543221  223


Q ss_pred             ccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHH
Q 003264          677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQ  756 (835)
Q Consensus       677 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  756 (835)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..    .     ........  ...+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~----~-----~~~~~~~~--~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KE----L-----KQRILNDS--VTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HH----H-----HHhhcccC--CCCccc
Confidence            457899999999999999999999999999999999999998753321100 00    0     00000000  011223


Q ss_pred             HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          757 MLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       757 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      ++..+.+++.+|++.+|++||     +++++++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            456788999999999999999     66777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-35  Score=323.81  Aligned_cols=241  Identities=25%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +|++.+.||+|+||.||+|+... ++.||||++....   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58889999999999999998764 7899999987532   23345567788888877 6899999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   345889999999999999999999987   999999999999999999999999999754221


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   ... ...         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~---~i~-~~~---------  217 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---SIM-EHN---------  217 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HH---HHH-hCC---------
Confidence            1  122345789999999999999999999999999999999999999975432211  10   000 000         


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                       ...+......+.+++.+|++.+|++|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             01112234567889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.1e-35  Score=311.58  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=193.3

Q ss_pred             cccccCCcccEEEEEecC---CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+|+..+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998643   4579999987543 334457889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          596 SLNFFLFDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       596 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|.+++....  .....++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999985432  2234567788899999999999999987   9999999999999999999999999997643333222


Q ss_pred             cccccccccceeCceeecCC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          674 NTKRVVGTYGYMSPEYALDG-------LFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||........  ....   . ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~-~~~~~~~~  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---V-REQQLKLP  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---h-hcccCCCC
Confidence            22334578899999988542       35789999999999999996 9999875432211  0000   0 01111112


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+.+..    .....+.+++..|+ .+|++||+++||+..|+
T Consensus       232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222211    12345677888998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.8e-35  Score=322.09  Aligned_cols=247  Identities=20%  Similarity=0.304  Sum_probs=194.6

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++.. +++.||||+++..   .....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 4889999999753   233456688999999998 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999888743   346899999999999999999999988   999999999999999999999999998753211  112


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc---cccccchhhhccccchhccCccccc
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF---NLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||........   ....+.........        .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence            2345789999999999999999999999999999999999999964331110   00011111111110        0  


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPT------MSKVVS  784 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  784 (835)
                      ..+......+.+++.+|++.+|++||+      ++++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            111223456788999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=314.42  Aligned_cols=252  Identities=25%  Similarity=0.304  Sum_probs=201.0

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|++.++||+|+||+||++... +++.||||++....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875 58899999986532   2234557889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887543 2345899999999999999999999988   9999999999999999999999999998653222


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||........  ...         ....+. ...
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~---------~~~~~~-~~~  221 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REE---------VERRVK-EDQ  221 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHH---------HHHHhh-hcc
Confidence               11234689999999999989999999999999999999999999975332110  000         000000 001


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      ...+......+.+++..|++.||++||     +++++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112233556678899999999999999     78788654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.3e-35  Score=309.81  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.++||+|+||.||++.+..+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688999999999999999998777789999886533 34567889999999999999999999875 456889999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999998543 2345789999999999999999999987   999999999999999999999999999865332211 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ...    .....     .    ...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~-----~----~~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLE----QVERG-----Y----RMP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC-----C----CCC
Confidence            1122345778999999988899999999999999999999 888886432211  000    00000     0    001


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      .+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=325.16  Aligned_cols=245  Identities=26%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             ccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhh
Q 003264          521 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF  599 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  599 (835)
                      +||+|.||+||.|++.+ ...+|||-+........+-+.+|+.+.++|+|.|||+++|.+.+++..-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999876 55799999988777777888999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeEecccCccccccCCCcccccc
Q 003264          600 FLFDPSRTHLL--GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDELQGNTK  676 (835)
Q Consensus       600 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~  676 (835)
                      +|...  =+++  .+.+.-.+.+||++||.|||++.   |||||||-.||||+ -.|.+||+|||-++.+.  .....+.
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE  734 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE  734 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence            99543  2333  67788889999999999999998   99999999999996 57899999999998873  3445666


Q ss_pred             ccccccceeCceeecCC--CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          677 RVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       677 ~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      ...||..|||||++..+  .|..++|||||||++.||.||++||-.....+-.       +.+.+-  -    ...+..+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVGm--y----KvHP~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVGM--Y----KVHPPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhcc--e----ecCCCCc
Confidence            78899999999999876  5899999999999999999999998755433211       111110  0    1123456


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.+.+...+|.+|+..+|.+||+++++++-
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            6778888999999999999999999999864

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-36  Score=325.82  Aligned_cols=238  Identities=26%  Similarity=0.296  Sum_probs=192.0

Q ss_pred             cccccCCcccEEEEEe----cCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          520 CKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      +.||+|+||.||+++.    ..|+.||+|++....  ......+.+|++++++++||||+++++++.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999975    347899999987542  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|+|.+++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998843   345899999999999999999999988   9999999999999999999999999997653221  1


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+....  ..   .... ..          ...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~---~i~~-~~----------~~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET--MT---MILK-AK----------LGM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH--HH---HHHc-CC----------CCC
Confidence            22345789999999999988899999999999999999999999875432111  00   0000 00          011


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      +......+.+++.+||+.+|++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1223456778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-35  Score=310.70  Aligned_cols=256  Identities=31%  Similarity=0.459  Sum_probs=206.3

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..++|++.++||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++.+....++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            347899999999999999999998888899999987543 3457789999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++... ....+++..+..++.+++.||+|||+++   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999998543 2345889999999999999999999988   99999999999999999999999999987643211


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       ........+..|+|||.+.+..++.++||||||++++||++ |+.|+.......  ....    ...     .    ..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~----~~~-----~----~~  222 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQ----VER-----G----YR  222 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHc-----C----CC
Confidence             11112234578999999998899999999999999999999 899886433111  0000    000     0    00


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            01111224568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.2e-35  Score=315.58  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            68999999999999999999864 58899999987665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999999832    34788999999999999999999988   99999999999999999999999999876533221 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...    .....      .+.+  .
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~----~~~~~------~~~~--~  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYL----IATNG------TPEL--Q  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHH----HhcCC------CCCC--C
Confidence             12234678899999999988899999999999999999999999864332111 000    00000      0000  1


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+......+.+++.+|++.+|++||++.|+++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            122344567889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-35  Score=319.99  Aligned_cols=240  Identities=24%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999986 48899999987532   23345667788888765 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999988843   345788999999999999999999988   999999999999999999999999998743211  112


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    ...      ...+..    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~~----~~~------~~~~~~----~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--FE----SIR------VDTPHY----P  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHH------hCCCCC----C
Confidence            2346789999999999999999999999999999999999999975432211  00    000      001111    1


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMS-KVV  783 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl  783 (835)
                      ......+.+++.+|++.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345677899999999999999985 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.7e-35  Score=345.60  Aligned_cols=261  Identities=23%  Similarity=0.280  Sum_probs=204.2

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.++||+|+||.||+|++.. ++.||||++....   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            579999999999999999999754 8899999986532   234567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          590 EYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      ||+++++|.+++....        .....++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1233566788999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCc----------------cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc
Q 003264          662 MARMFCGDEL----------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  725 (835)
Q Consensus       662 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~  725 (835)
                      +++.......                ........||+.|||||++.+..++.++|||||||+++||++|+.||...+...
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                001123569999999999999999999999999999999999999986533211


Q ss_pred             ccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccc
Q 003264          726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEH  790 (835)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  790 (835)
                      ....         .   ....+... ......+..+.+++.+|++.+|++|| +++++++.|+...
T Consensus       239 i~~~---------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ISYR---------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhh---------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1000         0   00000000 00123345678899999999999996 6777877776653

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-35  Score=323.47  Aligned_cols=242  Identities=21%  Similarity=0.323  Sum_probs=193.9

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|+||.||+|+... ++.||||++...   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998754 789999998753   233455677899998876 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      ++|...+..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   345889999999999999999999988   9999999999999999999999999987542221  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   ......    ..       .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~---~i~~~~----~~-------~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FE---SILHDD----VL-------YP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HH---HHHcCC----CC-------CC
Confidence            2345689999999999999999999999999999999999999975442211  00   000000    00       01


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRP-------TMSKVVSM  785 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  785 (835)
                      ......+.+++..|++.+|++||       ++.++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11235678899999999999999       77777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-35  Score=319.71  Aligned_cols=237  Identities=25%  Similarity=0.277  Sum_probs=187.5

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||+||+|+.. +++.||||++....   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999985 58999999986532   222344555554 56788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999988843   346889999999999999999999988   999999999999999999999999998753221  122


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  .   ..... ..      ..+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~---~~i~~-~~------~~~~----  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--Y---DNILN-KP------LRLK----  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--H---HHHHc-CC------CCCC----
Confidence            3345789999999999999999999999999999999999999875432211  0   00000 00      0111    


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      ......+.+++.+|++.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12245678899999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.9e-35  Score=322.05  Aligned_cols=237  Identities=24%  Similarity=0.283  Sum_probs=186.4

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|+||.||+|+.. +++.||+|++....   .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999985 48899999986532   222344555554 67888999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      ++|...+..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999888743   345788889999999999999999987   999999999999999999999999998753221  122


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....  ..   ... ..        ..  ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~---~i~-~~--------~~--~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YD---NIL-HK--------PL--QLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HH---HHh-cC--------CC--CCC
Confidence            3345789999999999998999999999999999999999999875432111  00   000 00        00  011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      ......+.+++.+|++.+|++||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12345678899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=304.65  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=211.8

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +-|.++++||+|+||.|||+.++. |+.||||.+..  +.+++++.+|+.+|.+++.|++|+++|.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            457888999999999999998765 99999999864  346788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ..|+..+++.  .+.+.+.+.++..+++.-++||+|||...   -||||||+.|||++.+|.+||+|||.|..+.+  ..
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM  183 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM  183 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence            9999999984  35678999999999999999999999876   89999999999999999999999999987643  33


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc-cCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL-LSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~  751 (835)
                      .....+.||+.|||||++..-.|..++||||||++..||.-|++|+...-...              .++-+ ..|.-..
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIFMIPT~PPPTF  249 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIFMIPTKPPPTF  249 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeEeccCCCCCCC
Confidence            44556899999999999999999999999999999999999999986422110              00000 0111122


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+...+..+.++++.||-..|++|-++.++++.
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            3466788899999999999999999999988764

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.9e-35  Score=311.63  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=191.2

Q ss_pred             cccccCCcccEEEEEecC---CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.||+|+||.||+|+...   ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997643   3578999876443 334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          596 SLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       596 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|.+++.....  ....++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  233567888999999999999999987   9999999999999999999999999987643332222


Q ss_pred             cccccccccceeCceeecC-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          674 NTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..|+.......  ...   .... .....+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---~~~~-~~~~~~~  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK---QVVR-EQDIKLP  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH---HHhh-ccCccCC
Confidence            2233456778999998643       456889999999999999999 777876433211  000   0000 1111122


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+..    .......+.+++..|+ .+|++||+++||+++|.
T Consensus       232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222    2233455667888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.9e-35  Score=308.62  Aligned_cols=249  Identities=32%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             cccccCCcccEEEEEecC--C--cEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998743  3  3699999987655 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc-cc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QG  673 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~  673 (835)
                      ++|.+++.+... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..... ..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 46899999999999999999999987   99999999999999999999999999987643221 11


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+....++.++||||||++++||++ |..|+........  ..   ......  ...       .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~---~~~~~~--~~~-------~  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LK---KIDKEG--ERL-------E  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HH---HHHhcC--CcC-------C
Confidence            2223456789999999998999999999999999999999 9999864332211  00   000000  000       0


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11123456888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-35  Score=335.51  Aligned_cols=261  Identities=18%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--------  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  582 (835)
                      ...+|++.++||+|+||.||+|+.. .++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3468999999999999999999875 48899999885432    2345799999999999999999887532        


Q ss_pred             CeEEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEeccc
Q 003264          583 GEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF  660 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DF  660 (835)
                      ...++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999986 56555532 223456889999999999999999999988   99999999999998665 6999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc-
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD-  738 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-  738 (835)
                      |+++.+....   ......||+.|+|||++.+. .++.++|||||||+||||++|.+||........ +.. ....... 
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~-i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVR-IIQVLGTP  290 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHHhCCC
Confidence            9998764322   12235689999999988764 689999999999999999999999875432110 000 0000000 


Q ss_pred             ---------ccchhc-----cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 ---------NRAYEL-----LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ---------~~~~~~-----~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                               ....+.     ....+....+...+..+.+++.+||+.+|++||++.|+++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                     000000     00011111122234578899999999999999999999854

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-35  Score=322.84  Aligned_cols=236  Identities=23%  Similarity=0.326  Sum_probs=190.2

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++... ++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999754 789999998653   223456677888888877 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988843   345889999999999999999999988   9999999999999999999999999987542211  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .+....   .       ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~----~i~~~~---~-------~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE----AILNDE---V-------VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH----HHhcCC---C-------CCC
Confidence            2345789999999999999999999999999999999999999975432211  00    000000   0       011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                      ......+.+++.+|++.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1234567889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.7e-35  Score=308.22  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=199.4

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~  592 (835)
                      ++|++.+.||+|+||.||++.. .+..||+|.+....  ..+.+.+|+.++++++|+|++++++++.+ +...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            5789999999999999999987 47889999986432  34678999999999999999999997654 45789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.||+.||+|||+++   ++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998543 2335789999999999999999999987   9999999999999999999999999987643221  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                         .....+..|+|||++.+..++.++||||||+++|||++ |+.|+........  .   . ....+         ...
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~---~-~~~~~---------~~~  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V---P-RVEKG---------YKM  218 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--H---H-HHhcC---------CCC
Confidence               22344678999999998899999999999999999998 8888764332110  0   0 00000         001


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ......+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            11123345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.2e-35  Score=324.85  Aligned_cols=258  Identities=19%  Similarity=0.242  Sum_probs=200.8

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      .+....++|++.+.||+|+||.||+++... ++.||+|++...   .....+.+.+|+.+++.++||||+++++.+.+..
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            344456899999999999999999999864 789999998642   2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999843    34788889999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCC----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      +.+..... .......||+.|+|||++...    .++.++|||||||++|||++|+.||...+....     ........
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~  263 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHK  263 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCC
Confidence            87643221 122345799999999998654    378999999999999999999999975432110     01111111


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                      ......       .....+..+.+++..|++..+.+  ||++.|+++.
T Consensus       264 ~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111111       11234556778999999844433  7899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.8e-35  Score=320.15  Aligned_cols=241  Identities=26%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+|+... ++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999765 7899999987542   23345567788888764 999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998843   345788999999999999999999988   9999999999999999999999999987532111  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...+...  +...    ..      ...+..    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~----i~------~~~~~~----~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQS----IR------MDNPCY----P  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHH----HH------hCCCCC----C
Confidence            234578999999999999999999999999999999999999987543211  1000    00      001111    1


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMS-KVVS  784 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  784 (835)
                      ......+.+++.+|++.+|++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            12345677899999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-35  Score=309.78  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=195.2

Q ss_pred             cccccCCcccEEEEEecC-Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+|++.+ +.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999754 33  5788988753 344557889999999999 899999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          595 KSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       595 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      |+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422             1234789999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhcccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      +++....   .........+..|+|||++....++.++||||||++++||++ |..||...+....  ..    ..... 
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~-  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----KLPQG-  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--HH----HHhCC-
Confidence            9863211   111111233567999999988899999999999999999997 9999864332110  00    00000 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                              .....+......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                    00011112335678999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.5e-35  Score=312.00  Aligned_cols=264  Identities=25%  Similarity=0.335  Sum_probs=198.4

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5888999999999999999975 58899999986432  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 678888754444456899999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccc--c----ccchhhhcccc----
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--L----GHAWNLWKDNR----  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~----~~~~~~~~~~~----  740 (835)
                       .......++..|+|||.+.+. .++.++||||||++++||++|+.|+..........  .    ......|....    
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             112233568899999988654 57899999999999999999999987533211000  0    00000000000    


Q ss_pred             chhccCc---cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSP---ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .......   ............++.+++.+|++.||++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000   0000111124566789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=306.72  Aligned_cols=248  Identities=31%  Similarity=0.439  Sum_probs=196.5

Q ss_pred             cccccCCcccEEEEEecC----CcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997532    26899999876543 34567899999999999999999999875 5578999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc-
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-  673 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  673 (835)
                      ++|.+++...   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999543   36889999999999999999999987   9999999999999999999999999998664322111 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+...+....  ...    .....  .       ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--~~~----~~~~~--~-------~~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAM----LESGE--R-------LP  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--HHH----HHcCC--c-------CC
Confidence            1112234568999999998999999999999999999998 9999875432211  110    00000  0       01


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-34  Score=329.12  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=195.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ...|.+.+.||+|+||.||++++.. ++.||||....      ..+.+|+.++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999865 78899996432      3457899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +. ++|..++..  ....+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 678777743  2346899999999999999999999988   99999999999999999999999999987643322


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc--ccccccchhhhccccc--hhc---
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES--FNLLGHAWNLWKDNRA--YEL---  744 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~--~~~---  744 (835)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++-......  ..........+.....  .++   
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222234579999999999999999999999999999999999886643221110  0000000001000000  000   


Q ss_pred             ----------------cCccccchhH---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 ----------------LSPALQHEAS---YQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ----------------~~~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                      ..+.......   ......+.+|+.+||+.||++||++.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            0000000000   0122367789999999999999999999975

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-34  Score=318.28  Aligned_cols=242  Identities=21%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++... ++.||||++....   ....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999754 7899999997542   33456688999999888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999888743   346899999999999999999999988   999999999999999999999999998753211  112


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccccccchhhhccccchhccCccccchh
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                      .....||+.|+|||++.+..++.++|||||||+||||++|+.||....... ..............        .  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~--~~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------P--IRI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------C--CCC
Confidence            234678999999999999999999999999999999999999996433211 11111111111100        0  011


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                      +......+.+++.+|++.||++||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            12234557789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-35  Score=311.43  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=203.6

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .+|++.+.||+|+||.||+|.... ++    .||+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578899999999999999998643 32    58999886553 3455788999999999999999999999987 78899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |+||+++|+|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998542  334889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............++..|+|||.+....++.++||||||++++||++ |+.|+........  ..    ......      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~------  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PD----LLEKGE------  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHhCCC------
Confidence            3322111112234568999999988899999999999999999998 9999875432211  00    000000      


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                         ....+..+...+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               001111123457789999999999999999999999988733

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.5e-35  Score=311.83  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=193.1

Q ss_pred             cccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||.||+++.. +|+.||+|.+....   ......+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 48999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9887543 2334788999999999999999999988   9999999999999999999999999998654321   1223


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ..    . ...    ........ ....+
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~----~-~~~----~~~~~~~~-~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EE----L-KRR----TLEDEVKF-EHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HH----H-HHH----hhcccccc-ccccC
Confidence            46899999999999989999999999999999999999998643321110 00    0 000    00000000 01123


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      ...+.+++.+||+.+|++||++.|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            45678999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=332.70  Aligned_cols=255  Identities=29%  Similarity=0.388  Sum_probs=213.5

Q ss_pred             CccccccccCCcccEEEEEe-cCC----cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKL-LNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~-~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ....++||+|+||+||||.+ ++|    -+||||++... ..+..+++++|+.+|.+++|||++||+++|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34567899999999999986 334    36899988654 4456789999999999999999999999998876 88999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      +|++.|.|.++++.  .+..+..+..+.+..|||+||.|||++.   ++||||.++||||++...+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999965  3456888999999999999999999887   999999999999999999999999999998777


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++               +.+++...
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~g  916 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKG  916 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhcc
Confidence            66655555666889999999999999999999999999999998 888887654332               22222222


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .+-..++.+...+..++.+||..|+..||+++++...+.....
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            3333455567788889999999999999999999988876543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-34  Score=315.05  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+++.. ++..+|+|.+... ......++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999875 4788999988654 333456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..   ...+++..+..++.||++||.|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            999999999843   245889999999999999999999742  3999999999999999999999999998765322  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-cccchhhhccc-----------
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGHAWNLWKDN-----------  739 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~-----------  739 (835)
                        ......++..|+|||.+.+..++.++||||||++++||++|+.|+...+...... ...........           
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1233568899999999988889999999999999999999999986433211100 00000000000           


Q ss_pred             ------cchhccCccc---cch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 ------RAYELLSPAL---QHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 ------~~~~~~~~~l---~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            ...+..+...   ... ....+...+.+++.+|++.+|++||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000000000   000 001134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.1e-35  Score=310.70  Aligned_cols=251  Identities=31%  Similarity=0.493  Sum_probs=199.0

Q ss_pred             cccccCCcccEEEEEecC-------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +.||+|+||.||+|+..+       ++.+|||.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998643       2579999886543 34567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-----CeEecccCc
Q 003264          592 MPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGM  662 (835)
Q Consensus       592 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl  662 (835)
                      +++++|.+++.+..    ....+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234788999999999999999999987   99999999999999877     899999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.......  ....    ...   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~---  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQH----VTA---  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHH----Hhc---
Confidence            986643332222223345788999999999999999999999999999998 999886433211  1100    000   


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                            ......+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus       229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  00111122345678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-34  Score=306.89  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4689999999999999999999877888999988653 3345678999999999999999999999887 7889999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998543 2345788899999999999999999987   999999999999999999999999999866432211


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......++..|+|||++....++.++|+||||++++||++ |+.|+...+....  ..    ......         ..
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~----~~~~~~---------~~  222 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IR----ALERGY---------RM  222 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHhCCC---------CC
Confidence             1222345678999999998889999999999999999999 8888865332111  00    000000         00


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5e-35  Score=317.44  Aligned_cols=256  Identities=29%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|+..+.||+|+||.||+|++.. +.    .||+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3578888999999999999998643 43    57999886543 23345788999999999999999999998754 567


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +++||+++|+|.+++...  ...+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999998532  335788999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  .    .......  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~--~~~  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--P----DLLEKGE--RLP  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHCCC--CCC
Confidence            43322222223445778999999998999999999999999999997 8888864331111  0    1111110  000


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .       +..+...+.+++..|+..+|++||+++++++.|..+
T Consensus       232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0       111234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-34  Score=310.36  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=200.9

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .|++.+.||+|+||.||+|+... +..+++|.+........+.+.+|+++++.++||||+++++++......++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            46888999999999999999865 77889999876666667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|..++..  ....+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            9999988743  2346899999999999999999999987   9999999999999999999999999987643221  1


Q ss_pred             cccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          674 NTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ......++..|+|||++.     +..++.++|||||||++|||++|++|+...+.... ...    ... ..     .+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~----~~~-~~-----~~~  227 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLK----IAK-SE-----PPT  227 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHH----Hhh-cC-----CCC
Confidence            223356889999999874     34578899999999999999999999864331110 000    000 00     000


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .  ..+......+.+++.+||+.+|++||++.++++.
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0  0112234568899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-34  Score=307.54  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +.+++++.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344566666679999999999999865 4778999998776666778899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~  667 (835)
                      +||+++++|.+++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999854322212277888899999999999999987   999999999999976 6799999999987653


Q ss_pred             CCCccccccccccccceeCceeecCCC--CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ...  .......++..|+|||++....  ++.++||||||+++|||++|+.|+...........       ... ..   
T Consensus       161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-------~~~-~~---  227 (268)
T cd06624         161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-------KVG-MF---  227 (268)
T ss_pred             cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-------hhh-hh---
Confidence            222  1122345789999999986643  78999999999999999999999864332111000       000 00   


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ......+......+.+++.+|++.+|++||++.|+++.
T Consensus       228 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 --KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              00111222344567889999999999999999999853

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.4e-35  Score=310.60  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=198.3

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec------C
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ------G  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~  583 (835)
                      ++..|++.+.||+|+||.||+|+... ++.||+|++.... ....++.+|+.++.++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            45778999999999999999998754 7889999986543 3446788999999998 799999999998763      4


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            579999999999999998542 2346889999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  738 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  738 (835)
                      +.....  ........|+..|+|||++.     +..++.++|||||||++|||++|+.|+..........     .... 
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~-  230 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR-  230 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc-
Confidence            765322  12233456889999999886     3468889999999999999999999986433111000     0000 


Q ss_pred             ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       739 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .     ..+..   .....+..+.+++.+||+.+|++||++.|+++
T Consensus       231 ~-----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 N-----PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C-----CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0     00001   11123456789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-35  Score=308.44  Aligned_cols=251  Identities=30%  Similarity=0.456  Sum_probs=200.1

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhH--HHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      |++.+.||+|+||+||+++... ++.||+|++........  ....+|+.++.+++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999865 66899999987654332  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++.   ....+++..+..++.||++||++||+.+   |+|+||||+||+++.++.++|+|||++...  ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            9999999995   3456899999999999999999999998   999999999999999999999999999764  1222


Q ss_pred             ccccccccccceeCceeec-CCCCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccccccchhhhccccchhccCcccc
Q 003264          673 GNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                      .......++..|+|||++. +..++.++||||+|+++++|++|..|+....... .....       ...........  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~--  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE-------KILKRPLPSSS--  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH-------HHHHTHHHHHT--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh-------hcccccccccc--
Confidence            3344567899999999998 8889999999999999999999999988642110 00000       00000000000  


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       .........+.+++..|++.+|++||++.++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000011267889999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-34  Score=310.30  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|++.++||+|+||.||+|+... ++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            679999999999999999999855 8899999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|..++.+.  ...+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.+||+|||++......  .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            999998877432  345889999999999999999999987   999999999999999999999999998754221  1


Q ss_pred             ccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          673 GNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .......++..|+|||++.     ...++.++|||||||++|||++|..|+........ ..    .. ...     ..+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~----~~-~~~-----~~~  233 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL----KI-AKS-----EPP  233 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HH----HH-hcC-----CCc
Confidence            1223356788999999985     34578899999999999999999999865332110 00    00 000     000


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..  ..+......+.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00  0112334567889999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.8e-35  Score=306.75  Aligned_cols=252  Identities=28%  Similarity=0.475  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .+|++.+.||+|+||.||++.+.+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4688899999999999999998778899999986532 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++...  ...+++..+..++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999988532  235788999999999999999999987   999999999999999999999999998765332211 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  ..   .. ..  ......+..   
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~---~~-~~--~~~~~~~~~---  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--VE---TI-NA--GFRLYKPRL---  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--HH---HH-hC--CCCCCCCCC---
Confidence            1122234678999999998899999999999999999998 8888864332110  00   00 00  001111111   


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                          .+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                2356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.3e-35  Score=317.07  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+|+.. .++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999875 47889999986543 22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            985 777776432  345788999999999999999999988   9999999999999999999999999997643221 


Q ss_pred             cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccc--------cchhhhccc-c
Q 003264          672 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLG--------HAWNLWKDN-R  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~--------~~~~~~~~~-~  740 (835)
                       .......++..|+|||.+.+ ..++.++||||||++++||++|++||...+.... ....        ..|..+... .
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             11223467899999998865 4689999999999999999999999975442211 0000        000000000 0


Q ss_pred             chhccCccccc----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+....    .........+.+++.+|++.||++||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            00000000000    0111234567899999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-34  Score=308.18  Aligned_cols=253  Identities=23%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57899999999999999999875 48899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......  .
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence            99999998843   346889999999999999999999988   999999999999999999999999998765322  1


Q ss_pred             ccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          673 GNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .......|+..|+|||++.   ...++.++|||||||++|||++|..|+........ ...    . ...   ....+..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~----~-~~~---~~~~~~~  231 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL----M-TKS---NFQPPKL  231 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHh----h-hcc---CCCCCcc
Confidence            2223456899999999874   45688999999999999999999999754331110 000    0 000   0000111


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..  .......+.+++.+|++.+|++||+++++++.
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00  01233457889999999999999999998853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-34  Score=305.60  Aligned_cols=240  Identities=21%  Similarity=0.350  Sum_probs=188.9

Q ss_pred             cccccCCcccEEEEEecC-------------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          520 CKLGEGGFGPVYKGKLLN-------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887665555678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-------eEecc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-------PKISD  659 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~D  659 (835)
                      +||||+++++|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988843  2345889999999999999999999987   999999999999987664       89999


Q ss_pred             cCccccccCCCccccccccccccceeCceeec-CCCCCccccchhHHHHHHHHH-hCCCCCCCCCcccccccccchhhhc
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETL-TSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      ||++.....      .....++..|+|||.+. ...++.++|||||||++|||+ .|..|+.........      ....
T Consensus       156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~  223 (262)
T cd05077         156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------RFYE  223 (262)
T ss_pred             CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------HHHh
Confidence            999875422      12345788999999886 467899999999999999998 577776543211100      0000


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                       .. ....     .    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 -~~-~~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 -GQ-CMLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -cC-ccCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             00 0000     1    12345788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-34  Score=305.98  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=202.3

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +|++.++||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+.++...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788999999999999999875 4889999988543 3345677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.||+.||.|||+++   |+|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  154 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--  154 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence            999999887532 3345789999999999999999999988   9999999999999999999999999997653321  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      .......++..|+|||++.+..++.++||||||+++|+|++|..||...+....     ..... ....         ..
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~-~~~~---------~~  219 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKVC-QGSY---------KP  219 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHHh-cCCC---------CC
Confidence            112335688899999999888999999999999999999999999875331110     00000 0000         01


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+......+.+++.+||+.+|++||++.|++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112234567889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.4e-35  Score=311.30  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35777889999999999999875 47889999987443 34556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.    ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999999883    345789999999999999999999987   9999999999999999999999999997654322 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......++..|+|||++.+..++.++||||||++++||++|+.|+........  ..    .         .......
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~----~---------~~~~~~~  219 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF----L---------IPKNSPP  219 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh----h---------hhcCCCC
Confidence             122234678899999999998999999999999999999999999764321110  00    0         0000011


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1112344567899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-34  Score=321.96  Aligned_cols=262  Identities=24%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  583 (835)
                      ..++|++.+.||+|+||.||+++.. .++.||||++...  ......++.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999875 4889999998643  2344567889999999999999999999986543     


Q ss_pred             -eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          584 -EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       584 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                       ..++||||++++ |...+.     ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             579999999765 544442     23778889999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-cc---cc------
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LL---GH------  731 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~---~~------  731 (835)
                      ++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... . ..   ..      
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            97643221   22335689999999999999999999999999999999999999975542110 0 00   00      


Q ss_pred             ------chhhhccc------cchhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 ------AWNLWKDN------RAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 ------~~~~~~~~------~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            ........      ...+......   ...........+.+++.+|++.||++||++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00000000      0000000000   000111224567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.3e-35  Score=319.39  Aligned_cols=238  Identities=24%  Similarity=0.291  Sum_probs=187.8

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++.. +|+.||||++....   .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 58899999986532   223345555654 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99988874   3346889999999999999999999988   999999999999999999999999998753211  122


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...+....  .   ..... ..   .   .+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~---~~~~~-~~---~---~~~----  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--Y---DNILH-KP---L---VLR----  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--H---HHHHc-CC---c---cCC----
Confidence            3345789999999999999999999999999999999999999875432111  0   00000 00   0   011    


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      ......+.+++.+|++.+|++||++.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            123455778999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-34  Score=307.00  Aligned_cols=250  Identities=30%  Similarity=0.426  Sum_probs=192.5

Q ss_pred             cccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCeEEEEEEecC
Q 003264          520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYEYMP  593 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~~  593 (835)
                      +.||+|+||.||+|++.+    ...||||++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            478999999999998642    357999998643 33456788999999999999999999998764 556889999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc-
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-  672 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-  672 (835)
                      +++|.+++...  ...+.+..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998532  234677888999999999999999987   999999999999999999999999999865332211 


Q ss_pred             -ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-CCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          673 -GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       673 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       .......++..|+|||.+....++.++||||||+++|||++|. +|+...+..  .+...   .....      .+   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~---~~~~~------~~---  221 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVY---LLQGR------RL---  221 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---HhcCC------CC---
Confidence             1112334577899999998889999999999999999999965 455432211  11110   00000      00   


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             01112345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-34  Score=307.06  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=201.1

Q ss_pred             CCccccccccCCcccEEEEEecCCcEEEEEEecCcC------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +|++.+.||+|+||.||+|...+++.+|||.+....      ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998889999999886432      22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||+++++|.+++.+   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   245788999999999999999999987   99999999999999999999999999986532


Q ss_pred             CC----ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          669 DE----LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       669 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ..    .........++..|+|||.+.+..++.++||||||++++||++|+.||...+...... .    . ..   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-~----~-~~---~~~  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-Y----I-GA---HRG  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-H----h-hh---ccC
Confidence            11    1112233568899999999998899999999999999999999999986533111000 0    0 00   000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..+.+    +..+...+.+++.+|++.+|++||++.|+++
T Consensus       226 ~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01111    1234456788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-34  Score=304.03  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|++.+.||+|+||.||+|+..+ ++.|++|.+.....  .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            679999999999999999999865 78999999865432  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999843  2356899999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+...........      ...     ...+.  ..
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~-----~~~~~--~~  220 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPN-----KPPPT--LS  220 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hcc-----CCCCC--CC
Confidence             22334578899999999988999999999999999999999999875332111000      000     00000  11


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .+......+.+++.+|++.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12234466888999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.1e-34  Score=306.96  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..|+..++||+|+||.||+|++. .++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999975 48899999987542 44567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999884    235788999999999999999999987   99999999999999999999999999977643221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||++.+..++.++||||||+++|||++|..|+.........               .........
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------~~~~~~~~~  219 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------FLIPKNNPP  219 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------hhhhcCCCC
Confidence              222346788999999999889999999999999999999999998653321100               000011112


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2233456678899999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-34  Score=312.06  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=204.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..+|++.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            378999999999999999999974 5899999999765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999832    35788999999999999999999987   99999999999999999999999999876533221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+........     ....      .+..  
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~~~~------~~~~--  235 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNG------TPEL--  235 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----ccCC------CCCC--
Confidence              122346788999999999989999999999999999999999998653321111000     0000      0000  


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+......+.+++.+|++.+|++||+++++++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122334567789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-34  Score=322.65  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=199.8

Q ss_pred             hhcCCccccccccCCcccEEEEEec---CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ...+|++.+.||+|+||.||++...   .++.||||.+...     ..+.+|+.++++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3468999999999999999999753   3578999988643     2346899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||++. ++|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99996 57777772   3456899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhc-------ccc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWK-------DNR  740 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~-------~~~  740 (835)
                      ...........||..|+|||++....++.++|||||||++|||++|+.|+........ ..+........       ...
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            4333333456799999999999999999999999999999999999999865442210 00000000000       000


Q ss_pred             ---c---hhccCccccch-------hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 ---A---YELLSPALQHE-------ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ---~---~~~~~~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .   ...........       ....+...+.+++.+|++.+|++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0   00000000000       001223467789999999999999999999976

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-34  Score=310.47  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhc---CCCceeeEeeEEEec-----C
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQ-----G  583 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~  583 (835)
                      +|++.+.||+|+||+||+|+.. +++.||+|.+....  ......+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999876 48899999986532  12234456677777665   799999999988653     4


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++ +|..++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999985 787777432 2245889999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc--ccccc----chhhhc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLGH----AWNLWK  737 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~~----~~~~~~  737 (835)
                      +......   ......++..|+|||++.+..++.++|||||||++|||++|++||........  .....    ....+.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8754221   12235678999999999999999999999999999999999999865432110  00000    000000


Q ss_pred             cc-c-chhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          738 DN-R-AYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       738 ~~-~-~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .. . ......+..   ...........+.+++.+|++.||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00 0 000000000   01111234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=319.91  Aligned_cols=245  Identities=31%  Similarity=0.431  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +-|+-++.||.|+||.||-+++. +.+.||||++.-.   ....+.++.+|+..|.+++|||+|.+.|++..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777889999999999999975 4678999998643   4456788999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      |||- |+-.+++.  -..+++.+.++..|..+.++||+|||+++   .||||||+.|||+.+.|.|||+|||.|.+..+ 
T Consensus       106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            9995 45556552  23456888999999999999999999998   99999999999999999999999999987543 


Q ss_pred             CccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                           -..++||+.|||||++.   .+.|+-|+||||||++..||.-.++|.-.++...-.+.           +...-.
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-----------IAQNes  242 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----------IAQNES  242 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-----------HHhcCC
Confidence                 34578999999999874   57899999999999999999999999765543221110           111122


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      |.+.   ..+++..+..++..||+.-|.+|||.++++.
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            3333   3467778889999999999999999998874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=307.87  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999975 48899999986543 34556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999999843    26899999999999999999999987   9999999999999999999999999998764322 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+....  ..    .....     ..+.+..
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~----~~~~~-----~~~~~~~  220 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LF----LIPKN-----NPPSLEG  220 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HH----Hhhhc-----CCCCCcc
Confidence             222335678899999999998899999999999999999999999865331111  00    00000     1111111


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   .+...+.+++.+|++.+|++||+++++++.
T Consensus       221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1   144567889999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-34  Score=306.62  Aligned_cols=249  Identities=29%  Similarity=0.442  Sum_probs=200.2

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh---------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999874 478999998864321         123568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++|+||+++++|..++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999843   345788999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCcc----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          665 MFCGDELQ----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       665 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      ........    .......++..|+|||.+.+..++.++||||||+++|||++|+.||........        ...   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~---  223 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--------IFK---  223 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--------HHH---
Confidence            76432111    111234578899999999988999999999999999999999999875321110        000   


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......+.    .+......+.+++.+||+.+|++||++.|+++
T Consensus       224 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00111111    22234566788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-34  Score=308.51  Aligned_cols=256  Identities=29%  Similarity=0.390  Sum_probs=203.6

Q ss_pred             cCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ++|++.+.||+|+||.||+|+..      ..+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999864      2467999988765433 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRT------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      +||||+++++|.+++......      ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998543321      25899999999999999999999988   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      |+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..|+........  ..    .....
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~--~~----~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--LN----RLQAG  234 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH--HH----HHHcC
Confidence            99875432221 12223456778999999988889999999999999999999 7778754322111  00    00000


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ...        ......++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            000        0011123457888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-34  Score=310.74  Aligned_cols=252  Identities=26%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|+..+.||+|+||.||++... .++.||||.+....   ....+.+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999875 48899999986532   2234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999888542 2335889999999999999999999987   9999999999999999999999999987643221


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ . ...         ..... ...
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~-~~~---------~~~~~-~~~  221 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R-EEV---------ERLVK-EVQ  221 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-H-HHH---------Hhhhh-hhh
Confidence               11234689999999999999999999999999999999999999975321100 0 000         00000 000


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                      ...+......+.+++..|++.+|++||+     ++|+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            1112223456788999999999999999     7788763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=303.74  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            368999999999999999999875 4788999999876555678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            9999999988432  246889999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             cccccccccccceeCceeecCC---CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                       .......++..|+|||.+...   .++.++||||||+++|||++|+.|+...........      ....   ....+.
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~---~~~~~~  225 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKS---NFPPPK  225 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc---cCCCcc
Confidence             112234678899999998776   889999999999999999999999865331111000      0000   000011


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +  ......+..+.+++.+|++.+|++||++.+|+.
T Consensus       226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1  122345567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-34  Score=308.20  Aligned_cols=256  Identities=22%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.++||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568899999999999999998643    2468999887654 4556789999999999999999999998875 56789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++...  ...+++..+..++.++++||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999998542  235889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ...... .....++..|+|||.+....++.++||||||++++||++ |..||........  ..   .. ....  ..  
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~---~~-~~~~--~~--  227 (270)
T cd05056         159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG---RI-ENGE--RL--  227 (270)
T ss_pred             ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH---HH-HcCC--cC--
Confidence            432211 112334568999999988889999999999999999996 9999865432211  00   00 0000  00  


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                           ..+...+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 011223456888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.2e-35  Score=318.62  Aligned_cols=241  Identities=23%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +|+..+.||+|+||.||+++.. +++.||||++....   ....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999875 48899999987532   234466788999998885 678888999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843   345889999999999999999999988   999999999999999999999999998754222


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .  .......||..|+|||++.+..++.++|||||||++|||++|+.||........  ..   .... ..         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~---~i~~-~~---------  217 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQ---SIME-HN---------  217 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH---HHHh-CC---------
Confidence            1  122345689999999999999999999999999999999999999875432211  00   0000 00         


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                       ...+......+.+++.+|++.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             01112234567889999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-34  Score=318.80  Aligned_cols=193  Identities=24%  Similarity=0.326  Sum_probs=164.8

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ....+|++.+.||+|+||.||+|+... ++.||+|+....      ....|+.++++++||||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            345689999999999999999999754 678999975432      2356899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+. ++|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777743  3346899999999999999999999988   999999999999999999999999999753221


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT  718 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~  718 (835)
                         .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1223456899999999999999999999999999999999966554

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=316.18  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=212.6

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  585 (835)
                      .....|++.+.||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|+++. |||||.+.+.+++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345789999999999999999999876 99999999976543   24568999999999998 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC----CCeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFG  661 (835)
                      ++|||++.+|.|.+.+...   . +++.++..++.||+.+++|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999998654   2 899999999999999999999988   9999999999999543    579999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      ++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........     ... ..  
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~-~~--  253 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AIL-RG--  253 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHH-cC--
Confidence            9998754   345567899999999999999999999999999999999999999998654322211     000 00  


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          +.......-......+.+++..++..||.+|+++.++++.
T Consensus       254 ----~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 ----DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                0122233344556778899999999999999999999984

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.1e-35  Score=325.20  Aligned_cols=261  Identities=23%  Similarity=0.293  Sum_probs=197.0

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----eEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  586 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  586 (835)
                      +|++.++||+|+||.||+++.. +++.||||++...  .....+++.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999974 5899999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +|+||+. ++|...+.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 46766663   2346889999999999999999999988   999999999999999999999999999865


Q ss_pred             cCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc-----
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR-----  740 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----  740 (835)
                      ..... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||...+....  ............     
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence            33221 122334678999999998774 578999999999999999999999975442110  000000000000     


Q ss_pred             -----chh-ccC-ccccc------hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 -----AYE-LLS-PALQH------EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 -----~~~-~~~-~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           ... +.. +....      .........+.+++.+|++.||++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 000 000 00000      0111224567899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=293.95  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=202.3

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+++|++.+.||+|.|+.||+... ..|+.+|+|++...  .....+++.+|+.+.+.|+|||||+|.....+....+||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            357899999999999999999875 45899999987532  344778899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~  665 (835)
                      +|++.++.|-.-+.   ....+++..+-..++||+++|.|+|.++   |||||+||+|+|+-+   ..-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999865442   2245778888999999999999999998   999999999999953   34599999999998


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      +...   .......||++|||||++...+|+..+|||+.||+||-|+.|.+||-..+.+.  +.+    .+..+ .++  
T Consensus       163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye----~I~~g-~yd--  230 (355)
T KOG0033|consen  163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYE----QIKAG-AYD--  230 (355)
T ss_pred             eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHH----HHhcc-ccC--
Confidence            7622   22334689999999999999999999999999999999999999987533221  111    11111 011  


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .....-....++..+|+.+||..||.+|.|+.|.+.
T Consensus       231 ---~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 ---YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               111222344566788999999999999999998773

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.2e-35  Score=319.98  Aligned_cols=240  Identities=23%  Similarity=0.285  Sum_probs=187.8

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHH-HHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEM-MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+++... ++.||+|++....   .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 7789999986532   12233444444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      ++|.+++..   ...+.+..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998843   345778888899999999999999988   999999999999999999999999999754221  122


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... .        ..  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~---~i~~-~--------~~--~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YD---NILN-K--------PL--QLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HH---HHHh-C--------Cc--CCC
Confidence            3345789999999999999999999999999999999999999875332111  00   0000 0        00  011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                      ......+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            12345678899999999999999887443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.1e-35  Score=325.34  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++.. .++.||||++....   ......+++|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999875 48899999986432   334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999843   345889999999999999999999988   999999999999999999999999998754221


Q ss_pred             Ccc---------------------------------ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCC
Q 003264          670 ELQ---------------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR  716 (835)
Q Consensus       670 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~  716 (835)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113479999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 003264          717 NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKVVSM  785 (835)
Q Consensus       717 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  785 (835)
                      ||........  ..   .......  .+.   ...  .......+.+++.+++. +|++|++   +.|+++.
T Consensus       235 Pf~~~~~~~~--~~---~i~~~~~--~~~---~p~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQET--YR---KVMNWKE--TLV---FPP--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHH--HH---HHHcCCC--cee---cCC--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            9875432211  00   0000000  000   000  01133456777777664 9999985   5565544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.5e-34  Score=302.53  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=203.7

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999864 4889999987643  344567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.... ...+++..+..++.|++++|+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999985432 346889999999999999999999987   99999999999999999999999999987643321


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||.+.+..++.++||||||++++||++|..|+........     ..... ..        .. .
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~~~~-~~--------~~-~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-----VVKIV-QG--------NY-T  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHH-cC--------CC-C
Confidence              22345688999999999888899999999999999999999999864331110     00000 00        00 0


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+.+++.+|++.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1112345568889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-34  Score=311.32  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            5799999999999999999986 458999999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|..++.    ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999999883    235889999999999999999999988   99999999999999999999999999886543321 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+......     .... ...     +.+  .
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~-~~~-----~~~--~  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIAT-NGT-----PEL--Q  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHh-cCC-----ccc--C
Confidence             1223467889999999998889999999999999999999999986543211100     0000 000     000  0


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+......+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            112234567789999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-34  Score=314.91  Aligned_cols=264  Identities=18%  Similarity=0.239  Sum_probs=195.5

Q ss_pred             cccccccC--CcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          518 MQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       518 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++++||+|  +|++||+++.. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  78899999874 58999999986542  334466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985422 234789999999999999999999988   999999999999999999999999876543221110


Q ss_pred             -----ccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc---cchhhhcc----
Q 003264          673 -----GNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG---HAWNLWKD----  738 (835)
Q Consensus       673 -----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~---~~~~~~~~----  738 (835)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||............   ........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 11122356778999999876  46899999999999999999999998753321110000   00000000    


Q ss_pred             ------ccchhccC-----------------ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 ------NRAYELLS-----------------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ------~~~~~~~~-----------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            .......+                 ..............+.+++.+|++.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                  00000000                 000011222345678899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-34  Score=308.56  Aligned_cols=239  Identities=22%  Similarity=0.319  Sum_probs=187.3

Q ss_pred             ccccCCcccEEEEEecC-------------------------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeE
Q 003264          521 KLGEGGFGPVYKGKLLN-------------------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL  575 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  575 (835)
                      +||+|+||.||+|.+..                         ...||+|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589999876555555678899999999999999999


Q ss_pred             eeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC--
Q 003264          576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM--  653 (835)
Q Consensus       576 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--  653 (835)
                      ++++.+....++||||+++|+|..++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988532  345789999999999999999999987   99999999999997654  


Q ss_pred             -----CeEecccCccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHH-hCCCCCCCCCcccc
Q 003264          654 -----NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETL-TSKRNTGVYDIESF  726 (835)
Q Consensus       654 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~ell-tG~~p~~~~~~~~~  726 (835)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3899999998653211      12346788999998865 56899999999999999985 68888764332111


Q ss_pred             cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                        ..    .....       .....    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       231 --~~----~~~~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --ER----FYEKK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HH----HHHhc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              00    00000       00111    11245788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-34  Score=303.11  Aligned_cols=238  Identities=24%  Similarity=0.414  Sum_probs=188.8

Q ss_pred             cccccCCcccEEEEEecCCc-----------EEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          520 CKLGEGGFGPVYKGKLLNGQ-----------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986533           5788887654333 6788999999999999999999999988 788999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-------CeEecccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-------NPKISDFG  661 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DFG  661 (835)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999985432  26889999999999999999999987   99999999999999888       79999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCC--CCCccccchhHHHHHHHHHhC-CCCCCCCCcccccccccchhhhcc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKD  738 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  738 (835)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+.........  .    .+..
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~----~~~~  221 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--R----FYQD  221 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--H----HHhc
Confidence            9986532      2234567789999998876  789999999999999999994 6666543211100  0    0000


Q ss_pred             ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       739 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .  .....+         ....+.+++.+|++.+|++||++.++++.|+
T Consensus       222 ~--~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 Q--HRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C--CCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0  000000         0156788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=309.42  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||+|+||.||+++.. .++.||+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999986 5899999988654 334457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|..++........+++..+..++.||++||.|||+..  +|+|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999998855433446899999999999999999999742  3999999999999999999999999998765322  


Q ss_pred             cccccccccccceeCceeecCC------CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                        ......++..|+|||.+.+.      .++.++|||||||++|||++|+.||........  ...         .....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~---------~~~~~  223 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQ---------LSAIV  223 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHH---------HHHHh
Confidence              12234578899999988554      358899999999999999999999864321110  000         00000


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      . ......+..+...+.+++.+|++.+|++||++.++++.
T Consensus       224 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 D-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             h-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0 00111223356678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=308.48  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=203.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+........+.+.+|++++++++||||+++++.+.+....++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999975 4889999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.+.  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999998432  345899999999999999999999998   9999999999999999999999999987643221 


Q ss_pred             cccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          672 QGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                       .......++..|+|||.+.     ...++.++||||||+++|||++|+.|+...+.... ..    . +...     ..
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~----~-~~~~-----~~  225 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LL----K-ILKS-----EP  225 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HH----H-HhcC-----CC
Confidence             1223356889999999875     34577899999999999999999999875432111 00    0 0000     00


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +.+  ..+......+.+++..|++.+|++||++.++++.
T Consensus       226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            011  1112334567889999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.1e-34  Score=305.36  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=200.8

Q ss_pred             CCccccccccCCcccEEEEEecC--CcEEEEEEecCc----------ChhhHHHHHHHHHHHHh-cCCCceeeEeeEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLMGCCVE  581 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  581 (835)
                      +|++.+.||+|+||.||+|++..  ++.+|||.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999865  678999987532          22344567788888875 699999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      .+..++||||+++++|.+++... .....+++..+++++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887432 23446889999999999999999999632  3999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+....  ..   .. ... 
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~~---~~-~~~-  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--AT---KI-VEA-  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--HH---HH-hhc-
Confidence            9998754332   23345688999999999988899999999999999999999999864331110  00   00 000 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                         ...+.    ........+.+++.+|++.+|++||++.|+.++++
T Consensus       229 ---~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 ---VYEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---cCCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               00010    01123456888999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-34  Score=309.53  Aligned_cols=261  Identities=25%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            67889999999999999999875 48899999876542 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..   ...+++..+..++.+++.+|.|||+..  +++||||||+||+++.++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999988843   345889999999999999999999742  3999999999999999999999999998754221  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||++.+..++.++|||||||+++||++|+.||........... .......  ............
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~  232 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGILD--LLQQIVQEPPPR  232 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHHH--HHHHHhhccCCC
Confidence              12235689999999999888999999999999999999999999875432210000 0000000  000000000000


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      .....+...+.+++.+|++.+|++||++.|++++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            01112456688999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.1e-34  Score=305.93  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=199.8

Q ss_pred             CccccccccCCcccEEEEEec----CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      |++.+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999863    3678999998654  3345677899999999999999999999887543      


Q ss_pred             eEEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          584 EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      ..++++||+++|+|..++...   .....+++....+++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998887432   12235788999999999999999999987   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |++|+...+...  ....   .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~---~~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNY---LIKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHH---HHcCC
Confidence            99987643332222223445678999999998999999999999999999999 788876433211  1110   00000


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .   .       ..+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       233 ~---~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 R---L-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             c---C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0   0       00112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-34  Score=303.24  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=194.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      .+|+..+.||+|+||.||+|... .++.||+|++....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999875 48899999885431     23346788999999999999999999988763  567


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++++||+++++|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999998843   234788999999999999999999887   99999999999999999999999999986


Q ss_pred             ccCCCc-cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      +..... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...+....     .....     ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~~~-----~~~  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFKIA-----TQP  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHHHh-----cCC
Confidence            532211 1112234578899999999988899999999999999999999999874321110     00000     000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..+    ..+......+.+++ .|+..+|++||+++||++
T Consensus       226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            011    11223334455666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.9e-34  Score=302.81  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             cccccCCcccEEEEEecCC---cEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCC
Q 003264          520 CKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      ++||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999976443   356777766443 345678999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          596 SLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       596 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      +|.+++.... .....++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999986432 2234567778899999999999999987   99999999999999999999999999865322222222


Q ss_pred             ccccccccceeCceeecC-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCcccccccccchhhhccccchhccC
Q 003264          675 TKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+......  ....   ..+ .+....+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~---~~~-~~~~~~~~~  231 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLN---HVI-KDQQVKLFK  231 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHH-hhcccccCC
Confidence            234567889999998743       2457899999999999999975 5666533211  1111   011 111122333


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      +.+...    ....+.+++..|+ .+|++||+++||++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333322    3456777888899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=315.37  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++... ++.||||++.+.   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            479999999999999999999754 889999998642   2234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2345889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||........     ............+
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~  229 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKEHFQF  229 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHHcCCCcccC
Confidence            21 11223468999999999863     4578899999999999999999999865332110     0001111110111


Q ss_pred             cCccccchhHHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQE--KAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~  785 (835)
                      .  .    .....+..+.+++.+|+..  ++..||++.++++.
T Consensus       230 ~--~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 P--P----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C--C----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0  0    0111344566777776654  44447899988876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.8e-34  Score=302.69  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=197.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc-----ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      ++|++.+.||+|+||.||+|+..+ ++.||||.+...     .....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            578999999999999999998754 889999987532     123456788999999999999999999988764  467


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++..   ...+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999998843   234788889999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+.... .             .+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-------------~~~  221 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I-------------FKI  221 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H-------------HHH
Confidence            5332111 122334688899999999888899999999999999999999999864321110 0             000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+......+.+++..|+. +|++||+++|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            00001111233445667788888885 89999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-34  Score=307.33  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=189.8

Q ss_pred             cccccCCcccEEEEEecC--------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +.||+|+||.||+|....        ...||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998643        235888988665555667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC--------eEecccCcc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PKISDFGMA  663 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFGla  663 (835)
                      +++|+|..++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  235789999999999999999999987   999999999999987765        699999988


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCC-CCCCCCCcccccccccchhhhccccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      .....      .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+....  ..    ....   
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~----~~~~---  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQ----FYED---  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HH----HHHc---
Confidence            65432      223457889999999987 45899999999999999999995 45443221110  00    0000   


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                              ....+......+.+++.+||+.+|++||+++++++.|+
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    00111122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4e-34  Score=301.88  Aligned_cols=251  Identities=35%  Similarity=0.522  Sum_probs=200.8

Q ss_pred             CccccccccCCcccEEEEEecC-----CcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +++.+.||+|+||.||+++..+     +..||+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998754     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854321 12899999999999999999999987   999999999999999999999999999876544


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ...... ...++..|+|||.+....++.++||||||++++||++ |..|+........  ..    .......       
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--~~----~~~~~~~-------  222 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--LE----YLKKGYR-------  222 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHhcCCC-------
Confidence            222211 2336789999999988889999999999999999998 7777764322111  00    0000000       


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                        ...+...+..+.+++.+|+..+|++||++.|+++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              011112456788899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.6e-34  Score=307.90  Aligned_cols=252  Identities=24%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .|+..+.||+|+||+||+++.. +++.||+|.+....   ....+.+.+|+.++.+++|+||+++.+++.+++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677889999999999999875 58899999986542   2234557889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999999888543 2345899999999999999999999987   9999999999999999999999999997643221


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ ... ..     ......     .
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~-~~-----~~~~~~-----~  221 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE-VD-----RRVLET-----E  221 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HH-----Hhhhcc-----c
Confidence               12234689999999999989999999999999999999999999875332111 000 00     000000     0


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                      ..........+.+++..|++.+|++||+     +.++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            0111223456778999999999999999     5566653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.7e-34  Score=303.15  Aligned_cols=247  Identities=28%  Similarity=0.437  Sum_probs=198.3

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.+.||+|+||.||+++. .++.||+|.+....  ..+.+.+|+.++.+++|||++++++++.+. ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5689999999999999999975 67889999986532  346789999999999999999999998764 5789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++... ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....    
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            99999998543 2335789999999999999999999987   999999999999999999999999998754221    


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       ......+..|+|||.+.+..++.++||||||++++||++ |+.|+........  .    ......         ....
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~---------~~~~  217 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--K----ECVEKG---------YRME  217 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--H----HHHhCC---------CCCC
Confidence             112234578999999998899999999999999999998 8888865432111  0    000000         0111


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      .+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112334667899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.1e-34  Score=301.32  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+......++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999864 57899999986542 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999855333356889999999999999999999988   99999999999999999999999999987654332


Q ss_pred             c--ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          672 Q--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       672 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  .......++..|+|||++... .++.++||||||++++||++|+.|+........ ..    .....      ..+.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~------~~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQN------DPPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcC------CCCC
Confidence            2  122344688999999998777 789999999999999999999999865432110 00    00000      0111


Q ss_pred             ccchh-HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          749 LQHEA-SYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       749 l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.... ....+..+.+++..|++.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111 1234567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=304.98  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=209.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .=|.+.+.||+|.|+.|-++++. .|..||||++.+.  +......+.+|++.|+.++|||||+|+.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45788899999999999999863 6999999999765  34456678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE-cCCCCeEecccCccccccCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~  669 (835)
                      .-.+|+|.+|+.++  ...+.+..+.+++.||+.|+.|+|+.+   +|||||||+||.+ ..-|-+||.|||++..+.+.
T Consensus        98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999543  456899999999999999999999998   9999999999766 66789999999999876443


Q ss_pred             CccccccccccccceeCceeecCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .   .....+|...|-|||++.+..|+ ++.||||||||||.|++|++||+..+....              +..++|  
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImD--  233 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMD--  233 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhc--
Confidence            2   34567899999999999999886 578999999999999999999987653322              111111  


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      -.-..+...+.++.+||..||..||.+|.+.+||+..
T Consensus       234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            1123456677889999999999999999999999864

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-34  Score=320.60  Aligned_cols=262  Identities=24%  Similarity=0.259  Sum_probs=196.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  582 (835)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4579999999999999999999875 4889999998753  233456788899999999999999999988644      


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ...++||||+++ +|...+.     ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999976 4555552     23788889999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc-cc----------
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-LG----------  730 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~-~~----------  730 (835)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... .. ..          
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9864322   122345789999999999999999999999999999999999999975431110 00 00          


Q ss_pred             -----cchhhhcc-ccchhccCccc--------cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          731 -----HAWNLWKD-NRAYELLSPAL--------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       731 -----~~~~~~~~-~~~~~~~~~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           ........ ........+..        ...........+.+++.+|++.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00000000 00000000000        001111234567899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-34  Score=306.47  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999986 48899999886432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|..++..   ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887632   335899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc--cc----c---chhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG----H---AWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~~----~---~~~~~~~~~  740 (835)
                      .  ......++..|+|||.+.+ ..++.++||||||++++||++|+.||..........  ..    .   ....+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223457889999998876 468899999999999999999999987544211100  00    0   000000000


Q ss_pred             ch---hccCccccc---hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AY---ELLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~---~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..   ....+....   .........+.+++.+|++.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   000000000   011123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-34  Score=310.27  Aligned_cols=264  Identities=22%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            67999999999999999999875 47899999986442 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++ ++|.+++.+.  ...+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 5888877432  345788999999999999999999987   9999999999999999999999999997643221 


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc--------cccchhhh-cccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL--------LGHAWNLW-KDNR  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~--------~~~~~~~~-~~~~  740 (835)
                       .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.... ..        ....|..+ ....
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             112234568899999988654 578899999999999999999999875442211 00        00000000 0000


Q ss_pred             chhccCccccc----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPALQH----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+....    .........+.+++.+|++.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000011110    1111234567899999999999999999999973

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.2e-34  Score=310.86  Aligned_cols=197  Identities=27%  Similarity=0.436  Sum_probs=160.1

Q ss_pred             ccccccCCcccEEEEEec---CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEEEEEecC
Q 003264          519 QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMP  593 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~  593 (835)
                      .++||+|+||+||+|+..   .++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   36789999986542  23456789999999999999999998864  356789999986


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE----cCCCCeEecccCcc
Q 003264          594 NKSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMA  663 (835)
Q Consensus       594 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla  663 (835)
                      + +|.+++...      .....+++..+..++.||+.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 676665321      12235888999999999999999999988   9999999999999    45678999999999


Q ss_pred             ccccCCCcc-ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 003264          664 RMFCGDELQ-GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY  721 (835)
Q Consensus       664 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~  721 (835)
                      +.+...... .......+|+.|+|||++.+. .++.++||||+||+++||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433211 222346789999999998774 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.9e-34  Score=328.21  Aligned_cols=266  Identities=20%  Similarity=0.259  Sum_probs=193.0

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCC------CceeeEeeEE
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH------RNLVRLMGCC  579 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~  579 (835)
                      .++...+++|++.++||+|+||+||+|++.. ++.||||+++... .....+..|+.++.+++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3344557899999999999999999998754 7889999986432 233455667777777754      4588999988


Q ss_pred             Eec-CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCC----
Q 003264          580 VEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM----  653 (835)
Q Consensus       580 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~----  653 (835)
                      ... .+.++|||++ +++|.+++.+   ...+++..+..++.||+.||+|||++ +   ||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            765 4788999988 6677777743   34688999999999999999999974 6   99999999999998765    


Q ss_pred             ------------CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003264          654 ------------NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY  721 (835)
Q Consensus       654 ------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~  721 (835)
                                  .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        49999999875421     1233467899999999999999999999999999999999999999764


Q ss_pred             Cccc-ccccccc----hhhhcc----ccchhcc------Cccccch-----------hHHHHHHHHHHHHHhccccCCCC
Q 003264          722 DIES-FNLLGHA----WNLWKD----NRAYELL------SPALQHE-----------ASYQMLNRYITVALLCVQEKAAD  775 (835)
Q Consensus       722 ~~~~-~~~~~~~----~~~~~~----~~~~~~~------~~~l~~~-----------~~~~~~~~l~~li~~cl~~dP~~  775 (835)
                      +... .......    ...+..    ....++.      .+.....           ........+.+|+.+||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            4211 1110000    000000    0000000      0000000           00112345779999999999999


Q ss_pred             CCCHHHHHHH
Q 003264          776 RPTMSKVVSM  785 (835)
Q Consensus       776 RPs~~evl~~  785 (835)
                      ||+++|+++.
T Consensus       429 R~ta~e~L~H  438 (467)
T PTZ00284        429 RLNARQMTTH  438 (467)
T ss_pred             CCCHHHHhcC
Confidence            9999999973

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-34  Score=300.63  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=200.7

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-CeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E  590 (835)
                      +|++.+.||+|++|.||+++... ++.||+|++...  .....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            48899999999999999999754 788999998643  234456789999999999999999999987644 46789999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++... ....+++.++..++.+++.||++||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988542 2345899999999999999999999988   9999999999999999999999999998763322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                        .......+++.|+|||++.+..++.++||||||++++||++|+.|+...+....     ...... ..         .
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~-~~---------~  219 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRIIE-GK---------L  219 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHh-cC---------C
Confidence              122345678999999999999999999999999999999999999864332111     000000 00         0


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+......+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11223345678899999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7e-35  Score=286.62  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=202.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      .-.+|.-.+.||+|..++|-+..++ .|+++|+|++....        ....+.-.+|+.+|+++ .||+|+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3467888899999999999988765 48899999885321        12345567899999998 79999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      ....++|+|.|+.|.|.++|.   ..-.++++...+|+.|+..|++|||..+   ||||||||+|||++++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            999999999999999999994   3446899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecC------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  735 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  735 (835)
                      ++..+...   ......+||++|+|||.+.-      ..|+...|+|++|||||-|+.|.+||=...  ++..+    .+
T Consensus       169 Fa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlML----R~  239 (411)
T KOG0599|consen  169 FACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLML----RM  239 (411)
T ss_pred             eeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHH----HH
Confidence            99877443   33456899999999998843      358889999999999999999999973211  00000    00


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +.++. ++     .....-.+.+....+||.+|++.||.+|.|.+|+++.
T Consensus       240 ImeGk-yq-----F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  240 IMEGK-YQ-----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHhcc-cc-----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            01110 01     1122334556778899999999999999999999854

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-34  Score=316.98  Aligned_cols=262  Identities=24%  Similarity=0.298  Sum_probs=195.3

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----  582 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----  582 (835)
                      ...++|++.+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999874 57899999986532  23345678899999999999999999987643     


Q ss_pred             -CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          583 -GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       583 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                       ...++++|++ +++|..++.    ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3568999987 778887773    345899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c---cc-hh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G---HA-WN  734 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~---~~-~~  734 (835)
                      +++.....     .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ... .   .. ..
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865322     233568999999999877 5789999999999999999999999865431110 000 0   00 00


Q ss_pred             h---hccccchhccC--ccccch----hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 L---WKDNRAYELLS--PALQHE----ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~---~~~~~~~~~~~--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   ...........  +.....    ........+.+++.+|++.||++||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0   00000000000  000000    000112346789999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-34  Score=315.56  Aligned_cols=255  Identities=18%  Similarity=0.234  Sum_probs=196.2

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++.. .++.||||.+.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999975 4788999998653   2233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|..++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  345788999999999999999999988   999999999999999999999999999865432


Q ss_pred             CccccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .. .......||+.|+|||++.+     +.++.++||||||++||||++|+.||...+....  .   ........... 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~---~~i~~~~~~~~-  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y---GKIMNHEERFQ-  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--H---HHHHcCCCccc-
Confidence            21 12223568999999998865     5688999999999999999999999875332110  0   00000000000 


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                          + .......+..+.+++.+|++..+.+  |++++++++.
T Consensus       229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                0 0011123456778888888865543  4678887754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.7e-34  Score=314.76  Aligned_cols=255  Identities=20%  Similarity=0.257  Sum_probs=195.8

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.++||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478999999999999999999865 778999998643   2223455888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  345888999999999999999999988   999999999999999999999999999765322


Q ss_pred             CccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....     .............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~  229 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKERFQF  229 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCccccC
Confidence            21 1223357899999999886     34688999999999999999999999875432111     0001111000000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKA--ADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~  785 (835)
                        +    .........+.+++.+|+..++  ..|++++|+++.
T Consensus       230 --p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 --P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0    0111234567778888775544  346889998866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-34  Score=301.10  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=200.2

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     .+..+.+.+|+.++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777889999999999999986 68999999886432     23557789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||+++++|.+++..   ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999843   235789999999999999999999988   99999999999999999999999999876533


Q ss_pred             CCccccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+........  .      +......     
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~------~~~~~~~-----  218 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V------FKIGRSK-----  218 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H------HHHHhcc-----
Confidence            22   223456889999999987776 89999999999999999999999865431100  0      0000000     


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       .....+......+.+++.+|++.+|++||++.++++
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             001112233466788999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-34  Score=338.15  Aligned_cols=256  Identities=23%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      ...++|+++++||+|+||+||++++.. ++.||+|.+...  .......|..|+.++.+++|||||++++++.+.  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            345789999999999999999999755 678999988643  334567789999999999999999999988654  468


Q ss_pred             EEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CcEEEecCCCCeEEEcC---------
Q 003264          586 ILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDS---------  651 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivHrDlkp~NILl~~---------  651 (835)
                      +|||||+++++|.++|... .....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998542 223468999999999999999999998542    34999999999999964         


Q ss_pred             --------CCCeEecccCccccccCCCccccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003264          652 --------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVY  721 (835)
Q Consensus       652 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~  721 (835)
                              .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    2348999999998653222   1234578999999999864  45889999999999999999999998643


Q ss_pred             CcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.... +.    ..+...       +.+.   ....+..+.+||..||+.+|++||++.|+++
T Consensus       247 ~~~~q-li----~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQ-LI----SELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHH-HH----HHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            32110 00    000000       0010   0112456788999999999999999999984

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-34  Score=306.08  Aligned_cols=261  Identities=24%  Similarity=0.327  Sum_probs=201.7

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEE---
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV---  580 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~---  580 (835)
                      +..+....++|++.+.||+|+||.||+++... ++.+|+|.+.... ....++.+|+.++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34455677899999999999999999998754 7899999886532 2346688899999999 7999999999885   


Q ss_pred             --ecCeEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          581 --EQGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       581 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                        .+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999887532 23346788999999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~  732 (835)
                      +|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+........ +..  
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~--  240 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK--  240 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh--
Confidence            99999986533221  2223468999999998753     4578899999999999999999999865432110 000  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ...........+       ..+...+.+++.+|++.+|++||++.|+++.
T Consensus       241 ---~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 ---IPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---ccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               000000011111       1123467889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.1e-34  Score=303.14  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC----------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS----------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      +|.+.+.||+|+||.||+|... +++.||||.+....          ....+.+.+|+.++++++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999864 58899999875321          112356888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998433   46888999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCC--CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +...............++..|+|||.+....  ++.++||||||++++||++|..|+...+....     ........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~--  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLGNKR--  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhhccc--
Confidence            7653322222233456889999999987654  88999999999999999999999864321100     00000000  


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ..+.........+...+.+++.+|++.+|++||++.+|++.
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 ---SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence               00111111222345678889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.3e-34  Score=305.29  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=201.2

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe-
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE-  581 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-  581 (835)
                      ++.++......|++.+.||+|+||.||+|+.. .++.||+|.+.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34445556688999999999999999999974 47899999986543 3446788899999998 79999999999863 


Q ss_pred             -----cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          582 -----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       582 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                           ....+++|||+++|+|.+++... ....+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45789999999999999988543 2345788889999999999999999988   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  731 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~  731 (835)
                      |+|||++.......  .......++..|+|||.+.     ...++.++|||||||++|||++|+.|+........ ..  
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~--  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LF--  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hh--
Confidence            99999987653211  1223356889999999875     34688899999999999999999999864321100 00  


Q ss_pred             chhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                           .   ......+..   ....++..+.+++.+||+.+|.+||++.|+++
T Consensus       237 -----~---~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 -----L---IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -----h---HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                 0   000000111   11234457889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.4e-34  Score=318.34  Aligned_cols=262  Identities=23%  Similarity=0.258  Sum_probs=196.4

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  582 (835)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999875 4889999998753  233456788999999999999999999987643      


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ...++||||+++ +|...+.     ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999976 5655552     23778889999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c---c-chhh-
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G---H-AWNL-  735 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~---~-~~~~-  735 (835)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... ... .   . .... 
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9865322   122335689999999999999999999999999999999999999975442110 000 0   0 0000 


Q ss_pred             ----------hcccc-----chhccCccc----cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 ----------WKDNR-----AYELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ----------~~~~~-----~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                .....     ..+...+..    ...........+.+++.+|++.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      00000     000000000    001111123567899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-33  Score=300.84  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=201.8

Q ss_pred             CCccccccccCCcccEEEEEe-cCCcEEEEEEecCcC------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      +|+..+.||+|+||.||+++. .+++.||+|.+....      ....+.+++|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999986 458899999986432      1235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF  666 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~  666 (835)
                      |+||+++++|.+++.+   ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999843   345789999999999999999999988   99999999999998776 5999999999876


Q ss_pred             cCCCcc--ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          667 CGDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       667 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|..|+...+.....  ..         ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~---------~~~~  223 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--AL---------IFKI  223 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HH---------HHHH
Confidence            433211  1122346789999999998888999999999999999999999998643321100  00         0000


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .........+......+.+++.+|++.+|++||++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0001112233345577889999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-34  Score=315.51  Aligned_cols=197  Identities=26%  Similarity=0.366  Sum_probs=170.4

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-C-----CceeeEeeEEEecCeEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l  587 (835)
                      +|++.+.||+|.||.|.|+.+.. ++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++++|....+.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            89999999999999999998754 899999999764 334556678999999996 4     489999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC--CCeEecccCcccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARM  665 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~  665 (835)
                      |+|.+ ..+|.++++..+. ..++...+..|+.||+.||..||+.+   |||+||||+||||.+.  ..+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 4589999965433 44889999999999999999999988   9999999999999754  3699999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      ....-+     ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|...+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            533221     4667889999999999999999999999999999999987776654

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-34  Score=308.28  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.++||+|+||.||+|...+ ++.||+|++.....  ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468899999999999999999864 88999998865322  235678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|..+...   ...+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887632   234889999999999999999999987   9999999999999999999999999998653322


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc--cccc-------cchhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG-------HAWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~-------~~~~~~~~~~  740 (835)
                        .......++..|+|||++.+ ..++.++||||||++++||++|++|+........  .+..       ..........
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              12223457899999998875 4578899999999999999999988864331100  0000       0000000000


Q ss_pred             ch-hccCccccc-----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AY-ELLSPALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~-~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .. ....+....     .........+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 000000000     011234567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.1e-34  Score=299.36  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.++||+|+||.||+++.. +++.||+|++...  .....+++.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999875 4889999998643  234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++... ....+++..+.+++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-  155 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-  155 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence            9999999888532 2335788999999999999999999987   9999999999999999999999999997653321 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......++..|+|||++.+..++.++||||||++++||++|+.|+...+....     ...... +.         ..
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~~~~~-~~---------~~  219 (256)
T cd08218         156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-----VLKIIR-GS---------YP  219 (256)
T ss_pred             -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----HHHHhc-CC---------CC
Confidence             112234578899999999988999999999999999999999999864332110     000000 00         01


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+......+.+++.+|++.+|++||++.||++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1122345668899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.1e-34  Score=301.68  Aligned_cols=254  Identities=27%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|+..+.||+|+||.||++.+. +++.||+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36888899999999999999986 48899999987653 34557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++++|.+++....  ..+++..+..++.|+++||+|||+ .+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985432  568889999999999999999999 76   9999999999999999999999999987653221


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                          .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...+..............      ....+.+.
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~  225 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV------NEPPPRLP  225 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh------cCCCCCCC
Confidence                11256788999999999999999999999999999999999998754321111111110000      00011111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   ......+.+++.+|+..+|++||++.+++..
T Consensus       226 ~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 S---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             h---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1   1155668899999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-33  Score=303.97  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      .+.++..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            33455566789999999999999999999875 58899999986532 2346678899999999 899999999998754


Q ss_pred             C-----eEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          583 G-----EKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       583 ~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                      +     ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence            3     589999999999999988532 23356889999999999999999999987   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeecCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  731 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~  731 (835)
                      |+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.|+...+.... +.. 
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~-  244 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK-  244 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH-
Confidence            999999886533221  12234678899999987543     368899999999999999999999865332110 000 


Q ss_pred             chhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          +.......+.       .+......+.+++.+|++.+|++||++.|+++.
T Consensus       245 ----~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 ----IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                0000000111       112234568899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=317.08  Aligned_cols=240  Identities=22%  Similarity=0.289  Sum_probs=185.6

Q ss_pred             cccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhc---CCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ||+|+||+||+|+.. +++.||||++....   ......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 48899999986432   22334455666777655   799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999988843   345889999999999999999999988   9999999999999999999999999987542221  22


Q ss_pred             ccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          675 TKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||...+....  .    ..+.... ..     +..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~----~~i~~~~-~~-----~~~--  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--Y----RNIAFGK-VR-----FPK--  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--H----HHHHcCC-CC-----CCC--
Confidence            2345789999999998765 489999999999999999999999865332111  0    0000000 00     110  


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRP----TMSKVVS  784 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  784 (835)
                       ......+.+++.+||+.+|.+||    ++.++++
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             11345667899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-34  Score=309.15  Aligned_cols=255  Identities=25%  Similarity=0.308  Sum_probs=204.9

Q ss_pred             HhhcCCccccccccCCcccEEEEEecCCcEEEEEEec--CcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  587 (835)
                      .....|+++++||+||.+.||++...+.+.+|+|++.  ..+.+...-|++|+.+|.+| .|.+||+|++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            4557899999999999999999998888889999764  34667788999999999999 59999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||- ..+|..+|.....  .++...+..+..|++.++.++|.++   |||.||||.|+|+ -.|.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            99986 5689898854322  2332377889999999999999998   9999999999988 46899999999999988


Q ss_pred             CCCccccccccccccceeCceeecCCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGL-----------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      .+.........+||+.||+||.+....           .+.++||||||||||+|+.|+.||+.....           +
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----------~  579 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----------I  579 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----------H
Confidence            777777777889999999999885432           567999999999999999999998743211           0


Q ss_pred             ccccchhccCccccchhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..+..+.+|...-+++.- ....+++++..||+.||.+||+..|+++.
T Consensus       580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              112334444321111100 01128899999999999999999999975

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-33  Score=301.16  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=200.1

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      -|++.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778889999999999999874 57899999986442 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++.    ...+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999999883    245789999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       ......++..|+|||.+.+..++.++||||||+++|||++|..|+........  ..    .....         ....
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~---------~~~~  220 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LF----LIPKN---------NPPT  220 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HH----HHhcC---------CCCC
Confidence             12234678899999999888899999999999999999999999864321110  00    00000         0011


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+.+++.+|++.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            112234567889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.5e-33  Score=307.75  Aligned_cols=197  Identities=28%  Similarity=0.442  Sum_probs=159.6

Q ss_pred             cccccCCcccEEEEEecC---CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~~  594 (835)
                      .+||+|+||.||+|+..+   +..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            589999999999998653   5789999986543  23467889999999999999999999864  4577999999876


Q ss_pred             CChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE----cCCCCeEecccCccc
Q 003264          595 KSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  664 (835)
Q Consensus       595 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~  664 (835)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             565555311      12335888999999999999999999988   9999999999999    566789999999998


Q ss_pred             cccCCCcc-ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          665 MFCGDELQ-GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       665 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      .+...... .......+|..|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76433221 122345789999999998764 58999999999999999999999986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=296.33  Aligned_cols=270  Identities=27%  Similarity=0.400  Sum_probs=221.9

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeE
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGC  578 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~  578 (835)
                      ..++.....++++..++-+|.||.||.|.+.+      .+.|-||.++.. +.-....+..|..++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45555666788888999999999999996543      456778877654 33456778999999999999999999999


Q ss_pred             EEec-CeEEEEEEecCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC
Q 003264          579 CVEQ-GEKILIYEYMPNKSLNFFLF-----DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  652 (835)
Q Consensus       579 ~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~  652 (835)
                      +.+. ...++++.++.-|+|..||.     +......+...+...++.|++.|++|||.++   +||.||.++|++|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            8875 46799999999999999997     5566677888999999999999999999998   9999999999999999


Q ss_pred             CCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccccccc
Q 003264          653 MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGH  731 (835)
Q Consensus       653 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~  731 (835)
                      .++||+|=.+++.+-+.++.......-.+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+..++.  . 
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--~-  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--H-  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--H-
Confidence            9999999999998877777666666667889999999999999999999999999999998 88887755533221  1 


Q ss_pred             chhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                         .+++  .+++.       -+.+++.++..++.-||...|++||+++|++..|.+.+..+
T Consensus       510 ---ylkd--GyRla-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  510 ---YLKD--GYRLA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ---HHhc--cceec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence               1111  12222       23346678899999999999999999999999998775443

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-33  Score=299.80  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~  589 (835)
                      +|++.+.||.|+||.||++... +++.||+|.+...  .....+++.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5788899999999999999874 4789999998643  34456678899999999999999999998764  34678999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ||+++++|.+++... .....+++..++.++.||++||+|||..+  ..+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542 22456899999999999999999999332  334999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .....  ......++..|+|||.+....++.++||||||+++++|++|+.|+...+...  ...    ...         
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~---------  223 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LAS----KIK---------  223 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHH----HHh---------
Confidence            43321  1223468899999999999889999999999999999999999987544211  000    001         


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .......+......+.+++.+|++.+|++||++.+|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            011112233455678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.7e-34  Score=308.08  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=200.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|.....||+|+||.||++... ++..||||.+........+.+.+|+..+.+++|+||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34455568999999999999875 48899999987665566677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.......  
T Consensus       102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            99999998732    34789999999999999999999987   9999999999999999999999999987653222  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      .......++..|+|||.+.+..++.++||||||++++||++|+.|+...+....  ..    .     ......+.... 
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~-----~~~~~~~~~~~-  240 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MR----R-----IRDNLPPRVKD-  240 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H-----HHhcCCCcccc-
Confidence            122335688999999999888999999999999999999999999864331110  00    0     00011111111 


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .......+.+++.+|++.+|++||+++|+++.
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             11234467789999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-33  Score=307.08  Aligned_cols=256  Identities=20%  Similarity=0.264  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++... ++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468899999999999999999754 7899999987543   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   345889999999999999999999987   999999999999999999999999998742111


Q ss_pred             Cc-------------cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          670 EL-------------QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       670 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ..             ........++..|+|||.+.+..++.++||||||+++|||++|..|+.......  ...    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~----~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFG----QV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HH
Confidence            00             001112457889999999998899999999999999999999999986432111  000    00


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      ...   ....+..    ....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       229 ~~~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISD---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hhc---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            000   0001111    11234567889999999999999998878777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-33  Score=298.10  Aligned_cols=251  Identities=27%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||+|++|.||+++... ++.|+||++..... ...+.+.+|+..+.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368899999999999999999865 89999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998532   568999999999999999999999 87   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCc-ccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-ESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      ..  .....++..|+|||.+....++.++||||||+++|||++|+.|+...+. ........   ..      ....   
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~------~~~~---  220 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---IC------DGPP---  220 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---Hh------cCCC---
Confidence            21  1235678899999999999999999999999999999999999875432 11111100   00      0000   


Q ss_pred             cchhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ...+.. ++..+.+++.+|++.+|++||++.|+++.
T Consensus       221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             111122 45678899999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.3e-33  Score=302.90  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            368999999999999999999864 5789999998755555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999843    34788999999999999999999988   99999999999999999999999999876543221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                        ......++..|+|||.+....++.++||||||+++|||++|+.||........ +..    .....      .+..  
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~----~~~~~------~~~~--  235 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IATNG------TPEL--  235 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee----hhcCC------CCCC--
Confidence              22234688899999999888899999999999999999999999875332111 000    00000      0001  


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+......+.+++.+||+.+|++||++.+++..
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122334567889999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-33  Score=301.89  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=193.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHH-HHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.+.||+|+||.||+++.. +|+.||||++.... .....++..|+.. ++.++||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999985 48999999987542 2334455566665 556699999999999999999999999


Q ss_pred             ecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          591 YMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       591 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |++ |+|.+++... .....+++..+..++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6777776432 2335689999999999999999999986 5   99999999999999999999999999986532


Q ss_pred             CCccccccccccccceeCceeecC----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALD----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.........+.    ...      ..
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~------~~  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVV------EE  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHH------hc
Confidence            21   1122457889999998865    4568899999999999999999999864321100000    000      00


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+.+   ....++..+.+++.+|++.+|++||++.++++.
T Consensus       224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111   111245678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=307.50  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             CCccccccccCCcccEEEEEecC---CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI  586 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  586 (835)
                      +|++.++||+|+||.||+|+...   ++.||||.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999754   7899999987632   33446678899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhcCC-C-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC----CCCeEeccc
Q 003264          587 LIYEYMPNKSLNFFLFDP-S-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF  660 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF  660 (835)
                      +||||+++ +|.+++... . ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 555555322 1 2236889999999999999999999988   999999999999999    999999999


Q ss_pred             CccccccCCCc-cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCccccccc-------cc
Q 003264          661 GMARMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL-------GH  731 (835)
Q Consensus       661 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~-------~~  731 (835)
                      |+++.+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+...........       ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1222345678999999988764 588999999999999999999999875543220000       00


Q ss_pred             chhhhc------------cccchh---c-----cC-ccccchhHH--HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 AWNLWK------------DNRAYE---L-----LS-PALQHEASY--QMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 ~~~~~~------------~~~~~~---~-----~~-~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ....+.            ......   .     .. ..+......  .....+.+++.+|++.+|++||++.|+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000            000000   0     00 000000111  234568899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=299.71  Aligned_cols=248  Identities=24%  Similarity=0.424  Sum_probs=199.7

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcC---CCceeeEeeEEEecCeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .|++.+.||+|+||.||+|++. +++.||||.+... .....+++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5788899999999999999974 5889999998654 3345567889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998833    36889999999999999999999988   999999999999999999999999999876433


Q ss_pred             CccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  .......|+..|+|||.+.++ .++.++||||||+++|||++|..|+..........      ...     ....+.
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~-----~~~~~~  221 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIP-----KSKPPR  221 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccc-----cCCCCC
Confidence            2  122334688899999988654 57899999999999999999999987543211100      000     001111


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +...   .....+.+++.+|++.+|++||++.|+++.
T Consensus       222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1111   134568889999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=307.56  Aligned_cols=253  Identities=22%  Similarity=0.256  Sum_probs=201.7

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++..+ ++.||||.+.....   ...+.+.+|++++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468899999999999999999865 89999999875432   24567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++... ....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988532 3356899999999999999999999987   999999999999999999999999998765322


Q ss_pred             Ccc---------------------------ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          670 ELQ---------------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       670 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|||++|+.|+...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123467889999999998899999999999999999999999987544


Q ss_pred             cccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 003264          723 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT----MSKVVS  784 (835)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  784 (835)
                      .... +             .+.................+.+++.+|++.+|++||+    +.|+++
T Consensus       237 ~~~~-~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET-F-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH-H-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2211 0             0001111111111114567889999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-33  Score=299.97  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  589 (835)
                      ++|+..++||.|++|.||++.+. .++.+|+|.+.... .....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999985 47899999987543 34567789999999999999999999998654  3689999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++++|.+++... .....+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887432 23445788999999999999999999988   99999999999999999999999999875432


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ..........+.+. 
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPELKDE-  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhhccC-
Confidence            21    1234578899999999999999999999999999999999999875432111001100 00000000000000 


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..........+.+++.+|++.+|++||++.|+++.
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence              00011245678899999999999999999999974

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=303.47  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.+.||+|+||.||+|...+ ++.||||++...  .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            368999999999999999999864 789999988653  23345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++++.+..++.   +...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999988776653   2344789999999999999999999987   9999999999999999999999999998764432


Q ss_pred             ccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccc--cc-------cchhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG-------HAWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~~-------~~~~~~~~~~  740 (835)
                      . .......++..|+|||++... .++.++||||||+++|||++|+.|+..........  ..       .....+....
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2 122335678899999999888 88999999999999999999999987543211000  00       0000000000


Q ss_pred             -c--hhccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 -A--YELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 -~--~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .  .+.......    ...+...+..+.+++.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             0  000000000    01112236778999999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-33  Score=296.61  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|+..+.||+|+||.||++... +++.+|||.+...  .....+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999874 4789999998654  234567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~  670 (835)
                      +++++|.+++... ....+++..+.+++.+++++|+|||+++   ++|+||+|+||+++.++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345789999999999999999999987   99999999999998654 58999999998764322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...+....  ..   .... ..         .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~---~~~~-~~---------~  218 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VL---KIMS-GT---------F  218 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HH---HHHh-cC---------C
Confidence               12234678899999999988899999999999999999999999865432211  00   0000 00         0


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+......+.+++.+|++.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            01112245567899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.6e-33  Score=297.08  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=201.6

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888899999999999999875 588999999876543  3678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..   ...+++..+..++.++++||+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   235788999999999999999999988   99999999999999999999999999987644322


Q ss_pred             ccc--ccccccccceeCceeecCCC---CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          672 QGN--TKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       672 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ...  .....++..|+|||++....   ++.++||||||++++||++|+.||...+.... ...   .. ..     ...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~---~~-~~-----~~~  224 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMF---HV-GA-----GHK  224 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHH---HH-hc-----CCC
Confidence            111  12356788999999998766   88999999999999999999999875431110 000   00 00     001


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.+..  .......+.+++.+|++.+|++||++.|++.
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111  1122456778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.8e-34  Score=304.83  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=195.0

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999985 48899999986432  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 67776643  2345899999999999999999999988   9999999999999999999999999998653221 


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc----------cchhhhcc-c
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG----------HAWNLWKD-N  739 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~----------~~~~~~~~-~  739 (835)
                       .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........+..          ..+..... .
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             112234568899999988765 4789999999999999999999886432211100000          00000000 0


Q ss_pred             c--chhccCcccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          740 R--AYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       740 ~--~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .  .......... ..........+.+++.+|++.+|++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0  0000000000 0111234567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3e-33  Score=302.52  Aligned_cols=261  Identities=24%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh-----hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-----QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +|++.+.||+|+||.||+|... +++.||||++.....     .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999975 589999999875432     2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+ +++|.+++....  ..+++..+..++.||++||+|||+++   ++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985432  36899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh--------hhcc-
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN--------LWKD-  738 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~-  738 (835)
                      ..  .......++..|+|||.+.+ ..++.++|||||||+++||++|.+++.......  .......        .+.. 
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence            22  11222346788999998855 467899999999999999999987765433211  0000000        0000 


Q ss_pred             ccchhccCccc-----cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 NRAYELLSPAL-----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...........     ...........+.+++.+|++.+|++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000     001112335678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.7e-34  Score=306.77  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=199.1

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      |.....||+|+||.||+++.. +++.||||.+........+.+.+|+.++..++||||+++++++..+...++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344558999999999999875 5889999998765545567788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      ++|..++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+....  ..
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence            999988732    45789999999999999999999988   9999999999999999999999999987653222  12


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....++..|+|||++.+..++.++||||||++++||++|+.|+...+....  ..    .+....     .+..  ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~-----~~~~--~~~  240 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK----RLRDSP-----PPKL--KNA  240 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhccC-----CCCc--ccc
Confidence            2335688999999999988999999999999999999999999864331110  00    000000     0000  011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+.+++.+|++.+|++||+++++++.
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1233557789999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=302.29  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67999999999999999999976 578999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++ +|.+++.+.  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  157 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-  157 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence            985 888887543  236789999999999999999999987   9999999999999999999999999987542211 


Q ss_pred             cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc---cc-------
Q 003264          672 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD---NR-------  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~-------  740 (835)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...........   ..       
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhhhc
Confidence             11122346789999998875 4588999999999999999999999864431100 00000000000   00       


Q ss_pred             --c----hhccCccccchhHHHH--HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 --A----YELLSPALQHEASYQM--LNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 --~----~~~~~~~l~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        .    .....+..........  ...+.+++.+|++.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0    0000000000000011  256778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=299.24  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=200.6

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------  583 (835)
                      .+++|++.+.||+|++|.||+|+.. +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999985 478999999875443 446789999999999 7999999999997654      


Q ss_pred             eEEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999885422 2456889999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      +.......  .......++..|+|||.+..     ..++.++||||||++++||++|+.|+........ +..    . .
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~-~  231 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFK----I-P  231 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHH----h-h
Confidence            87653221  22233568889999998753     3477899999999999999999999864321110 000    0 0


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..     ..+.+  ..+......+.+++.+|+..||++||++.|+++
T Consensus       232 ~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00     00111  112235567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-33  Score=302.63  Aligned_cols=244  Identities=25%  Similarity=0.310  Sum_probs=199.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999975 48899999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..   ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999843   356889999999999999999999987   999999999999999999999999999876433


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....+++.|+|||.+.+..++.++||||||++++||++|+.|+...+....  .    ......      ..  
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~------~~--  215 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--Y----EKILEG------KV--  215 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHhcC------Cc--
Confidence                 2334688999999999888899999999999999999999999865431110  0    000000      00  


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  784 (835)
                        ..+......+.+++.+|++.+|.+||     +++|+++
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              11122346778899999999999999     6666663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=313.52  Aligned_cols=252  Identities=22%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             cCCccccccccCCcccEEEEEecCCc-EEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|+++..||.|+||.|||++.++.. ..|.|++....+..++.|.-||+||+.++||+||+|++.|.....++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            56888899999999999999887643 45788888888888999999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      .||-.+.++..  -...+.+.++.-+++|++.||.|||+++   |||||||+.|||++-+|.++|+|||.+....  ...
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            99999888754  3457899999999999999999999998   9999999999999999999999999986532  222


Q ss_pred             ccccccccccceeCceee-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          673 GNTKRVVGTYGYMSPEYA-----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .....+.||+.|||||++     .+.+|+.++||||||++|.||..+.+|....+.....+.      +.+..     .|
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK------iaKSe-----PP  253 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------IAKSE-----PP  253 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH------HhhcC-----CC
Confidence            334567899999999986     456899999999999999999999999764432211110      00111     11


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.  -+..+...+.+++..||..+|+.||++.++++.
T Consensus       254 TLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  254 TLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            111  234567788999999999999999999999854

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.7e-33  Score=299.72  Aligned_cols=264  Identities=22%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999975 58999999987543  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885432  56899999999999999999999987   99999999999999999999999999987643321


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc-cc-------cchhhhcc-cc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL-LG-------HAWNLWKD-NR  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~-~~-------~~~~~~~~-~~  740 (835)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|.+++........ .. ..       ..+..... ..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             122335688999999988654 468999999999999999999877754331110 00 00       00000000 00


Q ss_pred             chhccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+...    .....+....+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    01111234778899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-33  Score=300.58  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999875 58899999886432  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +. ++|..++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.+.... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 5788877543 2346889999999999999999999987   9999999999999999999999999987653221 


Q ss_pred             cccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCCCcccccc--cc-------cchhhhccc-c
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG-------HAWNLWKDN-R  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~~-------~~~~~~~~~-~  740 (835)
                       .......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...+......  ..       ..+...... .
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1122235678999999887654 6889999999999999999999986543211000  00       000000000 0


Q ss_pred             chhccC---ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLS---PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......   ..............+.+++.+|++.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000   00000111123456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.7e-33  Score=292.72  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=205.8

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY  589 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  589 (835)
                      +|++.+.||+|++|.||+|+.. +++.|++|++....  ....+.+.+|+.++++++|+||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999986 58899999986554  24567899999999999999999999999988  8999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998532   27899999999999999999999987   999999999999999999999999999876544


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      ..........++..|+|||.+....++.++||||||+++++|++|+.|+...+.....    .+.         +.....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~---------~~~~~~  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----LYK---------IGSSGE  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----HHh---------ccccCC
Confidence            3221233456889999999998888999999999999999999999998765411100    000         000011


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ....+......+.+++.+|++.+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11122233567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.6e-33  Score=298.74  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +|++.++||+|++|.||+|+.. +++.||||.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999985 488999999875432 23466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++ +|.+++........+++..+..++.||+.||+|||+.+   ++||||||+||++++++.++|+|||+++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 78887754443456899999999999999999999987   9999999999999999999999999997653221  


Q ss_pred             ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-ccc-------cchhhhccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLG-------HAWNLWKDNRAY  742 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~-------~~~~~~~~~~~~  742 (835)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...+.... . ...       ..+..+......
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            112234568899999988664 578999999999999999999999875442211 0 000       000000000000


Q ss_pred             hccCccc----cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          743 ELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       743 ~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ....+..    ...........+.+++.+|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000    01112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-33  Score=300.77  Aligned_cols=264  Identities=25%  Similarity=0.286  Sum_probs=195.5

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999875 58899999986543 223346788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+. ++|..++..  ....+++..+..++.||+.||+|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 566666533  2245778888999999999999999987   999999999999999999999999999754221


Q ss_pred             CccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc----------
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD----------  738 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------  738 (835)
                      .  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .....+.....          
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence            1  112234568899999998764 578899999999999999999999875432111 10000000000          


Q ss_pred             ---ccchhccCccccchh-----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          739 ---NRAYELLSPALQHEA-----SYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       739 ---~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         ....+..........     .......+.+++.+|++.+|++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               000000000000000     0011356778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.6e-33  Score=301.40  Aligned_cols=247  Identities=29%  Similarity=0.432  Sum_probs=196.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+++.+|+++++.++||||+++++++.+....++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356889999999999999999875 58899999886432   33446788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 566665532  2345899999999999999999999987   99999999999999999999999999875422


Q ss_pred             CCccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+...+.....     ..... .     .
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-----~~~~~-~-----~  230 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQ-N-----D  230 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-----HHHhc-C-----C
Confidence            1      2345788999999874   456889999999999999999999998643321110     00000 0     0


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.+   ....+...+.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0111   112345678899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.2e-33  Score=298.31  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++.|+..+.||+|++|.||+|++. +++.|++|++..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34577899999999999999999986 588999999976544 5677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999995432  36899999999999999999999987   999999999999999999999999998765322


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+......      .+.......     .
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~-----~  236 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LITTKGIPP-----L  236 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCCC-----C
Confidence            11  1223457889999999988889999999999999999999999986433211000      000000000     0


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        .....+...+.+++.+|++.+|.+||++.++++.
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              1112244678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.8e-33  Score=290.86  Aligned_cols=250  Identities=28%  Similarity=0.434  Sum_probs=204.6

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      +|++.+.||+|++|.||+++.. +++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999986 588999999977655567889999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++....  ..+++..+..++.|++++|+|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985432  46899999999999999999999987   99999999999999999999999999987643321  


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                       .....++..|+|||.+....++.++||||||++++||++|+.|+...+.......      ..........       .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~-------~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IATNGPPGLR-------N  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HHhcCCCCcC-------c
Confidence             3345688999999999888899999999999999999999999875431111000      0000000110       1


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .......+.+++.+|++.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124568899999999999999999999853

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-33  Score=326.01  Aligned_cols=255  Identities=29%  Similarity=0.406  Sum_probs=193.0

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe------
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------  581 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------  581 (835)
                      ++-..+|++++.||+||||.|||++.+ ||+.||||+|... .......+.+|+..|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            566789999999999999999999964 7999999999754 34456778899999999999999999865432      


Q ss_pred             --------------------------------------------------------------------------------
Q 003264          582 --------------------------------------------------------------------------------  581 (835)
Q Consensus       582 --------------------------------------------------------------------------------  581 (835)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------c--------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003264          582 -------------------------Q--------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY  628 (835)
Q Consensus       582 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  628 (835)
                                               +        ..+||-||||+..+|.+++.+.....  .....++++++|+.||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        12467799999988888884332111  367788999999999999


Q ss_pred             HHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc----C------------CCccccccccccccceeCceeecC
Q 003264          629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC----G------------DELQGNTKRVVGTYGYMSPEYALD  692 (835)
Q Consensus       629 LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~  692 (835)
                      +|+.+   ||||||||.||++++++.|||+|||+|....    .            .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721    0            011123456789999999999876


Q ss_pred             C---CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc--hhHHHHHHHHHHHHHh
Q 003264          693 G---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH--EASYQMLNRYITVALL  767 (835)
Q Consensus       693 ~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~  767 (835)
                      .   .|+.|+|+|||||||+||+.   ||+..- +....+            ..+-+..++.  +........-..+|.+
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa~iL------------~~LR~g~iP~~~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-ERASIL------------TNLRKGSIPEPADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchH-HHHHHH------------HhcccCCCCCCcccccccchHHHHHHHH
Confidence            5   49999999999999999996   343211 111111            1111111211  1223334445679999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 003264          768 CVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       768 cl~~dP~~RPs~~evl~~  785 (835)
                      +++.||.+|||+.|++..
T Consensus       854 Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HhcCCCccCCCHHHHhhc
Confidence            999999999999999853

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-33  Score=299.90  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=196.2

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|+..+.||+|+||.||+++... ++.||||++.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            456777899999999999998754 8899999986543 344567889999999996 9999999999999999999999


Q ss_pred             ecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |++. +|.++...  ......+++..+.+++.++++||+|||+. +   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 44433211  11235688999999999999999999975 5   9999999999999999999999999997654


Q ss_pred             CCCccccccccccccceeCceeecCC---CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ...   ......++..|+|||.+...   .++.++||||||+++|||++|+.||......    .......      ...
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~------~~~  226 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQV------VKG  226 (288)
T ss_pred             cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhh------cCC
Confidence            322   11233578899999998776   6899999999999999999999998753310    0000000      001


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+.+.......++..+.+++.+|++.+|++||++.+|++.
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11122222223456678899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=298.61  Aligned_cols=262  Identities=22%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      |++.+.||.|++|.||+|... +|+.||||++....  ....+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999875 58999999986442  223467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      + ++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||+++......  
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--  153 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--  153 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence            5 68888874332 245899999999999999999999987   9999999999999999999999999997643221  


Q ss_pred             ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc--cccc-------cchhhhcc-ccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG-------HAWNLWKD-NRA  741 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~-------~~~~~~~~-~~~  741 (835)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||...+....  ....       ..+..... ...
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            111223568899999988664 578999999999999999999999865432110  0000       00000000 000


Q ss_pred             ---hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          742 ---YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       742 ---~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         ...................+.+++.+|++.+|++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0000000011112233467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.8e-33  Score=299.63  Aligned_cols=263  Identities=23%  Similarity=0.294  Sum_probs=197.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+|+.. +++.+|+|.++...  ......+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57999999999999999999986 48899999986442  22234577899999999999999999999887  889999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 888887432  236899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc--------ccchhhh--
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------GHAWNLW--  736 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~--------~~~~~~~--  736 (835)
                      ..  .......++..|+|||.+.+. .++.++|+||||++++||++|..|+........ ...        ...|..+  
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            32  112234578899999988764 468999999999999999999999875432110 000        0000000  


Q ss_pred             ----ccccchhccCccccchhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          737 ----KDNRAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       737 ----~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          ............+....+.. ....+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                00000000001111111111 3566788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=307.14  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----eE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~  585 (835)
                      +++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            478999999999999999999874 58899999986432 334567888999999999999999999876543     57


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+||+++ +|..++.    ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 7776662    345899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc---cc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD---NR  740 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~  740 (835)
                      ....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...+....  ..........   +.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~~  233 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHH
Confidence            5432211 12233568899999998755 5689999999999999999999999865431110  0000000000   00


Q ss_pred             chhccC-------------cccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhccc
Q 003264          741 AYELLS-------------PALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEH  790 (835)
Q Consensus       741 ~~~~~~-------------~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  790 (835)
                      .....+             +... ..........+.+++.+|++.+|++||++.|+++.  ++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000             0000 00112235668899999999999999999999987  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-33  Score=297.59  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=199.9

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .|...+.||+|++|.||++... +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3445579999999999999864 588999999876555556678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999843    45788999999999999999999988   99999999999999999999999999876533221  


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                      ......|+..|+|||.+.+..++.++||||||++++||++|+.|+...+...  ...   . ....     ..+...  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~~---~-~~~~-----~~~~~~--~  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AMK---R-IRDN-----LPPKLK--N  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HHH---H-HHhc-----CCCCCc--c
Confidence            1223468899999999988889999999999999999999999986432110  000   0 0000     001111  1


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .......+.+++.+|++.+|++||++.++++.
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            11234578899999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-33  Score=296.40  Aligned_cols=247  Identities=25%  Similarity=0.278  Sum_probs=201.4

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      +|++.+.||.|+||.||+++.. .++.||+|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999986 48899999986532   2456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|..++..   ...+++..+..++.||++||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   246889999999999999999999987   9999999999999999999999999998754322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......++..|+|||.+....++.++|+||||+++|+|++|+.|+............   .....          ..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~----------~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQET----------AD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH---HHhcc----------cc
Confidence               223356788999999998888999999999999999999999998754422110000   00000          11


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTM--SKVV  783 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  783 (835)
                      ...+...+..+.+++.+|++.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11222344678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-32  Score=297.76  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe-----
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE-----  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-----  584 (835)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....  ......+.+|+.+++++ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999975 48899999876432  22346788899999999 56999999999987765     


Q ss_pred             EEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFG  661 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG  661 (835)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78777744322  346899999999999999999999987   999999999999998 8999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc--ccc-------c
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLG-------H  731 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~--~~~-------~  731 (835)
                      +++.+....  .......+++.|+|||++.+ ..++.++||||||+++|||++|..|+...+.....  +..       .
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            998653221  11122356788999998865 45789999999999999999999998654321100  000       0


Q ss_pred             chhhhccccc-hh--ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          732 AWNLWKDNRA-YE--LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       732 ~~~~~~~~~~-~~--~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .+........ .+  ...+.............+.+++.+|++.+|.+||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000 00  00000001111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-32  Score=300.77  Aligned_cols=263  Identities=23%  Similarity=0.273  Sum_probs=196.0

Q ss_pred             ccccccC--CcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          519 QCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       519 ~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .+.||+|  +||+||++++. .++.||||++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  88999999975 5899999998643  23345778999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999885432 235888999999999999999999987   9999999999999999999999998654332211110


Q ss_pred             -----cccccccccceeCceeecCC--CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh------------
Q 003264          674 -----NTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN------------  734 (835)
Q Consensus       674 -----~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~------------  734 (835)
                           ......++..|+|||++.+.  .++.++|||||||+++||++|+.|+................            
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                 01112346679999998764  47899999999999999999999987543221100000000            


Q ss_pred             -------------------hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 -------------------LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 -------------------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                         ...........+..+.......+...+.+++.+||+.+|++||+++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                               000000001111122233344567788999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.4e-33  Score=293.37  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=199.7

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|+||.||+|.... +..||+|.+....  ....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            57889999999999999999864 7899999986432  23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-eEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~  670 (835)
                      +++++|.+++.+. ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988543 2235789999999999999999999987   999999999999998864 6999999998764322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                      .  ......|+..|+|||++.+..++.++||||||++++||++|..|+........     ...... .    ...    
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~----~~~----  220 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----VLKICQ-G----YFA----  220 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhc-c----cCC----
Confidence            1  12234588899999999888899999999999999999999999864331111     000000 0    000    


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .........+.+++.+|++.+|++||++.|+++.
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             1111234568889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-32  Score=292.07  Aligned_cols=242  Identities=25%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             cccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||.|+||.||+++... ++.||+|.+....   ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999999864 8899999986532   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++.+   ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   234889999999999999999999987   9999999999999999999999999998764332   2223


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..++..|+|||.+....++.++|+||||+++|||++|..|+.....+......            ...........+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN------------DILKGNGKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH------------HHhccCCCCCCCccc
Confidence            46788999999998888999999999999999999999998754422111110            000000111112222


Q ss_pred             HHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003264          758 LNRYITVALLCVQEKAADRPT-----MSKVVS  784 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs-----~~evl~  784 (835)
                      ...+.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            567889999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=297.45  Aligned_cols=260  Identities=15%  Similarity=0.189  Sum_probs=184.7

Q ss_pred             hcCCccccccccCCcccEEEEEecCC----cEEEEEEecCcChhhH-----------HHHHHHHHHHHhcCCCceeeEee
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      .++|++.++||+|+||.||+|+..++    ..+|+|+.........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999997543    4566665432221110           11223344556678999999999


Q ss_pred             EEEecC----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          578 CCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       578 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            776554    34677887643 45555422   223567888999999999999999987   99999999999999999


Q ss_pred             CeEecccCccccccCCCc-----cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc
Q 003264          654 NPKISDFGMARMFCGDEL-----QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL  728 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~  728 (835)
                      .++|+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643211     112233469999999999999999999999999999999999999998653221111


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .......     ...+..+...   ....+..+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            0000000     0011111000   1122466888999999999999999999999874

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=336.03  Aligned_cols=257  Identities=28%  Similarity=0.379  Sum_probs=207.9

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      ++..+-+|.-...||.|.||.||-+...+ |.-.|||-++.+.  ........+|+.++..|+|||+|+++|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            33445677778899999999999998654 8889999776542  33456678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      +|.||||++|+|.+.+.   .....++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999983   3445667777788899999999999998   99999999999999999999999999998


Q ss_pred             ccCCC--ccccccccccccceeCceeecCC---CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          666 FCGDE--LQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       666 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      +.+..  .........||+-|||||++.+.   ....++||||+|||+.||+||++||...+.+-. +.-+         
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~--------- 1453 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYH--------- 1453 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhH---------
Confidence            86552  22334567899999999999764   466789999999999999999999987664311 1100         


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          +.....+..+...+..=.+++.+|++.||++|.++.|+++.
T Consensus      1454 ----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 ----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                00111223334466667789999999999999999888876

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=327.44  Aligned_cols=263  Identities=30%  Similarity=0.436  Sum_probs=211.2

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC--------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCC  579 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  579 (835)
                      +...++..+.+.||+|.||.|++|....        ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344556677799999999999997531        3579999997653 35678899999999999 799999999999


Q ss_pred             EecCeEEEEEEecCCCChhhhhcCCC------C-----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCe
Q 003264          580 VEQGEKILIYEYMPNKSLNFFLFDPS------R-----T--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  646 (835)
Q Consensus       580 ~~~~~~~lV~E~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  646 (835)
                      .+++..++|+||+++|+|..+|.+.+      .     .  ..+...+.+.++.|||.|++||++..   +|||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence            99999999999999999999996644      0     0  23888999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEecccCccccccCCCccccc-cccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcc
Q 003264          647 ILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIE  724 (835)
Q Consensus       647 ILl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~  724 (835)
                      ||+..+..+||+|||+++........... ..-.-+..|||||.+....|+.|+|||||||+||||+| |..|+......
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999976555444322 11114667999999999999999999999999999999 67777642100


Q ss_pred             cccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          725 SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                                    ..+.+.+.+..+.+.+..+..++.+++..||+.+|++||++.|+++.|+..
T Consensus       529 --------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 --------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                          011122223333344445567788999999999999999999999999884

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=290.51  Aligned_cols=250  Identities=27%  Similarity=0.378  Sum_probs=197.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      .+|++.+.||+|+||.||+|++. +++.||+|.+...     .......+++|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999875 4889999987432     233456789999999999999999999998764  457


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+||+++++|.+++..   ...+++....+++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998843   234788999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ....... .......++..|+|||.+.+..++.++||||||++++||++|+.||........              ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~  221 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--------------IFKI  221 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--------------HHHH
Confidence            5322111 112235688999999999988899999999999999999999999864321100              0001


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .........+......+.+++.+|++ +|..||+..+++.
T Consensus       222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11111122233455678889999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-32  Score=304.02  Aligned_cols=262  Identities=23%  Similarity=0.253  Sum_probs=197.5

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  582 (835)
                      ..++|++.+.||+|+||.||+++.. +++.||||++...  .....+++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3478999999999999999999875 5899999998643  233456778899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ...++||||+.+ +|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999964 77776632     2788899999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc-cccc------------
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLL------------  729 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~------------  729 (835)
                      ++......   ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+... ....            
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98653321   1223457889999999999999999999999999999999999987544211 0000            


Q ss_pred             ---ccchhh-hcc------ccchhccCccc----cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          730 ---GHAWNL-WKD------NRAYELLSPAL----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       730 ---~~~~~~-~~~------~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ...... ...      ....++.....    ...........+.+++.+|++.||++||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000000 000      00001110000    011122345567899999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=295.26  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=197.9

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIYE  590 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E  590 (835)
                      |++.++||+|+||.||+|+..+ ++.||+|++....  ....+.+.+|+.++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6778999999999999999764 8899999997653  33446788999999999999999999999988  89999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++ +|..++...  ...+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 788777432  246889999999999999999999987   9999999999999999999999999998764432


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-ccc-------cchhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLG-------HAWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~-------~~~~~~~~~~  740 (835)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+.... . +..       ..+.....-.
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            1 11223456788999998765 4678999999999999999999999875442211 0 000       0000000000


Q ss_pred             chhcc------CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELL------SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....      ...+.......+...+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00000      0000011111125678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-32  Score=297.98  Aligned_cols=250  Identities=28%  Similarity=0.404  Sum_probs=197.0

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +.|+..+.||+|+||.||+++.. ++..||+|++...   .......+.+|+.++++++|||++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34788899999999999999975 5889999998643   2234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 66666632  2345889999999999999999999987   99999999999999999999999999875422 


Q ss_pred             CccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                           .....++..|+|||++.   .+.++.++||||||+++|||++|+.|+...+....  ..   ....         
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~---~~~~---------  238 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY---HIAQ---------  238 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HH---HHHh---------
Confidence                 22346788999999874   45789999999999999999999999764321110  00   0000         


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..............+.+++.+|++.+|.+||++.++++.+-..
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            0000111123445678899999999999999999999875443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=277.21  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++.+.+..||.|..|.|++.+... |..+|||.+... +.+..++++..+.++.+.+ .|+||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            456667889999999999999865 889999998755 4556677888888887774 8999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      .|.- .++.++..  -.+++++..+-++...+++||.||.+++  .|+|||+||+|||+|+.|++||+|||++..+.+..
T Consensus       172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            8843 34455532  2345888888899999999999999876  79999999999999999999999999998764432


Q ss_pred             ccccccccccccceeCceeecCC---CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                         ......|-+.|||||.+.-.   .|+.++||||||+.|+||.||+.|+...+.+-..+. .+.         .-..|
T Consensus       247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kvl---------n~ePP  313 (391)
T KOG0983|consen  247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KVL---------NEEPP  313 (391)
T ss_pred             ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HHH---------hcCCC
Confidence               23446788999999998543   688999999999999999999999987554322111 110         11113


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+....  .++..+.+++..||+.|+.+||.+.++++.
T Consensus       314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            333222  267888999999999999999999999875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-34  Score=309.52  Aligned_cols=244  Identities=26%  Similarity=0.382  Sum_probs=191.4

Q ss_pred             cccccccCCcccEEEEEecC-CcEEEEEEec----CcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe--EEEEEE
Q 003264          518 MQCKLGEGGFGPVYKGKLLN-GQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE--KILIYE  590 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~E  590 (835)
                      ..++||+|.|-+||||.+.. |-+||--.++    .......++|..|+++|+.|+|||||+++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            44689999999999998744 6677633221    1245567899999999999999999999999997765  789999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCccccccCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD  669 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~  669 (835)
                      .+..|+|..|+.+.   +.+....+..+++||++||.|||++. ++|||||||-.||+|+. -|.+||+|+|||......
T Consensus       124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999543   45778899999999999999999986 79999999999999975 589999999999876332


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                          ....+.||+.|||||... ..|.+.+||||||+.++||+|+..|+..-....              ++++.+-...
T Consensus       200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--------------QIYKKV~SGi  260 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--------------QIYKKVTSGI  260 (632)
T ss_pred             ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--------------HHHHHHHcCC
Confidence                233479999999999665 899999999999999999999999987433211              1111111111


Q ss_pred             cch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+. ...-.-..+.++|.+|+.. .++||++.|+|+-
T Consensus       261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            110 0000123467799999999 9999999999964

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-32  Score=317.86  Aligned_cols=269  Identities=20%  Similarity=0.302  Sum_probs=187.7

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC--CcEEEEE------------------EecCcChhhHHHHHHHHHHHHhcCCC
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVK------------------RLSSQSGQGLKEFKNEMMLIAKLQHR  570 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~  570 (835)
                      ...++|+++++||+|+||+||++....  +..+++|                  .+. ........+.+|+.+|.+++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987532  2222222                  111 1223456688999999999999


Q ss_pred             ceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       571 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ||+++++++.+.+..++|+|++.. +|..++.....  ........+..++.||+.||+|||+++   ||||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            999999999999999999999964 56666543211  122345667789999999999999988   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCC-CCCCCcccc-
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESF-  726 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~-  726 (835)
                      ++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|..+ +........ 
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987643221 122235789999999999999999999999999999999998754 432221111 


Q ss_pred             cccccchhh------hcc--ccchhccCcc----ccchh-----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          727 NLLGHAWNL------WKD--NRAYELLSPA----LQHEA-----SYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       727 ~~~~~~~~~------~~~--~~~~~~~~~~----l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+......+      +..  ....+.++..    .....     .......+.+++.+|++.||++||++.|+++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111000000      000  0000000000    00000     00123456778999999999999999999864

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-32  Score=302.72  Aligned_cols=266  Identities=25%  Similarity=0.316  Sum_probs=198.4

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec--CeE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~  585 (835)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3578999999999999999999975 4789999988542  233456678899999999 999999999998654  368


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||++ ++|..++..    ..+.+..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588888732    26788999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc---ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc--------c
Q 003264          666 FCGDELQ---GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH--------A  732 (835)
Q Consensus       666 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~--------~  732 (835)
                      +......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .....        .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6433221   22234568899999998765 4678999999999999999999999865432110 00000        0


Q ss_pred             hhhhccccchhccCc----cc--cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 WNLWKDNRAYELLSP----AL--QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~----~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+.......+++.    ..  ...........+.+++.+|++.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000001100    00  001111235678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=287.86  Aligned_cols=247  Identities=29%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++.+++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999875 478999999876543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999843   256899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .  .....++..|+|||.+....++.++||||||++++||++|+.|+........     .+.... .         ...
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~---------~~~  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIVQ-D---------DHP  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhc-c---------CCC
Confidence            1  2334678899999999888889999999999999999999999864331100     000000 0         001


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..+......+.+++.+|++.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111223456788999999999999999999884

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=294.22  Aligned_cols=246  Identities=25%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+.|+.-++||+|+||.||-++... |+.+|.|++.+.   ......-.++|-.+|.+++.+.||.+-..++..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            3678888999999999999998754 899999988543   233455678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +..|.||+|..+|++... ..+++..++.++.+|+.||++||...   ||.|||||+|||||+.|+++|+|.|||..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999977543 57899999999999999999999987   99999999999999999999999999988754


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ...   ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.......               -.+-+|.+
T Consensus       340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdrr  401 (591)
T KOG0986|consen  340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDRR  401 (591)
T ss_pred             CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHHH
Confidence            432   223489999999999999999999999999999999999999987432110               00111111


Q ss_pred             c---cchhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          749 L---QHEASYQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       749 l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      .   ...++..++++..++....|+.||++|..-.
T Consensus       402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            1   2345567788888999999999999997433

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-32  Score=293.11  Aligned_cols=260  Identities=21%  Similarity=0.277  Sum_probs=192.8

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEec--CeEEEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIYE  590 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E  590 (835)
                      |++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677899999999999999875 58899999987542 222234457888999885 99999999999988  88999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++ ++|.+++...  ...+++..+..++.||++||+|||+.+   ++||||+|+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 4777776432  246899999999999999999999988   999999999999999 999999999998764322


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc----cccchh----hhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL----LGHAWN----LWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~----~~~~~~----~~~~~~  740 (835)
                      .   .....++..|+|||.+.. ..++.++|||||||++|||++|..|+...+.... ..    ......    ......
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   123457889999997654 5678899999999999999999999975432110 00    000000    000000


Q ss_pred             chhccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+...    .......+..+.+++.+|++.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000    01122446788999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.4e-32  Score=287.98  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=204.7

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|++++++++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888899999999999999985 48899999987543  35567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++++|.+++.... ....+++..+..++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885432 2366899999999999999999999987   9999999999999999999999999998754332


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                        .......++..|+|||.+....++.++||||+|+++++|++|+.|+...+....  ..   .... ..         .
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~---~~~~-~~---------~  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL--AL---KILK-GQ---------Y  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH--HH---HHhc-CC---------C
Confidence              122334688899999999888999999999999999999999999865432110  00   0000 00         0


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+......+.+++.+|+..+|++||++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11112344667889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-32  Score=290.34  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=203.8

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|++.++||+|+||.||+++.. +++.+|+|.+...  ......++.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999865 5789999998653  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++++|..++.+. .....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988542 12356889999999999999999999988   999999999999999999999999999876443 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.|+...+......      ...         ....
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~---------~~~~  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQ---------RGKY  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHh---------cCCC
Confidence               1223457889999999999999999999999999999999999987544221100      000         0111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+......+.+++.+|++.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11223456678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-32  Score=292.27  Aligned_cols=244  Identities=25%  Similarity=0.339  Sum_probs=192.0

Q ss_pred             cccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||+||++... +|+.||+|.+....   ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 48899999986432   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++..... ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999854322 35889999999999999999999988   999999999999999999999999998765331   12223


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.||..........      .+... ...     .....+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~~~-----~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------ELKRR-TLE-----MAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------HHHhc-ccc-----ccccCCccC
Confidence            457889999999988889999999999999999999999986543211000      00000 000     011112233


Q ss_pred             HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003264          758 LNRYITVALLCVQEKAADRP-----TMSKVVS  784 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RP-----s~~evl~  784 (835)
                      ...+.+++.+||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            56678999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-32  Score=297.62  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999985 48999999986432  22234567899999999999999999998765  46899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 777777432  256899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c-------cchhhhc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G-------HAWNLWK  737 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~-------~~~~~~~  737 (835)
                      ...  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+.... ... .       ..+....
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            322  11222345788999998865 4688999999999999999999999875432111 000 0       0000000


Q ss_pred             cc---cchhccCcccc--chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DN---RAYELLSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~---~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..   ....+......  ..........+.+++.+|++.||++||+++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00   00000000000  00001135567889999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-32  Score=292.29  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=186.7

Q ss_pred             ccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHH---hcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIA---KLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .||+|+||.||+++.. +++.||||.+....   ......+.+|..++.   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 48899999886432   122233444544433   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988843   345899999999999999999999988   9999999999999999999999999987553221   


Q ss_pred             cccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       .....|+..|+|||.+.. ..++.++|||||||+++||++|..||.............   .      .    ......
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~------~----~~~~~~  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M------T----LTVNVE  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH---H------h----hcCCcC
Confidence             123468999999998864 568999999999999999999999987543221110000   0      0    001111


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .+......+.+++.+|++.+|++||     +++|+++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2233456788899999999999999     59988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.4e-32  Score=293.81  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=194.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999975 58899999986432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCccccccCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD  669 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~  669 (835)
                      |+++ +|.+++... ....+++..+..++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 676666332 2233577888899999999999999987   999999999999985 567999999999765322


Q ss_pred             CccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc-------chhhhcc---
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-------AWNLWKD---  738 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~-------~~~~~~~---  738 (835)
                        ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+...+.... +...       ....|..   
T Consensus       157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        157 --VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             --ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhcccccc
Confidence              1112234568899999988664 578999999999999999999999875432110 0000       0000000   


Q ss_pred             ----ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 ----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ........+.............+.+++.+|++.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00000000000001112334567889999999999999999999864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-32  Score=292.08  Aligned_cols=247  Identities=24%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             cccCCcccEEEEEecC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||.||+++... ++.|++|.+.....   ...+.+.+|+.++.+++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999865 89999999865433   4567789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc------
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL------  671 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------  671 (835)
                      .+++.+.   ..+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998542   36899999999999999999999987   99999999999999999999999999876533211      


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      ........++..|+|||.+....++.++||||||++++||++|..|+........  ..    ......        ...
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~----~~~~~~--------~~~  220 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQ----NILNGK--------IEW  220 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhcCC--------cCC
Confidence            1122335678899999999888899999999999999999999999865432211  00    000000        000


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                      .........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0011125667889999999999999999777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-32  Score=302.77  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=197.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----Ce
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  584 (835)
                      .++|.+.+.||+|+||+||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999875 4889999998653  233455678899999999999999999988654     35


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++|+||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 678877743   345899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccccc--------cchh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLG--------HAWN  734 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~--------~~~~  734 (835)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+... .....        ..+.
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            653321  12233467889999998865 468999999999999999999999986543110 00000        0000


Q ss_pred             hhccccchh-------ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYE-------LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~-------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+       ...+.. .......+..+.+++.+|++.+|++||+++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000       000000 01112345678899999999999999999999977

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.3e-32  Score=288.17  Aligned_cols=249  Identities=22%  Similarity=0.231  Sum_probs=192.7

Q ss_pred             HHHHHhhcCCcccccc--ccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          507 ASVSAATENFSMQCKL--GEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      .+.....++|++.+.+  |+|+||.||+++.. +++.+|+|.+.......     .|+.....+ +||||+++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444556788888877  99999999999874 47889999986532111     122222223 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccC
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFG  661 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG  661 (835)
                      +..++||||+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999998432   37899999999999999999999988   99999999999999998 99999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +++.....      ....++..|+|||++.+..++.++||||||++++||++|+.|+.....+..........       
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  222 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-------  222 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-------
Confidence            98765322      22467899999999999899999999999999999999999987443222111111000       


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVS  784 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  784 (835)
                         ....  ..........+.+++.+|++.+|++||+ ++|+++
T Consensus       223 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 ---QQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---hccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               0000  0111235567889999999999999995 688874

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-32  Score=294.95  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=197.0

Q ss_pred             ccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ..+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            468999999999999874 5889999998655555667789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            998732    34789999999999999999999987   9999999999999999999999999987653322  11233


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..++..|+|||.+....++.++||||||++++||++|..|+...+....  ..    ...     ....+.+..  ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~----~~~-----~~~~~~~~~--~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MK----MIR-----DNLPPKLKN--LHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH-----hhCCcccCC--cccC
Confidence            5678999999999888899999999999999999999999864331110  00    000     000011100  1123


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+.+++.+|++.+|.+||++.++++.
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            3457789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=289.10  Aligned_cols=244  Identities=22%  Similarity=0.246  Sum_probs=190.1

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcCh---hhHHHHHHHHHHH-HhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLI-AKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.||+|+||.||+|+.. +++.||||.+.....   .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 488999999865432   2233445555544 445899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      ++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999843   345889999999999999999999987   99999999999999999999999999876432      


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....++..|+|||.+.+..++.++||||||++++||++|..|+...+....  .    ........      .......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~------~~~~~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--F----DNILSRRI------NWPEEVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--H----HHHHhccc------CCCCccc
Confidence            2234578899999999888899999999999999999999999865432211  0    00000000      0011111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ..+...+.+++.+|++.+|++||++.++.+.|+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            234567889999999999999998877766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-32  Score=295.77  Aligned_cols=266  Identities=23%  Similarity=0.352  Sum_probs=193.4

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|++.++||+|+||.||+++.. +++.||||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            367999999999999999999975 48899999886432  222345678999999999999999999987654      


Q ss_pred             --eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          584 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       584 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                        ..++||||+.+ +|..++..  ....+++.++..++.||+.||+|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999975 67776632  2235899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCcc--ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccch----
Q 003264          662 MARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW----  733 (835)
Q Consensus       662 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~----  733 (835)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||++++||++|+.|+...+.... .......    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99866432211  112234578899999988664 478899999999999999999999865432110 0000000    


Q ss_pred             -hhhccccchhcc----Cccc-cchhH-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          734 -NLWKDNRAYELL----SPAL-QHEAS-----YQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       734 -~~~~~~~~~~~~----~~~l-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ..+......+..    .+.. .....     ......+.+++.+|++.+|++||+++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             000000000000    0000 00000     011345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-33  Score=301.34  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=206.5

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ....|.+...||+|.|++|.++++. .+..||||.+.+.  +....+.+.+|+++|..++|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4568999999999999999999975 4899999999765  334456689999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+.+|.+.+++.+.   ....+..+..++.|+.+|++|||+++   |||||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999544   33455888899999999999999998   99999999999999999999999999988742


Q ss_pred             CCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                         .......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+.....                  ++-.+
T Consensus       208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------~Lr~r  266 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------ELRPR  266 (596)
T ss_pred             ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------cccch
Confidence               334456789999999999998876 57999999999999999999999853311                  11111


Q ss_pred             cccc--hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+..  ..+.-....+.+++++++-.+|.+|++++++.+.
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            1211  1223344567789999999999999999998765

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.6e-32  Score=294.96  Aligned_cols=263  Identities=21%  Similarity=0.244  Sum_probs=195.2

Q ss_pred             ccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      .+.+.+|.|+++.||+++. +++.||||++...  .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3445555566666666554 6899999998654  345567899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc---
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---  671 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---  671 (835)
                      ++|.+++... ....+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||.+........   
T Consensus        84 ~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999998543 2235788999999999999999999988   99999999999999999999999999876532211   


Q ss_pred             --cccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc----hhhhccc----
Q 003264          672 --QGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA----WNLWKDN----  739 (835)
Q Consensus       672 --~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~----~~~~~~~----  739 (835)
                        ........++..|+|||++..  ..++.++|||||||++|||++|+.||........ +....    ...+...    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhh
Confidence              111233457789999999876  3588999999999999999999999875432111 00000    0000000    


Q ss_pred             ---cchh----ccCc----cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 ---RAYE----LLSP----ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 ---~~~~----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ....    ..++    .........+...+.+++.+||+.+|++||+++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               0000    0000    01112334456678899999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-33  Score=305.90  Aligned_cols=204  Identities=30%  Similarity=0.440  Sum_probs=178.4

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------eEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------EKI  586 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~  586 (835)
                      .|...+.||+|+||.||+|+.+ .|+.||||.+... .....+...+|+++|++++|+|||+++++-.+..      ..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4556689999999999999964 5999999998764 3345677889999999999999999999866543      678


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCCC--eEecccCc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMN--PKISDFGM  662 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~--~kl~DFGl  662 (835)
                      +|||||.+|+|...|.++++...+++.+.+.++.++..||.|||+++   |+||||||.||++-  .+|+  -||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999988899999999999999999999999988   99999999999983  4454  69999999


Q ss_pred             cccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  724 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~  724 (835)
                      |+.+.++.   ......||..|++||.... +.|+..+|.|||||++||.+||..||......
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99875543   5667899999999999984 88999999999999999999999999765533

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=2.8e-32  Score=295.42  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=196.4

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----  583 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  583 (835)
                      ...++|++.+.||+|+||.||+|+... ++.||||+++...  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            456789999999999999999999864 8899999986542  233456788999999999999999999987655    


Q ss_pred             ------eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          584 ------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       584 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                            ..++|+||+++ +|..++..  ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 56566532  2346899999999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc----
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH----  731 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~----  731 (835)
                      +|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++|+...+.... .....    
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987643321 11122345778999998765 4578999999999999999999999875331110 00000    


Q ss_pred             ----chhhhccccchhccC------ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          732 ----AWNLWKDNRAYELLS------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       732 ----~~~~~~~~~~~~~~~------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          .+..+.........+      .... ......+..+.+++..|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                000000000000000      0000 011123467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=1.6e-32  Score=302.14  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=199.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  585 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999875 48999999987542  2345677889999999999999999998763    3468


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+. ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 588888743   345899999999999999999999987   99999999999999999999999999976


Q ss_pred             ccCCCcc--ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc----cccc----h
Q 003264          666 FCGDELQ--GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL----LGHA----W  733 (835)
Q Consensus       666 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~----~~~~----~  733 (835)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ..    ....    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5433221  11123478899999998765 4688999999999999999999999965432110 00    0000    0


Q ss_pred             hhhccccchhccC---cccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 NLWKDNRAYELLS---PALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ~~~~~~~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+..+   ....   .......+..+.+++.+|++.+|++||+++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000001111000   0000   01112346778999999999999999999998875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=3.1e-32  Score=291.91  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=199.5

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      |++.+.||+|++|.||+++.. +++.+++|++.....  .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 588999999865432  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 777777432  246889999999999999999999988   9999999999999999999999999998764432  


Q ss_pred             ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c-------cchhhhcc---c
Q 003264          673 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G-------HAWNLWKD---N  739 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~-------~~~~~~~~---~  739 (835)
                      .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...+.... ... .       ..+.....   .
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            112234578899999998776 789999999999999999999999865442110 000 0       00000000   0


Q ss_pred             cchhccCc--cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          740 RAYELLSP--ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       740 ~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ........  .............+.+++.+|++.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000000  0001223345678899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=287.52  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=194.4

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhc---CCCceeeEeeEEEecCe-----
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGE-----  584 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----  584 (835)
                      |++.+.||+|+||.||+|+... ++.||||++....  ......+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778999999999999999865 8999999986432  22234566788777666   59999999999998876     


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .+++|||+++ +|.+++.... ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7888774322 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-ccccc----hhhhcc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLGHA----WNLWKD  738 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~~~----~~~~~~  738 (835)
                      .+.....   .....++..|+|||.+.+..++.++||||||++++||++|.+|+........ . .....    ...+..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7633221   1223578899999999999999999999999999999999988865332110 0 00000    000000


Q ss_pred             cc--chhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          739 NR--AYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       739 ~~--~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..  .........   ...........+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00  000000000   11122344567789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=7.2e-32  Score=289.30  Aligned_cols=262  Identities=25%  Similarity=0.313  Sum_probs=195.4

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcCh-hhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      |++.+.||+|++|+||+|+..+ ++.|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6778899999999999999864 78899999865422 22334567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                       +++|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             888888875432 246899999999999999999999987   9999999999999999999999999998653322  


Q ss_pred             ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-----cccc-chhhhcc-----cc
Q 003264          673 GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-----LLGH-AWNLWKD-----NR  740 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-----~~~~-~~~~~~~-----~~  740 (835)
                       ......++..|+|||.+.. ..++.++|+||||++++||++|+.|+.........     .... ....+..     ..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             1223457889999998754 45789999999999999999999988654321100     0000 0000000     00


Q ss_pred             chhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ....+....   ...........+.+++.+|++.+|++||+++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   011111124678899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.2e-31  Score=292.38  Aligned_cols=244  Identities=29%  Similarity=0.445  Sum_probs=191.8

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      |...++||+|+||+||+|+.. .++.|++|++....   ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999875 48899999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +. ++|.+++..  ....+++..+..++.||+.+|+|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 466666632  2345889999999999999999999987   9999999999999999999999999986432    


Q ss_pred             cccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          672 QGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                        ......++..|+|||++.   ...++.++||||||+++|||++|..|+...+....  .   ...... ..     +.
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~---~~~~~~-~~-----~~  239 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQN-DS-----PT  239 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--H---HHHHhc-CC-----CC
Confidence              122356888999999974   45688999999999999999999999764331110  0   000000 00     00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   ........+.+++.+|++.+|++||++.++++.
T Consensus       240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1   111233457889999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=5.6e-32  Score=292.46  Aligned_cols=252  Identities=24%  Similarity=0.391  Sum_probs=193.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .++|++.+.||+|+||.||+|+... ++.||||++.... .....++..|+.++.+. .||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678999999999999999999865 8899999987543 23445667788777777 4999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++ +|..++...  ...+++..+..++.||++||+|||+. +   |+||||+|+||+++.++.+||+|||++..+..
T Consensus        94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 666665332  23688999999999999999999974 5   99999999999999999999999999976533


Q ss_pred             CCccccccccccccceeCceeecCCC----CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ...   .....++..|+|||.+....    ++.++||||||+++|||++|+.|+.....+. .....   .... ..   
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~---~~~~-~~---  236 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTK---ILQE-EP---  236 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHH---HhcC-CC---
Confidence            221   12235778999999987554    7889999999999999999999986432111 00000   0000 00   


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        +...  ....+...+.+++.+|++.+|++||++.++++.
T Consensus       237 --~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 --PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0000  001234568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.3e-32  Score=298.12  Aligned_cols=266  Identities=24%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  582 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  582 (835)
                      ..++...+++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4566778899999999999999999999864 58899999987532  23346688899999999999999999988643


Q ss_pred             ------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          583 ------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       583 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                            ...++++|++ +++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467788876 788888773    235889999999999999999999988   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh-
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN-  734 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-  734 (835)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...+.... +...... 
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLV  234 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence            999999876422     2233567889999998866 5688999999999999999999999864332110 0000000 


Q ss_pred             hhccccchh------------ccCccccc---hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYE------------LLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~------------~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........            .+......   +........+.+++.+|++.+|.+||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000000            00000000   0000124567899999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=2.7e-32  Score=291.78  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=202.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999975 5899999998653   2334567889999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++.+   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999843   336899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCcc------------------ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc
Q 003264          669 DELQ------------------GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  730 (835)
Q Consensus       669 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~  730 (835)
                      ....                  .......++..|+|||.+....++.++||||||++++|+++|+.|+........  ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~  232 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQ  232 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HH
Confidence            3221                  222335678999999999888899999999999999999999999875431100  00


Q ss_pred             cchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 003264          731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTM----SKVVS  784 (835)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  784 (835)
                                  ...  ......+......+.+++.+|++.+|++||++    +++++
T Consensus       233 ------------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 ------------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ------------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                        000  00111122335668899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=8e-32  Score=293.02  Aligned_cols=247  Identities=31%  Similarity=0.437  Sum_probs=194.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999999975 4788999988642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 577666632  2345789999999999999999999987   999999999999999999999999998765321


Q ss_pred             CccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                            ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+...+......     .. ...     ..
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~-~~~-----~~  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HI-AQN-----ES  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-----HH-hhc-----CC
Confidence                  2345788999999874   3568889999999999999999999976432111000     00 000     00


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  786 (835)
                      +..   ....+...+.+++.+||+.+|++||++.++++..
T Consensus       232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            111   1123445678899999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=5.2e-32  Score=294.48  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=193.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999975 48899999885432  222346788999999999999999999876543      


Q ss_pred             --eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          584 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       584 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                        ..++|+||+.. +|...+..  ....+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999976 56555533  2346899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCccc---------cccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-
Q 003264          662 MARMFCGDELQG---------NTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-  729 (835)
Q Consensus       662 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-  729 (835)
                      +++.........         ......++..|+|||.+.+. .++.++||||||++++||++|++|+........ ... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998654322111         11234668889999987654 588999999999999999999999865432110 000 


Q ss_pred             -------ccchhhhccc------cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          730 -------GHAWNLWKDN------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       730 -------~~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                             ...+..+...      .......+.+. .........+.+++.+|++.+|++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                   0000000000      00000001100 011123356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=7.2e-33  Score=277.28  Aligned_cols=205  Identities=28%  Similarity=0.391  Sum_probs=169.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC-----CcEEEEEEecCcChh--hHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  584 (835)
                      ...|+....||+|.||.|||+.-.+     .+.+|||+++.....  .-....+|+.+++.++||||+.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4679999999999999999995422     347999999765221  22456789999999999999999999988 778


Q ss_pred             EEEEEEecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC----CCeEec
Q 003264          585 KILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKIS  658 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~  658 (835)
                      ++|++||.++. |..+++.  ..+.+.++...+..|+.||+.|+.|||++=   |+||||||.||||..+    |.+||+
T Consensus       103 v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            99999999875 4455532  234467899999999999999999999986   9999999999999877    899999


Q ss_pred             ccCccccccCCCcc-ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 003264          659 DFGMARMFCGDELQ-GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVY  721 (835)
Q Consensus       659 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~  721 (835)
                      |||+++.+.+.-.. .....++-|.+|.|||.+.+. .|+.+.|||+.|||+.||++-.+-|...
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99999988654222 244567889999999999885 6899999999999999999988777643

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.3e-31  Score=286.80  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=186.5

Q ss_pred             ccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHH---HHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM---LIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .||+|+||.||+++.. .++.||+|.+....   ......+..|..   .+...+||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 48899999886532   122223344443   3444579999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|..++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   346899999999999999999999987   9999999999999999999999999987653221   


Q ss_pred             cccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                       .....|+..|+|||.+.++ .++.++||||+|++++||++|+.||............   ...      ....+.    
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~------~~~~~~----  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT------LTMAVE----  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHh------hccCCC----
Confidence             2234689999999998754 6899999999999999999999998754211110000   000      000111    


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .+...+..+.+++.+|+..+|++||     ++.++++.
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1122356788899999999999999     99999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=9.5e-32  Score=289.39  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=199.5

Q ss_pred             CCccccccccCCcccEEEEEec----CCcEEEEEEecCcC----hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      +|++.+.||+|+||.||+++..    +++.||||.+....    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999753    46789999986432    22346688999999999 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   345788999999999999999999987   99999999999999999999999999887


Q ss_pred             ccCCCccccccccccccceeCceeecCCC--CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      +...... ......++..|+|||.+.+..  .+.++||||||++++||++|..|+...+.... ........      ..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~------~~  226 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRI------LK  226 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHH------Hc
Confidence            5433211 122345789999999987665  78899999999999999999999864321110 00000000      00


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                       ..+    ..+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       227 -~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 -SKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -cCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             001    1122234567889999999999999999999888755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=5.2e-32  Score=297.43  Aligned_cols=268  Identities=25%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----eEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI  586 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  586 (835)
                      +|++.+.||+|+||.||+|+... ++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58889999999999999999754 8899999987643  345577899999999999999999999998875     789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478888743   237899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCc-cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc-----chhh---
Q 003264          667 CGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH-----AWNL---  735 (835)
Q Consensus       667 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~-----~~~~---  735 (835)
                      ..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||...+.... .....     ....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            44321 0122334678899999999888 899999999999999999999999875542210 00000     0000   


Q ss_pred             hccccchhccC---ccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          736 WKDNRAYELLS---PAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       736 ~~~~~~~~~~~---~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                      .......+.+.   ...   ...........+.+++.+||+.+|++||+++++++.  +++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            00000000000   000   001112245678899999999999999999999975  4443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=9e-32  Score=297.14  Aligned_cols=262  Identities=23%  Similarity=0.293  Sum_probs=196.3

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC---
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG---  583 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---  583 (835)
                      ....++|++.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            335678999999999999999999864 5889999998643  2334467889999999999999999999987653   


Q ss_pred             ---eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          584 ---EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       584 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                         ..++||||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               458999998 678888873    245889999999999999999999987   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc--cccc---c---
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF--NLLG---H---  731 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~---~---  731 (835)
                      |+++.....     .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||...+....  ....   .   
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999865321     223457889999998876 4588999999999999999999999875432100  0000   0   


Q ss_pred             -chhhhccccchhcc--Ccccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          732 -AWNLWKDNRAYELL--SPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       732 -~~~~~~~~~~~~~~--~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ....+.........  -+...    ..........+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00000000000000  00000    0011123456789999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.2e-32  Score=297.85  Aligned_cols=261  Identities=25%  Similarity=0.333  Sum_probs=194.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999974 5899999998653  2233456889999999999999999999987543      


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 666554     234789999999999999999999987   999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh--------
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN--------  734 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------  734 (835)
                      +....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+....  ......        
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  237 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPE  237 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence            76422     1223467889999999876 4688999999999999999999999975432110  000000        


Q ss_pred             ---hhccccchhccC--cccc-chh---HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          735 ---LWKDNRAYELLS--PALQ-HEA---SYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       735 ---~~~~~~~~~~~~--~~l~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                         .+..........  +... ...   .......+.+++.+|++.+|++||+++|+++.  ++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence               000000000000  0000 000   01234567899999999999999999999954  5554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=9.7e-32  Score=294.93  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=197.1

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCeE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEK  585 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~  585 (835)
                      ...+++|++.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+.++.+++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            345789999999999999999999865 5889999988543  22345678899999999999999999999876 4578


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||+|+||+++.++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 568888773    235788888899999999999999988   99999999999999999999999999875


Q ss_pred             ccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc----cc----chhh
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH----AWNL  735 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~----~~----~~~~  735 (835)
                      ...     ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...+.... ...    ..    ....
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            422     1223456889999998866 5689999999999999999999999865432110 000    00    0000


Q ss_pred             hccccchhccCc-cccc-----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 WKDNRAYELLSP-ALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ~~~~~~~~~~~~-~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +......+++.. ....     .........+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000 0000     0111234678899999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-33  Score=278.00  Aligned_cols=270  Identities=23%  Similarity=0.285  Sum_probs=212.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      -++|..+++||+|.||.|.+++.+. ++.+|||++++..   ......-..|-++|...+||.+..|...|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4789999999999999999998754 8899999998753   33445567788999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||..+|.|..+|   ++...+++.....+-..|+.||.|||+++   ||.||||.+|.|+|.+|++||+|||+++.-. 
T Consensus       247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            9999999998888   45567888888889999999999999988   9999999999999999999999999998531 


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                       .....+...+||+.|+|||++.+..|....|.|.+||++|||++|+.||-..+.+..               ++++.-.
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---------------FeLIl~e  383 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---------------FELILME  383 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---------------HHHHHhh
Confidence             234556778999999999999999999999999999999999999999875443321               1111000


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHhh-----------cccCCCCCCCCCccccccc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP--TMSKVVSMIT-----------NEHATLPYPKQSAFSYARR  806 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~-----------~~~~~l~~p~~~~~~~~~~  806 (835)
                       .-..+.....+...|+...|..||.+|.  ..+++.+..+           -..+.+++|..|-....+.
T Consensus       384 -d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetD  453 (516)
T KOG0690|consen  384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETD  453 (516)
T ss_pred             -hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccc
Confidence             0012333445566788889999999996  3344443321           1224667776665444433

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1.7e-31  Score=287.69  Aligned_cols=252  Identities=24%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             CCccccccccCCcccEEEEEe----cCCcEEEEEEecCcC----hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      +|++.+.||+|+||.||+++.    .+|+.||+|++....    ....+++.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    358899999986532    22346788999999999 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999843   345788999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccccceeCceeecCC--CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ....... ......|+..|+|||.+...  .++.++||||||+++|||++|+.|+....... ...........      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~------  226 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILK------  226 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhc------
Confidence            5332211 12235688999999998753  47789999999999999999999986422110 00000000000      


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                       ..    ...+......+.+++.+|++.+|++||     +..+++..
T Consensus       227 -~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 -SE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -cC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence             00    111223445678899999999999997     56666543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=6.5e-32  Score=298.21  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=194.6

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec---------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ---------  582 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------  582 (835)
                      ..+|++.+.||+|+||.||+|+.. .++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999875 4889999998766556667889999999999999999999776543         


Q ss_pred             -----CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeE
Q 003264          583 -----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPK  656 (835)
Q Consensus       583 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~k  656 (835)
                           ...++|+||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 58887773    235889999999999999999999987   999999999999974 56789


Q ss_pred             ecccCccccccCCCcc-ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccch
Q 003264          657 ISDFGMARMFCGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW  733 (835)
Q Consensus       657 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~  733 (835)
                      |+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999765322111 11122357889999997654 5688899999999999999999999965431110 0000000


Q ss_pred             hhhcc---ccch-----hcc----Cccc-cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 NLWKD---NRAY-----ELL----SPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ~~~~~---~~~~-----~~~----~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....   ....     ...    .+.. ...........+.+++.+|++.+|++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000   0000     000    0000 000111234567899999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=2.1e-31  Score=293.36  Aligned_cols=263  Identities=24%  Similarity=0.309  Sum_probs=194.9

Q ss_pred             cCCcc-ccccccCCcccEEEEEec-CCcEEEEEEecCcChhh--------------HHHHHHHHHHHHhcCCCceeeEee
Q 003264          514 ENFSM-QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       514 ~~~~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      ++|.. .+.||+|+||+||+|++. .++.||||.+.......              ...+.+|++++.+++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            56654 467999999999999975 58899999886432211              125778999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       578 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      ++...+..++||||++ ++|.+++..   ...+++.....++.|+++||+|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 588888742   345889999999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCc------------cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcc
Q 003264          658 SDFGMARMFCGDEL------------QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  724 (835)
Q Consensus       658 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~  724 (835)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||++++||++|+.|+...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986642110            1111223467889999998764 4789999999999999999999998754422


Q ss_pred             cccccccchhh--------hccc---cchhccCcccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          725 SFNLLGHAWNL--------WKDN---RAYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       725 ~~~~~~~~~~~--------~~~~---~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..  .......        |...   .......+...   ..........+.+++..|++.+|++||+++|++..
T Consensus       241 ~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 DQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            11  0000000        0000   00000000000   01112234668899999999999999999999964

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.3e-31  Score=283.69  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCc-----ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      +|.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58888999999999999998754 445556655421     222344677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      +||+++++|..++... .....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888532 23456899999999999999999999987   999999999999975 569999999997764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......  .   ....      .....+
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~---~~~~------~~~~~~  223 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--V---VLRI------VEGPTP  223 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--H---HHHH------HcCCCC
Confidence            322  12233467889999999988889999999999999999999999985322110  0   0000      000111


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ..+..+...+.+++.+|++.+|++||++.|+++.
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                1223445678889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=284.98  Aligned_cols=261  Identities=26%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      |+..+.||+|++|.||+|+... ++.||+|++....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5677899999999999999865 8999999987653  334567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      + ++|.+++....  ..+++..+..++.|+++||+|||+.+   |+||||+|+||+++.++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58998885321  46889999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-cc-------ccchhhhcccc--
Q 003264          673 GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LL-------GHAWNLWKDNR--  740 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~-------~~~~~~~~~~~--  740 (835)
                       ......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ . ..       ...+..+....  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12223457789999998776 889999999999999999999999865432110 0 00       00000000000  


Q ss_pred             --chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 --AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 --~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        ....................+.+++..|++.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              00000000000111122567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-33  Score=276.39  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=196.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++.+.+..||.|.||+|+|-.++ .|+..|||++.... +...++++.|.+...+- +.||||+++|.+..++..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            45556678999999999999875 49999999997654 35677888999887766 78999999999999999999999


Q ss_pred             ecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          591 YMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       591 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      .|. .+|+.+-..  ..+...+++...-.|+....+||.||....  .|||||+||+||||+..|.+||+|||++..+.+
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            994 455544311  123456888888889999999999998754  699999999999999999999999999976533


Q ss_pred             CCccccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .-   ..+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+.|+...+.-    .++.... ..++.     
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~V-v~gdp-----  287 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQV-VIGDP-----  287 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHHH-HcCCC-----
Confidence            21   1223467789999999854  35899999999999999999999998765521    1111111 11111     


Q ss_pred             cccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      |.+. .....+++..+..++.-|+.+|..+||.+.++.++
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1221 12234567788899999999999999999999865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.2e-31  Score=290.53  Aligned_cols=264  Identities=24%  Similarity=0.289  Sum_probs=192.1

Q ss_pred             CCccccccccCCcccEEEEEecC---CcEEEEEEecCc--ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec----Ce
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ----GE  584 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~  584 (835)
                      +|++.+.||+|+||.||+++...   ++.||||++...  .....+.+.+|+.++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47888999999999999999743   678999998643  222356788899999999 599999999976533    35


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788889886 57888773   3346889999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcc--ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccc--------cc
Q 003264          665 MFCGDELQ--GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLG--------HA  732 (835)
Q Consensus       665 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~--------~~  732 (835)
                      .+......  .......|+..|+|||.+.+ ..++.++||||||+++++|++|+.|+...+.... ....        ..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            66432211  11233568999999998765 4689999999999999999999999875432110 0000        00


Q ss_pred             hhhhccccchhc---cC--ccc-cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 WNLWKDNRAYEL---LS--PAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 ~~~~~~~~~~~~---~~--~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+........   ..  +.. ...........+.+++.+|++.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000   00  000 000011124568899999999999999999998744

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=295.31  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=197.0

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe----
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  584 (835)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999985 4789999998653  22344667889999999999999999998876654    


Q ss_pred             --EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          585 --KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       585 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                        .++|+||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5689888742    45899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-ccc---cc----
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLG---HA----  732 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~---~~----  732 (835)
                      +......     .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...+.... . +..   ..    
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9865322     233467889999998865 3678999999999999999999999865432110 0 000   00    


Q ss_pred             hhhhccccchhccC---ccccc---hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 WNLWKDNRAYELLS---PALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 ~~~~~~~~~~~~~~---~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+........+.   .....   .....+...+.+++.+|++.+|++||++.||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000000000   00000   0111235678899999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=281.02  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-------ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  584 (835)
                      ++|-++++||+|||+.|||+.+. ..+.||||+-...       .+...+...+|..+.+.|+||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            67888999999999999999864 4788999985322       12234557789999999999999999999874 457


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc---CCCCeEecccC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFG  661 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFG  661 (835)
                      .+-|+|||++.+|+.||+   ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||.   .-|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence            789999999999999994   4567899999999999999999999874 7899999999999994   45789999999


Q ss_pred             ccccccCCCcc-----ccccccccccceeCceeecCC----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc
Q 003264          662 MARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDG----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       662 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~  732 (835)
                      |++++.++.+.     ..+....||.+|++||.+.-+    .++.|+||||.|||+|..+.|+.||+..... .+++...
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqeN  697 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQEN  697 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhhh
Confidence            99998765443     223456899999999988544    5788999999999999999999999853322 2222111


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                       .+++...+        .....+....+...+|++||+..-++|....++.
T Consensus       698 -TIlkAtEV--------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  698 -TILKATEV--------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -chhcceec--------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             11111111        1111223345567899999999999998776654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=296.12  Aligned_cols=257  Identities=22%  Similarity=0.372  Sum_probs=210.1

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe-----
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE-----  581 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----  581 (835)
                      +...++.|++.+.||.|.+|.||+++.. +++.+|||++... ....+++..|.++|+.+ +|||++.++|++..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            3344678999999999999999999864 5888999998654 33456778899999988 79999999999985     


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      +++++||||||.+|+..++++... ...+.|..+..|++.++.||.+||.+.   ++|||||-.|||++.++.+||.|||
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence            468999999999999999997765 667899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ++..+.  ..........||+.|||||++...     .|+.++|+||||++..||.-|.+|.-.+-..        ..++
T Consensus       169 vSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF  238 (953)
T KOG0587|consen  169 VSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALF  238 (953)
T ss_pred             eeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhc
Confidence            998763  233444567899999999998543     4788999999999999999999997532211        0111


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   +.+  .|......+....+++.++|..|+..|.++||++.++++.
T Consensus       239 ~---IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  239 L---IPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             c---CCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            1   111  2222233467788999999999999999999999998864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-31  Score=275.59  Aligned_cols=236  Identities=27%  Similarity=0.335  Sum_probs=191.9

Q ss_pred             cccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ||+|+||.||+++... ++.+|+|.+....   ....+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999754 8899999986543   23456889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR  677 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  677 (835)
                      .+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9998432   35889999999999999999999987   9999999999999999999999999998754322  12334


Q ss_pred             cccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       678 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      ..++..|+|||.+.+...+.++|+||||+++|||++|+.|+...+....  ..   ....         .  ....+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~---~~~~---------~--~~~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI--YE---KILK---------D--PLRFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HHhc---------C--CCCCCCCC
Confidence            5678899999999888899999999999999999999999865432110  00   0000         0  01111122


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHH
Q 003264          758 LNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      ...+.+++.+|+..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            466788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=267.51  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=198.9

Q ss_pred             cccccCCcccEEEEE-ecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          520 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      +.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++... .|+||+.|+++|+++...|||||-|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            589999999999886 467999999999998888889999999999999 599999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecccCccccccCC-----
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGD-----  669 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~-----  669 (835)
                      ..++.   +...+++.++.++.++|+.||.+||.++   |.||||||+|||-.+...   +||+||.+..-+...     
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99984   3456899999999999999999999998   999999999999976654   899999887543211     


Q ss_pred             CccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch--
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY--  742 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  742 (835)
                      .........+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||...-...-        -|..+..-  
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~  309 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV  309 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence            1112233568899999999762     23688999999999999999999999986543221        12211111  


Q ss_pred             ------hccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          743 ------ELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       743 ------~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                            +-+....   +...-...+....+++...+-.++.+|-++.++++
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  1111111   11222345566778999999999999999999887

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=290.80  Aligned_cols=241  Identities=23%  Similarity=0.247  Sum_probs=197.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .++.|++...+|.|+|+.|-.+... +++..+||++.+...    +..+|+.++.+. +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3688999999999999999998864 488999999976622    234577666666 7999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE-cCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~  668 (835)
                      |.+.++.|.+-+...    ......+..|+.+|+.|+.|||+++   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999887766322    2223777889999999999999988   9999999999999 6999999999999987644


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .     ....+-|..|.|||++....|++++|+||||++||+||+|+.|+...+.+ .                ++....
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~----------------ei~~~i  526 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I----------------EIHTRI  526 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H----------------HHHHhh
Confidence            3     23345688999999999999999999999999999999999999865533 1                111111


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+......+....+|+.+||+.||.+||+|.++...
T Consensus       527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            2233335667778899999999999999999999854

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.3e-30  Score=310.36  Aligned_cols=146  Identities=28%  Similarity=0.410  Sum_probs=131.4

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.++||+|+||.||+|++. .++.||||++....   ....+.+.+|+.++..++||||+++++++......+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999986 58899999986532   33457788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      |||+++++|.+++..   ...+++..++.++.||+.||+|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999843   345788999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=244.93  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=191.2

Q ss_pred             CCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +|...++||+|.||+||||+..+ ++.||+|++.-.  ++.......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            56677899999999999999755 788999987543  333456678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      |.. .|..+..  +-++.++.+.+..++.|+++||.++|+++   +.||||||+|.||+.+|++|++|||+++.+.-.  
T Consensus        83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--  154 (292)
T ss_pred             hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence            954 5655542  24556888999999999999999999998   999999999999999999999999999976321  


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCC-CCCCCcccc-cccccchhhhcccc---chhcc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESF-NLLGHAWNLWKDNR---AYELL  745 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~  745 (835)
                      -......+.|.+|.+|.++.+. .|+...|+||.||++.|+....+| |...+.+.. ...-+......++.   +..+.
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            1223334679999999999886 589999999999999999885544 555443221 11100000001111   11111


Q ss_pred             C----ccccch-----hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 S----PALQHE-----ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~----~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      |    |.....     .-+.....=.+++...+.-+|.+|.++++.++.
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1    111111     111112223467777777899999999987753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=282.97  Aligned_cols=242  Identities=26%  Similarity=0.350  Sum_probs=195.5

Q ss_pred             cccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCC
Q 003264          520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      +.||+|-||+||-|+++ .|+.||||++.+..  ......+++|+.+|..++||.||.|-..|+..+..++|||-+.+.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            78999999999999975 59999999997652  3345789999999999999999999999999999999999997666


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCccccccCCCccc
Q 003264          597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      |.-+|.  +....+++.....++.||+.||.|||.++   |+|+||||+|||+.+   -.++||+|||+|+++.....  
T Consensus       650 LEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  650 LEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             HHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            655553  34456888888899999999999999998   999999999999964   35799999999999854332  


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                       ...++||+.|+|||++.++.|...-|+||.|||+|--++|..||...+.....+..           ..++   .....
T Consensus       723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-----------AaFM---yPp~P  787 (888)
T KOG4236|consen  723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-----------AAFM---YPPNP  787 (888)
T ss_pred             -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-----------cccc---cCCCc
Confidence             34578999999999999999999999999999999999999999854322111111           1111   12223


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                      -.+.....+++|...||..-++|-+..+-+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            345566678888888888888888877654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=261.04  Aligned_cols=254  Identities=20%  Similarity=0.237  Sum_probs=199.1

Q ss_pred             hhcCCccc-cccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe----cCe
Q 003264          512 ATENFSMQ-CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGE  584 (835)
Q Consensus       512 ~~~~~~~~-~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  584 (835)
                      .+++|++. ++||-|-.|.|-....+. |+.+|+|++...     ...++|+++.-+. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            46777765 579999999999998754 889999998643     4457888887776 69999999999874    346


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG  661 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG  661 (835)
                      +++|||.|+||.|..-+.+. ....+.+.++..|+.||..|+.|||+.+   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999998887543 4456899999999999999999999998   999999999999964   5579999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +|+....   .......+-|+.|.|||++-...|+...|+||+||++|-|++|.+||-..-.  ..+..-....+..+. 
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gq-  283 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQ-  283 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccC-
Confidence            9987432   3344556789999999999999999999999999999999999999843211  111100000011010 


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +     .+....-.+.++...++|+.+|..+|++|.++.|++..
T Consensus       284 y-----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 Y-----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             c-----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            1     12334455677888999999999999999999999865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=305.41  Aligned_cols=260  Identities=21%  Similarity=0.240  Sum_probs=207.9

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      ...+....++|+++++||+|+||.|..++.+. ++.||+|++++-   ......-|..|-.+|..-+.+-|+.|+-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34555667899999999999999999999865 788999999863   33455779999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      ..++|+||||++||+|..++.+.   ..+++..+..++..|.-||..||+.|   +|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999999433   36899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeec----C-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYAL----D-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      .+-.+..+. .......+|||.|++||++.    + +.|+...|.||+||++|||+.|..||-...     +.+....++
T Consensus       221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm  294 (1317)
T KOG0612|consen  221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIM  294 (1317)
T ss_pred             hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHh
Confidence            987765333 33345578999999999984    2 579999999999999999999999986432     122112222


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT---MSKVVSM  785 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  785 (835)
                      ..+....+.+       ....+....+||...+. +|+.|-.   ++++...
T Consensus       295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  295 NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            2222222221       12245666777777665 6788887   8888754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2e-30  Score=270.92  Aligned_cols=220  Identities=19%  Similarity=0.109  Sum_probs=175.6

Q ss_pred             CCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhhhhcC
Q 003264          525 GGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD  603 (835)
Q Consensus       525 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  603 (835)
                      |.+|.||++++. +++.||+|++....     .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999985 48899999987643     233455556666799999999999999999999999999999998843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccc
Q 003264          604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG  683 (835)
Q Consensus       604 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  683 (835)
                      .   ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++++|||++......     .....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            2   34889999999999999999999987   999999999999999999999999988765322     122345678


Q ss_pred             eeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHH
Q 003264          684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  763 (835)
Q Consensus       684 y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  763 (835)
                      |+|||.+....++.++||||+|++++||++|+.|+........           ...  .       ...+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~~~--~-------~~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------THT--T-------LNIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------ccc--c-------cCCcccCCHHHHH
Confidence            9999999888899999999999999999999987643211100           000  0       0111223456788


Q ss_pred             HHHhccccCCCCCCCHH
Q 003264          764 VALLCVQEKAADRPTMS  780 (835)
Q Consensus       764 li~~cl~~dP~~RPs~~  780 (835)
                      ++.+|++.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=273.31  Aligned_cols=242  Identities=24%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  586 (835)
                      ...+|..+.+||+|+||.|.++..+. .+.+|||++++..   ....+--+.|-++|+.. +-|.++.++.++..-+.++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34678899999999999999997654 5679999997652   22333445677788777 6789999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+.+|+|-.++   ++-+.+.+..+..++..||-||-+||+++   ||.||||..||||+.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999998777   34456778888999999999999999998   999999999999999999999999999853


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .  .....+...+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..+.+..-.              .+.+
T Consensus       501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------aI~e  564 (683)
T KOG0696|consen  501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------AIME  564 (683)
T ss_pred             c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------HHHH
Confidence            2  12334567899999999999999999999999999999999999999999766443210              1111


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                      ..  -.++...+.+...+....+...|.+|.
T Consensus       565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            11  123445566777788888899999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.3e-31  Score=260.98  Aligned_cols=266  Identities=23%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--------
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--------  582 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  582 (835)
                      ..|+-..+||+|.||+||+++..+ |+.||+|++--.  .+.-.....+|+++|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            456677899999999999999755 788999875322  222234457899999999999999999988643        


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ...++||.+|++ +|.-+|.+  ....++..++.+++.++..||.|+|...   |+|||+||.|+||+.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            357999999976 56666633  3345888999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcc--ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccc--------cc
Q 003264          663 ARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNL--------LG  730 (835)
Q Consensus       663 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~--------~~  730 (835)
                      ++.+...+..  ...+..+.|.+|.+||.+.+. .|+++.|||..|||+.||+++.+-++.....+ ..+        ..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9877543321  222345669999999998875 79999999999999999999998876543221 111        11


Q ss_pred             cchhhhccccchhccC-ccccc---hhHHHHH------HHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          731 HAWNLWKDNRAYELLS-PALQH---EASYQML------NRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       731 ~~~~~~~~~~~~~~~~-~~l~~---~~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+|....+-...+.+. +.+..   ..-.+..      ...++++..++..||.+|+.+++++..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            2233222222222221 00111   0111111      256789999999999999999998865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.9e-29  Score=262.66  Aligned_cols=238  Identities=29%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             CcccEEEEEecC-CcEEEEEEecCcChhh-HHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhhhhcC
Q 003264          526 GFGPVYKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD  603 (835)
Q Consensus       526 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  603 (835)
                      +||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999865 8999999997665444 68899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccc
Q 003264          604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG  683 (835)
Q Consensus       604 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  683 (835)
                      ..   .+++..+..++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2789999999999999999999987   9999999999999999999999999998764332   2334567889


Q ss_pred             eeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHH
Q 003264          684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  763 (835)
Q Consensus       684 y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  763 (835)
                      |++||.+....++.++||||||++++||++|..|+........ ...    ....... .      ...........+.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~----~~~~~~~-~------~~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFK----KIGKPKP-P------FPPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHH----HHhccCC-C------CccccccCCHHHHH
Confidence            9999999888899999999999999999999999865321110 000    0000000 0      00000004467888


Q ss_pred             HHHhccccCCCCCCCHHHHHH
Q 003264          764 VALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       764 li~~cl~~dP~~RPs~~evl~  784 (835)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.1e-29  Score=283.15  Aligned_cols=265  Identities=20%  Similarity=0.281  Sum_probs=180.7

Q ss_pred             hhcCCccccccccCCcccEEEEEe-----------------cCCcEEEEEEecCcChhhHHH--------------HHHH
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-----------------LNGQEVAVKRLSSQSGQGLKE--------------FKNE  560 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E  560 (835)
                      ..++|++.++||+|+||.||+|.+                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235679999986543322233              3347


Q ss_pred             HHHHHhcCCCce-----eeEeeEEEe--------cCeEEEEEEecCCCChhhhhcCCCC---------------------
Q 003264          561 MMLIAKLQHRNL-----VRLMGCCVE--------QGEKILIYEYMPNKSLNFFLFDPSR---------------------  606 (835)
Q Consensus       561 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------  606 (835)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876654     677777753        3568999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeC
Q 003264          607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS  686 (835)
Q Consensus       607 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  686 (835)
                      ...+++..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123467788899999999999999987   99999999999999999999999999976533221 11112234789999


Q ss_pred             ceeecCCC--------------------C--CccccchhHHHHHHHHHhCCC-CCCCCCccccccc--ccchhhhccccc
Q 003264          687 PEYALDGL--------------------F--SVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLL--GHAWNLWKDNRA  741 (835)
Q Consensus       687 PE~~~~~~--------------------~--s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~--~~~~~~~~~~~~  741 (835)
                      ||.+....                    +  ..+.||||+||+++||++|.. |+.....-...+.  ......|+....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875432                    1  134799999999999999875 5542210000000  000011110000


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKA---ADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  785 (835)
                      ..     ..-...........+++.+++..+|   .+|+|++|+++.
T Consensus       459 ~~-----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QK-----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cC-----CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00     0001112234567789999998765   689999999854

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.5e-29  Score=292.20  Aligned_cols=261  Identities=20%  Similarity=0.220  Sum_probs=167.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-----CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeE------EE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC------CV  580 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~  580 (835)
                      ..++|++.++||+|+||.||+|++.+     +..||||++......  +....|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     689999998643221  111111  1112222222222211      24


Q ss_pred             ecCeEEEEEEecCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC
Q 003264          581 EQGEKILIYEYMPNKSLNFFLFDPSRT-----------------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  643 (835)
Q Consensus       581 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  643 (835)
                      +....++|+||+++++|.+++......                 .......+..++.||+.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566899999999999999988543210                 01123345679999999999999987   9999999


Q ss_pred             CCeEEEcC-CCCeEecccCccccccCCCccccccccccccceeCceeecCC----------------------CCCcccc
Q 003264          644 ASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG----------------------LFSVKSD  700 (835)
Q Consensus       644 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD  700 (835)
                      |+|||++. ++.+||+|||+++.+.... ........+++.|||||.+...                      .+..++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 5899999999998653322 1122345789999999965332                      2345679


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCccccccc---ccchhhhccccchhccCccccch------hHHHHHHHHHHHHHhcccc
Q 003264          701 VFSFGVLLLETLTSKRNTGVYDIESFNLL---GHAWNLWKDNRAYELLSPALQHE------ASYQMLNRYITVALLCVQE  771 (835)
Q Consensus       701 VwSlGvvl~elltG~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~  771 (835)
                      ||||||+||||+++..+.......-....   ......|     .....+....+      ..........+|+.+|++.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW-----RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHH-----HHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999997766432100000000   0000000     00111110000      0001122345899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 003264          772 KAADRPTMSKVVSM  785 (835)
Q Consensus       772 dP~~RPs~~evl~~  785 (835)
                      ||++|||++|+++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999975

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-30  Score=263.40  Aligned_cols=267  Identities=21%  Similarity=0.232  Sum_probs=201.2

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-C-C----ceeeEeeEEE
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-R----NLVRLMGCCV  580 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~  580 (835)
                      .....+++|.+..++|+|.||.|-+..+.. +..||||+++.- ....+..+-|+++|.++. + |    -+|.+.+++.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            334457899999999999999999998754 688999998643 344566788999999993 3 2    3778888899


Q ss_pred             ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---------
Q 003264          581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---------  651 (835)
Q Consensus       581 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---------  651 (835)
                      ..++.++|+|.+ +-++.++|... ....++...+..|+.|+++++++||+..   ++|-||||+|||+.+         
T Consensus       162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence            999999999998 55888888543 3456888999999999999999999987   999999999999931         


Q ss_pred             -----------CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003264          652 -----------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV  720 (835)
Q Consensus       652 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~  720 (835)
                                 +..+||+|||.|..-..     ....++.|..|.|||++.+-.++.++||||+||||+|+.+|..-|+.
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       23589999999986432     22557889999999999999999999999999999999999988876


Q ss_pred             CCc-ccccccccc-----hhhhccc---------c-----------chhccCcccc----chhHHHHHHHHHHHHHhccc
Q 003264          721 YDI-ESFNLLGHA-----WNLWKDN---------R-----------AYELLSPALQ----HEASYQMLNRYITVALLCVQ  770 (835)
Q Consensus       721 ~~~-~~~~~~~~~-----~~~~~~~---------~-----------~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~  770 (835)
                      .+. +...+.+..     ..++...         +           .....++...    ......+...|.+|+..+|.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            652 211111100     0000000         0           0000110000    11233456679999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 003264          771 EKAADRPTMSKVVSM  785 (835)
Q Consensus       771 ~dP~~RPs~~evl~~  785 (835)
                      .||.+|+|+.|+++.
T Consensus       392 fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  392 FDPARRITLREALSH  406 (415)
T ss_pred             cCccccccHHHHhcC
Confidence            999999999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=255.08  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|.++++||+|+|++|..+++.. .+.+|+|++++.   ..+..+-.+.|-.+...- +||.+|-|+.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4789999999999999999999865 678999998764   334455567777777766 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |.||+++|+|-.++   ++...++++.+..+...|.-||.|||+.+   ||.||||..|||+|..|++||.|+|+.+.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999986555   56677999999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcc--cccccccchhhhccccchhcc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE--SFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  745 (835)
                        .....+...+||+.|+|||++.+..|....|.|+|||+++||+.|+.||+.-..+  ..+--++....        ++
T Consensus       403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il  472 (593)
T KOG0695|consen  403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL  472 (593)
T ss_pred             --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence              2234456789999999999999999999999999999999999999999754321  11111111111        11


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                      .+.++  .+...+-+...++..-+.+||.+|.
T Consensus       473 ekqir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  473 EKQIR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence            11111  2233344556678888999999884

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.96  E-value=4.7e-30  Score=233.04  Aligned_cols=110  Identities=51%  Similarity=0.808  Sum_probs=83.4

Q ss_pred             CCeeEEecCCCCCCcCC--CceEEEecCCceEEecCCCceEEee-cCCCCc-cCceEEEecCCCeEEEeccCCCCCCCce
Q 003264           70 PDTVVWVANRNSPIVDS--NAVLTIGNNGNLVLLNQTDGIIWSS-NLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSY  145 (835)
Q Consensus        70 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~  145 (835)
                      ++||||+|||+.|+.+.  ..+|.|+.||||+|++..++++|++ ++.+.+ ....|.|+|+|||||++.      .+++
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~------~~~~   74 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS------SGNV   74 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET------TSEE
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee------cceE
Confidence            46999999999999653  4889999999999999999999999 666555 578899999999999985      6789


Q ss_pred             eEeecCCCCcccccccccccccccCcceeeEeecCCCCCC
Q 003264          146 LWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS  185 (835)
Q Consensus       146 ~WqsFd~PTDTlLpg~~l~~~~~tg~~~~L~Sw~s~~dps  185 (835)
                      |||||||||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus        75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999999999999988888888899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=239.99  Aligned_cols=209  Identities=27%  Similarity=0.381  Sum_probs=172.0

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ++...+...-+..||+|++|.|-+-++. +|...|+|++... ..+..++..+|+.+..+. ..|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3445566777789999999999988874 5899999999765 455667788899888776 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          586 ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      ++.||.|. .+|+.+-.+ -++...+++...-+|+..+.+||.|||++-  .+||||+||+||||+.+|++|++|||++.
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999994 566655432 245567899999999999999999999864  69999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecC----CCCCccccchhHHHHHHHHHhCCCCCCCCCc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALD----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDI  723 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~  723 (835)
                      .+.+.-   ..+...|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|+.....
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            764321   1122356789999998854    4689999999999999999999999876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-29  Score=280.41  Aligned_cols=246  Identities=27%  Similarity=0.360  Sum_probs=189.4

Q ss_pred             CccccccccCCccc-EEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEecC
Q 003264          516 FSMQCKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       516 ~~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      |.-.+.+|.|+-|+ ||+|.. +|++||||++-..   .....++|+..|+.- +|||||++++.-.+.+..||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            34446789998875 699988 6889999998543   334567899999998 79999999999999999999999995


Q ss_pred             CCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---C--CCeEecccCcccccc
Q 003264          594 NKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D--MNPKISDFGMARMFC  667 (835)
Q Consensus       594 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~  667 (835)
                       -+|++++... ...........+.+..|+++||++||+.+   ||||||||+||||..   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5899998553 11111122456788999999999999987   999999999999975   3  468999999999986


Q ss_pred             CCCccc-cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhC-CCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQG-NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .+.... ......||-+|+|||++....-+.++||||+||++|+.++| .+||+..-..+.+++.....+       ..+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L-------~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL-------VHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce-------eee
Confidence            654332 24557899999999999999888999999999999999997 799985443333333211111       111


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .    .  ..++  ...+||.+|+..+|..||++.+|+.
T Consensus       736 ~----~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 E----P--LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             c----c--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1    1  0111  5678999999999999999999983

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=274.48  Aligned_cols=274  Identities=22%  Similarity=0.260  Sum_probs=217.7

Q ss_pred             hcCCccccccccCCcccEEEEEecCCc-EEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..+++.+..||-|+||.|=+++.+... .+|+|++++.   +....+.+..|-.+|...+.|.||+|+-.|.+.+..|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            356677788999999999999886544 4899988765   334456788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||-|-+|.|...|.+   .+.++......++..+.+|++|||.++   ||.|||||+|.+|+.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            999999999999944   456788888899999999999999998   99999999999999999999999999998754


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc-ccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .   ..+-..+||+.|.|||++.++.++..+|.||||++++||++|.+||...+... +++.-      +.-+.      
T Consensus       573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------kGid~------  637 (732)
T KOG0614|consen  573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------KGIDK------  637 (732)
T ss_pred             C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------hhhhh------
Confidence            3   34556899999999999999999999999999999999999999998765321 11110      00011      


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH--hh-----cc-cCCCCCCCCCcccccccCccc
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM--IT-----NE-HATLPYPKQSAFSYARRGEKI  810 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~--L~-----~~-~~~l~~p~~~~~~~~~~~~~~  810 (835)
                         -..+........+++.+.+..+|.+|..     ..+|.+.  ++     ++ ...+++|-.+....+......
T Consensus       638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~F  710 (732)
T KOG0614|consen  638 ---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNF  710 (732)
T ss_pred             ---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhc
Confidence               1233444566778999999999999986     5566544  22     22 246777777776666655443

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.9e-28  Score=264.92  Aligned_cols=204  Identities=24%  Similarity=0.352  Sum_probs=174.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..-|..++.||-|+||+|.+++-.+ ...+|+|.|.+.+   .......+.|-.||+.-+.+-||+|+-.|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3567788899999999999997654 5678999987654   33456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc-
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~-  667 (835)
                      |||++||++-.+|.   +.+.+++..+..++..+..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+. 
T Consensus       708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            99999999999984   5567889999999999999999999998   9999999999999999999999999985331 


Q ss_pred             --CCCcc---------------------c----------------cccccccccceeCceeecCCCCCccccchhHHHHH
Q 003264          668 --GDELQ---------------------G----------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL  708 (835)
Q Consensus       668 --~~~~~---------------------~----------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl  708 (835)
                        +..+.                     .                .-...+||..|+|||++....|+..+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence              00000                     0                00135799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 003264          709 LETLTSKRNTGVYD  722 (835)
Q Consensus       709 ~elltG~~p~~~~~  722 (835)
                      |||+.|+.||-...
T Consensus       862 ~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHhhCCCCccCCC
Confidence            99999999997544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.2e-26  Score=233.46  Aligned_cols=210  Identities=36%  Similarity=0.589  Sum_probs=183.2

Q ss_pred             cccCCcccEEEEEecC-CcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhh
Q 003264          522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF  599 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  599 (835)
                      ||+|.+|.||+++... ++++++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999998765432 45789999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCccccccCCCcccccccc
Q 003264          600 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRV  678 (835)
Q Consensus       600 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  678 (835)
                      ++....  ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            984321  35789999999999999999999997   999999999999999 89999999999987643321  22335


Q ss_pred             ccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHH
Q 003264          679 VGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM  757 (835)
Q Consensus       679 ~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  757 (835)
                      .+...|++||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999998877 888999999999999998                                              


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          758 LNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       758 ~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-29  Score=244.60  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=189.8

Q ss_pred             ccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CeEEEE
Q 003264          517 SMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEKILI  588 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV  588 (835)
                      +-.+.||-|+||.||.+++. +|+.||+|++..-  .-...+++.+|+++|..++|.|++..++...-.     ++.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34478999999999999974 5999999998643  233567889999999999999999998876533     356788


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +|.| ..+|..++.   ....++...+.-+.+||++||.|||+.+   |.||||||.|.|++++..+||+|||+++....
T Consensus       136 TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            8887 446776663   3345777888889999999999999988   99999999999999999999999999997644


Q ss_pred             CCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCC-ccccccc----cc-----chhhhc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLL----GH-----AWNLWK  737 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~----~~-----~~~~~~  737 (835)
                      ++ ...++..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+.-|+..+ .++.++.    ..     ...-.+
T Consensus       209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            33 2334445678999999999885 69999999999999999998877666544 2222111    10     000000


Q ss_pred             cccchhccCccccc--------hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          738 DNRAYELLSPALQH--------EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       738 ~~~~~~~~~~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ..+..-+-.+...+        ..+...-.+..++...++..+|+.|.+..+.+..+.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            00000000000000        011122234566778899999999999998887653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=9e-28  Score=231.20  Aligned_cols=254  Identities=20%  Similarity=0.309  Sum_probs=194.4

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEec--CeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~l  587 (835)
                      ..++|++.+++|+|.|++||.|.. .+.+.++||++++-   ..+.+++|+++|..|. ||||++|+++..+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            357899999999999999999985 56789999999753   3467889999999996 99999999998865  46789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMF  666 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~  666 (835)
                      |+||+.+.+...+-      ..+...++..++.++++||.|+|+.|   |.|||+||.|++||.. -.++|+|+|+|.+.
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998876554      34777888999999999999999998   9999999999999865 56999999999887


Q ss_pred             cCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh----------
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL----------  735 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~----------  735 (835)
                      .+.....   ..+.+..|.-||.+.+ ..|+..-|+|||||+|.+|+..+.||-.......++...+..+          
T Consensus       184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            5543222   2345678889998866 4688899999999999999999999865443322222211110          


Q ss_pred             ----------------hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          736 ----------------WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       736 ----------------~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                                      ........++.+...+    -...+.++++...+..|-.+|||++|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence                            0011111222211111    12356788999999999999999998764

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.94  E-value=5.2e-27  Score=212.76  Aligned_cols=108  Identities=36%  Similarity=0.865  Sum_probs=101.1

Q ss_pred             EeecCCCCcccccCCCCcc--ccccceeecccceEEEEEEecCCceeeEEEEccCCcEEEEEEEecCCceEEEEeecCCC
Q 003264          211 SCTGPWNGLAFGADPTNTS--YLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNF  288 (835)
Q Consensus       211 ~~~g~w~g~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~  288 (835)
                      ||+|||||..|.++|++..  .+.+.++.+ .+|.+|+|...+.++++|++||.+|++++|.|++..++|.+.|++|.++
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~-~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~   79 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSN-NEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ   79 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEEC-CCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence            8999999999999999874  566667766 8999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCccccCCCCCcccccccccccc
Q 003264          289 CQLYGYCGANSVCSVDDTANCECLKGFKLKL  319 (835)
Q Consensus       289 C~~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~  319 (835)
                      ||+|+.||+||+|+.+..+.|.|++||+|++
T Consensus        80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            9999999999999988889999999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.1e-27  Score=229.70  Aligned_cols=254  Identities=19%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeE-EEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC-CVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~  589 (835)
                      .+.|.+.+.||+|.||.+-+++++. .+.+++|-+... ....++|.+|...--.| .|.||+.-+++ |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4679999999999999999999865 678999988653 33568899999877777 69999998875 45566788999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCCCeEecccCcccccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFC  667 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~  667 (835)
                      ||++.|+|.+.+    ....+.+....+++.|++.||.|+|+++   +||||||.+||||-  +..++||+|||+.+...
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999999887    3456888899999999999999999998   99999999999993  34589999999987542


Q ss_pred             CCCccccccccccccceeCceeecCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDG-----LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      .     ......-+..|.+||.....     ...+.+|||.||++++.++||+.||+........+..  |..|..+...
T Consensus       175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~--~~~w~~rk~~  247 (378)
T KOG1345|consen  175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE--WEQWLKRKNP  247 (378)
T ss_pred             c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH--HHHHhcccCc
Confidence            1     12223446689999976432     2467799999999999999999999965544333333  2333333222


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .     ++. .-..+++++.++..+-+..+|++|-...++.++..
T Consensus       248 ~-----~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  248 A-----LPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             c-----Cch-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            1     111 11234566778888999999999977766666643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=3.8e-27  Score=250.24  Aligned_cols=268  Identities=20%  Similarity=0.221  Sum_probs=206.4

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcC------CCceeeEeeEEEe
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ------HRNLVRLMGCCVE  581 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~  581 (835)
                      .+..-.+|.+....|+|-|++|.+|.+.. |..||||+|... +...+.=+.|+++|++|+      --|+++|+-.|.+
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            34455789999999999999999999754 889999999754 333445578999999995      3589999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEeccc
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF  660 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DF  660 (835)
                      ..++|||+|-+ .-+|.++|.+..+.-.|....+..++.|+.-||..|...+   |+|.||||.||||++. ..+|||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence            99999999988 5589999987777777889999999999999999999988   9999999999999865 56899999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccccc-----c-cchh
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL-----G-HAWN  734 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~-----~-~~~~  734 (835)
                      |.|.....++.    +.+..+..|.|||++.+..|+...|+||.||.||||.||+..|......++.-+     . ....
T Consensus       582 GSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  582 GSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             ccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            99987644332    234556789999999999999999999999999999999987765443322110     0 0000


Q ss_pred             hhccc---------------------------cchhccCc-----------cccchhHHHHHHHHHHHHHhccccCCCCC
Q 003264          735 LWKDN---------------------------RAYELLSP-----------ALQHEASYQMLNRYITVALLCVQEKAADR  776 (835)
Q Consensus       735 ~~~~~---------------------------~~~~~~~~-----------~l~~~~~~~~~~~l~~li~~cl~~dP~~R  776 (835)
                      ++..+                           .+...+.|           .-..+........|.+|+..|+..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            00000                           01111111           00122344567788999999999999999


Q ss_pred             CCHHHHHHH
Q 003264          777 PTMSKVVSM  785 (835)
Q Consensus       777 Ps~~evl~~  785 (835)
                      .+..+.|+.
T Consensus       738 it~nqAL~H  746 (752)
T KOG0670|consen  738 ITVNQALKH  746 (752)
T ss_pred             CCHHHHhcC
Confidence            999988753

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=8.8e-26  Score=207.06  Aligned_cols=115  Identities=47%  Similarity=0.787  Sum_probs=103.0

Q ss_pred             cccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEee
Q 003264           32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS  111 (835)
Q Consensus        32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst  111 (835)
                      ++|++|++|+|++|.|++|||.+......|.+|||++.+.++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S   80 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS   80 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence            578999999999999999999987665589999998876889999999998 6677899999999999999999999999


Q ss_pred             cCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCC
Q 003264          112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP  153 (835)
Q Consensus       112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~P  153 (835)
                      ++.+.....+|+|+|||||||++.      .+++||||||||
T Consensus        81 ~~~~~~~~~~~~L~ddGnlvl~~~------~~~~~W~Sf~~P  116 (116)
T cd00028          81 NTTRVNGNYVLVLLDDGNLVLYDS------DGNFLWQSFDYP  116 (116)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC------CCCEEEcCCCCC
Confidence            987634556789999999999986      578999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-27  Score=260.46  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++..++|.|.||.|||+++.. ++..|||.++-.......-.+.|+-+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            4789999999999999999999754 889999999877667777888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      |.+|+|.+.-+   ....+++.++..+.+..++||+|||+.+   -+|||||-.|||+++.|.+|++|||.+..+.  ..
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--at  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--hh
Confidence            99999998763   4567889999999999999999999998   8999999999999999999999999997663  22


Q ss_pred             cccccccccccceeCceee---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          672 QGNTKRVVGTYGYMSPEYA---LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      -...+...||+.|||||+.   ..+.|..++|||++|+...|+---++|....-  ++    .+..++.    ....+|.
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pm----r~l~LmT----kS~~qpp  235 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PM----RALFLMT----KSGFQPP  235 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hH----HHHHHhh----ccCCCCC
Confidence            3345568899999999987   34679999999999999999977666632111  00    0000110    1112222


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ... -.....+.+.+++..|+..+|.+||+++.+++
T Consensus       236 ~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111 22345667888999999999999999987764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=237.80  Aligned_cols=132  Identities=26%  Similarity=0.332  Sum_probs=110.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-----C---CceeeEeeEEEec--
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLMGCCVEQ--  582 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~--  582 (835)
                      .+|.+.++||.|.|++||++.+.. .+.||+|+.+. .....+....||++|++++     |   .+||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            789999999999999999998754 67899999864 3445567788999999984     3   3799999999864  


Q ss_pred             --CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          583 --GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       583 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                        .+++||+|++.. +|..+|.. ...+.++...+.+|++||+.||.|||.++  +|||-||||+|||+.
T Consensus       157 NG~HVCMVfEvLGd-nLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGD-NLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhhhh-HHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              589999999954 55555533 34556899999999999999999999987  799999999999993

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.7e-25  Score=230.58  Aligned_cols=199  Identities=34%  Similarity=0.471  Sum_probs=172.7

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      |++.+.||+|++|.||+++..+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999876 889999999766544 67889999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +++|.+++.....  .+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence            9999999854321  1788999999999999999999987   9999999999999999999999999998764432 11


Q ss_pred             cccccccccceeCceee-cCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003264          674 NTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTSKRNTGV  720 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvl~elltG~~p~~~  720 (835)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678899999998 666788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=249.26  Aligned_cols=195  Identities=24%  Similarity=0.340  Sum_probs=165.6

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChh--------hHHHHHHHHHHHHhcC---CCceeeEeeEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ--------GLKEFKNEMMLIAKLQ---HRNLVRLMGCCVE  581 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~~~~~~  581 (835)
                      .+|+.++.||+|+||.|+.+.++. ..+|+||.+.+..-.        ..-..-.|+.+|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468999999999999999999865 678999988764211        1112456999999997   9999999999999


Q ss_pred             cCeEEEEEEecC-CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          582 QGEKILIYEYMP-NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       582 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      ++.++|+||-.. +-+|.+++   .....+.+.++..|+.|++.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999875 44677777   34556899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCC-ccccchhHHHHHHHHHhCCCCC
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNT  718 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvl~elltG~~p~  718 (835)
                      |.+......    .....+||..|.|||++.+..|- ..-|||++|++||-++....|+
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999875433    34567899999999999998875 4579999999999988776664

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=6.1e-26  Score=229.51  Aligned_cols=259  Identities=25%  Similarity=0.263  Sum_probs=191.4

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------Ce
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GE  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  584 (835)
                      .+|.-++.+|.|.- .|..+-+ -.+++||+|++...  .....++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56777788899988 5555543 34899999987543  334567788999999999999999999998743      36


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++|||+|. .+|...+.     ..++-.....+..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            799999995 46666653     23556788899999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC-ccccccc--------------
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD-IESFNLL--------------  729 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~--------------  729 (835)
                      .-..   .-..+..+.|..|.|||++.+..+.+.+||||+||++.||++|.--|.+.+ .+++...              
T Consensus       167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            6422   234566788999999999999889999999999999999999997766443 2221110              


Q ss_pred             --ccchhhhc------cccchhcc-Cccccc--hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          730 --GHAWNLWK------DNRAYELL-SPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       730 --~~~~~~~~------~~~~~~~~-~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..+.....      .-...+++ |.....  +.+......+.+++.+||-.+|++|.+.+++++.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence              11111111      00011111 111111  1112234456789999999999999999999976

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.7e-25  Score=234.80  Aligned_cols=265  Identities=22%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC----CcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      ....+.|..+++||+|.|++||++.+..    .+.||+|.+....  ...++.+|+++|..+ -+.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3455789999999999999999998643    6789999986543  346688999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCcc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMA  663 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla  663 (835)
                      ..+|+||+++....++..      .++..++..+++.+++||+++|+++   ||||||||+|+|.+. -++-.|.|||+|
T Consensus       110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            999999999999988873      3567889999999999999999998   999999999999974 567889999999


Q ss_pred             ccccCCC------------------------------------------ccccccccccccceeCceeecC-CCCCcccc
Q 003264          664 RMFCGDE------------------------------------------LQGNTKRVVGTYGYMSPEYALD-GLFSVKSD  700 (835)
Q Consensus       664 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksD  700 (835)
                      .......                                          .........||++|.|||++.. ...++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7211000                                          0001123579999999999866 46889999


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCcccccccccc-----------------hhhhccccc---------hhccC-cc-----
Q 003264          701 VFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-----------------WNLWKDNRA---------YELLS-PA-----  748 (835)
Q Consensus       701 VwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~---------~~~~~-~~-----  748 (835)
                      |||.|||++-+++++.||-....+...+.+.+                 ..+|+....         ++-++ ..     
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999865543322211110                 001111110         00010 00     


Q ss_pred             ---cc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 ---LQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 ---l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .. ......+...+.+++.+|++.||.+|.+++|.++.
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence               01 11122234478899999999999999999999864

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=5.4e-24  Score=194.69  Aligned_cols=113  Identities=45%  Similarity=0.787  Sum_probs=99.3

Q ss_pred             cccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEee
Q 003264           32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS  111 (835)
Q Consensus        32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst  111 (835)
                      +.|..|+.|+|++|.|++|||.+... ..+.+|||++.+.++||+|||+.|+.+ .+.|.|+.||+|+|++.+|.++|+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S   79 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS   79 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence            57889999999999999999998654 679999998766789999999999654 4899999999999999999999999


Q ss_pred             cCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCC
Q 003264          112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (835)
Q Consensus       112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~  152 (835)
                      ++.......+|+|+|+|||||++.      .+++|||||||
T Consensus        80 ~t~~~~~~~~~~L~ddGnlvl~~~------~~~~~W~Sf~~  114 (114)
T smart00108       80 NTTGANGNYVLVLLDDGNLVIYDS------DGNFLWQSFDY  114 (114)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC------CCCEEeCCCCC
Confidence            987334556789999999999986      56799999997

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=9.7e-25  Score=266.49  Aligned_cols=197  Identities=19%  Similarity=0.226  Sum_probs=138.9

Q ss_pred             hcCC-CceeeEeeEE-------EecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 003264          566 KLQH-RNLVRLMGCC-------VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  637 (835)
Q Consensus       566 ~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  637 (835)
                      .++| +||+++++++       .+.+..++++||+ +++|.++|...  ...+++.+++.++.||++||+|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3445 5777788876       3334567788887 66999999532  345899999999999999999999988   9


Q ss_pred             EEecCCCCeEEEcC-------------------CCCeEecccCccccccCCCc--------------cccccccccccce
Q 003264          638 IHRDLKASNILLDS-------------------DMNPKISDFGMARMFCGDEL--------------QGNTKRVVGTYGY  684 (835)
Q Consensus       638 vHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  684 (835)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566777777654211000              0001124578899


Q ss_pred             eCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHH
Q 003264          685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITV  764 (835)
Q Consensus       685 ~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l  764 (835)
                      ||||++.+..++.++|||||||+||||++|..|+......   ..     .+.    .....+..     .........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~-----~~~----~~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MS-----SLR----HRVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HH-----HHH----HhhcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999988875421100   00     000    00111110     1112345678


Q ss_pred             HHhccccCCCCCCCHHHHHHH
Q 003264          765 ALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       765 i~~cl~~dP~~RPs~~evl~~  785 (835)
                      +.+||+.+|.+||+|.|+++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=6e-23  Score=203.91  Aligned_cols=167  Identities=19%  Similarity=0.122  Sum_probs=124.6

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |+|.+++..  +...+++.++..++.||++||+|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            678888843  2346899999999999999999999875         999999999999999  99998653321    


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                         ..|++.|||||++.+..++.++|||||||++|||++|+.|+.........+..    ....  ... ..+.. ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~----~~~~--~~~-~~~~~-~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI----LLNG--MPA-DDPRD-RSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH----HHHH--hcc-CCccc-cccH
Confidence               25889999999999999999999999999999999999998643211111100    0000  000 00000 0112


Q ss_pred             HHHHH--HHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          755 YQMLN--RYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       755 ~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .....  .+.+++.+|++.+|++||++.|+++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22333  689999999999999999999999987554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=219.80  Aligned_cols=174  Identities=21%  Similarity=0.267  Sum_probs=134.5

Q ss_pred             hhcCCccccccccCCcccEEEEEec--CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHhcCCCceee-EeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVR-LMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~  583 (835)
                      ..++|++.+.||+|+||+||+|++.  +++.||||++...     .....+.|.+|+++|++++|+|+++ ++.    .+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            4578999999999999999999875  4777899987533     1224567999999999999999985 443    24


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC-CCCeEEEcCCCCeEecccCc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGl  662 (835)
                      ..++||||+++++|....  .  .   .   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~--~--~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR--P--H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC--c--c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            689999999999996321  0  0   1   1467889999999999988   999999 99999999999999999999


Q ss_pred             cccccCCCccc------cccccccccceeCceeecCCC------CCccccch
Q 003264          663 ARMFCGDELQG------NTKRVVGTYGYMSPEYALDGL------FSVKSDVF  702 (835)
Q Consensus       663 a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~s~ksDVw  702 (835)
                      ++.+.......      .-....++..|+|||.+....      .+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99775432111      113567888999999986543      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-22  Score=218.32  Aligned_cols=274  Identities=20%  Similarity=0.251  Sum_probs=199.4

Q ss_pred             CCccccccccCCcccEEEEEecCC--cEEEEEEecCcChhhHHHHHHHHHHHHhcCC----CceeeEeeEE-EecCeEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLNG--QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH----RNLVRLMGCC-VEQGEKIL  587 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l  587 (835)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    .++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997653  4789888765433322367889999998863    6889999888 47778899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-----CCeEecccCc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGM  662 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGl  662 (835)
                      ||+.+ +-+|.++..... ...++..+.++++.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 778888764433 567999999999999999999999998   9999999999999765     4599999999


Q ss_pred             cc--cccCCCc-----ccc-ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          663 AR--MFCGDEL-----QGN-TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       663 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ++  .+.....     ... .....||..|+++..+.+...+.+.|+||++.++.|++.|..||........ ..     
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~-----  247 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS-----  247 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH-----
Confidence            99  4322221     111 2345699999999999999999999999999999999999999965442111 00     


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  804 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  804 (835)
                      .............     ........+.++...+-..+..++|.+..+...|..............+.|.
T Consensus       248 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~  312 (322)
T KOG1164|consen  248 KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE  312 (322)
T ss_pred             HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence            0000000001110     1111223344555555668999999999999998776554444443444433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-22  Score=202.95  Aligned_cols=279  Identities=18%  Similarity=0.228  Sum_probs=208.6

Q ss_pred             hhcCCccccccccCCcccEEEEE-ecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..-+|++.++||+|.||.++.|+ +-+++.||||.-...+  ...+++.|....+.| ..++|...+-+..++.+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34689999999999999999998 4579999999864433  234567788888888 5799999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-----CCeEecccCccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGMAR  664 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~  664 (835)
                      |.+ +-+|.++..  --...++.+++..+|.|++.-++|+|+++   +|.|||||+|+||...     ..+.|+|||+|+
T Consensus       104 dLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            998 556766541  12345889999999999999999999998   9999999999999644     358999999999


Q ss_pred             cccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          665 MFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       665 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      .+.+....     ...+...||.+||+-..+.+...+.+.|+-|||-|+++.|.|..||+.........   .++.+  +
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---kYeKI--G  252 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---KYEKI--G  252 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---HHHHh--c
Confidence            88655432     33456789999999999999999999999999999999999999998754332100   00000  0


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCccccccc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARR  806 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~~  806 (835)
                      +..+   ..-..+....++.++...+...-..+-++-|.++-+...+..+...+..-..-.|.|-.-
T Consensus       253 e~Kr---~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l  316 (449)
T KOG1165|consen  253 ETKR---STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL  316 (449)
T ss_pred             cccc---cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence            0000   001112223344555566666667788899999988888877666666555555555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.6e-22  Score=195.23  Aligned_cols=277  Identities=18%  Similarity=0.213  Sum_probs=209.8

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC-CceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..+|.++++||.|+||.+|.|.. .+|.+||||.-+....  ..++..|..+...|+| ..|..+..+..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            47899999999999999999985 5699999998654432  2456778899999965 788888888999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~  667 (835)
                      .+ +-+|.++..-  -...++..+++-++-|++.-++|+|.++   +|||||||+|+|+.-   -..+.++|||+++.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 5567666521  2234777899999999999999999998   999999999999964   3568999999999875


Q ss_pred             CCCc-----cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          668 GDEL-----QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       668 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      +...     ........||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||+......-   .+..+     .+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyE-----kI~  237 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYE-----KIS  237 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHH-----HHH
Confidence            4432     2334557899999999888888899999999999999999999999986442211   00011     111


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  805 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  805 (835)
                      +.--..........++.++.-.+..|-+..-++-|...-+.+++.-+...+..-..-.|.|.-
T Consensus       238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~  300 (341)
T KOG1163|consen  238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM  300 (341)
T ss_pred             HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence            111111111222234556677888899999999999999999887776777666666665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=5.3e-20  Score=199.67  Aligned_cols=260  Identities=30%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             CccccccccCCcccEEEEEecCCcEEEEEEecCcChh---hHHHHHHHHHHHHhcCCC-ceeeEeeEEEecCeEEEEEEe
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~E~  591 (835)
                      |++.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+++......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999986  88999998765332   467899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~  670 (835)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977633211136888999999999999999999998   99999999999999998 79999999998654433


Q ss_pred             ccc----cccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcc--cccccccchhhhccccc
Q 003264          671 LQG----NTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE--SFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       671 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~  741 (835)
                      ...    ......|+..|+|||.+..   ..+....|+||+|++++++++|..|+......  ........    .....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcCC
Confidence            221    3456789999999999987   67889999999999999999999996544321  00111100    00000


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      . .................+.+++..++..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000001110002223567788899999999999999887764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.7e-22  Score=196.87  Aligned_cols=249  Identities=20%  Similarity=0.347  Sum_probs=190.6

Q ss_pred             CCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +..+..+|.+...|+.|+|++.. ..+++|++....  ....+.|..|.-.|+.+.||||+.+++.|.....+.++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            34556789999999999999954 456667775432  233467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec--ccCccccccCCC
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS--DFGMARMFCGDE  670 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~--DFGla~~~~~~~  670 (835)
                      +.|+|...|++. ..-..+-.++.+++.+|++|++|||+.. +-|..--|.++.|+||++.+.+|+  |--++.      
T Consensus       270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------  341 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------  341 (448)
T ss_pred             cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee------
Confidence            999999999654 3345677899999999999999999986 234444689999999999887764  322221      


Q ss_pred             ccccccccccccceeCceeecCCCCC---ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFS---VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                         ......-.+.||+||.+...+-+   ..+|+|||.++||||.|...||..........              .+...
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kiale  404 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALE  404 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhc
Confidence               11223346899999999776543   57899999999999999999987654322111              11122


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .++...++..+..+.+++.-|...||.+||.+..|+-.|+..
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            334445555667788899999999999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.3e-21  Score=224.87  Aligned_cols=254  Identities=19%  Similarity=0.232  Sum_probs=190.0

Q ss_pred             cccccccCCcccEEEEEecC-CcEEEEEEec----C-cChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          518 MQCKLGEGGFGPVYKGKLLN-GQEVAVKRLS----S-QSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~----~-~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..+.+|.|.+|.|+...... .+..+.|...    . .... ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45689999999888776432 3334444322    1 1111 12226678888888999999998888887777666799


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ||++ +|..++..   ...+...++..++.|+..|++|||+.+   |.|||||++|++++.+|.+||+|||.+..+.-..
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 99888832   246788899999999999999999998   9999999999999999999999999998765443


Q ss_pred             cc--ccccccccccceeCceeecCCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQ--GNTKRVVGTYGYMSPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..  ......+|...|+|||.+.+..|.+. .||||.|+++..|++|+.||...............       ....-..
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~~~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQRNIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------ccccccc
Confidence            33  44556789999999999999999875 79999999999999999999865533222111000       0001111


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .-........+.+...++.++++.+|.+|.++++|++.
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            11223444556677889999999999999999999864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=3.3e-20  Score=187.98  Aligned_cols=171  Identities=16%  Similarity=0.176  Sum_probs=134.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhh---HHH------HHHHHHHHHhcCCCceeeEeeEEEec
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG---LKE------FKNEMMLIAKLQHRNLVRLMGCCVEQ  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~------~~~E~~~l~~l~H~niv~l~~~~~~~  582 (835)
                      ...+|++.++||.|+||.||.... +++.+|||.+.......   .+.      +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999655 57789999997543222   222      68999999999999999999886643


Q ss_pred             --------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          583 --------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       583 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                              ...+|||||++|.+|.++..       ++.    ....+++.+|..||..+   ++|||+||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999987641       222    34569999999999998   99999999999999988 


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHH
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL  712 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ell  712 (835)
                      ++|+|||...........              ..++....|..++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988754211100              01344556778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=9e-20  Score=182.78  Aligned_cols=139  Identities=17%  Similarity=0.159  Sum_probs=107.9

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChh--h-------HHH-----------------HHHHHHHHHhcCCCce
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL  572 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  572 (835)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ..+                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999998653210  1       112                 2349999999988776


Q ss_pred             eeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEEecCCCCeEEEcC
Q 003264          573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       573 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NILl~~  651 (835)
                      .....+.  ....+|||||++++++...+.   ....++......++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4333222  223489999999987765432   224578899999999999999999 6777   99999999999998 


Q ss_pred             CCCeEecccCccccc
Q 003264          652 DMNPKISDFGMARMF  666 (835)
Q Consensus       652 ~~~~kl~DFGla~~~  666 (835)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-20  Score=216.64  Aligned_cols=251  Identities=20%  Similarity=0.197  Sum_probs=179.5

Q ss_pred             CCccccccccCCcccEEEEEecCCcEEEEEEecCcC-hhhHHHHHHHHHH--HHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-GQGLKEFKNEMML--IAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++...+.||+++|=+|.++++++|. |+||++-+.. .-..+.|.++++.  ...++|||.+++.-.-...+..|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6778899999999999999998887 9999986654 3344445444433  4455999999998887777778899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC-CC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-DE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-~~  670 (835)
                      ..+ +|.+-|   .....+...+...|+.|++.||..+|..+   |+|+|||.+||||+.-+-+.|+||..-+...- .+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            865 455544   34456777888899999999999999998   99999999999999999999999987765421 11


Q ss_pred             ----ccccccccccccceeCceeecCC----------C-CCccccchhHHHHHHHHHhC-CCCCCCCCcccccccccchh
Q 003264          671 ----LQGNTKRVVGTYGYMSPEYALDG----------L-FSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       671 ----~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~  734 (835)
                          +.-.......-.+|+|||.+...          . .+++.||||+||++.||++- +++|...     ++..+...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~  250 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG  250 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence                11112233445689999987442          1 57789999999999999984 6666521     11111100


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                        .......++. .+       +...+..++..|++.||++|.++++.++.-.+
T Consensus       251 --~~~~~e~~Le-~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  251 --NADDPEQLLE-KI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             --CccCHHHHHH-hC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              0000000000 00       11256789999999999999999999988443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=7.7e-19  Score=176.62  Aligned_cols=140  Identities=19%  Similarity=0.215  Sum_probs=110.9

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChh--------------------------hHHHHHHHHHHHHhcCCCce
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL  572 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni  572 (835)
                      .+.||+|+||.||+|++.+|+.||||++......                          ....+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754210                          01234679999999999987


Q ss_pred             eeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcC
Q 003264          573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       573 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~  651 (835)
                      .....+...  ..+|||||++++++.....   ....++.....+++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3489999999886543321   12346778899999999999999999 77   99999999999998 


Q ss_pred             CCCeEecccCcccccc
Q 003264          652 DMNPKISDFGMARMFC  667 (835)
Q Consensus       652 ~~~~kl~DFGla~~~~  667 (835)
                      ++.++|+|||++..+.
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8999999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-18  Score=191.87  Aligned_cols=219  Identities=23%  Similarity=0.365  Sum_probs=163.4

Q ss_pred             HHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC
Q 003264          564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  643 (835)
Q Consensus       564 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  643 (835)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..  ....+++.-...++++|++||+|||+..  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999965  3456888999999999999999999864  23999999


Q ss_pred             CCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCC-------CCccccchhHHHHHHHHHhCCC
Q 003264          644 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-------FSVKSDVFSFGVLLLETLTSKR  716 (835)
Q Consensus       644 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDVwSlGvvl~elltG~~  716 (835)
                      ++|++++....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311111122223456799999887642       4667999999999999999999


Q ss_pred             CCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          717 NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       717 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ||......... .+.+..+ +. .....+.|.+....  +....+..++..||..+|++||++++|...++....
T Consensus       157 ~~~~~~~~~~~-~eii~~~-~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDP-DEIILRV-KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCCh-HHHHHHH-Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            99864422111 1111111 11 01111222222111  444578999999999999999999999999887643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=6e-18  Score=167.75  Aligned_cols=185  Identities=16%  Similarity=0.126  Sum_probs=138.3

Q ss_pred             ccccccccCCcccEEEEEecCCcEEEEEEecCcChh----hHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEEe
Q 003264          517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+++|+++|++|+ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999997765 6788888887654321    1235889999999994 5889999886    456999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC-CCCeEEEcCCCCeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      +++.+|...+.         . ....++.|++++|.++|.++   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99998865431         0 12357889999999999998   999999 7999999999999999999998654322


Q ss_pred             cc----c--c-----ccccccccceeCceeecCC-CCC-ccccchhHHHHHHHHHhCCCCCC
Q 003264          671 LQ----G--N-----TKRVVGTYGYMSPEYALDG-LFS-VKSDVFSFGVLLLETLTSKRNTG  719 (835)
Q Consensus       671 ~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSlGvvl~elltG~~p~~  719 (835)
                      ..    .  .     ......++.|++|+...-. ..+ ...+.++-|..+|.++|++.+.-
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            10    0  0     0112356777777754322 233 46789999999999999998743

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=1.7e-19  Score=195.41  Aligned_cols=173  Identities=24%  Similarity=0.306  Sum_probs=125.4

Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++.|++|...+|.++|.+.......++.....++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence            46677778888888888655555567778888999999999999   55   9999999999999999999999999997


Q ss_pred             cccCCC----ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccc
Q 003264          665 MFCGDE----LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       665 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      ......    .........||..||+||.+.+..|+.|+||||||++|+||+. =..++...                 .
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------------~  467 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------------A  467 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------H
Confidence            764443    2234456789999999999999999999999999999999997 11111100                 0


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      ...++-+..+.+....+.+. -..++.+++...|.+||++.+
T Consensus       468 t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 TLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence            01111111122111112222 256888999999999994433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=3.1e-18  Score=178.82  Aligned_cols=234  Identities=18%  Similarity=0.241  Sum_probs=149.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcC----------CCceeeEeeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQ----------HRNLVRLMGCC  579 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~  579 (835)
                      ..+...+.||.|+++.||.+++.+ ++++|||++...   .....+++++|.-....+.          |-.++.-++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            345667899999999999999866 899999987432   2345677887776665532          22222222222


Q ss_pred             E---------ecC--------eEEEEEEecCCCChhhhhc---CC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 003264          580 V---------EQG--------EKILIYEYMPNKSLNFFLF---DP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII  638 (835)
Q Consensus       580 ~---------~~~--------~~~lV~E~~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  638 (835)
                      .         ...        ..+++|+-+ .++|.+++.   .. .....+....++.+..|+++.+++||+.+   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         111        235667766 567776642   11 11223445666778899999999999998   99


Q ss_pred             EecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecC--------CCCCccccchhHHHHHHH
Q 003264          639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--------GLFSVKSDVFSFGVLLLE  710 (835)
Q Consensus       639 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvvl~e  710 (835)
                      |+||+|+|++++.+|.++|+||+..........     ....+..|.+||....        -.++.+.|.|+||+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999999999999999988765321111     0234578999997643        247889999999999999


Q ss_pred             HHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCC
Q 003264          711 TLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR  776 (835)
Q Consensus       711 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  776 (835)
                      |++|+.|++....+.....                  .+ .... +.++.+..||..+|+.+|++|
T Consensus       243 lWC~~lPf~~~~~~~~~~~------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999986432211110                  11 1222 566778889999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.3e-17  Score=166.99  Aligned_cols=136  Identities=23%  Similarity=0.270  Sum_probs=105.9

Q ss_pred             ccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-----CCCceeeEeeEEEecC---e-EEE
Q 003264          517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-----QHRNLVRLMGCCVEQG---E-KIL  587 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~l  587 (835)
                      .-.+.||+|+||.||.  +++....+||++........+.+.+|+.++..+     +||||+++++++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456899999999996  444333479988765444567899999999999     5799999999998874   3 337


Q ss_pred             EEEe--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEEEecCCCCeEEEcC----CCCeEeccc
Q 003264          588 IYEY--MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF  660 (835)
Q Consensus       588 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF  660 (835)
                      |+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5689999999432    24444  35677888777 9999998   999999999999974    347999995


Q ss_pred             Ccc
Q 003264          661 GMA  663 (835)
Q Consensus       661 Gla  663 (835)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.3e-17  Score=196.72  Aligned_cols=250  Identities=19%  Similarity=0.228  Sum_probs=183.2

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC---CCceeeEeeEEEecCeEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~  586 (835)
                      ....+.|.|.+.||+|+||+||+|...+|+.||+|+-+....-   +|.--.+++.||+   -+-|+.+...+.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3456789999999999999999999988999999997654321   1222233444444   234555555666677889


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-------CCCCeEecc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-------SDMNPKISD  659 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-------~~~~~kl~D  659 (835)
                      ||+||.+.|+|.+++.   ..+.++|..++.++.|+++.+++||..+   |||+||||+|+||.       ....++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999995   5567899999999999999999999998   99999999999994       234599999


Q ss_pred             cCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      ||-+..+.--.........++|-.+--+|...+..++.++|.|.|+.+++-||.|+..- ..+                +
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~----------------g  907 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKN----------------G  907 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcC----------------C
Confidence            99997664333334556678899999999999999999999999999999999998642 000                0


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       ....++..+++....+...++.++   +|..+-..=|...++...|+..
T Consensus       908 -~~~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  908 -SSWMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             -cceeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHH
Confidence             011112223333334444444444   4445555557777777776654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=7.1e-19  Score=194.22  Aligned_cols=225  Identities=24%  Similarity=0.309  Sum_probs=177.9

Q ss_pred             ccccCCcccEEEEEe----cCCcEEEEEEecCcChh--hHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEEecC
Q 003264          521 KLGEGGFGPVYKGKL----LNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      .+|+|.||.|++++-    +.|.-+|+|.+.+....  .......|..++..++ ||.+|++...+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998752    34777899988654321  1125566888899996 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|.|...+.   ....+.+.....+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999877663   3344666777777888999999999998   99999999999999999999999999987643322  


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchh
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA  753 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  753 (835)
                          .+||..|||||++.  .+...+|.||||++++||++|-.||..   +..               ..++  ......
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~---------------~~Il--~~~~~~  206 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTM---------------KRIL--KAELEM  206 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHH---------------HHHh--hhccCC
Confidence                28999999999988  677889999999999999999999875   100               0111  112234


Q ss_pred             HHHHHHHHHHHHHhccccCCCCCCCH
Q 003264          754 SYQMLNRYITVALLCVQEKAADRPTM  779 (835)
Q Consensus       754 ~~~~~~~l~~li~~cl~~dP~~RPs~  779 (835)
                      +.+......+++..++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            55666777788888999999999755

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.70  E-value=1e-17  Score=136.11  Aligned_cols=66  Identities=45%  Similarity=1.095  Sum_probs=59.0

Q ss_pred             ccccceEEEeeccCCCcccccccccccCHHHHHHHHHhcccccceecccccCCCccceeccccccch
Q 003264          337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDI  403 (835)
Q Consensus       337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~~~l~~~  403 (835)
                      |+.+|+|+++++|++|+.....++.++++++|++.||+||||+||+|.++. ++++|++|+|+|+|+
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            456699999999999999777776779999999999999999999998666 678999999999985

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.8e-16  Score=164.41  Aligned_cols=147  Identities=16%  Similarity=0.135  Sum_probs=113.2

Q ss_pred             HHhhcCCccccccccCCcccEEEEE--ecCCcEEEEEEecCcChh------------------------hHHHHHHHHHH
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------------------------GLKEFKNEMML  563 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~  563 (835)
                      ......|++.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+..
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3344568999999999999999998  467999999998643210                        11235789999


Q ss_pred             HHhcCCC--ceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEec
Q 003264          564 IAKLQHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD  641 (835)
Q Consensus       564 l~~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  641 (835)
                      +.++.+.  .+.++++.    ...++||||+++.+|......   ...+.......++.||+.++++||+.+  .|+|||
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D  174 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD  174 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence            9999753  34444442    235899999999888665421   223455667899999999999999876  499999


Q ss_pred             CCCCeEEEcCCCCeEecccCccccc
Q 003264          642 LKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       642 lkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      |||+||+++ ++.++|+|||.+...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=2.6e-16  Score=161.15  Aligned_cols=134  Identities=20%  Similarity=0.299  Sum_probs=113.8

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcCh--------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      +.||+|++|.||+|.. .|..|+||+......        ....++.+|+.++..++|+++.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998654321        1234678899999999999988877777778889999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      +++++|.+++...      .. .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432      12 78899999999999999988   99999999999999 88999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=4.4e-16  Score=157.85  Aligned_cols=143  Identities=19%  Similarity=0.194  Sum_probs=112.6

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcCh----------------------hhHHHHHHHHHHHH
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG----------------------QGLKEFKNEMMLIA  565 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~  565 (835)
                      ++......|.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444455888899999999999999988899999998754220                      01123677899999


Q ss_pred             hcCCCc--eeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC
Q 003264          566 KLQHRN--LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  643 (835)
Q Consensus       566 ~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  643 (835)
                      .+.|++  +.+.++    ....++||||+++++|..+..         ......++.+|++++.++|+.+   |+|||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            998874  444443    245689999999999876541         0345678899999999999987   9999999


Q ss_pred             CCeEEEcCCCCeEecccCccccc
Q 003264          644 ASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       644 p~NILl~~~~~~kl~DFGla~~~  666 (835)
                      |+||+++.++.++|+|||++...
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999999755

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=7.7e-16  Score=156.16  Aligned_cols=130  Identities=22%  Similarity=0.359  Sum_probs=106.8

Q ss_pred             ccccCCcccEEEEEecCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .||+|+||.||+|.. +++.|++|+.....        ....+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 57889999865321        112356788999999999887665555566677789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++++|.+++....          ..++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988873211          078999999999999988   99999999999999 89999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=6.9e-16  Score=180.04  Aligned_cols=137  Identities=20%  Similarity=0.317  Sum_probs=112.5

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEE-ecCc-C------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR-LSSQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ...|...++||+|+||+||+|.+.... +++|+ +.+. .      ....+++.+|++++.+++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345567789999999999999875443 44443 2221 1      1124568899999999999999988888888778


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998872           45789999999999999988   9999999999999 67899999999997


Q ss_pred             c
Q 003264          665 M  665 (835)
Q Consensus       665 ~  665 (835)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=2.7e-15  Score=156.07  Aligned_cols=197  Identities=20%  Similarity=0.247  Sum_probs=137.2

Q ss_pred             CCCceeeEeeEEEe---------------------------cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 003264          568 QHRNLVRLMGCCVE---------------------------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE  620 (835)
Q Consensus       568 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  620 (835)
                      +|||||++.++|.+                           ....|+||.-.+. +|..++..    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999988764                           2356888887744 68888843    3456667788899


Q ss_pred             HHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCC--CeEecccCccccccCC----CccccccccccccceeCceeecC
Q 003264          621 GIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDM--NPKISDFGMARMFCGD----ELQGNTKRVVGTYGYMSPEYALD  692 (835)
Q Consensus       621 ~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  692 (835)
                      |+++|+.|||.++   |.|||+|++||||.  +|+  .+.|+|||.+-.-...    .+........|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   99999999999994  333  4789999987432211    11222233457778999998754


Q ss_pred             CC------CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHH
Q 003264          693 GL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVAL  766 (835)
Q Consensus       693 ~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~  766 (835)
                      .+      --.|+|.|+.|.+.||++....||-.......+...          .++---|.+    +..++..+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPal----p~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPAL----PSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCC----cccCChHHHHHHH
Confidence            32      235899999999999999999887542211111111          111112222    2334456778999


Q ss_pred             hccccCCCCCCCHHHHHHHh
Q 003264          767 LCVQEKAADRPTMSKVVSMI  786 (835)
Q Consensus       767 ~cl~~dP~~RPs~~evl~~L  786 (835)
                      ..++.||++||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999887666554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=4.8e-16  Score=179.69  Aligned_cols=212  Identities=23%  Similarity=0.278  Sum_probs=144.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..+|..++.|..|+||.||.++++. .+++|+| +.++.--    +++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            4689999999999999999999865 5678884 4332210    111   33333444444                  


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC--
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--  669 (835)
                         |+-...+.   ..+.++...        +.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++...-.  
T Consensus       136 ---gDc~tllk---~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               33333332   223333332        77899999988   999999999999999999999999999764211  


Q ss_pred             -----------CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc
Q 003264          670 -----------ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  738 (835)
Q Consensus       670 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  738 (835)
                                 ..+...+.++||+.|+|||++....|...+|.|++|+|+||.+-|..||.....+..  ......  ..
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~vis--d~  274 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVIS--DD  274 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhh--hh
Confidence                       011123456899999999999999999999999999999999999999886533321  111000  00


Q ss_pred             ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       739 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      ....         +.......+..+++.+.++.+|..|--..
T Consensus       275 i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  275 IEWP---------EEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             cccc---------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence            0000         11222334567889999999999996333

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.6e-14  Score=138.67  Aligned_cols=135  Identities=22%  Similarity=0.238  Sum_probs=115.7

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC--CceeeEeeEEEecCeEEEEEEecCCC
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNK  595 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~g  595 (835)
                      +.+.||+|.++.||+++..+ +.++||.......  ...+.+|+.++..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999865443  5678999999999976  58999999888888899999999988


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      .+..+          +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77533          4567778899999999999987555699999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.4e-14  Score=145.25  Aligned_cols=137  Identities=20%  Similarity=0.204  Sum_probs=99.1

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChh--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L  572 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i  572 (835)
                      .+.||+|+||.||+|.+.+++.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999988643211  1111                      135666666664432  4


Q ss_pred             eeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcC
Q 003264          573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       573 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~  651 (835)
                      .+.+++    ...++||||++++.+........    ........++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh----hhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    24689999999965432111100    0015678899999999999998 76   99999999999999 


Q ss_pred             CCCeEecccCcccccc
Q 003264          652 DMNPKISDFGMARMFC  667 (835)
Q Consensus       652 ~~~~kl~DFGla~~~~  667 (835)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            9999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=7.8e-14  Score=145.02  Aligned_cols=135  Identities=23%  Similarity=0.261  Sum_probs=105.0

Q ss_pred             cccc-cCCcccEEEEEecCCcEEEEEEecCcC-------------hhhHHHHHHHHHHHHhcCCCce--eeEeeEEEecC
Q 003264          520 CKLG-EGGFGPVYKGKLLNGQEVAVKRLSSQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLMGCCVEQG  583 (835)
Q Consensus       520 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~  583 (835)
                      ..|| .|+.|+||+++.. +..++||++....             .....++.+|+.++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999999874 7789999874311             1233567889999999998875  67777654432


Q ss_pred             ----eEEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          584 ----EKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       584 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                          ..++|+|++++ .+|.+++.+    ..++..    .+.+|+++|.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688888733    223433    3678999999999998   9999999999999999999999


Q ss_pred             ccCccccc
Q 003264          659 DFGMARMF  666 (835)
Q Consensus       659 DFGla~~~  666 (835)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.4e-15  Score=174.81  Aligned_cols=257  Identities=21%  Similarity=0.252  Sum_probs=193.5

Q ss_pred             cCCccccccccCCcccEEEEEecC--CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..|.+.+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |.|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            467778889999999998887633  4567777765442  333455566888888886 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF  666 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~  666 (835)
                      .||..++++.+.+... .....+......++.|+..++.|+| +.+   +.||||||+|.+++..+ .++++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998777321 1113556677889999999999999 776   99999999999999999 9999999999988


Q ss_pred             cC-CCcccccccccc-ccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          667 CG-DELQGNTKRVVG-TYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       667 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      .. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+...-   ...  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~--  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF--  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc--
Confidence            76 444445556678 9999999999884 557789999999999999999999987654432222221110   000  


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            .............+++.+++..+|+.|.+.+++...
T Consensus       251 ------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  251 ------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ------ccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                  001111223445667788888999999998887643

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.47  E-value=5e-14  Score=118.09  Aligned_cols=71  Identities=21%  Similarity=0.397  Sum_probs=60.5

Q ss_pred             ccccceEEEeeccCCCcccccccccccCHHHHHHHHHh---cccccceecccccCCCccceeccccc-cchhhhccCCCC
Q 003264          337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK---NCTCRAYANSKVTGGGSGCLMWFGDL-IDIRKITGYNNG  412 (835)
Q Consensus       337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~  412 (835)
                      |.+.+.|+++.+||+|++..      ++++||++.|++   ||||+||+|.+.   +.||++|+++| +|++.+  ...+
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~--~~~g   73 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKE--FSHG   73 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhc--cCCC
Confidence            44557899999999997754      689999999999   999999999753   35899999999 999887  4458


Q ss_pred             cceeec
Q 003264          413 QPIYVR  418 (835)
Q Consensus       413 ~~ly~r  418 (835)
                      +++|+|
T Consensus        74 ~~Ly~r   79 (80)
T cd00129          74 FDLYEN   79 (80)
T ss_pred             ceeEeE
Confidence            899987

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=1.4e-12  Score=147.36  Aligned_cols=140  Identities=22%  Similarity=0.260  Sum_probs=100.8

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChhhH----------------------------------------HHHHH
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL----------------------------------------KEFKN  559 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~  559 (835)
                      +.||.|++|.||+|++.+|+.||||+.........                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999999999999999865321100                                        02445


Q ss_pred             HHHHHHhcC----CCceeeEeeEEE-ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003264          560 EMMLIAKLQ----HRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ-GLLYLHQYS  633 (835)
Q Consensus       560 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~  633 (835)
                      |+..+.+++    |.+-+.+-.++. .....+|||||+++++|.++......  ..   ...+++..+++ .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            666555552    333344433333 34567999999999999887632111  11   34556666666 467888877


Q ss_pred             CCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       634 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                         ++|+|+||.||+++.+++++++|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.9e-12  Score=132.38  Aligned_cols=206  Identities=20%  Similarity=0.221  Sum_probs=140.7

Q ss_pred             HHHHHhcCCCceeeEeeEEEecC-----eEEEEEEecCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003264          561 MMLIAKLQHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSR  634 (835)
Q Consensus       561 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~  634 (835)
                      ..-|-.+.|.|||+++.|+.+.+     ...++.||++-|+|..+|++.++ ...+......+++.||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34455667999999999987654     57899999999999999976433 345778888899999999999999975 


Q ss_pred             CcEEEecCCCCeEEEcCCCCeEecccCcccc--ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHH
Q 003264          635 LRIIHRDLKASNILLDSDMNPKISDFGMARM--FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL  712 (835)
Q Consensus       635 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ell  712 (835)
                      ++|+|+++..+.|++..++-+|+.----...  .-............+-++|.|||.=.....+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8899999999999999999888753211110  00000111122335678999999877777888999999999999998


Q ss_pred             hCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          713 TSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       713 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      -+..-.........  .+     ....++.-.....+           -..++..|++.+|..||+|++++..
T Consensus       277 ilEiq~tnseS~~~--~e-----e~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVE--VE-----ENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceee--hh-----hhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence            87643221110000  00     00000000111111           1236778999999999999988743

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.29  E-value=3.7e-12  Score=109.72  Aligned_cols=79  Identities=37%  Similarity=0.857  Sum_probs=62.7

Q ss_pred             cccccc---ceEEEeeccCCCcccccccccccCHHHHHHHHHhcccccceecccccCCCccceeccccccchhhhccCCC
Q 003264          335 SDCITR---ERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNN  411 (835)
Q Consensus       335 ~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~~  411 (835)
                      ++|...   +.|..++++++|+.....  .+.++++|++.||+||+|+||+|.+   ++++|.+|.+.+.+.+..  ...
T Consensus         3 ~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~--~~~   75 (84)
T cd01098           3 LNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSL--SSG   75 (84)
T ss_pred             cccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEee--cCC
Confidence            455443   689999999999775433  6789999999999999999999974   367899999999886653  333


Q ss_pred             CcceeeccC
Q 003264          412 GQPIYVRVP  420 (835)
Q Consensus       412 ~~~ly~r~~  420 (835)
                      +..+|+|++
T Consensus        76 ~~~~yiKv~   84 (84)
T cd01098          76 GGTLYLRLA   84 (84)
T ss_pred             CcEEEEEeC
Confidence            578899875

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.9e-11  Score=120.36  Aligned_cols=131  Identities=23%  Similarity=0.162  Sum_probs=98.2

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCcee-eEeeEEEecCeEEEEEEecCCCCh
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      ++.|+.|.++.||+++.. ++.|++|....... ....+.+|+.++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            357899999999999874 78899999765432 223467899999998655544 444433  3346899999999887


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ....           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5320           111345678999999999876  33479999999999999 67899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=4.7e-12  Score=140.84  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=181.9

Q ss_pred             cCCcccccccc--CCcccEEEEEe---cCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          514 ENFSMQCKLGE--GGFGPVYKGKL---LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ..|.+.+.+|.  |.+|.||+++.   .+++.+|+|+-+..  .......=.+|+...+++ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  99999999987   34788999984332  223333335677777777 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEeccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF  660 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DF  660 (835)
                      ++-+|++. .+|..+...  ....++.........+..+    ||.++|+.+   ++|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999986 667666633  3344677777888888888    999999988   9999999999999999 88999999


Q ss_pred             CccccccCCCcccc---ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          661 GMARMFCGDELQGN---TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       661 Gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |+...+........   .....|...|++||. ..+.++..+|+|++|.++.|..++.......-..       .|...+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR  339 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence            99998866553222   233467889999995 4567889999999999999999987654322111       111111


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...        +..++...-..++..++..+++.+|..|++.+.+...
T Consensus       340 ~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 QGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111        1111111223344458888999999999988776643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=4.4e-11  Score=136.66  Aligned_cols=145  Identities=18%  Similarity=0.213  Sum_probs=96.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChh------------------------------h----HH--
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ------------------------------G----LK--  555 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~------------------------------~----~~--  555 (835)
                      -..|+. +.||+|++|.||+|++.+ |+.||||++.+....                              .    .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987 999999998754210                              0    01  


Q ss_pred             ----HHHHHHHHHHhcC----CCceeeEeeEEEe-cCeEEEEEEecCCCChhhhhcCCCCC---CCCCHHHHHHHHHHHH
Q 003264          556 ----EFKNEMMLIAKLQ----HRNLVRLMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIA  623 (835)
Q Consensus       556 ----~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia  623 (835)
                          +|.+|+.-+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++..-....   ..+....+..++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence                1344555555542    4445555555543 45789999999999997742111111   11222222223333  


Q ss_pred             HHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEecccCccccccC
Q 003264          624 QGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARMFCG  668 (835)
Q Consensus       624 ~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~  668 (835)
                           ++..+   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 33455   99999999999999888    999999999987744

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.09  E-value=1e-09  Score=123.28  Aligned_cols=167  Identities=17%  Similarity=0.221  Sum_probs=126.5

Q ss_pred             ecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHH
Q 003264          535 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT  614 (835)
Q Consensus       535 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  614 (835)
                      ..++.+|.|+..+.......+...+-++.|+.++||||++++....+++..|||+|-+.  .|..++.+      ++...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688899988876665445567788899999999999999999999999999999873  45555522      33566


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCC
Q 003264          615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL  694 (835)
Q Consensus       615 ~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  694 (835)
                      ....+.||+.||.+||..+  .++|++|....|+|+..|+-||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6778899999999999765  599999999999999999999999998865432221  111122233456666543322


Q ss_pred             CCccccchhHHHHHHHHHhCC
Q 003264          695 FSVKSDVFSFGVLLLETLTSK  715 (835)
Q Consensus       695 ~s~ksDVwSlGvvl~elltG~  715 (835)
                        -..|.|.||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999994

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.07  E-value=1.6e-09  Score=107.94  Aligned_cols=135  Identities=15%  Similarity=0.107  Sum_probs=98.2

Q ss_pred             cccccCCcccEEEEEecC-------CcEEEEEEecCcC----------------------hhhHHHHH----HHHHHHHh
Q 003264          520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS----------------------GQGLKEFK----NEMMLIAK  566 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~~  566 (835)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ....+.++    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999998653       4799999764210                      01122333    89999999


Q ss_pred             cCC--CceeeEeeEEEecCeEEEEEEecCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEEecC
Q 003264          567 LQH--RNLVRLMGCCVEQGEKILIYEYMPNKSLNF-FLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDL  642 (835)
Q Consensus       567 l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDl  642 (835)
                      +..  -++.+.+++    ...+|||||+.++.+.. .+.    ...++..+...+..+++.+|..| |..+   |||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            953  456666654    56789999998754421 221    12344556677889999999999 7776   999999


Q ss_pred             CCCeEEEcCCCCeEecccCccccc
Q 003264          643 KASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       643 kp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ++.|||++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 578999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.07  E-value=1.1e-09  Score=112.68  Aligned_cols=142  Identities=17%  Similarity=0.259  Sum_probs=110.4

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCC--CceeeEeeEEEecC---eEEEEEEecC
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG---EKILIYEYMP  593 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~E~~~  593 (835)
                      +.|+.|..+.||+++..+|+.+++|....... .....+.+|++++..+++  ..+.+++.+..+..   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999999765332 245678899999999965  44577777766543   5689999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS----------------------------------------  633 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------  633 (835)
                      +.++...+..    ..++..+...++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765421    34667777888888888888888521                                        


Q ss_pred             -------------CCcEEEecCCCCeEEEcC--CCCeEecccCcccc
Q 003264          634 -------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARM  665 (835)
Q Consensus       634 -------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~  665 (835)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         246899999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=3.4e-10  Score=126.20  Aligned_cols=247  Identities=19%  Similarity=0.166  Sum_probs=173.9

Q ss_pred             HhhcCCccccccccCCcccEEEEEec--CCcEEEEEEecCcChhhH--HHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQGL--KEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ....+|.++..||.|.|+.|++...+  ++..+++|.+........  ..-..|+.+...+ -|.++++....+...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34578999999999999999998643  477899998765432222  2224566666666 689999999888888888


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  664 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~  664 (835)
                      ++--||++++++...+   .-...+.+..++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8999999999887655   23345677888999999999999999887   9999999999999876 788999999986


Q ss_pred             cccCCCcccccccccccccee--CceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          665 MFCGDELQGNTKRVVGTYGYM--SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      .+.-     ........-+++  +|+......+..+.|++|||..+.|.+++..-.....       .  +..     +.
T Consensus       416 ~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~--~~~-----i~  476 (524)
T KOG0601|consen  416 RLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------Q--SLT-----IR  476 (524)
T ss_pred             ccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------c--cee-----ee
Confidence            4211     111112233344  5555566788899999999999999998875322111       0  000     00


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      .-.-+.+..     ....+..+...++..++..||.+.++..+.+
T Consensus       477 ~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  477 SGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            111111111     1134555666788899999999888776543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=5.9e-09  Score=100.13  Aligned_cols=131  Identities=21%  Similarity=0.323  Sum_probs=101.8

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEE-ecCcC--h-----hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKR-LSSQS--G-----QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~~--~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..+++|+-+.+|.+.+. |..+++|. +++.-  +     -..++-.+|+.++.+++--.|.--.=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999763 44566663 33321  1     1234567899999999776666656666778888999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      +++..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++...+ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432          3567778888889999998   99999999999997665 99999999974

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=2.7e-08  Score=108.52  Aligned_cols=170  Identities=22%  Similarity=0.292  Sum_probs=129.7

Q ss_pred             CcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeEEEEEEecCC-CChhh
Q 003264          526 GFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYMPN-KSLNF  599 (835)
Q Consensus       526 ~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~  599 (835)
                      .-.+.||+.. .+|..|++|+++....+....-..-+++++++.|+|||+|..++..    +..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3457788875 5799999999955433333333456889999999999999998873    3478999999986 56766


Q ss_pred             hhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          600 FLFDP------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       600 ~l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      +-+..            ......++...+.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            65432            22345778999999999999999999998   8889999999999999999999999876653


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  717 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p  717 (835)
                      .+..                |.+.+   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3321                11111   1346888999999999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=5.2e-10  Score=130.51  Aligned_cols=249  Identities=19%  Similarity=0.195  Sum_probs=171.4

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ...+.+.+.+-+-+|.++.++.++-.. |...++|.....   .....+..+.+-.++-..+||-+++...-+.......
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            345788888899999999999876432 444444443222   1222333444445555556788887766666677889


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      |+++|+.+++|...|+..   ...+.......+..+.++++|||...   ++|+|++|.|+|+..++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999998888543   24555566667778889999999876   899999999999999999999999844322


Q ss_pred             cC------C-------------------Ccc----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCC
Q 003264          667 CG------D-------------------ELQ----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  717 (835)
Q Consensus       667 ~~------~-------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p  717 (835)
                      ..      .                   ...    .......+|+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10      0                   000    112345789999999999999999999999999999999999999


Q ss_pred             CCCCCcccc--cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          718 TGVYDIESF--NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       718 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      +......+.  ++..        ..    +.   -...+........+++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq~~f~ni~~--------~~----~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILN--------RD----IP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhhhhcccc--------CC----CC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            875432211  0100        00    00   0111222334455677778888888887666

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.88  E-value=1.2e-08  Score=97.31  Aligned_cols=143  Identities=24%  Similarity=0.307  Sum_probs=106.6

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEE-EecCcC-------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVK-RLSSQS-------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK-~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ....|-+|+-+.|+++.. .|+...|| ++.+.-       .-..++.++|+++|.+++--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456889999999999988 56666666 343321       123466788999999997666655555677777888999


Q ss_pred             EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEecccCcccc
Q 003264          590 EYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM  665 (835)
Q Consensus       590 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~  665 (835)
                      ||+++ .++.+++...-... ........++..|-+.+.-||..+   |||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47777775432222 222333678899999999999998   99999999999997655   358999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=9.1e-08  Score=95.02  Aligned_cols=125  Identities=26%  Similarity=0.274  Sum_probs=83.5

Q ss_pred             cEEEEEecCCcEEEEEEecCcC--------------------------hhhHHHHHHHHHHHHhcCCC--ceeeEeeEEE
Q 003264          529 PVYKGKLLNGQEVAVKRLSSQS--------------------------GQGLKEFKNEMMLIAKLQHR--NLVRLMGCCV  580 (835)
Q Consensus       529 ~Vy~~~~~~~~~vavK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~  580 (835)
                      .||.|...+|..+|||+.....                          .......++|++.|.++...  ++.+.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999899999999864210                          01134467899999999765  466666442 


Q ss_pred             ecCeEEEEEEecC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          581 EQGEKILIYEYMP--NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       581 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                         ..+|||||++  +..+..+...     .+.......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999999  6555443311     11234566778888886655 46776   9999999999999887 9999


Q ss_pred             cccCccccc
Q 003264          658 SDFGMARMF  666 (835)
Q Consensus       658 ~DFGla~~~  666 (835)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.73  E-value=1.7e-07  Score=98.67  Aligned_cols=133  Identities=18%  Similarity=0.153  Sum_probs=96.7

Q ss_pred             ccEEEEEecCCcEEEEEEecCcChh-----------hHHHHHHHHHHHHhcCCC--ceeeEeeEEEe-----cCeEEEEE
Q 003264          528 GPVYKGKLLNGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAKLQHR--NLVRLMGCCVE-----QGEKILIY  589 (835)
Q Consensus       528 g~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~--niv~l~~~~~~-----~~~~~lV~  589 (835)
                      ..|++... +|+.|.||+.......           ....+.+|...+.++...  ..++.+++...     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            33667655 6788999977443211           112478899999888533  33445555543     23578999


Q ss_pred             EecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-------CCCeEecccC
Q 003264          590 EYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DMNPKISDFG  661 (835)
Q Consensus       590 E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFG  661 (835)
                      |++++. +|.+++.+.. ....+......++.++++.+.-||..+   |+|+|++++|||++.       +..+.|+||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 8888874221 233456677889999999999999998   999999999999975       4679999999


Q ss_pred             cccc
Q 003264          662 MARM  665 (835)
Q Consensus       662 la~~  665 (835)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.59  E-value=2.7e-07  Score=93.98  Aligned_cols=136  Identities=21%  Similarity=0.217  Sum_probs=98.5

Q ss_pred             CCccccccccCCcccEEEEEecCCcEEEEEEecCc--------------------C--hhhHHHHHHHHHHHHhcCCC--
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--------------------S--GQGLKEFKNEMMLIAKLQHR--  570 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--  570 (835)
                      =..+.++||-|--+.||.|..++|.++|||.-...                    +  .......++|.++|.+|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45567899999999999999999999999953211                    0  11234467899999999654  


Q ss_pred             ceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       571 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      .+.+.++.    +...+||||+++-.|...-        +.....-.++..|++-+.-+-..|   |||+|+.+-||+++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            66666654    4557999999997775432        123333445555555555444555   99999999999999


Q ss_pred             CCCCeEecccCcccc
Q 003264          651 SDMNPKISDFGMARM  665 (835)
Q Consensus       651 ~~~~~kl~DFGla~~  665 (835)
                      ++|.+.++||--+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.46  E-value=3.8e-06  Score=89.76  Aligned_cols=261  Identities=16%  Similarity=0.132  Sum_probs=154.6

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceee--------EeeEEEecCeEEEE
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR--------LMGCCVEQGEKILI  588 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------l~~~~~~~~~~~lV  588 (835)
                      ..+.||+|+-+.+|-.-.- +.. +.|+..........+   -+..|... .||-+-.        |+|- ..+...-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence            4568999999999964321 222 447766543332222   22333333 5664433        1111 111224566


Q ss_pred             EEecCCCC-hhhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          589 YEYMPNKS-LNFFLFD---PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       589 ~E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      |..+++.. ...++..   .+......|.-.++.++.++.+.+.||..+   .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            77766542 2222211   122345789999999999999999999998   8999999999999999999998854332


Q ss_pred             cccCCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhC-CCCCCCCCccc--ccccccchhhh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIES--FNLLGHAWNLW  736 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~--~~~~~~~~~~~  736 (835)
                      ..   .......-.+|...|.+||...     +..-+...|.|.||+++++++.| ++|+.......  ..-.+.   .+
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~I  239 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DI  239 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hh
Confidence            21   1112223357888999999654     23446778999999999999987 88986533110  000000   00


Q ss_pred             ccccchh------ccCccccchhHHHHHHHHHHHHHhccccC--CCCCCCHHHHHHHhhcccCCC
Q 003264          737 KDNRAYE------LLSPALQHEASYQMLNRYITVALLCVQEK--AADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       737 ~~~~~~~------~~~~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~l  793 (835)
                      ..+....      -..+.-....-.-.+..+..+..+|+...  +.-||+++..+..|..+...|
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            0000000      00011111111122345566777787653  678999999999987765555

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.42  E-value=1e-06  Score=80.52  Aligned_cols=87  Identities=24%  Similarity=0.350  Sum_probs=62.1

Q ss_pred             eEEEecCCceEEecCC-CceEEeecCCCCcc-CceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccccc
Q 003264           89 VLTIGNNGNLVLLNQT-DGIIWSSNLSREVK-NPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (835)
Q Consensus        89 ~l~~~~~g~l~l~~~~-~~~~wst~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~  166 (835)
                      ++.++.||+||+++.. +.++|++++..... ...+.|+++|||||++.      .+.++|+|   .|            
T Consensus        23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S---~t------------   81 (114)
T smart00108       23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG------DGRVVWSS---NT------------   81 (114)
T ss_pred             ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC------CCCEEEEe---cc------------
Confidence            4566789999999765 58999999864432 25678999999999985      46789987   11            


Q ss_pred             cccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEee
Q 003264          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCT  213 (835)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~  213 (835)
                                      ....|.|.+.|+.+|...++-.+ ..+.|.+
T Consensus        82 ----------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~S  111 (114)
T smart00108       82 ----------------TGANGNYVLVLLDDGNLVIYDSD-GNFLWQS  111 (114)
T ss_pred             ----------------cCCCCceEEEEeCCCCEEEECCC-CCEEeCC
Confidence                            01246688899999887654222 3466754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.39  E-value=1.5e-06  Score=88.53  Aligned_cols=106  Identities=25%  Similarity=0.260  Sum_probs=84.0

Q ss_pred             HHHHHHHHHHHHhcCC--CceeeEeeEEEecC----eEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 003264          554 LKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG----EKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL  626 (835)
Q Consensus       554 ~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L  626 (835)
                      ..+..+|...+.+|..  -.+.+.+++.....    ..+||+|++++. +|.+++....   ..+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence            3467888888888853  34556666666533    458999999984 7988884321   155667889999999999


Q ss_pred             HHHHhcCCCcEEEecCCCCeEEEcCCC---CeEecccCcccc
Q 003264          627 LYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM  665 (835)
Q Consensus       627 ~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~  665 (835)
                      +-||..+   |+|+|++++|||++.+.   .+.++||+-++.
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999998   99999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=1.6e-06  Score=98.79  Aligned_cols=141  Identities=19%  Similarity=0.214  Sum_probs=94.5

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChh------------------------------hHH----------HHHH
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ------------------------------GLK----------EFKN  559 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------------------~~~----------~~~~  559 (835)
                      +-|+.++-|.||+|++.+|+.||||+..+.-..                              ..+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            578999999999999999999999987542110                              011          1344


Q ss_pred             HHHHHHhcC----CCceeeEeeEEE-ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 003264          560 EMMLIAKLQ----HRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG-LLYLHQYS  633 (835)
Q Consensus       560 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~  633 (835)
                      |+.-+.+++    +.--+++-.++. -....+|+|||++|-.+.++..-..  ...+   +..++..++++ +..+-..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhcC
Confidence            555555542    333344444444 3568899999999999888742221  2233   23344444333 22232334


Q ss_pred             CCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       634 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                         +.|.|.+|.||+++.+|++.+.|||+...+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999987644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=2e-07  Score=105.68  Aligned_cols=154  Identities=19%  Similarity=0.290  Sum_probs=104.8

Q ss_pred             HHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC-c------cccccccccccceeCceeec
Q 003264          619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE-L------QGNTKRVVGTYGYMSPEYAL  691 (835)
Q Consensus       619 ~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~------~~~~~~~~gt~~y~aPE~~~  691 (835)
                      +.+++.|+.|+|...  .+||++|.|++|.++.++..||+.|+.+....+.. +      ........-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            344569999999764  79999999999999999999999999887654311 1      11111234456899999999


Q ss_pred             CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhcccc
Q 003264          692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQE  771 (835)
Q Consensus       692 ~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~  771 (835)
                      +...+.++|+||+|++++-+..|..+.-....... .....          ...+..-...+..+.+.++.+-+.+.+..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhh----------hcccccccccccccCcHHHHHHHHHHhcC
Confidence            98899999999999999999965554322211100 00000          00111111122345566777788889999


Q ss_pred             CCCCCCCHHHHHHH
Q 003264          772 KAADRPTMSKVVSM  785 (835)
Q Consensus       772 dP~~RPs~~evl~~  785 (835)
                      ++.-||++.++...
T Consensus       252 ~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  252 DSAVRPTLDLLLSI  265 (700)
T ss_pred             CcccCcchhhhhcc
Confidence            99999988777644

>PRK09902 hypothetical protein; Provisional

Probab=98.28  E-value=1.2e-05  Score=80.50  Aligned_cols=139  Identities=16%  Similarity=0.174  Sum_probs=102.4

Q ss_pred             cccCCcccEEEEEecCCcEEEEEEecCc------ChhhHHHHHHHHHHHHhcCCC--ceeeEeeEEEec----CeEEEEE
Q 003264          522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQ------SGQGLKEFKNEMMLIAKLQHR--NLVRLMGCCVEQ----GEKILIY  589 (835)
Q Consensus       522 LG~G~fg~Vy~~~~~~~~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~----~~~~lV~  589 (835)
                      -|+||.+.|++... +|+.+-+|+-...      .+.....|.+|+..|.+|...  .+.+.+......    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46789999999776 4457888976421      133567899999999999532  344444222221    2468999


Q ss_pred             EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC--eEecccCcccc
Q 003264          590 EYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARM  665 (835)
Q Consensus       590 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~  665 (835)
                      |-+++ .+|.+++.+. .....+...+..++.++++.++-||..+   +.|+|+.++||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 5788887432 2234567778899999999999999998   999999999999986677  99999987654

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.26  E-value=3.1e-06  Score=77.53  Aligned_cols=89  Identities=21%  Similarity=0.250  Sum_probs=62.6

Q ss_pred             eEEEec-CCceEEecCC-CceEEeecCCCC-ccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccccccccc
Q 003264           89 VLTIGN-NGNLVLLNQT-DGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW  165 (835)
Q Consensus        89 ~l~~~~-~g~l~l~~~~-~~~~wst~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~  165 (835)
                      ++.++. ||+||+++.. +.++|++|+... .....+.|+++|||||++.      ++.++|+|=-.             
T Consensus        23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S~~~-------------   83 (116)
T cd00028          23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG------SGTVVWSSNTT-------------   83 (116)
T ss_pred             cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC------CCcEEEEeccc-------------
Confidence            345666 9999999765 589999998642 3445678999999999985      56789986210             


Q ss_pred             ccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       166 ~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                        .+.+.+.+.|+.+|...++-.+ ..+.|.+..
T Consensus        84 ------------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~  114 (116)
T cd00028          84 ------------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD  114 (116)
T ss_pred             ------------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence                              0246788899999876654322 455776543

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.26  E-value=1.2e-05  Score=82.98  Aligned_cols=140  Identities=18%  Similarity=0.217  Sum_probs=86.1

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc--eeeEeeEEEecCeEEEEEEecCCCC-
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGCCVEQGEKILIYEYMPNKS-  596 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gs-  596 (835)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   35567888876533  3345688999999986433  4667777777777889999999963 


Q ss_pred             hhhhhcC--------------------CCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-cCCCcEEEecCC
Q 003264          597 LNFFLFD--------------------PSRTHLLGWQTRV-KIIE----------GIAQ-GLLYLHQ-YSRLRIIHRDLK  643 (835)
Q Consensus       597 L~~~l~~--------------------~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~ivHrDlk  643 (835)
                      +...+..                    .-.....+..... .+..          .+.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2211100                    0000000100000 0000          0111 1122221 123457999999


Q ss_pred             CCeEEEcCCCCeEecccCcccc
Q 003264          644 ASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       644 p~NILl~~~~~~kl~DFGla~~  665 (835)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=98.24  E-value=9.3e-06  Score=73.91  Aligned_cols=99  Identities=25%  Similarity=0.425  Sum_probs=68.6

Q ss_pred             CeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEec-CCCCCCcCCCceEEEecCCceEEecCCCceEEeecCCCC
Q 003264           38 EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVA-NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSRE  116 (835)
Q Consensus        38 ~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~  116 (835)
                      +.+.+.+|.+.|-|..+|+     |-|.-  -..+++|.. +.... ....+.+.|..||||||+|..+.++|+|.  ..
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~--~~~~~iWss~~t~~~-~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVLYD--SNGSVIWSSNNTSGR-GNSGCYLVLQDDGNLVLYDSSGNVLWQSF--DY   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEEEE--TTTEEEEE--S-TTS-S-SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred             cccccccccccceECCCCe-----EEEEc--CCCCEEEEecccCCc-cccCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence            4566656999999998886     44432  345779999 44443 22578899999999999999999999994  23


Q ss_pred             ccCceEEEec--CCCeEEEeccCCCCCCCceeEeecCCC
Q 003264          117 VKNPVAQLLD--TGNLVLREKFSSNTSEGSYLWQSFDCP  153 (835)
Q Consensus       117 ~~~~~~~l~d--~GNlvl~~~~~~~~~~~~~~WqsFd~P  153 (835)
                      ....+...++  +||++ +..      ...+.|.|=+.|
T Consensus        82 ptdt~L~~q~l~~~~~~-~~~------~~~~sw~s~~dp  113 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVT-GKN------DSLTSWSSNTDP  113 (114)
T ss_dssp             SS-EEEEEET--TSEEE-EES------TSSEEEESS---
T ss_pred             CccEEEeccCcccCCCc-ccc------ceEEeECCCCCC
Confidence            3455567888  89999 653      356899886666

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.23  E-value=1.7e-06  Score=72.92  Aligned_cols=72  Identities=32%  Similarity=0.783  Sum_probs=53.0

Q ss_pred             ceEEEeeccCCCcccccccccccCHHHHHHHHHh-cccccceecccccCCCccceecc-ccccchhhhccCCCCcceeec
Q 003264          341 ERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMWF-GDLIDIRKITGYNNGQPIYVR  418 (835)
Q Consensus       341 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~~~ly~r  418 (835)
                      ..|..++++++++..... ....++++|++.|++ +|+|.||+|..   ++.+|.+|. +.+.+.+..  ...+.++|.+
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~--~~~~~~~y~~   77 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLF--PSGGVDLYEK   77 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceec--ccCCceeEEe
Confidence            568999999998554322 356799999999999 99999999974   456899999 777766522  3334444543

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.14  E-value=2.9e-05  Score=78.00  Aligned_cols=138  Identities=17%  Similarity=0.181  Sum_probs=91.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHH---------HHHHHHHHhcCCC---ceeeEeeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEF---------KNEMMLIAKLQHR---NLVRLMGCC  579 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H~---niv~l~~~~  579 (835)
                      ...+|.+.+++-......|.+-.. +|+.+++|..........+.|         .+++..+.+++..   ....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346788878887777777776655 578899998765543333332         2344444444322   222222222


Q ss_pred             E-----ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          580 V-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       580 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      .     .....+|+|||++|..|.++..       ++.    .++..|.+++.-||..|   +.|+|..|.|++++.++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     2235679999999988866531       222    34566778899999998   99999999999998554 


Q ss_pred             eEecccCcccc
Q 003264          655 PKISDFGMARM  665 (835)
Q Consensus       655 ~kl~DFGla~~  665 (835)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.13  E-value=3.6e-05  Score=79.61  Aligned_cols=144  Identities=22%  Similarity=0.230  Sum_probs=86.5

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC--ceeeEeeEEEe---cCeEEEEEEecC
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGCCVE---QGEKILIYEYMP  593 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lV~E~~~  593 (835)
                      ++.|+.|..+.||+....+ +.+++|.....  .....+.+|+.++..+...  .+.+++.+...   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678999999999999876 69999997654  4567788899998888533  35566664432   335789999999


Q ss_pred             CCChhh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 003264          594 NKSLNF----------------FL---FDP-SRTHLLGWQT---------RVKI------------IEGIAQ-GLLYLHQ  631 (835)
Q Consensus       594 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~  631 (835)
                      +..+..                .+   +.. ..........         ....            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                11   000 0000111100         0000            111222 2333332


Q ss_pred             ----cCCCcEEEecCCCCeEEEc-CCCCeEecccCcccc
Q 003264          632 ----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM  665 (835)
Q Consensus       632 ----~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~  665 (835)
                          .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2446799999999999999 666678999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.08  E-value=3.2e-05  Score=81.01  Aligned_cols=141  Identities=16%  Similarity=0.135  Sum_probs=86.5

Q ss_pred             ccccCCc-ccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEEecCCCChh
Q 003264          521 KLGEGGF-GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLN  598 (835)
Q Consensus       521 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~  598 (835)
                      .|-.|.. ..||+.... +..+.||+.....   ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 788998764 4788888875443   345678999988883 445667787777666789999999998876


Q ss_pred             hhhc-------------------CCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 003264          599 FFLF-------------------DPSR-THLLGW--QTRVKIIE--------------------GIAQGLLYLHQ----Y  632 (835)
Q Consensus       599 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~  632 (835)
                      ....                   .... ......  ........                    .+.+.+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                   0000 000000  00000000                    01111222211    1


Q ss_pred             CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       633 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ..+.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            235699999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.04  E-value=9.8e-07  Score=98.80  Aligned_cols=191  Identities=16%  Similarity=0.096  Sum_probs=136.9

Q ss_pred             HhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~  589 (835)
                      ..++-+...+.+++|++++++|.+....+....+.+...     ....-++++|.+++||| .++.++-+..+...++++
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            344556666789999999999987654454455555432     34456889999999999 777777777777889999


Q ss_pred             EecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      +++..+ +-.....  ...-.+...+...+.+.-.+++++||+..   =+|+|    ||+..+ +..|..||+....+..
T Consensus       314 ~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  314 RICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence            999887 2211110  00111223344455566678899999854   48998    776654 7789999999877644


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCC
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTG  719 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~  719 (835)
                      ..   ......+++.++|||+.....+..+.|+|++++-..++.-|-+|-.
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            32   3445678999999999999999999999999998778877776643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.02  E-value=2.2e-05  Score=78.30  Aligned_cols=105  Identities=23%  Similarity=0.224  Sum_probs=84.3

Q ss_pred             HHHHHHHHhcCC-CceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003264          558 KNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR  636 (835)
Q Consensus       558 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  636 (835)
                      .+|..++..+++ +++++++|+|-    .++|.||.+.+++...-....+-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999976 69999999994    4789999998766422100012234689999999999999999999866666


Q ss_pred             EEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          637 IIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       637 ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.97  E-value=8.7e-05  Score=75.35  Aligned_cols=152  Identities=18%  Similarity=0.198  Sum_probs=100.8

Q ss_pred             ccHHHHHHhhcCCccccc---cccCCcccEEEEEecCCcEEEEEEecCcChh-------------------hH-----HH
Q 003264          504 FSLASVSAATENFSMQCK---LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-------------------GL-----KE  556 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~-----~~  556 (835)
                      .+...+.....+..+.+.   |..|.-+.||+|...++..||||++......                   ..     .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            455666666666666555   4567778899998878999999998543211                   00     11


Q ss_pred             HHHHHHHHHhcC--CCceeeEeeEEEecCeEEEEEEecCCCCh-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 003264          557 FKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS  633 (835)
Q Consensus       557 ~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  633 (835)
                      ..+|+.-|.++.  +-.+.+-+++.    ...|||||+....+ .-.|.    ...+...+...+..++++.+.-|-...
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            245777777773  33344444432    45799999976521 11111    112233357777888888888777632


Q ss_pred             CCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       634 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                        ++||+||..-|||+. ++.+.|+|||-|...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              499999999999999 899999999988654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.90  E-value=6.4e-05  Score=85.58  Aligned_cols=140  Identities=18%  Similarity=0.242  Sum_probs=89.5

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChhh-------------------------------------HHHHHHHHH
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-------------------------------------LKEFKNEMM  562 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~  562 (835)
                      +.||.-+.|.||+|++++|+.||||+-++.-+..                                     .-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999865431110                                     001334443


Q ss_pred             HHHh----cCCCc---eeeEeeEEEe-cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcC
Q 003264          563 LIAK----LQHRN---LVRLMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL-YLHQYS  633 (835)
Q Consensus       563 ~l~~----l~H~n---iv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~  633 (835)
                      -..+    ++|-+   -|.+-.++.+ ....+|+|||++|..+.+...-  ....++..   .++..+.++.. -|-..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~---~i~~~l~~~~~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPH---DILNKLVEAYLEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHH---HHHHHHHHHHHHHHHhcC
Confidence            3333    34555   2233344433 3578999999999888766421  12223444   33333333322 112233


Q ss_pred             CCcEEEecCCCCeEEEcC----CCCeEecccCcccccc
Q 003264          634 RLRIIHRDLKASNILLDS----DMNPKISDFGMARMFC  667 (835)
Q Consensus       634 ~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~  667 (835)
                         ++|+|=.|.||++..    ++++.+-|||+...+.
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999984    6789999999998764

>PLN02876 acyl-CoA dehydrogenase

Probab=97.83  E-value=0.00019  Score=88.46  Aligned_cols=79  Identities=18%  Similarity=0.393  Sum_probs=58.6

Q ss_pred             ccccccCCcccEEEEEecCC---cEEEEEEecCcC-hhhHHHHHHHHHHHHhcC-CCce--eeEeeEEEec---CeEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLMGCCVEQ---GEKILI  588 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV  588 (835)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999877554   467888764432 123456889999999995 6665  7788887764   467899


Q ss_pred             EEecCCCCh
Q 003264          589 YEYMPNKSL  597 (835)
Q Consensus       589 ~E~~~~gsL  597 (835)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.73  E-value=0.00019  Score=74.78  Aligned_cols=74  Identities=12%  Similarity=0.200  Sum_probs=46.7

Q ss_pred             cccccCCcc-cEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC---ceeeEeeEEEec---CeEEEEEEec
Q 003264          520 CKLGEGGFG-PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCVEQ---GEKILIYEYM  592 (835)
Q Consensus       520 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lV~E~~  592 (835)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|++++..+...   -+.+.++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777776 58975    245777875432  2345788999999888531   234444433322   2348899999


Q ss_pred             CCCChhh
Q 003264          593 PNKSLNF  599 (835)
Q Consensus       593 ~~gsL~~  599 (835)
                      +|.++..
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9987743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.73  E-value=0.0005  Score=68.39  Aligned_cols=125  Identities=22%  Similarity=0.396  Sum_probs=90.2

Q ss_pred             cCCccccccccCCc-ccEEEEEecCCcEEEEEEecC---c---------C--h-------hhHHHHHHHHHHHHhcC---
Q 003264          514 ENFSMQCKLGEGGF-GPVYKGKLLNGQEVAVKRLSS---Q---------S--G-------QGLKEFKNEMMLIAKLQ---  568 (835)
Q Consensus       514 ~~~~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~---~---------~--~-------~~~~~~~~E~~~l~~l~---  568 (835)
                      .+++.++.||.|.- |.|||+++ +|+.+|+|.+..   .         .  +       ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78999999999999 99999998 678999999321   0         0  0       11235788998888885   


Q ss_pred             CCce--eeEeeEEEecC------------------eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003264          569 HRNL--VRLMGCCVEQG------------------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY  628 (835)
Q Consensus       569 H~ni--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  628 (835)
                      +.++  |+.+|+..-..                  ...||.||.+...                ....+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence            4456  89999874321                  2356777765432                1123345667777888


Q ss_pred             HHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       629 LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999975     3488999864

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.00045  Score=74.48  Aligned_cols=79  Identities=14%  Similarity=0.122  Sum_probs=57.8

Q ss_pred             CccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC---CceeeEeeEEEec---CeEEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH---RNLVRLMGCCVEQ---GEKILIY  589 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~---~~~~lV~  589 (835)
                      ....+.||.|..+.||+....++ .+.+|..+..  .....+.+|++.|+.|.-   ..+.++++++...   +..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            33456899999999999876555 4666774331  123578899999998843   4677888877543   5689999


Q ss_pred             EecCCCCh
Q 003264          590 EYMPNKSL  597 (835)
Q Consensus       590 E~~~~gsL  597 (835)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.62  E-value=0.00087  Score=67.25  Aligned_cols=128  Identities=17%  Similarity=0.227  Sum_probs=88.9

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcC----------------hhhHHHHHHHHHHHHhcC------CCceeeEe
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLM  576 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~  576 (835)
                      ...||+|+.-.||.  +++.....||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999996  4456667888876544                123456667776666655      88999999


Q ss_pred             eEEEecCeEEEEEEecCC--C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          577 GCCVEQGEKILIYEYMPN--K----SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       577 ~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      |+...+...-+|+|.+.+  |    +|.+++.    ...++. .   +...+-+-..||-.++   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998754  2    4666662    223433 2   3333344456666666   99999999999995


Q ss_pred             CCC----CeEecc
Q 003264          651 SDM----NPKISD  659 (835)
Q Consensus       651 ~~~----~~kl~D  659 (835)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332    467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.00048  Score=71.57  Aligned_cols=141  Identities=19%  Similarity=0.236  Sum_probs=82.5

Q ss_pred             cccccCCcccEEEEEecC--CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEEEEecCCCC
Q 003264          520 CKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      +.|..|-...+|+....+  ++.|++|+....... .....+|+.++..+...+ ..++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567888888999998764  678999987543222 123357888888885333 344444322    248999999977


Q ss_pred             hhhhh-----------------cCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 003264          597 LNFFL-----------------FDPSRT--------HLLG-WQTRVKIIE----------------------GIAQGLLY  628 (835)
Q Consensus       597 L~~~l-----------------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~y  628 (835)
                      +....                 +.....        .... +..+..+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            63220                 110000        0111 112111111                      11111111


Q ss_pred             ----HHhc-CCCcEEEecCCCCeEEEcC-CCCeEecccCcccc
Q 003264          629 ----LHQY-SRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  665 (835)
Q Consensus       629 ----LH~~-~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~  665 (835)
                          +... ....++|+|+.+.|||++. ++.+.|+||..+..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence                1111 2356999999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.55  E-value=0.00041  Score=66.76  Aligned_cols=130  Identities=20%  Similarity=0.266  Sum_probs=87.2

Q ss_pred             CccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceee-EeeEEEecCeEEEEEEecCC
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR-LMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~E~~~~  594 (835)
                      .+..+.|++|.+|.||+|.+. |..+|+|+-..  +.....+..|+++|..+.-.++-+ ++.|-    .-++.|||+.+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            345678999999999999884 55889998543  345577899999999998666543 44433    23455999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC-CCeEEEcCCCCeEecccCcccc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~  665 (835)
                      -.|.+.-...      ..+.    ...+++.---|...+   |-|..|. |...+|..++.+.|+||.-|.+
T Consensus        97 ~~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887654211      1222    233334433344444   8899887 4445555555999999998874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.54  E-value=0.0008  Score=74.79  Aligned_cols=75  Identities=15%  Similarity=0.196  Sum_probs=55.4

Q ss_pred             cccccCCcccEEEEEecCC-cEEEEEEecCc------C-hhhHHHHHHHHHHHHhcC-C--CceeeEeeEEEecCeEEEE
Q 003264          520 CKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQ------S-GQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV  588 (835)
                      +.||.|.+..||++...+| +.|+||.-...      . ....+++..|.+.|..+. +  .++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999999777 58999984321      1 224567788888888862 2  456777766  44667899


Q ss_pred             EEecCCCC
Q 003264          589 YEYMPNKS  596 (835)
Q Consensus       589 ~E~~~~gs  596 (835)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.49  E-value=0.00051  Score=72.49  Aligned_cols=139  Identities=14%  Similarity=0.078  Sum_probs=79.7

Q ss_pred             ccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-eeEeeEEEecCeEEEEEEecCCCChhh
Q 003264          521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKSLNF  599 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~  599 (835)
                      .+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++....    ..+|+||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456688889998873 567888987654322211235778889888854333 33444322    368999999877643


Q ss_pred             h-----------------hcCCC-CCCCCCHHH-HHHHHHH---------HHHHHHHHHhc-----CCCcEEEecCCCCe
Q 003264          600 F-----------------LFDPS-RTHLLGWQT-RVKIIEG---------IAQGLLYLHQY-----SRLRIIHRDLKASN  646 (835)
Q Consensus       600 ~-----------------l~~~~-~~~~l~~~~-~~~i~~~---------ia~~L~yLH~~-----~~~~ivHrDlkp~N  646 (835)
                      -                 ++... ....++... ...+..+         +.+.+..+...     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 01110 011111111 1111111         11112222211     13469999999999


Q ss_pred             EEEcCCCCeEecccCcccc
Q 003264          647 ILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       647 ILl~~~~~~kl~DFGla~~  665 (835)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.44  E-value=0.00053  Score=82.56  Aligned_cols=199  Identities=19%  Similarity=0.191  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE----EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003264          554 LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL  629 (835)
Q Consensus       554 ~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL  629 (835)
                      ......|+..+.++.|+|++.++.+..+....-    +..|++..-++...+.   ....++......+..++.+||+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence            344556788888999999999999988765433    3457787777777763   345677888889999999999999


Q ss_pred             HhcCCCcEEEecCCCC---eEEEcCCCCeEec--ccCccccccCCCccccccccccccceeCceeecCCCCCc--cccch
Q 003264          630 HQYSRLRIIHRDLKAS---NILLDSDMNPKIS--DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV--KSDVF  702 (835)
Q Consensus       630 H~~~~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVw  702 (835)
                      |+..   +.|.-|..+   +.-++.++...++  ||+.++.+......   ....-+..+.+||.........  ..|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence            9985   556555555   5555677777777  99888776433222   1223455677888777665544  47999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003264          703 SFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV  782 (835)
Q Consensus       703 SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  782 (835)
                      .+|..+..+..|..+.......                 ..+++    .    .....+.+....|+..++++|++..++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~-----------------~~~l~----~----~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVP-----------------VSLLD----V----LSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccch-----------------hhhhc----c----ccchhhhhhhhhhcchhhhhccchhhh
Confidence            9999999999887664321100                 01111    0    011145667788999999999999999


Q ss_pred             HHHh
Q 003264          783 VSMI  786 (835)
Q Consensus       783 l~~L  786 (835)
                      +...
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            9874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.30  E-value=0.002  Score=69.54  Aligned_cols=143  Identities=17%  Similarity=0.132  Sum_probs=86.6

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc--eeeEeeE------EEecCeEEEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGC------CVEQGEKILIYE  590 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~E  590 (835)
                      .+.|..|....+|+....+ ..+++|+...   ...++...|+.++..+.+.+  +.+++..      ....+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567888888999987644 5788898764   23355677888888884332  4444431      223456789999


Q ss_pred             ecCCCChhhh----h----------cC----CCC----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 003264          591 YMPNKSLNFF----L----------FD----PSR----THLLGWQTRV----------KIIEGIAQGLLYLHQ----YSR  634 (835)
Q Consensus       591 ~~~~gsL~~~----l----------~~----~~~----~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  634 (835)
                      |++|..+...    .          +.    ...    .....|....          .....+..++.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998776430    0          00    000    0111221110          111223344455543    123


Q ss_pred             CcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          635 LRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       635 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ..++|+|+.|.||++++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999887788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.03  E-value=0.0037  Score=67.64  Aligned_cols=141  Identities=26%  Similarity=0.305  Sum_probs=83.7

Q ss_pred             cccccCCcccEEEEEecC-------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E~  591 (835)
                      +.|..|--..+|+....+       ++.+++|+...... ......+|++++..+...+ ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777899988654       57899999765432 2344577888888884333 3345555432    368999


Q ss_pred             cCCCChhhhh-----------------cCCCCCC------CCC--HHHHHH--------------------------HHH
Q 003264          592 MPNKSLNFFL-----------------FDPSRTH------LLG--WQTRVK--------------------------IIE  620 (835)
Q Consensus       592 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  620 (835)
                      ++|..+....                 +......      ..+  +....+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987764321                 1110000      011  111100                          111


Q ss_pred             HHHHHHHHHHh------cCCCcEEEecCCCCeEEEcCC----CCeEecccCcccc
Q 003264          621 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  665 (835)
Q Consensus       621 ~ia~~L~yLH~------~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~  665 (835)
                      .+.+.+..|..      .....++|+|+.+.|||++.+    +.++|+||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      234679999999999999985    8899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.01  E-value=0.016  Score=63.29  Aligned_cols=142  Identities=20%  Similarity=0.224  Sum_probs=77.3

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC--ceeeEee------EEEecCeEEEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMG------CCVEQGEKILIYE  590 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~------~~~~~~~~~lV~E  590 (835)
                      .+.|+.|....+|+.+..+| .+++|++....   .+.+..|+.++..|...  .+.+.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577788789999886555 68889875222   23334455555555321  1233332      1223456789999


Q ss_pred             ecCCCChhh-----------hh---cCCC------C--CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 003264          591 YMPNKSLNF-----------FL---FDPS------R--THLLGW-QTRVK------------IIEG-IAQGLLYLHQY--  632 (835)
Q Consensus       591 ~~~~gsL~~-----------~l---~~~~------~--~~~l~~-~~~~~------------i~~~-ia~~L~yLH~~--  632 (835)
                      |++|..+..           .+   +...      .  ...+.| .....            .+.+ +...++.+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421           11   1000      0  001111 11111            1111 11122333211  


Q ss_pred             --CCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          633 --SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       633 --~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                        -+..++|+|+.|.||+++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999876656899999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.96  E-value=0.0077  Score=64.18  Aligned_cols=31  Identities=29%  Similarity=0.546  Sum_probs=26.1

Q ss_pred             CcEEEecCCCCeEEEcCCCC-eEecccCcccc
Q 003264          635 LRIIHRDLKASNILLDSDMN-PKISDFGMARM  665 (835)
Q Consensus       635 ~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~  665 (835)
                      ..++|+|+++.|||++.+++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997565 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.91  E-value=0.0066  Score=64.76  Aligned_cols=76  Identities=16%  Similarity=0.208  Sum_probs=49.4

Q ss_pred             CccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC---CCceeeEeeEEEecCeEEEEEEec
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .+..+.|+.|....+|+.. .+++.+.||.-.   ......|..|++-|+.|.   --.+.+.+++....+..+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678999999999987 568889999865   233466788888888883   446778888888777889999999


Q ss_pred             CCC
Q 003264          593 PNK  595 (835)
Q Consensus       593 ~~g  595 (835)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.89  E-value=0.0014  Score=68.70  Aligned_cols=142  Identities=15%  Similarity=0.148  Sum_probs=95.2

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecC-----------------c---Chh--hHHHHHHHHHHH
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS-----------------Q---SGQ--GLKEFKNEMMLI  564 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~-----------------~---~~~--~~~~~~~E~~~l  564 (835)
                      ..+..-..-+.+.+.||-|--+.||.+-..+|++.++|.-.-                 .   +..  ..-...+|+..|
T Consensus        85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm  164 (465)
T KOG2268|consen   85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM  164 (465)
T ss_pred             HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence            333333345778899999999999999999999999984210                 0   001  112346788888


Q ss_pred             HhcC-C-CceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC
Q 003264          565 AKLQ-H-RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  642 (835)
Q Consensus       565 ~~l~-H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  642 (835)
                      +.|. | --+.+.+++    ...++|||++.+-.|...-+      .....+   +...+..-+.-|..+|   +||+|+
T Consensus       165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDF  228 (465)
T KOG2268|consen  165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDF  228 (465)
T ss_pred             HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence            8884 3 234444443    45689999999888765431      122222   3333333444555666   999999


Q ss_pred             CCCeEEEcCCCCeEecccCccc
Q 003264          643 KASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       643 kp~NILl~~~~~~kl~DFGla~  664 (835)
                      .--||+|++++.++++||--..
T Consensus       229 NEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  229 NEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             chheeEEecCCCEEEeechHhh
Confidence            9999999999999999996544

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.88  E-value=0.016  Score=62.89  Aligned_cols=143  Identities=19%  Similarity=0.206  Sum_probs=82.6

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC--ceeeEeeE------EEecCeEEEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGC------CVEQGEKILIYE  590 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lV~E  590 (835)
                      .+.++.|.-..+|+.+..++ .+++|+.....  ..++...|++++..|...  .+.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677787789999876444 67788875432  123455667777776422  23444331      122456789999


Q ss_pred             ecCCCChhhh--------------hcCCCC------C---CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 003264          591 YMPNKSLNFF--------------LFDPSR------T---HLLGWQTRV------------KIIEGIAQGLLYLHQ----  631 (835)
Q Consensus       591 ~~~~gsL~~~--------------l~~~~~------~---~~l~~~~~~------------~i~~~ia~~L~yLH~----  631 (835)
                      |++|..+...              ++....      .   ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              011000      0   001111110            011223344555542    


Q ss_pred             cCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       632 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.87  E-value=0.01  Score=63.85  Aligned_cols=137  Identities=20%  Similarity=0.271  Sum_probs=82.5

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecC--cChhhHHHHHHHHHHHHhcCC--CceeeEeeEEEecC--eEEEEEEec
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG--EKILIYEYM  592 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lV~E~~  592 (835)
                      .+.+..|.--.+|..... +++++++ ...  ..........+|+.+|+.+.-  .-+.+.+++|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            334433433344444433 7788888 331  223344566778888888743  33445667777666  679999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHH-----------------------------------------
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLH-----------------------------------------  630 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH-----------------------------------------  630 (835)
                      ++..+...+....    ..    .+++ ..+++.|+-||                                         
T Consensus       108 eGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            8854332221100    00    1111 13333333333                                         


Q ss_pred             ---------hc-----CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          631 ---------QY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       631 ---------~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                               .+     +++.++|+|+.+.||+++.++.+-|.||+++..
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                     22     345799999999999999998899999999875

>PLN02236 choline kinase

Probab=96.78  E-value=0.011  Score=65.09  Aligned_cols=141  Identities=18%  Similarity=0.241  Sum_probs=82.7

Q ss_pred             cccccCCcccEEEEEecC-----CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-eeEeeEEEecCeEEEEEEecC
Q 003264          520 CKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~  593 (835)
                      +.|-.|-.-.+|+....+     ++.|++|+..........+ .+|+.++..+...++ .++++.+..+    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            355557778899987532     3689999886654333333 678888888854333 3455655332    5899998


Q ss_pred             CCChhhh-h----------------cCCC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 003264          594 NKSLNFF-L----------------FDPS--R-THLLGWQTRVKIIEGI-----------------AQGLLYL----HQ-  631 (835)
Q Consensus       594 ~gsL~~~-l----------------~~~~--~-~~~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  631 (835)
                      +.+|... +                +...  . .....+.+..++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422 0                1110  0 0011122222322111                 1112222    21 


Q ss_pred             cCCCcEEEecCCCCeEEEcC-CCCeEecccCcccc
Q 003264          632 YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  665 (835)
Q Consensus       632 ~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~  665 (835)
                      ..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22356999999999999986 47899999988753

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=96.76  E-value=0.0012  Score=49.20  Aligned_cols=44  Identities=43%  Similarity=0.645  Sum_probs=34.5

Q ss_pred             cCCCCCCCCCcccccccCcccccccCCCc--cccccccceeccccCCC
Q 003264          790 HATLPYPKQSAFSYARRGEKISFLPSSRV--SEACSVNGVTLSLISPR  835 (835)
Q Consensus       790 ~~~l~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  835 (835)
                      ...||.|++|+|...+......  .++..  .+.+++|+||+|.|++|
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~--sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETD--SSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcC--CCcccccCCCCCeeeEEEEeEecC
Confidence            4689999999999998753333  22233  38899999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.37  E-value=0.037  Score=61.44  Aligned_cols=80  Identities=11%  Similarity=0.018  Sum_probs=54.1

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCc----C---hhhHHHHHHHHHHHHhcC---CCceeeEeeEEEecCeEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ----S---GQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+.||.|....||+.... ++.|+||+-...    .   .....+-..|+..|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            468899999999998874 567999975421    1   123444555677776663   247778888776  456888


Q ss_pred             EEecCC--CChhhhh
Q 003264          589 YEYMPN--KSLNFFL  601 (835)
Q Consensus       589 ~E~~~~--gsL~~~l  601 (835)
                      ||++++  ..+..-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3444443

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.27  E-value=0.0034  Score=52.10  Aligned_cols=35  Identities=17%  Similarity=0.516  Sum_probs=28.9

Q ss_pred             ccCHHHHHHHHHhcccccceecccccCCCccceecccc
Q 003264          362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGD  399 (835)
Q Consensus       362 ~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~~~  399 (835)
                      ..+.++|++.|+.+|+|.||.|..   +...|+++.+.
T Consensus        24 ~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~   58 (73)
T cd01100          24 ASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE   58 (73)
T ss_pred             cCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence            568999999999999999999963   24569987653

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.10  E-value=0.04  Score=60.12  Aligned_cols=79  Identities=14%  Similarity=0.139  Sum_probs=52.0

Q ss_pred             ccccCCcccEEEEEecCC-cEEEEEEecC-------cChhhHHHHHHHHHHHHhcC--CC-ceeeEeeEEEecCeEEEEE
Q 003264          521 KLGEGGFGPVYKGKLLNG-QEVAVKRLSS-------QSGQGLKEFKNEMMLIAKLQ--HR-NLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV~  589 (835)
                      .||.|...-||++...+| +.|+||.-..       .-+...++..-|.+.|....  -| .+.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998654 6899996421       12334566667888887663  24 3444443  3556677999


Q ss_pred             EecCCC-Chhhhh
Q 003264          590 EYMPNK-SLNFFL  601 (835)
Q Consensus       590 E~~~~g-sL~~~l  601 (835)
                      |+++.. .|+..|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999653 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.05  E-value=0.014  Score=59.43  Aligned_cols=31  Identities=39%  Similarity=0.557  Sum_probs=22.2

Q ss_pred             CcEEEecCCCCeEEE-cCCCCeEecccCcccc
Q 003264          635 LRIIHRDLKASNILL-DSDMNPKISDFGMARM  665 (835)
Q Consensus       635 ~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~  665 (835)
                      ..+.|.|+.+.|||+ +.++.++++||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            468999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.88  E-value=0.05  Score=58.45  Aligned_cols=140  Identities=18%  Similarity=0.182  Sum_probs=93.5

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEecCcC----------------------hhhHH----HHHHHHHHHHhcCCCc
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----------------------GQGLK----EFKNEMMLIAKLQHRN  571 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~----~~~~E~~~l~~l~H~n  571 (835)
                      +.-.|..|--+.||.+.-.+|..+|||+++..-                      ....+    -...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            334678899999999999999999999874210                      00011    1345777788876544


Q ss_pred             eeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC
Q 003264          572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       572 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~  651 (835)
                      |.----+..  ...+|||+|+.....   -...-+...++...+..+-.++++-|.-|.+.+  ++||.||.--|+|+ .
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence            322111111  234799999964321   111112334666677778888888888888776  69999999999998 5


Q ss_pred             CCCeEecccCcccc
Q 003264          652 DMNPKISDFGMARM  665 (835)
Q Consensus       652 ~~~~kl~DFGla~~  665 (835)
                      +|.+.|+|-+-+..
T Consensus       300 dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVE  313 (520)
T ss_pred             CCEEEEEEcccccc
Confidence            67899999887754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.79  E-value=0.073  Score=58.33  Aligned_cols=141  Identities=16%  Similarity=0.248  Sum_probs=80.4

Q ss_pred             cccccCCcccEEEEEecC----CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-eeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      +.|..|---.+|+....+    +..|++|+......... .-.+|..++..+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345557777889886543    24799998765443322 23678888888854444 45565553 22   58999987


Q ss_pred             CChhhh-------h----------cCCC---CCCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 003264          595 KSLNFF-------L----------FDPS---RTHLLGWQTRVKIIEGI----------------------AQGLLYLH--  630 (835)
Q Consensus       595 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~~i----------------------a~~L~yLH--  630 (835)
                      ..|..-       +          +...   ....-.+....++..++                      .+-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321       1          1110   00011122222222111                      11121111  


Q ss_pred             --h-cCCCcEEEecCCCCeEEEcC-CCCeEecccCcccc
Q 003264          631 --Q-YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARM  665 (835)
Q Consensus       631 --~-~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~  665 (835)
                        . ..+..++|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1 12345899999999999975 57899999998854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	835
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-34
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-25
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-25
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-19
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-18
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-16
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		1e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (492), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 116/294 (39%), Positives = 169/294 (57%), Gaps = 6/294 (2%)
Query: 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKN 559
           L  FSL  +  A++NFS +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKI 618
           E+ +I+   HRNL+RL G C+   E++L+Y YM N S+   L + P     L W  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
             G A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +       V
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI---ESFNLLGHAWNL 735
            GT G+++PEY   G  S K+DVF +GV+LLE +T +R   +  +   +   LL     L
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
            K+ +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  190 bits (482), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 167/294 (56%), Gaps = 6/294 (2%)
Query: 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKN 559
           L  FSL  +  A++NF  +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKI 618
           E+ +I+   HRNL+RL G C+   E++L+Y YM N S+   L + P     L W  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
             G A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +       V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI---ESFNLLGHAWNL 735
            G  G+++PEY   G  S K+DVF +GV+LLE +T +R   +  +   +   LL     L
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
            K+ +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (426), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 168/283 (59%), Gaps = 11/283 (3%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQ 624
             +H +LV L+G C E+ E ILIY+YM N +L   L+     T  + W+ R++I  G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QGNTKRVV-GTY 682
           GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++   G EL Q +   VV GT 
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK--GTELDQTHLXXVVKGTL 205
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI--ESFNLLGHAWNLWKDNR 740
           GY+ PEY + G  + KSDV+SFGV+L E L + R+  V  +  E  NL   A     + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
             +++ P L  +   + L ++   A+ C+   + DRP+M  V+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 168/283 (59%), Gaps = 11/283 (3%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQ 624
             +H +LV L+G C E+ E ILIY+YM N +L   L+     T  + W+ R++I  G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QGNTKRVV-GTY 682
           GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++   G EL Q +   VV GT 
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK--GTELGQTHLXXVVKGTL 205
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI--ESFNLLGHAWNLWKDNR 740
           GY+ PEY + G  + KSDV+SFGV+L E L + R+  V  +  E  NL   A     + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
             +++ P L  +   + L ++   A+ C+   + DRP+M  V+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 498 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 549
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 550 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 607
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 608 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 727
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 498 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 549
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 550 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 607
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 608 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 727
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 498 DSVLPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ-- 549
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 61
Query: 550 -SGQGLKE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT 607
            + + LK+ F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     T
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 608 HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN 727
                    R+VGT  YM+PE AL G  + KSD++SFGV+LLE +T       +      
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237
Query: 728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L        ++    + +   +    S  +   Y +VA  C+ EK   RP + KV  ++
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY-SVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 148/299 (49%), Gaps = 16/299 (5%)
Query: 504 FSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ---SGQGL 554
           FS   +   T NF  +       K GEGGFG VYKG  +N   VAVK+L++    + + L
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 555 KE-FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQ 613
           K+ F  E+ + AK QH NLV L+G   +  +  L+Y Y PN SL   L     T  L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
            R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW 733
              R+VGT  Y +PE AL G  + KSD++SFGV+LLE +T       +      L     
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 240
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT 792
              ++    + +        S  +   Y +VA  C+ EK   RP + KV  ++    A+
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSVEAXY-SVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 77  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 134
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 135 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 239
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 240 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 74  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 132 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 185
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 236
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 237 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 78  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 189
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 240
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 241 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 80
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 81  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 138
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 139 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 192
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 243
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 244 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 275

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 73  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 131 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 184
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 235
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 236 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 267

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 79
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 80  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFIEERN 137
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 138 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 191
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 242
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 243 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 78  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 189
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 240
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 241 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 81
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 82  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 139
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 140 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 193
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 244
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 245 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 276

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 66
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 67  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 124
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 125 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 178
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 229
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 230 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 68  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFIEERN 125
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHR+L+A+NIL+   ++ KI+DFG+AR+   +E    T R    +   + +PE   
Sbjct: 126 ---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 179
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 230
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 231 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 136/279 (48%), Gaps = 29/279 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G  G V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL    V Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+    E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAIN 183
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             E  YQ++        LC +E+  DRPT   + S++ +
Sbjct: 235 CPEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNL 572
           + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +   I+HRDLK+ N+L+D     K+ DFG++R+     L   +K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRD 213
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTG 719
              + KSDV+SFGV+L E  T ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 43/278 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL + S   +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 228
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
                YQ++N        C +E+  DRP  S+++  + 
Sbjct: 229 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLA 259

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 114/207 (55%), Gaps = 6/207 (2%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNL 572
           + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +   I+HR+LK+ N+L+D     K+ DFG++R+     L  ++K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRD 213
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTG 719
              + KSDV+SFGV+L E  T ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 181
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 226
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 227 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 186
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 231
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 232 ASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 263

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 228
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 229 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 260

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +   S     +F  E  ++ KL H  LV+L G C+
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L++E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 203
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 204 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 248
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 249 ASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 280

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV+L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           EQ    L+ E+M +  L+ +L   ++  L   +T + +   + +G+ YL +     +IHR
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L+  +   K+SDFGM R    D+   +T    GT     + SPE      +S 
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 184
Query: 698 KSDVFSFGVLLLETLTSKR--------NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
           KSDV+SFGVL+ E  +  +        +  V DI +                + L  P L
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------GFRLYKPRL 229
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                YQ++N        C +E+  DRP  S+++  +  
Sbjct: 230 ASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 113/217 (52%), Gaps = 31/217 (14%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRN 571
            +++  +G GGFG VY+   + G EVAVK           Q ++  + E  L A L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLL 627
           ++ L G C+++    L+ E+     LN  L      P    L+ W  +      IA+G+ 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQ------IARGMN 119
Query: 628 YLHQYSRLRIIHRDLKASNILL-----DSDMNPKI---SDFGMARMFCGDELQGNTK-RV 678
           YLH  + + IIHRDLK+SNIL+     + D++ KI   +DFG+AR     E    TK   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 174
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            G Y +M+PE     +FS  SDV+S+GVLL E LT +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 325
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+    ++ EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 380
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 437
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 66
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 67  QLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 121
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 178
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VGEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I+I EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I+I EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 69
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 70  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 124
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 125 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 181
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 485 PSEGDGDAKGTRRDSVLPCFSLASVSA-ATENFSMQCKLGEGGFGPVYKGK---LLNGQE 540
           P+EG G             FS A V      +  ++ +LGEG FG V+  +   LL  Q+
Sbjct: 11  PTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQD 70
Query: 541 ---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597
              VAVK L   S    ++F+ E  L+  LQH+++VR  G C E    ++++EYM +  L
Sbjct: 71  KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
Query: 598 NFFL--FDPSRTHL----------LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 645
           N FL    P    L          LG    + +   +A G++YL   + L  +HRDL   
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 187
Query: 646 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFG 705
           N L+   +  KI DFGM+R     +      R +    +M PE  L   F+ +SDV+SFG
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 706 VLLLETLT 713
           V+L E  T
Sbjct: 248 VVLWEIFT 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           +  ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 72
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL----------LGWQTRV 616
           H+++VR  G C E    ++++EYM +  LN FL    P    L          LG    +
Sbjct: 73  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
            +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      
Sbjct: 133 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           R +    +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           +  ++ +LGEG FG V+  +   LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 78
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL----------LGWQTRV 616
           H+++VR  G C E    ++++EYM +  LN FL    P    L          LG    +
Sbjct: 79  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
            +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      
Sbjct: 139 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           R +    +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 74  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQIASGMAYVE--- 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTAPEAAL 185
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +  +L   Q  V +   IA G+ Y+    
Sbjct: 74  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQIASGMAYVE--- 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 185
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 65
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 66  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 120
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 177
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 67
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 122
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 123 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 179
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  +  +LG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           RL      +    +I EYM   SL +F   D     LL     +     IA+G+ Y+   
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 127
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 690
            R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE  
Sbjct: 128 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 183
Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
             G F++KSDV+SFG+LL E +T  +    G  + +    L   + +           P 
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM-----------PR 232
Query: 749 LQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           +++  +  Y ++        +C +EKA +RPT   + S++ +
Sbjct: 233 VENCPDELYDIMK-------MCWKEKAEERPTFDYLQSVLDD 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L        + F  E  ++ KL+H  LV
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 244 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 298
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+ R+   +E    T R    +   + +PE AL
Sbjct: 299 RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY---TARQGAKFPIKWTAPEAAL 355
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 34/279 (12%)
Query: 519 QCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNL 572
           Q  +G G FG VYKG L      +EV V   + ++G   K+   F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLY 628
           +RL G   +    ++I EYM N +L+ FL +     S   L+G      ++ GIA G+ Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG------MLRGIAAGMKY 162
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSP 687
           L   + +  +HRDL A NIL++S++  K+SDFG++R+   D E    T        + +P
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E      F+  SDV+SFG+++ E +T       Y    +  L +   +   N  + L +P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                A YQ++       + C Q++ A RP  + +VS++
Sbjct: 273 MDCPSAIYQLM-------MQCWQQERARRPKFADIVSIL 304

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I++ EYM    L  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG+AR+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  +  +LG G FG V+ G      +VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLV 67
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL D      L     V +   +A G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE--- 122
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  IHRDL+++NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE---XTARQGAKFPIKWTAPEAAL 179
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E +T  R
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAKL 567
            N  ++ +LGEG FG V+  +  N    Q+   VAVK L   S    K+F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHL--------LGWQTRVK 617
           QH ++V+  G CVE    I+++EYM +  LN FL    P    +        L     + 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           I + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 185
Query: 678 VVGT----YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           V G       +M PE  +   F+ +SDV+S GV+L E  T
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM    L  FL      +L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYAL 691
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E    T R    +   + +PE AL
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 188
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
            G F++KSDV+SFG+LL E  T  R
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 696 SVKSDVFSFGVLLLETLT 713
           + +SDV+S+GV + E +T
Sbjct: 220 THQSDVWSYGVTIWELMT 237

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 34/282 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 70
Query: 574 RLMGCCVEQGEKILIYEYMPNKSL-NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           RL     ++    +I E+M   SL +F   D     LL     +     IA+G+ Y+   
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 126
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYA 690
            R   IHRDL+A+N+L+   +  KI+DFG+AR+   +E    T R    +   + +PE  
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 182
Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
             G F++KS+V+SFG+LL E +T  +    G  + +  + L   + +           P 
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-----------PR 231
Query: 749 LQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           +++  +  Y ++        +C +EKA +RPT   + S++ +
Sbjct: 232 MENCPDELYDIMK-------MCWKEKAEERPTFDYLQSVLDD 266

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C+    + L+ + MP+  L  ++ +      +G Q  +     IA+G++YL +    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N         +M+ E      F
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 696 SVKSDVFSFGVLLLETLT 713
           + +SDV+S+GV + E +T
Sbjct: 197 THQSDVWSYGVTIWELMT 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 29/216 (13%)
Query: 521 KLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
           +LGE  FG VYKG L         Q VA+K L  ++   L+E F++E ML A+LQH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 620
            L+G   +     +I+ Y  +  L+ FL            D  RT    L     V ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 677
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            +    +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 193 PI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 29/216 (13%)
Query: 521 KLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
           +LGE  FG VYKG L         Q VA+K L  ++   L+E F++E ML A+LQH N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 620
            L+G   +     +I+ Y  +  L+ FL            D  RT    L     V ++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTKR 677
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+  
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            +    +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 210 PI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 242
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 243 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 159
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 160 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 269
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 270 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 302

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 149
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 150 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 259
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 260 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ EYM N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG+ R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 16/278 (5%)
Query: 522 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V  Y     N   G+ VAVK L +  G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GCC +QGEK L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 692
               IHR+L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 790
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 16/278 (5%)
Query: 522 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V  Y     N   G+ VAVK L +  G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GCC +QGEK L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 692
               IHR+L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 790
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 259
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 279
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 280 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 317

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 252
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 253 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 290

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 137/282 (48%), Gaps = 35/282 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 630
           +L     ++   I I E+M   SL  FL     +     Q   K+I+    IA+G+ ++ 
Sbjct: 74  KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 128
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 688
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 182
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPR 233
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           P    E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 234 PENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 268

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 278
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 279 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 316

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 319
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 320 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 255
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 256 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 259
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 258
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 258
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 257
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 258 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 260
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +        +   LL P 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL------QGRRLLQPE 261
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 127/274 (46%), Gaps = 16/274 (5%)
Query: 522 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
           LGEG FG V  Y     N   G+ VAVK L    G  L+  ++ E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 576 MGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GCC +QGEK   L+ EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 692
               IHR L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F   SDV+SFGV L E LT   +      +   L+GH        R  ELL    +  
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 249
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +       +   C + +A+ RPT   +V ++
Sbjct: 250 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 127/274 (46%), Gaps = 16/274 (5%)
Query: 522 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
           LGEG FG V  Y     N   G+ VAVK L    G  L+  ++ E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 576 MGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GCC +QGEK   L+ EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 692
               IHR L A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F   SDV+SFGV L E LT   +      +   L+GH        R  ELL    +  
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 248
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +       +   C + +A+ RPT   +V ++
Sbjct: 249 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 630
           +L     ++   I I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPE 688
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +   + +PE
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 355
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
               G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPR 406
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           P    E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 407 PENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 441

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 265
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 266 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 303

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 200
Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 201 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 251
Query: 758 LNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                T+   C  EKA +RPT   ++S I +
Sbjct: 252 -----TIMYSCWHEKADERPTFKILLSNILD 277

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 522 LGEGGFGPVYKGKLLN--GQEV--AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           G C+  +G  +++  YM +  L  F+     +P+   L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEY 689
            +  + +HRDL A N +LD     K++DFG+AR     E     N         +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPA 748
                F+ KSDV+SFGVLL E +T  R    Y D+ +F++  +   L +  R   LL P 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---LLQPE 261
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
              +  Y+       V L C   KA  RP+ S++VS I+   +T 
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           +  ++ +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  LQ
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTR----------- 615
           H ++V+  G C +    I+++EYM +  LN FL    P    L+  Q R           
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           + I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R    D    + 
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDY 188
Query: 676 KRVVGT----YGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            RV G       +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDGLFSVK 698
           DL A N L++     K+SDFG++R    DE    T  V   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 699 SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQML 758
           SD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y   
Sbjct: 202 SDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY--- 251
Query: 759 NRYITVALLCVQEKAADRPTMSKVVSMITN 788
               T+   C  EKA +RPT   ++S I +
Sbjct: 252 ----TIMYSCWHEKADERPTFKILLSNILD 277

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 184
Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 185 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 235
Query: 758 LNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                T+   C  EKA +RPT   ++S I +
Sbjct: 236 -----TIMYSCWHEKADERPTFKILLSNILD 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 180
Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 181 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 231
Query: 758 LNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                T+   C  EKA +RPT   ++S I +
Sbjct: 232 -----TIMYSCWHEKADERPTFKILLSNILD 257

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 185
Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 186 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 236
Query: 758 LNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                T+   C  EKA +RPT   ++S I +
Sbjct: 237 -----TIMYSCWHEKADERPTFKILLSNILD 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYALDGLFSV 697
           DL A N L++     K+SDFG++R    DE   +    VG+     +  PE  +   FS 
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 191
Query: 698 KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQM 757
           KSD+++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y  
Sbjct: 192 KSDIWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY-- 242
Query: 758 LNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                T+   C  EKA +RPT   ++S I +
Sbjct: 243 -----TIMYSCWHEKADERPTFKILLSNILD 268

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 522 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 631
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEY 689
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  R    + Y +PE 
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 690 ALDGLFSVKSDVFSFGVLLLETLT 713
            +   F + SDV+SFGV L E LT
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E  ++  +LG G FG V  GK     +VAVK +   S     EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYLHQ 631
           +  G C ++    ++ EY+ N  L  +L    R+H  G +    +++   + +G+ +L  
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPE 688
           +   + IHRDL A N L+D D+  K+SDFGM R    D+   +    VGT     + +PE
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPE 175
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
                 +S KSDV++FG+L+ E  +  +         ++L  ++  + K ++ + L  P 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKM-------PYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L  +  YQ++         C  E    RPT  +++S I
Sbjct: 229 LASDTIYQIMYS-------CWHELPEKRPTFQQLLSSI 259

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 522 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V    Y  +  N G++VAVK L  +SG   + + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 631
            G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK--RVVGTYGYMSPEY 689
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K  R    + Y +PE 
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 690 ALDGLFSVKSDVFSFGVLLLETLT 713
            +   F + SDV+SFGV L E LT
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 21/268 (7%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N L++     K+SDFG++R    DE   +         +  PE  +   FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 701 VFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNR 760
           +++FGVL+ E  +     G    E F     A ++ +  R Y    P L  E  Y     
Sbjct: 189 IWAFGVLMWEIYS----LGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY----- 236
Query: 761 YITVALLCVQEKAADRPTMSKVVSMITN 788
             T+   C  EKA +RPT   ++S I +
Sbjct: 237 --TIMYSCWHEKADERPTFKILLSNILD 262

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 242
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 243 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH 569
           N S+   +G G FG V  G  KL + +E++V   + + G   +  ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N++RL G   +    +++ E M N SL+ FL    R H   +     V ++ GIA G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMS 686
           YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + S
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+S+G++L E ++       Y    +  + +   +   +  Y L  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           P     A YQ++       L C Q+   +RP   ++VS++
Sbjct: 272 PMDCPAALYQLM-------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 238
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 239 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            G C   G +   LI EY+P  SL  +L   +    +     ++    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMSPEYALD 692
             R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +PE   +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 693 GLFSVKSDVFSFGVLLLETLT 713
             FSV SDV+SFGV+L E  T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 126
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 235
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 236 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 277

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 238
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 239 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 151
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 260
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 261 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 21/268 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    ++ EYMP  +L  +L + +R  +      + +   I+  + YL    
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYL---E 147
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ Y+LL    + E 
Sbjct: 207 TFSIKSDVWAFGVLLWEIATY----GMSPYPGIDL----------SQVYDLLEKGYRMEQ 252
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSK 781
                 +   +   C +   ADRP+ ++
Sbjct: 253 PEGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 49/283 (17%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V  G+L + GQ    VA+K L +  + +  ++F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 634
           G        +++ EYM N SL+ FL    RTH         V ++ G+  G+ YL   S 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG-----YMSPEY 689
           L  +HRDL A N+L+DS++  K+SDFG++R+   D     T     T G     + +PE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEA 225
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAYE 743
                FS  SDV+SFGV++ E L        Y    +      WN+   +        Y 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-------YGERPY------WNMTNRDVISSVEEGYR 272
Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L +P     A +Q++       L C  +  A RP  S++VS++
Sbjct: 273 LPAPMGCPHALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 127
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 132
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 144/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 261
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 262 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 135
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 619
            QH N+V L+G C   G  ++I EY     L  FL        D      L  +  +   
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTK 676
             +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +
Sbjct: 159 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 734
             V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F      + 
Sbjct: 216 LPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YK 266
Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
           L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 267 LVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 312

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 133
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G FG VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
               IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 694 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMR-------ACWQWNPSDRPSFAEI 260

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 134
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----------HLLGWQTR 615
            QH N+V L+G C   G  ++I EY     L  FL   SR              L  +  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQ 672
           +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLG 730
           GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F    
Sbjct: 224 GNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---- 276
Query: 731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
             + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 277 --YKLVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 324

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 126
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 49/283 (17%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V  G+L + GQ    VA+K L +  + +  ++F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 634
           G        +++ EYM N SL+ FL    RTH         V ++ G+  G+ YL   S 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG-----YMSPEY 689
           L  +HRDL A N+L+DS++  K+SDFG++R+   D     T     T G     + +PE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEA 225
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN------RAYE 743
                FS  SDV+SFGV++ E L        Y    +      WN+   +        Y 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-------YGERPY------WNMTNRDVISSVEEGYR 272
Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L +P     A +Q++       L C  +  A RP  S++VS++
Sbjct: 273 LPAPMGCPHALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
              +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 25/271 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 126
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 694 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMRA-------CWQWNPSDRPSFAEI 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 619
            QH N+V L+G C   G  ++I EY     L  FL        D      L  +  +   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTK 676
             +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +
Sbjct: 167 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 734
             V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F      + 
Sbjct: 224 LPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YK 274
Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
           L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 275 LVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQEQ 320

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
               IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 694 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P    
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL---------EKDYRMERPEGCP 236
Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           E  Y+++         C Q   +DRP+ +++
Sbjct: 237 EKVYELMR-------ACWQWNPSDRPSFAEI 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 16/278 (5%)
Query: 522 LGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V  Y     N   G+ VAVK L + +G Q    +K E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            GCC + G   L  + EY+P  SL  +L      H +G    +   + I +G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYALD 692
               IHRDL A N+LLD+D   KI DFG+A+    G E     +       + +PE   +
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F   SDV+SFGV L E LT   ++     +   L+G A       R  ELL    +  
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH 790
              +       +   C + +A+ RPT   ++ ++   H
Sbjct: 272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 132
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 237
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 95  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 144
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 253
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 254 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 295

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY----GMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 233
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 135/280 (48%), Gaps = 41/280 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 630
           +L     ++   I I E+M   SL  FL    ++     Q   K+I+    IA+G+ ++ 
Sbjct: 241 KLHAVVTKEPIYI-ITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+     ++           + +PE  
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAI 341
Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
             G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  P 
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPE 392
Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
              E  Y ++ R       C + +  +RPT   + S++ +
Sbjct: 393 NCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 425

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 233
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 234 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI------AQGLLYLHQYSR 634
           +  +  ++ ++    SL   L      H++  +T+ ++I+ I      AQG+ YLH  S 
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL------HII--ETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL--- 691
             IIHRDLK++NI L  D+  KI DFG+A            +++ G+  +M+PE      
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
              +S +SDV++FG++L E +T +       +   N+      ++   R Y  LSP L  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ-------LPYSNINNRDQIIFMVGRGY--LSPDLSK 261
Query: 752 EASY--QMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
             S   + + R +     C+++K  +RP   ++++ I     +LP
Sbjct: 262 VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 234
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 136/301 (45%), Gaps = 47/301 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQ 613
            QH N+V L+G C   G  ++I EY     L  FL           ++PS      L  +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--- 670
             +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    
Sbjct: 167 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNL 728
           ++GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F  
Sbjct: 224 VKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-- 278
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  
Sbjct: 279 ----YKLVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQE 325
Query: 789 E 789
           +
Sbjct: 326 Q 326

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 238
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI E++P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSL--------REYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 141
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 246
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 247 PEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHRDL   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYL---E 335
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHR+L A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 394
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 440
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           F+PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 145/293 (49%), Gaps = 37/293 (12%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 561
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 676
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG+++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVS 184
Query: 677 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 734
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----------HLLGWQTR 615
            QH N+V L+G C   G  ++I EY     L  FL   SR                 +  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQ 672
           +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLG 730
           GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+     F    
Sbjct: 224 GNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---- 276
Query: 731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
             + L KD   Y++  PA   +  Y ++         C   +   RPT  ++ S +  +
Sbjct: 277 --YKLVKD--GYQMAQPAFAPKNIYSIMQ-------ACWALEPTHRPTFQQICSFLQEQ 324

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 150
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 694
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 263
Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 264 HQLM-------LDCWQKERSDRPKFGQIVNML 288

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD              + +PE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 189
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 235
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 129
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHRDL A N L+  +   K++DFG++R+  GD              + +PE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 188
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 234
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 129
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 694
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 242
Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 243 HQLM-------LDCWQKERSDRPKFGQIVNML 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------GIAQGLL 627
            G C   G +   LI EY+P  SL        R +L   + R+  I+       I +G+ 
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGME 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV-VGTYGYMS 686
           YL      R IHR+L   NIL++++   KI DFG+ ++   D+     K        + +
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FSV SDV+SFGV+L E  T
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL    
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 374
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           +   IHR+L A N L+  +   K++DFG++R+  GD    +         + +PE     
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 433
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS+KSDV++FGVLL E  T     G+      +L          ++ YELL    + E 
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL----------SQVYELLEKDYRMER 479
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKV 782
                 +   +   C Q   +DRP+ +++
Sbjct: 480 PEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G+L + G+    VA+K L +  + +  ++F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLF-DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G   +    ++I EYM N SL+ FL  +  R  ++     V ++ GI  G+ YL   S +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL---SDM 135
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEYALDGL 694
             +HRDL A NIL++S++  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           F+  SDV+S+G+++ E ++       +D+ + +++            Y L  P     A 
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPPPMDCPIAL 248
Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           +Q++       L C Q++ +DRP   ++V+M+
Sbjct: 249 HQLM-------LDCWQKERSDRPKFGQIVNML 273

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 561
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 676
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG ++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-----HSVS 184
Query: 677 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 734
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 571
           E +    K+GEG +G VYK K   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V L+     +    L++E+M  K L   L D ++T L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           +   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 692 -DGLFSVKSDVFSFGVLLLETLTSK 715
               +S   D++S G +  E +T K
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 571
           E +    K+GEG +G VYK K   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V L+     +    L++E+M  K L   L D ++T L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           +   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 692 -DGLFSVKSDVFSFGVLLLETLTSK 715
               +S   D++S G +  E +T K
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 258

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 262

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +  +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 79  KP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 697
           DLK++NI L  D   KI DFG+A +          +++ G+  +M+PE         +S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 698 KSDVFSFGVLLLETLTSK 715
           +SDV++FG++L E +T +
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 45/301 (14%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G G FG V K K    ++VA+K++ S+S +  K F  E+  ++++ H N+V+L G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 582 QGEKILIYEYMPNKSLNFFLF--DP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                L+ EY    SL   L   +P    +  H + W  +       +QG+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 636 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            +IHRDLK  N+LL +     KI DFG A   C  ++Q +     G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA---C--DIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           +S K DVFS+G++L E +T ++        +F ++   W +    R      P L     
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTR------PPL----- 226
Query: 755 YQMLNRYI-TVALLCVQEKAADRPTMSKVVSMITNEHATLP-------YPKQSAFSYARR 806
            + L + I ++   C  +  + RP+M ++V ++T+     P       YP Q +      
Sbjct: 227 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 286
Query: 807 G 807
           G
Sbjct: 287 G 287

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 261

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
           L H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 262
Query: 736 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 263 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
           L H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 141/301 (46%), Gaps = 45/301 (14%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G G FG V K K    ++VA+K++ S+S +  K F  E+  ++++ H N+V+L G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 582 QGEKILIYEYMPNKSLNFFLF--DP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                L+ EY    SL   L   +P    +  H + W  +       +QG+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 636 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            +IHRDLK  N+LL +     KI DFG A   C  ++Q +     G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA---C--DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           +S K DVFS+G++L E +T ++        +F ++   W +    R      P +++   
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTR-----PPLIKN--- 228
Query: 755 YQMLNRYI-TVALLCVQEKAADRPTMSKVVSMITNEHATLP-------YPKQSAFSYARR 806
              L + I ++   C  +  + RP+M ++V ++T+     P       YP Q +      
Sbjct: 229 ---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
Query: 807 G 807
           G
Sbjct: 286 G 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 35/271 (12%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 571
           FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
            ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 172
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           ++   +IHRD+KA NILL      K+ DFG A       +       VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 223
Query: 692 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSP 747
              +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESP 271
Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPT 778
           ALQ     +    ++     C+Q+   DRPT
Sbjct: 272 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 299

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 514 ENFSMQCKLGEGGFGPVY--KGKLLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQ 568
           E + +  KLG GG   VY  +  +LN + VA+K +     +  + LK F+ E+   ++L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLL 627
           H+N+V ++    E     L+ EY+   +L+ ++     +H  L   T +     I  G+ 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H    +RI+HRD+K  NIL+DS+   KI DFG+A+      L   T  V+GT  Y SP
Sbjct: 126 HAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSP 181
Query: 688 EYALDGLFSVKSDVFSFGVLLLETL 712
           E A        +D++S G++L E L
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEML 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 35/271 (12%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 571
           FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
            ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 133
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
           ++   +IHRD+KA NILL      K+ DFG A       +       VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 692 ---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-AWNLWKDNRAYELLSP 747
              +G +  K DV+S G+  +E   ++R   ++++ + + L H A N           SP
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQN----------ESP 232
Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPT 778
           ALQ     +    ++     C+Q+   DRPT
Sbjct: 233 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           +  ++G G FG VYKGK      V + ++   + +  + F+NE+ ++ K +H N++  MG
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 578 CCVEQGEKIL--------IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
              +    I+        +Y+++  +   F +F             + I    AQG+ YL
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ-----------LIDIARQTAQGMDYL 148
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H  +   IIHRD+K++NI L   +  KI DFG+A +          ++  G+  +M+PE 
Sbjct: 149 HAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 690 AL---DGLFSVKSDVFSFGVLLLETLTSK 715
                +  FS +SDV+S+G++L E +T +
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQG-------LKEFKNEM 561
           + A      + ++G+GGFG V+KG+L+  +  VA+K L     +G        +EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            +++ L H N+V+L G         ++ E++P   L   L D  + H + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMARMFCGDELQGNTK 676
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DF +++         +  
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-----HSVS 184
Query: 677 RVVGTYGYMSPEY--ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN 734
            ++G + +M+PE   A +  ++ K+D +SF ++L   LT +   G +D  S+  +    N
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFI-N 240
Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
           + ++    E L P +  +   ++ N    V  LC       RP  S +V  ++
Sbjct: 241 MIRE----EGLRPTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           ++PS      L  +  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR     +    T   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVLL E  TL      GV   E F LL  GH
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 194
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 239
Query: 736 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 240 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSS-QSGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 262
Query: 736 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 263 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +  +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  KP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 697
           DLK++NI L  D   KI DFG+A            +++ G+  +M+PE         +S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 698 KSDVFSFGVLLLETLTSK 715
           +SDV++FG++L E +T +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 262
Query: 736 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 263 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 209
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           N      LG G FG V +      G+E     VAVK L S +    KE   +E+ +++ L
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 568 -QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------------------FDPSR 606
            QH N+V L+G C   G  ++I EY     L  FL                     D   
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
              L  +  +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 667 CGDE---LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 721
             D    ++GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +   N   G+ 
Sbjct: 209 MNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
               F      + L KD   Y++  PA   +  Y ++         C   +   RPT  +
Sbjct: 266 VNSKF------YKLVKD--GYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQ 310
Query: 782 VVSMITNE 789
           + S +  +
Sbjct: 311 ICSFLQEQ 318

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  + +  R  
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 219
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++  MG   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
              +  ++ ++    SL   L        +  +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSV 697
           DLK++NI L  D   KI DFG+A            +++ G+  +M+PE         +S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 698 KSDVFSFGVLLLETLTSK 715
           +SDV++FG++L E +T +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKL-LNGQE---VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHR 570
            +++  +G G FG V  G+L L G+    VA+K L    + +  ++F  E  ++ +  H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N++ L G   +    +++ EYM N SL+ FL        +     V ++ GI+ G+ YL 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL- 140
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT-YGYMSPEY 689
             S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R       + +PE 
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
                F+  SDV+S+G+++ E ++       Y    +  + +   +      Y L SP  
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVS-------YGERPYWEMTNQDVIKAVEEGYRLPSPMD 251
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              A YQ++       L C Q++   RP   ++V+M+
Sbjct: 252 CPAALYQLM-------LDCWQKERNSRPKFDEIVNML 281

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 132/288 (45%), Gaps = 48/288 (16%)
Query: 452 WRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSA 511
           +RRKH+E    +++ Q  L+   Y     RT+           T      P +S A  ++
Sbjct: 2   YRRKHQE----LQAMQMELQSPEYKLSKLRTS-----------TIMTDYNPNYSFAGKTS 46
Query: 512 AT--------ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKE 556
           +         +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 557 FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGW 612
           F  E ++I+K  H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L  
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGD 669
              + +   IA G  YL +      IHRD+ A N LL         KI DFGMAR    D
Sbjct: 167 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----D 219
Query: 670 ELQGNTKRVVG----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             + +  R  G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 569
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 616
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 187
Query: 677 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 732
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 247
Query: 733 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 248 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 282

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  +    R  
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 243
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
           G       +M PE  ++G+F+ K+D +SFGVLL E  +               LG+    
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYP 288
Query: 736 WKDNR-AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            K N+   E ++   + +           +   C Q +  DRP  + ++  I
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMAR    D  +    R  
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 220
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 569
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 616
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 197
Query: 677 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 732
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
Query: 733 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 258 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 292

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 43/323 (13%)
Query: 504 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 551
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 552 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 608
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 609 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 721
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 240 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 283
Query: 782 VVSMITNEHATLPYPKQSAFSYA 804
           ++S I  E    P  ++ +F Y+
Sbjct: 284 IISSIKEEME--PGFREVSFYYS 304

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 242
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L                + +  +C Q     RP+  +++S I  E    
Sbjct: 243 LLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSIKEEME-- 284
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 285 PGFREVSFYYS 295

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 147/323 (45%), Gaps = 43/323 (13%)
Query: 504 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 551
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 552 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 608
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P+  +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 609 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 721
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 289
Query: 782 VVSMITNEHATLPYPKQSAFSYA 804
           ++S I  E    P  ++ +F Y+
Sbjct: 290 IISSIKEEME--PGFREVSFYYS 310

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +   NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 117/252 (46%), Gaps = 39/252 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 666 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 721
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 722 DIESFNLL--GH 731
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 179
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P+  +  +L   +  K+
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 247
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 248 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 289
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 290 PGFREVSFYYS 300

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 173
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 691 L-DGLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 691 L-DGLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 116/252 (46%), Gaps = 39/252 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
               L     +     I+QG+ YL + S   ++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 666 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 721
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 722 DIESFNLL--GH 731
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 117/252 (46%), Gaps = 39/252 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 666 FCGDELQGNTKRVVG--TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVY 721
               E     KR  G     +M+ E   D +++ +SDV+SFGVLL E +T   N   G+ 
Sbjct: 200 VY--EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 722 DIESFNLL--GH 731
               FNLL  GH
Sbjct: 258 PERLFNLLKTGH 269

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL +    PS+   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVV 679
           A G  YL +      IHRD+ A N LL         KI DFGMA+    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKG 203
Query: 680 G----TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G       +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 144/323 (44%), Gaps = 43/323 (13%)
Query: 504 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 551
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 552 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 608
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 609 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 721
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 180 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
           + +    +     L K +   ++L   ++                +C Q     RP+  +
Sbjct: 240 NEQVLRFVMEGGLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLE 283
Query: 782 VVSMITNEHATLPYPKQSAFSYA 804
           ++S I  E    P  ++ +F Y+
Sbjct: 284 IISSIKEEME--PGFREVSFYYS 304

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 41/292 (14%)
Query: 522 LGEGGFGPVYKGKLLNGQ----EVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LGEG FG V +G L        +VAVK  +L + S + ++EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 576 MGCCVE---QG--EKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGL 626
           +G C+E   QG  + ++I  +M    L+ +L     +    H +  QT +K +  IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQTLLKFMVDIALGM 160
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDEL-QGNTKRVVGTYGY 684
            YL   S    +HRDL A N +L  DM   ++DFG++ +++ GD   QG   ++     +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 215
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAY 742
           ++ E   D +++ KSDV++FGV + E  T       GV + E ++ L H   L +     
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL 275
Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
           + L     +E  Y            C +    DRPT S +   +     +LP
Sbjct: 276 DEL-----YEIMYS-----------CWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 43/323 (13%)
Query: 504 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 551
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 552 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 608
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 609 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 721
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
           + +    +     L K +   ++L         ++++        +C Q     RP+  +
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDML---------FELMR-------MCWQYNPKMRPSFLE 289
Query: 782 VVSMITNEHATLPYPKQSAFSYA 804
           ++S I  E    P  ++ +F Y+
Sbjct: 290 IISSIKEEME--PGFREVSFYYS 310

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 250
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 251 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 292
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 293 PGFREVSFYYS 303

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 244
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 245 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 286
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 287 PGFREVSFYYS 297

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 144/323 (44%), Gaps = 43/323 (13%)
Query: 504 FSLASV------SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSG 551
           FS A V        A E  +M  +LG+G FG VY+G      K      VA+K ++  + 
Sbjct: 31  FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 90
Query: 552 QGLK-EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH 608
              + EF NE  ++ +    ++VRL+G   +    ++I E M    L  +L    P   +
Sbjct: 91  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 150
Query: 609 --LLGWQTRVKIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +L   +  K+I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 151 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 207
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVY 721
           R     +      + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ 
Sbjct: 208 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 267
Query: 722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSK 781
           + +    +     L K +   ++L   ++                +C Q     RP+  +
Sbjct: 268 NEQVLRFVMEGGLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLE 311
Query: 782 VVSMITNEHATLPYPKQSAFSYA 804
           ++S I  E    P  ++ +F Y+
Sbjct: 312 IISSIKEEME--PGFREVSFYYS 332

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 189 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 248
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 249 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 290
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 291 PGFREVSFYYS 301

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 250
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L   ++                +C Q     RP+  +++S I  E    
Sbjct: 251 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKEEME-- 292
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 293 PGFREVSFYYS 303

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSS-QSGQGLKEFKNEMMLIAKL-QH 569
           +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 616
            N++ L+G C  +G   L  EY P+ +L  FL        DP      S    L  Q  +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                +A+G+ YL   S+ + IHR+L A NIL+  +   KI+DFG++R   G E+    K
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVY--VK 194
Query: 677 RVVGT--YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHA 732
           + +G     +M+ E     +++  SDV+S+GVLL E  +L      G+   E +  L   
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 254
Query: 733 WNLWK----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           + L K    D+  Y+L+                      C +EK  +RP+ ++++
Sbjct: 255 YRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQIL 289

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 37/311 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
             A E  +M  +LG+G FG VY+G      K      VA+K ++  +    + EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTH--LLGWQTRVKI 618
           ++ +    ++VRL+G   +    ++I E M    L  +L    P   +  +L   +  K+
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 619 IE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           I+    IA G+ YL+     + +HRDL A N  +  D   KI DFGM R     +     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +MSPE   DG+F+  SDV+SFGV+L E  TL  +   G+ + +    +    
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 244
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            L K +   ++L                + +  +C Q     RP+  +++S I  E    
Sbjct: 245 LLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSIKEEME-- 286
Query: 794 PYPKQSAFSYA 804
           P  ++ +F Y+
Sbjct: 287 PGFREVSFYYS 297

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 582 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTKSD 187
Query: 701 VFSFGVLLLETLTSKR 716
           V+SFG+LL E  +  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 568
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSK 715
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 568
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSK 715
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+L+G     G+  ++ E+ P  +++  + +  R  L   Q +V +   + + L +LH  
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-VCRQMLEALNFLHSK 128
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYA 690
              RIIHRDLKA N+L+  + + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 691 L-----DGLFSVKSDVFSFGVLLLE 710
           +     D  +  K+D++S G+ L+E
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIE 206

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 246
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 247 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 290
Query: 793 LP 794
            P
Sbjct: 291 FP 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 568
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSK 715
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 793 LP 794
            P
Sbjct: 294 FP 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+L+G     G+  ++ E+ P  +++  + +  R  L   Q +V +   + + L +LH  
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-VCRQMLEALNFLHSK 136
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYA 690
              RIIHRDLKA N+L+  + + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 691 L-----DGLFSVKSDVFSFGVLLLE 710
           +     D  +  K+D++S G+ L+E
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIE 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 568
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSK 715
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKN 559
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 24  LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVK 617
            M+ I  L H ++VRL+G C     + L+ +Y+P  SL     D  R H   LG Q  + 
Sbjct: 83  HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLN 137
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
               IA+G+ YL ++    ++HR+L A N+LL S    +++DFG+A +   D+ Q     
Sbjct: 138 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                 +M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 176
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 17/220 (7%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 555
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S +  K
Sbjct: 5   PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 63
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 613
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXL----LDYVREHKDNIGSQ 118
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 119 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 26/244 (10%)
Query: 478 VATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLN 537
           + T  N   +G G+A         P  +L  +   TE F     LG G FG VYKG  + 
Sbjct: 14  IPTTENLYFQGSGEA---------PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIP 63
Query: 538 GQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
             E     VA+K L  + S +  KE  +E  ++A + + ++ RL+G C+    + LI + 
Sbjct: 64  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQL 122
Query: 592 MPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
           MP   L     D  R H   +G Q  +     IA+G+ YL      R++HRDL A N+L+
Sbjct: 123 MPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLV 175
Query: 650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL 709
            +  + KI+DFG+A++   +E + + +       +M+ E  L  +++ +SDV+S+GV + 
Sbjct: 176 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 235
Query: 710 ETLT 713
           E +T
Sbjct: 236 ELMT 239

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 176
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 691 LD-GLFSVKSDVFSFGVLLLETLTSK 715
           L    +S   D++S G +  E +T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 189 IYTHQSDVWSYGVTVWELMT 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 505 SLAS-VSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKN 559
           SLA+ +    E+F +   LG+G F  VY+ + ++ G EVA+K +  ++      ++  +N
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E+ +  +L+H +++ L     +     L+ E   N  +N +L   +R            +
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM 118
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             I  G+LYLH +    I+HRDL  SN+LL  +MN KI+DFG+A        +  T  + 
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y+SPE A      ++SDV+S G +    L  +
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQ 568
           + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
            H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSK 715
             L    +S   D++S G +  E +T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 17/220 (7%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 555
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S +  K
Sbjct: 4   PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 613
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXL----LDYVREHKDNIGSQ 117
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 118 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293
Query: 793 LP 794
            P
Sbjct: 294 FP 295

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 140
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 141 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 582 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 368
Query: 701 VFSFGVLLLETLTSKR 716
           V+SFG+LL E  +  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 137
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 138 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR- 133
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 134 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 192 IYTHQSDVWSYGVTVWELMT 211

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKN 559
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 6   LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVK 617
            M+ I  L H ++VRL+G C     + L+ +Y+P  SL     D  R H   LG Q  + 
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLN 119
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
               IA+G+ YL ++    ++HR+L A N+LL S    +++DFG+A +   D+ Q     
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                 +M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 550
           R    P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 551 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 609
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 610 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 142
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 143 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 201 IYTHQSDVWSYGVTVWELMT 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ ++ L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 582 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181
Query: 701 VFSFGVLLLETLTSKR 716
           V+SFG+LL E  +  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 146
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 147 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 205 IYTHQSDVWSYGVTVWELMT 224

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 117/245 (47%), Gaps = 30/245 (12%)
Query: 514 ENFSMQCKLGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLI 564
           +  ++   LGEG FG V         K K      VAVK L   + +  L +  +EM ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLL 610
             + +H+N++ L+G C + G   +I EY    +L  +L           +D +R     +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 728
               T        +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F L
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 729 L--GH 731
           L  GH
Sbjct: 318 LKEGH 322

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++     +F   D S    +        +  + QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++     +F   D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 793 LP 794
            P
Sbjct: 294 FP 295

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 139
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 140 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 522 LGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVR 574
           +GEG FG V++ +   LL  +    VAVK L  ++   ++ +F+ E  L+A+  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------LGWQTRVK---------- 617
           L+G C       L++EYM    LN FL   S   +       L  + RV           
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 618 ----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQ 672
               I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R ++  D  +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA 732
            +    +    +M PE      ++ +SDV+++GV+L E  +       Y ++ +  + H 
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS-------YGLQPYYGMAHE 283
Query: 733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
             ++       L  P       Y ++        LC  +  ADRP+   +
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMR-------LCWSKLPADRPSFCSI 326

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+L+G  VE
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 582 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           + G   ++ EYM   SL  +L    R+ +LG    +K    + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSD 700
           DL A N+L+  D   K+SDFG+ +     +  G          + +PE   +  FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 196
Query: 701 VFSFGVLLLETLTSKR 716
           V+SFG+LL E  +  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 261
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 262 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 312
Query: 790 H 790
Sbjct: 313 E 313

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 264
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 265 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 315
Query: 790 H 790
Sbjct: 316 E 316

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   +I+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQH 569
            E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+++L     +     ++ E      L   +    R          +II+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 684
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 114/237 (48%), Gaps = 30/237 (12%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I EY    +L  +L           +D +R     + ++  V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL--GH 731
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL  GH
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 263

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ +  L  F+ D S    +        +  + QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQH 569
            E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+++L     +     ++ E      L   +    R          +II+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 684
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKL 567
            + ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N+V+L+     + +  L++E++ +  L  F+ D S    +        +  + QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++     VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 688 EYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           E  L    +S   D++S G +  E +T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 140/279 (50%), Gaps = 41/279 (14%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G+L L G+    VA+K L    + +  ++F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII---EGIAQGLLYLHQYS 633
           G        +++ E+M N +L+ FL    R H  G  T ++++    GIA G+ YL   +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL----RKHD-GQFTVIQLVGMLRGIAAGMRYL---A 162
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSP 687
            +  +HRDL A NIL++S++  K+SDFG++R+     ++ + + V  T G      + +P
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E      F+  SDV+S+G+++ E ++       +D+ + +++            Y L +P
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAI------EEGYRLPAP 270
Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                  +Q++       L C Q++ A+RP   ++V ++
Sbjct: 271 MDCPAGLHQLM-------LDCWQKERAERPKFEQIVGIL 302

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +     
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 249 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 292
Query: 793 LP 794
            P
Sbjct: 293 FP 294

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 140
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 141 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 507 ASVSAATENF---SMQCKLGE----GGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN 559
           + V   TEN    SM  +L E    G FG V+K +LLN + VAVK    Q  Q  +  + 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EY 67
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKI-----LIYEYMPNKSLNFFLFDPSRTHLLGWQT 614
           E+  +  ++H N+++ +G   ++G  +     LI  +    SL+ FL    + +++ W  
Sbjct: 68  EVYSLPGMKHENILQFIGA-EKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122
Query: 615 RVKIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
              I E +A+GL YLH+         +  I HRD+K+ N+LL +++   I+DFG+A  F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVF 702
             +  G+T   VGT  YM+PE  L+G  + + D F
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAF 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HRDL A N ++  D   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293
Query: 793 LP 794
            P
Sbjct: 294 FP 295

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 550
           R    P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 551 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 609
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 610 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 176
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 27/273 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +    ++I E+M N SL+ FL        +     V ++ GIA G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALDG 693
            +HRDL A NIL++S++  K+SDFG++R    D         +G      + +PE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            F+  SDV+S+G+++ E ++       +D+ + +++          + Y L  P     A
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-YWDMTNQDVINAI------EQDYRLPPPMDCPSA 268
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            +Q++       L C Q+    RP   ++V+ +
Sbjct: 269 LHQLM-------LDCWQKDRNHRPKFGQIVNTL 294

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 564
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 565 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 555
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+K L  + S +  K
Sbjct: 6   PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 64
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 613
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQ 119
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG A++   +E + 
Sbjct: 120 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQHR 570
           E +++ C LG+G FG V K K  +  QE AVK ++  S +         E+ L+ KL H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYL 629
           N+++L     +     ++ E      L    FD   +          +II+ +  G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV--VGTYGY 684
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK    +GT  Y
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYY 189
Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAV-KRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G FG   K       EV V K L     +  + F  E+ ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +      I EY+   +L   +   S      W  RV   + IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR------------VVGTYGYMSPE 688
           DL + N L+  + N  ++DFG+AR+   ++ Q    R            VVG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
                 +  K DVFSFG++L E +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 138
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG A++   +E + + +       +M+ E  L  
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 576 MGCCVEQG--EKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
            G     G  E  L+ EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 125
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 683
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 126 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPI 178
Query: 684 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 730
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 226

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 683
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 129 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 181
Query: 684 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +R  
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLL 241
Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           ELL    +  A          +  LC      DRP+ S +
Sbjct: 242 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
           LGEG FG V         K K      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
           ++ L+G C + G   +I  Y    +L  +L           +D +R     + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLW 736
                +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F LL       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNE 789
                + +  PA      Y M+         C     + RPT       + +++++ TNE
Sbjct: 273 --KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 790 H 790
Sbjct: 324 E 324

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 564
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 565 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQG---LKEFKNEMML--I 564
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 565 AKLQHRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
              +H N+VRL   C       + +  L++E++ ++ L  +L D      +  +T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 522 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G +G VY G+ L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 581 EQGEKILIYEYMPNKSLNFFL---FDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           E G   +  E +P  SL+  L   + P +     +G+ T+      I +GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 141
Query: 636 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 695 --FSVKSDVFSFGVLLLETLTSK 715
             +   +D++S G  ++E  T K
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 550
           R    P  +L  +   TE F     L  G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 551 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 609
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKD 119
Query: 610 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQS 550
           R    P  +L  +   TE F     L  G FG VYKG  +   E     VA+K L  + S
Sbjct: 6   RSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 64
Query: 551 GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL- 609
            +  KE  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H  
Sbjct: 65  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKD 119
Query: 610 -LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            +G Q  +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +E + + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 250
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 251 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 294
Query: 793 LP 794
            P
Sbjct: 295 FP 296

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           L  G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A + + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + LI + MP   L     D  R H   +G Q  +     IA+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ E  L  
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 694 LFSVKSDVFSFGVLLLETLT 713
           +++ +SDV+S+GV + E +T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK---LLNGQ---EVAVKRLS-SQSGQGLKEFKNEMM 562
             + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLG-----WQTR 615
           ++      ++VRL+G   +    +++ E M +  L  +L    P   +  G      Q  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +++   IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAW 733
            + +    +M+PE   DG+F+  SD++SFGV+L E  +L  +   G+ + +    +    
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE-HAT 792
            L + +   E                R   +  +C Q     RPT  ++V+++ ++ H +
Sbjct: 250 YLDQPDNCPE----------------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293
Query: 793 LP 794
            P
Sbjct: 294 FP 295

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 522 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G +G VY G+ L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 581 EQGEKILIYEYMPNKSLNFFL---FDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           E G   +  E +P  SL+  L   + P +     +G+ T+      I +GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 127
Query: 636 RIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 695 --FSVKSDVFSFGVLLLETLTSK 715
             +   +D++S G  ++E  T K
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 10/203 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E F +  KLGEG +G VYK      GQ VA+K++  +S   L+E   E+ ++ +    ++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHV 86
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+  G   +  +  ++ EY    S++  +    R   L       I++   +GL YLH  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
             +R IHRD+KA NILL+++ + K++DFG+A        + N   V+GT  +M+PE   +
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQE 199
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             ++  +D++S G+  +E    K
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 135/309 (43%), Gaps = 51/309 (16%)
Query: 514 ENFSMQCKLGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLI 564
           +  ++   LGEG FG V         K K      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLL 610
             + +H+N++ L+G C + G   +I  Y    +L  +L           +D +R     +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNL 728
               T        +M+PE   D +++ +SDV+SFGVL+ E  TL      G+   E F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSK 781
           L            + +  PA      Y M+         C     + RPT       + +
Sbjct: 272 L---------KEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDR 315
Query: 782 VVSMITNEH 790
           ++++ TNE 
Sbjct: 316 ILTLTTNEE 324

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLK 555
           P  +L  +   TE F     LG G FG VYKG  +   E     VA+  L  + S +  K
Sbjct: 38  PNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK 96
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQ 613
           E  +E  ++A + + ++ RL+G C+    + LI + MP   L     D  R H   +G Q
Sbjct: 97  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQ 151
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
             +     IA+G+ YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + 
Sbjct: 152 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + +       +M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 26/244 (10%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQ--SGQGLKEFKN 559
           L  V    + F++   LG+G FG V + +L        +VAVK L +   +   ++EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRT----HL 609
           E   + +  H ++ +L+G  +    K      ++I  +M +  L+ FL   SR       
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFN 133
Query: 610 LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCG 668
           L  QT V+ +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R ++ G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 669 DEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIES 725
           D   QG   ++     +++ E   D L++V SDV++FGV + E +T  +    G+ + E 
Sbjct: 191 DYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 726 FNLL 729
           +N L
Sbjct: 249 YNYL 252

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 141
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 683
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 142 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 194
Query: 684 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +R  
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           ELL    +  A          +  LC      DRP+ S +
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L    +V+ 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
            G     G + L  + EY+P+  L  FL       D SR  L   Q        I +G+ 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG---- 683
           YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+       VV   G    
Sbjct: 130 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPI 182
Query: 684 -YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 730
            + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 135/274 (49%), Gaps = 29/274 (10%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V +G+L   G++   VA+K L    + +  +EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL-FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G        +++ E+M N +L+ FL  +  +  ++     V ++ GIA G+ YL + S  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALD 692
             +HRDL A NIL++S++  K+SDFG++R    +         +G      + +PE    
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F+  SD +S+G+++ E ++       +D+ + +++          + Y L  P     
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERP-YWDMSNQDVINAI------EQDYRLPPPPDCPT 248
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           + +Q++       L C Q+    RP   +VVS +
Sbjct: 249 SLHQLM-------LDCWQKDRNARPRFPQVVSAL 275

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V +G+L   G++   VA+K L    + +  +EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL-FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G        +++ E+M N +L+ FL  +  +  ++     V ++ GIA G+ YL + S  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALD 692
             +HRDL A NIL++S++  K+SDFG++R    +         +G      + +PE    
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 693 GLFSVKSDVFSFGVLLLETLT 713
             F+  SD +S+G+++ E ++
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS 218

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGWQTRVKIIEGIAQGLLYLHQYS 633
           +G C+    + L+ + MP   L     D  R +   LG Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL----LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
            +R++HRDL A N+L+ S  + KI+DFG+AR+   DE + +         +M+ E  L  
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 694 LFSVKSDVFSFGVLLLETLT 713
            F+ +SDV+S+GV + E +T
Sbjct: 197 RFTHQSDVWSYGVTVWELMT 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           E+  +  ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +VRL+G C ++    ++ E +  +  +F  F  +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG----TYGYMSP 687
                 IHRDL A N L+      KISDFGM+R    +E  G      G       + +P
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAP 284
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E    G +S +SDV+SFG+LL ET +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           E+  +  ++G G FG V+ G+L  +   VAVK         LK +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +VRL+G C ++    ++ E +  +  +F  F  +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                 IHRDL A N L+      KISDFGM+R         +         + +PE   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
            G +S +SDV+SFG+LL ET +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 27/273 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G FG V  G L L G+    VA+K L S  + +  ++F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +    ++I E+M N SL+ FL        +     V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG---TYGYMSPEYALDG 693
            +HR L A NIL++S++  K+SDFG++R    D         +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            F+  SDV+S+G+++ E ++       +D+ + +++          + Y L  P     A
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-YWDMTNQDVINAI------EQDYRLPPPMDCPSA 242
Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            +Q++       L C Q+    RP   ++V+ +
Sbjct: 243 LHQLM-------LDCWQKDRNHRPKFGQIVNTL 268

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHR 570
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 622
           N+++     +E  E  ++ E      L+  +          P RT    W+  V++   +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT---VWKYFVQLCSAL 149
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
                  H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT 
Sbjct: 150 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            YMSPE   +  ++ KSD++S G LL E    +              G   NL+   +  
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS----------PFYGDKMNLYSLCKKI 250
Query: 743 ELLS-PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA 791
           E    P L  +   + L + +    +C+      RP ++ V  +    HA
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHA 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSEMVGT 179
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 126
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGT 179
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL   +   + T +   Q      E + 
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL- 127
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGT 180
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
             +M+PE      +  K D++S G++ +E +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 559
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 81
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 138
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 676
             +  G+ Y+H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 139 RQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 192
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 54/294 (18%)
Query: 522 LGEGGFGPVYKGKLL----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G+G FG VY G+ +    N  + A+K LS  +  Q ++ F  E +L+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 577 GCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G  +  +G   ++  YM +  L  F+  P R   +  +  +     +A+G+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQ 143
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL----QGNTKRVVGTYGYMSPEYAL 691
           + +HRDL A N +LD     K++DFG+AR     E     Q    R+   +       AL
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------AL 197
Query: 692 DGL----FSVKSDVFSFGVLLLETLT----SKRNTGVYDIESFNLLGHAWNLWKDNRAYE 743
           + L    F+ KSDV+SFGVLL E LT      R+   +D+  F   G             
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-----------R 246
Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-------MSKVVSMITNEH 790
           L  P    ++ YQ++ +       C +   A RPT       + ++VS +  +H
Sbjct: 247 LPQPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQIVSALLGDH 293

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 508 SVSAATE------NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFK 558
           S+++AT+      N+ +Q  +G+G F  V   + +L G+EVAVK +     +   L++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 559 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
            E+ ++  L H N+V+L      +    L+ EY     +  +L    R  +   + R K 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF 120
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF-CGDELQGNTKR 677
            + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F  G++L      
Sbjct: 121 RQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG- 175
Query: 678 VVGTYGYMSPEYALDGLFSVKS------DVFSFGVLLLETLTS 714
                   SP YA   LF  K       DV+S GV+L  TL S
Sbjct: 176 --------SPPYAAPELFQGKKYDGPEVDVWSLGVILY-TLVS 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 559
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVK 617
           E+ L+ +L H N+++L     ++G   L+ E      L    FD   SR          +
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-AR 130
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGN 674
           II  +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E    
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
            K  +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 568
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 569 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 568
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 569 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVV 173
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 559
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 98
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 155
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 676
             +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 209
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 210 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 559
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 99
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E+ L+ +L H N+++L     ++G   L+ E      L   +    R          +II
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARII 156
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTK 676
             +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 210
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 211 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
            K+GEG  G V   +  + G++VAVK +  +  Q  +   NE++++   QH N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
            +   E  ++ E++   +L     D      L  +    + E + Q L YLH      +I
Sbjct: 111 YLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 696
           HRD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT  +M+PE     L++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 697 VKSDVFSFGVLLLETL 712
            + D++S G++++E +
Sbjct: 220 TEVDIWSLGIMVIEMV 235

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +N  +   +G G +G VYKG L + + VAVK  S  + Q     KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 574 RLMG-----CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           R +          + E +L+ EY PN SL  +L      H   W +  ++   + +GL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 629 LH------QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-----QGNTK- 676
           LH       + +  I HRDL + N+L+ +D    ISDFG++    G+ L     + N   
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 677 RVVGTYGYMSPEYALDGLFSVKS--------DVFSFGVLLLE 710
             VGT  YM+PE  L+G  +++         D+++ G++  E
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 46/292 (15%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 572 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTH--LLGWQTRVKII 619
           +V L+G C + G  +++            Y+ +K   F  + P   +   L  +  +   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D          
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLW 736
               +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     + 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM- 270
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
              RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 271 ---RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
           EN      LG G FG V         K     +VAVK L  ++    +E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYM-PNKSLNFF-------------------LFDPS 605
           L  H N+V L+G C   G   LI+EY      LN+                    L +  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
             ++L ++  +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 666 FCGDE---LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              D    ++GN +  V    +M+PE   +G++++KSDV+S+G+LL E  +
Sbjct: 222 IMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 521 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 691
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 692 -----DGLFSVKSDVFSFGVLLLE 710
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--- 559
           F   S +  ++ +  Q  LG+G FG V   K  + GQE AVK +S +  +   + ++   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVK 617
           E+ L+ +L H N+ +L     ++G   L+ E      L    FD   SR          +
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-AR 130
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGN 674
           II  +  G+ Y H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E    
Sbjct: 131 IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
            K  +GT  Y++PE  L G +  K DV+S GV+L
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 521 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 691
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 692 -----DGLFSVKSDVFSFGVLLLE 710
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    LI EY     +  +L    R      +++ + I    Q   Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 129
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               RI+HRDLKA N+LLD+DMN KI+DFG +  F    + G      G     SP YA 
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDTFCG-----SPPYAA 178
Query: 692 DGLFSVKS------DVFSFGVLL 708
             LF  K       DV+S GV+L
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVIL 201

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V  GK  L G +VAVK L+ Q  + L    + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
                 +  ++ EY+    L  ++    R   L  +   ++ + I  G+ Y H++    +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 696
           +HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  Y +PE     L++ 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPEVISGRLYAG 194
Query: 697 VKSDVFSFGVLLLETL 712
            + D++S GV+L   L
Sbjct: 195 PEVDIWSSGVILYALL 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    LI EY     +  +L    R      +++ + I    Q   Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 132
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               RI+HRDLKA N+LLD+DMN KI+DFG +  F    + G      G   Y +PE   
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPE--- 183
Query: 692 DGLFSVKS------DVFSFGVLLLETLTS 714
             LF  K       DV+S GV+L  TL S
Sbjct: 184 --LFQGKKYDGPEVDVWSLGVILY-TLVS 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 29/204 (14%)
Query: 521 KLGEGGFGPVYKGKLLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           +LG+G FG VYK +  N +     A K + ++S + L+++  E+ ++A   H N+V+L+ 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
               +    ++ E+    +++  + +  R  L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV------VGTYGYMSPEYAL 691
           IHRDLKA NIL   D + K++DFG++          NT+ +      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 692 -----DGLFSVKSDVFSFGVLLLE 710
                D  +  K+DV+S G+ L+E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLL 610
           +FKNE+ +I  +++   +   G      E  +IYEYM N S+      FF+ D + T  +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
             Q    II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 671 LQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL 728
           ++G+     GTY +M PE+  +       K D++S G+ L            Y++  F+L
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLY--------VMFYNVVPFSL 254
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNR 760
                 L+ + R   +  P  ++   Y + N+
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNK 286

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ 568
           AT  +    ++G G +G VYK +   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 569 ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
              H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
              +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVV 173
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
           +V L+G C + G  +++            Y+ +K   F  +       L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLLGHAWNLWKDN 739
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F          +  
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXR--------RLK 261
Query: 740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               + +P       YQ +       L C   + + RPT S++V  + N
Sbjct: 262 EGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR 574
           F +   +G G +G VYKG+ +   ++A  ++   +G   +E K E+ ++ K   HRN+  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 575 LMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
             G  +++       +  L+ E+    S+   + + ++ + L  +    I   I +GL +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSH 144
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LHQ+   ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT  +M+PE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 199
Query: 689 YAL-----DGLFSVKSDVFSFGVLLLE 710
                   D  +  KSD++S G+  +E
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIE 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 569 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 621 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 675
            IA   Q L + HQ     IIHRD+K +NIL+ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX-QT 176
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 525 GGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--- 581
           G FG V+K +L+N   VAVK    Q  Q  +  + E+     ++H NL++ +        
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 582 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-------- 632
            + E  LI  +    SL  +L    + +++ W     + E +++GL YLH+         
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
            +  I HRD K+ N+LL SD+   ++DFG+A  F   +  G+T   VGT  YM+PE  L+
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 693 GLFSVKSDVF------SFGVLLLETLT 713
           G  + + D F      + G++L E ++
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW----QTRVKIIEGIAQGLL 627
           +V+L      +    L+ EY     +    FD    H  GW    + R K  + I   + 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAH--GWMKEKEARAKFRQ-IVSAVQ 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMS 686
           Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              S
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------S 168
Query: 687 PEYALDGLFSVKS------DVFSFGVLL 708
           P YA   LF  K       DV+S GV+L
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVIL 196

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 132/299 (44%), Gaps = 59/299 (19%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 93
Query: 572 LVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL------FDPSRT------------HLLGW 612
           +V L+G C + G  ++ I E+    +L+ +L      F P +T            HL+ +
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
             +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D   
Sbjct: 154 SFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLL 729
                      +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 265 KEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLK 555
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 3   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 59
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
             + E+  +  L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 116
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN- 674
            +  + I   + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN 
Sbjct: 117 -RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 168
Query: 675 TKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 715
            K   G+  Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 169 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLK 555
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 2   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 58
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
             + E+  +  L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 115
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN- 674
            +  + I   + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN 
Sbjct: 116 -RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 167
Query: 675 TKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 715
            K   G+  Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 569 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 621 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 675
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
           +V L+G C + G  +++            Y+ +K   F  +       L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 266
Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 267 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 569 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 621 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 675
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 511 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQ 568
           +++  F    KLG G +  VYKG     G  VA+K +   S +G       E+ L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR------VKIIE-G 621
           H N+VRL      + +  L++E+M N    +     SRT  +G   R      VK  +  
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYM---DSRT--VGNTPRGLELNLVKYFQWQ 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           + QGL + H+    +I+HRDLK  N+L++     K+ DFG+AR F G  +   +  VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 682 YGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 715
             Y +P+  +    +S   D++S G +L E +T K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
           + SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE++++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
            + ++ N+V  +   +   E  ++ EY+   SL     D      +       +     Q
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 128
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTY 682
            L +LH     ++IHR++K+ NILL  D + K++DFG    FC       +KR  +VGT 
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTP 181
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
            +M+PE      +  K D++S G++ +E +
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-- 578
           +G GGFG V+K K  ++G+   ++R+   + +  +E K     +AKL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 75
Query: 579 -----CVEQGEKILIYEYMPNKSLN--------FFL-------------FDPSRTHLLGW 612
                     + +   +Y P  S N         F+              +  R   L  
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
              +++ E I +G+ Y+H     ++IHRDLK SNI L      KI DFG+      D   
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--- 189
Query: 673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           G   R  GT  YMSPE      +  + D+++ G++L E L
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 691 LDGLFSVKS------DVFSFGVLL 708
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 23/249 (9%)
Query: 522 LGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G FG V+K  +   G ++A K + ++  +  +E KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
            + + +L+ EY+    L   + D S    L     +  ++ I +G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 641 DLKASNIL-LDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVK 698
           DLK  NIL ++ D    KI DFG+AR +   E     K   GT  +++PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 699 SDVFSFGV---LLLETLTSKRNTGVYDIESF-NLLGHAWNLWKD------NRAYELLSPA 748
           +D++S GV   +LL  L+     G  D E+  N+L   W+L  +        A E +S  
Sbjct: 269 TDMWSVGVIAYMLLSGLSP--FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326
Query: 749 LQHEASYQM 757
           L  E S+++
Sbjct: 327 LIKEKSWRI 335

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 691 LDGLFSVKS------DVFSFGVLLLETLTS 714
              LF  K       DV+S GV+L  TL S
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILY-TLVS 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 511 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLI 564
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
             L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R +  + I  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 114
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 683
            + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN  K   G+  
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 167
Query: 684 YMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 715
           Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 691 LDGLFSVKS------DVFSFGVLL 708
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 511 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLI 564
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
             L+H ++++L      + E I++ EY  N+  ++ +    R  +   + R +  + I  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 118
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYG 683
            + Y H++   +I+HRDLK  N+LLD  +N KI+DFG++ +       GN  K   G+  
Sbjct: 119 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 171
Query: 684 YMSPEYALDGLFS-VKSDVFSFGVLLLETLTSK 715
           Y +PE     L++  + DV+S GV+L   L  +
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG----DELQGNTKRVVGTYGYMSP 687
                I+HRDLKA N+LLD+DMN KI+DFG +  F      DE  G            SP
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG------------SP 176
Query: 688 EYALDGLFSVKS------DVFSFGVLL 708
            YA   LF  K       DV+S GV+L
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 569 HRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           H  +V       + GE          ++ EY+   +L   +      H  G  T  + IE
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIE 120
Query: 621 GIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNT 675
            IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QT 176
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 569 HRNLVRLMGCCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA- 623
           H  +V +      +        ++ EY+   +L   +      H  G  T  + IE IA 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIAD 124
Query: 624 --QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVV 679
             Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T  V+
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVI 180
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R  +   + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
                I+HRDLKA N+LLD+DMN KI+DFG +  F  G++L              SP YA
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 691 LDGLFSVKS------DVFSFGVLL 708
              LF  K       DV+S GV+L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNE 560
           L S   A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRRE 61
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTR 615
           + + + L+H N++RL G   +     LI EY P  ++   L     FD  RT        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-------- 113
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
              I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   +
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPS 163
Query: 676 KR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            R   + GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 164 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 122
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 178
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 231
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 232 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 266

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 155 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 265
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 266 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 309

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEF-----KNEMML 563
           S AT  +    ++G G +G VYK +   +G  VA+K +   +G G           E+ L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 564 IAKLQ---HRNLVRLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
           + +L+   H N+VRLM  C       + +  L++E++ ++ L  +L D +    L  +T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
             ++    +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++     Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMAL 176
Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 138
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 194
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 247
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 248 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 282

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +   C       T  + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTT-LSGT 170
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK---EFKNEM 561
           + + S  ++ + +   LG GG   V+  + L   ++VAVK L +   +       F+ E 
Sbjct: 21  MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 80
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEK--------ILIYEYMPNKSLNFFLFDPSRTHLLGWQ 613
              A L H  +V       + GE          ++ EY+   +L   +      H  G  
Sbjct: 81  QNAAALNHPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPM 130
Query: 614 TRVKIIEGIA---QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--G 668
           T  + IE IA   Q L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G
Sbjct: 131 TPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           + +   T  V+GT  Y+SPE A       +SDV+S G +L E LT +
Sbjct: 188 NSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
           A E+  +   LGEG FG VY+G   N +     VAVK          KE F +E +++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L H ++V+L+G  +E+    +I E  P   L  +L      + L   T V     I + +
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 126
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            YL     +  +HRD+   NIL+ S    K+ DFG++R +  DE             +MS
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMS 182
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+ F V + E L+  +    + +E+ +++G    L K +R   L  
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIG---VLEKGDR---LPK 235
Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           P L     Y ++ R       C     +DRP  +++V  +++
Sbjct: 236 PDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 270

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKN 559
           ++ S   A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + 
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRR 60
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQT 614
           E+ + + L+H N++RL G   +     LI EY P  ++   L     FD  RT       
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------- 113
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
               I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   
Sbjct: 114 -ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAP 162
Query: 675 TKR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           + R   + GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 163 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 153 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 264 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 507 ASVSAATENFSMQC--------KLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQ 552
           + V   TEN   Q         K+GEG FG          G+    +E+ + R+SS+  +
Sbjct: 9   SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 553 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
              E + E+ ++A ++H N+V+      E G   ++ +Y     L F   +  +  L   
Sbjct: 69  ---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQE 124
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-EL 671
               +I++   Q  L L      +I+HRD+K+ NI L  D   ++ DFG+AR+     EL
Sbjct: 125 D---QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
               +  +GT  Y+SPE   +  ++ KSD+++ G +L E  T K
Sbjct: 182 ---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 635
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 635
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 635
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P   +   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT--------ATYITE 121
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGT 174
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
           LG GGFG V+  ++   G+  A K+L+ +  +  K ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII--EGIAQGLLYLHQYSRL 635
               + +  L+   M    + + +++    +  G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
            II+RDLK  N+LLD D N +ISD G+A  +  G   Q  TK   GT G+M+PE  L   
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEE 365
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           +    D F+ GV L E + ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P   +   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT--------ATYITE 121
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E F+   ++G+G FG VYKG   + +EV A+K +   ++   +++ + E+ ++++     
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKS-LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           + R  G  ++  +  +I EY+   S L+     P     +       I+  I +GL YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 133
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
                R IHRD+KA+N+LL    + K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVI 188
Query: 691 LDGLFSVKSDVFSFGVLLLE 710
               +  K+D++S G+  +E
Sbjct: 189 KQSAYDFKADIWSLGITAIE 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 131
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 187
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-- 578
           +G GGFG V+K K  ++G+   +KR+   + +  +E K     +AKL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 74
Query: 579 ----CVEQGEK----------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
                 E   K           +  E+    +L  ++ +  R   L     +++ E I +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G   R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRY 187
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETL 712
           MSPE      +  + D+++ G++L E L
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 144 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NL 728
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254
Query: 729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           L     +    RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 255 LKEGTRM----RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGT 169
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 507 ASVSAATENFSMQC------KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEF 557
           + V   TEN   Q       +LG+G F  V +  K+L GQE A K ++++  S +  ++ 
Sbjct: 9   SGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 558 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 617
           + E  +   L+H N+VRL     E+G   LI++ +    L     D              
Sbjct: 69  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASH 125
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGN 674
            I+ I + +L+ HQ   + ++HRDLK  N+LL S +     K++DFG+A      E++G 
Sbjct: 126 CIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-----IEVEGE 177
Query: 675 TKR---VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
            +      GT GY+SPE      +    D+++ GV+L
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH---- 569
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ML+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 570 ---------RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KI 618
                    RN V+ M    ++    +  EY  N++L    +D   +  L  Q     ++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQRDEYWRL 121
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGD 669
              I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+              
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 670 ELQG---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 712
            L G   N    +GT  Y++ E  LDG   ++ K D++S G++  E +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTL 167
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 117
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 167
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 166
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 166
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 166
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 63
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 115
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 116 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 165
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAP 183
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGT 169
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 183
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
           LG G FG V +       K    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 129
Query: 572 LVRLMGCCVEQGEKILIY------------------EYMPNKSLNFFLFDPSRT--HLLG 611
           +V L+G C + G  +++                   E++P K     L+    T  HL+ 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           +  +V      A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 190 YSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESFNLL 729
                       +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--- 297
Query: 730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                  +      + +P       YQ +       L C   + + RPT S++V  + N
Sbjct: 298 -----CRRLKEGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGN 344

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 137
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAP 193
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDL 171
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAAL 166
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 116
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 169
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 68
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 120
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 121 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 170
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 621
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 622 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 731
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 230 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 284
Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 285 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 328

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 142
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDL 192
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLS----SQSGQGL-KEFKNEMMLIAKLQHRNLVRL 575
           LGEG F  VYK +  N  Q VA+K++     S++  G+ +    E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA-QGLLYLHQYSR 634
           +     +    L++++M    L   + D S   L+   + +K    +  QGL YLHQ+  
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG- 693
             I+HRDLK +N+LLD +   K++DFG+A+ F G   +    +VV T  Y +PE      
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPELLFGAR 188
Query: 694 LFSVKSDVFSFGVLLLETL 712
           ++ V  D+++ G +L E L
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 169
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 142
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 192
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 118
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 171
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 169
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG    +           + GT
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 172
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y+ PE     +   K D++S GVL  E L  K
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 137
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 193
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 92  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 139
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 191
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 127
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 183
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF 125
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 81
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 133
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 134 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 183
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 184 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 177
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V     + +G ++AVK+LS   QS    K    E+ L+  ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P  SL  F      THL+G      VK           
Sbjct: 111 NVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 158
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 210
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + +++  D++S G ++ E LT +
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 521 KLGEGGFGPVYKGK--LLNGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLV 573
           KLG+G FG V +G+    +G+   VAVK L        + + +F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
           RL G  +    K ++ E  P  SL     D  R H    LLG  +R  +   +A+G+ YL
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 131
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSP 687
                 R IHRDL A N+LL +    KI DFG+ R      D       R V  + + +P
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAP 187
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS  SD + FGV L E  T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 61
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 113
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 114 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 163
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRN 571
           N+ +   +G+G F  V   + +L G+EVAVK +  +  +   L++   E+ +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +    L+ EY     +  +L    R      + R K  + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK--EKEARAKFRQ-IVSAVQYCHQ 131
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
                I+HRDLKA N+LLD+D N KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 KF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 691 LDGLFSVKS------DVFSFGVLLLETLTS 714
              LF  K       DV+S GV+L  TL S
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILY-TLVS 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 621
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 622 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 731
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 207 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 261
Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 262 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 305

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 621
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 622 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 166 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 731
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 223 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 277
Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 278 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 321

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG---- 201
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 621
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 622 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 168 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 731
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 225 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 279
Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 280 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 522 LGEGGFGPVYKG------KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
           LG G FG V +       K      VAVK L   +    +E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------------ 621
            L+G C   G  ++I EY     L  FL    R   +  +T   I+E             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 622 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGV-YDIESFNLLGH 731
            +  V    +M+PE   + +++ +SDV+S+G+ L E  +L S    G+  D + + ++  
Sbjct: 230 ARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 284
Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
                     + +LSP       Y ++         C       RPT  ++V +I  +
Sbjct: 285 -------KEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIEKQ 328

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 562
           + +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKII 619
           L+ +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 620 EGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
             +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   DE     K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKE 175
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            VGT  YMSPE      ++ KSD++S G LL E
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ML+A L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFF---------LFDPSRTHLLGWQTRV--KIIEGI 622
           R     +E+   +     +  KS  F          L+D   +  L  Q     ++   I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGDELQG 673
            + L Y+H      IIHRDLK  NI +D   N KI DFG+A+               L G
Sbjct: 126 LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 674 ---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 712
              N    +GT  Y++ E  LDG   ++ K D++S G++  E +
Sbjct: 183 SSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAV-----KRLSSQSGQGLKEFKNEMMLIAK 566
           TE + +  +LG+G F  V +  K+L GQE A      K+LS++  Q L+    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L+H N+VRL     E+G   LI++ +    L     D               I+ I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVG 680
           L+ HQ   + ++HR+LK  N+LL S +     K++DFG+A      E++G  +      G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGFAG 175
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           T GY+SPE      +    D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 101 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 200
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS-SQSGQGLKEFK-NEM 561
           S A  + + + +    KLGEG +G VYK    +  + VA+KR+      +G+      E+
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            L+ +LQHRN++ L           LI+EY  N    +   +P  +  +      ++I G
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNP--KISDFGMARMFCGDELQGNTK 676
           +     + H  SR R +HRDLK  N+LL   D+   P  KI DFG+AR F G  ++  T 
Sbjct: 145 VN----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196
Query: 677 RVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
            ++ T  Y  PE  L    +S   D++S   +  E L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 121
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +       +   + R   +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTL 171
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE         K D++S GVL  E L  K
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 201
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 186
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 94
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L  C  +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 146
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQ 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG---- 188
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRL--SSQSGQGLK-EFKNEMMLIAKL 567
           A E+F +   LG+G FG VY  +  N + + A+K L  +     G++ + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
           +H N++RL G   +     LI EY P  ++   L     FD  RT           I  +
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITEL 117
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VV 679
           A  L Y H     ++IHRD+K  N+LL S    KI+DFG +       +   + R   + 
Sbjct: 118 ANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALC 167
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V  G+  L G +VAVK L+ Q  + L    + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
                 +  ++ EY+    L  ++    R   +  +   ++ + I   + Y H++    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---V 132
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 696
           +HRDLK  N+LLD+ MN KI+DFG++ M    E   ++    G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLYAG 189
Query: 697 VKSDVFSFGVLLLETL 712
            + D++S GV+L   L
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 514 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N++RL G   +     LI EY P  ++   L   SR      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSY 127
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYM 685
            H     R+IHRD+K  N+LL S+   KI+DFG +       +   + R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYL 177
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLT 713
            PE     +   K D++S GVL  E L 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 514 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N++RL G   +     LI EY P  ++   L   SR      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSY 127
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYM 685
            H     R+IHRD+K  N+LL S+   KI+DFG +       +   + R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYL 177
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLT 713
            PE     +   K D++S GVL  E L 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 186
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 692 DGLFSVKSDVFSFGVLLLE 710
              +  K+D++S G+  +E
Sbjct: 178 QSAYDSKADIWSLGITAIE 196

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 177
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 79  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 178
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 79  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 178
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 93  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG---- 192
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLK---EFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V  G+  L G +VAVK L+ Q  + L    + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
                 +  ++ EY+    L  ++    R   +  +   ++ + I   + Y H++    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---V 132
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS- 696
           +HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAG 189
Query: 697 VKSDVFSFGVLLLETL 712
            + D++S GV+L   L
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 80  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 179
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 186
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 81  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 180
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 89  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 188
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG---- 187
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 118
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI++FG +       +   + R   +
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTL 168
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 142
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT  +M+PE   
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 692 DGLFSVKSDVFSFGVLLLE 710
              +  K+D++S G+  +E
Sbjct: 198 QSAYDSKADIWSLGITAIE 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 87  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 186
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 183
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           T+ + +   +G+G F  V +  KL  G E A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+G   L+++ +    L     D               I+ I + +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVGTYG 683
           HQ   + ++HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 84  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG---- 183
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIA 565
           +++   E F+   ++G+G FG V+KG     Q+V A+K +   ++   +++ + E+ +++
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           +     + +  G  ++  +  +I EY+   S      D  R           +++ I +G
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKG 132
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L YLH   +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT  +M
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 187
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE      +  K+D++S G+  +E
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIE 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 105 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG---- 204
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 512 ATENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           A E+F +   LG+G FG VY     + K +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           L+H N++RL G   +     LI EY P  ++   L     FD  RT           I  
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITE 119
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---V 678
           +A  L Y H     R+IHRD+K  N+LL S    KI++FG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTL 169
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            GT  Y+ PE     +   K D++S GVL  E L  K
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 94  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 193
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 93  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 192
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 101 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 200
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 201
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 521 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+GEG  G V    +   G++VAVK++  +  Q  +   NE++++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQYSRLRII 638
           +   E  ++ E++   +L   +     TH    + ++  +   + + L YLH      +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 163
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALDGLFS 696
           HRD+K+ +ILL SD   K+SDFG    FC    +   KR  +VGT  +M+PE      + 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 697 VKSDVFSFGVLLLETL 712
            + D++S G++++E +
Sbjct: 220 TEVDIWSLGIMVIEMI 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 105 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 204
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G    
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 187
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRN 571
           +++ +Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           +V      V + E  L+ + +   S+     +       ++ +L   T   I+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVGTYG 683
            YLH+  +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 684 YMSPEY--ALDGLFSVKSDVFSFGVLLLETLT 713
           +M+PE    + G +  K+D++SFG+  +E  T
Sbjct: 187 WMAPEVMEQVRG-YDFKADIWSFGITAIELAT 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRN 571
           +++ +Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           +V      V + E  L+ + +   S+     +       ++ +L   T   I+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVGTYG 683
            YLH+  +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 684 YMSPEY--ALDGLFSVKSDVFSFGVLLLETLT 713
           +M+PE    + G +  K+D++SFG+  +E  T
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELAT 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 225
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 518 MQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
           +QC LG GGFG V++ K  ++    A+KR+   + +  +E    E+  +AKL+H  +VR 
Sbjct: 10  IQC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE------------GIA 623
               +E+     +    P   L   +    + +L  W      IE             IA
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------G 673
           + + +LH      ++HRDLK SNI    D   K+ DFG+      DE +           
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
                VGT  YMSPE      +S K D+FS G++L E L
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 166 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 219
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 625
           +  C  +        Y   K+  + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 682
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 683 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +   S  SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQ 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D+G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 210
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 227
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 199
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 229
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 511 AATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
           +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ L+
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLL 59
Query: 565 AKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEG 621
            +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 622 IAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
           +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV 177
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           GT  YMSPE      ++ KSD++S G LL E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 19/237 (8%)
Query: 484 EPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL----NGQ 539
           +PS+ +G  K     S+       S  A   +F +   LG+G FG V+  + +    +G 
Sbjct: 1   QPSKDEGVLKEI---SITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH 57
Query: 540 EVAVKRLSSQSGQGLKEFKNEMM--LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597
             A+K L   + +     + +M   ++A + H  +V+L      +G+  LI +++    L
Sbjct: 58  LYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL 117
Query: 598 NFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656
               F      ++  +  VK  +  +A GL +LH    L II+RDLK  NILLD + + K
Sbjct: 118 ----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIK 170
Query: 657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           ++DFG+++     E +  +    GT  YM+PE       S  +D +S+GVL+ E LT
Sbjct: 171 LTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 196
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 204
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 625
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 682
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 683 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 511 AATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
           +  E++ +   +G G +G   K      GK+L  +E+    ++    Q L    +E+ L+
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLL 59
Query: 565 AKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEG 621
            +L+H N+VR     +++    L  + EY     L   +   ++    L  +  ++++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 622 IAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
           +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFV 177
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           GT  YMSPE      ++ KSD++S G LL E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 571
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 692 -DGLFSVKSDVFSFGVLLLETL 712
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++     QG K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 571
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 692 -DGLFSVKSDVFSFGVLLLETL 712
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE   
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIK 192
Query: 692 DGLFSVKSDVFSFGVLLLE 710
              +  K+D++S G+  +E
Sbjct: 193 QSAYDSKADIWSLGITAIE 211

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 192
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 184
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 238
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 270
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCC 579
           +G G FG VY+ KL + G+ VA+K++        K FKN E+ ++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 580 VEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-----IEGIAQGLLY 628
              GEK       L+ +Y+P       ++  +R +    QT   I     +  + + L Y
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y Y +P
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 195
Query: 688 EYALDGL-FSVKSDVFSFGVLLLETL 712
           E       ++   DV+S G +L E L
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +++ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           + +  G  ++  +  +I EY+   S    L +P     L       I+  I +GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP---LDETQIATILREILKGLDYLHS 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT  +M+PE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIK 177
Query: 692 DGLFSVKSDVFSFGVLLLE 710
              +  K+D++S G+  +E
Sbjct: 178 QSAYDSKADIWSLGITAIE 196

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRN 571
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +   +L++E++        L D     L     +  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  +V T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 692 -DGLFSVKSDVFSFGVLLLETL 712
               +S   D++S G +  E +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMM---- 562
            +    E+F +   LG+G FG V+  +     Q  A+K L         + +  M+    
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 616
           L    +H  L   M C  +  E +  + EY+    L + +     FD SR      +   
Sbjct: 72  LSLAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--- 127
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                I  GL +LH      I++RDLK  NILLD D + KI+DFGM    C + + G+ K
Sbjct: 128 -----IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAK 175
Query: 677 --RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
                GT  Y++PE  L   ++   D +SFGVLL E L  +
Sbjct: 176 TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 507 ASVSAATENFSMQCK--------LGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKE 556
           + V   TEN   Q          +GEG +G V K +  + G+ VA+K+ L S   + +K+
Sbjct: 10  SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 557 FK-NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
               E+ L+ +L+H NLV L+  C ++    L++E++ +  L+     P+    L +Q  
Sbjct: 70  IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVV 126
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-DELQGN 674
            K +  I  G+ + H ++   IIHRD+K  NIL+      K+ DFG AR      E+  +
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 675 TKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
               V T  Y +PE  + D  +    DV++ G L+ E    +
Sbjct: 184 E---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 81
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 625
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 82  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 682
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 192
Query: 683 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+ R    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            K+G+G FG V+K +    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV----------KIIEGIAQG 625
           +  C  +        Y   K   + +FD     L G  + V          ++++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGN--TKRVVGTY 682
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F      Q N    RVV T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 683 GYMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
            Y  PE  L +  +    D++  G ++ E  T
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 692 DGLFSVKSDVFSFGVLLLETLTSK 715
              +SV+SD++S G+ L+E    +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DF +AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 521 KLGEGGFGPVYKGKLLNGQ-EVAVKRLS-SQSGQGL------------KEFKNEMMLIAK 566
           KLG G +G V   K  NG  E A+K +  SQ  +G             +E  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L H N+++L     ++    L+ E+     L          H         I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKFDECDAANIMKQILSGI 159
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
            YLH+++   I+HRD+K  NILL++    +N KI DFG++  F  D      +  +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAY 213
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y++PE  L   ++ K DV+S GV++
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIM 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 521 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +LG G FG V +G  ++   Q +VA+K L   + +   +E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G C  Q E + L+ E      L+ FL    +   +      +++  ++ G+ YL + +  
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDG 693
             +HRDL A N+LL +    KISDFG+++    D+    T R  G +   + +PE     
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 188
Query: 694 LFSVKSDVFSFGVLLLETLT 713
            FS +SDV+S+GV + E L+
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHR 570
            E++ +   LGEG  G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+  G   E   + L  EY     L F   +P     +      +    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 121
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 691 LDGLFSVKS-DVFSFGVLLLETLTSK 715
               F  +  DV+S G++L   L  +
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +F     LG+G FG V K +  L+ +  A+K++   + + L    +E+ L+A L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFF---------LFDPSRTHLLGWQTRV--KIIEGI 622
           R     +E+   +     +  KS  F          L+D   +  L  Q     ++   I
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---------MFCGDELQG 673
            + L Y+H      IIHR+LK  NI +D   N KI DFG+A+               L G
Sbjct: 126 LEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 674 ---NTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETL 712
              N    +GT  Y++ E  LDG   ++ K D +S G++  E +
Sbjct: 183 SSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 150
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 141
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQ 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 64
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 65  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 116
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQ 201

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 66
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 67  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 118
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQ 203

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 32  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 143
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 144 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 196
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 197 ISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 154 DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 266 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 34  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 145
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 146 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 198
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 199 ISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 23  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 134
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 187
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 67
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 68  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 119
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQ 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLV 573
           + M+ +LG GGFG V +    + G++VA+K+   + S +  + +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IAQG 625
                 V  G + L    +P  ++ +      R +L  ++    + EG        I+  
Sbjct: 76  SARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 626 LLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           L YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
            Y++PE      ++V  D +SFG L  E +T  R
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++     DE+       VGT  YMSPE   
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DEM---ANEFVGTRSYMSPERLQ 179
Query: 692 DGLFSVKSDVFSFGVLLLETLTSK 715
              +SV+SD++S G+ L+E    +
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLV 573
           + M+ +LG GGFG V +    + G++VA+K+   + S +  + +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IAQG 625
                 V  G + L    +P  ++ +      R +L  ++    + EG        I+  
Sbjct: 77  SARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 626 LLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           L YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 188
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
            Y++PE      ++V  D +SFG L  E +T  R
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 92
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 144
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 145 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQ 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 65
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 66  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 117
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQ 202

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 71
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 123
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 124 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQ 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 27  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH  +  +    +   + Q L  LH 
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 138
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 139 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 191
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 192 ISRLPYGPEVDIWSLGIMVIEMV 214

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 13/225 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWN 734
              +SV+SD++S G+ L+E    +    +G   +  F LL +  N
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN 240

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V+K     +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YMSPE   
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL 729
              +SV+SD++S G+ L+E    +      D +   L+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMM---- 562
            +    E+F +   LG+G FG V+  +     Q  A+K L         + +  M+    
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 616
           L    +H  L   M C  +  E +  + EY+    L + +     FD SR      +   
Sbjct: 71  LSLAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--- 126
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                I  GL +LH      I++RDLK  NILLD D + KI+DFGM    C + + G+ K
Sbjct: 127 -----IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAK 174
Query: 677 --RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
                GT  Y++PE  L   ++   D +SFGVLL E L  +
Sbjct: 175 TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI  FG+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +   M  ++G+G +G V+ GK   G++VAVK   +++     +E   E+     ++H N+
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENI 93
Query: 573 VRLMGCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           +  +   ++      +  LI +Y  N SL    +D  ++  L  ++ +K+      GL +
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCH 149
Query: 629 LHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD----ELQGNTKRVV 679
           LH        +  I HRDLK+ NIL+  +    I+D G+A  F  D    ++  NT+  V
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--V 207
Query: 680 GTYGYMSPEYALDGLFS------VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 731
           GT  YM PE   + L        + +D++SFG++L E      + G+  +E + L  H
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQLPYH 263

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA++++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F   V   +L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 521 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLM 576
           +LG G FG V +G  ++   Q +VA+K L   + +   +E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           G C  Q E + L+ E      L+ FL    +   +      +++  ++ G+ YL + +  
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALDG 693
             +HR+L A N+LL +    KISDFG+++    D+    T R  G +   + +PE     
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 514
Query: 694 LFSVKSDVFSFGVLLLETLT 713
            FS +SDV+S+GV + E L+
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL 567
           E+F     LGEG F  V   + L   +E A+K L  +    +KE K      E  ++++L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
            H   V+L     +  +      Y  N  L  ++     FD + T     +        I
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y+SPE   +      SD+++ G ++ +
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q  +   NE++++   QH N+
Sbjct: 77  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQ 631
           V +    +   E  ++ E++   +L   +     TH    + ++  +   + Q L  LH 
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA 188
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
                +IHRD+K+ +ILL  D   K+SDFG    FC    +   +R  +VGT  +M+PE 
Sbjct: 189 QG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPEL 241
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
                +  + D++S G++++E +
Sbjct: 242 ISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMM 562
           +A+ +  T+++ +  +LG+G F  V +  K    QE A K ++++  S +  ++ + E  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           +   L+H N+VRL     E+G   L+++ +    L     D               I  I
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQI 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR-- 677
            + + ++HQ+    I+HRDLK  N+LL S       K++DFG+A      E+QG  +   
Sbjct: 140 LESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAI-----EVQGEQQAWF 191
Query: 678 -VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
              GT GY+SPE      +    D+++ GV+L
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 563
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 133
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                 +  L++E+       +F       DP       +Q        + +GL + H  
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKGLGFCHSR 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +   ++HRDLK  N+L++ +   K++DFG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 693 G-LFSVKSDVFSFGVLLLETLTSKR 716
             L+S   D++S G +  E   + R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK----------- 617
           N++ L+              + P +SL  F      THL+G      VK           
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
           +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G    
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG---- 181
Query: 678 VVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            V T  Y +PE  L+ + ++   D++S G ++ E LT +
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 24/259 (9%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK---NEMMLIAKL 567
           + ++F +   LG G FG V+  +   NG+  A+K L  +    LK+ +   +E ++++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H  ++R+ G   +  +  +I +Y+    L   L    ++              +   L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALE 120
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           YLH      II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y++P
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAP 172
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E      ++   D +SFG+L+ E L     T  YD  +        N        EL  P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTMKTYEKILNA-------ELRFP 223
Query: 748 ALQHEASYQMLNRYITVAL 766
              +E    +L+R IT  L
Sbjct: 224 PFFNEDVKDLLSRLITRDL 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 577 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                   +E   ++ +   +    LN  +    ++  L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 692 DGL-FSVKSDVFSFGVLLLETLTSK 715
           + + ++   D++S G ++ E L  K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + +  ++    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 563
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 133
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 510 SAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSS-QSGQGLKEFKNEMM 562
           S   +++ M  +LG G F  V K      GK    + +  +RLSS + G   +E + E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++ +++H N++ L      + + +LI E +    L  FL   +    L      + ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 117
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKR 677
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 170
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
           + GT  +++PE        +++D++S GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +   L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL----KCQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGLKEFKNEMM--L 563
            A    F +   LG+G FG V+  K ++G    Q  A+K L   + +     + +M   +
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + ++ H  +V+L      +G+  LI +++    L    F      ++  +  VK    +A
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LA 134
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +  L L     L II+RDLK  NILLD + + K++DFG+++     E +  +    GT  
Sbjct: 135 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 192
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           YM+PE       +  +D +SFGVL+ E LT
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 577 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                   +E   ++ +   +    LN  +    +   L  +    ++  + +GL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 193
Query: 692 DGL-FSVKSDVFSFGVLLLETLTSK 715
           + + ++   D++S G ++ E L  K
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 576
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 695
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           KLGEG +  VYKGK  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
               +    L++EY+ +K L  +L D    +++        +  + +GL Y H   R ++
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALDGL-F 695
           +HRDLK  N+L++     K++DFG+AR      +   T    V T  Y  P+  L    +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++  G +  E  T +
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNE 560
           F + + +  ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             +  KLQH N+VRL     E+    L+++ +    L     D               I+
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ 135
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKR 677
            I + + Y H      I+HR+LK  N+LL S       K++DFG+A      E       
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--- 189
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             GT GY+SPE      +S   D+++ GV+L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 687 PEYALDGLFSVKSDVFSFGVLL 708
           PE      +S   D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRL--SSQSGQGLK-EFKNEMMLIAKLQH 569
           ++F +   LG+G FG VY  +       VA+K L  S    +G++ + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 624
            N++RL     ++    LI EY P   L   L     FD  RT          I+E +A 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRT--------ATIMEELAD 134
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L+Y H     ++IHRD+K  N+LL      KI+DFG +       L+  T  + GT  Y
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDY 187
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           + PE     + + K D++  GVL  E L 
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLV 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 510 SAATENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRL-SSQSGQGLKEFKNEMM 562
           S   +++ M  +LG G F  V K      GK    + +  +RL SS+ G   +E + E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++ +++H N++ L      + + +LI E +    L  FL   +    L      + ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 138
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKR 677
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 191
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
           + GT  +++PE        +++D++S GV+
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 174
Query: 687 PEYALDGLFSVKSDVFSFGVLL 708
           PE      +S   D+++ GV+L
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 522 LGEGGFGPV-----YKGKLLNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQHRNL 572
           LGEG FG V     YK +    Q+VA+K +S Q    S   ++  + E+  +  L+H ++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHI 71
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           ++L        + +++ EY   +  ++ +     T   G +   +II  I     Y H  
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGTYGYMSPEYAL 691
            R +I+HRDLK  N+LLD ++N KI+DFG++ +       GN  K   G+  Y +PE   
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----DGNFLKTSCGSPNYAAPEVIN 180
Query: 692 DGLFS-VKSDVFSFGVLLLETLTSK 715
             L++  + DV+S G++L   L  +
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRL---- 575
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
               +EQ + + I + +    L   L    +T  L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGL 694
            ++HRDLK SN+LL++  + KI DFG+AR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 695 FSVKS-DVFSFGVLLLETLTSK 715
              KS D++S G +L E L+++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 516 FSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRN 571
           + +  KLG+G +G V+K      G+ VAVK++      S    + F+  M+L     H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 572 LVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           +V L+       ++   L+++YM        L    R ++L    +  ++  + + + YL
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-------------------DE 670
           H      ++HRD+K SNILL+++ + K++DFG++R F                     D+
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
            Q      V T  Y +PE  L      K  D++S G +L E L  K
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+    L+++ +    L     D               I+ I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 687 PEYALDGLFSVKSDVFSFGVLL 708
           PE      +S   D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 576
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALDGLF 695
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 576
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 695
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++S G +L   L  K
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 28/236 (11%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           L   + A +   ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+    
Sbjct: 30  LVQRTVARQITLLEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTV 86
Query: 566 KLQHRNLVRLMGCCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            L+H N++  +   +       +  LI  Y    SL    +D  +   L   + ++I+  
Sbjct: 87  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLS 142
Query: 622 IAQGLLYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---G 673
           IA GL +LH        +  I HRDLK+ NIL+  +    I+D G+A M      Q   G
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 202
Query: 674 NTKRVVGTYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 722
           N  R VGT  YM+PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 203 NNPR-VGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 256

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G +G V   Y  +L   Q+VAVK+LS   QS    +    E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 577 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                   +E   ++ +   +    LN  +    +   L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                IIHRDLK SN+ ++ D   +I DFG+AR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 692 DGL-FSVKSDVFSFGVLLLETLTSK 715
           + + ++   D++S G ++ E L  K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VRLM 576
           LG+GGF   Y+   ++ +EV   ++  +S   LK  + E M      H++L     V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-MLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   +     ++ E    +SL        R  +   + R  + + I QG+ YLH     R
Sbjct: 93  GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 146
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYMSPEYALDGLF 695
           +IHRDLK  N+ L+ DM+ KI DFG+A      E  G  K+ + GT  Y++PE       
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + D++S G +L   L  K
Sbjct: 204 SFEVDIWSLGCILYTLLVGK 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+     L+H N++  + 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69
Query: 578 CCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--- 630
             +       +  LI  Y    SL    +D  +   L   + ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 631 --QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---GNTKRVVGTYGYM 685
                +  I HRDLK+ NIL+  +    I+D G+A M      Q   GN  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184
Query: 686 SPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 722
           +PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 45/209 (21%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLIAKLQHRNL 572
           KLG G +G V   K  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 83
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK----------IIEGI 622
           ++L             YE+  +K   + + +  R   L  +  ++          I++ +
Sbjct: 84  MKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVV 679
             G  YLH+++   I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +
Sbjct: 131 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERL 184
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           GT  Y++PE  L   +  K DV+S GV+L
Sbjct: 185 GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           ++C +G+G +G V++G    G+ VAVK  SS+  +     + E+     L+H N++  + 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69
Query: 578 CCV----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--- 630
             +       +  LI  Y    SL    +D  +   L   + ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 631 --QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ---GNTKRVVGTYGYM 685
                +  I HRDLK+ NIL+  +    I+D G+A M      Q   GN  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184
Query: 686 SPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGVYD 722
           +PE  LD    V       + D+++FG++L E      + G+ +
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 45/209 (21%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLIAKLQHRNL 572
           KLG G +G V   K  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 66
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK----------IIEGI 622
           ++L             YE+  +K   + + +  R   L  +  ++          I++ +
Sbjct: 67  MKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVV 679
             G  YLH+++   I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +
Sbjct: 114 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERL 167
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           GT  Y++PE  L   +  K DV+S GV+L
Sbjct: 168 GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 570
           E +    K+GEG +G V+K +  + GQ VA+K+ L S+    +K+    E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR----THL---LGWQTRVKIIEGIA 623
           NLV L+     +    L++EY  +  L+    D  +     HL   + WQT         
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVKSITWQT--------L 112
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           Q + + H+++    IHRD+K  NIL+      K+ DFG AR+  G     + +  V T  
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRW 167
Query: 684 YMSPEYAL-DGLFSVKSDVFSFGVLLLETLT 713
           Y SPE  + D  +    DV++ G +  E L+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSS-QSGQGLKEFKNEMMLIAK 566
           +++ M  +LG G F  V K      GK    + +  +RLSS + G   +E + E+ ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           ++H N++ L      + + +LI E +    L  FL   +    L      + ++ I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 128
Query: 627 LYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RMFCGDELQGNTKRVVGT 681
            YLH     RI H DLK  NI LLD ++ NP+I   DFG+A ++  G+E     K + GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGT 181
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVL 707
             +++PE        +++D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 201
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
           K+GEG +G V+K K     E VA+KR+      +G+      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                 +  L++E+       +F       DP       +Q        + +GL + H  
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKGLGFCHSR 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +   ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV T  Y  P+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 693 G-LFSVKSDVFSFGVLLLETLTSKR 716
             L+S   D++S G +  E   + R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
           ++F    +LG G  G V K +   +G  +A K +  +    ++ +   E+ ++ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
           +V   G     GE  +  E+M   SL+  L +  R    +LG     K+   + +GL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
            +  + +I+HRD+K SNIL++S    K+ DFG++    G  +       VGT  YM+PE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPER 184
Query: 690 ALDGLFSVKSDVFSFGVLLLE 710
                +SV+SD++S G+ L+E
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVE 205

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 218 FEVDVWSIGCIMYTLLVGK 236

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 505 SLASVSAATENFSMQC-------KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKE 556
           S A +S   +NF ++        +LG G +G V K + + +GQ +AVKR+ +       +
Sbjct: 35  SKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---Q 91
Query: 557 FKNEMMLIAKLQHRNL-----VRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT- 607
            +  +++   +  R +     V   G    +G+  +  E M + SL+ F   + D  +T 
Sbjct: 92  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTI 150
Query: 608 --HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
              +LG     KI   I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++  
Sbjct: 151 PEDILG-----KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-- 201
Query: 666 FCGDELQGNTKRV-VGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 710
             G  +    K +  G   YM+PE     L    +SVKSD++S G+ ++E
Sbjct: 202 --GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           E F +   LG+GG+G V++ + + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           +++H  +V L+      G+  LI EY+    L   L    R  +    T    +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L +LHQ     II+RDLK  NI+L+   + K++DFG+ +    D    +T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +PE  +    +   D +S G L+ + LT
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLT 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 162
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 183
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 181
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 137/330 (41%), Gaps = 46/330 (13%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMM 562
           +S     +NF     LG+G FG V   ++   G   AVK L          ++    E  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRV 616
           +++  ++   +  + CC +  +++  + E++    L F +     FD +R      +   
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--- 132
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                I   L++LH      II+RDLK  N+LLD + + K++DFGM +    + +   T 
Sbjct: 133 -----IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTA 182
Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW 736
              GT  Y++PE   + L+    D ++ GVLL E L        ++ E+ + L  A  + 
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH---APFEAENEDDLFEA--IL 237
Query: 737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP 796
            D    E++ P   HE +  +L  ++T             PTM         EHA L +P
Sbjct: 238 ND----EVVYPTWLHEDATGILKSFMT-----------KNPTMRLGSLTQGGEHAILRHP 282
Query: 797 KQSAFSYAR---RGEKISFLPSSRVSEACS 823
                 +A+   R  +  F P  +  E  S
Sbjct: 283 FFKEIDWAQLNHRQIEPPFRPRIKSREDVS 312

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY---APECIN 187
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 187
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN----LVRL 575
           ++G G +G V K     +GQ +AVKR+ S   +  KE K  +M +  +   +    +V+ 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLF------DPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            G    +G+  +  E M      F+ +      D     +LG     KI     + L +L
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHL 141
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPE 688
            +   L+IIHRD+K SNILLD   N K+ DFG++    G  +    K R  G   YM+PE
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPE 195
Query: 689 Y----ALDGLFSVKSDVFSFGVLLLETLTSK 715
                A    + V+SDV+S G+ L E  T +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           E F +   LG+GG+G V++ + + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           +++H  +V L+      G+  LI EY+    L   L    R  +    T    +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGTYG 683
           L +LHQ     II+RDLK  NI+L+   + K++DFG+    C + +     T    GT  
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL----CKESIHDGTVTHXFCGTIE 186
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           YM+PE  +    +   D +S G L+ + LT
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 489
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 545
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 84/279 (30%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKEFKNEMMLIA 565
           A E   +   LG G FG V +      ++      VAVK L  + G    E+K  M  + 
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKML--KEGATASEYKALMTELK 82
Query: 566 KL----QHRNLVRLMGCCVEQGEKILIY----------EYMPNKSLNFFLFDPSRTHLLG 611
            L     H N+V L+G C +QG  +++            Y+ +K   FFL   +  H+  
Sbjct: 83  ILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHM-- 140
Query: 612 WQTRVKIIEGIAQG---------------------------------------------- 625
              + K+  G+ QG                                              
Sbjct: 141 EPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMED 200
Query: 626 -LLYLHQYSR-------LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGN 674
            + Y  Q +R        + IHRDL A NILL  +   KI DFG+AR    +     +G+
Sbjct: 201 LISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           T+  +    +M+PE   D ++S KSDV+S+GVLL E  +
Sbjct: 261 TRLPL---KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 520 CK-LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMG 577
           CK +G G FG V++ KL+   EVA+K++        K FKN E+ ++  ++H N+V L  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 578 CCVEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                G+K       L+ EY+P       ++  SR +        K+ + +   L+ L+ 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPET-----VYRASRHY-------AKLKQTMPMLLIKLYM 147
Query: 632 YSRLR---------IIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGT 681
           Y  LR         I HRD+K  N+LLD      K+ DFG A++    E   N   +   
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSR 205
Query: 682 YGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           Y Y +PE       ++   D++S G ++ E +  +
Sbjct: 206 Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 521 KLGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG     K++    V + +  +       E   E  ++ +L +  +VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L    +   +  +  ++++  ++ G+ YL + +  
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 490
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEYAL 691
             +HRDL A N+LL +    KISDFG+++    DE     Q + K  V  Y   +PE   
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 546
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              FS KSDV+SFGVL+ E  +
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 511 AATENFSMQCK-------LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FK 558
           A+T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + +   ++E F 
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 61
Query: 559 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
            E + + +  H ++V+L+G   E    I I E      L  FL    R + L   + +  
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILY 118
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              ++  L YL      R +HRD+ A N+L+ S+   K+ DFG++R +  D       + 
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 174
Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
                +M+PE      F+  SDV+ FGV + E L
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 510 SAATENFSMQCK-------LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-F 557
           S +T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + +   ++E F
Sbjct: 2   SGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 61
Query: 558 KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 617
             E + + +  H ++V+L+G   E    I I E      L  FL    R + L   + + 
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLIL 118
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
               ++  L YL      R +HRD+ A N+L+ S+   K+ DFG++R +  D       +
Sbjct: 119 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 174
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
                 +M+PE      F+  SDV+ FGV + E L
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 106 GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 513 TENFSMQCKLGEGGFGPVY--KGKLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAKLQH 569
           +E +    KLG G +G V   + K+ + +  + + R +S S     +   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLL 627
            N+++L     ++    L+ E      L    FD    H + +       II+ +  G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEI-IHRMKFNEVDAAVIIKQVLSGVT 150
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+++   I+HRDLK  N+LL+S   D   KI DFG++ +F   E Q   K  +GT  Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYY 204
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLL 709
           ++PE  L   +  K DV+S GV+L 
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILF 228

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 +    L+   M    L F ++   +      +      E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           RI++RDLK  NILLD   + +ISD G+A  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           ++   D ++ G LL E +  +
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 75  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R + L   + +     ++  L YL      R
Sbjct: 83  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R   L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           T+ + +  +LG+G F  V +  K+  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+G   L+++ +    L     D               I+ I + + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVGTYG 683
           H      I+HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAI-----EVQGDQQAWFGFAGTPG 171
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+GGFG V        GK+   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 +    L+   M    L F ++   +      +      E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           RI++RDLK  NILLD   + +ISD G+A  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 695 FSVKSDVFSFGVLLLETLTSK 715
           ++   D ++ G LL E +  +
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           +G+G FG VY G+      + +  +   +   LK FK E+M   + +H N+V  MG C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641
                +I      ++L   + D ++  L   +TR +I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTR-QIAQEIVKGMGYLHAKG---ILHKD 155
Query: 642 LKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY-----------MSPEYA 690
           LK+ N+  D+     I+DFG+  +    +      ++    G+           +SP+  
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 691 LDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            D L FS  SDVF+ G +  E    +        E+         +W+       + P L
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--------IWQMGTG---MKPNL 263
Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +   M      + L C   +  +RPT +K++ M+
Sbjct: 264 ---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
           T+ + +  +LG+G F  V +  K+  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N+VRL     E+G   L+++ +    L     D               I+ I + + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFCGDELQGNTKR---VVGTYG 683
           H      I+HRDLK  N+LL S       K++DFG+A      E+QG+ +      GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAI-----EVQGDQQAWFGFAGTPG 171
Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y+SPE      +    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G G +G V       +G++VA+K+LS   QS    K    E++L+  +QH N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 579 CVEQGEKILIYEYMPNKSL----NFFLFDP----SRTHLLGWQTRVKIIEGIA----QGL 626
                       + P  SL    +F+L  P        ++G +   + I+ +     +GL
Sbjct: 110 ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            Y+H      ++HRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y +
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 209
Query: 687 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           PE  L  + ++   D++S G ++ E LT K
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           S+    ++     +LG G +G V K + + +GQ +AVKR+ +       + +  +++   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLD 57
Query: 567 LQHRNL-----VRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQTR 615
           +  R +     V   G    +G+  +  E M + SL+ F   + D  +T    +LG    
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG---- 112
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
            KI   I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++     D  +   
Sbjct: 113 -KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 676 KRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 710
               G   YM+PE     L    +SVKSD++S G+ ++E
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV- 580
           +G+G +G V++G L +G+ VAVK  SS+  Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 581 ---EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-----QY 632
                 +  LI  Y  + SL  FL    +   L     +++    A GL +LH       
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQ-GNTKRVVGTYGYMSPEY 689
            +  I HRD K+ N+L+ S++   I+D G+A M     D L  GN  R VGT  YM+PE 
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMAPEV 188
Query: 690 -----ALDGLFSVK-SDVFSFGVLLLE 710
                  D   S K +D+++FG++L E
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWE 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQ 568
           S       +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLR 61
Query: 569 HRNLVRLMGCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           H N++  +    +      +  L+ +Y  + SL    FD    + +  +  +K+    A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTAS 117
Query: 625 GLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKR 677
           GL +LH        +  I HRDLK+ NIL+  +    I+D G+A       D +      
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 678 VVGTYGYMSPEYALDGLFSVK-------SDVFSFGVLLLE 710
            VGT  YM+PE  LD   ++K       +D+++ G++  E
Sbjct: 178 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 576
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 64
Query: 577 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 631
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 632 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 685
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 686 SPEYALDGLFSVK-------SDVFSFGVLLLE 710
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 181 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 211

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 508 SVSAATENFSM-----QCK-LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFK 558
           SV  A   F++     Q K +G G  G V      + G  VAVK+LS   Q+    K   
Sbjct: 12  SVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 71
Query: 559 NEMMLIAKLQHRNLVRLMGCCVEQG------EKILIYEYMPNK--SLNFFLFDPSRTHLL 610
            E++L+  + H+N++ L+     Q       +  L+ E M      +     D  R   L
Sbjct: 72  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 131
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
            +Q        +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR  C + 
Sbjct: 132 LYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 180
Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           +   T  VV  Y Y +PE  L   ++   D++S G ++ E
Sbjct: 181 MM--TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGE 217

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 29/265 (10%)
Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT----------------ENFSMQC 520
           S+A    E    DG A+        P  + ASV+A                  + + +  
Sbjct: 2   SMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIE 61
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRL-- 575
            +G G +G V   +  L GQ+VA+K++ +        K    E+ ++   +H N++ +  
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 576 -MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
            +   V  GE   +Y  +     +      S   L     R  + + + +GL Y+H    
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMHS--- 177
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPEYALD 692
            ++IHRDLK SN+L++ +   KI DFGMAR  C    E Q      V T  Y +PE  L 
Sbjct: 178 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 237
Query: 693 -GLFSVKSDVFSFGVLLLETLTSKR 716
              ++   D++S G +  E L  ++
Sbjct: 238 LHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G G +G V       +G++VA+K+LS   QS    K    E++L+  +QH N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 579 CVEQGEKILIYEYMPNKSL----NFFLFDP----SRTHLLGWQTRVKIIEGIA----QGL 626
                       + P  SL    +F+L  P        ++G +   + I+ +     +GL
Sbjct: 92  ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            Y+H      ++HRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  Y +
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 191
Query: 687 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           PE  L  + ++   D++S G ++ E LT K
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 636
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 637 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 692
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 693 GLFSVKSDVFSFGVL 707
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 680 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 241
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 297
Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 298 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 350
Query: 680 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++    + +EV   ++  +S        ++   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
              +     ++ E    +SL        R  L   + R   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLFS 696
           IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 697 VKSDVFSFGVLLLETLTSK 715
            + DV+S G ++   L  K
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 680 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
           ++     +FS+   +G GGFG VY       GK+   + +  KR+  + G+ L   +  M
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
           + +        +  M       +K+  I + M    L++ L      H +  +  ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYA 298
Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    V
Sbjct: 299 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 351
Query: 680 GTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
           GT+GYM+PE    G+ +   +D FS G +L + L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 576
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 102
Query: 577 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 631
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 632 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 685
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 686 SPEYALDGLFSVK-------SDVFSFGVLLLE 710
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 249

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 516 FSMQCKLGEGGFGPVY-KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLV 573
           F  + KLG G FG V+   +  +G E  +K ++    Q  +++ + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 574 RLMGCCVEQGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           ++     +     ++ E     + L   +   +R   L      ++++ +   L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 633 SRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
               ++H+DLK  NIL   D +P    KI DFG+A +F  DE   N     GT  YM+PE
Sbjct: 144 ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPE 196
Query: 689 -YALDGLFSVKSDVFSFGVLLLETLT 713
            +  D  F  K D++S GV++   LT
Sbjct: 197 VFKRDVTF--KCDIWSAGVVMYFLLT 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 576
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 89
Query: 577 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 631
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 632 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 685
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 686 SPEYALDGLFSVK-------SDVFSFGVLLLE 710
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 206 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIA 565
           ENF +   LG G +G V+  + ++G +     A+K L      Q  +  +  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 566 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
            ++    +  +    +   K+ LI +Y+    L  F     R      + ++ + E I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT  Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 226
Query: 685 MSPEYAL--DGLFSVKSDVFSFGVLLLETLT 713
           M+P+     D       D +S GVL+ E LT
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 37/269 (13%)
Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT----------------ENFSMQC 520
           S+A    E    DG A+        P  + ASV+A                  + + +  
Sbjct: 1   SMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIE 60
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLV 573
            +G G +G V   +  L GQ+VA+K++       + + + L+E K    ++   +H N++
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNII 116
Query: 574 RL---MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            +   +   V  GE   +Y  +     +      S   L     R  + + + +GL Y+H
Sbjct: 117 AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMH 175
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD--ELQGNTKRVVGTYGYMSPE 688
                ++IHRDLK SN+L++ +   KI DFGMAR  C    E Q      V T  Y +PE
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSKR 716
             L    ++   D++S G +  E L  ++
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 88/161 (54%), Gaps = 16/161 (9%)
Query: 554 LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF--FLFDPSRTHLLG 611
           +++   E+ ++ KL H N+V+L+    +  E  L   YM  + +N    +  P+   L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG-DE 670
            Q R    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 671 LQGNTKRVVGTYGYMSPEYALD--GLFSVKS-DVFSFGVLL 708
           L  NT   VGT  +M+PE   +   +FS K+ DV++ GV L
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 636
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 637 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 692
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 693 GLFSVKSDVFSFGVL 707
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 576
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 63
Query: 577 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 631
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 632 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 685
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 686 SPEYALDGLFSVK-------SDVFSFGVLLLE 710
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 180 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 210

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLM 576
           +Q  +G+G FG V++GK   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 66
Query: 577 GCCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ- 631
               +      +  L+ +Y  + SL    FD    + +  +  +K+    A GL +LH  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 632 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGYM 685
                 +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 686 SPEYALDGLFSVK-------SDVFSFGVLLLE 710
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 183 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 13/264 (4%)
Query: 454 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 513
           R  KE E  + S   L   +    V + T   SE D  A+    +      S        
Sbjct: 331 RPQKEGERALPSIPKLANNE-KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR 389
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 568
           E   +   +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E    I I E      L  FL    R   L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           L      R +HRD+ A N+L+ S+   K+ DFG++R +  D       +      +M+PE
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 562
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
                 F+  SDV+ FGV + E L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EYMP   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EYMP   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 636
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 637 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 692
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 693 GLFSVKSDVFSFGVL 707
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCC 579
           LG G F  V   +    Q+ VA+K ++ ++ +G +   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLLYLHQYSRLR 636
              G   LI + +    L    FD  R    G+ T     ++I  +   + YLH    L 
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 637 IIHRDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEYALD 692
           I+HRDLK  N+L   LD D    ISDFG+++M    E  G+      GT GY++PE    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 693 GLFSVKSDVFSFGVL 707
             +S   D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LKE +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG+A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL----- 575
           LG GG G V+     +  + VA+K++     Q +K    E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 576 ---------MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
                    +G   E     ++ EYM     N     P    LL    R+ + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFMYQ-LLRGL 133
Query: 627 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGY 684
            Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+AR+       +G+    + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 685 MSPEYALD-GLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAY 742
            SP   L    ++   D+++ G +  E LT K    G +++E   L+  +  +  +    
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 743 ELLS 746
           ELLS
Sbjct: 251 ELLS 254

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPAFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G +G V     G+   G +VA+K+L    QS    K    E+ L+  ++H N++ L+
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 577 GCCVEQGEKILIYEYMPNKSLN----FFLFDPSRTHLLG--------WQTRVK-IIEGIA 623
                         + P+++L+    F+L  P     LG         + R++ ++  + 
Sbjct: 91  DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+ G     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMXGX----VVTRW 190
Query: 684 YMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           Y +PE  L+ + ++   D++S G ++ E +T K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
           F  +  LG G F  V   +    G+  AVK +  ++ +G +   +NE+ ++ K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK---IIEGIAQGLLYLH 630
            L           L+ + +    L    FD  R    G+ T      +I  +   + YLH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FD--RIVEKGFYTEKDASTLIRQVLDAVYYLH 137
Query: 631 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMS 686
              R+ I+HRDLK  N+L    D +    ISDFG+++M    E +G+      GT GY++
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGYVA 190
Query: 687 PEYALDGLFSVKSDVFSFGVL 707
           PE      +S   D +S GV+
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVI 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 320
Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 321 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 322
Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 323 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 359

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 313
Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 314 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 350

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
           CK+G G +G VYK K  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 579 CVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-----LHQ 631
            +   ++   L+++Y  +   +   F  +       +  V++  G+ + LLY     +H 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 632 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGD-ELQGNTKRVVGTYGYM 685
                ++HRDLK +NIL+  +  P     KI+D G AR+F    +   +   VV T+ Y 
Sbjct: 144 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 686 SPEYALDGLFSVKS-DVFSFGVLLLETLTSK 715
           +PE  L      K+ D+++ G +  E LTS+
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE--TLTSKRNTGVYDIESF-NLLGHAWNLWKD 738
             +M+PE   D +++++SDV+SFGVLL E  +L +    GV   E F   L     +   
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 315
Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            RA +  +P +     YQ +       L C   + + RPT S++V  + N
Sbjct: 316 -RAPDYTTPEM-----YQTM-------LDCWHGEPSQRPTFSELVEHLGN 352

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +++ +  +LG G FG V++  +   G   A K + +      +  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V L     +  E ++IYE+M    L   + D    + +     V+ +  + +GL ++H+ 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +    +H DLK  NI+  +  +   K+ DFG+       + + + K   GT  + +PE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 691 LDGLFSVKSDVFSFGVL 707
                   +D++S GVL
Sbjct: 329 EGKPVGYYTDMWSVGVL 345

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLM 576
           +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G   E    I I E      L  FL    R   L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
            +HRD+ A N+L+ +    K+ DFG++R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 697 VKSDVFSFGVLLLETL 712
             SDV+ FGV + E L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 22  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 187
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 188 VNYEPLGLEADMWSIGVI 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     +G G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 133
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 134 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 188
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYE 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 22  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 187
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 188 VNYEPLGLEADMWSIGVI 205

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LKE +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     +++DFG+A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 13/264 (4%)
Query: 454 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 513
           R  KE E  + S   L   +    V + T   SE D  A+    +      S        
Sbjct: 331 RPQKEGERALPSIPKLANNE-KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR 389
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 568
           E   +   +GEG FG V++G  ++ +     VA+K   + +   ++E F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E    I I E      L  FL    R   L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           L      R +HRD+ A N+L+ +    K+ DFG++R +  D       +      +M+PE
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 562
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
                 F+  SDV+ FGV + E L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 579
           +GEG +G V      +    VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
                + +   Y+    +   L+   ++  L        +  I +GL Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPEYALDGLFSVK 698
           RDLK SN+L+++  + KI DFG+AR+   + +  G     V T  Y +PE  L+     K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 699 S-DVFSFGVLLLETLTSK 715
           S D++S G +L E L+++
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 636 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 691 LDGLFSVKSDVFSFGVL 707
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 636 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 691 LDGLFSVKSDVFSFGVL 707
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 20/193 (10%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G F  V+  K  L G+  A+K +           +NE+ ++ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSRLRI 637
                 L+ + +    L    FD  R    G  T      +I+ +   + YLH+     I
Sbjct: 77  STTHYYLVMQLVSGGEL----FD--RILERGVYTEKDASLVIQQVLSAVKYLHENG---I 127
Query: 638 IHRDLKASNIL-LDSDMNPKI--SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL 694
           +HRDLK  N+L L  + N KI  +DFG+++M    E  G      GT GY++PE      
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 695 FSVKSDVFSFGVL 707
           +S   D +S GV+
Sbjct: 184 YSKAVDCWSIGVI 196

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAKLQH 569
           A ++ F ++ +LG G    VY+ K    Q+  A+K L     +  K  + E+ ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSH 107
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGL 626
            N+++L        E  L+ E +    L    FD  R    G+ +       ++ I + +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FD--RIVEKGYYSERDAADAVKQILEAV 161
Query: 627 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
            YLH+     I+HRDLK  N+L  +   D   KI+DFG++++    E Q   K V GT G
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPG 215
Query: 684 YMSPEYALDGLFSVKSDVFSFGVL 707
           Y +PE      +  + D++S G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGII 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +++ +  +LG G FG V++  +   G   A K + +      +  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V L     +  E ++IYE+M    L   + D    + +     V+ +  + +GL ++H+ 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +    +H DLK  NI+  +  +   K+ DFG+       + + + K   GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 691 LDGLFSVKSDVFSFGVL 707
                   +D++S GVL
Sbjct: 223 EGKPVGYYTDMWSVGVL 239

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +G+G F  V +      GQ+ AVK     + +S  G   ++ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLHQYSR 634
           +      G   +++E+M    L F +   +    +  +      +  I + L Y H  + 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 635 LRIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
             IIHRD+K  N+LL S  N    K+ DFG+A       L    +  VGT  +M+PE   
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 692 DGLFSVKSDVFSFGVLLLETLT 713
              +    DV+  GV+L   L+
Sbjct: 207 REPYGKPVDVWGCGVILFILLS 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S GV++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S GV++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--------RLS 547
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 548 SQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 605
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F +   
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE 117
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
           +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +  
Sbjct: 118 KVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-- 171
Query: 666 FCGDELQGNTKRVVGTYGYMSPE 688
            C  +     + V GT  Y++PE
Sbjct: 172 -CQLDPGEKLREVCGTPSYLAPE 193

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 105/266 (39%), Gaps = 73/266 (27%)
Query: 518 MQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
           +QC +G GGFG V++ K  ++    A+KR+   + +  +E    E+  +AKL+H  +VR 
Sbjct: 11  IQC-MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 576 MGCCVEQGEKILIYE----YMPNKSLNFFLFDPS-------------------------- 605
               +E   +    E    ++ ++S ++ L  PS                          
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 606 ---------------RTHLLGWQTR------------VKIIEGIAQGLLYLHQYSRLRII 638
                          + +L  W  R            + I   IA+ + +LH      ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LM 186
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------GNTKRVVGTYGYMSPE 688
           HRDLK SNI    D   K+ DFG+      DE +                VGT  YMSPE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTS 714
                 +S K D+FS G++L E L S
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS 272

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           ++++  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL     +  +  L+ E      L   +       +       +I++ +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 634 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +L + HRDLK  N L   DS  +P K+ DFG+A  F   ++    +  VGT  Y+SP+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-V 179
Query: 691 LDGLFSVKSDVFSFGVLL 708
           L+GL+  + D +S GV++
Sbjct: 180 LEGLYGPECDEWSAGVMM 197

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ L
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    L
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---L 133
Query: 636 RIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIV 189
Query: 691 LDGLFSVKSDVFSFGVL 707
                 +++D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVI 206

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            F++  K  E   G  Y  K +  +       SS+ G   ++ + E+ ++ ++QH N++ 
Sbjct: 23  QFAVVKKCREKSTGLQYAAKFIKKRRTK----SSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L      + + ILI E +    L  FL   +    L  +   + ++ I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 635 LRIIHRDLKASNILLDSDMNP----KISDFGMA-RMFCGDELQGNTKRVVGTYGYMSPEY 689
           L+I H DLK  NI+L     P    KI DFG+A ++  G+E     K + GT  +++PE 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEI 188
Query: 690 ALDGLFSVKSDVFSFGVL 707
                  +++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVI 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           ++++  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL     +  +  L+ E      L   +       +       +I++ +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 634 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
           +L + HRDLK  N L   DS  +P K+ DFG+A  F   ++    +  VGT  Y+SP+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-V 196
Query: 691 LDGLFSVKSDVFSFGVLL 708
           L+GL+  + D +S GV++
Sbjct: 197 LEGLYGPECDEWSAGVMM 214

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--------RLS 547
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 548 SQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 605
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F +   
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE 117
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
           +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +  
Sbjct: 118 KVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS-- 171
Query: 666 FCGDELQGNTKRVVGTYGYMSPE 688
            C  +     + V GT  Y++PE
Sbjct: 172 -CQLDPGEKLRSVCGTPSYLAPE 193

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G           
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 138
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQS-GQGLK-EFKNEMMLI--AKLQHRNLVRL 575
           +LG G F  V +      GQE A K L  +  GQ  + E  +E+ ++  AK   R ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                   E ILI EY     + F L  P    ++     +++I+ I +G+ YLHQ +  
Sbjct: 95  HEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN-- 151
Query: 636 RIIHRDLKASNILLDSDM---NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
            I+H DLK  NILL S     + KI DFGM+R   G   +   + ++GT  Y++PE    
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE--LREIMGTPEYLAPEILNY 207
Query: 693 GLFSVKSDVFSFGVLLLETLT 713
              +  +D+++ G++    LT
Sbjct: 208 DPITTATDMWNIGIIAYMLLT 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 116/264 (43%), Gaps = 33/264 (12%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEV--AVKRLSSQSGQGLKEFKNEM----MLI 564
           A   +F     +G+G FG V   +    +EV  AVK L  ++    KE K+ M    +L+
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA 623
             ++H  LV L        +   + +Y+    L F+     R  L   + R +     IA
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIA 149
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVGT 681
             L YLH    L I++RDLK  NILLDS  +  ++DFG+    C + ++ N  T    GT
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL----CKENIEHNSTTSTFCGT 202
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS-----KRNTG-VYDIESFNLLGHAWNL 735
             Y++PE      +    D +  G +L E L        RNT  +YD    N+L     L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQL 258
Query: 736 WKD--NRAYELLSPALQHEASYQM 757
             +  N A  LL   LQ + + ++
Sbjct: 259 KPNITNSARHLLEGLLQKDRTKRL 282

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 514 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKL 567
           ++F +   LG+G FG VY     + K +   +V  K  S    +G++ + + E+ + + L
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHL 71
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N++R+     ++    L+ E+ P   L   L    R      Q     +E +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           Y H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPP 181
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E         K D++  GVL  E L 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLV 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 546 LSSQSGQGLKEFK-NEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 603
            S++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L  F + 
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYL 102
Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +  L   +TR KI+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG +
Sbjct: 103 TEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPE 688
              C  +     + V GT  Y++PE
Sbjct: 159 ---CQLDPGEKLREVCGTPSYLAPE 180

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 514 ENFSMQCKLGEGGFGPVY-----KGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKL 567
           ++F +   LG+G FG VY     + K +   +V  K  S    +G++ + + E+ + + L
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N++R+     ++    L+ E+ P   L   L    R      Q     +E +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           Y H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ P
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPP 182
Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E         K D++  GVL  E L 
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLV 208

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 521 KLGEGGFGPVYKGKLLNGQ--------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           ++G G F  VYKG  L+ +        E+  ++L+    Q    FK E   +  LQH N+
Sbjct: 33  EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNI 87
Query: 573 VRLMGC--CVEQGEK--ILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGL 626
           VR         +G+K  +L+ E   + +L  +L  F   +  +L    R      I +GL
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGL 142
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
            +LH  +   IIHRDLK  NI +       KI D G+A +    +     K V+GT  + 
Sbjct: 143 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           +PE   +  +    DV++FG   LE  TS+
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 146
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+P   +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G         
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFXEPHARF 138
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY P   +       S    +G  +      
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARF 146
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 201
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 53  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             ++  +    LV+L     +     ++ EY+P   +       S    +G  +      
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF------SHLRRIGRFSEPHARF 166
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 221
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    L +L     +     ++ EY P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    L +L     +     ++ EY P   +       S    +G  +        
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFSEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 15/224 (6%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQ 552
            D   P  +L  V     NF M   LG+G FG V        +E+ A+K L         
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMV--LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDD 61
Query: 553 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLG 611
            ++    E  ++A L     +  +  C +  +++  + EY+    L + +    +     
Sbjct: 62  DVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFK 118
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
               V     I+ GL +LH+     II+RDLK  N++LDS+ + KI+DFGM +    D +
Sbjct: 119 EPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV 175
Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
              T+   GT  Y++PE      +    D +++GVLL E L  +
Sbjct: 176 --TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 511 AATENFSMQC-------KLGEGGFGPVYKGKLL-NGQEVAVKRL-SSQSGQGLKEFKNEM 561
            A ENF ++        +LG G +G V K + + +GQ  AVKR+ ++ + Q  K    ++
Sbjct: 24  GAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDL 83
Query: 562 MLIAK-LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQT 614
            +  + +     V   G    +G+ + I   + + SL+ F   + D  +T    +LG   
Sbjct: 84  DISXRTVDCPFTVTFYGALFREGD-VWICXELXDTSLDKFYKQVIDKGQTIPEDILG--- 139
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
             KI   I + L +LH  S+L +IHRD+K SN+L+++    K  DFG++     D  +  
Sbjct: 140 --KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDI 195
Query: 675 TKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLE 710
                G   Y +PE     L    +SVKSD++S G+  +E
Sbjct: 196 D---AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIE 232

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q  V        G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    L +L     +     ++ EY P   +       S    +G           
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMF------SHLRRIGRFXEPHARFYA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 540 EVAVKRLSSQSGQGLKEF-KNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSL 597
           EV  +RLS +  + ++E  + E  ++ ++  H +++ L+          L+++ M    L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657
             F +   +  L   +TR  I+  + + + +LH  +   I+HRDLK  NILLD +M  ++
Sbjct: 188 --FDYLTEKVALSEKETR-SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEY---ALDGL---FSVKSDVFSFGVLLLET 711
           SDFG +   C  E     + + GT GY++PE    ++D     +  + D+++ GV+L   
Sbjct: 242 SDFGFS---CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 712 LT 713
           L 
Sbjct: 299 LA 300

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKN---EMMLIAKLQH 569
           ++F +   +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             LV L     ++ +  ++ + +    L + L      H      ++ I E +   L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICE-LVMALDYL 131
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
                 RIIHRD+K  NILLD   +  I+DF +A M    E Q  T  + GT  YM+PE 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEM 185
Query: 690 --ALDGL-FSVKSDVFSFGVLLLETLTSKR 716
             +  G  +S   D +S GV   E L  +R
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGAGNFG---VARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           Y H    +++ HRDLK  N LLD    P  KI+DFG ++      L    K  VGT  Y+
Sbjct: 130 YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYI 183
Query: 686 SPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIE 724
           +PE  L   +  K +DV+S GV L   L      G Y  E
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVML-----VGAYPFE 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NE 560
           S A  +A  + F     LG G FG V   K    G   A+K L  Q    LK+ +   NE
Sbjct: 33  SPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
             +   +    LV+L     +     ++ EY P   +       S    +G  +      
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMF------SHLRRIGRFSEPHARF 146
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             AQ +L       L +I+RDLK  N+L+D     K++DFG A+      ++G T  + G
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 201
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           T  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 577 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 23/236 (9%)
Query: 521 KLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           +LG G FG V++  +   G+    K +++         KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
            ++ E +LI E++        LFD   +  + +     +  +    +GL ++H++S   I
Sbjct: 118 EDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 638 IHRDLKASNILLDSDM--NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
           +H D+K  NI+ ++    + KI DFG+A     DE+    K    T  + +PE       
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPV 227
Query: 696 SVKSDVFSFGVL---LLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRAYELLSP 747
              +D+++ GVL   LL  L+     G  D+E+  N+    W    D  A+  +SP
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEF--DEDAFSSVSP 279

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 26/229 (11%)
Query: 494 GTRRDSVLPCFSLASVSAATENFSMQCK-LGEGGFGPVYKG-KLLNGQEVAVKRLSS--Q 549
           G+  DS      +A  +        Q K +G G  G V      + G  VAVK+LS   Q
Sbjct: 1   GSHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ 60
Query: 550 SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------EKILIYEYMPNK--SLNFFL 601
           +    K    E++L+  + H+N++ L+     Q       +  L+ E M      +    
Sbjct: 61  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME 120
Query: 602 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
            D  R   L +Q           G+ +LH      IIHRDLK SNI++ SD   KI DFG
Sbjct: 121 LDHERMSYLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 169
Query: 662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           +AR    + +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 170 LARTASTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN---LVRLM 576
           ++G G  G V+K +    G  +AVK++  +SG   +  +  M L   L+  +   +V+  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 577 GCCVEQGEKILIYEYMPN--KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           G  +   +  +  E M    + L   +  P    +LG     K+   I + L YL +  +
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE--K 143
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY----- 689
             +IHRD+K SNILLD     K+ DFG++     D+ +    R  G   YM+PE      
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPD 200
Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSK 715
                + +++DV+S G+ L+E  T +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMM 562
           AS S   ++F +   +G G +  V   +L     +     VK+      + +   + E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 563 LIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
           +  +   H  LV L  C   +     + EY+    L F +    R   L  +        
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAE 129
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 679
           I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFC 182
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y++PE      +    D ++ GVL+ E +  +
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM +    D +   TK   GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             Y++PE      +    D ++FGVLL E L  +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFK---NEMM 562
           A  +A  + F     LG G FG V   K +  G   A+K L  Q    LK+ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           ++  +    LV+L     +     ++ EY+    +       S    +G  +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYA 147
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           AQ +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLE 710
            Y++PE  L   ++   D ++ GVL+ E
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMM 562
           AS S   ++F +   +G G +  V   +L     +     VK+      + +   + E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 563 LIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
           +  +   H  LV L  C   +     + EY+    L F +    R   L  +        
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAE 161
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVV 679
           I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFC 214
Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           GT  Y++PE      +    D ++ GVL+ E +  +
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 577 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 577 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 577 GC-----CVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                   +E+ + + +   + + +L   +    D  R   L +Q        +  G+ +
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ--------MLXGIKH 134
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 188
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 17  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 71
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 128
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           Y H    +++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y+
Sbjct: 129 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 182
Query: 686 SPEYALDGLFSVK-SDVFSFGVLL 708
           +PE  L   +  K +DV+S GV L
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTL 206

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 522 LGEGGFG--PVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGC 578
           +G G FG   + + KL   + VAVK +  + G  + E  + E++    L+H N+VR    
Sbjct: 28  IGSGNFGVARLMRDKL-TKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
            +      +I EY     L   + +  R             + +  G+ Y H    ++I 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 639 HRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
           HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  L   + 
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 697 VK-SDVFSFGVLL 708
            K +DV+S GV L
Sbjct: 196 GKIADVWSCGVTL 208

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 624
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 128 NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            E+    L++E M   S+   +    R H    +  V +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASV-VVQDVASALDFLHNKG---IAH 134
Query: 640 RDLKASNILLD--SDMNP-KISDFGMARMFCGDELQGNTKRV--------VGTYGYMSPE 688
           RDLK  NIL +  + ++P KI DFG+     G +L G+   +         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGS---GIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 689 YA-----LDGLFSVKSDVFSFGVLL 708
                     ++  + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 83
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 137
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 192
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYE 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 195
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 135
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 189
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 624
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 84  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 131
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 185
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 151
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 624
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 90  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 142
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 196
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 140
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 141 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 194
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 28/186 (15%)
Query: 539 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           + VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL 
Sbjct: 50  RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 707 LLLETL 712
           ++ E +
Sbjct: 214 IMGEMI 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 624
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 83  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQ 624
                         + P K+L  F        L D +   +    L  +    ++  +  
Sbjct: 128 NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           +G G  G V   Y   L   + VA+K+LS   Q+    K    E++L+  + H+N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 577 GCCVEQG------EKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
                Q       +  L+ E M            D  R   L +Q        +  G+ +
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 142
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      IIHRDLK SNI++ SD   KI DFG+AR      +   T  VV  Y Y +PE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 196
Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
             L   +    D++S G ++ E +  K
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-----CVEQGEKILIYEYMP 593
           VA+K+LS   Q+    K    E++L+  + H+N++ L+        +E+ + + I   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 594 NKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           + +L+  +    D  R   L +Q        +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 711 TL 712
            +
Sbjct: 218 MI 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 500 VLPCFSLASVSAATENFSMQCK-LGEGGFGPVYKG-KLLNGQEVAVK-----RLSSQSGQ 552
           ++P  S+A      E+    C+ +G+G F  V +      GQ+ AVK     + +S  G 
Sbjct: 11  LVPRGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL 70
Query: 553 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
             ++ K E  +   L+H ++V L+      G   +++E+M    L F +   +    +  
Sbjct: 71  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 130
Query: 613 QTRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARMFCG 668
           +      +  I + L Y H  +   IIHRD+K   +LL S  N    K+  FG+A     
Sbjct: 131 EAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 187
Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             L    +  VGT  +M+PE      +    DV+  GV+L   L+
Sbjct: 188 SGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 517 SMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVR 574
           + Q +LG G FG V++ +    G + AVK++       L+ F+  E+M  A L    +V 
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 130
Query: 575 LMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           L G  V +G  + I+ E +   SL   + +      L     +  +    +GL YLH  S
Sbjct: 131 LYGA-VREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 184
Query: 634 RLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPEY 689
           R RI+H D+KA N+LL SD  +  + DFG A     D L  +      + GT  +M+PE 
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
            L      K DV+S   ++L  L
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHML 266

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSSQSGQGLKEFKNEMMLIA 565
           S   ++F +   +G G +  V   +L     +     VK+      + +   + E  +  
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 566 KL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           +   H  LV L  C   +     + EY+    L F +    R   L  +        I+ 
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISL 117
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTY 682
            L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT 
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFCGTP 170
Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            Y++PE      +    D ++ GVL+ E +  +
Sbjct: 171 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 17/215 (7%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           ++ + +   +G G FG     +     E+   +   +  +     K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           VR     +      ++ EY     L   + +  R             + +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA- 133
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
             +++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 691 LDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIE 724
           L   +  K +DV+S GV L   L      G Y  E
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVML-----VGAYPFE 218

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           L EGGF  VY+ + + +G+E A+KRL S   +  +    E+  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 580 --------VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                     Q E +L+ E    + + F     SR  L    T +KI     + + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-SCDTVLKIFYQTCRAVQHMHR 154
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA---------------RMFCGDELQGNTK 676
             +  IIHRDLK  N+LL +    K+ DFG A               R    +E+  NT 
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT- 212
Query: 677 RVVGTYGYMSPEYA-LDGLFSV--KSDVFSFGVLL 708
               T  Y +PE   L   F +  K D+++ G +L
Sbjct: 213 ----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 517 SMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVR 574
           + Q +LG G FG V++ +    G + AVK++       L+ F+  E+M  A L    +V 
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 149
Query: 575 LMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           L G  V +G  + I+ E +   SL   + +      L     +  +    +GL YLH  S
Sbjct: 150 LYGA-VREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 203
Query: 634 RLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPEY 689
           R RI+H D+KA N+LL SD  +  + DFG A     D L  +      + GT  +M+PE 
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 690 ALDGLFSVKSDVFSFGVLLLETL 712
            L      K DV+S   ++L  L
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHML 285

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFAEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR   G       +  V T  Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMEPE--VVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 707 LLLETLTSK 715
           ++ E +  K
Sbjct: 214 IMGEMVCHK 222

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 91
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 145
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 200
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYE 225

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 93
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 94  EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 150
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 151 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGC 207
Query: 707 LLLETLTSK 715
           ++ E +  K
Sbjct: 208 IMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 104
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 105 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 161
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 162 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGC 218
Query: 707 LLLETLTSK 715
           ++ E +  K
Sbjct: 219 IMGEMVCHK 227

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 171
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYL 226
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYE 251

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 100
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 101 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 157
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 214
Query: 707 LLLETL 712
           ++ E +
Sbjct: 215 IMGEMI 220

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H  LV L  C   +     + EY+    L F +    R   L  +        I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNY 125
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMS 686
           LH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    GT  Y++
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSXFCGTPNYIA 178
Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           PE      +    D ++ GVL+ E +  +
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 707 LLLETL 712
           ++ E +
Sbjct: 214 IMGEMI 219

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G           AQ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFXEPHARFYAAQI 171
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 226
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 569
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 570 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 675
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 676 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 710
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+G    V++G+    G   A+K  ++ S        ++EF+    ++ KL H+N+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 576 MGCCVEQG--EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
                E     K+LI E+ P  SL   L +PS  + L     + ++  +  G+ +L +  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 634 RLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
              I+HR++K  NI+     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLYGTEEYLHPD 185

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 28/184 (15%)
Query: 541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
           VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL  F
Sbjct: 52  VAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 601 --------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
                   L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 158
Query: 649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           + SD   KI DFG+AR      +   T  VV  Y Y +PE  L   +    D++S G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 709 LETL 712
            E +
Sbjct: 216 GEMI 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 569
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 570 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 675
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 676 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 710
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 100/264 (37%), Gaps = 27/264 (10%)
Query: 461 TTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQC 520
           T +++  D LK      +  R+  PS+  G       + +    +          F    
Sbjct: 101 TAIQTVADGLKKQAAAEMDFRSGSPSDNSG------AEEMEVSLAKPKHRVTMNEFEYLK 154
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLM 576
            LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                      + EY     L F L     F   R    G +        I   L YLH 
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH- 265
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
            S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE 322
Query: 692 DGLFSVKSDVFSFGVLLLETLTSK 715
           D  +    D +  GV++ E +  +
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQ 230

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRL 575
           LG+G    V++G+    G   A+K  ++ S        ++EF+    ++ KL H+N+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 576 MGCCVEQG--EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
                E     K+LI E+ P  SL   L +PS  + L     + ++  +  G+ +L +  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 634 RLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
              I+HR++K  NI+     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 569
           + +F ++  LGEG +G V        G+ VA+K++    +    L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 570 RNLVRLMGC----CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            N++ +         E   ++ I + +    L+  +     T +L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----------LQGNT 675
           +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR+   DE           Q   
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGM 179
Query: 676 KRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLE 710
              V T  Y +PE  L    +S   DV+S G +L E
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 521 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           KLGEGGF  V     L +G   A+KR+     Q  +E + E  +     H N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 580 V-EQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           + E+G K   +  +P         +  R     + L     + ++ GI +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG- 154
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV--------GTYGYMS 686
               HRDLK +NILL  +  P + D G     C   ++G+ + +          T  Y +
Sbjct: 155 --YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 687 PEYALDGLFSVKS--------DVFSFGVLLLETLTSKRNTGVYDI 723
           PE     LFSV+S        DV+S G +L   +  +   G YD+
Sbjct: 212 PE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE---GPYDM 248

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 541 VAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
           VA+K+LS   Q+    K    E++L+  + H+N++ L+              + P KSL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
            F        L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGV 706
           I++ SD   KI DFG+AR   G       +  V T  Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMEPE--VVTRYYRAPEVILGMGYKENVDLWSVGC 213
Query: 707 LLLETLTSK 715
           ++ E +  K
Sbjct: 214 IMGEMVCHK 222

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+++D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  +   ++   D ++ GVL+ E
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYE 230

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVK----RLSSQSGQGL--KEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K    R S  S +G+  +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 537 NGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
            GQ+ AVK     + +S  G   ++ K E  +   L+H ++V L+      G   +++E+
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107
Query: 592 MPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           M    L F +   +    +  +      +  I + L Y H  +   IIHRD+K   +LL 
Sbjct: 108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLA 164
Query: 651 SDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
           S  N    K+  FG+A       L    +  VGT  +M+PE      +    DV+  GV+
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 708 LLETLT 713
           L   L+
Sbjct: 223 LFILLS 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           Y H    +++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYI 183
Query: 686 SPEYALDGLFSVK-SDVFSFGVLL 708
           +PE  L   +  K +DV+S GV L
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTL 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +LG G F  V K +  + G E A K +      +S+ G   +E + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L      + + +LI E +    L  FL   ++   L  +     I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 634 RLRIIHRDLKASNI-LLDSDM---NPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSP 687
             +I H DLK  NI LLD ++   + K+ DFG+A      E++     K + GT  +++P
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVAP 187
Query: 688 EYALDGLFSVKSDVFSFGVL 707
           E        +++D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 268
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 269 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLED 326
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            E+    L++E M   S+   +    R H    +  V +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASV-VVQDVASALDFLHNKG---IAH 134
Query: 640 RDLKASNILLD--SDMNP-KISDFGMARMFCGDELQGNTKRV--------VGTYGYMSPE 688
           RDLK  NIL +  + ++P KI DF +     G +L G+   +         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGS---GIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 689 YA-----LDGLFSVKSDVFSFGVLL 708
                     ++  + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRLSSQSGQGLKE-FKNEMMLIAKL 567
           ++ + +   +G G FG     +L+  ++    VAVK +  + G+ + E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           +H N+VR     +      ++ EY     L   + +  R             + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVS 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           Y H    +++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYI 183
Query: 686 SPEYALDGLFSVK-SDVFSFGVLL 708
           +PE  L   +  K +DV+S GV L
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT  Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +P   L   ++   D ++ GVL+ E
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYE 230

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 125
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 183
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 126
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 184
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   K    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYLH-- 127
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLED 185
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
           VA+K+LS       + F+N+    AK  +R LV LM C   +    L+  + P KSL  F
Sbjct: 54  VAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 103
Query: 601 --------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
                   L D +   +    L  +    ++  +  G+ +LH      IIHRDLK SNI+
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 160
Query: 649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           + SD   KI DFG+AR      +      VV  Y Y +PE  L   +    D++S G ++
Sbjct: 161 VKSDCTLKILDFGLARTAGTSFMM--VPFVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 217
Query: 709 LETL 712
            E +
Sbjct: 218 GEMI 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 39/238 (16%)
Query: 494 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 551
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 552 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 610
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 611 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKS-----------DVFSFGVLL 708
           +A     D         VGT  YM PE   D   S ++           DV+S G +L
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK---NEMMLIA 565
           +A  + F     LG G FG V   K   +G   A+K L  Q    LK+ +   NE  ++ 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            +    LV+L     +     ++ EY+    +       S    +G  +        AQ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF------SHLRRIGRFSEPHARFYAAQI 150
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           +L       L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT   +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEAL 205
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLE 710
           +PE  L   ++   D ++ GVL+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E + +   LG G FG V++    + ++  + +     G      K E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            L        E ++I+E++    L+ F    +    L  +  V  +  + + L +LH ++
Sbjct: 65  HLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 634 RLRIIHRDLKASNILLDSDMNP--KISDFGMARMFC-GDELQGNTKRVVGTYGYMSPEYA 690
              I H D++  NI+  +  +   KI +FG AR    GD    N + +     Y +PE  
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVH 175
Query: 691 LDGLFSVKSDVFSFGVLL 708
              + S  +D++S G L+
Sbjct: 176 QHDVVSTATDMWSLGTLV 193

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 494 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 551
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 552 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 610
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 611 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 662 MARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +A     D         VGT  YM PE   D
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQHRNLVR 574
           LGEG +G V   ++L+ + +  + +             G    K E+ L+ +L+H+N+++
Sbjct: 13  LGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 575 LMGCCV--EQGEKILIYEY-----------MPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
           L+      E+ +  ++ EY           +P K      F   + H    Q        
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQ-------- 117
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +  GL YLH      I+H+D+K  N+LL +    KIS  G+A            +   G+
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 682 YGYMSPEYA--LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 739
             +  PE A  LD     K D++S GV L         TG+Y  E  N+     N+ K +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI-----TTGLYPFEGDNIYKLFENIGKGS 229
Query: 740 RA 741
            A
Sbjct: 230 YA 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 22/218 (10%)
Query: 507 ASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMM 562
           A       +F     LG+G FG V   +    G+  A+K L  +      E  +   E  
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVK 617
           ++   +H  L  L            + EY     L F L     F   R    G +    
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE---- 116
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
               I   L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K 
Sbjct: 117 ----IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 167
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
             GT  Y++PE   D  +    D +  GV++ E +  +
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 128/311 (41%), Gaps = 66/311 (21%)
Query: 504 FSLASVSAATEN-------FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLK 555
            SL + +AA E        F ++   G+G FG V  GK  + G  VA+K++        +
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 556 EFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI-------LIYEYMPNK----SLNFFLFDP 604
           E +  M  +A L H N+V+L       GE+        ++ EY+P+       N++    
Sbjct: 66  ELQI-MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMA 663
           +   +L      ++I  I  G L+L     + + HRD+K  N+L+ ++D   K+ DFG A
Sbjct: 125 APPPILIKVFLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTS-------- 714
           +     E   N   +   Y Y +PE    +  ++   D++S G +  E +          
Sbjct: 180 KKLSPSE--PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236
Query: 715 ---------------------KRNTGVYDIESFNLLGHAW-NLWKDN------RAYELLS 746
                                K N    D++ +N  G  W N++ D+       AY+LLS
Sbjct: 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296
Query: 747 PALQHEASYQM 757
             LQ+    +M
Sbjct: 297 ALLQYLPEERM 307

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 573
            + Q +LG G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 574 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 128 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 183
Query: 633 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 688
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 184 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
             +      K D++S   ++L  L
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHML 264

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 28/199 (14%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMML 563
             S+S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 564 IAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE-- 620
           + KLQ            +  +KI+ +Y+Y       + + +     L  W  + K I+  
Sbjct: 80  LNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 127
Query: 621 -------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
                   + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D    
Sbjct: 128 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXV 183
Query: 674 NTKRVVGTYGYMSPEYALD 692
                VGT  YM PE   D
Sbjct: 184 VKDSQVGTVNYMPPEAIKD 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 28/199 (14%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMML 563
             S+S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 564 IAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE-- 620
           + KLQ            +  +KI+ +Y+Y       + + +     L  W  + K I+  
Sbjct: 80  LNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 127
Query: 621 -------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
                   + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D    
Sbjct: 128 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV 183
Query: 674 NTKRVVGTYGYMSPEYALD 692
                VGT  YM PE   D
Sbjct: 184 VKDSQVGTVNYMPPEAIKD 202

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE----FKNEMMLIAKLQ 568
            E++ +   +G G FG V   +    Q+V   +L S+     +     F  E  ++A   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 569 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFL--FD-PSRTHLLGWQTRVKIIEGIA 623
              +V+L   C  Q +K L  + EYMP   L   +  +D P +     W          A
Sbjct: 134 SPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----TA 181
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           + +L L     + +IHRD+K  N+LLD   + K++DFG   M   +    +    VGT  
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPD 240
Query: 684 YMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 713
           Y+SPE       DG +  + D +S GV L E L 
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHR 570
           +N+ ++  +G G +G VY     N  + VA+K+++      +  K    E+ ++ +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 571 NLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 624
            ++RL    + +      E  ++ E   +     F     +T +   +  VK I+  +  
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF-----KTPIFLTEQHVKTILYNLLL 142
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
           G  ++H+     IIHRDLK +N LL+ D + KI DFG+AR    D+
Sbjct: 143 GEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 566
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 567 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 620
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 67  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 114
Query: 621 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 115 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 170
Query: 677 RVVGTYGYMSPEYALDGLFSVKS-----------DVFSFGVLL 708
             VGT  YM PE   D   S ++           DV+S G +L
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           LGEG +  V     L NG+E AVK +  Q+G        E+  + + Q ++N++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            +     L++E +   S+   L    +      +   +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 640 RDLKASNILLDS--DMNP-KISDFGMARMF-----CGDELQGNTKRVVGTYGYMSPEYA- 690
           RDLK  NIL +S   ++P KI DF +         C            G+  YM+PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 691 ----LDGLFSVKSDVFSFGVLLLETLT 713
                   +  + D++S GV+L   L+
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLS 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 573
            + Q ++G G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 574 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 114 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 633 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 688
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
             +      K D++S   ++L  L
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHML 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 28/196 (14%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 566
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 567 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 620
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 63  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 110
Query: 621 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 111 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 166
Query: 677 RVVGTYGYMSPEYALD 692
             VGT  YM PE   D
Sbjct: 167 SQVGTVNYMPPEAIKD 182

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 570
           +F     LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 625
            L  L            + EY     L F L     F   R    G +        I   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSA 117
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYL 172
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           +PE   D  +    D +  GV++ E +  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 570
           +F     LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 625
            L  L            + EY     L F L     F   R    G +        I   
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSA 122
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYL 177
Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           +PE   D  +    D +  GV++ E +  +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLV 573
            + Q ++G G FG V++ K    G + AVK++       L+ F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 574 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
            L G  V +G  + I+ E +   SL   +    +   L     +  +    +GL YLH  
Sbjct: 130 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 633 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGN---TKRVVGTYGYMSPE 688
              RI+H D+KA N+LL SD +   + DFG A     D L  +      + GT  +M+PE
Sbjct: 186 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 689 YALDGLFSVKSDVFSFGVLLLETL 712
             +      K D++S   ++L  L
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHML 266

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 566
           +S     +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 567 LQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE----- 620
           LQ            +  +KI+ +Y+Y       + + +     L  W  + K I+     
Sbjct: 64  LQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK 111
Query: 621 ----GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D       
Sbjct: 112 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 167
Query: 677 RVVGTYGYMSPEYALDGLFSVKS------------DVFSFGVLL 708
             VGT  YM PE A+  + S +             DV+S G +L
Sbjct: 168 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLED 179
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLED 179
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
           LG+G FG V   +    G+  A+K L  +      E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                     + EY     L F L     F   R    G +        I   L YLH  
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYLHSR 124
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
               +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE   D
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179
Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    D +  GV++ E +  +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 28/211 (13%)
Query: 494 GTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSG 551
           GT  D      +   +S     +S+  ++G GG   V++      Q  A+K   L     
Sbjct: 36  GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 552 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLL 610
           Q L  ++NE+  + KLQ            +  +KI+ +Y+Y       + + +     L 
Sbjct: 96  QTLDSYRNEIAYLNKLQ------------QHSDKIIRLYDYEITDQYIYMVMECGNIDLN 143
Query: 611 GWQTRVKIIE---------GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
            W  + K I+          + + +  +HQ+    I+H DLK +N L+   M  K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFG 199
Query: 662 MARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
           +A     D         VG   YM PE   D
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 31/274 (11%)
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
            KL E   G ++KG+   G ++ VK L  +  S +  ++F  E   +    H N++ ++G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 578 CC--VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
            C         LI  +MP  SL   L +     ++     VK    +A+G+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY---ALD 692
            I    L + ++++D DM  +IS   MA +    +  G     +    +++PE      +
Sbjct: 134 -IPRHALNSRSVMIDEDMTARIS---MADVKFSFQSPGR----MYAPAWVAPEALQKKPE 185
Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
                 +D++SF VLL E +T  R     D+ +  +            A E L P +   
Sbjct: 186 DTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKV--------ALEGLRPTIPPG 235
Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            S  +      +  +C+ E  A RP    +V ++
Sbjct: 236 ISPHVSK----LMKICMNEDPAKRPKFDMIVPIL 265

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-----------L 554
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 555 KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGW 612
           K    E+ L+    H N++ L    V   E  +   Y+  + +        RT L  +  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--------RTDLAQVIH 125
Query: 613 QTRVKIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             R+ I     Q  +Y     LH      ++HRDL   NILL  + +  I DF +AR   
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--- 182
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            D    N    V    Y +PE  +    F+   D++S G ++ E    K
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-----------L 554
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 555 KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL--LGW 612
           K    E+ L+    H N++ L    V   E  +   Y+  + +        RT L  +  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--------RTDLAQVIH 125
Query: 613 QTRVKIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             R+ I     Q  +Y     LH      ++HRDL   NILL  + +  I DF +AR   
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--- 182
Query: 668 GDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            D    N    V    Y +PE  +    F+   D++S G ++ E    K
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 513 TENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
            E++ +   +G G FG V           Y  KLL+  E+ +KR  S        F  E 
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 120
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 168
Query: 622 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 227
Query: 677 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 713
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           ++F    +LG G +G V+K +   +G+  AVKR  S      +  K+    +A++     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP----FRGPKDRARKLAEVGSHEK 112
Query: 573 VRLMGCCV--EQG--EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQT---RVKIIEGIAQ 624
           V    CCV  EQ   E  ++Y       L   L  PS + H   W       ++   +  
Sbjct: 113 VGQHPCCVRLEQAWEEGGILY-------LQTELCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG----MARMFCGDELQGNTKRVVG 680
            LL L       ++H D+K +NI L      K+ DFG    +     G+  +G+ +    
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR---- 221
Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLET 711
              YM+PE  L G +   +DVFS G+ +LE 
Sbjct: 222 ---YMAPEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 513 TENFSMQCKLGEGGFG-----------PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
            E++ +   +G G FG            VY  KLL+  E+ +KR  S        F  E 
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 125
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 173
Query: 622 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 232
Query: 677 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 713
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 40/221 (18%)
Query: 513 TENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM 561
            E++ +   +G G FG V           Y  KLL+  E+ +KR  S        F  E 
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEER 125
Query: 562 MLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG 621
            ++A      +V+L     +     ++ EYMP   L            +   +   + E 
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEK 173
Query: 622 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                 A+ +L L     +  IHRD+K  N+LLD   + K++DFG   M    E      
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 232
Query: 677 RVVGTYGYMSPEY----ALDGLFSVKSDVFSFGVLLLETLT 713
             VGT  Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 34/183 (18%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
           LG G  G +    + + ++VAVKR+  +        +   +L    +H N++R    C E
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYF--CTE 87
Query: 582 QGEKI----------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +  +            + EY+  K       +P           + +++    GL +LH 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQQTTSGLAHLHS 136
Query: 632 YSRLRIIHRDLKASNILL-----DSDMNPKISDFGMA-RMFCGDELQGNTKRVVGTYGYM 685
              L I+HRDLK  NIL+        +   ISDFG+  ++  G         V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 686 SPE 688
           +PE
Sbjct: 194 APE 196

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--------SGQGLKEFKNEMML 563
           ++ +S    LG G FG V+        +EV VK +  +            L +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           +++++H N+++++     QG   L+ E      L+ F F      L        +   I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRL-----DEPLASYIF 136
Query: 624 QGLLYLHQYSRLR-IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           + L+    Y RL+ IIHRD+K  NI++  D   K+ DFG A      +L        GT 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTI 193
Query: 683 GYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRN 717
            Y +PE  +   +   + +++S GV L  TL  + N
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLY-TLVFEEN 228

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG--------KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
            E+      LG+G F  ++KG          L+  EV +K L        + F     ++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           +KL H++LV   G CV   E IL+ E++   SL+ +L        + W  ++++ + +A 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAA 124
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDM-----NP---KISDFGMA 663
            + +L + +   +IH ++ A NILL  +      NP   K+SD G++
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGL--KEFKNEMMLIAKLQHR 570
           +N+ ++  +G G +G VY     N ++ VA+K+++      +  K    E+ ++ +L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 571 NLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 624
            ++RL    +        E  ++ E   +     F     +T +   +  +K I+  +  
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-----KTPIFLTEEHIKTILYNLLL 140
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
           G  ++H+     IIHRDLK +N LL+ D + K+ DFG+AR
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           E+F +   +G G FG V   KL N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           + +  L     +     L+ +Y     L   L       L     R  +    A+ ++ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAI 188
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-ELQGNTKRVVGTYGYMSPE 688
               +L  +HRD+K  NIL+D + + +++DFG       D  +Q +    VGT  Y+SPE
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE 246
Query: 689 Y--ALD---GLFSVKSDVFSFGVLLLETL 712
              A++   G +  + D +S GV + E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
           + + ++  +G G +G V +    L  + VA+K++    +     K    E+ ++ +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 571 NLVRLMGCC----VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           ++V+++       VE+ +++ +   + +         P     L  +T   ++  +  G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT---LLYNLLVGV 169
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
            Y+H      I+HRDLK +N L++ D + K+ DFG+AR
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 540 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 599
           E AVK +        +E +   +L+   QH N++ L     +     ++ E M    L  
Sbjct: 49  EFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-- 103
Query: 600 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 655
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 104 -LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESI 159
Query: 656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +I DFG A+    +   G       T  +++PE      +    D++S GVLL   LT
Sbjct: 160 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP---KISDFGMARMFCGDELQGNTKR 677
           I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+    +   G    
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLXT 179
Query: 678 VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              T  +++PE      +    D++S GVLL   LT
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           E+F +   +G G FG V   K+ N + + A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           + +  L     ++    L+ +Y     L   L       L     R  I E +    L +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 188
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
               +L  +HRD+K  N+LLD + + +++DFG   +   D+    +   VGT  Y+SPE 
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 690 --ALD---GLFSVKSDVFSFGVLLLETL 712
             A++   G +  + D +S GV + E L
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           E+F +   +G G FG V   K+ N + + A+K L+        E   F+ E  ++     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           + +  L     ++    L+ +Y     L   L       L     R  I E +    L +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 204
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
               +L  +HRD+K  N+LLD + + +++DFG   +   D+    +   VGT  Y+SPE 
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 690 --ALD---GLFSVKSDVFSFGVLLLETL 712
             A++   G +  + D +S GV + E L
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEF------ 557
           F   S+    + + ++  +G+G +G V     +  Q  A++ +   +   +++       
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 558 --KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE-----YMPNKSLNFFLFDPS----- 605
             K E+ L+ KL H N+ RL     ++    L+ E     ++ +K LN F+ D +     
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAM 132
Query: 606 ---RTHL---------------------LGWQTRVKIIEGIAQGLL-YLHQYSRLRIIHR 640
              +T +                     L +  R K+I  I + +   LH      I HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 641 DLKASNILLDSD--MNPKISDFGMARMFC---GDELQGNTKRVVGTYGYMSPEY--ALDG 693
           D+K  N L  ++     K+ DFG+++ F      E  G T +  GT  +++PE     + 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNE 251
Query: 694 LFSVKSDVFSFGVLL-LETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
            +  K D +S GVLL L  + +    GV D ++ + + +   L  +N  Y +LSP L  +
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSP-LARD 309
Query: 753 ASYQMLNRYI 762
               +LNR +
Sbjct: 310 LLSNLLNRNV 319

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 5/77 (6%)
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALDGLFS 696
           HRD+K  NIL+ +D    + DFG+A     ++L   GNT   VGT  Y +PE   +   +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT---VGTLYYXAPERFSESHAT 213
Query: 697 VKSDVFSFGVLLLETLT 713
            ++D+++   +L E LT
Sbjct: 214 YRADIYALTCVLYECLT 230

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKG--------KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
            E+      LG+G F  ++KG          L+  EV +K L        + F     ++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           +KL H++LV   G C    E IL+ E++   SL+ +L        + W  ++++ + +A 
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAW 124
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDM-----NP---KISDFGMA 663
            + +L + +   +IH ++ A NILL  +      NP   K+SD G++
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 38/223 (17%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 95
Query: 581 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 96  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 633 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 677
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 678 VVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRN 717
             GT G+ +PE   +      +   D+FS G +    L+  ++
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 38/223 (17%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 95
Query: 581 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 96  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 633 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 677
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 678 VVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRN 717
             GT G+ +PE   +      +   D+FS G +    L+  ++
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 35/191 (18%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 77
Query: 581 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 78  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 633 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 677
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 678 VVGTYGYMSPE 688
             GT G+ +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 35/191 (18%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG G  G V       G+ VAVKR L       L E K   +L     H N++R    C 
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY--CS 77
Query: 581 EQGEKILIYEYMPNKSLNFFLFD--------PSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           E  ++ L   Y+  +  N  L D             L      + ++  IA G+ +LH  
Sbjct: 78  ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 633 SRLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKR 677
             L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 678 VVGTYGYMSPE 688
             GT G+ +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 540 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 599
           E AVK +        +E +   +L+   QH N++ L     +     L+ E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 600 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 655
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 109 -LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           +I DFG A+    +   G       T  +++PE      +    D++S G+LL   L
Sbjct: 165 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN------EMMLIAKLQ----HR 570
           LG+GGFG V+ G +L +  +VA+K +      G     +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            ++RL+     Q   +L+ E  P  + + F +   +  L    +R    + +A      H
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA---IQH 154
Query: 631 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
            +SR  ++HRD+K  NIL+D      K+ DFG   +   DE   +     GT  Y  PE+
Sbjct: 155 CHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFD---GTRVYSPPEW 209
Query: 690 -ALDGLFSVKSDVFSFGVLLLETL 712
            +     ++ + V+S G+LL + +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMV 233

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 540 EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 599
           E AVK +        +E +   +L+   QH N++ L     +     L+ E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 600 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL-LDSDMNP--- 655
            L    R      +    ++  I + + YLH      ++HRDLK SNIL +D   NP   
Sbjct: 109 -LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
           +I DFG A+    +   G       T  +++PE      +    D++S G+LL   L
Sbjct: 165 RICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 181
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 188
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 182
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 307
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 14/198 (7%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LGEG F    K     + Q  AVK +S +     ++    + L     H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
           +Q    L+ E +    L  F     + H    +    I+  +   + ++H    + ++HR
Sbjct: 77  DQLHTFLVMELLNGGEL--FERIKKKKHFSETEASY-IMRKLVSAVSHMHD---VGVVHR 130
Query: 641 DLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSV 697
           DLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE      +  
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 698 KSDVFSFGVLLLETLTSK 715
             D++S GV+L   L+ +
Sbjct: 189 SCDLWSLGVILYTMLSGQ 206

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + + GT  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTY 321
Query: 685 MSPEYALD---GLFSVKSDVFSFGVLLLETLT 713
           ++PE  +      ++   D +S GV+L   L+
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 353

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	835
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-135
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-134
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-77
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-48
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-47
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-46
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-46
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-45
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-45
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-44
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-43
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-43
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-43
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-43
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-43
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-42
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-42
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-41
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-12
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	9e-10
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	3e-09
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	4e-09
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	5e-09
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	2e-07
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	9e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  404 bits (1040), Expect = e-135
 Identities = 109/307 (35%), Positives = 157/307 (51%), Gaps = 18/307 (5%)

Query: 497 RDSVLPCFSLASVSAATENFSMQC------KLGEGGFGPVYKGKLLNGQEVAVKRLSS-- 548
            D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++  
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMV 66

Query: 549 --QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR 606
              + +  ++F  E+ ++AK QH NLV L+G   +  +  L+Y YMPN SL   L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
           T  L W  R KI +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF 726
                   T R+VGT  YM+PE  L G  + KSD++SFGV+LLE +T       +  E  
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQ 241

Query: 727 NLLGHAWNLWKDNRAYE-LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 785
            LL     +  + +  E  +   +  +A    +    +VA  C+ EK   RP + KV  +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 786 ITNEHAT 792
           +    A+
Sbjct: 301 LQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  401 bits (1033), Expect = e-134
 Identities = 115/291 (39%), Positives = 169/291 (58%), Gaps = 6/291 (2%)

Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
           FSL  +  A++NFS +  LG GGFG VYKG+L +G  VAVKRL  +  QG + +F+ E+ 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEG 621
           +I+   HRNL+RL G C+   E++L+Y YM N S+   L +   +   L W  R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
            A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +    T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT---GVYDIESFNLLGHAWNLWKD 738
            G+++PEY   G  S K+DVF +GV+LLE +T +R      + + +   LL     L K+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
            +   L+   LQ     + + + I VALLC Q    +RP MS+VV M+  +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  364 bits (936), Expect = e-120
 Identities = 103/285 (36%), Positives = 162/285 (56%), Gaps = 5/285 (1%)

Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
             L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGI 622
           ++  +H +LV L+G C E+ E ILIY+YM N +L   L+      + + W+ R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           A+GL YLH  +   IIHRD+K+ NILLD +  PKI+DFG+++     +    +  V GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT-GVYDIESFNLLGHAWNLWKDNRA 741
           GY+ PEY + G  + KSDV+SFGV+L E L ++         E  NL   A     + + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            +++ P L  +   + L ++   A+ C+   + DRP+M  V+  +
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  283 bits (726), Expect = 6e-89
 Identities = 69/308 (22%), Positives = 128/308 (41%), Gaps = 29/308 (9%)

Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
               ++   +    +      G FG V+K +L   + VAVK    Q  Q   + + E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 564 IAKLQHRNLVRLMGCCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           +  ++H N+++ +G          +  LI  +    SL+ FL    + +++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 620 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
           E +A+GL YLH+         +  I HRD+K+ N+LL +++   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 673 GNTKRVVGTYGYMSPEYALDGL-----FSVKSDVFSFGVLLLETLTSKRNTGV----YDI 723
           G+T   VGT  YM+PE     +       ++ D+++ G++L E  +           Y +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 724 ESFNLLGHAWNL--WKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMS 780
                +G   +L   ++   ++   P L  +   +  +         C    A  R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 781 KVVSMITN 788
            V   IT 
Sbjct: 308 CVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  253 bits (649), Expect = 1e-77
 Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 42/332 (12%)

Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
            + +  S   +N  +   +G G +G VYKG L + + VAVK  S  + Q     K  +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60

Query: 564 IAKLQHRNLVRLMGCCVE-----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
           +  ++H N+ R +          + E +L+ EY PN SL  +L      H   W +  ++
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116

Query: 619 IEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG---- 668
              + +GL YLH       + +  I HRDL + N+L+ +D    ISDFG++    G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 669 --DELQGNTKRVVGTYGYMSPEYALDGLFSV--------KSDVFSFGVLLLETLTSKRNT 718
              E        VGT  YM+PE  L+G  ++        + D+++ G++  E      + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 719 GVYDIESFNLLGHAWNLWKDNRAYELLSPALQH----------EASYQMLNRYITVALLC 768
              +      +     +       ++     +           + +   +         C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 769 VQEKAADRPTMSKVVSMITNEHATLPYPKQSA 800
             + A  R T       +          K  +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  214 bits (546), Expect = 3e-63
 Identities = 72/295 (24%), Positives = 138/295 (46%), Gaps = 29/295 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
            + +++ K+G G FG V++ +  +G +VAVK L  Q    + + EF  E+ ++ +L+H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V  MG   +     ++ EY+   SL   L        L  + R+ +   +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                I+HR+LK+ N+L+D     K+ DFG++R+     L   +K   GT  +M+PE   
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVY-DIESFNLLGHAWNLWKDNRAYELLSPALQ 750
           D   + KSDV+SFGV+L E  T ++    + ++    ++            ++     + 
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ---PWGNLNPAQVVAAV--------GFKCKRLEIP 261

Query: 751 ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN-EHATLPYPKQSAF 801
              +     ++         C   +   RP+ + ++ ++     + +P P +S  
Sbjct: 262 RNLNPQVAAIIEG-------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (534), Expect = 1e-61
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 24/276 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +   ++  +G G FG V K K    ++VA+K++ S+S    K F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L G C+      L+ EY    SL   L              +      +QG+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 634 RLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
              +IHRDLK  N+LL +     KI DFG A      ++Q +     G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             +S K DVFS+G++L E +T ++    +D          W +    R           +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR---PPLIKNLPK 231

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               ++ R       C  +  + RP+M ++V ++T+
Sbjct: 232 PIESLMTR-------CWSKDPSQRPSMEEIVKIMTH 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 3e-60
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 41/311 (13%)

Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
            LG+G FG   K      G+ + +K L     +  + F  E+ ++  L+H N+++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
            +      I EY+   +L   +          W  RV   + IA G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131

Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR------------VVGTYGYMSP 687
           RDL + N L+  + N  ++DFG+AR+   ++ Q    R            VVG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E      +  K DVFSFG++L E +         D     +              +   P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDFGL----NVRGFLDRYCP 245

Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS----MITNEHATLPYPKQ----- 798
                + + +        + C       RP+  K+      +  +    LP   Q     
Sbjct: 246 PNCPPSFFPI-------TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298

Query: 799 -SAFSYARRGE 808
              +   RRGE
Sbjct: 299 RGFWETYRRGE 309

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (514), Expect = 3e-59
 Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRL----SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
            +G GGFG VY+     G EVAVK           Q ++  + E  L A L+H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
           G C+++    L+ E+     LN  L        +     V     IA+G+ YLH  + + 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 637 IIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           IIHRDLK+SNIL+   +          KI+DFG+AR +             G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSK 715
                +FS  SDV+S+GVLL E LT +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (512), Expect = 9e-59
 Identities = 64/290 (22%), Positives = 129/290 (44%), Gaps = 37/290 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIA 565
                + ++G+GGFG V+KG+L+ +   VA+K L     +G        +EF+ E+ +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            L H N+V+L G         ++ E++P   L   L D +    + W  +++++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARMFCGDELQGNTKRVVG 680
           + Y+       I+HRDL++ NI L S      +  K++DFG+++     +   +   ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 681 TYGYMSPE--YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 738
            + +M+PE   A +  ++ K+D +SF ++L   LT +     +  + ++     +     
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF--DEYSYGKIKFINMIR 243

Query: 739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                   P         ++         C       RP  S +V  ++ 
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIEL-------CWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  199 bits (508), Expect = 3e-58
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 19/210 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
           +  +   KL E   G ++KG+   G ++ VK L  +  S +  ++F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 572 LVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           ++ ++G C          I  +MP  SL   L +     ++     VK    +A+G+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H    L I    L + ++++D DM  +IS   +   F        +   +    +++PE 
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178

Query: 690 ALDG----LFSVKSDVFSFGVLLLETLTSK 715
           AL           +D++SF VLL E +T +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (508), Expect = 4e-58
 Identities = 72/280 (25%), Positives = 134/280 (47%), Gaps = 27/280 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
              ++  ++G G FG VYKGK  +G +VAVK L+    + Q L+ FKNE+ ++ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           ++  MG        I + ++    SL   L           +  + I    A+G+ YLH 
Sbjct: 82  ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE--- 688
                IIHRDLK++NI L  D   KI DFG+A            +++ G+  +M+PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLS- 746
                 +S +SDV++FG++L E +T +   + + + +          + + + + +L   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKV 250

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            +   +   +++         C+++K  +RP+  ++++ I
Sbjct: 251 RSNCPKRMKRLMAE-------CLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (487), Expect = 8e-55
 Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 42/285 (14%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
            +G+G FG VY G+  +G EVA++ +  +  +   LK FK E+M   + +H N+V  MG 
Sbjct: 40  LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
           C+      +I      ++L   + D      L      +I + I +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGTYGYMSPE------- 688
           H+DLK+ N+  D +    I+DFG+  +    +      +     G   +++PE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 689 --YALDGLFSVKSDVFSFGVLLLETLTSK---RNTGVYDIESFNLLGHAWNLWKDNRAYE 743
                   FS  SDVF+ G +  E    +   +      I         W +    +   
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--------IWQMGTGMKP-- 261

Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            LS     +    +L         C   +  +RPT +K++ M+  
Sbjct: 262 NLSQIGMGKEISDILLF-------CWAFEQEERPTFTKLMDMLEK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (474), Expect = 2e-53
 Identities = 66/301 (21%), Positives = 119/301 (39%), Gaps = 33/301 (10%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHR 570
             + ++   +G+G +G V++G    G+ VAVK  SS+     K +  E  +     L+H 
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62

Query: 571 NLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           N++  +   +          LI  Y    SL  +L    +   L   + ++I+  IA GL
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118

Query: 627 LYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVV 679
            +LH        +  I HRDLK+ NIL+  +    I+D G+A M     ++L       V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 680 GTYGYMSPE------YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI-----ESFNL 728
           GT  YM+PE               + D+++FG++L E      + G+ +           
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 729 LGHAWNLWKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
              ++   +     +   P +     S   L     +   C  +  + R T  ++   +T
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 788 N 788
            
Sbjct: 299 K 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 5e-53
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 35/301 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRN 571
           +   M  ++G+G +G V+ GK   G++VAVK   +        +  E  +     ++H N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92

Query: 572 LVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           ++  +   ++         LI +Y  N SL  +L    ++  L  ++ +K+      GL 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148

Query: 628 YLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 680
           +LH        +  I HRDLK+ NIL+  +    I+D G+A  F    +E+       VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 681 TYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLG 730
           T  YM PE  LD   +         +D++SFG++L E      + G+   Y +   +L+ 
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 731 H--AWNLWKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
              ++   ++    + L P+     +S + L +   +   C     A R T  +V   + 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

Query: 788 N 788
            
Sbjct: 328 K 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (457), Expect = 2e-50
 Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 35/297 (11%)

Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRNLVRL 575
           +Q  +G+G FG V++GK   G+EVAVK  SS+     + +  E  +     L+H N++  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101

Query: 576 MGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +    +         L+ +Y  + SL  +L      + +  +  +K+    A GL +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 632 -----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGTYGY 684
                  +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 685 MSPEYALDGLFSV-------KSDVFSFGVLLLETLTSKRNTGV---YDIESFNLLGHAWN 734
           M+PE  LD   ++       ++D+++ G++  E        G+   Y +  ++L+    +
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 735 L--WKDNRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           +   +     + L P +     S + L     +   C     A R T  ++   ++ 
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  174 bits (442), Expect = 1e-48
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 40/297 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
            +     +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           H N+V+  G C   G +   LI EY+P  SL  +L        +     ++    I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 679
            YL      R IHRDL   NIL++++   KI DFG+ ++   D+    ++   +      
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKD 738
               + +PE   +  FSV SDV+SFGV+L E  T    +     E   ++G+        
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 739 NRAYELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               ELL        P    +  Y ++         C       RP+   +   +  
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 319

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  172 bits (439), Expect = 2e-48
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 40/297 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
            +     +LG+G FG V   +        G+ VAVK+L   + + L++F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           H N+V+  G C   G +   LI EY+P  SL  +L        +     ++    I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 679
            YL      R IHRDL   NIL++++   KI DFG+ ++   D+    ++   +      
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKD 738
               + +PE   +  FSV SDV+SFGV+L E  T    +     E   ++G+        
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 739 NRAYELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               ELL        P    +  Y ++         C       RP+   +   +  
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  173 bits (440), Expect = 2e-48
 Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 36/294 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
                   LGEG FG V            G+ VAVK L + +G Q    +K E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 568 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            H ++++  GCC + G     L+ EY+P  SL  +L      H +G    +   + I +G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGT 681
           + YLH       IHRDL A N+LLD+D   KI DFG+A+          ++ +    V  
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA 741
             + +PE   +  F   SDV+SFGV L E LT   ++     +   L+G A       R 
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260

Query: 742 YELLS-------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            ELL        P       Y ++         C + +A+ RPT   ++ ++  
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPILKT 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  174 bits (443), Expect = 4e-48
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 41/287 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 571
           E+  +  ++G G FG V+ G+L  +   VAVK    +       +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +VRL+G C ++    ++ E +       FL   +    L  +T ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMSPEY 689
                 IHRDL A N L+      KISDFGM+R          G  ++V     + +PE 
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR-------NTGVYD-IESFNLLGHAWNLWKDNRA 741
              G +S +SDV+SFG+LL ET +          N    + +E               + 
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---------------KG 331

Query: 742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
             L  P L  +A ++++ +       C   +   RP+ S +   + +
Sbjct: 332 GRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  170 bits (433), Expect = 1e-47
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRLSSQSGQGLKEFKNEMMLIAKL 567
            +  ++ +LGEG FG V+  +  N         VAVK L   +    K+F+ E  L+  L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQT 614
           QH ++V+  G C +    I+++EYM +  LN FL                     LG   
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 671
            + I   IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R ++  D   +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 672 QGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            G+T    R      +M PE  +   F+ +SDV+SFGV+L E  T
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  169 bits (431), Expect = 4e-47
 Identities = 80/320 (25%), Positives = 136/320 (42%), Gaps = 39/320 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
            +     +LG+G FG V   +        G  VAVK+L        ++F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
              +V+  G     G +   L+ EY+P+  L  FL        L     +     I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVV 679
            YL      R +HRDL A NIL++S+ + KI+DFG+A++   D+    ++   +      
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 739
               + +PE   D +FS +SDV+SFGV+L E  T    +     E   ++G   ++   +
Sbjct: 196 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 740 RAYELLS-----PALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT 792
           R  ELL      PA        ++++        LC      DRP+ S +   +    + 
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM-------KLCWAPSPQDRPSFSALGPQLDMLWSG 304

Query: 793 LPYPKQSAFSYARRGEKISF 812
               +  AF+    G+  S 
Sbjct: 305 SRGCETHAFTAHPEGKHHSL 324

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  168 bits (428), Expect = 1e-46
 Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 33/224 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKEFKNEMMLIAKL 567
            +  ++ +LGEG FG V+  +  N         VAVK L   S    ++F+ E  L+  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------------FDPSRTHLLGWQTR 615
           QH+++VR  G C E    ++++EYM +  LN FL             +      LG    
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQ 672
           + +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R ++  D   + 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217

Query: 673 GNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           G T    R      +M PE  L   F+ +SDV+SFGV+L E  T
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (426), Expect = 1e-46
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 40/295 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
                   LGEG FG V   +        G++VAVK L  +SG   + + K E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 568 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
            H N+V+  G C E G     LI E++P+ SL  +L  P   + +  + ++K    I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RV 678
           + YL      + +HRDL A N+L++S+   KI DFG+ +    D+    ++ +       
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD 738
                + +PE  +   F + SDV+SFGV L E LT   +          ++G        
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 739 NRAYELL-------SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            R    L        P    +  YQ++         C + + ++R +   ++   
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLIEGF 297

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  171 bits (435), Expect = 2e-46
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 37/285 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 574 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +L+G  VE+   + ++ EYM   SL  +L    R  +LG    +K    + + + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
                +HRDL A N+L+  D   K+SDFG+ +       Q   K  V    + +PE   +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
             FS KSDV+SFG+LL E  +  R     +   +    +          + Y++ +P   
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGC 411

Query: 751 HEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVS----MITNEH 790
             A Y  M N        C    AA RPT  ++      + T+E 
Sbjct: 412 PPAVYDVMKN--------CWHLDAATRPTFLQLREQLEHIRTHEL 448

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  171 bits (435), Expect = 5e-46
 Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 31/279 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 334

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYA 690
            +   IHR+L A N L+  +   K++DFG++R+  GD     T      +     +PE  
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
               FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P 
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPE 442

Query: 749 LQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              E  Y+ M          C Q   +DRP+ +++    
Sbjct: 443 GCPEKVYELMRA--------CWQWNPSDRPSFAEIHQAF 473

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  165 bits (420), Expect = 7e-46
 Identities = 73/226 (32%), Positives = 110/226 (48%), Gaps = 35/226 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
                  +LGE  FG VYKG L         Q VA+K L     G   +EF++E ML A+
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQ 613
           LQH N+V L+G   +     +I+ Y  +  L+ FL              D +    L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--E 670
             V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 671 LQGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           L GN+    R      +M+PE  + G FS+ SD++S+GV+L E  +
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  164 bits (417), Expect = 1e-45
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77

Query: 574 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +L+G  VE+   + I  EYM   SL  +L    R+ L G    +K    + + + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 133

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMS 686
                +HRDL A N+L+  D   K+SDFG+ +    +                    + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   +  FS KSDV+SFG+LL E  +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  163 bits (415), Expect = 2e-45
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 29/299 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+L+G C  +    +I E+M   +L  +L + +R  +      + +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 127

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYA 690
            +   IHRDL A N L+  +   K++DFG++R+  GD     T      +     +PE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 184

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
               FS+KSDV++FGVLL E  T   +   G+   + + LL          + Y +  P 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPE 235

Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYARRG 807
              E  Y+++         C Q   +DRP+ +++               +      +RG
Sbjct: 236 GCPEKVYELM-------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (413), Expect = 3e-45
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 47/286 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
              +   ++G G FG V+ G  LN  +VA+K +   +    ++F  E  ++ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L G C+EQ    L+ E+M +  L+ +L   ++  L   +T + +   + +G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTK---RVVGTYGYMSPE 688
              +IHRDL A N L+  +   K+SDFGM R    D+      TK   +      + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPE 175

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT-------SKRNTGVYD-IESFNLLGHAWNLWKDNR 740
                 +S KSDV+SFGVL+ E  +       ++ N+ V + I                 
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------------T 220

Query: 741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            + L  P L     YQ++         C +E+  DRP  S+++  +
Sbjct: 221 GFRLYKPRLASTHVYQIM-------NHCWRERPEDRPAFSRLLRQL 259

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  164 bits (417), Expect = 3e-45
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           E  +M  +LG+G FG VY+G      +      VA+K +  + S +   EF NE  ++ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 619
               ++VRL+G   +    ++I E M    L  +L        +            +++ 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK 676
             IA G+ YL   +  + +HRDL A N ++  D   KI DFGM R ++  D     G   
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 677 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              R      +MSPE   DG+F+  SDV+SFGV+L E  T
Sbjct: 202 LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  163 bits (416), Expect = 3e-45
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 41/300 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL--SSQSGQGLKEFKNEMMLIAKL 567
               +   LGEG FG V +G L         VAVK +   + S + ++EF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 568 QHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKII 619
            H N++RL+G C+E       + ++I  +M    L+ +L      +    +  QT +K +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK 676
             IA G+ YL   S    +HRDL A N +L  DM   ++DFG+++ ++ GD        K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWN 734
             V    +++ E   D +++ KSDV++FGV + E  T       GV + E ++ L     
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----- 262

Query: 735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
                  + L  P    +  Y+++         C +    DRPT S +   +     +LP
Sbjct: 263 ----LHGHRLKQPEDCLDELYEIM-------YSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  162 bits (412), Expect = 5e-45
 Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 43/284 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           ++ +   +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L G C +Q    +I EYM N  L  +L      H    Q  +++ + + + + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYA 690
             + +HRDL A N L++     K+SDFG++R    DE        VG+     +  PE  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVL 193

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR-------NTGVYD-IESFNLLGHAWNLWKDNRAY 742
           +   FS KSD+++FGVL+ E  +  +       N+   + I                +  
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---------------QGL 238

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            L  P L  E  Y ++         C  EKA +RPT   ++S I
Sbjct: 239 RLYRPHLASEKVYTIM-------YSCWHEKADERPTFKILLSNI 275

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  167 bits (425), Expect = 6e-45
 Identities = 81/278 (29%), Positives = 129/278 (46%), Gaps = 31/278 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG G FG V+        +VAVK +   S   ++ F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     ++   I I E+M   SL  FL     +        +     IA+G+ ++    
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---E 301

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYAL 691
           +   IHRDL+A+NIL+ + +  KI+DFG+AR+   +E    T R    +     +PE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL+E +T  R    G+ + E    L          R Y +  P  
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPEN 409

Query: 750 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             E  Y  M+         C + +  +RPT   + S++
Sbjct: 410 CPEELYNIMMR--------CWKNRPEERPTFEYIQSVL 439

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  162 bits (412), Expect = 6e-45
 Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 31/278 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L   S      F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL     ++   I I EYM N SL  FL  PS   L      + +   IA+G+ ++    
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--MSPEYAL 691
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E    T R    +     +PE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
            G F++KSDV+SFG+LL E +T  R    G+ + E    L          R Y ++ P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDN 234

Query: 750 QHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             E  YQ M          C +E+  DRPT   + S++
Sbjct: 235 CPEELYQLMRL--------CWKERPEDRPTFDYLRSVL 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  163 bits (415), Expect = 1e-44
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 43/234 (18%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
            N      +GEG FG V++ +            VAVK L    S     +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
             + N+V+L+G C       L++EYM    LN FL                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 664
               L    ++ I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 665 MFCGD--ELQGNTK---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           ++  D  +  GN     R      +M PE      ++ +SDV+++GV+L E  +
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  162 bits (412), Expect = 1e-44
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 42/307 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRL--SSQSGQGLKEFKNEMMLIAKL 567
           + F++   LG+G FG V + +L        +VAVK L     +   ++EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 568 QHRNLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKI 618
            H ++ +L+G  +    K       +I  +M +  L+ FL           L  QT V+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNT 675
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R ++ GD       +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAW 733
           K  V    +++ E   D L++V SDV++FGV + E +T  +    G+ + E +N L    
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---- 252

Query: 734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
                     L  P    E  Y ++         C       RP+ + +   + N    L
Sbjct: 253 -----IGGNRLKQPPECMEEVYDLM-------YQCWSADPKQRPSFTCLRMELENILGHL 300

Query: 794 PYPKQSA 800
                S 
Sbjct: 301 SVLSTSQ 307

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (410), Expect = 1e-44
 Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 39/287 (13%)

Query: 521 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 576 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           +G C+      L +  YM +  L  F+ + +       +  +     +A+G+ YL   + 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 146

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG------YMSPE 688
            + +HRDL A N +LD     K++DFG+AR    D        V    G      +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLS 746
                 F+ KSDV+SFGVLL E +T        V   +    L          +   LL 
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQ 253

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
           P    +  Y+++       L C   KA  RP+ S++VS I+   +T 
Sbjct: 254 PEYCPDPLYEVM-------LKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  160 bits (408), Expect = 1e-44
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 33/279 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E  ++  +LG G FG V  GK     +VAVK +   S     EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +  G C ++    ++ EY+ N  L  +L   S    L     +++   + +G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT---YGYMSPEYA 690
             + IHRDL A N L+D D+  K+SDFGM R    D+        VGT     + +PE  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
               +S KSDV++FG+L+ E  +  +       + E    +         ++ + L  P 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---------SQGHRLYRPH 228

Query: 749 LQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           L  +  YQ M +        C  E    RPT  +++S I
Sbjct: 229 LASDTIYQIMYS--------CWHELPEKRPTFQQLLSSI 259

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  162 bits (412), Expect = 2e-44
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            + ++ RL+G C+    ++ I + MP   L  ++ +      +G Q  +     IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--- 684
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E           Y     
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179

Query: 685 ------MSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                 M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  161 bits (409), Expect = 2e-44
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 31/283 (10%)

Query: 521 KLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            +G+G FG VY G+ ++  +     A+K L      Q ++ F  E +L+  L H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 576 MGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           +G  +       +   YM +  L  F+  P R      +  +     +A+G+ YL   + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AE 142

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALD 692
            + +HRDL A N +LD     K++DFG+AR     E     +         + + E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
             F+ KSDV+SFGVLL E LT        +   +  + L          +   L  P   
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---------AQGRRLPQPEYC 253

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            ++ YQ++         C +   A RPT   +V  +    + L
Sbjct: 254 PDSLYQVM-------QQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  163 bits (415), Expect = 9e-44
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 27/276 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL   +    L     V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 694 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P    
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 407

Query: 752 EASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           E+ +  M          C +++  +RPT   + + +
Sbjct: 408 ESLHDLMCQ--------CWRKEPEERPTFEYLQAFL 435

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  160 bits (406), Expect = 1e-43
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL      PS+   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR-MFCGD--ELQGNTK 676
           A G  YL        IHRD+ A N LL         KI DFGMAR ++        G   
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 677 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              +      +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  159 bits (405), Expect = 1e-43
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +   +   LG G FG V +            + VAVK L    +    +   +E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 567 L-QHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-------------FDPSRTHLLG 611
           +  H N+V L+G C + G  + +I E+    +L+ +L              +      L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE 670
            +  +     +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR ++   +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 671 LQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                      +      +M+PE   D +++++SDV+SFGVLL E  +
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  159 bits (405), Expect = 1e-43
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 43/234 (18%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N  +   LGEG FG V K    +         VAVK L  + S   L++  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
           + H ++++L G C + G  +LI EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 664
               L     +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 665 MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           ++  D     ++     +      +M+ E   D +++ +SDV+SFGVLL E +T
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  160 bits (407), Expect = 2e-43
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 622
             H+N+VR +G  ++   + ++ E M    L  FL      PS+   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR-MFCGD--ELQGNTK 676
           A G  YL        IHRD+ A N LL         KI DFGMAR ++        G   
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 677 ---RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              +      +M PE  ++G+F+ K+D +SFGVLL E  +
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  159 bits (405), Expect = 2e-43
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 38/229 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 564
           +  ++   LGEG FG V   + +            VAVK L    + + L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLL 610
             + +H+N++ L+G C + G   +I EY    +L  +L              +      +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 669
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 670 ELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
             +  T      +      +M+PE   D +++ +SDV+SFGVL+ E  T
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  160 bits (407), Expect = 2e-43
 Identities = 89/383 (23%), Positives = 146/383 (38%), Gaps = 72/383 (18%)

Query: 453 RRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAK-----GTRRDSVLPCFSLA 507
              H        +   L K        T + E S             TR  S      LA
Sbjct: 4   SHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLA 63

Query: 508 SVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-S 547
            VS              +  ++   LGEG FG V   + +            VAVK L  
Sbjct: 64  GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123

Query: 548 SQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----- 601
             + + L +  +EM ++  + +H+N++ L+G C + G   +I EY    +L  +L     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 602 --------FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653
                    +      + ++  V     +A+G+ YL   +  + IHRDL A N+L+  + 
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENN 240

Query: 654 NPKISDFGMAR-MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
             KI+DFG+AR +   D  +  T      +      +M+PE   D +++ +SDV+SFGVL
Sbjct: 241 VMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVL 294

Query: 708 LLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVA 765
           + E  T   +   G+   E F LL            + +  PA      Y M+       
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFKLL---------KEGHRMDKPANCTNELYMMM------- 338

Query: 766 LLCVQEKAADRPTMSKVVSMITN 788
             C     + RPT  ++V  +  
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDR 361

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  164 bits (417), Expect = 2e-43
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 27/276 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L     E+   I + EYM   SL  FL        L     V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---E 380

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 694 LFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            F++KSDV+SFG+LL E  T  R    G+ + E  + +          R Y +  P    
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 490

Query: 752 EASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           E+ +  M          C +++  +RPT   + + +
Sbjct: 491 ESLHDLMCQ--------CWRKEPEERPTFEYLQAFL 518

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  158 bits (403), Expect = 3e-43
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKL-Q 568
            +   Q  +GEG FG V K ++         A+KR+    S    ++F  E+ ++ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 615
           H N++ L+G C  +G   L  EY P+ +L  FL                S    L  Q  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +     +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R    +     T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKT 199

Query: 676 K-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                 R      +M+ E     +++  SDV+S+GVLL E ++
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  158 bits (401), Expect = 5e-43
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
                   LG G FG V+KG  +   E     V +K +  +SG Q  +   + M+ I  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H ++VRL+G C     ++ + +Y+P  SL   +        LG Q  +     IA+G+ 
Sbjct: 73  DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMY 129

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL---QGNTKRVVGTYGY 684
           YL       ++HR+L A N+LL S    +++DFG+A +   D+        K  +    +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KW 183

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           M+ E    G ++ +SDV+S+GV + E +T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  159 bits (404), Expect = 6e-43
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 31/283 (10%)

Query: 521 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 576 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           +G C+      L +  YM +  L  F+ + +       +  +     +A+G+ +L   + 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 210

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMSPEYALD 692
            + +HRDL A N +LD     K++DFG+AR     E      +        +M+ E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
             F+ KSDV+SFGVLL E +T        V   +    L          +   LL P   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQPEYC 321

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
            +  Y+++       L C   KA  RP+ S++VS I+   +T 
Sbjct: 322 PDPLYEVM-------LKCWHPKAEMRPSFSELVSRISAIFSTF 357

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  157 bits (399), Expect = 9e-43
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
               ++  +G G  G V  G+L         VA+K L +  + +  ++F +E  ++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N++RL G        +++ EYM N SL+ FL              V ++ G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG----- 683
           L   S L  +HRDL A N+L+DS++  K+SDFG++R      L+ +      T G     
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAYTTTGGKIPI 218

Query: 684 -YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            + +PE      FS  SDV+SFGV++ E L 
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  156 bits (396), Expect = 3e-42
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
              + Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N++RL G   +    ++I EYM N +L+ FL +            V ++ GIA G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--M 685
           YL   + +  +HRDL A NIL++S++  K+SDFG++R    D+ +       G       
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +PE      F+  SDV+SFG+++ E +T
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  156 bits (396), Expect = 3e-42
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
            N      LG G FG V +       +      VAVK L S+      +   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQT 614
           L QH N+V L+G C   G  ++I EY     L  FL                      + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDE--L 671
            +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR +       +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +GN +  V    +M+PE   D +++V+SDV+S+G+LL E  +
Sbjct: 223 KGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  155 bits (394), Expect = 5e-42
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            + ++ RL+G C+    ++ I + MP   L  ++ +      +G Q  +     IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY--- 684
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E           Y     
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179

Query: 685 ------MSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                 M+ E  L  +++ +SDV+S+GV + E +T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  154 bits (391), Expect = 5e-42
 Identities = 65/213 (30%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL---SSQSGQGLKEFKNEMMLIAK 566
           ++  +  KLG+G FG V +G+          VAVK L        + + +F  E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L HRNL+RL G  +    K+ + E  P  SL   L            T  +    +A+G+
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 134

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG--- 683
            YL      R IHRDL A N+LL +    KI DFG+ R      L  N    V       
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-----LPQNDDHYVMQEHRKV 186

Query: 684 ---YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              + +PE      FS  SD + FGV L E  T
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  157 bits (398), Expect = 5e-42
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 51/264 (19%)

Query: 491 DAKGTRRDSVLPCFSLASVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLLN-- 537
           D      +++     LA VS              +   +   LGEG FG V   + +   
Sbjct: 35  DYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD 94

Query: 538 ------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589
                   +VAVK L S  + + L +  +EM ++  + +H+N++ L+G C + G   +I 
Sbjct: 95  KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154

Query: 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------------IAQGLLYLHQYSRL 635
           EY    +L  +L    R   L +                       +A+G+ YL   +  
Sbjct: 155 EYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASK 210

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNTK---RVVGTYGYMSPEY 689
           + IHRDL A N+L+  D   KI+DFG+AR +   D  +   N +   +      +M+PE 
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEA 264

Query: 690 ALDGLFSVKSDVFSFGVLLLETLT 713
             D +++ +SDV+SFGVLL E  T
Sbjct: 265 LFDRIYTHQSDVWSFGVLLWEIFT 288

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  154 bits (392), Expect = 6e-42
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 38/229 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
              S    LG G FG V +       +      VAVK L  S      +   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG---- 621
           L  H N+V L+G C   G  ++I EY     L  FL     + +    +   + +     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 622 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 669
                      +A+G+ +L   +    IHRDL A NILL      KI DFG+AR +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 670 ELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                       +      +M+PE   + +++ +SDV+S+G+ L E  +
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  153 bits (389), Expect = 8e-42
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 38/222 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
           E+      LG+G F  ++KG          L+  EV +K L        + F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           KL H++LV   G CV   E IL+ E++   SL+ +L        + W+  +++ + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDELQGNTKR 677
           + +L       +IH ++ A NILL  + +         K+SD G++      +       
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 678 VVGTYGY-----MSPEYALDG-LFSVKSDVFSFGVLLLETLT 713
                       + PE   +    ++ +D +SFG  L E  +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  153 bits (389), Expect = 9e-42
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 19/205 (9%)

Query: 518 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
              +LG G FG V +G     ++   VA+K L         +E   E  ++ +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 574 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           RL+G C  Q E +++  E      L+ FL        +      +++  ++ G+ YL   
Sbjct: 74  RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL--- 126

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL----QGNTKRVVGTYGYMSPE 688
                +HRDL A N+LL +    KISDFG+++    D+     +   K  +    + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT 713
                 FS +SDV+S+GV + E L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  153 bits (388), Expect = 1e-41
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
           E   +   +GEG FG V++G  ++ +     VA+K   +  S    ++F  E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E    I I E      L  FL    R + L   + +     ++  L Y
Sbjct: 75  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMS 686
           L      R +HRD+ A N+L+ S+   K+ DFG++R             K  +    +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE      F+  SDV+ FGV + E L 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  152 bits (386), Expect = 2e-41
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
           E+  +   LGEG FG VY+G   N +     VAVK      +    ++F +E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E+   I I E  P   L  +L     +  L   T V     I + + Y
Sbjct: 72  HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAY 128

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY--GYMS 686
           L     +  +HRD+   NIL+ S    K+ DFG++R    ++     K  V      +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMS 182

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE      F+  SDV+ F V + E L+
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  154 bits (392), Expect = 3e-41
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
            N S+   +G G FG V  G+L    +    VA+K L    + +  ++F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGL 626
           H N++RL G   +    +++ EYM N SL+ FL    R H         V ++ GIA G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGM 160

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG--- 683
            YL   S +  +HRDL A NIL++S++  K+SDFG+ R      L+ + +    T G   
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKI 212

Query: 684 ---YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              + SPE      F+  SDV+S+G++L E ++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  152 bits (385), Expect = 3e-41
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 521 KLGEGGFGPVYKGKLLNG---QEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG        + VAVK L   +       E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           +G C  + E   L+ E      LN +L        +  +  ++++  ++ G+ YL     
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EE 135

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTK---RVVGTYGYMSP 687
              +HRDL A N+LL +    KISDFG+++    DE     Q + K   +      + +P
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK------WYAP 189

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E      FS KSDV+SFGVL+ E  +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  152 bits (385), Expect = 1e-40
 Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 43/234 (18%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
           EN      LG G FG V         +      VAVK L         +   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 619
           L  H N+V L+G C   G   LI+EY     L  +L      F          +   +  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 620 EG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 664
           +               +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 665 MFCGDELQGNTK-----RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +                +      +M+PE   +G++++KSDV+S+G+LL E  +
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (390), Expect = 3e-39
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
           E   +   +GEG FG V++G  ++ +     VA+K   +  S    ++F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E    I I E      L  FL    R   L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE--LQGNTKRVVGTYGYMS 686
           L      R +HRD+ A N+L+ S+   K+ DFG++R             K  +    +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE      F+  SDV+ FGV + E L 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  153 bits (387), Expect = 4e-39
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 518 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
              +LG G FG V +G     ++   VA+K L         +E   E  ++ +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL+G C  +   + + E      L+ FL        +      +++  ++ G+ YL    
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---E 453

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE----LQGNTKRVVGTYGYMSPEY 689
               +HR+L A N+LL +    KISDFG+++    D+     +   K  +    + +PE 
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510

Query: 690 ALDGLFSVKSDVFSFGVLLLETLT 713
                FS +SDV+S+GV + E L+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (364), Expect = 1e-38
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 28/217 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            +F     +G GGFG V+K K  ++G+   +KR+   +    ++ + E+  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 573 VRLMGCCVEQGEKI----------------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
           V   GC                        +  E+    +L  ++ +  R   L     +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
           ++ E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G   
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           R  GT  YMSPE      +  + D+++ G++L E L 
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (363), Expect = 3e-38
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
            +F     LG GGFG V++ K  ++    A+KR+         ++   E+  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 572 LVRLMGCCVE---------QGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           +VR     +E            K+ +Y   +    ++L  ++              + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV- 678
             IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      DE +       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 679 ---------VGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
                    VGT  YMSPE      +S K D+FS G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 1e-37
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 9/206 (4%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           E +    K+GEG FG     K   +G++  +K   +S  S +  +E + E+ ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+      E G   ++ +Y     L F   +  +  L      +     I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
                +I+HRD+K+ NI L  D   ++ DFG+AR+             +GT  Y+SPE  
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR 716
            +  ++ KSD+++ G +L E  T K 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  141 bits (358), Expect = 2e-37
 Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 28/288 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQH 569
            NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLY 628
            N+++     +E  E  ++ E      L+  +    +   L  +  V K    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           +H     R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT  YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA---YELL 745
              +  ++ KSD++S G LL E    +     +  +  NL      + + +      +  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL 793
           S  L+             +  +C+      RP ++ V  +    HA  
Sbjct: 264 SEELRQ------------LVNMCINPDPEKRPDVTYVYDVAKRMHACT 299

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (356), Expect = 3e-37
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
             +F     LG+G FG V K +  L+ +  A+K++     + L    +E+ML+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVKIIE 620
           +VR     +E+   +     +  KS  F          L+D   S           ++  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF------------CG 668
            I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+                
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 669 DELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLE 710
                N    +GT  Y++ E     G ++ K D++S G++  E
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (354), Expect = 4e-37
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           ++G G F  VYKG       EVA    +    +    + FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 578 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
                 +     +L+ E M + +L  +L    R  ++  +        I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 634 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
              IIHRDLK  NI +     + KI D G+A +          K V+GT  +M+PE   +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204

Query: 693 GLFSVKSDVFSFGVLLLETLTSK 715
             +    DV++FG+ +LE  TS+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (346), Expect = 4e-36
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           E++ +   +G G +G   K +   +G+ +  K     S +    +   +E+ L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 571 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 627
           N+VR     +++    L  + EY     L   +   ++      +  V +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 628 YLHQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
             H+       ++HRDLK +N+ LD   N K+ DFG+AR+   D     T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
           SPE      ++ KSD++S G LL E      
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  137 bits (347), Expect = 7e-36
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 23/217 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
             +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 572 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
              +RL    +      ++ E   N  LN +L    +  +  W+ +    + + + +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 143

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE- 688
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 689 ----------YALDGLFSVKSDVFSFGVLLLETLTSK 715
                            S KSDV+S G +L      K
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 7e-36
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
           LG+G +G VY G+ L N   +A+K +  +  +  +    E+ L   L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 581 EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
           E    I I+ E +P  SL+  L           QT     + I +GL YLH     +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 640 RDLKASNILLDSDM-NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE---YALDGLF 695
           RD+K  N+L+++     KISDFG ++      +   T+   GT  YM+PE       G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKGPRG-Y 202

Query: 696 SVKSDVFSFGVLLLETLTSKR 716
              +D++S G  ++E  T K 
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 9e-36
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM 576
           ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +   +RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
              +      ++ E   N  LN +L    +  +  W+ +      + + +  +HQ+    
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKN-MLEAVHTIHQH---G 175

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE-------- 688
           I+H DLK +N L+  D   K+ DFG+A     D         VG   YM PE        
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 689 ---YALDGLFSVKSDVFSFGVLLLETLTSK 715
                     S KSDV+S G +L      K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  136 bits (345), Expect = 2e-35
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
             +S+  ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 572 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
              +RL    +      ++ E   N  LN +L    +   +    R    + + + +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE- 688
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 689 ----------YALDGLFSVKSDVFSFGVLLLETLTSK 715
                            S KSDV+S G +L      K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (340), Expect = 6e-35
 Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 29/221 (13%)

Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL 567
           V    +++    KLGEGGF  V   + L +G   A+KR+     Q  +E + E  +    
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83

Query: 568 QHRNLVRLMGCCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGI 622
            H N++RL+  C+ +        L+  +    +L   +         L     + ++ GI
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD-------ELQGNT 675
            +GL  +H        HRDLK +NILL  +  P + D G     C             + 
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 676 KRVVGTYGYMSPEYALDGLFSV--------KSDVFSFGVLL 708
                T  Y +PE     LFSV        ++DV+S G +L
Sbjct: 201 AAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVL 236

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 8e-35
 Identities = 54/216 (25%), Positives = 80/216 (37%), Gaps = 26/216 (12%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 566
           S   ++F    +LG G +G V+K     +G+  AVK      +  +       E+    K
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 619
           + QH   VRL     E G   L  E     SL             ++             
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD------ 165

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
                 L +LH      ++H D+K +NI L      K+ DFG+     G    G      
Sbjct: 166 --TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QE 217

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           G   YM+PE  L G +   +DVFS G+ +LE   + 
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (333), Expect = 6e-34
 Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 29/251 (11%)

Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
           S + +         D +G      L               + Q ++G G FG V++ K  
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80

Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY-EYMPN 594
             G + AVK++  +  +       E++  A L    +V L G   E G  + I+ E +  
Sbjct: 81  QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEG 134

Query: 595 KSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
            SL   +         R         +  +    +GL YLH     RI+H D+KA N+LL
Sbjct: 135 GSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT---RRILHGDVKADNVLL 183

Query: 650 DSDMNP-KISDFGMARMFCGDELQGNTKR---VVGTYGYMSPEYALDGLFSVKSDVFSFG 705
            SD +   + DFG A     D L  +      + GT  +M+PE  +      K D++S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 706 VLLLETLTSKR 716
            ++L  L    
Sbjct: 244 CMMLHMLNGCH 254

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 4e-33
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
           KLG GG   VY  +  +   +VA+K +     +    LK F+ E+   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
               E     L+ EY+   +L+ ++        L   T +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
           I+HRD+K  NIL+DS+   KI DFG+A+    +     T  V+GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 697 VKSDVFSFGVLLLETLT 713
             +D++S G++L E L 
Sbjct: 191 ECTDIYSIGIVLYEMLV 207

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (322), Expect = 9e-33
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE++++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V  +   +   E  ++ EY+   SL     D      +       +     Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
               ++IHRD+K+ NILL  D + K++DFG    FC       +KR  +VGT  +M+PE 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 690 ALDGLFSVKSDVFSFGVLLLE 710
                +  K D++S G++ +E
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIE 208

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 9e-33
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 15/228 (6%)

Query: 487 EGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKR 545
           E + D +  +R                ++F    +LG G  G V+K     +G  +A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 546 LSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
           +  +       +   E+ ++ +     +V   G     GE  +  E+M   SL+  L   
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125

Query: 605 SRT--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
            R    +LG     K+   + +GL YL    + +I+HRD+K SNIL++S    K+ DFG+
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           +      +   N+   VGT  YMSPE      +SV+SD++S G+ L+E
Sbjct: 179 SGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 1e-32
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
           S +   + +   LG+G    V++G+    G   A+K  +     + +     E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 568 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
            H+N+V+L     E+          E+ P  SL   L +PS  + L     + ++  +  
Sbjct: 65  NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 625 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE       + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177

Query: 681 TYGYMSPE--------YALDGLFSVKSDVFSFGVLLLETLT 713
           T  Y+ P+              +    D++S GV      T
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 1e-32
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 12/210 (5%)

Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 564
           S+    ++     +LG G +G V K + + +GQ +AVKR+ +    Q  K    ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
             +     V   G    +G+  +  E M      F+     +   +      KI   I +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L +LH  S+L +IHRD+K SN+L+++    K+ DFG++     D++  +     G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI--DAGCKPY 175

Query: 685 MSPE----YALDGLFSVKSDVFSFGVLLLE 710
           M+PE          +SVKSD++S G+ ++E
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIE 205

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 1e-32
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 30/209 (14%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
                   K+GEG  G V   +   +G++VAVK +  +  Q  +   NE++++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 623
           +V +    +   E  ++ E++   +L         T ++   ++V++ E  IA       
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL---------TDIV---SQVRLNEEQIATVCEAVL 151

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
           Q L YLH      +IHRD+K+ +ILL  D   K+SDFG    FC    +   KR  +VGT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
             +M+PE     L++ + D++S G++++E
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE 233

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 3e-32
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 569
             +     LG+GGF   ++       +  A K +  S       +E    E+ +   L H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           +++V   G   E  + + ++ E    +SL        R  L   + R   +  I  G  Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSP 687
           LH+    R+IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++P
Sbjct: 157 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAP 210

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSK 715
           E       S + DV+S G ++   L  K
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (324), Expect = 4e-32
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
           S +   + +   LG+G    V++G+    G   A+K  +     + +     E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 568 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
            H+N+V+L     E+          E+ P  SL   L +PS  + L     + ++  +  
Sbjct: 65  NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 625 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE       + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177

Query: 681 TYGYMSPE--------YALDGLFSVKSDVFSFGVLLLETLT 713
           T  Y+ P+              +    D++S GV      T
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (317), Expect = 4e-32
 Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 34/236 (14%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEM 561
           ++   S  T  F    K+G G FG V+K  K L+G   A+KR           +    E+
Sbjct: 2   AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61

Query: 562 MLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
              A L QH ++VR      E    ++  EY    SL   + +  R      +  +K + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KISDF 660
             + +GL Y+H    + ++H D+K SNI +     P                   KI D 
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 661 GMARMFCGDELQGNTKRVVGTYGYMSPE-YALDGLFSVKSDVFSFGVLLLETLTSK 715
           G            + +   G   +++ E    +     K+D+F+  + ++    ++
Sbjct: 179 GHVTRI------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (332), Expect = 5e-32
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 572
            + M+ +LG GGFG V +      G++VA+K+   +     +E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 573 VRL------MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           V        +         +L  EY     L  +L        L       ++  I+  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 627 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
            YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL       VGT  
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           Y++PE      ++V  D +SFG L  E +T
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (316), Expect = 5e-32
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 16/200 (8%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
           LG+GGF   ++       +  A K +  S       +E    E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 578 CCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
              E  + + ++ E    +SL        R  L   + R   +  I  G  YLH   R R
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLH---RNR 135

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSPEYALDGLF 695
           +IHRDLK  N+ L+ D+  KI DFG+A      E  G  K+V+ GT  Y++PE       
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 696 SVKSDVFSFGVLLLETLTSK 715
           S + DV+S G ++   L  K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (331), Expect = 9e-32
 Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 24/204 (11%)

Query: 521 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL-- 575
            +  GG G +Y      +NG+ V +K L        +     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 576 MGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                ++    + Y   EY+  +SL            L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
             + +++ DLK  NI+L  +   K+ D G            +   + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRT 251

Query: 693 GLFSVKSDVFSFGVLLLETLTSKR 716
           G  +V +D+++ G  L        
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (313), Expect = 2e-31
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
            LG GG   V+  + L + ++VAVK L +   +       F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 577 GCCVEQGEKILIY----EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
                +     +     EY+   +L   +        +  +  +++I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-NTKRVVGTYGYMSPEYAL 691
            +  IIHRD+K +NI++ +    K+ DFG+AR           T  V+GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
                 +SDV+S G +L E LT + 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (311), Expect = 3e-31
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            E + +  +LG+G FG VYK K    G   A K + ++S + L+++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L+G     G+  ++ E+ P  +++  +       L   Q +V +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPE- 688
               RIIHRDLKA N+L+  + + +++DFG         L+   KR   +GT  +M+PE 
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 689 ----YALDGLFSVKSDVFSFGVLLLE 710
                  D  +  K+D++S G+ L+E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (310), Expect = 5e-31
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 11/197 (5%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
            +G GG G VY+ +  +  + VA+K +S             + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
                 G+  +    +    L   L    R   L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS 696
             HRD+K  NIL+ +D    + DFG+A     DE        VGT  YM+PE   +   +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 697 VKSDVFSFGVLLLETLT 713
            ++D+++   +L E LT
Sbjct: 214 YRADIYALTCVLYECLT 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (317), Expect = 5e-31
 Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 27/213 (12%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLV 573
           +F  +  LG G  G +    + + ++VAVKR+  +          E+ +L    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 574 RLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           R    C E+  +   +  E          L +    +         + +++    GL +L
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 630 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMARMFCGDEL-QGNTKRVVGTYG 683
           H    L I+HRDLK  NIL+        +   ISDFG+ +              V GT G
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 684 YMSPEY---ALDGLFSVKSDVFSFGVLLLETLT 713
           +++PE          +   D+FS G +    ++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (310), Expect = 7e-31
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 15/206 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAKLQHR 570
           E+     ++G G +G V K     +GQ +AVKR+ S    +  K+   ++ +++      
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLY 628
            +V+  G    +G+  +  E M + S + F               +  KI     + L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           L     L+IIHRD+K SNILLD   N K+ DFG++        +       G   YM+PE
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPE 195

Query: 689 ----YALDGLFSVKSDVFSFGVLLLE 710
                A    + V+SDV+S G+ L E
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYE 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (308), Expect = 9e-31
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 14/201 (6%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            E F +  KLGEG +G VYK      GQ VA+K++  +    L+E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+  G   +  +  ++ EY    S++  +       L   +    I++   +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEY 689
              +R IHRD+KA NILL+++ + K++DFG      G       KR  V+GT  +M+PE 
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEV 196

Query: 690 ALDGLFSVKSDVFSFGVLLLE 710
             +  ++  +D++S G+  +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 2e-30
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 15/206 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 569
           E+F +   LG+G F  VY+ + +  G EVA+K +   +    G+ +  +NE+ +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
            +++ L     E    + L+ E   N  +N +L +  +      + R   +  I  G+LY
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEAR-HFMHQIITGMLY 127

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTYGYMSP 687
           LH +    I+HRDL  SN+LL  +MN KI+DFG+A      ++       + GT  Y+SP
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL---KMPHEKHYTLCGTPNYISP 181

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E A      ++SDV+S G +    L 
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLI 207

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 3e-30
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 33/217 (15%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
            L EGGF  VY+ + + +G+E A+KRL S   +  +    E+  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 579 CVEQGEK-------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
                E+        L+   +    L  FL        L   T +KI     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR----------VVGT 681
             +  IIHRDLK  N+LL +    K+ DFG A           + +             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 682 YGYMSPEYALDGLFSV--------KSDVFSFGVLLLE 710
             Y +PE     +  +        K D+++ G +L  
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYL 245

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (304), Expect = 3e-30
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
            E F+   K+G+G FG V+KG      + VA+K +  +  +  +++ + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            + +  G  ++  +  +I EY+   S      D      L       I+  I +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPE 688
                + IHRD+KA+N+LL      K++DFG      G       KR   VGT  +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 689 YALDGLFSVKSDVFSFGVLLLE 710
                 +  K+D++S G+  +E
Sbjct: 190 VIKQSAYDSKADIWSLGITAIE 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (302), Expect = 6e-30
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 20/213 (9%)

Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 564
              A   +     ++G G  G V+K +    G  +AVK++      +  K    ++ +++
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGI 622
                  +V+  G  +   +  +  E M   +              +LG     K+   I
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAI 133

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
            + L YL    +  +IHRD+K SNILLD     K+ DFG++     D+   +     G  
Sbjct: 134 VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDR--SAGCA 188

Query: 683 GYMSPE-----YALDGLFSVKSDVFSFGVLLLE 710
            YM+PE           + +++DV+S G+ L+E
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (300), Expect = 2e-29
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-----------------SQSGQGLKE 556
            ++ +   L +G F  +   +  + +  A+K+                           +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 557 FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLG 611
           FKNE+ +I  +++   +   G      E  +IYEYM N S+      FF+ D + T  + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
            Q    II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 672 QGNTKRVVGTYGYMSPE-----YALDGLFSVKSDVFSFGVLLLETLT 713
           +G      GTY +M PE      + +G    K D++S G+ L     
Sbjct: 208 KG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFY 247

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  117 bits (295), Expect = 4e-29
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 34/190 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
           ENF    K+GEG +G VYK +  L G+ VA+K++       L             E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN------KSLNFFLFDPSRTHLLGWQTRVKI 618
            +L H N+V+L+     + +  L++E++         +               +Q     
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
              + QGL + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  V
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164

Query: 679 VGTYGYMSPE 688
           V T  Y +PE
Sbjct: 165 V-TLWYRAPE 173

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 7e-29
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           +++ +Q  +G G    V         ++VA+KR++  +    + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 623
           +V      V + E  L+ + +   S+   +         G      + E  IA       
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVL 131

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVG 680
           +GL YLH   +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 681 TYGYMSPEYALDGL-FSVKSDVFSFGVLLLE 710
           T  +M+PE       +  K+D++SFG+  +E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  118 bits (298), Expect = 1e-28
 Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 38/223 (17%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLVRLMGCC 579
            LG G  G V       G+ VAVKR+             E+ +L     H N++R    C
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76

Query: 580 VEQGEK--ILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
            E  ++   +  E   N +L   +           L      + ++  IA G+ +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133

Query: 634 RLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKRV 678
            L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N    
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 679 VGTYGYMSPEYALDGLFSV-------KSDVFSFGVLLLETLTS 714
            GT G+ +PE   +              D+FS G +    L+ 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 2e-28
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
            + FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N ++  GC + +    L+ EY    + +  L +  +  L   +    +  G  QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      +IHRD+KA NILL      K+ DFG            N+   VGT  +M+PE
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWMAPE 220

Query: 689 ---YALDGLFSVKSDVFSFGVLLLE 710
                 +G +  K DV+S G+  +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (289), Expect = 2e-28
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
           + +    K+GEG +G V+K K     + VA+KR+       L +           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKII 619
            +L+H+N+VRL        +  L++E+     K          DP       +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             + +GL + H      ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

Query: 680 GTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 716
            T  Y  P+      L+S   D++S G +  E   + R
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 2e-28
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 568
           E+F +   LG+G FG VY  +   +   +A+K L      ++G    + + E+ + + L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
           H N++RL G   +     LI EY P  ++   L     FD  RT           I  +A
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELA 119

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV-GTY 682
             L Y H     R+IHRD+K  N+LL S    KI+DFG +          + +  + GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTDLCGTL 171

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            Y+ PE     +   K D++S GVL  E L 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 2e-28
 Identities = 23/241 (9%), Positives = 53/241 (21%), Gaps = 45/241 (18%)

Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLI 564
           +S       +   L  G    V+  + +   ++ A+K     +  S   L+         
Sbjct: 57  LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116

Query: 565 AKLQHRNLVRLMGCC--------------------------VEQGEKILIYEYMP---NK 595
           A+L   +                                        +L+          
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176

Query: 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655
             +   F        G      +   + +    L       ++H      N+ +  D   
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRL 233

Query: 656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLETL 712
            + D             G            +P   L+     F+   + +  G+ +    
Sbjct: 234 MLGDVSALW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 713 T 713
            
Sbjct: 288 C 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  115 bits (290), Expect = 2e-28
 Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 32/188 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 565
           E +    K+GEG +G VYK K   G+ VA+KR+       L             E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 620
           +L H N+V L+     +    L++E+M    K +   N      S+  +  +Q       
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
            + +G+ + HQ+   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  VV 
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181

Query: 681 TYGYMSPE 688
           T  Y +P+
Sbjct: 182 TLWYRAPD 189

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (294), Expect = 2e-28
 Identities = 45/226 (19%), Positives = 82/226 (36%), Gaps = 32/226 (14%)

Query: 505 SLASVSAATENFSMQCKLGEG--GFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKN 559
            ++S       + +   +G+G      V   +    G+ V V+R  L + S + +   + 
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
           E+ +     H N+V      +   E  ++  +M   S            L+       + 
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA---------KDLICTHFMDGMN 126

Query: 620 EG-IA-------QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           E  IA       + L Y+H    +  +HR +KAS+IL+  D    +S             
Sbjct: 127 ELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 672 QGNT-----KRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLE 710
           +        K  V    ++SPE     L  +  KSD++S G+   E
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (294), Expect = 3e-28
 Identities = 31/231 (13%), Positives = 64/231 (27%), Gaps = 43/231 (18%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-------- 569
           LG+       +      G+   V             +K+ K E++ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 570 --------RNLVRLMGCC-----VEQGEKILIYEY---MP-----NKSLNFFLFDPSRTH 608
                    +LV+                + +       P      ++    L   S TH
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 609 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             L    R+++   + + L  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 668 GDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLT 713
           G        R        +            L +   D ++ G+ +     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (289), Expect = 6e-28
 Identities = 32/222 (14%), Positives = 65/222 (29%), Gaps = 22/222 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
           ++   +   LGEG F  VY+          N Q+  +K     +          M  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ 624
                 ++     + Q   +L+ E     +L   +  +  +   ++     +     +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 625 GLLYLHQYSRLRIIHRDLKASNILL-----------DSDMNPKISDFGMARMFCGDELQG 673
            +  +H      IIH D+K  N +L           D      + D G +          
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
                  T G+   E   +  ++ + D F     +   L   
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 8e-28
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
           +E +    KLG G +G V   +  +   E A+K +  +S S     +   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
            N+++L     ++    L+ E      L    FD    R           II+ +  G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150

Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           YLH+     I+HRDLK  N+LL+S   D   KI DFG++ +F   +     K  +GT  Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204

Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L   +  K DV+S GV+L
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (293), Expect = 1e-27
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
           ++ +  Q  LG+G FG V   K  + GQE AVK +S    +     +    E+ L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGL 626
           H N+++L     ++G   L+ E      L    FD   SR          +II  +  G+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139

Query: 627 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
            Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   +     K  +GT  
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y++PE  L G +  K DV+S GV+L
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  113 bits (285), Expect = 1e-27
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 33/194 (17%)

Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLI 564
           +++  F    KLG G +  VYKG     G  VA+K +   S +G     ++E      L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYM----------PNKSLNFFLFDPSRTHLLGWQT 614
            +L+H N+VRL      + +  L++E+M                    + +      WQ 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
                  + QGL + H+    +I+HRDLK  N+L++     K+ DFG+AR F G  +   
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165

Query: 675 TKRVVGTYGYMSPE 688
           +  VV T  Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  116 bits (292), Expect = 2e-27
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
            E +++ C LG+G FG V K K  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
            N+++L     +     ++ E      L    FD    R          +II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           Y+H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189

Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (282), Expect = 2e-27
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 32/188 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 565
           E +    K+GEG +G VYK +   G+  A+K++       L++           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 620
           +L+H N+V+L      +   +L++E++    K L        +         Q       
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
            +  G+ Y H     R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  +V 
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162

Query: 681 TYGYMSPE 688
           T  Y +P+
Sbjct: 163 TLWYRAPD 170

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  112 bits (282), Expect = 4e-27
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 24/191 (12%)

Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKN----EMM 562
           V +  + +     LGEG F  VYK +     Q VA+K++        K+        E+ 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVK 617
           L+ +L H N++ L+     +    L++++M    + +   N  +  PS            
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM---- 120

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
                 QGL YLHQ+    I+HRDLK +N+LLD +   K++DFG+A+ F G   +  T +
Sbjct: 121 ----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQ 172

Query: 678 VVGTYGYMSPE 688
           VV T  Y +PE
Sbjct: 173 VV-TRWYRAPE 182

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 5e-27
 Identities = 59/263 (22%), Positives = 88/263 (33%), Gaps = 66/263 (25%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
            +F     +G GGFG V++ K  ++    A+KR+         ++   E+  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI------------- 618
           +VR     +E   +    E       +     P  +        VKI             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 619 --IEGIAQGLLY----------LHQYSRLR-----------------------------I 637
                  +  LY          L  +   R                             +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK----------RVVGTYGYMSP 687
           +HRDLK SNI    D   K+ DFG+      DE +                VGT  YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 688 EYALDGLFSVKSDVFSFGVLLLE 710
           E      +S K D+FS G++L E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (278), Expect = 5e-27
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
            E +++ C LG+G FG V K K  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
            N+++L     +     ++ E      L    FD    R          +II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           Y+H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189

Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           ++PE  L G +  K DV+S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (283), Expect = 7e-27
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           L+ L     ++ E +LI E++        LFD   +  + +     +  +    +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           H+     I+H D+K  NI+ ++      KI DFG+A     DE     K    T  + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 688 EYALDGLFSVKSDVFSFGVLL 708
           E          +D+++ GVL 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  111 bits (279), Expect = 7e-27
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLIAKL 567
           E +    KLGEG +  VYKGK  L    VA+K +  +  +G     ++E      L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGI 622
           +H N+V L      +    L++EY+    K        + +     L  +Q        +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
            +GL Y H+    +++HRDLK  N+L++     K++DFG+AR       +     VV T 
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164

Query: 683 GYMSPE 688
            Y  P+
Sbjct: 165 WYRPPD 170

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 1e-26
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 21/206 (10%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHR 570
            + F  + KLG G FG V+  +   +G E  +K ++  +S   +++ + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQG 625
           N++++     +     ++ E      L     +   S        +     ++++ +   
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           L Y H      ++H+DLK  NIL          KI DFG+A +F  DE         GT 
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLL 708
            YM+PE       + K D++S GV++
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 2e-26
 Identities = 35/237 (14%), Positives = 71/237 (29%), Gaps = 54/237 (22%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQ--------- 568
           LG+       +      G+   V             +K+ K E++ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 569 ----------------HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFF--LFDPSRTH 608
                            + ++R+     +        +Y  M +    F   L   S TH
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 609 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
             L    R+++   + + L  LH Y    ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 668 GDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLT 713
                G       + G+  PE                L +   D ++ G+++     
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 2e-26
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHR 570
              F +   +G G +G VYKG+ +  GQ  A+K +   +G   +E K E+ ++ K   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81

Query: 571 NLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           N+    G  +++          L+ E+    S+   L   ++ + L  +    I   I +
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILR 140

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           GL +LHQ    ++IHRD+K  N+LL  +   K+ DFG++        + NT   +GT  +
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYW 195

Query: 685 MSPE-----YALDGLFSVKSDVFSFGVLLLE 710
           M+PE        D  +  KSD++S G+  +E
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (272), Expect = 3e-26
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + ++++  +G G +G V            A K++     + +  FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           ++RL     +  +  L+ E          LF+    +          +I++ +   + Y 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122

Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           H+   L + HRDLK  N L  +   D   K+ DFG+A  F   ++    +  VGT  Y+S
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176

Query: 687 PEYALDGLFSVKSDVFSFGVLL 708
           P+  L+GL+  + D +S GV++
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (276), Expect = 3e-26
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 23/210 (10%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 566
            + + +   +G+G F  V +      GQ+ AVK     + +S  G   ++ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQT-RV--KIIEG 621
           L+H ++V L+      G   +++E+M        L      R       +  V    +  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
           I + L Y H      IIHRD+K   +LL S       K+  FG+A      E        
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGR 193

Query: 679 VGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           VGT  +M+PE      +    DV+  GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (277), Expect = 3e-26
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
             S    LG G FG V+K +    G ++A K + ++  +  +E KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +L      + + +L+ EY+        LFD     ++ L     +  ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 632 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
              + I+H DLK  NIL  +      KI DFG+AR +   E     K   GT  +++PE 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259

Query: 690 ALDGLFSVKSDVFSFGVLL 708
                 S  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 3e-26
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 568
           ++F +   LG+G FG VY  +   N   +A+K L      + G    + + E+ + + L+
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
           H N++R+     ++    L+ E+ P   L   L     FD  R+     +        +A
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LA 124

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
             L Y H     ++IHRD+K  N+L+      KI+DFG +           T  + GT  
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLD 177

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           Y+ PE         K D++  GVL  E L 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  109 bits (274), Expect = 4e-26
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
           + +    KLGEG +G VYK    +  + VA+KR+       L+  +         E+ L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKII 619
            +LQHRN++ L           LI+EY     L  ++               +Q      
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------ 140

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN 674
             +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F G  ++  
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194

Query: 675 TKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
           T  ++ T  Y  PE  L    +S   D++S   +  E L   
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (280), Expect = 6e-26
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-------------SQSGQGLKEFK 558
            E++    KLG G +G V   K      E A+K +                  +  +E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 559 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRV 616
           NE+ L+  L H N+++L     ++    L+ E+     L    F+   +R          
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQG 673
            I++ I  G+ YLH+     I+HRD+K  NILL++    +N KI DFG++  F  D    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205

Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
             +  +GT  Y++PE  L   ++ K DV+S GV++
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 2e-25
 Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 33/189 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
           E +    K+GEG +G V+K +    GQ VA+K+          E           E+ ++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKII 619
            +L+H NLV L+     +    L++EY  +  L+                + WQ      
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
               Q + + H++     IHRD+K  NIL+      K+ DFG AR+            V 
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164

Query: 680 GTYGYMSPE 688
            T  Y SPE
Sbjct: 165 -TRWYRSPE 172

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (271), Expect = 3e-25
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)

Query: 520 CKLGEGGFGPVYKGK---LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNL 572
           CK+G G +G VYK K     + ++ A+K++     S S         E+ L+ +L+H N+
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80

Query: 573 VRLMGCCVEQGEKI--LIYEYM-------------PNKSLNFFLFDPSRTHLLGWQTRVK 617
           + L    +   ++   L+++Y                 +             L +Q    
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ---- 136

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQG 673
               I  G+ YLH      ++HRDLK +NIL+  +       KI+D G AR+F    L+ 
Sbjct: 137 ----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKP 188

Query: 674 NT---KRVVGTYGYMSPE 688
                  VV T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (267), Expect = 3e-25
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMM---------L 563
           E +     +GEG +G V K +    G+ VA+K+        L+   ++M+         L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVK 617
           + +L+H NLV L+  C ++    L++E++ + ++   L       D        +Q    
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ---- 132

Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
               I  G+ + H +    IIHRD+K  NIL+      K+ DFG AR       +     
Sbjct: 133 ----IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDE 184

Query: 678 VVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
           V  T  Y +PE  + D  +    DV++ G L+ E    +
Sbjct: 185 VA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (264), Expect = 4e-25
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--------RLS 547
           RD+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59

Query: 548 SQSGQGLKE-FKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-- 603
           ++  Q L+E    E+ ++ K+  H N+++L           L+++ M    L    FD  
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115

Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
             +  L   +TR KI+  + + +  LH+   L I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 664 RMFCGDELQGNTKRVVGTYGYMSPE------YALDGLFSVKSDVFSFGVLL 708
                 E     + V GT  Y++PE            +  + D++S GV++
Sbjct: 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (268), Expect = 4e-25
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
            + + +  +LG G F  V K +    G E A K     +  +      +E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
           ++ H N++ L      + + +LI E +        LFD    +  L   +     I+ I 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
            G+ YLH     +I H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           GT  +++PE        +++D++S GV+ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 5e-25
 Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 25/250 (10%)

Query: 476 MSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKL 535
           MS A           D     +       +          ++    +G G FG V++ KL
Sbjct: 5   MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQR---EIAYTNCKVIGNGSFGVVFQAKL 61

Query: 536 LNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LI 588
           +   EVA+K++        K FKN E+ ++  ++H N+V L       G+K       L+
Sbjct: 62  VESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647
            EY+P +++       ++         +K  +  + + L Y+H    + I HRD+K  N+
Sbjct: 117 LEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNL 172

Query: 648 LLDSDMNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFG 705
           LLD      K+ DFG A++    E   N   +   Y Y +PE       ++   D++S G
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRY-YRAPELIFGATNYTTNIDIWSTG 229

Query: 706 VLLLETLTSK 715
            ++ E +  +
Sbjct: 230 CVMAELMQGQ 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (262), Expect = 6e-25
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
            +++ M  +LG G F  V K +    G+E A K     RLSS      +E  + E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
           +++H N++ L      + + +LI E +        LFD    +  L   +   + ++ I 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQIL 118

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
            G+ YLH     RI H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           GT  +++PE        +++D++S GV+ 
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 8e-25
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
            + + +  +LG G F  V K +    G E A K     +  +      +E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
           ++ H N++ L      + + +LI E +        LFD    +  L   +     I+ I 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
            G+ YLH     +I H DLK  NI+L     P    K+ DFG+A            K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           GT  +++PE        +++D++S GV+ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  108 bits (272), Expect = 9e-25
 Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 23/241 (9%)

Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
            +       S    +          P           +++ +  +LG G FG V++    
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
             G   A K + +      +  + E+  ++ L+H  LV L     +  E ++IYE+M   
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 596 SLNFFLFD---PSRTHLLGWQTRVKIIEGIAQ---GLLYLHQYSRLRIIHRDLKASNILL 649
                LF+        +    +  + +E + Q   GL ++H+      +H DLK  NI+ 
Sbjct: 240 E----LFEKVADEHNKM----SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 288

Query: 650 DSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVL 707
            +  +   K+ DFG+       +   + K   GT  + +PE A        +D++S GVL
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 708 L 708
            
Sbjct: 346 S 346

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (262), Expect = 1e-24
 Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 52/245 (21%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 566
            + + ++  +G+G +G V            A+K     ++   + + ++  K E+ L+ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYM-------------------------PNKSLNFFL 601
           L H N+ RL     ++    L+ E                             +      
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 602 FDPSRTHLLGWQTRV------------KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
            +    +      R              I+  I   L YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 650 DSD--MNPKISDFGMARMFCGDELQGNT--KRVVGTYGYMSPE--YALDGLFSVKSDVFS 703
            ++     K+ DFG+++ F               GT  +++PE     +  +  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 704 FGVLL 708
            GVLL
Sbjct: 262 AGVLL 266

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (260), Expect = 2e-24
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 32/205 (15%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNLVRL- 575
           LGEG +G V +          AVK L      +   G    K E+ L+ +L+H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 576 --MGCCVEQGEKI-LIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVK---IIEGIAQGLLY 628
             +    E+ +K+ ++ EY         + D          Q       +I+G+     Y
Sbjct: 73  DVLYN--EEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      I+H+D+K  N+LL +    KIS  G+A            +   G+  +  PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 689 YAL-----DGLFSVKSDVFSFGVLL 708
            A       G    K D++S GV L
Sbjct: 182 IANGLDTFSGF---KVDIWSAGVTL 203

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (260), Expect = 2e-24
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKN----EMM 562
           S AT  +    ++G G +G VYK +   +G  VA+K  R+ +  G G          E+ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVA 63

Query: 563 LIAKLQ---HRNLVRLMGCCVEQGEKI-----LIYEYMPN------KSLNFFLFDPSRTH 608
           L+ +L+   H N+VRLM  C            L++E++                      
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
            L  Q          +GL +LH      I+HRDLK  NIL+ S    K++DFG+AR++  
Sbjct: 124 DLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-S 171

Query: 669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            ++   T  VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 172 YQMA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 3e-24
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
            N+VRL     E+    L+++ +    L    F+   +R            I+ I + + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119

Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           Y H      I+HR+LK  N+LL S       K++DFG+A                GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGY 173

Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           +SPE      +S   D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (259), Expect = 3e-24
 Identities = 68/234 (29%), Positives = 106/234 (45%), Gaps = 49/234 (20%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
           +G+G F  V   + +L G+EVA+K +  +  +   L++   E+ ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 579 CVEQGEKI-LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQY 632
            +E  + + LI EY     +    FD   +   +   + R K   I+  +     Y H  
Sbjct: 83  -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE---- 688
            + RI+HRDLKA N+LLD+DMN KI+DFG +  F             G   Y +PE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187

Query: 689 --YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDIESF 726
             Y  DG    + DV+S GV+L              L+ L  +   G Y I  +
Sbjct: 188 KKY--DGP---EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (259), Expect = 3e-24
 Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 16/201 (7%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            E + +   LG G FG V++     + +    K +    G      K E+ ++   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           ++ L        E ++I+E++    +    F+   +    L  +  V  +  + + L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           H      I H D++  NI+  +  +   KI +FG AR     +     + +     Y +P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172

Query: 688 EYALDGLFSVKSDVFSFGVLL 708
           E     + S  +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 4e-24
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
            + +    +LG G F  V K +    G + A K     R  S      +E  + E+ ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIE 620
           ++QH N++ L      + + ILI E +        LFD    +  L    T     + ++
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESL----TEEEATEFLK 121

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTK 676
            I  G+ YLH    L+I H DLK  NI+L     P    KI DFG+A            K
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 175

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
            + GT  +++PE        +++D++S GV+ 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  103 bits (260), Expect = 4e-24
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 44/228 (19%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
             +    K+G+G FG V+K +    GQ+VA+K++       ++  K         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 565 AKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPN--KSL---NFFLFDPSRTHLLG 611
             L+H N+V L+  C  +            L++++  +    L       F  S    + 
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF---CG 668
                     +  GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F     
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 669 DELQGNTKRVVGTYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSK 715
            +    T RVV T  Y  PE  L +  +    D++  G ++ E  T  
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  103 bits (258), Expect = 4e-24
 Identities = 48/221 (21%), Positives = 79/221 (35%), Gaps = 52/221 (23%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQS---GQGLKEFKNEMMLIA 565
            +S    LG G FG V+        +EV VK     ++          L +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQ 613
           +++H N++++              +   N+               LF        L    
Sbjct: 85  RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
               I   +   + YL       IIHRD+K  NI++  D   K+ DFG A      +L  
Sbjct: 132 AS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-- 185

Query: 674 NTKRVVGTYGYMSPE------YALDGLFSVKSDVFSFGVLL 708
                 GT  Y +PE      Y   G    + +++S GV L
Sbjct: 186 -FYTFCGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTL 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  102 bits (257), Expect = 5e-24
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 18/202 (8%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + F     LG G F  V+  K  L G+  A+K +           +NE+ ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           +V L           L+ + +    L    FD    R           +I+ +   + YL
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS-LVIQQVLSAVKYL 122

Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           H+     I+HRDLK  N+L  +   +    I+DFG+++M     +        GT GY++
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175

Query: 687 PEYALDGLFSVKSDVFSFGVLL 708
           PE      +S   D +S GV+ 
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (254), Expect = 5e-24
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 47/209 (22%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70

Query: 580 VEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIAQG 625
                    Y +    ++ +          LFD       +     +     ++ G+   
Sbjct: 71  ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
             YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y+
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 686 SPE------YALDGLFSVKSDVFSFGVLL 708
           +PE      +          DV+S G++L
Sbjct: 175 APELLKRREF--HAE---PVDVWSCGIVL 198

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 5e-24
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-------RLSSQSGQGLKE-FKNEMML 563
            + +  +  +G G    V +      G E AVK       RLS +  + ++E  + E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 564 IAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIE 620
           + ++  H +++ L+          L+++ M    L    FD    +  L   +TR  I+ 
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
            + + + +LH      I+HRDLK  NILLD +M  ++SDFG +      E     + + G
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261

Query: 681 TYGYMSPE------YALDGLFSVKSDVFSFGVLL 708
           T GY++PE            +  + D+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  101 bits (255), Expect = 8e-24
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
           E+F     LGEG F  V   + L   +E A+K L  +      +      E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 570 RNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
              V+L      Q ++ L     Y  N  L  ++     FD + T       R    E I
Sbjct: 90  PFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-I 139

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
              L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT 
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            Y+SPE   +      SD+++ G ++ + + 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 1e-23
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSR 634
            E   + L  EY     L    FD       +     +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE------ 688
           + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 689 YALDGLFSVKSDVFSFGVLL 708
           +          DV+S G++L
Sbjct: 184 F--HAE---PVDVWSCGIVL 198

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (255), Expect = 1e-23
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE---FKNEMML 563
            + + M   LG G  G V         ++VA+K     + +  S +        + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 621
           + KL H  ++++     +  +  ++ E M    L    FD       L     +      
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
           +   + YLH      IIHRDLK  N+LL S   D   KI+DFG +++     L    + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176

Query: 679 VGTYGYMSPE---YALDGLFSVKSDVFSFGVLL 708
            GT  Y++PE         ++   D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (259), Expect = 1e-23
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--------SQSGQGLKEFKNEMML 563
            + + M   LG G  G V         ++VA++ +S        ++        + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 621
           + KL H  ++++     +  +  ++ E M    L    FD       L     +      
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
           +   + YLH+     IIHRDLK  N+LL S   D   KI+DFG +++     L    + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301

Query: 679 VGTYGYMSPE---YALDGLFSVKSDVFSFGVLL 708
            GT  Y++PE         ++   D +S GV+L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  101 bits (254), Expect = 2e-23
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIA 565
           + +    ++GEG +G V+K +     G+ VA+KR+  Q+G+       ++E    +  + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69

Query: 566 KLQHRNLVRL----MGCCVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLLGWQT 614
             +H N+VRL         ++  K+ L++E++          +            + +Q 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
                  + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+AR++   ++   
Sbjct: 129 -------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-L 176

Query: 675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           T  VV T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (255), Expect = 2e-23
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
            N+VRL     E+    L+++ +    L    F+   +R            I+ I + + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 142

Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           Y H      I+HR+LK  N+LL S       K++DFG+A      E         GT GY
Sbjct: 143 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196

Query: 685 MSPEYALDGLFSVKSDVFSFGVLL 708
           +SPE      +S   D+++ GV+L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-23
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 45/221 (20%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS-----------------SQSGQGLKEFKNEMML 563
           +G+G +G V       +    A+K LS                           +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 564 ------IA---KLQHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFD-PSRTHLL 610
                 IA   KL H N+V+L+   ++   +  +Y   E +    +     + P+   L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
             Q R    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G +
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 671 LQGNTKRVVGTYGYMSPE--YALDGLFS-VKSDVFSFGVLL 708
                   VGT  +M+PE       +FS    DV++ GV L
Sbjct: 192 --ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (256), Expect = 4e-23
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 506 LASVSAA--TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNE 560
           +A+++    TE + +  +LG+G F  V +   +L GQE A   +     S +  ++ + E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKI 618
             +   L+H N+VRL     E+G   LI++ +    L    F+   +R +          
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HC 115

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNT 675
           I+ I + +L+ HQ   + ++HR+LK  N+LL S       K++DFG+A    G+  Q   
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAW 170

Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
               GT GY+SPE      +    D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (254), Expect = 5e-23
 Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 37/243 (15%)

Query: 491 DAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ 549
           D  G++  +V+             +++    +G G FG VY+ KL  +G+ VA+K++   
Sbjct: 31  DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 90

Query: 550 SGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LIYEYMP--------N 594
                K FKN E+ ++ KL H N+VRL       GEK       L+ +Y+P        +
Sbjct: 91  -----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145

Query: 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
            S            L  +Q        + + L Y+H      I HRD+K  N+LLD D  
Sbjct: 146 YSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICHRDIKPQNLLLDPDTA 194

Query: 655 P-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETL 712
             K+ DFG A+     E   N   +   Y Y +PE       ++   DV+S G +L E L
Sbjct: 195 VLKLCDFGSAKQLVRGEP--NVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

Query: 713 TSK 715
             +
Sbjct: 252 LGQ 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 27/205 (13%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
            E+    L++E M   S+          R H    +    +++ +A  L +LH      I
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132

Query: 638 IHRDLKASNILL---DSDMNPKISDFGMARMF-----CGDELQGNTKRVVGTYGYMSPEY 689
            HRDLK  NIL    +     KI DF +         C            G+  YM+PE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE- 191

Query: 690 ALDGLFSV------KSDVFSFGVLL 708
            ++           + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKL 567
            + F ++   G+G FG V  GK    G  VA+K++          F+N     M  +A L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76

Query: 568 QHRNLVRLMGCCVEQGEK-------ILIYEYMP------NKSLNFFLFDPSRTH--LLGW 612
            H N+V+L       GE+        ++ EY+P       ++       P      +  +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDEL 671
           Q        + + +  LH  S + + HRD+K  N+L++ +D   K+ DFG A+       
Sbjct: 137 Q--------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185

Query: 672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSK 715
           + N   +   Y Y +PE       ++   D++S G +  E +  +
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.7 bits (239), Expect = 6e-22
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 52/211 (24%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVK---RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V  G+  L G +VAVK   R   +S   + + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 578 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 623
                      Y+ +   +  F          LFD       +   + R     I+  + 
Sbjct: 77  -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
               Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  
Sbjct: 126 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 175

Query: 684 YMSPE------YALDGLFSVKSDVFSFGVLL 708
           Y +PE      Y   G    + D++S GV+L
Sbjct: 176 YAAPEVISGRLY--AGP---EVDIWSCGVIL 201

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 65/242 (26%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
           LGEG FG V         Q+VA+K +S Q      +    + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 578 CCVEQGEKILIYEYMPNKSLNFF--------LFD--PSRTHLLGWQTRVK---IIEGIAQ 624
                      Y+ +   +            LFD    +  +   + R     II  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
              Y H   R +I+HRDLK  N+LLD ++N KI+DFG++ +          K   G+  Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNY 173

Query: 685 MSPE------YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDIE 724
            +PE      Y   G    + DV+S G++L              +  L  K N+ VY + 
Sbjct: 174 AAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228

Query: 725 SF 726
            F
Sbjct: 229 DF 230

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 20/198 (10%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR-NLVRLM 576
           +LG G F  V +      GQE A K  +   +      E  +E+ ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
                  E ILI EY         +F    P    ++     +++I+ I +G+ YLHQ  
Sbjct: 96  EVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149

Query: 634 RLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
              I+H DLK  NILL       + KI DFGM+R           + ++GT  Y++PE  
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205

Query: 691 LDGLFSVKSDVFSFGVLL 708
                +  +D+++ G++ 
Sbjct: 206 NYDPITTATDMWNIGIIA 223

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.5 bits (243), Expect = 3e-21
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
           + F     LG GGFG V+  ++    ++ A K+L+ +     +G +    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLL 627
           R +V L     E    + L+   M    + + +++    +    + R       I  GL 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           +LHQ     II+RDLK  N+LLD D N +ISD G+A      +    TK   GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLT 713
           E  L   +    D F+ GV L E + 
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIA 384

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 4e-21
 Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 66/243 (27%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           LG G FG V  GK  L G +VAVK L+ Q   S   + + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 578 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 623
                      Y+ +   S  F          LFD       L   ++R     I+ G+ 
Sbjct: 82  -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
               Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ M    E     +   G+  
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 180

Query: 684 YMSPE------YALDGLFSVKSDVFSFGVLL--------------LETLTSKRNTGVYDI 723
           Y +PE      Y   G    + D++S GV+L              + TL  K   G++  
Sbjct: 181 YAAPEVISGRLY--AGP---EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235

Query: 724 ESF 726
             +
Sbjct: 236 PQY 238

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 24/207 (11%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKL 567
            + +   LG GGFG VY G  + +   VA+K +                   E++L+ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 568 QHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
                 ++RL+         +LI E          LFD    R  L     R      + 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELAR-SFFWQVL 159

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTY 682
           + + + H      ++HRD+K  NIL+D +    K+ DFG   +              GT 
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212

Query: 683 GYMSPEYALDGLFS-VKSDVFSFGVLL 708
            Y  PE+     +    + V+S G+LL
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILL 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 4e-21
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 13/205 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
             F     LG+GGFG V   ++    ++ A K+L  +     +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           R +V L     E  + + L+   M    L F ++   +      +      E I  GL  
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH   R RI++RDLK  NILLD   + +ISD G+A      +     K  VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355

Query: 689 YALDGLFSVKSDVFSFGVLLLETLT 713
              +  ++   D ++ G LL E + 
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIA 380

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 5e-21
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF------KNEMMLIAK 566
            +FS+   +G GGFG VY  +  +  ++ A+K L  +  +  +        +  + L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 567 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIE 620
                +V +        +K+  I + M    L++ L     F  +         R    E
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
            I  GL ++H      +++RDLK +NILLD   + +ISD G+A  F   +        VG
Sbjct: 301 -IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 352

Query: 681 TYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLT 713
           T+GYM+PE    G+    S   D FS G +L + L 
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLR 386

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 20/203 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           T+ + ++  +G G +    +        E AVK +        +E     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
           ++ L     +     ++ E M    L     D    +      +    ++  I + + YL
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTYGYM 685
           H      ++HRDLK SNIL   +       +I DFG A+    +   G       T  ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187

Query: 686 SPEYALDGLFSVKSDVFSFGVLL 708
           +PE      +    D++S GVLL
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 47/212 (22%), Positives = 77/212 (36%), Gaps = 46/212 (21%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS----------SQSGQGLKEFKNEMMLIAKLQHR 570
           LG+GGFG V+ G  L +  +VA+K +           S S     E      + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTRVKI 618
            ++RL              ++   +               LFD    +  L    +R   
Sbjct: 99  GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CF 144

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDELQGNTKR 677
              +   + + H      ++HRD+K  NIL+D      K+ DFG   +   +        
Sbjct: 145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TD 197

Query: 678 VVGTYGYMSPEYALDGLFS-VKSDVFSFGVLL 708
             GT  Y  PE+     +  + + V+S G+LL
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           ++ F ++ +LG G    VY+ K     +  A+K L     +  K  + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQGL 626
           +++L        E  L+ E +    L    FD    + +     +       ++ I + +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY----SERDAADAVKQILEAV 161

Query: 627 LYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
            YLH+     I+HRDLK  N+L      D   KI+DFG++++     L    K V GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPG 215

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLL 708
           Y +PE      +  + D++S G++ 
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 20/195 (10%)

Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
            LGEG F    K     + Q  AVK +S +        + E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 579 CVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
             +Q    L+ E +    L    F+    + H    +    I+  +   + ++H    + 
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126

Query: 637 IIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           ++HRDLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184

Query: 694 LFSVKSDVFSFGVLL 708
            +    D++S GV+L
Sbjct: 185 GYDESCDLWSLGVIL 199

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 44/208 (21%)

Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
            LG G  G V +      GQ+ A+K L         + + E+    +     ++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89

Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT-----RVKIIEGIA 623
                    +YE M +                LF   R    G Q        +I+  I 
Sbjct: 90  ---------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIG 138

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
             + +LH      I HRD+K  N+L    + D   K++DFG A+    + LQ        
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCY 191

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           T  Y++PE      +    D++S GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 24/198 (12%), Positives = 58/198 (29%), Gaps = 43/198 (21%)

Query: 521 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRL 575
             G       ++     L  ++VA+  +  Q       L+E  +  + ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +     +   +++ E++   SL         T        ++ ++ +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF 695
            +       S + +  D        G                V+     M          
Sbjct: 149 GVALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA------- 179

Query: 696 SVKSDVFSFGVLLLETLT 713
           + + D+   G  L   L 
Sbjct: 180 NPQDDIRGIGASLYALLV 197

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 2e-19
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN--TGVYDIESFNLLGHAWNLWKDN 739
             +M+PE   D +++++SDV+SFGVLL E  +   +   GV   E F          K+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEG 312

Query: 740 RAYELLSPALQHEASYQ-MLNRYITVALLCVQEKAADRPTMSKVVSMI 786
               + +P       YQ ML+        C   + + RPT S++V  +
Sbjct: 313 --TRMRAPDYTTPEMYQTMLD--------CWHGEPSQRPTFSELVEHL 350

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 35/166 (21%), Positives = 61/166 (36%), Gaps = 19/166 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 565
           +   +   LG G FG V +            + VAVK L   +     +   +E+ +LI 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 566 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
              H N+V L+G C + G  + +I E+    +L+ +L             R + +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
           G  +      +  I  DLK     + S  +   S F   +     E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 54/211 (25%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
           +G G FG     +  L  + VAVK +    G  + E  + E++    L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81

Query: 580 VEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIAQG 625
                     E +   +             L++   +       + R     ++ G++  
Sbjct: 82  ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS-- 130

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
             Y H    ++I HRDLK  N LLD       KI DFG ++           K  VGT  
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 182

Query: 684 YMSPE------YALDGLFSVKSDVFSFGVLL 708
           Y++PE      Y  DG     +DV+S GV L
Sbjct: 183 YIAPEVLLRQEY--DGK---IADVWSCGVTL 208

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 45/245 (18%), Positives = 94/245 (38%), Gaps = 53/245 (21%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHR 570
           ++ +S+   LG G FG V +   + +G+  A+K++          +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-------------- 616
           N+++L+      G++       P+        +    +                      
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 617 -----KIIEG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
                K+++                    + + + ++H    L I HRD+K  N+L++S 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 653 MNP-KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLE 710
            N  K+ DFG A+       + +   +   + Y +PE  L    ++   D++S G +  E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 711 TLTSK 715
            +  K
Sbjct: 235 LILGK 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 43/208 (20%)

Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
            LG G  G V +       ++ A+K L         + + E+ L  +     ++VR++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122

Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT---R--VKIIEGIA 623
                    +YE +                  LF   R    G Q    R   +I++ I 
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG 171

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVG 680
           + + YLH    + I HRD+K  N+L  S   +   K++DFG A+         +      
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCY 225

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           T  Y++PE      +    D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 45/222 (20%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR 570
            +++ +  KLG G +  V++   + N ++V VK L        K+ K E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91

Query: 571 NLVRLMGCCVEQGEK--ILIYEYMPNKSLN------------FFLFDPSRTHLLGWQTRV 616
           N++ L     +   +   L++E++ N                F+++      +L      
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-----EIL------ 140

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNT 675
                  + L Y H  S   I+HRD+K  N+++D +    ++ D+G+A        Q   
Sbjct: 141 -------KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYN 188

Query: 676 KRVVGTYGYMSPEYALDGLFSVKS-DVFSFGVLLLETLTSKR 716
            RV   Y +  PE  +D      S D++S G +L   +  K 
Sbjct: 189 VRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQH 569
           ++F +   +G+G FG V    K    +  A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 570 RNLVRLMGCCVEQ-GEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 621
             LV L      Q  E + ++ + +    L        R HL   Q  V   E       
Sbjct: 75  PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--------RYHL---QQNVHFKEETVKLFI 121

Query: 622 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             +   L YL      RIIHRD+K  NILLD   +  I+DF +A M   +        + 
Sbjct: 122 CELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMA 175

Query: 680 GTYGYMSPEYALDGL-----FSVKSDVFSFGVLLLETLTSKR 716
           GT  YM+PE           F+V  D +S GV   E L  +R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 38/207 (18%), Positives = 82/207 (39%), Gaps = 57/207 (27%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            + + ++  +G G +G V +    L  + VA+K++        + F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 563 LIAKLQHRNLVRLMGCCV----EQGEKI-LIYEYMP---------NKSLN-----FFLFD 603
           ++ +L H ++V+++   +    E+ +++ ++ E               L        L+ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163

Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
                             +  G+ Y+H  S   I+HRDLK +N L++ D + K+ DFG+A
Sbjct: 164 ---------N--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYA 690
           R     E   +   +      M+    
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTF 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            + +     +G G  G V      +  + VA+K+LS       + F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFL---FDPSRTHLLGWQ 613
           L+  + H+N++ L+        +E+ + + ++ E M   +L   +    D  R   L +Q
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
                   +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR         
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM 182

Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            T  VV T  Y +PE  L   +    D++S G ++ E +   
Sbjct: 183 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 17/210 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           E+F +   +G G FG V   KL N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           + +  L     +    + L+ +Y     L   L       L     R  + E +   +  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           +HQ   L  +HRD+K  NIL+D + + +++DFG       D     +   VGT  Y+SPE
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246

Query: 689 -----YALDGLFSVKSDVFSFGVLLLETLT 713
                    G +  + D +S GV + E L 
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 7e-17
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            + +     +G G  G V      +  + VA+K+LS       + F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113

Query: 563 LIAKLQHRNLVRLM------GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
           L+  + H+N++ L+          E  +  L+ E M        L    +  L   +   
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
            + + +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR          T 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 222

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            VV T  Y +PE  L   +    D++S G ++ E +  K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 58/245 (23%), Positives = 96/245 (39%), Gaps = 26/245 (10%)

Query: 479 ATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKL-L 536
           A +     E   +     ++  L  +   S + A  + F     LG G FG V   K   
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 537 NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593
           +G   A+K L  Q    LK+     NE  ++  +    LV+L     +     ++ EY+ 
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 594 NKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
              +   L     F            R    + I     YLH      +I+RDLK  N+L
Sbjct: 125 GGEMFSHLRRIGRFSEPHA-------RFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLL 173

Query: 649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLL 708
           +D     +++DFG A+      ++G T  + GT   ++PE  L   ++   D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

Query: 709 LETLT 713
            E   
Sbjct: 229 YEMAA 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 50/226 (22%), Positives = 83/226 (36%), Gaps = 38/226 (16%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE--FKN---------EM 561
              +++Q  +  G +G V  G    G  VA+KR+ +    G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 562 MLIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLL 610
            L+    H N++ L             K+ L+ E M              +      + +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
            +         I  GL  LH+     ++HRDL   NILL  + +  I DF +AR    D 
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
            +  T  V     Y +PE  +    F+   D++S G ++ E    K
Sbjct: 189 NK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 7e-16
 Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 29/267 (10%)

Query: 457 KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENF 516
           +E  T +++  D LK      +  R+  PS+  G  +           +          F
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVS------LAKPKHRVTMNEF 150

Query: 517 SMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNL 572
                LG+G FG V   K        A+K L  +      E      E  ++   +H  L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 573 VRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGL 626
             L     +  +++  + EY     L F L     F   R    G +        I   L
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSAL 261

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D      K   GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLA 317

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLT 713
           PE   D  +    D +  GV++ E + 
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMC 344

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.8 bits (197), Expect = 7e-16
 Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 19/212 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           ++F +   +G G F  V   K+    +V A+K ++        E   F+ E  ++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           R + +L     +    + L+ EY     L   L       +     R  + E I   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           +H+   L  +HRD+K  NILLD   + +++DFG       D     +   VGT  Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233

Query: 689 -------YALDGLFSVKSDVFSFGVLLLETLT 713
                      G +  + D ++ GV   E   
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 8e-16
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            + +     +G G +G V       +G++VA+K+LS       + F++         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 613
           L+  +QH N++ L+        +       L+  +M     K +     +    +L+ +Q
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
                   + +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR    +    
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180

Query: 674 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
            T  VV T  Y +PE  L    ++   D++S G ++ E LT K
Sbjct: 181 -TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 34/225 (15%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
              +     LG GG G V+        + VA+K++     Q +K    E+ +I +L H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 572 LVRLM--------------GCCVEQGEKILIYEYMP---NKSLNFFLFDPSRTHLLGWQT 614
           +V++               G   E     ++ EYM       L           L  +Q 
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQG 673
                  + +GL Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+AR+        
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 674 N--TKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
              ++ +V T  Y SP   L    ++   D+++ G +  E LT K
Sbjct: 179 GHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
           ++F +   LG G FG V+  +  +     A+K L  +    LK+     +E ++++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 624
             ++R+ G   +  +  +I +Y+    L   L     F            +    E +  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAE-VCL 117

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            L YLH      II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDY 169

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           ++PE      ++   D +SFG+L+ E L 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 41/224 (18%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
              ++    +GEG +G V      LN   VA+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 563 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQT 614
           ++ + +H N++ +        +EQ + + ++ + M     K L              +Q 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136

Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
                  I +GL Y+H  S   ++HRDLK SN+LL++  + KI DFG+AR+   D     
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 675 --TKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
             T+ V  T  Y +PE  L+   ++   D++S G +L E L+++
Sbjct: 187 FLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.8 bits (188), Expect = 3e-15
 Identities = 36/199 (18%), Positives = 58/199 (29%), Gaps = 46/199 (23%)

Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL--------SSQSGQGLKEFKNEMML 563
            TE      K+GEG FG V++    +   VA+K +        +    +  +E   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 564 IAKLQ---------HRNLVRLMGCCVEQGE--KILIYEYMPNKSLNFFLFDPSR------ 606
             +L              + L      QG    +L+  +    S      D         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 607 ------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
                             T L    T   I+  +   L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 649 LDSDMNPKISDFGMARMFC 667
           L      K+      +   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 64/243 (26%), Positives = 97/243 (39%), Gaps = 28/243 (11%)

Query: 484 EPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKLLNGQEV- 541
           EP   + +       S       +S   A   +F     +G+G FG V   +    +   
Sbjct: 7   EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66

Query: 542 AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKS 596
           AVK L  ++    KE K+ M     L+  ++H  LV L     +  +K+  + +Y+    
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125

Query: 597 LNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
           L F+       F   R        R    E IA  L YLH    L I++RDLK  NILLD
Sbjct: 126 L-FYHLQRERCFLEPRA-------RFYAAE-IASALGYLHS---LNIVYRDLKPENILLD 173

Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE 710
           S  +  ++DFG+ +          T    GT  Y++PE      +    D +  G +L E
Sbjct: 174 SQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231

Query: 711 TLT 713
            L 
Sbjct: 232 MLY 234

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
           E++ +   +G G FG V   +  + ++V A+K LS        +   F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----- 624
             +V+L     +     ++ EYMP               L+   +   + E  A+     
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGG------------DLVNLMSNYDVPEKWARFYTAE 176

Query: 625 ---GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
               L  +H    +  IHRD+K  N+LLD   + K++DFG   M    E        VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGT 232

Query: 682 YGYMSPE----YALDGLFSVKSDVFSFGVLLLETLT 713
             Y+SPE       DG +  + D +S GV L E L 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.1 bits (190), Expect = 6e-15
 Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 57/210 (27%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            +N+ ++  +G G +G VY        + VA+K+++       + F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77

Query: 563 LIAKLQHRNLVRLMGCCVEQGEKI-----LIYEYMP---------NKSLN-----FFLFD 603
           ++ +L+   ++RL    +           ++ E               L        L  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-- 135

Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
                   +         +  G  ++H      IIHRDLK +N LL+ D + K+ DFG+A
Sbjct: 136 --------YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
           R    ++       +            L  
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 24/210 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
            +F     LG+G FG V   +        A+K L  +      E      E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
             L  L     +  +++  + EY     L F L     F   R    G +        I 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IV 115

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
             L YLH      +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 170

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           Y++PE   D  +    D +  GV++ E + 
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
              +     +G G +G V        G +VA+K+L        + F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76

Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
           L+  ++H N++ L+        ++      L+  +M    L   +    +   LG     
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQ 131

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
            ++  + +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     E+   T 
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEM---TG 184

Query: 677 RVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
            VV T  Y +PE  L+   ++   D++S G ++ E +T K
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 46/222 (20%)

Query: 514 ENFSMQCKLGEGGFGPVY----KGKLLNGQEVAVKRLSSQSGQGLKEF---------KNE 560
             F +   LG+G FG V+           Q  A+K L        K           K E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76

Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
             ++ ++ H  +V+L     +   K+ LI +++    L F         L      V   
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL-FT-------RL---SKEVMFT 124

Query: 620 EG--------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
           E         +A  L +LH    L II+RDLK  NILLD + + K++DFG+++     E 
Sbjct: 125 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +  +    GT  YM+PE       +  +D +SFGVL+ E LT
Sbjct: 182 KAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQ 568
           E+F +   LG+G FG V+  +     +  A+K L         + +  M    +L    +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 624
           H  L  +  C  +  E +  + EY+    L  +       H+   Q+  K     A    
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL-MY-------HI---QSCHKFDLSRATFYA 124

Query: 625 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
                GL +LH      I++RDLK  NILLD D + KI+DFGM +     +    T    
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC 179

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           GT  Y++PE  L   ++   D +SFGVLL E L 
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 58/273 (21%), Positives = 99/273 (36%), Gaps = 42/273 (15%)

Query: 454 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 513
             H   +  + ++++L       S      E        K +     L  F L  V    
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG-LQDFDLLRV---- 59

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
                   +G G +  V   +L     + A++ +  +     ++                
Sbjct: 60  --------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
           H  LV L   C +   ++  + EY+    L F +                  R    E I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 162

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 680
           +  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    G
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCG 215

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           T  Y++PE      +    D ++ GVL+ E + 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 66/240 (27%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
           + +F ++  LGEG +G V        G+ VA+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 563 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP--------NKSLN-----FFLFDP 604
           ++   +H N++ +         E   ++ +I E M          + L+     +F+   
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI--- 118

Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
                  +Q          + +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+AR
Sbjct: 119 -------YQ--------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

Query: 665 MFCGDELQGNTKRV--------VGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
           +        +            V T  Y +PE  L    +S   DV+S G +L E    +
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
            E +     +G G +G V        G  VAVK+LS       + F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80

Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 613
           L+  ++H N++ L+        +E+   + L+   M    N  +            L +Q
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140

Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
                   I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+  
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-TADEM-- 186

Query: 674 NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSK 715
            T  V  T  Y +PE  L+   ++   D++S G ++ E LT +
Sbjct: 187 -TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 34/217 (15%)

Query: 514 ENFSMQCKLGEGGFGPVY---KGKLLNGQEV-AVKRLSSQS-GQGLKEF---KNEMMLIA 565
           E F +   LG+GG+G V+   K    N  ++ A+K L      +  K+    K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 566 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           +++H  +V L+    + G K+ LI EY+    L F         L   +     +E  A 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL-FM-------QL---EREGIFMEDTAC 124

Query: 625 --------GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
                    L +LHQ     II+RDLK  NI+L+   + K++DFG+ +    D    +T 
Sbjct: 125 FYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180

Query: 677 RVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
              GT  YM+PE  +    +   D +S G L+ + LT
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
            +F+    LG+G FG V   +     E+ AVK L         + +  M+    L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
              L +L   C +  +++  + EY+    L + +     F                 E I
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 130

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 680
           A GL +L       II+RDLK  N++LDS+ + KI+DFGM    C + +     TK   G
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFCG 183

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           T  Y++PE      +    D ++FGVLL E L 
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
           ++F +   +G G +  V   +L     + A+K +  +     ++                
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
           H  LV L   C +   ++  + EY+    L F +                  R    E I
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 119

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVVG 680
           +  L YLH+     II+RDLK  N+LLDS+ + K++D+GM    C + L+    T    G
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCG 172

Query: 681 TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           T  Y++PE      +    D ++ GVL+ E + 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 2e-13
 Identities = 78/454 (17%), Positives = 155/454 (34%), Gaps = 39/454 (8%)

Query: 278 WQVFFTAPNNFCQLYGYCGANSVCSVDDTANC-ECLKGFKLKLQNNQTWPRECVRSHSSD 336
           +++   +   FC    +CG+     +     C  C     +  +     P  C   H+  
Sbjct: 105 FKIHTYSSPTFC---DHCGSLLYGLIHQGMKCDTC--MMNVHKRCVMNVPSLCGTDHTER 159

Query: 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK--NCTCRAYANSKVTGGGSGCL 394
                     D   L  +V  + N         ++            + SK         
Sbjct: 160 RGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSS 219

Query: 395 MW-FGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWR 453
           +    +     ++   +  + + V + D +   +      +   +      G   + +  
Sbjct: 220 LNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLL 279

Query: 454 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 513
            + + +   +    +  + +  +       +  +G    +    +++    +  +     
Sbjct: 280 SQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMK 339

Query: 514 -ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKL 567
             +F+    LG+G FG V   +     E+ AVK L         + +  M+    L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 568 QHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEG 621
           +   L +L   C +  +++  + EY+    L + +     F                 E 
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE- 450

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN--TKRVV 679
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM    C + +     TK   
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 503

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           GT  Y++PE      +    D ++FGVLL E L 
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
           +NF     LG+G FG V   ++    ++ AVK L         + +  M     L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 624
           H  L +L  CC +  +++  + E++    L  F       H+   Q   +  E  A+   
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MF-------HI---QKSRRFDEARARFYA 130

Query: 625 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
                 L++LH      II+RDLK  N+LLD + + K++DFGM +    +     T    
Sbjct: 131 AEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFC 185

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           GT  Y++PE   + L+    D ++ GVLL E L 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 54/208 (25%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
              + +  KLG+G +G V+K      G+ VAVK++          F+N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 563 LIAKLQ-HRNLVRLMGCCV-EQGEKI-LIYEYMP--------NKSLN-----FFLFDPSR 606
           ++ +L  H N+V L+     +    + L+++YM            L      + +     
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV----- 115

Query: 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
                +Q        + + + YLH  S   ++HRD+K SNILL+++ + K++DFG++R F
Sbjct: 116 -----YQ--------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 667 CGDELQGNTKRVVGTYGYMSPEYALDGL 694
                  N   +       + +     L
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPIL 187

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 10/96 (10%)

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           I   L +LH+   L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223

Query: 682 YGYMSPEYALDGL----FSVKSDVFSFGVLLLETLT 713
             YM+P+    G      +V  D +S GVL+ E LT
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLT 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 46/166 (27%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC 578
            LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78

Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTR------VKIIE 620
                    +YE +                  LF     R                +I++
Sbjct: 79  ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMK 124

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 663
            I + + YLH    + I HRD+K  N+L  S   +   K++DFG A
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 42/220 (19%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFK-------NEMMLIAKLQH 569
           KLG G F  V+  K ++N   VA+K +            E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 570 RNLVRLMGCCVEQGEKI----LIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 619
            ++++L+     +G       +++E +  N     K              +  Q      
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ------ 139

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMARMFCGDELQG 673
             +  GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  +  +    
Sbjct: 140 --LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY-- 192

Query: 674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                + T  Y SPE  L   +   +D++S   L+ E +T
Sbjct: 193 --TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 38/191 (19%), Positives = 70/191 (36%), Gaps = 28/191 (14%)

Query: 521 KLGEGGFGPVYKGKLLNGQ------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
            +G+GGFG +Y   + + +         VK   S +G    E K         Q +  +R
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 575 LMGCCVEQGEKILIY--EYMPNKSLNFFLFD---PSRTHLLGWQTR---VKIIEGIAQGL 626
                     K           KS  F + D        +     +    K +  ++  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 627 L----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGDEL-----QGNT 675
           L    Y+H++     +H D+KASN+LL+     ++   D+G+A  +C + +         
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 676 KRVVGTYGYMS 686
           +   GT  + S
Sbjct: 219 RCHDGTIEFTS 229

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 44/220 (20%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 570
           + +   +G+G FG V K    +  + VA+K + ++     Q   E +    L+  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111

Query: 571 -----NLVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 619
                 +V L    + +    L++E +  N     ++ NF     + T     Q      
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ------ 165

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKR 677
             +   LL+L     L IIH DLK  NILL +      KI DFG +    G         
Sbjct: 166 --MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR------- 214

Query: 678 VVGTY----GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
            +  Y     Y SPE  L   + +  D++S G +L+E  T
Sbjct: 215 -IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 61.4 bits (149), Expect = 1e-11
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 20/126 (15%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +T    +  G+ L      +                + Y     T VW +N       
Sbjct: 2   NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
                 + ++GN V+ +     +W+S+  R   N V  L + GN+V+          GS 
Sbjct: 51  KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSD 101

Query: 146 LWQSFD 151
           +W +  
Sbjct: 102 IWSTGT 107

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 60.6 bits (147), Expect = 2e-11
 Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 13/117 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           ++++    +  G  L      + L              + Y       VW +N       
Sbjct: 2   NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNT 140
               L   NNGNLV+ +Q++ +IW +  + +  + V  L    N+V+     +++ +
Sbjct: 53  CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGS 107

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 44/190 (23%), Positives = 69/190 (36%), Gaps = 32/190 (16%)

Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           NF +  K+G G FG +  GK L   + VA+K    +S       +             + 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL--- 627
           ++           ++ E          L  PS   L     R   +K +  IA  L+   
Sbjct: 69  QVYYFGPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 628 -YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMFCGDE-----LQGNTK 676
            Y+H  +   +I+RD+K  N L+    N       I DF +A+ +   E          K
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175

Query: 677 RVVGTYGYMS 686
            + GT  YMS
Sbjct: 176 SLTGTARYMS 185

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 30/202 (14%), Positives = 65/202 (32%), Gaps = 36/202 (17%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK---------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
             + ++        G +Y+               Q+ ++K L ++ G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 565 AKLQHRNLVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD---PSRTHLLGWQTR---- 615
             LQ     +L          I   +   +      F +      S    L    +    
Sbjct: 101 KPLQVNKWKKLYST---PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157

Query: 616 VKIIEGIAQGLL----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGD 669
            + +  +A  LL    +LH+      +H ++ A NI +D +   ++  + +G A  +C  
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

Query: 670 EL-----QGNTKRVVGTYGYMS 686
                  +G+     G   ++S
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFIS 236

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 60.3 bits (146), Expect = 2e-11
 Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 19/125 (15%)

Query: 25  TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
           +D +     +  G  L      +     +        L ++     +  VW +  N    
Sbjct: 1   SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            S  VL + N+GNLV+ +     IW+SN +R+  N    L    N+V+        +  +
Sbjct: 49  ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIY------DNSNN 101

Query: 145 YLWQS 149
            +W +
Sbjct: 102 AIWAT 106

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 36/189 (19%), Positives = 67/189 (35%), Gaps = 27/189 (14%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
           K+G GGFG +Y        ++ A   VK    ++G    E K    + AK          
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV-AKKDCIKKWIER 102

Query: 577 GCCVEQGEKILIY---EYMPNKSLNFFLFD---PSRTHLLGWQTR--VKIIEGIAQGLL- 627
                 G  +           +S  F + +        + G         +  +   +L 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 628 ---YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFCGDEL-----QGNTKR 677
              Y+H+      +H D+KA+N+LL      ++  +D+G++  +C +       +   K 
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 678 VVGTYGYMS 686
             GT  + S
Sbjct: 220 HNGTIEFTS 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 38/194 (19%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
            ++ +  ++GEG FG +++G  LLN Q+VA+K     S + Q   E++   +L       
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL 627
            +  +     E    +L+ +          L  PS   LL    R   VK +   A+ +L
Sbjct: 67  GIPNVYYFGQEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQML 116

Query: 628 ----YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMFCGDELQGN---- 674
                +H+ S   +++RD+K  N L+    +       + DFGM + +  D +       
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPY 172

Query: 675 --TKRVVGTYGYMS 686
              K + GT  YMS
Sbjct: 173 REKKNLSGTARYMS 186

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 38/186 (20%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLM 576
           K+G G FG +Y G  +   +EVA+K   + ++  Q L E K    +   LQ    +  + 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69

Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL----YL 629
              VE    +L+ +          L  PS   L  + +R   +K +  +A  ++    ++
Sbjct: 70  WFGVEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFCGDELQG------NTKRVVG 680
           H  S    +HRD+K  N L+          I DFG+A+ +  D            K + G
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTHQHIPYRENKNLTG 175

Query: 681 TYGYMS 686
           T  Y S
Sbjct: 176 TARYAS 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 40/194 (20%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQH- 569
             + +  K+G G FG +Y G  +  G+EVA+K   + ++  Q   E K    +   +Q  
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGG 64

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGL 626
             +  +  C  E    +++ E          L  PS   L  + +R   +K +  +A  +
Sbjct: 65  VGIPTIRWCGAEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQM 114

Query: 627 L----YLHQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFCGDELQGNT---- 675
           +    Y+H  +    IHRD+K  N L+          I DFG+A+ +   + + +     
Sbjct: 115 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR--DARTHQHIPY 169

Query: 676 ---KRVVGTYGYMS 686
              K + GT  Y S
Sbjct: 170 RENKNLTGTARYAS 183

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 4e-10
 Identities = 97/632 (15%), Positives = 171/632 (27%), Gaps = 196/632 (31%)

Query: 224 DPTNTSYLFRPIVEQKEDEIIYR---------YESYSSRILMMLKINPSGDVQRLIWH-- 272
           D  + +      +  K++E++ +         Y+   S I    +  PS   +  I    
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRD 117

Query: 273 EMSTGWQVF----------FTA---------PNNFCQLYGY--CG----ANSVCSVDDT- 306
            +    QVF          +           P     + G    G    A  VC      
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 307 ------------ANCECLKGFKLKLQN--NQTWPRECVRSHSSDCITRE---------RF 343
                        NC   +     LQ    Q  P    RS  S  I            R 
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 344 IKFDDIKLPYLV--DVSLNESMNLKECEAECLK----NC----TCRAYANSKVTGGGSGC 393
           +K    +   LV  +V            A+       +C    T R     +VT   S  
Sbjct: 238 LKSKPYENCLLVLLNV----------QNAKAWNAFNLSCKILLTTR---FKQVTDFLSAA 284

Query: 394 LMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGD--KKLLWI--FVILVLPAALLPGFFIF 449
                 L         +  + + ++  D  P D  +++L      + ++  ++  G   +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344

Query: 450 CRWRRKHKEK-ETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLAS 508
             W+  + +K  T +ESS ++L             EP+E        R+      F   S
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVL-------------EPAE-------YRK-----MFDRLS 379

Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
           V      F     +       ++   + +   V V +L   S            L+ K  
Sbjct: 380 V------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS------------LVEKQP 421

Query: 569 HRNLVRLMGC-------CVEQGE--KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
             + + +             +    + ++  Y  N    F   D    +L          
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHY--NIPKTFDSDDLIPPYLDQ-------- 471

Query: 620 EGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQG 673
                   Y + +       +    R      + LD   +  KI     A    G  L  
Sbjct: 472 --------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL-- 521

Query: 674 NTKRVVGTY-GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA 732
           NT + +  Y  Y+      D  +                        V  I  F L    
Sbjct: 522 NTLQQLKFYKPYICDN---DPKYERL---------------------VNAILDF-LPKIE 556

Query: 733 WNLWKDNRAYELLSPALQHEAS--YQMLNRYI 762
            NL    +  +LL  AL  E    ++  ++ +
Sbjct: 557 ENLICS-KYTDLLRIALMAEDEAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 5e-07
 Identities = 56/411 (13%), Positives = 114/411 (27%), Gaps = 129/411 (31%)

Query: 417 VRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD--- 473
           +   D+  G  +L W                         K++E   +  +++L+ +   
Sbjct: 55  IMSKDAVSGTLRLFWTL---------------------LSKQEEMVQKFVEEVLRINYKF 93

Query: 474 IYMSVATRTNEPSEGDGDAKGTRRD---SVLPCFSLASVSAATENFSMQCKL-------- 522
           +   + T   +PS         +RD   +    F+  +VS       ++  L        
Sbjct: 94  LMSPIKTEQRQPS-MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152

Query: 523 ----GEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
               G  G G   K  +      A+    S   Q   +FK     I  L        +  
Sbjct: 153 VLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFK-----IFWLN-------LKN 191

Query: 579 CVEQGEKI-----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           C      +     L+Y+  PN +         +  +   Q  ++        LL    Y 
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR-------LLKSKPYE 244

Query: 634 RLRIIHRDLKASNILLDSDMNPKI----SDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
              ++  +++ +      +++ KI        +      D L   T   +      S ++
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT-----DFLSAATTTHI------SLDH 293

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD----IESFNLLGHA------------W 733
               L   +             L    +    D    + + N    +            W
Sbjct: 294 HSMTLTPDEV---------KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344

Query: 734 NLWKD----------NRAYELLSPALQHEASYQML-----NRYITVALLCV 769
           + WK             +  +L PA  +   +  L     + +I   LL +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAE-YRKMFDRLSVFPPSAHIPTILLSL 394

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 1e-06
 Identities = 56/416 (13%), Positives = 116/416 (27%), Gaps = 152/416 (36%)

Query: 435 ILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD---IYMSVATRTNEPSEGDGD 491
           I++   A+     +F  W    K++E   +  +++L+ +   +   + T   +PS     
Sbjct: 54  IIMSKDAVSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS----- 106

Query: 492 AKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG 551
                                T  +  Q            + +L N  +V  K  +    
Sbjct: 107 -------------------MMTRMYIEQ------------RDRLYNDNQVFAKY-NVSRL 134

Query: 552 QGLKEFKNEMMLIAKLQHRNLVRL--MGCCVEQGEKILIYE----YMPNKSLNFFLFDPS 605
           Q   + +  ++   +L+    V +  +      G+  +  +    Y     ++F +F   
Sbjct: 135 QPYLKLRQALL---ELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKIF--- 185

Query: 606 RTHLLGWQT--RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
                 W         E + + L  L         ++         D   N K+      
Sbjct: 186 ------WLNLKNCNSPETVLEMLQKLL--------YQIDPNWTSRSDHSSNIKLRI---- 227

Query: 664 RMFCGDELQGNTKRVVGTYGYMSPEYA-----LDGLFSVKS-DVFSFGVLLLETLTSKRN 717
                  +Q   +R++      S  Y      L  + + K+ + F+    +L  LT+ R 
Sbjct: 228 -----HSIQAELRRLL-----KSKPYENCLLVLLNVQNAKAWNAFNLSCKIL--LTT-RF 274

Query: 718 TGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRP 777
             V D  S     H         + +  S  L  +    +L +Y+               
Sbjct: 275 KQVTDFLSAATTTH--------ISLDHHSMTLTPDEVKSLLLKYL--------------- 311

Query: 778 TMSKVVSMITNEHATLPYPKQSAFSYARRGEKISFLPSSRVSEACSVNGVTLSLIS 833
                                          +   LP     E  + N   LS+I+
Sbjct: 312 -----------------------------DCRPQDLPR----EVLTTNPRRLSIIA 334

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 1e-04
 Identities = 60/373 (16%), Positives = 98/373 (26%), Gaps = 142/373 (38%)

Query: 49  LGFFSPGKS--------KYKYLGIWYKQVPDTVVW--VANRNSPIVDSNAVLTIGNNGNL 98
           LG    GK+         YK       ++   + W  + N NSP      VL +      
Sbjct: 159 LGS---GKTWVALDVCLSYKVQ----CKMDFKIFWLNLKNCNSP----ETVLEMLQK--- 204

Query: 99  VLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYL----------WQ 148
            LL Q D   W+S             + +    LR    S   E   L          W 
Sbjct: 205 -LLYQIDPN-WTSRSDHSSNIK--LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260

Query: 149 SFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSV 208
           +F+     LL          T R + +T     D  S    T         H+ +     
Sbjct: 261 AFNLSCKILL----------TTRFKQVT-----DFLSAATTT---------HISL----- 291

Query: 209 KLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQR 268
                   +  +    P     L    ++ +  ++    E        +L  NP      
Sbjct: 292 --------DHHSMTLTPDEVKSLLLKYLDCRPQDL--PRE--------VLTTNPR--RLS 331

Query: 269 LIW---HEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECL-KGFKLKLQNNQT 324
           +I     +    W        N+  +                NC+ L    +  L N   
Sbjct: 332 IIAESIRDGLATWD-------NWKHV----------------NCDKLTTIIESSL-NVLE 367

Query: 325 WPRECVRSHSSDCITRERFIKF----DDIKLPYLV------DVSLNESMN-LKECEAECL 373
            P E           R+ F +         +P ++      DV  ++ M  + +     L
Sbjct: 368 -PAE----------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416

Query: 374 -----KNCTCRAY 381
                K  T    
Sbjct: 417 VEKQPKESTISIP 429

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 46/214 (21%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR------N 571
           +G+G FG V K       Q VA+K + ++     Q  +E +    ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160

Query: 572 LVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
           ++ ++     +    + +E +  N     K   F  F                   I Q 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS--------ILQC 212

Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTY- 682
           L  LH   + RIIH DLK  NILL        K+ DFG +  +            V TY 
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR--------VYTYI 260

Query: 683 ---GYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
               Y +PE  L   + +  D++S G +L E LT
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 56.1 bits (135), Expect = 9e-10
 Identities = 18/118 (15%), Positives = 41/118 (34%), Gaps = 14/118 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +     L + +  + L   +          + Y+      +W +N +     
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
           S   LT+ ++GNLV+ +  +  +W S    +       L   G  V+     +S   +
Sbjct: 51  SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSLGPN 108

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 54.5 bits (131), Expect = 3e-09
 Identities = 17/124 (13%), Positives = 45/124 (36%), Gaps = 13/124 (10%)

Query: 20  LLSLATDTITPATL-IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
           + S   D   P  L   +  +++  + ++     +          + Y    +  +W  N
Sbjct: 4   IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATN 55

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--F 136
                  +     +  +G LV++   +  +W S ++ +  + V  L    N+V+     +
Sbjct: 56  TGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALW 113

Query: 137 SSNT 140
           ++ T
Sbjct: 114 ATQT 117

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 54.1 bits (130), Expect = 4e-09
 Identities = 19/120 (15%), Positives = 41/120 (34%), Gaps = 15/120 (12%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
              + +    ++    +L + +   +L              + Y        W +N +  
Sbjct: 4   FTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCNL------VLYGG---KYGWQSNTHG- 51

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
               +  L + + G L++ +     IWSS  S +    V  L D G  V+     F +++
Sbjct: 52  -NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPAIFETSS 110

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 53.7 bits (129), Expect = 5e-09
 Identities = 24/118 (20%), Positives = 46/118 (38%), Gaps = 14/118 (11%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +  GE L  ++  +                + Y    D  +W  N      D
Sbjct: 2   NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
               L++ ++GNLV+ +  +  IW+SN   E  N V  L    N+V+     +++ T+
Sbjct: 50  RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTN 107

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 51.8 bits (124), Expect = 2e-08
 Identities = 23/120 (19%), Positives = 37/120 (30%), Gaps = 17/120 (14%)

Query: 23  LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
           L T+ +     +     L +    F+L           Y G W              N+ 
Sbjct: 1   LGTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLVL-YNGNWQS------------NTA 45

Query: 83  IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
               +  LT+ + G LV+ N     +W S       N  A +   G LV+     F  + 
Sbjct: 46  NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKIDP 105

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 49.1 bits (117), Expect = 2e-07
 Identities = 15/109 (13%), Positives = 41/109 (37%), Gaps = 10/109 (9%)

Query: 24  ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPI 83
             + +  + ++ D  +L  +++ + L              +  K     +VW +  +   
Sbjct: 5   VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55

Query: 84  VDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL 132
              +  + +G++G L + +     ++ SN   +  + V  L   G  V+
Sbjct: 56  -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 14/73 (19%), Positives = 30/73 (41%), Gaps = 7/73 (9%)

Query: 78  NRNSPIVDSNAVLTIGNNGNLVL-LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKF 136
             N+ +   +  L + ++ NLVL       I+W S  S   ++   +L  +G L + +  
Sbjct: 16  YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITD-- 73

Query: 137 SSNTSEGSYLWQS 149
                  + ++ S
Sbjct: 74  ----DRLNTVFVS 82

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 54/235 (22%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 570
           F +  K+G+G FG V   + + N +  AVK + +          E      ++ K+Q+  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92

Query: 571 ----NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
               N+V+  G  +         E     +YE +     N+  F      L   +     
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII--TRNNYNGFHIEDIKLYCIE----- 145

Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR- 677
              I + L YL    ++ + H DLK  NILLD     K                  TK  
Sbjct: 146 ---ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 678 -------------------VVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
                              ++ T  Y +PE  L+  + V SD++SFG +L E  T
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 52/241 (21%), Positives = 83/241 (34%), Gaps = 70/241 (29%)

Query: 516 FSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFK----------NE 560
           + +   LGEG FG V +       G+ VAVK + +          E +          N 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 561 MMLIAKL----QHRN---LV-RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
                ++    +H     +V  L+G           Y+++  K   F  F       + +
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLST--------YDFI--KENGFLPFRLDHIRKMAY 125

Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----------------- 655
           Q        I + + +LH     ++ H DLK  NIL                        
Sbjct: 126 Q--------ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 656 --KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETL 712
             K+ DFG A  +  +        +V T  Y +PE  L  L +S   DV+S G +L+E  
Sbjct: 175 DIKVVDFGSA-TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY 228

Query: 713 T 713
            
Sbjct: 229 L 229

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 60/236 (25%)

Query: 516 FSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR 570
           + +   LGEG FG V +         +VA+K + +          E      ++ K++ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76

Query: 571 ------NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
                   V +       G      E      +E++  K  NF  +       + +Q   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--KENNFQPYPLPHVRHMAYQ--- 131

Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KI 657
                +   L +LH     ++ H DLK  NIL  +                       ++
Sbjct: 132 -----LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT 713
           +DFG A  F  +        +V T  Y  PE  L+  ++   DV+S G +L E   
Sbjct: 184 ADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 54/265 (20%), Positives = 88/265 (33%), Gaps = 86/265 (32%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRN 571
           KLG G F  V+    +   + VA+K + S      +   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR----------VK-IIE 620
           +V+L+      G          N +    +F+    HLL W  +          VK II+
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILL------------------------------- 649
            + QGL YLH  ++ RIIH D+K  NILL                               
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 650 ------------------DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
                                +  KI+D G A  +            + T  Y S E  +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLI 266

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKR 716
              ++  +D++S   +  E  T   
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDY 291

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 46.8 bits (110), Expect = 9e-06
 Identities = 21/80 (26%), Positives = 28/80 (35%), Gaps = 11/80 (13%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
            D  VW  N         AVL    NG + +L   +  +W+S  SR     V  L    N
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224

Query: 130 LVLREKFSSNTSEGSYLWQS 149
           L +          G  LW +
Sbjct: 225 LAIY---------GGALWTT 235

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 45.7 bits (107), Expect = 2e-05
 Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 12/147 (8%)

Query: 71  DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
           D  VW +N       +     + ++G LV+L   + I WSS     + N V  L     +
Sbjct: 44  DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100

Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFT 190
            +             LW S      ++++  N    L + +             S     
Sbjct: 101 TIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151

Query: 191 FRLEIRVLPHLCIYNGSVKLSCTGPWN 217
           +RL +    +L +++   ++  T    
Sbjct: 152 YRLSMETDCNLVLFDRDDRVWSTNTAG 178

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.9 bits (102), Expect = 1e-04
 Identities = 35/211 (16%), Positives = 61/211 (28%), Gaps = 33/211 (15%)

Query: 22  SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNS 81
            + T  +     +  G+ L+S +Q F+L     G      L I         VWVAN   
Sbjct: 11  GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62

Query: 82  PIV------DSNAVLTIGNNGNLVLLNQTDGIIWSS-----NLSREVKNPVAQLLDTGNL 130
           P        +  A L         L + +   +W +       + +       L D GN+
Sbjct: 63  PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122

Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLI--GMNMGWDLKTGRERY-------LTSWRTA 181
           VL +  +      +         S  L     +  G     G  +        L ++   
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPN 182

Query: 182 DDPS-----PGNFTFRLEIRVLPHLCIYNGS 207
              +      G    R   +   +L +Y   
Sbjct: 183 GAATWNAGTQGKGAVRAVFQGDGNLVVYGAG 213

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.5 bits (101), Expect = 1e-04
 Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 7/88 (7%)

Query: 71  DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
               W A                 +GNLV+    + ++W S+ +    + V +L   G++
Sbjct: 183 GAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSH-TGGHASAVLRLQANGSI 238

Query: 131 VL---REKFSSNTSEGSYLWQSFDCPSD 155
            +   +  ++    + +Y       P  
Sbjct: 239 AILDEKPVWARFGFQPTYRHIRKINPDQ 266

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	835
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.86
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.85
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.83
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.82
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.8
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.77
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.7
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.67
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.6
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.59
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.58
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.31
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.12
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.08
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.18
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.84
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.81
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.42
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.35
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.06
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.98
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.94
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.91
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.46
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.11
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.0
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.64
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.46
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	90.26
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.58

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-53  Score=453.95  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=217.3

Q ss_pred             cCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            67899999999999999999864      367899999988777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          588 IYEYMPNKSLNFFLFDP----------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      |||||++|+|.++|...          .....++|.+++.++.||++||+|||+++   ||||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999542          22356999999999999999999999987   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhh
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......  +..    .+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~----~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----CI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH----HH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HH
Confidence            99999997755444444445679999999999999999999999999999999999 899997644221  111    11


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      ..+..         ...+..++..+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11110         111223456788999999999999999999999999887443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=455.29  Aligned_cols=262  Identities=28%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            367888999999999999999864      37889999998877777889999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          587 LIYEYMPNKSLNFFLFDPS------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                      ||||||++|+|.+++....            ....++|.++++|+.||++||+|||+++   ||||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999996532            1246899999999999999999999987   999999999999999999


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccch
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  733 (835)
                      +||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......  ...   
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~---  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AID---  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHH---
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHH---
Confidence            99999999998755544444556789999999999999999999999999999999999 899997644221  111   


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                       .+..+.         +...+..++..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       272 -~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 -CITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -HHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence             111110         0111223456788999999999999999999999999987443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.6e-52  Score=448.12  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=214.0

Q ss_pred             cCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++++.++||+|+||+||+|++.      +++.||||+++... ....++|++|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45678899999999999999863      46789999997543 345678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          587 LIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ||||||++|+|.++|.....             ...+++.++++++.||++||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             245899999999999999999999988   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||.......  +..  
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~--  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVE--  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHH--
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHH--
Confidence            999999999998765554444556789999999999999999999999999999999998 899987644221  111  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        .+..+.         ....+..++..+.+|+.+||+.||++||+|+||++.|+..
T Consensus       259 --~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 --MIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              111111         1112233456788999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=440.15  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .+++++.++||+|+||+||+|++.  ..||||+++..  .....++|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467889999999999999999875  36999998643  34567889999999999999999999998865 56899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ||++|+|.++|...  ...+++.+++.|+.||++||+|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999643  346899999999999999999999987   9999999999999999999999999998765444


Q ss_pred             ccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .........||+.|||||++.+   +.|+.++|||||||+||||+||+.||...+.... +.    ......    ...|
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~----~~~~~~----~~~p  257 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-II----FMVGRG----YASP  257 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH----HHHHTT----CCCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HH----HHHhcC----CCCC
Confidence            3444456789999999999864   4689999999999999999999999975432211 00    000100    1111


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                      .+ ...+..++..+.+|+.+||+.+|++||||.||++.|+.+...+|
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            11 11222345678899999999999999999999999988765554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.9e-50  Score=434.67  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=202.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|+++++||+|+||+||+|++. +|+.||||++...  .....+.+++|+.+|++++|||||++++++.+.+..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999975 4899999999654  34456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ||++|+|.+++... +...+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999999542 3345789999999999999999999998   999999999999999999999999999876321 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+....  ..   .... ...     +.  
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~---~i~~-~~~-----~~--  244 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL--VL---KIIS-GSF-----PP--  244 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH---HHHH-TCC-----CC--
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH---HHHc-CCC-----CC--
Confidence             1123456899999999999999999999999999999999999999976442211  10   0100 100     11  


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11234456889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-49  Score=430.53  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=209.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            57999999999999999999985 48999999997655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++.+    ..+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999999843    45899999999999999999999998   9999999999999999999999999998764332  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+...  ...    .+.     ....+.+.  
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~----~i~-----~~~~~~~~--  291 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MIR-----DNLPPRLK--  291 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHH-----HSSCCCCS--
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----HHH-----cCCCCCCC--
Confidence            22345789999999999999999999999999999999999999997543211  111    000     11111111  


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....+..+.+|+.+||+.||++|||++|+++.
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            122345678899999999999999999998863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.5e-50  Score=437.23  Aligned_cols=268  Identities=26%  Similarity=0.389  Sum_probs=217.5

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCC-CceeeEe
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQH-RNLVRLM  576 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~  576 (835)
                      .....+...++|++.++||+|+||+||+|++..      ++.||||++.... ....++|.+|+.+|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            334455567899999999999999999998643      3689999997653 3456789999999999955 9999999


Q ss_pred             eEEEec-CeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC
Q 003264          577 GCCVEQ-GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  642 (835)
Q Consensus       577 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  642 (835)
                      |+|.+. +..+||||||++|+|.++|....             ....+++.+++.++.||++||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999775 56899999999999999996432             1345899999999999999999999998   999999


Q ss_pred             CCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 003264          643 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVY  721 (835)
Q Consensus       643 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~  721 (835)
                      ||+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765544444556789999999999999999999999999999999998 89999754


Q ss_pred             CcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..... +    ...+..+         .+...+..++..+.+++.+||+.||++|||++||++.|+.+
T Consensus       292 ~~~~~-~----~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          292 KIDEE-F----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCSHH-H----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHH-H----HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            42211 0    0111111         01111223345688899999999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.5e-49  Score=424.03  Aligned_cols=271  Identities=24%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----eEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~  589 (835)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            5688899999999999999998 6899999999754322 223345666777899999999999998764    579999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      ||+++|+|.++|..    ..+++..+.+++.|+++||+|||++     +.++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999943    4589999999999999999999986     23459999999999999999999999999998


Q ss_pred             cccCCCcc--ccccccccccceeCceeecCC------CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc----
Q 003264          665 MFCGDELQ--GNTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA----  732 (835)
Q Consensus       665 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~----  732 (835)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||+||++|+..............    
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543321  223346799999999998764      467899999999999999999988765443222111110    


Q ss_pred             -hhhhccccchhccCccccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          733 -WNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       733 -~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                       ...+.........+|.+... .+.+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             00011111112223333322 22356678899999999999999999999999998763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-49  Score=424.20  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=209.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67999999999999999999975 4899999999753   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++.   +...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999994   3356899999999999999999999998   999999999999999999999999999987655


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .........+||+.|||||++.+..|+.++||||+||+||||++|+.||...+....  ..   ... ...      ..+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~---~i~-~~~------~~~  253 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--FA---KII-KLE------YDF  253 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHH-HTC------CCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHH-cCC------CCC
Confidence            444455667899999999999999999999999999999999999999975442211  10   000 000      011


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                          +...+..+.+|+.+||+.||++|||++|++
T Consensus       254 ----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 ----PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                122345678999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-49  Score=426.45  Aligned_cols=253  Identities=22%  Similarity=0.237  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .+.|++.++||+|+||+||+|++. +|+.||||+++....     +.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            357888999999999999999985 489999999975422     24699999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccccCCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE  670 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~  670 (835)
                      +++|+|.+++.+   ...+++..+..++.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999943   356999999999999999999999998   99999999999999988 69999999999875433


Q ss_pred             ccc---cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQG---NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...   .....+||+.|||||++.+..|+.++|||||||+||||++|++||........  ..   .......       
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~~~~~-------  273 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CL---KIASEPP-------  273 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HH---HHHHSCC-------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH---HHHcCCC-------
Confidence            221   22346799999999999999999999999999999999999999975443221  10   0111100       


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       .....+..++..+.+++.+||+.||++|||+.|+++.|...
T Consensus       274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             00112233456788999999999999999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-48  Score=414.68  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             CccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI  588 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV  588 (835)
                      |++.++||+|+||+||+|++.. ++.||||++...  .....++|.+|+.+|++++|||||++++++.+    ....+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            3677889999999999999754 889999998643  34456789999999999999999999999875    3458999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~  667 (835)
                      ||||++|+|.+++.+   ...+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999943   456899999999999999999999875 46999999999999984 7999999999998643


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .    ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||........ +..    .....     .. 
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~----~i~~~-----~~-  247 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYR----RVTSG-----VK-  247 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHH----HHTTT-----CC-
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHH----HHHcC-----CC-
Confidence            2    22345689999999998764 699999999999999999999999964332111 100    00000     00 


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       248 --~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11112223346788999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=431.96  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=209.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999985 48999999997665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++..    ..+++.++..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+....  
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            99999999843    35899999999999999999999998   9999999999999999999999999998764332  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+...  ...    .+.     ....+.+.  
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~----~i~-----~~~~~~~~--  368 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MIR-----DNLPPRLK--  368 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHH-----HSCCCCCS--
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----HHH-----cCCCCCCc--
Confidence            23345789999999999999999999999999999999999999997543211  110    011     01111111  


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112234568899999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9e-48  Score=405.71  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=190.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999975 58999999996542   334567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+ +|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6788888843   356999999999999999999999998   999999999999999999999999999875432


Q ss_pred             CccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .   ......||+.|||||++.+..+ +.++||||+||+||||++|+.||...+....  ..    .+....      ..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--~~----~i~~~~------~~  230 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--FK----NISNGV------YT  230 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC------CC
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCC------CC
Confidence            2   2334689999999999998876 5799999999999999999999975432211  10    000000      01


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +    +...+..+.+++.+||+.||++|||++|+++.
T Consensus       231 ~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          231 L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1    11234567889999999999999999999873

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.2e-47  Score=407.58  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC--------
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--------  583 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  583 (835)
                      ++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999975 58999999986543 445678999999999999999999999998654        


Q ss_pred             ----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecc
Q 003264          584 ----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  659 (835)
Q Consensus       584 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  659 (835)
                          ..++||||+++|+|.+++..........+..+..++.||++||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976544445667778999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCccc----------cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccccc
Q 003264          660 FGMARMFCGDELQG----------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL  729 (835)
Q Consensus       660 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~  729 (835)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||+||||++   ||.... +.....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HHHHHH
Confidence            99998875432211          1234579999999999999999999999999999999996   554211 100000


Q ss_pred             ccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                                  ........ +.........+.+++.+||+.||++|||+.|+++
T Consensus       238 ------------~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          238 ------------TDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ------------HHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------HHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                        00000011 1222334455678999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-48  Score=413.67  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             cCCccccccccCCcccEEEEEec----CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|++++.||+|+||+||+|+..    .++.||||+++...  .....++.+|+.+|++++|||||++++++.+.+..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    36899999997542  2234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999943   356899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+....  ..   ... ...      .
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~---~i~-~~~------~  243 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MT---MIL-KAK------L  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHH-HCC------C
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HH---HHH-cCC------C
Confidence            322  223456899999999999999999999999999999999999999976442211  10   000 000      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  784 (835)
                      .    .+...+..+.+|+.+||+.||++||++     +|+++
T Consensus       244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1    112234567889999999999999984     56664

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=399.37  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe------cC
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QG  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~  583 (835)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            368999999999999999999975 5899999999754  23455778999999999999999999998764      35


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..+|||||++ |+|.+++.   ....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67888884   3457999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCc--cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc-----chh
Q 003264          664 RMFCGDEL--QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH-----AWN  734 (835)
Q Consensus       664 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~-----~~~  734 (835)
                      +.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+.... .....     ...
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            87644321  2234457899999999998875 569999999999999999999999976542211 00000     000


Q ss_pred             hhc---cccch---hccCcccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWK---DNRAY---ELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~---~~~~~---~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.   .....   ..+.+...   ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000   00000   00000000   00111234567899999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-43  Score=387.19  Aligned_cols=283  Identities=36%  Similarity=0.605  Sum_probs=238.5

Q ss_pred             ccHHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 003264          504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  583 (835)
                      +++.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44455666789999999999999999999998889999999998776667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      ..++||||+++|+|.+++..... ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999965432 235899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcc-cccccccchhhhccccc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE-SFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~  741 (835)
                      ++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......+..........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            98754333333334456899999999999999999999999999999999999998754422 22222333333334445


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ...+++.+........+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            556666666666778889999999999999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-43  Score=390.29  Aligned_cols=201  Identities=23%  Similarity=0.351  Sum_probs=172.3

Q ss_pred             HhhcCCccccccccCCcccEEEEEec----CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ...++|++.++||+|+||+||+|+.+    .++.||||++....  ...++.+|+++|.++ +|||||++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45688999999999999999999863    36789999986543  345678999999998 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  664 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~  664 (835)
                      ++||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999982      3889999999999999999999998   9999999999999877 799999999998


Q ss_pred             cccCCCcc--------------------------ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCC
Q 003264          665 MFCGDELQ--------------------------GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRN  717 (835)
Q Consensus       665 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p  717 (835)
                      ........                          ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432211                          112335799999999999876 589999999999999999999999


Q ss_pred             CCCCC
Q 003264          718 TGVYD  722 (835)
Q Consensus       718 ~~~~~  722 (835)
                      |....
T Consensus       247 f~~~~  251 (361)
T 4f9c_A          247 FYKAS  251 (361)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            86443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.5e-43  Score=382.10  Aligned_cols=288  Identities=40%  Similarity=0.639  Sum_probs=241.4

Q ss_pred             CCcccHHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcCh-hhHHHHHHHHHHHHhcCCCceeeEeeEE
Q 003264          501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCC  579 (835)
Q Consensus       501 l~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~  579 (835)
                      +..++..++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456888999999999999999999999999999988899999999976432 2334689999999999999999999999


Q ss_pred             EecCeEEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          580 VEQGEKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       580 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                      .+....++||||+++|+|.+++.... ....+++..+..++.||+.||+|||++...+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999996643 33458999999999999999999999833339999999999999999999999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC---cccccccccchhh
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD---IESFNLLGHAWNL  735 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~---~~~~~~~~~~~~~  735 (835)
                      |||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....   ........+....
T Consensus       177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999998764332 222334569999999999999999999999999999999999999996322   2222333344444


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..........+..+........+..+.+++.+|++.+|++||+++||+++|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            455556666777777777788899999999999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.8e-43  Score=408.48  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=210.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++........+.+++|+.+|+.++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999985 4899999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC--CCeEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~  669 (835)
                      |++|+|.+++.+  +...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999843  3346899999999999999999999998   9999999999999854  89999999999987433


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+....  ..   .... .      +..+
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~---~i~~-~------~~~~  375 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR---NVKS-C------DWNM  375 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HHHT-T------CCCC
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH---HHHh-C------CCCC
Confidence            2   23456899999999999999999999999999999999999999976442211  00   0000 0      0011


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+..+.+|+.+||+.||++||++.|+++.
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111222345667899999999999999999999873

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=9e-43  Score=366.20  Aligned_cols=234  Identities=19%  Similarity=0.194  Sum_probs=181.3

Q ss_pred             hccccCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCC----CceEEEecCC
Q 003264           21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDS----NAVLTIGNNG   96 (835)
Q Consensus        21 ~~~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g   96 (835)
                      |+++.|+|++||+|++|++|+|++|+|+||||+++   ++|+   |+ ..+ |||+|||++|+.++    +++|+|+.||
T Consensus        10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G   81 (276)
T 3m7h_A           10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV   81 (276)
T ss_dssp             CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred             ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence            56678999999999999999999999999999543   6787   76 445 99999999999875    8899999999


Q ss_pred             ceEE--ecCCCceEEeecCCCC-----ccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccccccccccccc
Q 003264           97 NLVL--LNQTDGIIWSSNLSRE-----VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKT  169 (835)
Q Consensus        97 ~l~l--~~~~~~~~wst~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~~~t  169 (835)
                      +|||  .|++|.+||+|+++..     .....|+|+|+|||||++        +.+||||  |||||||||||||.++++
T Consensus        82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--------~~~lWqS--~ptdtlLpg~~~~~~l~~  151 (276)
T 3m7h_A           82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--------SLALWNG--TPAIPLVPGAIDSLLLAP  151 (276)
T ss_dssp             SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred             cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--------CceeeCc--cccccccccccccccccc
Confidence            9999  7888999999998642     345688999999999996        3589999  999999999999999998


Q ss_pred             CcceeeEeecCCCCCCCCceEEEeecCCcceEEEEc-CCeEEEeecCCCCcccccCCCCccccccceeecccceEEEEEE
Q 003264          170 GRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYN-GSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYE  248 (835)
Q Consensus       170 g~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~-~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (835)
                      |..  |   ++.+||++|.|+++++++|.  ++++. ++.+||++|+|++......-.....  ..+..+....+.++++
T Consensus       152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGn--Lvl~d~~~~~vWsS~t  222 (276)
T 3m7h_A          152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDGN--LVVYGAGNAVLWHSHT  222 (276)
T ss_dssp             SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTSC--EEEECTTSCEEEECSC
T ss_pred             Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCCe--EEEEeCCCcEEEEecC
Confidence            876  6   67899999999999999984  45565 4689999999976421100000000  0111121223333332


Q ss_pred             ecCCceeeEEEEccCCcEEEEEEEecCCceEEEEeecC
Q 003264          249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPN  286 (835)
Q Consensus       249 ~~~~~~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~  286 (835)
                        .....+|++|+.||+++.|.|   ...|..++.+|.
T Consensus       223 --~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~  255 (276)
T 3m7h_A          223 --GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT  255 (276)
T ss_dssp             --TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred             --CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence              223358999999999999999   346777766664

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-42  Score=400.86  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHH---HHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLK---EFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~---~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|+++++||+|+||+||+|+... |+.||||++.+..   .....   +.+.++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            3789999999999999999999854 8999999996431   11222   334456777788999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      +|||||+++|+|..+|.+   ...+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999943   356899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      +....    ....+||+.|||||++.. ..|+.++|||||||+||||++|++||...........  ......       
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i--~~~i~~-------  408 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLT-------  408 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH--HHHHHH-------
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhhcC-------
Confidence            64332    334689999999999975 5799999999999999999999999975332211000  000000       


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                      ...    ..+...+..+.+|+.+||+.||++|++     ++||++.
T Consensus       409 ~~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          409 MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CCC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            000    112234566889999999999999998     6777753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.2e-41  Score=362.00  Aligned_cols=283  Identities=36%  Similarity=0.551  Sum_probs=229.4

Q ss_pred             CCcccHHHHHHhhcCCccc------cccccCCcccEEEEEecCCcEEEEEEecCc----ChhhHHHHHHHHHHHHhcCCC
Q 003264          501 LPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQHR  570 (835)
Q Consensus       501 l~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~  570 (835)
                      .+.|++.++..++++|...      ++||+|+||.||+|+. +++.||||++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568899999999998877      8899999999999987 6889999998653    234567899999999999999


Q ss_pred             ceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       571 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      ||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+++   |+||||||+|||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999965544567899999999999999999999998   99999999999999


Q ss_pred             CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc
Q 003264          651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  730 (835)
Q Consensus       651 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~  730 (835)
                      .++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........ +..
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence            999999999999987644333333344678999999998764 589999999999999999999999876543221 111


Q ss_pred             cchhhhc-cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          731 HAWNLWK-DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       731 ~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ....... .....+.+++.+ ...+......+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1111111 112223333333 2244566788999999999999999999999999998873

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.1e-42  Score=372.46  Aligned_cols=269  Identities=26%  Similarity=0.415  Sum_probs=207.0

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .....+|++.+.||+|+||+||+|+. .++.||||++....  ....+++.+|+.++++++||||+++++++.+....++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34457899999999999999999987 68899999987543  4456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999999965433345899999999999999999999875 349999999999999999999999999998643


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .   .....     .. 
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~--~---~~~~~-----~~-  257 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA--A---VGFKC-----KR-  257 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH--H---HHHSC-----CC-
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H---HHhcC-----CC-
Confidence            221  22334678999999999999999999999999999999999999997544221100  0   00000     00 


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCC
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  796 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p  796 (835)
                         ...+......+.+++.+||+.+|++||++.|+++.|+.+.+...+|
T Consensus       258 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          258 ---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence               0111223456788999999999999999999999999886554433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-41  Score=376.48  Aligned_cols=259  Identities=27%  Similarity=0.447  Sum_probs=213.3

Q ss_pred             hcCCccccccccCCcccEEEEEec--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      .++|++.+.||+|+||.||+|++.        ++..||||++... .....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999863        3457999999765 344567899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  649 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl  649 (835)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999864321             235789999999999999999999998   9999999999999


Q ss_pred             cCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccc
Q 003264          650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  728 (835)
Q Consensus       650 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~  728 (835)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+....  
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence            9999999999999987655443334445567889999999999999999999999999999999 9999875442211  


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .    .......         ....+..+...+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       315 ~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          315 F----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             H----HHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0    0011110         1111223445688899999999999999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=365.34  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=215.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.++||+|+||+||+|++. +++.||+|++........+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            368999999999999999999985 4899999999877777788999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999542  345899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cc------------cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          672 QG------------NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       672 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+...............      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------  237 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------  237 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh------
Confidence            11            111457999999999999999999999999999999999999988754332221111100      


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                         ...+..    .+..++..+.+++.+||+.||++||++.|+++.|+.+...+
T Consensus       238 ---~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          238 ---GFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ---HHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---cccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence               000000    11223346788999999999999999999999998875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.1e-41  Score=360.69  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=208.3

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            47899999999999999999997 45899999999766555677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++|+|.+++..    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence            999999999843    35889999999999999999999998   9999999999999999999999999998764332 


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+......     ......      .+.+  
T Consensus       171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~------~~~~--  236 (297)
T 3fxz_A          171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNG------TPEL--  236 (297)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHC------SCCC--
T ss_pred             -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCC------CCCC--
Confidence             22334679999999999999999999999999999999999999997543221100     000000      0000  


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+...+..+.+++.+||+.||++||+++|+++.
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1122334567889999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-41  Score=365.40  Aligned_cols=273  Identities=25%  Similarity=0.330  Sum_probs=210.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----eEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  587 (835)
                      ..++|++.++||+|+||.||+|+.. ++.||||++.... .....+.+|+.++.+++||||+++++++.+..    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3478999999999999999999875 7899999996543 33455667999999999999999999999865    3699


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      ||||+++|+|.+++..    ..+++..+..++.||++||+|||+.       +..+|+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999943    3489999999999999999999987       0113999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc----
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH----  731 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~----  731 (835)
                      |+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............    
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99988755444444445679999999999876     356678999999999999999999987543221110000    


Q ss_pred             --chhhhccccchhccCccccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          732 --AWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       732 --~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                        ....+..........+.+... .....+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              000000000011111222111 12245567899999999999999999999999998763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=365.25  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=209.4

Q ss_pred             hcCCccccccccCCcccEEEEEec----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|++.    .+..||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999984    3456999999765 44556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999542  346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........  ..    .....      
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----~~~~~------  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--IS----SVEEG------  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH----HHHTT------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHHcC------
Confidence            43221 12223456788999999999999999999999999999999 9999865442211  00    00000      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                         .....+..++..+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0111112344568889999999999999999999999998743

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.8e-41  Score=377.98  Aligned_cols=259  Identities=25%  Similarity=0.354  Sum_probs=211.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3478999999999999999999986 58999999987543 334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999853  2345889999999999999999999998   999999999999999999999999999865433


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..|+........  .    ......         
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~----~~~~~~---------  331 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--R----EFVEKG---------  331 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--H----HHHHTT---------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcC---------
Confidence            22222223346788999999998999999999999999999998 9999875442211  0    001110         


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .....+..++..+.+++.+||+.+|++||+++++++.|+.+.
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            001111223456788999999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-41  Score=364.69  Aligned_cols=276  Identities=26%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|+.++.+++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            47899999999999999999984     35889999999877777778899999999999999999999998654  568


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  335899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc-hhhhccccchh
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  743 (835)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+........ ..........+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6433221 222334577889999999999999999999999999999999998764322111000000 00000000001


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      .+........+..++..+.+++.+||+.+|++||+++|+++.|+.+...+
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            11111111122334567889999999999999999999999998875443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.2e-41  Score=371.49  Aligned_cols=270  Identities=26%  Similarity=0.382  Sum_probs=216.0

Q ss_pred             ccHHHHHHhhcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeE
Q 003264          504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRL  575 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l  575 (835)
                      +.........++|++.+.||+|+||.||+|++      .+++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34556666779999999999999999999974      23578999999764 334567899999999999 89999999


Q ss_pred             eeEEEecCe-EEEEEEecCCCChhhhhcCCCC------------------------------------------------
Q 003264          576 MGCCVEQGE-KILIYEYMPNKSLNFFLFDPSR------------------------------------------------  606 (835)
Q Consensus       576 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  606 (835)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999988654 8999999999999999965432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          607 ---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       607 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                                     ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122889999999999999999999998   99999999999999999999999999987654443


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.........     ........     ...  
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~-----~~~--  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGT-----RMR--  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHHHTC-----CCC--
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----HHHHHcCC-----CCC--
Confidence            334445678999999999999999999999999999999998 99998754322110     00001000     001  


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                        .+......+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       317 --~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence              11123356788999999999999999999999998763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.8e-40  Score=357.04  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=214.4

Q ss_pred             cccHHHHHHhhcC----------CccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc
Q 003264          503 CFSLASVSAATEN----------FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN  571 (835)
Q Consensus       503 ~~~~~~~~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n  571 (835)
                      .++..++..+++.          |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4667777766654          777889999999999999986 59999999997766666788999999999999999


Q ss_pred             eeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC
Q 003264          572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       572 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~  651 (835)
                      |+++++++...+..++||||+++++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            99999999999999999999999999999843    35899999999999999999999988   999999999999999


Q ss_pred             CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc
Q 003264          652 DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  731 (835)
Q Consensus       652 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~  731 (835)
                      ++.+||+|||+++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  .. 
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--~~-  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK-  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH-
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-
Confidence            9999999999998764332  123346799999999999999999999999999999999999999875432111  00 


Q ss_pred             chhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .     ......+.+.  .....+..+.+++.+||+.||++||++.|+++.
T Consensus       252 ---~-----~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 ---R-----LRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ---H-----HHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---H-----HhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0     0011111111  112234567889999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-40  Score=359.55  Aligned_cols=254  Identities=24%  Similarity=0.311  Sum_probs=204.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999976 58999999986543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999843   345899999999999999999999988   9999999999999999999999999998764433


Q ss_pred             ccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+     ....        .
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~--------~  226 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK--------T  226 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTTC--------T
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hccc--------c
Confidence            3333445689999999999988775 778999999999999999999997544322111110     0000        0


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...........+.+++.+||+.||++||++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            001112234567789999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.3e-41  Score=372.85  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=199.3

Q ss_pred             hcCCccccccccCCcccEEEEEec----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|++.    .+..||||+++.. .....++|.+|+.++.+++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999875    4678999999764 34556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999542  346899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ..    ...        
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~----~i~--------  264 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IK----AVD--------  264 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HH----HHH--------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH--------
Confidence            33211 11222345778999999999999999999999999999998 9999865432211  00    000        


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                       .......+..++..+.+++.+||+.+|++||++.||+++|+.+..
T Consensus       265 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence             001111112344668899999999999999999999999987643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-40  Score=361.36  Aligned_cols=276  Identities=18%  Similarity=0.206  Sum_probs=218.4

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            47899999999999999999997 4588999999865432  24688999999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-----eEecccCcccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM  665 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~  665 (835)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998542  346899999999999999999999998   999999999999998887     99999999987


Q ss_pred             ccCCCccc-----cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          666 FCGDELQG-----NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       666 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........  .... ... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~--~~~i-~~~-  235 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER--YQKI-GDT-  235 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH--HHHH-HHH-
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH--HHHH-Hhh-
Confidence            64432211     12456899999999999999999999999999999999999999986442211000  0000 000 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccccc
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYAR  805 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~~  805 (835)
                        ....+  ........+ .+.+++..|++.+|.+||++++|++.|+.+...+..+....+.|..
T Consensus       236 --~~~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          236 --KRATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             --HHHSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             --hccCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence              00000  000001122 7889999999999999999999999999887777666666666654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=366.00  Aligned_cols=268  Identities=26%  Similarity=0.409  Sum_probs=216.8

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeE
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGC  578 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~  578 (835)
                      +..+....++|++.+.||+|+||.||+|+...      ++.||||++... .....+.+.+|+.++++++||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34445567899999999999999999999753      478999999765 34456789999999999999999999999


Q ss_pred             EEecCeEEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 003264          579 CVEQGEKILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  637 (835)
Q Consensus       579 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  637 (835)
                      +.+.+..++||||+++|+|.+++.....                     ...+++.+++.++.||++||+|||+++   |
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            9999999999999999999999854321                     256899999999999999999999998   9


Q ss_pred             EEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCC
Q 003264          638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKR  716 (835)
Q Consensus       638 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~  716 (835)
                      +||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999987654433333445678899999999999999999999999999999999 999


Q ss_pred             CCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          717 NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       717 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ||........  ..    ........         ..+..++..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       276 p~~~~~~~~~--~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHEEV--IY----YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHHHH--HH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChHHH--HH----HHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            9875432211  00    00111100         1112234568889999999999999999999999998744

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-40  Score=364.46  Aligned_cols=258  Identities=25%  Similarity=0.401  Sum_probs=202.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|++.++||+|+||+||+|++.. ++    +||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            3679999999999999999998643 44    4688888643 3345678999999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +|+||+++|+|.+++...  ...+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999998542  346899999999999999999999998   999999999999999999999999999887


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .............+|..|+|||++.+..++.++||||||+++|||++ |+.||.........      ......      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~------  235 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKG------  235 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------HHHHTT------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH------HHHHcC------
Confidence            55444434444567889999999999999999999999999999999 99998754432210      001100      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                         .....+..+...+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       236 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          236 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               0011112234568889999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.2e-40  Score=353.37  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=207.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||++++. .++.||||++...   .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999975 4889999998543   344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999843   346899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..........     .....      ..+.
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~------~~~~  231 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQD------SVPN  231 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-----HHHSS------CCCC
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhhc------cCCC
Confidence            22 122334578999999999999999999999999999999999999997544221100     00000      0011


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhcccC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEHA  791 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~  791 (835)
                      .........+..+.+++.+|++.+|++|| +++++.+.|+....
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11112223456788899999999999998 99999999988743

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=370.49  Aligned_cols=265  Identities=28%  Similarity=0.434  Sum_probs=216.3

Q ss_pred             hhcCCccccccccCCcccEEEEEec--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      ..++|++.++||+|+||.||+|+..        .+..||||++... .....+++.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4578999999999999999999863        2357999999765 344567899999999999 99999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999854321             245899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~  727 (835)
                      |+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||++ |..|+...+.... 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987654443344445677899999999999999999999999999999999 9999875442211 


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                       .    ..+....         ....+..+...+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus       303 -~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 -F----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             -H----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             -H----HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence             0    0111110         001112234568889999999999999999999999988754433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-40  Score=351.95  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=210.0

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            36899999999999999999999889999999997543 33467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            99999999954  2346899999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .......+|..|+|||.+.+..++.++||||||++++||++ |+.|+........  ..    .....  .....     
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~----~~~~~--~~~~~-----  228 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE----DISTG--FRLYK-----  228 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT--CCCCC-----
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHhcC--ccCCC-----
Confidence            12233456788999999999999999999999999999999 8999875432211  00    00000  00111     


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        +......+.+++.+|++.+|++||+++|+++.|+.+
T Consensus       229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence              111235678899999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-40  Score=360.39  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=206.4

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.+.||+|+||.||+|++ .+|+.||||++...  .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            347899999999999999999998 46899999998654  344567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999843   345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...+....  ..   .... ..      .
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~i~~-~~------~  231 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RE---RVLR-GK------Y  231 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-CC------C
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HH---HHHh-CC------C
Confidence            22   23456799999999999888775 799999999999999999999976442211  00   0000 00      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .    .+...+..+.+++.+||+.||++|||++|+++.
T Consensus       232 ~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 R----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0    111234567889999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-40  Score=360.47  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=213.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ..++|++.+.||+|+||.||+|+..      +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4578999999999999999999862      3578999999754 34556789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  643 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  643 (835)
                      .++||||+++++|.+++.....                     ...+++..+..++.||++||+|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999965322                     234889999999999999999999998   9999999


Q ss_pred             CCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 003264          644 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYD  722 (835)
Q Consensus       644 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~  722 (835)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999999 999987544


Q ss_pred             cccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          723 IESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ....  .    .......         ....+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       258 ~~~~--~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          258 PERL--F----NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GGGH--H----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH--H----HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2211  0    0111110         01111233456889999999999999999999999998763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.6e-41  Score=364.22  Aligned_cols=266  Identities=24%  Similarity=0.407  Sum_probs=196.5

Q ss_pred             HhhcCCccccccccCCcccEEEEEecCC----cEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ...++|++.+.||+|+||.||+|++...    ..||||++...  .....+++.+|+.++++++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3457899999999999999999987553    27999998754  34557889999999999999999999999988765


Q ss_pred             E------EEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          585 K------ILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       585 ~------~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      .      ++||||+++|+|.+++...   .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      9999999999999998532   12235899999999999999999999998   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........  ..    
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----  250 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN----  250 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH----
Confidence            9999999987654443333444567889999999999999999999999999999999 8999875442211  00    


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                      ......         ....+...+..+.+++.+||+.||++||++.|+++.|+++...+.
T Consensus       251 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          251 YLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            000000         001112234568899999999999999999999999998755443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-39  Score=356.35  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=203.2

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3468999999999999999999986 68999999987543 345678999999999999999999999987654      


Q ss_pred             ---------------------------------------------------eEEEEEEecCCCChhhhhcCCCCCCCCCH
Q 003264          584 ---------------------------------------------------EKILIYEYMPNKSLNFFLFDPSRTHLLGW  612 (835)
Q Consensus       584 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~  612 (835)
                                                                         ..++||||+++++|.+++..........+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999977655566777


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc----------cccccccccc
Q 003264          613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ----------GNTKRVVGTY  682 (835)
Q Consensus       613 ~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~  682 (835)
                      ..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            789999999999999999998   999999999999999999999999999876543211          1223457999


Q ss_pred             ceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHH
Q 003264          683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYI  762 (835)
Q Consensus       683 ~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  762 (835)
                      .|+|||++.+..++.++||||||+++|||++|..|+....    ...            ..... .............+.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~------------~~~~~-~~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RII------------TDVRN-LKFPLLFTQKYPQEH  303 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHH------------HHHHT-TCCCHHHHHHCHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHH------------HHhhc-cCCCcccccCChhHH
Confidence            9999999999999999999999999999999876632100    000            00000 011222334456678


Q ss_pred             HHHHhccccCCCCCCCHHHHHHH
Q 003264          763 TVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       763 ~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +++.+||+.||++||++.|+++.
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            89999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-39  Score=350.98  Aligned_cols=261  Identities=26%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHh--cCCCceeeEeeEEEec----CeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQ----GEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~  586 (835)
                      .++|++.+.||+|+||+||+|+. +++.||||++...   ..+.+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            47899999999999999999988 6899999998653   33555667777766  7999999999997653    4589


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                      +||||+++|+|.+++.    ...+++..+..++.||++||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    346899999999999999999999        665   9999999999999999999999


Q ss_pred             ccCccccccCCCcc--ccccccccccceeCceeecCC------CCCccccchhHHHHHHHHHhC----------CCCCCC
Q 003264          659 DFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTS----------KRNTGV  720 (835)
Q Consensus       659 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvl~elltG----------~~p~~~  720 (835)
                      |||+++........  .......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999876443221  112335799999999999876      455799999999999999999          666643


Q ss_pred             CCcccccccccchhhhccccchhccCcccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          721 YDIESFNLLGHAWNLWKDNRAYELLSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ............ ...    ......+... .......+..+.+++.+||+.||++||++.||++.|+.+
T Consensus       236 ~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDMR-KVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHHH-HHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhhh-HHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            321111110000 000    0011111111 123345677899999999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=369.84  Aligned_cols=261  Identities=28%  Similarity=0.428  Sum_probs=211.2

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+|++.      .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468999999999999999999853      3678999999654 445566789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEec
Q 003264          586 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS  658 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~  658 (835)
                      ++||||+++|+|.+++....    ....+++..++.++.||++||+|||+++   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999985422    2245889999999999999999999998   99999999999999555   59999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhc
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||........  ..    ...
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~----~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LE----FVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH
Confidence            9999987644433334445678999999999999999999999999999999998 9999875442211  10    000


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ...         ....+..++..+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            000         011112234567889999999999999999999999977643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.8e-40  Score=349.09  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=211.0

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+|+..++..||||++.... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            47899999999999999999999888899999997543 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus        86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999843  2345899999999999999999999998   999999999999999999999999999876433221


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                       ......+|..|+|||.+.+..++.++||||||++++||++ |+.||...........     ... .  .....+    
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-----~~~-~--~~~~~~----  227 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-----VSQ-G--HRLYRP----  227 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----HHT-T--CCCCCC----
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-----HHc-C--CCCCCC----
Confidence             2233456778999999999899999999999999999999 9999875442211000     000 0  011111    


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                         ...+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus       228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               1123467889999999999999999999999998743

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=362.93  Aligned_cols=266  Identities=25%  Similarity=0.426  Sum_probs=211.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      ...++|++.+.||+|+||.||+|++.      .++.||||++... .....+.+.+|+.++.++ +||||+++++++.+.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34578999999999999999999862      3568999999754 233457899999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRT--------------------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  642 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  642 (835)
                      +..++||||+++|+|.+++......                    ..+++..+..++.||++||+|||+++   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            9999999999999999999654321                    34789999999999999999999998   999999


Q ss_pred             CCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 003264          643 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVY  721 (835)
Q Consensus       643 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~  721 (835)
                      ||+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987654433333445667889999999999999999999999999999998 99998754


Q ss_pred             CcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      ..... .    .......         .....+......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus       279 ~~~~~-~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          279 PVDAN-F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCSHH-H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcHHH-H----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            42211 0    0011110         001111223456888999999999999999999999998875443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-40  Score=363.99  Aligned_cols=276  Identities=26%  Similarity=0.360  Sum_probs=213.7

Q ss_pred             hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEE--ecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  585 (835)
                      .++|++.+.||+|+||.||++++     ..++.||||++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            37899999999999999999984     357899999998777777788999999999999999999999987  45568


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999998532  235899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCc-cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDEL-QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ...... ........+|..|+|||++.+..++.++||||||+++|||++|+.|+.....+..................+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            643322 1223345678889999999999999999999999999999999999764332211111000000000011111


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      +........+..++..+.+++.+||+.+|++||+++|+++.|+.+....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1111111222344567889999999999999999999999999875544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.6e-40  Score=347.70  Aligned_cols=254  Identities=30%  Similarity=0.462  Sum_probs=197.8

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|++. ++.||||++....    ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999974 8899999986542    23357889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC--------CCCeEeccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------DMNPKISDF  660 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--------~~~~kl~DF  660 (835)
                      |||+++++|.+++.    ...+++..+..++.|+++||+|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    346899999999999999999999987666999999999999986        778999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      |+++......    .....||+.|+|||.+.+..++.++||||||++++||++|+.||...+......     .....  
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~--  229 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVAMN--  229 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHTS--
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhcC--
Confidence            9998653322    224578999999999999999999999999999999999999997544221100     00000  


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                             ......+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   001111122345688899999999999999999999999753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-39  Score=357.47  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=206.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ..++|++.+.||+|+||.||+++.. +|+.||||++.....      ...+.+.+|+.++.+++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3478999999999999999999986 489999999875432      135789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEeccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDF  660 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  660 (835)
                      .++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999943   346899999999999999999999998   99999999999998877    7999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      |+++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..   .. ... 
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~---~i-~~~-  233 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NI-TAV-  233 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HH-HTT-
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HH-Hhc-
Confidence            9998764322   23346799999999999999999999999999999999999999975432211  00   00 000 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                           ............+..+.+++.+||+.||++||++.|+++
T Consensus       234 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 -----SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 001111122234566889999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-40  Score=360.75  Aligned_cols=270  Identities=29%  Similarity=0.399  Sum_probs=210.6

Q ss_pred             CccccccccCCcccEEEEEec-----CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL  587 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  587 (835)
                      |++.++||+|+||.||++...     +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            499999999999999988642     57899999997653 34567899999999999999999999999984  57899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    34899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ..... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+........................+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43221 22334567889999999999899999999999999999999999986533221111111111111111111111


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      .......+..++..+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            1222222334456788999999999999999999999999887443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.6e-40  Score=378.21  Aligned_cols=259  Identities=27%  Similarity=0.422  Sum_probs=213.5

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..++|++.++||+|+||.||+|++.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+....++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45679999999999999999999865 8899999997543 346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999643 2345889999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      . .......++..|+|||++....++.++|||||||+||||++ |+.|+...+....  .    .....         ..
T Consensus       373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~---------~~  436 (495)
T 1opk_A          373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y----ELLEK---------DY  436 (495)
T ss_dssp             E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H----HHHHT---------TC
T ss_pred             e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHc---------CC
Confidence            2 12223456789999999999999999999999999999999 8999875442211  0    11111         11


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ....+..++..+.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            111122344678889999999999999999999999998743

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-40  Score=376.71  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=211.8

Q ss_pred             HhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ...++|++.++||+|+||.||+|++.++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3457899999999999999999999888999999997643 45688999999999999999999999986 667899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999542 1235788999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .. ......+|..|+|||++....++.++||||||++||||++ |+.|+........  ..    ....+  ...     
T Consensus       339 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~--~~~-----  404 (454)
T 1qcf_A          339 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IR----ALERG--YRM-----  404 (454)
T ss_dssp             HH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHHHT--CCC-----
T ss_pred             ee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC--CCC-----
Confidence            11 1223456789999999999999999999999999999999 9999875442211  00    00000  001     


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                        ..+..++..+.+++.+||+.+|++||++++|++.|+.+...
T Consensus       405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence              11123446788999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-39  Score=351.93  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=207.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+++... ++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            4789999999999999999999864 789999998754 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC--CCCeEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~  669 (835)
                      +++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999843  2346899999999999999999999998   999999999999987  789999999999876432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|..||........  ..   ......       ...
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~---~i~~~~-------~~~  222 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE---NIMNAE-------YTF  222 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHHTC-------CCC
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HH---HHHcCC-------CCC
Confidence            2   23346789999999999998899999999999999999999999975432211  00   000000       001


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+..+.+++.+|++.||++||++.|+++.
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111122345678899999999999999999999974

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.9e-39  Score=350.46  Aligned_cols=265  Identities=24%  Similarity=0.312  Sum_probs=203.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|++.++||+|+||+||+|++.+++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            457899999999999999999999889999999986542  233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++ +|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 67777643  2345899999999999999999999998   999999999999999999999999999875322


Q ss_pred             CccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-cc-c-------cchhhhcc-
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LL-G-------HAWNLWKD-  738 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~-~-------~~~~~~~~-  738 (835)
                        ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. .       ..+..... 
T Consensus       173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence              122334578999999999876 56899999999999999999999999764432210 00 0       00000000 


Q ss_pred             ----ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          739 ----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       739 ----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          ..................+...+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                0000011111111112233457889999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-39  Score=350.17  Aligned_cols=274  Identities=18%  Similarity=0.216  Sum_probs=218.3

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46899999999999999999996 458999999986442  234578899999999 89999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-----eEecccCcccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM  665 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~  665 (835)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999542  345899999999999999999999988   999999999999987776     99999999987


Q ss_pred             ccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhccc
Q 003264          666 FCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDN  739 (835)
Q Consensus       666 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~  739 (835)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~------  234 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------  234 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH------
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH------
Confidence            6543221     123456799999999999999999999999999999999999999976432211 1000000      


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  803 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  803 (835)
                         ....+.........++..+.+++.+|++.+|++||++++|++.|+++...+.......+.|
T Consensus       235 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          235 ---EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             ---HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             ---hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence               0000000011112345678899999999999999999999999998877776666665655

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=349.83  Aligned_cols=270  Identities=21%  Similarity=0.286  Sum_probs=213.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC--eEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  588 (835)
                      .++|++.++||+|+||+||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            4689999999999999999999865 8999999997543 344677889999999999999999999998765  78999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE----cCCCCeEecccCccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  664 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~  664 (835)
                      |||+++++|.+++........+++..+..++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976544455899999999999999999999998   9999999999999    788889999999998


Q ss_pred             cccCCCccccccccccccceeCceeec--------CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYAL--------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ......   ......||..|+|||++.        +..++.++|||||||++|||++|+.||.......... .......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~  240 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII  240 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHh
Confidence            764332   223456899999999886        5788999999999999999999999987543221110 0000000


Q ss_pred             ccc---c---chhc------c--CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          737 KDN---R---AYEL------L--SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       737 ~~~---~---~~~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ...   .   ....      .  ...............+.+++.+||+.||++||+++|+++...+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            000   0   0000      0  00111234466778889999999999999999999999998765

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.3e-40  Score=350.30  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..++|++.+.||+|+||.||+++..++..||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            457899999999999999999999888899999997543 2346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999542  345899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........  .   .. ...  .....    
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~--~---~~-~~~--~~~~~----  242 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--E---HI-AQG--LRLYR----  242 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--H---HH-HTT--CCCCC----
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH--H---HH-hcc--cCCCC----
Confidence             11223456788999999999999999999999999999998 99998764422110  0   00 000  00011    


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         +......+.+++.+||+.+|++||+++|+++.|.++
T Consensus       243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence               111235678899999999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=352.05  Aligned_cols=252  Identities=22%  Similarity=0.285  Sum_probs=206.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999985 489999999865422      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG  661 (835)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999943   356899999999999999999999998   99999999999999887    89999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|..||........  ...   . .    
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---~-~----  230 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN---V-S----  230 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH---H-H----
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH---H-H----
Confidence            998764322   22345799999999999999999999999999999999999999865432111  000   0 0    


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..............+..+.+++.+||+.||++||++.|+++.
T Consensus       231 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          231 --AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              000111111222344667899999999999999999999974

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.7e-40  Score=375.38  Aligned_cols=263  Identities=27%  Similarity=0.421  Sum_probs=208.1

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..++|++.++||+|+||.||+|++..+..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            457899999999999999999999888889999997643 345789999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++|+|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999431 2245889999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       .......++..|+|||.+....++.++||||||++||||++ |+.|+........  ..    ....+         ..
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~---------~~  399 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG---------YR  399 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTT---------CC
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC---------CC
Confidence             12223456789999999999999999999999999999999 8999875432211  10    00000         01


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCC
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  796 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p  796 (835)
                      ...+..++..+.+++.+||+.+|++||++++|++.|+.+.....+.
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            1112234567889999999999999999999999999886554443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.8e-40  Score=355.11  Aligned_cols=262  Identities=26%  Similarity=0.375  Sum_probs=212.9

Q ss_pred             hhcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      ..++|++.+.||+|+||.||+|++      ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            347899999999999999999985      246789999997653 34567899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSR---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ..++||||+++|+|.+++.....               ...+++..+..++.||++||+|||+++   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999864322               124899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~  727 (835)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999987654443333344567889999999999999999999999999999999 99998754422110


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                           ......     ...+    ..+...+..+.+++.+|++.||++||++.|+++.|++..
T Consensus       258 -----~~~~~~-----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          258 -----YKMIKE-----GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             -----HHHHHH-----TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHhcc-----CCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                 000000     0001    111123456888999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=349.45  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=196.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--------------------------hhHHHHHHHHHHHH
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------------------------QGLKEFKNEMMLIA  565 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~  565 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999975 488999999865421                          12356899999999


Q ss_pred             hcCCCceeeEeeEEEe--cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCC
Q 003264          566 KLQHRNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK  643 (835)
Q Consensus       566 ~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  643 (835)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..+..++.||++||+|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56889999999999998875    3346899999999999999999999998   9999999


Q ss_pred             CCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCC---CCccccchhHHHHHHHHHhCCCCCCC
Q 003264          644 ASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGV  720 (835)
Q Consensus       644 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvl~elltG~~p~~~  720 (835)
                      |+|||++.++.+||+|||+++.+....  .......||+.|+|||++.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998764332  1223457899999999997765   47889999999999999999999875


Q ss_pred             CCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          721 YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......  ..    ...... ...  +     .....+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~--~~----~~~~~~-~~~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCL--HS----KIKSQA-LEF--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHH--HH----HHHHCC-CCC--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHH--HH----HHhccc-CCC--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            332111  00    000000 000  0     01123356788999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-39  Score=356.17  Aligned_cols=249  Identities=21%  Similarity=0.270  Sum_probs=205.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999985 4899999999653   233467789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998843   346899999999999999999999998   99999999999999999999999999986422


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... ..      ..
T Consensus       158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~---~i~~-~~------~~  223 (337)
T 1o6l_A          158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE---LILM-EE------IR  223 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-CC------CC
T ss_pred             C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HH---HHHc-CC------CC
Confidence            2  1223456799999999999999999999999999999999999999875432211  00   0000 00      00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                          .+...+..+.+++.+||+.||++||     +++|+++.
T Consensus       224 ----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                1112345678899999999999999     89999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=351.52  Aligned_cols=264  Identities=27%  Similarity=0.445  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+++.. ++.||||++...  ...+.|.+|+.++++++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            367999999999999999999884 789999998643  34578999999999999999999999887  4589999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-eEecccCccccccCCCc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDEL  671 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~  671 (835)
                      ++++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976544445788999999999999999999943334999999999999998887 799999999765321  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........   +.... .     ..+... 
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~-----~~~~~~-  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHN-G-----TRPPLI-  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHT-T-----CCCCCB-
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhc-C-----CCCCcc-
Confidence               2234689999999999999999999999999999999999999875432221111   00000 0     011111 


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS  799 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~  799 (835)
                         ...+..+.+++.+||+.+|++||+++|+++.|+.+....+....+
T Consensus       227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence               123456788999999999999999999999999886666554443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-39  Score=370.79  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=206.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC-eEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  590 (835)
                      ..++|++.++||+|+||.||+|+.. ++.||||+++...  ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4578999999999999999999884 7899999997643  4578999999999999999999999988766 7899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999999643 2234789999999999999999999998   999999999999999999999999999854221 


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                          .....++..|+|||++.+..++.++||||||++||||++ |+.|+........  ..    ....+         .
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~---------~  403 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----RVEKG---------Y  403 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HH----HHHTT---------C
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC---------C
Confidence                122356889999999999999999999999999999998 9999875442211  00    01111         0


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111223456788899999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-39  Score=356.31  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=212.2

Q ss_pred             hhcCCccccccccCCcccEEEEEec--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      ..++|++.+.||+|+||.||+|++.        +++.||||++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        4678999999755 344567899999999999 99999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965432             234889999999999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~  727 (835)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence            99999999999999987654433333344567889999999998899999999999999999999 9999875432211 


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                       ..    ......     .+    ..+..+...+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       269 -~~----~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          269 -FK----LLKEGH-----RM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -HH----HHHHTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HH----HHhcCC-----CC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             00    000000     00    1112234567889999999999999999999999987743

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4e-40  Score=355.18  Aligned_cols=271  Identities=25%  Similarity=0.383  Sum_probs=206.9

Q ss_pred             cCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK  585 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  585 (835)
                      +.|++.+.||+|+||.||+|++     .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5689999999999999999983     35889999999754 334567899999999999999999999999877  668


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999843  2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+..........................
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6443221 223345688899999999999999999999999999999999988542211000000000000000001111


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +........+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            111111112223456788999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-40  Score=359.99  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ++|++.++||+|+||.||+|++.. ++    +||+|.+.... ....+.+.+|+.++.+++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            689999999999999999998744 44    38888875432 334456788999999999999999999886 567899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999998543  346889999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............+|..|+|||++.+..++.++||||||+++|||++ |+.||.........      .......  ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~--~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------DLLEKGE--RLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH------HHHHTTC--BCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH------HHHHcCC--CCCC
Confidence            5544444455678889999999999999999999999999999999 99998764422110      0011100  0000


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                             +......+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       239 -------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 -------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   11122346779999999999999999999999988744

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-39  Score=359.82  Aligned_cols=285  Identities=15%  Similarity=0.203  Sum_probs=213.6

Q ss_pred             hhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcChhhH-----------HHHHHHHHHHHhcCCCceee
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGL-----------KEFKNEMMLIAKLQHRNLVR  574 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~  574 (835)
                      ..++|++.++||+|+||.||+|++..      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998755      47899999876542211           12344666777888999999


Q ss_pred             EeeEEEec----CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          575 LMGCCVEQ----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       575 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      +++++.+.    ...+|||||+ +++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4589999999 9999999854  2356899999999999999999999998   99999999999999


Q ss_pred             --CCCCeEecccCccccccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCc
Q 003264          651 --SDMNPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDI  723 (835)
Q Consensus       651 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~  723 (835)
                        .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876433221     112335699999999999999999999999999999999999999974322


Q ss_pred             ccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003264          724 ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  803 (835)
Q Consensus       724 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  803 (835)
                      .... ........ .....+++++.+..   ...+..+.+++..|++.+|++||++.+|++.|+.+...+..+....+.|
T Consensus       267 ~~~~-~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          267 DPKY-VRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             CHHH-HHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             CHHH-HHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            2110 00000000 01111111111110   1224578889999999999999999999999998877777777666666


Q ss_pred             cccC
Q 003264          804 ARRG  807 (835)
Q Consensus       804 ~~~~  807 (835)
                      ....
T Consensus       342 ~~~~  345 (364)
T 3op5_A          342 SVVE  345 (364)
T ss_dssp             ----
T ss_pred             Eecc
Confidence            5443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.4e-40  Score=357.06  Aligned_cols=266  Identities=27%  Similarity=0.409  Sum_probs=214.6

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEE
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV  580 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  580 (835)
                      +.....++|++.+.||+|+||.||+|+..      .++.||||++.... .....++.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            44456689999999999999999999864      36789999997543 345567899999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          581 EQGEKILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       581 ~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      +.+..++||||+++|+|.+++....       ....+++..++.++.||++||+|||+++   |+||||||+|||++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence            9999999999999999999985321       1245789999999999999999999998   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........  ..  
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~--  251 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR--  251 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH--
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HH--
Confidence            999999999987654433333344567889999999999999999999999999999999 8888875432211  00  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                        .......         ...+...+..+.+++.+|++.+|++||++.|+++.|+....
T Consensus       252 --~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 --FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             --HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence              0000100         00112234567889999999999999999999999988633

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-39  Score=357.34  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=204.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999875 58999999985321     224678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecccCc
Q 003264          587 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM  662 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGl  662 (835)
                      +||||+++++|.+++... .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877432 12335889999999999999999999998   999999999999987655   99999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..    .+....  
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~i~~~~--  248 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FE----GIIKGK--  248 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HH----HHHHTC--
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HH----HHHcCC--
Confidence            98764332  12234579999999999999999999999999999999999999987532110   00    000000  


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          ...........+..+.+++.+||+.||++||++.|+++
T Consensus       249 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          249 ----YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                00011111233567889999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.7e-39  Score=346.74  Aligned_cols=262  Identities=29%  Similarity=0.462  Sum_probs=196.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|++.++||+|+||.||+|+..  ..||||++...  .....+.+.+|+.++++++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3478999999999999999999864  36999998654  345567899999999999999999999965 556789999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999853  3356899999999999999999999998   999999999999999999999999999866443


Q ss_pred             CccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ..........||+.|+|||.+.   ...++.++||||||+++|||++|+.||........ ..    .......    ..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~~~----~~  244 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----EMVGRGS----LS  244 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HH----HHHHHTS----CC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HH----HHhcccc----cC
Confidence            3333344567899999999986   56788999999999999999999999975432211 00    0000000    00


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      +.. ......++..+.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus       245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            100 01112334678899999999999999999999999998743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-39  Score=356.61  Aligned_cols=253  Identities=21%  Similarity=0.258  Sum_probs=207.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999985 4889999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC--CCCeEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~  669 (835)
                      +++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999853  2345899999999999999999999998   999999999999974  577999999999876433


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   ......       ...
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~---~i~~~~-------~~~  269 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQ---NVKRCD-------WEF  269 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HHHHCC-------CCC
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--HH---HHHhCC-------CCC
Confidence            2   22345789999999999999999999999999999999999999975432111  00   000000       000


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+..+.+++.+||+.||++||++.|+++.
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            111112234568899999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.9e-39  Score=344.04  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.++||+|+||+||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999985 4889999998654  23345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |++++.+..+..   ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred             cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence            998755444442   2356899999999999999999999998   999999999999999999999999999876322 


Q ss_pred             ccccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCCCccccccccc----------chhhhccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH----------AWNLWKDN  739 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~  739 (835)
                       ........||+.|+|||++.+.. ++.++|||||||+++||++|..|+.........+...          .+..+...
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence             22233457899999999998765 8999999999999999999988854322111100000          00000000


Q ss_pred             -c---chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 -R---AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 -~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .   ....................+.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             0   000000000011112344567899999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=357.49  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|++.+.||+|+||.||+|+... ++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34789999999999999999999754 899999999753   233456788999999998 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999843   345899999999999999999999998   999999999999999999999999999854


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... .   ..  
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~~-~---~~--  241 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE---AILN-D---EV--  241 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-C---CC--
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HH---HHHc-C---CC--
Confidence            222  2233456799999999999999999999999999999999999999975442211  00   0000 0   00  


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTM------SKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  784 (835)
                           ..+......+.+++.+||+.+|++||++      +|+++
T Consensus       242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 0111234567889999999999999998      77765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.6e-39  Score=358.41  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=201.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.++||+|+||.||+++... ++.||||++++..   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999865 7889999997542   23345678899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999998843   346899999999999999999999998   9999999999999999999999999998632


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc---cccchhhhccccchhc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL---LGHAWNLWKDNRAYEL  744 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~  744 (835)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .......+...     
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-----  277 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-----  277 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence            21  223445689999999999999999999999999999999999999996433211100   00000000000     


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTM------SKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  784 (835)
                       ..    ..+...+..+.+++.+||+.||++||++      .|+++
T Consensus       278 -~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          278 -QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -CC----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -cc----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence             00    1112244567889999999999999985      56654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.8e-39  Score=344.17  Aligned_cols=255  Identities=27%  Similarity=0.528  Sum_probs=203.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChh-------hHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+|++. +++.||||++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999985 5899999998654221       1267899999999999999999999986654 


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC-----eEecc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISD  659 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~D  659 (835)
                       ++||||+++++|.+++.+  ....+++..+..++.|+++||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999888854  3346899999999999999999999875 34999999999999988776     99999


Q ss_pred             cCccccccCCCccccccccccccceeCceee--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYA--LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      ||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||..............    .
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----R  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----H
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----h
Confidence            999975422     23346789999999998  445678999999999999999999999976543322111110    0


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .    ....+.    .+..++..+.+++.+||+.||++||+++|+++.|+++
T Consensus       244 ~----~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 E----EGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             H----SCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             c----cCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0    001111    1223345688999999999999999999999999763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-39  Score=344.58  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=199.7

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.+.||+|+||.||+|+...++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999999779999999986543  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 888887432  345889999999999999999999998   9999999999999999999999999998753221 


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccc--cc----cchhhhccccchhc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--LG----HAWNLWKDNRAYEL  744 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~~----~~~~~~~~~~~~~~  744 (835)
                       .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||..........  ..    .....+........
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             122345689999999998764 58999999999999999999999997644221100  00    00000000000000


Q ss_pred             cCccc-------cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPAL-------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .++..       ...........+.+++.+||+.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            01100       01111223456789999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-39  Score=352.47  Aligned_cols=269  Identities=26%  Similarity=0.418  Sum_probs=202.7

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      ++....++|++.+.||+|+||.||+|+...    ++.||||++...  .....+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            334456889999999999999999998643    458999998754  34456789999999999999999999999987


Q ss_pred             cC-----eEEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          582 QG-----EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       582 ~~-----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ..     ..++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence            65     359999999999999998432   23456899999999999999999999988   99999999999999999


Q ss_pred             CeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccc
Q 003264          654 NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHA  732 (835)
Q Consensus       654 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~  732 (835)
                      .+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........  ..  
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~--  260 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD--  260 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH--
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH--
Confidence            999999999987654433333444567889999999999999999999999999999999 8888865432211  00  


Q ss_pred             hhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          733 WNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       733 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                        ......     .+    ..+...+..+.+++.+||+.+|++||++.++++.|+.+...+|
T Consensus       261 --~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 --YLLHGH-----RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             --HHHTTC-----CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --HHHcCC-----CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              000000     00    1112234568899999999999999999999999998755544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=347.46  Aligned_cols=246  Identities=24%  Similarity=0.270  Sum_probs=195.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.++||+|+||+||+|++. +++.||||++...  ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999986 5899999998654  233444556666666665 999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+ +++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 66888887432  345899999999999999999999988   99999999999999999999999999987533


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....         +.        .+....
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~--------~~~~~~  268 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQ--------QLRQGY  268 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HH--------HHTTTC
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HH--------HHhccC
Confidence            22   2334568999999998875 799999999999999999999766542110         00        111111


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ............+.+++.+||+.||++||+++|+++.
T Consensus       269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1222333445678899999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-39  Score=352.07  Aligned_cols=269  Identities=26%  Similarity=0.378  Sum_probs=214.7

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEe
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLM  576 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~  576 (835)
                      .........++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445555678999999999999999999984      246789999997653 34557899999999999 799999999


Q ss_pred             eEEEecC-eEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecC
Q 003264          577 GCCVEQG-EKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL  642 (835)
Q Consensus       577 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  642 (835)
                      +++.+.+ ..++||||+++++|.+++.....             ...+++..+..++.||++||+|||+++   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9988765 58999999999999999965432             223789999999999999999999998   999999


Q ss_pred             CCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 003264          643 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVY  721 (835)
Q Consensus       643 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~  721 (835)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333445667899999999999999999999999999999998 99998754


Q ss_pred             CcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          722 DIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ..... ..    .......     ....    +......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       255 ~~~~~-~~----~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEE-FC----RRLKEGT-----RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHH-HH----HHHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHH-HH----HHhccCc-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            32211 00    0001000     0011    1123456788999999999999999999999998763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.9e-39  Score=354.41  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=205.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999999999975 4899999999654  344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~  665 (835)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++   .+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998843   346899999999999999999999998   99999999999998654   599999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .+.... ... 
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~----~i~~~~-~~~-  249 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA----QIKAGA-YDY-  249 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC-CCC-
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHhCC-CCC-
Confidence            64322   22346799999999999999999999999999999999999999875432111  00    000000 000 


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ........+..+.+++.+||+.||++||++.|+++.
T Consensus       250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                011112234567889999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-39  Score=352.81  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=198.8

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe----
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  584 (835)
                      .++|++.+.||+|+||.||++++ .+++.||||++...   .....+.+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            47899999999999999999997 45889999999754   23445678999999999999999999999887653    


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4999999999999999843   345899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          665 MFCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       665 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........     ......    
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~----  235 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVRED----  235 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHCC----
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhcCC----
Confidence            76433221 22334578999999999999999999999999999999999999997544221100     000000    


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHH-HHHhhcccCC
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV-VSMITNEHAT  792 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-l~~L~~~~~~  792 (835)
                         +..........+..+.+++.+||+.||++||++.++ .+.|......
T Consensus       236 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          236 ---PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ---CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ---CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence               000011112245668899999999999999965554 4556555333

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=363.82  Aligned_cols=255  Identities=23%  Similarity=0.313  Sum_probs=205.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ...++|++.+.||+|+||.||+++.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34578999999999999999999874 58899999986543  3455678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc---CCCCeEecccCccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR  664 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~  664 (835)
                      ||||+++|+|.+.+..   ...+++..+..++.||++||+|||+++   |+||||||+|||++   .++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999988853   345899999999999999999999998   99999999999998   46789999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|..||...+....  ..    .+..+. ...
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~-~~~  232 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ----QIKAGA-YDF  232 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTC-CCC
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhCC-CCC
Confidence            764332  222346799999999999999999999999999999999999999875432211  00    000000 001


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..     ......+..+.+++.+||+.||++||++.|+++.
T Consensus       233 ~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Cc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11     1111234567889999999999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=356.39  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCC--CceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++.+....++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35789999999999999999999988999999998643  34556789999999999976  999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||| +.+++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 568899999853   346889999999999999999999998   99999999999997 6789999999998765


Q ss_pred             CCCccccccccccccceeCceeecC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........         
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------  229 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------  229 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---------
Confidence            4443333445679999999999865           67899999999999999999999998643211100         


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ....+++......+......+.+++.+||+.||++||++.|+++.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                011111111111111123467889999999999999999999865

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.5e-39  Score=345.50  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=196.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            34789999999999999999998743    457999998754 344567899999999999999999999997 456789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999998532  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ...... ......+++.|+|||.+....++.++||||||+++|||++ |..||........  ..    ......     
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~----~i~~~~-----  234 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE-----  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTC-----
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH----HHHcCC-----
Confidence            433211 2223456789999999998999999999999999999997 8999875432211  00    000000     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ..    ..+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       235 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00    11123345678899999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.4e-39  Score=346.60  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=213.4

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ...++|++.+.||+|+||.||+|++.. ++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            356789999999999999999999865 889999999754 345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999543 2345899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      . ........+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...+.....      .....         .
T Consensus       165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~------~~~~~---------~  228 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEK---------D  228 (288)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------HHHHT---------T
T ss_pred             c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhc---------c
Confidence            2 222334567889999999999999999999999999999999 89998754422110      00000         0


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .....+...+..+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            011111223456889999999999999999999999998763

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-38  Score=355.59  Aligned_cols=270  Identities=18%  Similarity=0.253  Sum_probs=206.7

Q ss_pred             hhcCCccccccccC--CcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|++.++||+|  +||.||+++.. +++.||||++...  .....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34789999999999  99999999986 5899999998654  2445677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++... ....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998543 2245899999999999999999999998   999999999999999999999999998754


Q ss_pred             cCCC-----ccccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh---hh
Q 003264          667 CGDE-----LQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN---LW  736 (835)
Q Consensus       667 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~---~~  736 (835)
                      ....     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...+............   ..
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            3221     1112233478999999999987  679999999999999999999999997644322111000000   00


Q ss_pred             cc-----cc-------------chhccC---------ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 KD-----NR-------------AYELLS---------PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~~-----~~-------------~~~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..     ..             ..+...         ..............+.+|+.+||+.||++||+++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00     00             000000         000011223345678899999999999999999999865

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=356.72  Aligned_cols=263  Identities=28%  Similarity=0.415  Sum_probs=211.1

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      ....++|++.+.||+|+||.||+|+...      .+.||||++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3446889999999999999999998743      2479999997653 34567899999999999 89999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  650 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~  650 (835)
                      .+..++||||+++|+|.+++....           ....+++..+..++.||++||+|||+++   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999985321           1345789999999999999999999998   99999999999999


Q ss_pred             CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCccccccc
Q 003264          651 SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLL  729 (835)
Q Consensus       651 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  729 (835)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........ . 
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~-  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-F-  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-H-
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-H-
Confidence            999999999999987644433333344567889999999999999999999999999999999 8889875432211 0 


Q ss_pred             ccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          730 GHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         .......     ....    .+...+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus       277 ---~~~~~~~-----~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 ---YKLVKDG-----YQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---HHHHHHT-----CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcC-----CCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               0000000     0000    1111235678899999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-39  Score=342.52  Aligned_cols=256  Identities=28%  Similarity=0.444  Sum_probs=209.7

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+++..+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            36899999999999999999999888999999997643 23477899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++...  ...+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999998542  345889999999999999999999998   99999999999999999999999999987543211 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.|+........  ..   .. ...  .....     
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~---~i-~~~--~~~~~-----  226 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE---DI-STG--FRLYK-----  226 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH---HH-HTT--CCCCC-----
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HH---HH-hcC--CcCCC-----
Confidence            11223456789999999998999999999999999999999 8999875432211  00   00 000  00011     


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                        +...+..+.+++.+|++.+|++||+++|+++.|+.+.
T Consensus       227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              1122456788999999999999999999999998763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-39  Score=342.15  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=209.4

Q ss_pred             hcCCcccc-ccccCCcccEEEEEec---CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|.+.+ .||+|+||.||+|++.   .++.||||++... .....+++.+|+.++.+++||||+++++++ +.+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35677776 9999999999999863   4778999999765 344567899999999999999999999999 5667999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999853  3445899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........  ..    ......     
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~i~~~~-----  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK-----  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTC-----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHhcCC-----
Confidence            33221 22233456889999999988899999999999999999998 9999875442211  00    000000     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                          ....+...+..+.+++..||+.+|++||++.|+++.|+.+...
T Consensus       231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                0111123446788899999999999999999999999877443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=347.74  Aligned_cols=277  Identities=24%  Similarity=0.342  Sum_probs=203.3

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc--CCCceeeEeeEEEec---
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL--QHRNLVRLMGCCVEQ---  582 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~---  582 (835)
                      ......++|++.++||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++.+.   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            34445689999999999999999999985 8999999986432   23445555555554  999999999999987   


Q ss_pred             -CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEEecCCCCeEEEcCCCCeE
Q 003264          583 -GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       583 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                       ...++||||+++|+|.+++..    ..+++..+..++.|++.||+|||++.     +.+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence             789999999999999999943    35899999999999999999999871     12399999999999999999999


Q ss_pred             ecccCccccccCCCccc--cccccccccceeCceeecCCCCCcc------ccchhHHHHHHHHHhCCCCCCCCCcccccc
Q 003264          657 ISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEYALDGLFSVK------SDVFSFGVLLLETLTSKRNTGVYDIESFNL  728 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlGvvl~elltG~~p~~~~~~~~~~~  728 (835)
                      |+|||+++.+.......  ......||+.|+|||++.+.....+      +|||||||++|||++|..|+..........
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997764332211  1224579999999999988776665      999999999999999954433211111100


Q ss_pred             ccc-----chhhhccccchhccCccccc-hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          729 LGH-----AWNLWKDNRAYELLSPALQH-EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       729 ~~~-----~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      ...     ...............+.... .....++..+.+++.+||+.||++||++.||++.|+.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            000     00000000001111122211 12336778899999999999999999999999999887443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-38  Score=349.17  Aligned_cols=253  Identities=20%  Similarity=0.301  Sum_probs=202.6

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+++... ++.||||++...   .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            679999999999999999999864 889999999754   334566788999999988 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999843   346899999999999999999999998   99999999999999999999999999986422


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc---cccchhhhccccchhcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL---LGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  745 (835)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .......+....     
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            1  122345689999999999999999999999999999999999999996532211100   000000000000     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTM------SKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  784 (835)
                       ..    .+...+..+.+++.+||+.||++||++      .|+++
T Consensus       236 -~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 -IR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -CC----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence             01    112234567889999999999999995      56664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=353.37  Aligned_cols=258  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|++.++||+|+||.||+|++.. ++    +||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            3689999999999999999999743 44    4688887543 3446788999999999999999999999998754 88


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +|+||+++|+|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998542  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..........      ......     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~~~-----  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGE-----  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTC-----
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHcCC-----
Confidence            54443333344567889999999999999999999999999999999 999997644322110      000000     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                          ....+......+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                011112234467889999999999999999999999988743

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=354.33  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++... ++.||||++....   ....+.+.+|+.++..++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3689999999999999999999754 8899999986432   33457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999953   346899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .   .......||+.|+|||++..   ..++.++|||||||++|||++|+.||............   ......      
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~------  235 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETT------  235 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHHC------
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhhc------
Confidence            2   22345679999999999864   45899999999999999999999999754322111000   000000      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPT-MSKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  784 (835)
                      .    ...+...+..+.+++.+||+.+|++||+ ++++++
T Consensus       236 ~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 V----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             c----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0    0111223467889999999999999998 777764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-39  Score=347.20  Aligned_cols=251  Identities=22%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcccEEEEEecC-C-------cEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-G-------QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3689999999999999999998754 3       4799999987666777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC--------eE
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PK  656 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~k  656 (835)
                      .++||||+++++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999542  334899999999999999999999998   999999999999998887        99


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCC-CCCCCcccccccccchh
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWN  734 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~  734 (835)
                      |+|||++.....      .....++..|+|||++.+ ..++.++||||||+++|||++|..| +...+.... .     .
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~-----~  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-L-----Q  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-H-----H
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-H-----H
Confidence            999999875422      233567899999999987 7799999999999999999996554 433221110 0     0


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .....       ..+..    .....+.+++.+||+.||++||++.|+++.|+.+..
T Consensus       230 ~~~~~-------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYEDR-------HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHTT-------CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             Hhhcc-------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            00000       00000    112347789999999999999999999999998744

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-39  Score=351.87  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|++ .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999997 458999999986432   22346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+ +|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788887743   345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........  ....    ...   .    
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i----~~~---~----  224 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKV----NSC---V----  224 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCC----CSS---C----
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHH----HcC---C----
Confidence            32   2234579999999999988776 7899999999999999999999975432211  0000    000   0    


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ...+...+..+.+++.+||+.||++|||++|+++.
T Consensus       225 ---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 ---YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ---CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ---CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               00111234567889999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-38  Score=336.76  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=206.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            468999999999999999999985 5899999998644 23456788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999843   346899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             ccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .........|+..|+|||.+.+..+ +.++||||||++++||++|+.||............     +.....  ..    
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~--~~----  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--YL----  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-----HHTTCT--TS----
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----hhhccc--cc----
Confidence            2233345678999999999987765 77899999999999999999999764432211111     111000  00    


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        .........+.+++.+|++.||++||+++|+++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              011123456788999999999999999999886

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.8e-39  Score=340.61  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=205.6

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec--CeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|++. ++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            368999999999999999999984 889999998754  344567899999999999999999999999887  788999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++... ....+++..+..++.||++||+|||+++ ..|+||||||+|||++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999653 2335899999999999999999999864 459999999999999999999999888875432 


Q ss_pred             CCccccccccccccceeCceeecCCCCCc---cccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSV---KSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                            .....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||..........     ....     ...
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~-----~~~  228 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-----KVAL-----EGL  228 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-----HHHH-----SCC
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-----HHHh-----cCC
Confidence                  12346799999999998765554   7999999999999999999997544221100     0000     001


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .+..    +...+..+.+++..||+.+|++||+++|+++.|+.+.
T Consensus       229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          229 RPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111    1223456888999999999999999999999998873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=347.03  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=204.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999985 58999999986542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999953   345889999999999999999999988   99999999999999999999999999986532


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                           ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  .   .......       ..
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~i~~~~-------~~  221 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--Y---EKILNAE-------LR  221 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHHCC-------CC
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--H---HHHHhCC-------CC
Confidence                 22346799999999999999999999999999999999999999975432111  0   0000000       00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                          .+......+.+++.+|++.+|++||     +++|+++.
T Consensus       222 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          222 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                1112345678899999999999999     88998853

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.8e-39  Score=342.72  Aligned_cols=257  Identities=31%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            47899999999999999999999888899999997543 34578999999999999999999999876 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            999999998432 1125889999999999999999999998   99999999999999999999999999987643322 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccc
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH  751 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  751 (835)
                      .......++..|+|||.+.+..++.++||||||++++||++ |+.|+........  ..    .....     ....   
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----~~~~~-----~~~~---  230 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQ----NLERG-----YRMV---  230 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTT-----CCCC---
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--HH----HHhcc-----cCCC---
Confidence            12233456789999999998899999999999999999999 8999875432211  00    00000     0000   


Q ss_pred             hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                       .+...+..+.+++.+|++.+|++||++.++++.|+.+..
T Consensus       231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             111234568889999999999999999999999988643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.8e-39  Score=359.20  Aligned_cols=252  Identities=24%  Similarity=0.309  Sum_probs=197.9

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcC--CCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||++....++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4679999999999999999999888999999998643  3456678999999999996  59999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      || +.+++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 678899999854   236788999999999999999999988   99999999999995 68999999999987654


Q ss_pred             CCccccccccccccceeCceeecC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      ...........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.........+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---------  277 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------  277 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---------
Confidence            433333345679999999999865           468999999999999999999999996432111000         


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ..++++......+......+.+++.+||+.||++||++.|+++.
T Consensus       278 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                01111111111111113467889999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-39  Score=365.22  Aligned_cols=263  Identities=19%  Similarity=0.248  Sum_probs=208.5

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      +..+....++|++.++||+|+||+||+|++.. ++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555567899999999999999999999865 7889999986532   1223348899999999999999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      .+..++||||+++|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999542  346899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      +++....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....  ..   ...
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~---~i~  294 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIM  294 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHH
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HH---hhh
Confidence            9987643322 1223467999999999987     56799999999999999999999999975442211  00   000


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                      ...  ..+.-|...    ...+..+.+++.+|++.+|++  ||+++|+++.
T Consensus       295 ~~~--~~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHK--ERFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THH--HHCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hcc--ccccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            000  001111110    113456788999999888888  9999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=377.52  Aligned_cols=261  Identities=28%  Similarity=0.429  Sum_probs=211.6

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ..++|++.++||+|+||.||+|++..+..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+|||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            457899999999999999999999888899999997643 345789999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999431 2245889999999999999999999998   99999999999999999999999999987643221


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                       .......++..|+|||++....++.++|||||||+||||++ |+.||........  ..    .....         ..
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~----~i~~~---------~~  482 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERG---------YR  482 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HH----HHHTT---------CC
T ss_pred             -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC---------CC
Confidence             11223456789999999999999999999999999999999 8999875432211  10    00000         00


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                      ...+..+...+.+|+.+||+.+|++||++++|+++|+.+.....
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            11112344568889999999999999999999999998855443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=350.91  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=190.8

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ...++|++.+.||+|+||.||+|+... ++.||||++....  ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            345789999999999999999999864 7899999997543  3467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCccccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~  666 (835)
                      ||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999843   345899999999999999999999998   999999999999975   889999999999875


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||............    . .... .... 
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----i-~~~~-~~~~-  271 (349)
T 2w4o_A          202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR----I-LNCE-YYFI-  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH----H-HTTC-CCCC-
T ss_pred             Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH----H-HhCC-CccC-
Confidence            3321   223457899999999999999999999999999999999999998654322111100    0 0000 0000 


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          .......+..+.+++.+||+.||++||++.|+++.
T Consensus       272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                11112234567899999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=350.68  Aligned_cols=266  Identities=17%  Similarity=0.201  Sum_probs=200.6

Q ss_pred             hcCCccccccccCCcccEEEEEec----CCcEEEEEEecCcChh-----------hHHHHHHHHHHHHhcCCCceeeEee
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      .++|++.+.||+|+||.||+|+..    .+..||||++......           ..+.+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999985    4678999998754321           1233667889999999999999999


Q ss_pred             EEEe----cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC
Q 003264          578 CCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  653 (835)
Q Consensus       578 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  653 (835)
                      ++.+    ....++||||+ +++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67899999999 9999999853   237899999999999999999999998   99999999999999887


Q ss_pred             --CeEecccCccccccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc
Q 003264          654 --NPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  726 (835)
Q Consensus       654 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~  726 (835)
                        .+||+|||+++.+......     .......||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876433211     112445799999999999999999999999999999999999999964221111


Q ss_pred             cccccchhhhccccchhccCccccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ......      ......+.+.+... .....+..+.+++..||+.+|++||++++|++.|+....
T Consensus       269 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAK------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHH------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHH------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111000      00000000000000 000344578899999999999999999999999988644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=352.57  Aligned_cols=247  Identities=25%  Similarity=0.309  Sum_probs=197.6

Q ss_pred             cccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCCCC
Q 003264          518 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      ..+.||+|+||.||+|+.. +|+.||||++........+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3578999999999999875 589999999987766677889999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE--cCCCCeEecccCccccccCCCcccc
Q 003264          597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMNPKISDFGMARMFCGDELQGN  674 (835)
Q Consensus       597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~  674 (835)
                      |.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....   .
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9988853  2345889999999999999999999998   9999999999999  567889999999998764332   2


Q ss_pred             ccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhH
Q 003264          675 TKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS  754 (835)
Q Consensus       675 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  754 (835)
                      .....||+.|+|||++....++.++|||||||++|||++|+.||...+....  ..   ......       ........
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~---~i~~~~-------~~~~~~~~  312 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN---NILACR-------WDLEDEEF  312 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHHTC-------CCSCSGGG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHhcc-------CCCChhhh
Confidence            2334689999999999999999999999999999999999999975442211  00   000000       00011111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          755 YQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       755 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......+.+++.+||+.+|++||++.|+++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            223467889999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-38  Score=349.97  Aligned_cols=263  Identities=19%  Similarity=0.206  Sum_probs=203.1

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      ++....++|++.+.||+|+||.||+|+.. +++.||||++...     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34556789999999999999999999975 4789999998643     23456789999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPS-------------------------------------RTHLLGWQTRVKIIEGIAQ  624 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  624 (835)
                      .+..++||||+++|+|.+++....                                     ....+++..+..++.||++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884210                                     0112356778899999999


Q ss_pred             HHHHHHhcCCCcEEEecCCCCeEEEcCCC--CeEecccCccccccCCCc--cccccccccccceeCceeecC--CCCCcc
Q 003264          625 GLLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARMFCGDEL--QGNTKRVVGTYGYMSPEYALD--GLFSVK  698 (835)
Q Consensus       625 ~L~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~k  698 (835)
                      ||+|||+.+   |+||||||+|||++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998776  899999999987643221  112345679999999999865  678999


Q ss_pred             ccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCC
Q 003264          699 SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT  778 (835)
Q Consensus       699 sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  778 (835)
                      +||||||+++|||++|+.||.........     ........  .     ............+.+++.+||+.+|++||+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~--~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI-----SQVLNKKL--C-----FENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCCC--C-----TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHhccc--c-----cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            99999999999999999999754422110     00111000  0     011111123456888999999999999999


Q ss_pred             HHHHHHH
Q 003264          779 MSKVVSM  785 (835)
Q Consensus       779 ~~evl~~  785 (835)
                      +.|+++.
T Consensus       325 ~~~~l~h  331 (345)
T 3hko_A          325 AMRALQH  331 (345)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.7e-39  Score=346.95  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=206.9

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~  586 (835)
                      ..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            457899999999999999999997 4589999999876666777889999999999999999999999873    34789


Q ss_pred             EEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          587 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      +||||+++++|.+++... .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988542 12456899999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCcc-------ccccccccccceeCceeecCCC---CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh
Q 003264          666 FCGDELQ-------GNTKRVVGTYGYMSPEYALDGL---FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  735 (835)
Q Consensus       666 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  735 (835)
                      .......       .......||+.|+|||++....   ++.++||||||+++|||++|+.||............    .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~  259 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----A  259 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----H
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----H
Confidence            5321111       0112345799999999987654   789999999999999999999998532111100000    0


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ...         ..........+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            000         00000112234568899999999999999999999999998743

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-38  Score=352.99  Aligned_cols=253  Identities=22%  Similarity=0.265  Sum_probs=193.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            478999999999999999999986 58899999997543 2336688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC--eEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~  669 (835)
                      +++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999843   345899999999999999999999998   999999999999987765  999999999753221


Q ss_pred             CccccccccccccceeCceeecCCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVK-SDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                         .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ......         ......
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~---------~~~~~~  238 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQ---------RILSVK  238 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHH---------HHHTTC
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHH---------HHhcCC
Confidence               22234579999999999988888766 8999999999999999999975432211 000000         000000


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+..+.+++.+||+.+|++|||+.|+++.
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0000111234567889999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-39  Score=351.15  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      .++|++.+.||+|+||.||+|+...     +..||||++... .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678889999999999999998753     236999999754 3445667999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++++|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999853  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          667 CGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       667 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........  ..    .....     
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----~~~~~-----  266 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MK----AINDG-----  266 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT-----
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHHCC-----
Confidence            433211 11223346789999999999999999999999999999999 9999865432211  00    00000     


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                          .....+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0001112234568889999999999999999999999987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-39  Score=362.89  Aligned_cols=259  Identities=20%  Similarity=0.247  Sum_probs=206.8

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  582 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  582 (835)
                      ..+....++|++.++||+|+||+||+|+... ++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3445566899999999999999999999865 8899999986431   12234578999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      +..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999843    35889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCC----CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhcc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGL----FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKD  738 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  738 (835)
                      ++.+..... .......||+.|+|||++.+..    ++.++|||||||+||||++|+.||...+....  .   ......
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~---~~i~~~  288 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y---SKIMNH  288 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHTH
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--H---HHHHhc
Confidence            987643321 1233567999999999998765    88999999999999999999999975442211  0   000000


Q ss_pred             ccchhccCccccchhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003264          739 NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAAD--RPTMSKVVSM  785 (835)
Q Consensus       739 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  785 (835)
                      ..  .+..|     .....+..+.+++.+||+.+|.+  ||+++||++.
T Consensus       289 ~~--~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 KN--SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HH--HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cc--cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00  00000     01123456788999999999988  9999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-39  Score=353.44  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  585 (835)
                      ...++|++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34589999999999999999999985 48899999997542   23456788899999987 999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999843   345899999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .+...      
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~------  233 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH----SIRMD------  233 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHHhC------
Confidence            43221  223456899999999999999999999999999999999999999975442211  00    00000      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMS-KVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  784 (835)
                      .+..    +......+.+++.+||+.+|++||++. |+++
T Consensus       234 ~~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            0111    112345678899999999999999998 6653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-38  Score=337.49  Aligned_cols=251  Identities=19%  Similarity=0.292  Sum_probs=205.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..++|++.+.||+|+||.||+|+... +..||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34689999999999999999999865 77999999977655667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~  667 (835)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||+   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999988843   345899999999999999999999998   9999999999999   788999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...   ......||+.|+|||.+.+ .++.++||||||++++||++|+.||........  ..    .....      ..
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~------~~  224 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--ML----KIREG------TF  224 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------CC
T ss_pred             Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHhC------CC
Confidence            332   2234568999999998765 489999999999999999999999875442211  00    00000      00


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..........+..+.+++.+|++.+|++||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0111111134567889999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.9e-39  Score=345.82  Aligned_cols=268  Identities=24%  Similarity=0.385  Sum_probs=201.6

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...   .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            467999999999999999999974 5899999998753   344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |||+++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988532 12355889999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.........+...    ......     +
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-----~  256 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDY-----P  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCS-----C
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccC-----C
Confidence            322  12234568999999999999999999999999999999999999986433221111100    000000     0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCC
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPK  797 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~  797 (835)
                      ...   .......+.+++.+||+.||++||++.+|++.|+.+.+....|+
T Consensus       257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            110   11234568889999999999999999999999998865544443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=341.93  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=200.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|++.++||+|+||.||+|++.. ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            689999999999999999999864 8999999986543  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|..++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999988743   345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-ccc--------chhhhcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGH--------AWNLWKDNR  740 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~--------~~~~~~~~~  740 (835)
                        .......||..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ...        ....+....
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence              12234578999999999876 678999999999999999999999997654321100 000        000000000


Q ss_pred             c---hhccCccccch---hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 A---YELLSPALQHE---ASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~---~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   ....++.....   .....+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0   00111100000   011244568899999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=352.66  Aligned_cols=267  Identities=23%  Similarity=0.271  Sum_probs=194.2

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEe------
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE------  581 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~------  581 (835)
                      .....+|++.++||+|+||.||+|++. +++.||||++........+.+.+|+.++.++. ||||+++++++..      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            344578999999999999999999975 58999999987666667788999999999995 9999999999953      


Q ss_pred             --cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecc
Q 003264          582 --QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  659 (835)
Q Consensus       582 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  659 (835)
                        ....++||||++ |+|.+++........+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence              335799999996 788888754334456899999999999999999999874 3599999999999999999999999


Q ss_pred             cCccccccCCCcc----------ccccccccccceeCceee---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc
Q 003264          660 FGMARMFCGDELQ----------GNTKRVVGTYGYMSPEYA---LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  726 (835)
Q Consensus       660 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~  726 (835)
                      ||+++........          .......||+.|+|||++   .+..++.++||||||+++|||++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9999876433211          111235689999999998   566789999999999999999999999864332111


Q ss_pred             cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCC
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  796 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p  796 (835)
                        ..       ..  ...       .........+.+++.+||+.+|++||++.|+++.|+.+....+.+
T Consensus       262 --~~-------~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          262 --VN-------GK--YSI-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ---------------CCC-------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             --hc-------Cc--ccC-------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence              00       00  000       000111233678999999999999999999999998876544433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-38  Score=354.87  Aligned_cols=265  Identities=22%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecC--e
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG--E  584 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~  584 (835)
                      ...++|++.+.||+|+||.||+|++. +++.||||++...  .....+++.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34579999999999999999999875 5899999998643  3445677889999999997 999999999998654  7


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||++ ++|..++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 588888843    46889999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCC-------------------ccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcc
Q 003264          665 MFCGDE-------------------LQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  724 (835)
Q Consensus       665 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~  724 (835)
                      .+....                   .........||+.|+|||++.+ ..++.++|||||||+++||++|++||...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            753311                   1112234679999999999987 67899999999999999999999999765422


Q ss_pred             cccccccchhhhccc---cchhcc------------------Cccccchh------------HHHHHHHHHHHHHhcccc
Q 003264          725 SFNLLGHAWNLWKDN---RAYELL------------------SPALQHEA------------SYQMLNRYITVALLCVQE  771 (835)
Q Consensus       725 ~~~~~~~~~~~~~~~---~~~~~~------------------~~~l~~~~------------~~~~~~~l~~li~~cl~~  771 (835)
                      ..  ...........   ......                  ........            .......+.+|+.+||+.
T Consensus       238 ~~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          238 NQ--LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HH--HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HH--HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            11  00000000000   000000                  00000000            002245688999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 003264          772 KAADRPTMSKVVSM  785 (835)
Q Consensus       772 dP~~RPs~~evl~~  785 (835)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999865

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-38  Score=350.71  Aligned_cols=245  Identities=21%  Similarity=0.232  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999985 58999999986542   234577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999853   245899999999999999999999998   999999999999999999999999999875332


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .+....      .. 
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~~------~~-  256 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YE----KIVSGK------VR-  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------CC-
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--HH----HHHcCC------CC-
Confidence                 2346799999999999999999999999999999999999999875432111  00    000000      00 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                         .+...+..+.+++.+||+.||++||+     ++|+++.
T Consensus       257 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence               11123456889999999999999998     8888754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-38  Score=340.07  Aligned_cols=275  Identities=19%  Similarity=0.263  Sum_probs=213.6

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEE-EecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC-VEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+++.+|+.++.+++|++++..+..+ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            47899999999999999999997 5689999999865432  24688999999999888766655555 56678899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~  667 (835)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998532  345899999999999999999999998   9999999999999   488999999999998765


Q ss_pred             CCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhccccc
Q 003264          668 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRA  741 (835)
Q Consensus       668 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~  741 (835)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......    .....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~  235 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----SEKKM  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH----HHHHH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh----ccccc
Confidence            43321     122456799999999999999999999999999999999999999976432211 111000    00000


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  804 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  804 (835)
                       ...    ........+..+.+++.+||+.+|++||+++++++.|+.+......+....+.|.
T Consensus       236 -~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          236 -STP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             -HSC----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             -CCc----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence             000    0011122346788999999999999999999999999988776666655555553

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-38  Score=344.84  Aligned_cols=267  Identities=25%  Similarity=0.339  Sum_probs=189.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999875 48999999986543 2344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |++ ++|.+++...   .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888887432   12245889999999999999999999998   9999999999999999999999999998763


Q ss_pred             CCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c---c-chhhhcccc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G---H-AWNLWKDNR  740 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~---~-~~~~~~~~~  740 (835)
                      ...  .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ... .   . ....+....
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            221  12234578999999999876 4689999999999999999999999976542211 000 0   0 000000000


Q ss_pred             chhccCcc------------ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 AYELLSPA------------LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 ~~~~~~~~------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......+.            +...........+.+++.+||+.||++||+++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00000000            0000111234578899999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.6e-38  Score=342.51  Aligned_cols=252  Identities=23%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++.....      ...+++.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999986 489999999865422      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG  661 (835)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999953   345889999999999999999999998   99999999999999888    79999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..   .. ...  
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~i-~~~--  233 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NI-TSV--  233 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HH-HTT--
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HH-Hhc--
Confidence            998764322   22345689999999999999999999999999999999999999875432211  00   00 000  


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ............+..+.+++.+|++.||++||++.|+++.
T Consensus       234 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          234 ----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0011111222344568899999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-38  Score=344.11  Aligned_cols=266  Identities=21%  Similarity=0.246  Sum_probs=200.1

Q ss_pred             hcCCccc-cccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3678885 78999999999999964 5899999999776656678899999999985 7999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecccCccccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~  666 (835)
                      ||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||+++..
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999853   345889999999999999999999998   999999999999988776   999999999865


Q ss_pred             cCCCc-----cccccccccccceeCceeecC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc-hhh
Q 003264          667 CGDEL-----QGNTKRVVGTYGYMSPEYALD-----GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNL  735 (835)
Q Consensus       667 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~  735 (835)
                      .....     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||.............. ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223568999999999875     5688999999999999999999999976442211000000 000


Q ss_pred             hccccchh-cc--CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 WKDNRAYE-LL--SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ~~~~~~~~-~~--~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .. ....+ +.  ...............+.+++.+||+.||++||++.|+++.
T Consensus       245 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQ-NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HH-HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH-HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00 00000 00  0001111112245678899999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-38  Score=350.94  Aligned_cols=272  Identities=23%  Similarity=0.248  Sum_probs=209.2

Q ss_pred             CcccHHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-----CCceeeE
Q 003264          502 PCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----HRNLVRL  575 (835)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l  575 (835)
                      ..+++.......++|++.++||+|+||.||+|+.. +++.||||++.. .....+.+..|+.++.+++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34556666667799999999999999999999984 588999999974 3345567788999999996     9999999


Q ss_pred             eeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC----
Q 003264          576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----  651 (835)
Q Consensus       576 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~----  651 (835)
                      ++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            99999999999999999 99999998543 2235889999999999999999999998   999999999999975    


Q ss_pred             ---------------------CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHH
Q 003264          652 ---------------------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLE  710 (835)
Q Consensus       652 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~e  710 (835)
                                           ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 78999999999986432     2234578999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCcccc-cccccc-----hhh------------hccccchhccCccc------------cchhHHHHHHH
Q 003264          711 TLTSKRNTGVYDIESF-NLLGHA-----WNL------------WKDNRAYELLSPAL------------QHEASYQMLNR  760 (835)
Q Consensus       711 lltG~~p~~~~~~~~~-~~~~~~-----~~~------------~~~~~~~~~~~~~l------------~~~~~~~~~~~  760 (835)
                      |++|+.||...+.... ......     ...            ..............            ...........
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999976442211 000000     000            00000000000000            00011112256


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 003264          761 YITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       761 l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.+++.+||+.||++|||++|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            789999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-39  Score=356.62  Aligned_cols=261  Identities=30%  Similarity=0.437  Sum_probs=197.1

Q ss_pred             cCCccccccccCCcccEEEEEecC--C--cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l  587 (835)
                      ..|++.+.||+|+||.||+|++.+  +  ..||||.+... .....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            457788999999999999998642  2  36899998654 34556889999999999999999999998765 457899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999954  2345788999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc--ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          668 GDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       668 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .....  .......+|..|+|||.+.+..++.++||||||+++|||++ |.+|+........  ..   ......   ..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~---~~~~~~---~~  315 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV---YLLQGR---RL  315 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HH---HHHTTC---CC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HH---HHHcCC---CC
Confidence            33221  12233567889999999999999999999999999999999 6667664332211  10   000000   01


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                      ..       +..++..+.+++.+||+.+|++||+++|+++.|+.+...+.
T Consensus       316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            11       11234568889999999999999999999999998755544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-38  Score=338.32  Aligned_cols=276  Identities=19%  Similarity=0.265  Sum_probs=208.9

Q ss_pred             hhcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEE-EecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC-VEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~  589 (835)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++.....  .+++.+|+.++.+++|++++..+..+ .+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999997 4588999998754322  24578899999999887766666555 5677889999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCccccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~  666 (835)
                      ||+ +++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998532  345899999999999999999999998   9999999999999   78999999999999876


Q ss_pred             cCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhcccc
Q 003264          667 CGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNR  740 (835)
Q Consensus       667 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~  740 (835)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......    ... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~-  233 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----SEK-  233 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH----HHH-
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh----hcc-
Confidence            543321     122356789999999999999999999999999999999999999976442211 110000    000 


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  804 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  804 (835)
                        ....  .........+..+.+++.+|++.+|++||+++++++.|+++......+....+.|.
T Consensus       234 --~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          234 --KMST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             --HHHS--CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             --cccc--hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence              0000  00001112346788999999999999999999999999987665555544444443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.4e-39  Score=348.90  Aligned_cols=260  Identities=28%  Similarity=0.432  Sum_probs=205.3

Q ss_pred             hcCCccccccccCCcccEEEEEe------cCCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+|++      .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999984      24678999999754 345567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEec
Q 003264          586 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKIS  658 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~  658 (835)
                      ++||||+++++|.+++....    ....+++..++.++.||++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999996432    1245889999999999999999999998   999999999999984   4469999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhc
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+........  ..    ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LE----FVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH--HH----HHh
Confidence            9999987654443333445667899999999999999999999999999999998 8899875432211  00    000


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ...     .    ...+..+...+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       260 ~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 SGG-----R----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TTC-----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC-----C----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            000     0    0111223456788999999999999999999999998763

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=351.62  Aligned_cols=273  Identities=26%  Similarity=0.406  Sum_probs=210.1

Q ss_pred             hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC--eE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~  585 (835)
                      .++|++.+.||+|+||.||+++.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984     358899999998776677788999999999999999999999987654  78


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999542  245899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc-hhhhccccchh
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA-WNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  743 (835)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+........ ..........+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6443221 112334577889999999988899999999999999999999988753211100000000 00000000001


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .+........+..++..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111111112234567889999999999999999999999998763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=341.37  Aligned_cols=261  Identities=26%  Similarity=0.346  Sum_probs=206.3

Q ss_pred             cCCccccccccCCcccEEEEEecC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE-EE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK-IL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~l  587 (835)
                      -.|++.++||+|+||.||+|++.+    +..||||++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            356677999999999999998643    2379999997643 34567899999999999999999999999877665 99


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+.+++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999954  3356789999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCc--cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCC-CCCCcccccccccchhhhccccchhc
Q 003264          668 GDEL--QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNT-GVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       668 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ....  ........+|..|+|||.+.+..++.++||||||+++|||++|..|+ ...+...  ...    ......    
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~----~~~~~~----  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTH----FLAQGR----  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHH----HHHTTC----
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHH----HhhcCC----
Confidence            4321  22233456789999999999999999999999999999999966554 3222111  110    000000    


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                           ....+...+..+.+++.+|++.+|++||+++|+++.|+.+...+.
T Consensus       246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 000111233568889999999999999999999999988755443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=340.16  Aligned_cols=266  Identities=25%  Similarity=0.344  Sum_probs=199.4

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHhcC---CCceeeEeeEEEec
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQ  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  582 (835)
                      ..++|++.++||+|+||+||+|++. +++.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4679999999999999999999974 58999999986322     112345667777777664   99999999999876


Q ss_pred             C-----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          583 G-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       583 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      .     ..++||||++ ++|.+++.... ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 59999886532 234899999999999999999999998   999999999999999999999


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-ccccc----
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGHA----  732 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~----  732 (835)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....    
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999865322   2234567899999999999999999999999999999999999999764422110 00000    


Q ss_pred             -hhhhccc-cc-hhccC---ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 -WNLWKDN-RA-YELLS---PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 -~~~~~~~-~~-~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ...|... .. ...+.   +.............+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence             0000000 00 00000   000111122345678899999999999999999999863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-38  Score=347.52  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             hcCCccccccccCCcccEEEEEe----cCCcEEEEEEecCcC----hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+++.    .+++.||||++....    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999987    468999999997542    2345668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999843   345889999999999999999999998   9999999999999999999999999997


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+....  ..   .....      
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~---~i~~~------  236 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--ID---KILKC------  236 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH---HHHHT------
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--HH---HHHhC------
Confidence            643221  122345789999999999999999999999999999999999999975432211  00   00000      


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                       ...+    +......+.+++.+||+.+|++||     ++.|+++.
T Consensus       237 -~~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 -KLNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -CCCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -CCCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence             0011    112345678899999999999999     67787763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.2e-38  Score=345.65  Aligned_cols=255  Identities=22%  Similarity=0.232  Sum_probs=182.8

Q ss_pred             cCCccc---cccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQ---CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~---~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.   +.||+|+||.||++++. +++.||||++...   ....+.+|+.++.+++ ||||+++++++.+....++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            345543   78999999999999985 4899999998643   3467788999999996 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~  665 (835)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++   .+||+|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           85 MELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             ECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999853   346899999999999999999999998   99999999999997765   799999999986


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-ccccchhhhccccchhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  744 (835)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..... ........+...     
T Consensus       159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          159 KPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             cCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence            53322  2223456899999999999999999999999999999999999999764422110 000000000000     


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ............+..+.+++.+||+.||++||+++|+++.
T Consensus       232 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          232 -DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             0111222223456778899999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-38  Score=339.44  Aligned_cols=256  Identities=27%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             hhcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|++.+.||+|+||.||+|+...    +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34789999999999999999998643    346999999765 34456789999999999999999999999764 4678


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999853  2345889999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........  ..    ......  .. 
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~----~~~~~~--~~-  233 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG----VLEKGD--RL-  233 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH----HHHHTC--CC-
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH----HHhcCC--CC-
Confidence            43321 12233456889999999998999999999999999999998 9999875432211  00    000000  00 


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                            ..+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                  01112345688899999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.3e-39  Score=343.25  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=205.0

Q ss_pred             hhcCCcccc-ccccCCcccEEEEEec---CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          512 ATENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       512 ~~~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      ..++|++.+ .||+|+||.||+|.+.   .++.||||++....  ....+++.+|+.++++++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346888888 9999999999999653   36789999997543  33467899999999999999999999999 66788


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999953   345889999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchh
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........  .    .......   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~----~~~~~~~---  237 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T----AMLEKGE---  237 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTC---
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H----HHHHcCC---
Confidence            6443221 11223456789999999998889999999999999999999 9999875442211  0    0001110   


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                            ....+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  01111233466889999999999999999999999998764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=374.84  Aligned_cols=257  Identities=24%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             hcCCcccc-ccccCCcccEEEEEec---CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .+++.+.+ +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+|++++|||||++++++.. +..++
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            34555555 7999999999999874   45679999997653 3467889999999999999999999999876 56999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999999999954  3456899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......+|+.|+|||++....++.++|||||||+||||++ |+.||........  ..    .+..+.     
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~----~i~~~~-----  556 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK-----  556 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HH----HHHTTC-----
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HH----HHHcCC-----
Confidence            33211 11222345789999999999999999999999999999998 9999976443211  10    111110     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                          ....+..++..+.+|+..||+.+|++||++.+|++.|+.+.
T Consensus       557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                11112234567889999999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.7e-38  Score=335.79  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .++|++.+.||+|+||.||+|+... ++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4789999999999999999999754 889999998654  3445678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecccCccccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~  666 (835)
                      ||+++++|.+.+..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999888743   345899999999999999999999998   999999999999987665   999999999765


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+....  ..    ...... .... 
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~~~-~~~~-  227 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA----QIKAGA-YDYP-  227 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC-CCCC-
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HH----HHHhcc-ccCC-
Confidence            4322   22345789999999999999999999999999999999999999875432211  00    000000 0000 


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ..........+.+++.+|++.+|++||++.|+++.
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 ----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                00111234567889999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-38  Score=341.56  Aligned_cols=261  Identities=30%  Similarity=0.430  Sum_probs=204.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCeEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~  586 (835)
                      ..+|++.++||+|+||.||+|++.+    ...||||.+... .....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578999999999999999998643    236899998764 34456789999999999999999999998654 55789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999954  3345789999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcc--ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhC-CCCCCCCCcccccccccchhhhccccchh
Q 003264          667 CGDELQ--GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTS-KRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       667 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ......  .......+|+.|+|||.+.+..++.++||||||++++||++| .+|+........  ..   ......   .
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~---~~~~~~---~  250 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV---YLLQGR---R  250 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HH---HHHTTC---C
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HH---HHhcCC---C
Confidence            443321  223345678899999999999999999999999999999995 555544332211  00   000000   0


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      ...       +...+..+.+++.+|++.+|++||+++|+++.|+.+...+
T Consensus       251 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          251 LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            000       1112346888999999999999999999999998875544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=335.06  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=183.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999974 68999999986432   22357789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999854  2356899999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..  .......||+.|+|||.+.+..++.++||||||++++||++|+.|+........  ..       .......   .
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-------~~~~~~~---~  230 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LN-------KVVLADY---E  230 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSSCC---C
T ss_pred             CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HH-------HHhhccc---C
Confidence            21  122335689999999999999999999999999999999999999875432211  00       0000000   0


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .    +......+.+++.+|++.||++||+++|+++
T Consensus       231 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 M----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1    1123356788999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.6e-38  Score=345.33  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=204.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-CcE--EEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQE--VAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||.||+|+... +..  ||||++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            679999999999999999998754 554  499998653 334556789999999999 999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          589 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      |||+++++|.+++....             ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999998   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++....   ........++..|+|||++.+..++.++||||||+++|||++ |+.||........  ..    
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HH----
Confidence            9999999974321   112233456889999999998899999999999999999998 9999875442211  00    


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHAT  792 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  792 (835)
                      .....     ..    ...+......+.+++.+||+.+|++||+++|+++.|+.+...
T Consensus       253 ~~~~~-----~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQG-----YR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGT-----CC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcC-----CC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00000     00    011112345688899999999999999999999999876443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.7e-38  Score=357.40  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999985 58999999986532   23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999843   356899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........  ..   .. ....   ..  
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~---~i-~~~~---~~--  234 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FK---KI-CDGI---FY--  234 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HH---HH-HTTC---CC--
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HH---HH-hcCC---cC--
Confidence            32   2234579999999999988765 6899999999999999999999975432211  00   00 0000   00  


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                           .+......+.+++.+||+.||++||++.|+++
T Consensus       235 -----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 -----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                 01122356788999999999999999999997

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-38  Score=340.98  Aligned_cols=263  Identities=21%  Similarity=0.229  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999975 58899999987542   33457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999853   345899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........  .    ......    ...  
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~~~----~~~--  253 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM--G----AHINQA----IPR--  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH--H----HHHHSC----CCC--
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH--H----HHhccC----CCC--
Confidence            321 122345689999999999999999999999999999999999999875432210  0    000000    000  


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhcccCCCCC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNEHATLPY  795 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~l~~  795 (835)
                       ........+..+.+++.+||+.+|++|| +++++++.|+........
T Consensus       254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence             0111223345678899999999999999 999999999887554443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-38  Score=349.78  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|++.+.||+|+||.||+|+... ++.||||++....   ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34789999999999999999999865 7899999987542   23456788999999988 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999843   345899999999999999999999998   999999999999999999999999999864


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... ..      
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~~-~~------  237 (353)
T 2i0e_A          172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---SIME-HN------  237 (353)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHH-CC------
T ss_pred             ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-CC------
Confidence            222  1223456799999999999999999999999999999999999999975432211  00   0000 00      


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVSM  785 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  785 (835)
                      ..    .+...+..+.+++.+||+.+|++||+     ++|+++.
T Consensus       238 ~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 VA----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CC----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00    11223456888999999999999995     4677643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=346.28  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....        ....+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            34578999999999999999999864 58899999987542        1133467889999999999999999999999


Q ss_pred             cCeEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          582 QGEKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       582 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      .+..++||||+..| +|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999877 99998853   345899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      |+++......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........             
T Consensus       175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------  238 (335)
T 3dls_A          175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------  238 (335)
T ss_dssp             TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred             ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence            9998764332   2234578999999999988876 7899999999999999999999864221100             


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ....+      +...+..+.+++.+||+.+|++||++.|+++.
T Consensus       239 ---~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 ---AAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---TCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---hccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000      01123567889999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=358.27  Aligned_cols=262  Identities=20%  Similarity=0.229  Sum_probs=206.9

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      +.+.....++|++.+.||+|+||.||+++.. +++.||||++.+..   ....+.+++|+.++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4455556789999999999999999999985 58999999996532   2233458899999999999999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      .+..++||||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            99999999999999999999532  236899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccceeCceeec-------CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYAL-------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      +++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+....  ..   .
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~---~  281 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YG---K  281 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---H
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HH---H
Confidence            9987643321 1223457999999999987       45789999999999999999999999975442211  00   0


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR---PTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~  785 (835)
                      .....  .....+.    .....+..+.+++.+||+ +|++|   |+++|+++.
T Consensus       282 i~~~~--~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYK--EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhcc--cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            00000  0000111    112345678899999999 99998   589998865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=349.50  Aligned_cols=255  Identities=15%  Similarity=0.138  Sum_probs=205.7

Q ss_pred             HHhhcCCccccccccCCcccEEEEE------ecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC---CCceeeEeeEEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCV  580 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~  580 (835)
                      ....++|++.++||+|+||.||+|+      ...++.||||++....   ..++..|+.++.+++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3456889999999999999999994      3458899999997643   456778888888886   999999999999


Q ss_pred             ecCeEEEEEEecCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-------
Q 003264          581 EQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------  651 (835)
Q Consensus       581 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------  651 (835)
                      +.+..++||||+++|+|.+++...  .....+++..+..++.||++||+|||+++   |+||||||+||||+.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            999999999999999999999532  13456999999999999999999999988   999999999999998       


Q ss_pred             ----CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc
Q 003264          652 ----DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  727 (835)
Q Consensus       652 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~  727 (835)
                          ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999998654333333445567999999999999999999999999999999999999998543222111


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhhccc
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADR-PTMSKVVSMITNEH  790 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~  790 (835)
                      ..             ..    +....   ....+.+++..|++.+|.+| |+++++.+.|+...
T Consensus       295 ~~-------------~~----~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          295 PE-------------GL----FRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             EC-------------SC----CTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ec-------------hh----ccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            00             00    00001   13356678899999999999 68888888887753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=353.46  Aligned_cols=272  Identities=21%  Similarity=0.279  Sum_probs=212.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC--eEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  588 (835)
                      .++|++.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            4689999999999999999999865 8999999997543 334677889999999999999999999998765  78999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE----cCCCCeEecccCccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  664 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~  664 (835)
                      |||+++|+|.+++........+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965444445899999999999999999999998   9999999999999    777889999999998


Q ss_pred             cccCCCccccccccccccceeCceeecC--------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALD--------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ......   ......||..|+|||++.+        ..++.++|||||||++|||++|+.||.......... .......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII  240 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence            764332   2234568999999998865        567889999999999999999999986543221100 0000000


Q ss_pred             cccc------chhc------c--CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          737 KDNR------AYEL------L--SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       737 ~~~~------~~~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ....      ....      .  +..............+.+++..||+.||++||++.|+++.++.+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            0000      0000      0  0011122345677888999999999999999999999999877533

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.3e-38  Score=342.86  Aligned_cols=270  Identities=24%  Similarity=0.308  Sum_probs=209.1

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHh--cCCCceeeEeeEEEecC
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG  583 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~  583 (835)
                      ........++|++.+.||+|+||.||+|+. +++.||||++...   ..+.+.+|++++..  ++||||+++++++.+..
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            333455668999999999999999999998 5899999999643   34667888888887  79999999999998876


Q ss_pred             ----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEEecCCCCeEEEcC
Q 003264          584 ----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDS  651 (835)
Q Consensus       584 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NILl~~  651 (835)
                          ..++||||+++|+|.+++..    ..+++..++.++.||++||+|||        +.+   |+||||||+|||++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence                78999999999999999943    35899999999999999999999        555   999999999999999


Q ss_pred             CCCeEecccCccccccCCCccc--cccccccccceeCceeecCC------CCCccccchhHHHHHHHHHhC---------
Q 003264          652 DMNPKISDFGMARMFCGDELQG--NTKRVVGTYGYMSPEYALDG------LFSVKSDVFSFGVLLLETLTS---------  714 (835)
Q Consensus       652 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvl~elltG---------  714 (835)
                      ++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999998764433211  22345789999999998775      234689999999999999999         


Q ss_pred             -CCCCCCCCcccccccccchhhhccccchhccCccccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          715 -KRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       715 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                       ..||.............. ...    ......+.+... ........+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       263 ~~~p~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMR-KVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHH-HHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCccccCcCcccHHHHH-HHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             556543321111110000 000    011112222211 234567789999999999999999999999999988743

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=347.47  Aligned_cols=268  Identities=25%  Similarity=0.371  Sum_probs=196.5

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHH--HHhcCCCceeeEeeEEEec-----CeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML--IAKLQHRNLVRLMGCCVEQ-----GEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~-----~~~  585 (835)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+...     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999987 68999999986543   2334444444  4558999999999865532     256


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCcEEEecCCCCeEEEcCCCCeE
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY---------SRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                      ++||||+++|+|.+++..    ...++..+..++.||++||+|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999943    3358899999999999999999998         6   99999999999999999999


Q ss_pred             ecccCccccccCCCc------cccccccccccceeCceeecC-------CCCCccccchhHHHHHHHHHhCCCCCCCCCc
Q 003264          657 ISDFGMARMFCGDEL------QGNTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDI  723 (835)
Q Consensus       657 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~  723 (835)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987644321      112234579999999999877       4567799999999999999999877643322


Q ss_pred             ccccccccchhhhccc---c-----chhccCccccc--hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          724 ESFNLLGHAWNLWKDN---R-----AYELLSPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       724 ~~~~~~~~~~~~~~~~---~-----~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ................   .     ......+.+..  ......+..+.+++.+||+.||++||+++|+++.|+.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            1110000000000000   0     00001111111  1122356678999999999999999999999999988743

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-38  Score=345.15  Aligned_cols=265  Identities=24%  Similarity=0.326  Sum_probs=201.7

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .++|++.+.||+|+||.||+|+... ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3689999999999999999999865 8999999986543  334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988643   345899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccc--c-------ccchhhhcc-
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL--L-------GHAWNLWKD-  738 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~-------~~~~~~~~~-  738 (835)
                      .  .......||..|+|||++.+. .++.++||||||+++|||++|+.||..........  .       ......+.. 
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  122345689999999998875 78999999999999999999999997654221100  0       000000000 


Q ss_pred             -----ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 -----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 -----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           ....+..............+..+.+++.+||+.||++||++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 00011111111111112345678999999999999999999998863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.8e-38  Score=338.10  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999875 58899999986543 3456889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++.    ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999984    346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                        .......|+..|+|||++.+..++.++||||||+++|||++|+.|+........  ..    ...     ....+.+.
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~-----~~~~~~~~  240 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LF----LIP-----KNNPPTLE  240 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHH-----HSCCCCCC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HH----Hhh-----cCCCCCCc
Confidence              122345789999999999999999999999999999999999999875432211  00    000     00011111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .    .....+.+++..||+.+|++||++.|+++.
T Consensus       241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1    223567889999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-38  Score=336.85  Aligned_cols=248  Identities=25%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      +.++|++.+.||+|+||.||+|+... ++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34789999999999999999998755 7799999986432   2235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999998843   245889999999999999999999987   9999999999999999999999999986543


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........  ..    ....      ...
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~------~~~  224 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YK----RISR------VEF  224 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHH------TCC
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HH----HHHh------CCC
Confidence            22    22345789999999999999999999999999999999999999875432211  00    0000      000


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .    .+......+.+++.+||+.+|++||+++|+++.
T Consensus       225 ~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             C----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             C----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1    111233567789999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-38  Score=349.21  Aligned_cols=247  Identities=31%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .+.|++.+.||+|+||.||+|+. .+++.||||++....   ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35699999999999999999997 468899999986432   33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||++ |+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 577777632  2346899999999999999999999998   99999999999999999999999999986532


Q ss_pred             CCccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                            .....||+.|+|||++.   ...++.++|||||||++|||++|+.|+........     ........      
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~------  269 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE------  269 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC------
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC------
Confidence                  22357899999999984   56789999999999999999999999865432111     00010100      


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+...   ....+..+.+++.+||+.+|++||+++++++.
T Consensus       270 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11111   11223567889999999999999999999865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.4e-38  Score=343.56  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=206.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|.+.+.||+|+||.||++++.+ ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34789999999999999999999865 789999998654   33456788999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998843   346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......|+..|+|||++.+..++.++||||||+++|||++|+.||.........      .......      .
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~------~  258 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNE------Y  258 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC------C
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcCC------C
Confidence            322  1233457899999999999999999999999999999999999998754322110      0000000      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+.    ......+.+++.+||+.||++||+++|+++.
T Consensus       259 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 SIP----KHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011    1223457789999999999999999999973

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9e-38  Score=333.45  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++....      ....+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            367999999999999999999986 58999999986532      12467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG  661 (835)
                      ++||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999843   346899999999999999999999998   99999999999998877    89999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      ++.......   ......+++.|+|||++.+..++.++||||||++++||++|+.||........  ..    .+..   
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~---  225 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LT----NISA---  225 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHT---
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HH----HhHh---
Confidence            998753322   22345689999999999999999999999999999999999999875432211  00    0000   


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .............+..+.+++.+|++.+|++||++.|+++
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          226 ---VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ---TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence               0011111222234566889999999999999999999997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-38  Score=338.59  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=204.3

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe---------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE---------  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  581 (835)
                      ...+|++.+.||+|+||.||+|+.. +++.||||++....    +.+.+|++++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4578999999999999999999986 68999999997543    356789999999999999999998865         


Q ss_pred             -------cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC
Q 003264          582 -------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  654 (835)
Q Consensus       582 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  654 (835)
                             ....++||||+++++|.+++... ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   44589999999999999998542 2346889999999999999999999998   999999999999999999


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      +||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....    .    ...
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~----~~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----K----FFT  229 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----H----HHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----H----HHH
Confidence            9999999998764332   2233568999999999999999999999999999999999998753210    0    000


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      ...        ...+.    ......+.+++.+||+.||++||++.|+++.|..+.+..
T Consensus       230 ~~~--------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          230 DLR--------DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHH--------TTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             Hhh--------ccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            000        01111    112345778999999999999999999999998875443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.8e-38  Score=336.56  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++... ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4789999999999999999999864 789999998654   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998843   346899999999999999999999998   99999999999999999999999999987642


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      ..  .......|++.|+|||.+.+..++.++||||||++++||++|+.|+.........      .......      ..
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~------~~  233 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNE------YS  233 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC------CC
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhhcc------CC
Confidence            22  1223457899999999999999999999999999999999999998754322110      0000000      00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      +    +......+.+++.+|++.+|++||+++|+++.
T Consensus       234 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 I----PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1    11223467889999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=352.35  Aligned_cols=277  Identities=14%  Similarity=0.183  Sum_probs=213.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC---------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceee---------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR---------  574 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  574 (835)
                      .++|++.+.||+|+||.||+|+...         ++.||||++...     +.+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999864         789999998754     45789999999999999987         


Q ss_pred             ------EeeEEEe-cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeE
Q 003264          575 ------LMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  647 (835)
Q Consensus       575 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  647 (835)
                            +++++.+ ....++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 67889999999 99999999542 2356899999999999999999999998   99999999999


Q ss_pred             EEcCCC--CeEecccCccccccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003264          648 LLDSDM--NPKISDFGMARMFCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGV  720 (835)
Q Consensus       648 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~  720 (835)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876433211     112345799999999999999999999999999999999999999975


Q ss_pred             CCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCc
Q 003264          721 YDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSA  800 (835)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~  800 (835)
                      .......+........  .....+......   ....+..+.+++.+||+.||++||+++++++.|+.+...........
T Consensus       271 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             GTTCHHHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             CCcCHHHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            4322111111110000  000111111000   01123568889999999999999999999999998876666655555


Q ss_pred             cccc
Q 003264          801 FSYA  804 (835)
Q Consensus       801 ~~~~  804 (835)
                      +.|.
T Consensus       346 ~dw~  349 (352)
T 2jii_A          346 IGLP  349 (352)
T ss_dssp             CCCC
T ss_pred             ccCc
Confidence            5443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-38  Score=363.92  Aligned_cols=249  Identities=22%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.++||+|+||.||+++.. +++.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999999975 4889999998653   233456778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999998843   3468999999999999999999998 76   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+....  ..    .+....      .
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~~------~  366 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILMEE------I  366 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------C
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH----HHHhCC------C
Confidence            221  223446799999999999999999999999999999999999999975442211  00    000000      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                      .    .+......+.+++.+||+.||++||     +++|+++.
T Consensus       367 ~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0    1112345678899999999999999     99999863

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-37  Score=352.26  Aligned_cols=254  Identities=21%  Similarity=0.272  Sum_probs=193.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      ...++|.+.+.||+|+||.||+|+... ++.||||++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            456899999999999999999998754 7899999986432        122335889999999999999999999974 


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---CeEec
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS  658 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~  658 (835)
                      .+..++||||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            5568999999999999998843   356899999999999999999999998   99999999999997544   59999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  735 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  735 (835)
                      |||+++.....   .......||+.|+|||++..   ..++.++|||||||++|||++|+.||........ +..    .
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~----~  356 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----Q  356 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHH----H
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHH----H
Confidence            99999876432   22334679999999999853   5788899999999999999999999975432211 000    0


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....      ...........+..+.+++.+||+.||++||++.|+++.
T Consensus       357 i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGK------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCC------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000      001111222345678899999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7e-38  Score=336.30  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=200.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            44555668999999999999974 58899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-CCCeEecccCccccccCCCc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++++|.+++........+++..+..++.||++||+|||+++   |+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999965444445678899999999999999999998   999999999999987 8999999999998754321 


Q ss_pred             cccccccccccceeCceeecCCC--CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                       .......|+..|+|||++.+..  ++.++||||||+++|||++|+.||.............         ......+.+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------~~~~~~~~~  247 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---------GMFKVHPEI  247 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---------HHHCCCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---------ccccccccc
Confidence             1223457899999999987654  8899999999999999999999986433211110000         000011111


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          +......+.+++.+||+.+|++||++.|+++.
T Consensus       248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                12234567889999999999999999999853

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.1e-38  Score=357.06  Aligned_cols=261  Identities=24%  Similarity=0.261  Sum_probs=197.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------C
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  583 (835)
                      .++|++.++||+|+||+||+|++. +++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999875 4889999999754  344567889999999999999999999999754      3


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||++++ |.+.+.     ..+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999876 555552     23889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc----cc-------
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL----GH-------  731 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~----~~-------  731 (835)
                      +.....   .......||+.|+|||++.+..++.++|||||||+|+||++|+.||...+.... ...    ..       
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            875332   223446899999999999999999999999999999999999999976542111 000    00       


Q ss_pred             -----chhhhcc------ccchhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 -----AWNLWKD------NRAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 -----~~~~~~~------~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           .......      ..........+   ...........+.+|+.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0000000      00000000000   011223346678999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-38  Score=337.47  Aligned_cols=250  Identities=27%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-CeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+++. .++.||||++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            47899999999999999999987 48899999987543  457889999999999999999999997655 478999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++... ....+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998432 1223788999999999999999999998   999999999999999999999999999764322  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+........  .    ......         ..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~----~~~~~~---------~~  232 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKG---------YK  232 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--H----HHHTTT---------CC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcC---------CC
Confidence               223357889999999999999999999999999999998 9999875432211  0    000000         01


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      ...+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            111122345688899999999999999999999999876

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-38  Score=336.70  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=198.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            368999999999999999999975 48899999986543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCccccc
Q 003264          591 YMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMF  666 (835)
Q Consensus       591 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~  666 (835)
                      |+++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999888432 12356899999999999999999999998   9999999999999   45688999999999865


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ....   ......||+.|+|||++. ..++.++||||||++++||++|+.||...........     ....       .
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~-----~~~~-------~  241 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-----ATYK-------E  241 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHC-------C
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh-----hccC-------C
Confidence            4322   233457899999999875 5789999999999999999999999976442211000     0000       0


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.... ........+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000 00012356778999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.6e-37  Score=345.75  Aligned_cols=253  Identities=19%  Similarity=0.224  Sum_probs=192.2

Q ss_pred             hcCCccc-cccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe----cCeE
Q 003264          513 TENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       513 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~  585 (835)
                      .++|.+. +.||+|+||+||++++. +++.||||++...     ..+.+|+.++.++ +||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4577776 68999999999999985 4889999998642     4567888887554 89999999999876    5678


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  662 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  662 (835)
                      ++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999653 2345899999999999999999999988   999999999999987   78999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......+.... .
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~-~  284 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQ-Y  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTC-C
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCc-c
Confidence            9865322   1233467899999999999999999999999999999999999999754322110  00000000000 0


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...     .......+..+.+|+.+||+.||++||++.|+++.
T Consensus       285 ~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000     00112234568899999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.4e-38  Score=343.25  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=194.5

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ...++|++.++||+|+||+||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44578999999999999999999875 58899999997543  2235667899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-----CCCCeEecccCc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----SDMNPKISDFGM  662 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DFGl  662 (835)
                      ||||+++ +|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999984 88888843   345899999999999999999999998   99999999999994     455699999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc-c--------c
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG-H--------A  732 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~-~--------~  732 (835)
                      ++.+....  .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||............ .        .
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            98763221  223345679999999999875 5899999999999999999999999754422110000 0        0


Q ss_pred             hhhhc-----cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          733 WNLWK-----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       733 ~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +....     ...........+...........+.+++.+||+.||++||+++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000     00000111111111122224467789999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-37  Score=340.32  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=207.6

Q ss_pred             ccHHHHHHhhcCCccc-cccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhc-CCCceeeEeeE
Q 003264          504 FSLASVSAATENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGC  578 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~  578 (835)
                      ..+.......++|.+. +.||+|+||.||+|+.. +++.||||++....  .....++.+|+.++.++ +||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3344556667788887 88999999999999986 48999999987542  33467889999999999 56999999999


Q ss_pred             EEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCe
Q 003264          579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNP  655 (835)
Q Consensus       579 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~  655 (835)
                      +.+.+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998543 3356899999999999999999999998   999999999999987   7899


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL  735 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  735 (835)
                      ||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......     .
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----i  245 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-----I  245 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----H
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----H
Confidence            999999998764322   22345789999999999999999999999999999999999999975442211000     0


Q ss_pred             hccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..       ................+.+++.+||+.+|++||+++|+++.
T Consensus       246 ~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQ-------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HH-------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hh-------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00       00001111112234567889999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-37  Score=352.85  Aligned_cols=201  Identities=25%  Similarity=0.383  Sum_probs=168.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----Ce
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  584 (835)
                      .++|++.+.||+|+||.||+|++.. ++.||||++...  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4789999999999999999999754 789999999754  344567899999999999999999999999876     57


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 589988843   346899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc--------------------ccccccccccceeCceee-cCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003264          665 MFCGDELQ--------------------GNTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTSKRNTGV  720 (835)
Q Consensus       665 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvl~elltG~~p~~~  720 (835)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            76433211                    123456899999999986 556799999999999999999997666543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.4e-38  Score=357.34  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=207.8

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC-CceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||.||+|++ .+++.||||++.....  .+++.+|++++..++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999997 4589999998765432  2457889999999976 667777777788889999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~  667 (835)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998532  345899999999999999999999998   9999999999999   688999999999998765


Q ss_pred             CCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhccccc
Q 003264          668 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRA  741 (835)
Q Consensus       668 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~  741 (835)
                      .....     .......||..|+|||++.+..++.++|||||||+||||++|+.||........ .....    +.....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----ISEKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH----HHHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH----Hhhccc
Confidence            43321     122356799999999999999999999999999999999999999976442211 00000    000000


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCC
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATL  793 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l  793 (835)
                      .     .........++..+.+++..||+.+|++||++.+|+++|+.+....
T Consensus       234 ~-----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          234 A-----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             H-----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             c-----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            0     0001111233567889999999999999999999999998764433

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-38  Score=337.38  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999985 5899999998654  34456789999999999999999999998865  568899


Q ss_pred             EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          588 IYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      ||||+++++|.+++.... ....+++..+..++.||++||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985421 2345899999999999999999999976  2349999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...+....  ..    .+.....   
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~i~~~~~---  233 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AG----KIREGKF---  233 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC---
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HH----HHhhccc---
Confidence            753321  112345689999999999999999999999999999999999999875442211  00    0001100   


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                        +.+    +...+..+.+++.+||+.+|++||++.|+++.+..
T Consensus       234 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 --RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             --CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence              111    12234568889999999999999999999987543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.5e-38  Score=335.32  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999986 5899999998754  334567788999999999 99999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC--------------
Q 003264          588 IYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--------------  652 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--------------  652 (835)
                      ||||+++++|.+++.... ....+++..+..++.||++||+|||+++   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999985421 1245899999999999999999999998   9999999999999844              


Q ss_pred             -----CCeEecccCccccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc
Q 003264          653 -----MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF  726 (835)
Q Consensus       653 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~  726 (835)
                           ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||++++||++|.+++.....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                 479999999998764322      23589999999999776 567899999999999999999887543211   


Q ss_pred             cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            .........     +.+.    ......+.+++.+||+.||++||++.|+++.
T Consensus       237 ------~~~~~~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 ------WHEIRQGRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ------HHHHHTTCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------HHHHHcCCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                  000111111     1111    1234567889999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-37  Score=353.19  Aligned_cols=195  Identities=24%  Similarity=0.375  Sum_probs=155.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----Ce
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  584 (835)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999875 5899999998653  344567899999999999999999999999543     57


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+. ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999984 688888843   346899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc-------------------------ccccccccccceeCceee-cCCCCCccccchhHHHHHHHHHhC
Q 003264          665 MFCGDELQ-------------------------GNTKRVVGTYGYMSPEYA-LDGLFSVKSDVFSFGVLLLETLTS  714 (835)
Q Consensus       665 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvl~elltG  714 (835)
                      ........                         .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76432110                         123346789999999986 456799999999999999999994

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-38  Score=341.56  Aligned_cols=268  Identities=22%  Similarity=0.319  Sum_probs=196.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChh-hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|++.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986 5889999998654322 122456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++ |+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--  153 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence            98 5788877432  346889999999999999999999998   999999999999999999999999999865322  


Q ss_pred             cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-cccc--------chh-hhcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGH--------AWN-LWKDNR  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~--------~~~-~~~~~~  740 (835)
                      ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ....        .+. ......
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            122234568999999999876 56899999999999999999999999765422110 0000        000 000000


Q ss_pred             chhccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          741 AYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       741 ~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                      ......+...    ..........+.+++.+||+.||++|||++|+++.  +.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence            0000000000    01112234567899999999999999999999974  4444

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=2.2e-37  Score=320.28  Aligned_cols=217  Identities=14%  Similarity=0.192  Sum_probs=169.1

Q ss_pred             cccCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEec
Q 003264           23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLN  102 (835)
Q Consensus        23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~  102 (835)
                      ++.|+|++||+|.+|++|  ++|.|+|||+.+++     +.+ |.  .+|+||+|||+.|   ..+.|+|+.||||||+|
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~--~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d   72 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FD--SDVRVWASNTAGA---TGCRAVLQSDGLLVILT   72 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EE--SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EE--CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence            567999999999999999  59999999998776     334 43  2799999999988   57899999999999999


Q ss_pred             CCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccc-cccccccccc-ccCc-----ceee
Q 003264          103 QTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTL-LIGMNMGWDL-KTGR-----ERYL  175 (835)
Q Consensus       103 ~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTl-Lpg~~l~~~~-~tg~-----~~~L  175 (835)
                      ++|.+||+|++........|+|+|+|||||++.         ++||||||||||+ ||+|  +.|. .+|+     +++|
T Consensus        73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L  141 (236)
T 1dlp_A           73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL  141 (236)
T ss_dssp             TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred             CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence            999999999986544556789999999999842         8999999999887 6665  5555 5555     6678


Q ss_pred             EeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecCCCCcccccCCCCccccccceeecccceEEEEEEecCCcee
Q 003264          176 TSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRIL  255 (835)
Q Consensus       176 ~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (835)
                      +|   .+||++|.|+++++++|  ++++++++.+||++++|++. +...+++...-.......+.+++++.|..... ..
T Consensus       142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~  214 (236)
T 1dlp_A          142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GR  214 (236)
T ss_dssp             CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SC
T ss_pred             Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CC
Confidence            74   78999999999999998  67888888899999999754 54555543211101112224455555544333 46


Q ss_pred             eEEEEccCCcEEEEE
Q 003264          256 MMLKINPSGDVQRLI  270 (835)
Q Consensus       256 ~r~~L~~~G~l~~~~  270 (835)
                      .|++|+.||++++|.
T Consensus       215 ~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          215 YVFVLQPDRNLAIYG  229 (236)
T ss_dssp             CEEEECSSSCEEEEC
T ss_pred             EEEEEcCCCcEEEeC
Confidence            899999999999884

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4e-38  Score=372.98  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             cccccCCcccEEEEEec---CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.+|.+++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   36789999997542  344688999999999999999999999986 4568899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc-cc
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL-QG  673 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~  673 (835)
                      |+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999943   346899999999999999999999998   99999999999999999999999999987644322 12


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||........  .    ..+....         ...
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~----~~i~~~~---------~~~  592 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T----AMLEKGE---------RMG  592 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTC---------CCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcCC---------CCC
Confidence            2233456789999999999999999999999999999998 9999976443211  0    0111110         111


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      .+..++..+.+++..||+.||++||++.+|++.|+++.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            12234467889999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.2e-38  Score=350.32  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=191.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHH-HHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+++... ++.||||++.+..   ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4689999999999999999999864 7899999996542   2234556677776 567899999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999843   346889999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..   .... ..      .
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~---~i~~-~~------~  256 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YD---NILN-KP------L  256 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HH---HHHH-SC------C
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-cc------c
Confidence            22  2233456899999999999999999999999999999999999999975432211  00   0000 00      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      .+    +......+.+++.+||+.||++||++.+
T Consensus       257 ~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 QL----KPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CC----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            01    1123456788999999999999999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-37  Score=358.14  Aligned_cols=255  Identities=25%  Similarity=0.324  Sum_probs=206.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+|.+++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999985 58999999986532   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999986532 334899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........      .  
T Consensus       338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~------~--  404 (576)
T 2acx_A          338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE------V--  404 (576)
T ss_dssp             TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHH------C--
T ss_pred             cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhc------c--
Confidence            322   223457999999999999999999999999999999999999999754321100  000000000      0  


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                        ....+...+..+.+++.+||+.||++||     +++||++.
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              0011123346788999999999999999     67888754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4e-37  Score=355.53  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=205.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.++.+++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999985 48999999996532   23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |||+++|+|..++.... ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986542 2446899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... .        
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~-~--------  408 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLE-Q--------  408 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHH-C--------
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhh-c--------
Confidence            332  123345899999999999999999999999999999999999999975432110 0000000000 0        


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  784 (835)
                      .  ...+...+..+.+++.+||+.||++||++     +++++
T Consensus       409 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            0  01112344677889999999999999975     56654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-38  Score=337.27  Aligned_cols=258  Identities=27%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             hcCCccccccccCCcccEEEEEecC--Cc--EEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN--GQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||.||+|++..  ++  .||||++...   .....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4689999999999999999998632  33  6899998654   2345678999999999999999999999988764 8


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+||+++++|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998532  345889999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchh
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||........  ..   .......   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~---~~~~~~~---  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LH---KIDKEGE---  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH---HHHTSCC---
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HH---HHHccCC---
Confidence            6443221 12234567889999999998889999999999999999999 9999875442211  00   0000000   


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                            ....+...+..+.+++.+|++.+|++||++.++++.|++..
T Consensus       243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                  00111223466889999999999999999999999998763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-38  Score=344.46  Aligned_cols=252  Identities=20%  Similarity=0.260  Sum_probs=199.9

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|++.+.||+|+||.||+++.. +++.||||++.....    .+.+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3578999999999999999999986 488999999976432    235688888888 8999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC----CCeEecccCcccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  665 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~  665 (835)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+..+    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   345899999999999999999999998   9999999999998543    3499999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccchhhhccccchhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  744 (835)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|..||........ .+..    .+....    
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~----  239 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGK----  239 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCC----
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCC----
Confidence            64332  223345789999999999888899999999999999999999999975332111 1110    000000    


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..+........+..+.+++.+||+.||++||++.|+++.
T Consensus       240 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          240 --FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              001111112344668889999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-37  Score=336.28  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            468999999999999999999985 5899999999765544556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCccccccC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~  668 (835)
                      +++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||++   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999998843   345889999999999999999999998   9999999999999   7889999999999976432


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .    ......|++.|+|||++.+..++.++||||||+++|||++|+.||........  ..    .+.... ..     
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~i~~~~-~~-----  225 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FE----KIKEGY-YE-----  225 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHCC-CC-----
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCC-CC-----
Confidence            1    22345689999999999999999999999999999999999999875432111  00    000000 00     


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........+..+.+++.+|++.||++||++.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0011112234568889999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-37  Score=343.50  Aligned_cols=259  Identities=23%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999984 5899999998643  3345677899999999999999999999998763      


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899998843    45889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc-----c---h
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH-----A---W  733 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~-----~---~  733 (835)
                      +....     ......+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+.... .....     .   .
T Consensus       176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            87532     2234578999999999887 6899999999999999999999999976542111 00000     0   0


Q ss_pred             hhhccccch-------hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 NLWKDNRAY-------ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ~~~~~~~~~-------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+......       ......+ ..........+.+++.+||+.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000000000       0000000 01112234568899999999999999999999984

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-37  Score=331.14  Aligned_cols=246  Identities=22%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|+... ++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3689999999999999999999864 7889999986432   22356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999843   245889999999999999999999988   99999999999999999999999999976532


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........  .   ..... .      +..
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~-~------~~~  230 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--H---RRIVN-V------DLK  230 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHT-T------CCC
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--H---HHHhc-c------ccC
Confidence            2    22345789999999999999999999999999999999999999875432211  0   00000 0      001


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .    +......+.+++.+|++.+|++||+++|+++
T Consensus       231 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 F----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1    1123456788999999999999999999996

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-38  Score=347.67  Aligned_cols=263  Identities=25%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999986 5889999998765 34456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      |+++++|.+++..   ...+++..+..++.||++||+|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999843   34588999999999999999999985 6   999999999999999999999999999765322


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc----------hhhh---
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA----------WNLW---  736 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~----------~~~~---  736 (835)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..........          ....   
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence                22345789999999999999999999999999999999999999976543221110000          0000   


Q ss_pred             -----------ccccchhccC----ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 -----------KDNRAYELLS----PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 -----------~~~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                 ......+..+    ...........+..+.+++.+||+.||++|||++|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                       0000000000    000000111234568899999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.7e-37  Score=330.17  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=199.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  585 (835)
                      .+.|++.+.||+|+||.||+|++. ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            356888999999999999999875 4789999998644  34556789999999999999999999999876    3468


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeEecccCccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMAR  664 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~  664 (835)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999943   345889999999999999999999874 3599999999999997 78999999999997


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .....    ......||+.|+|||++. +.++.++||||||++++||++|+.||...........     .....     
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~~~-----  245 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-----RVTSG-----  245 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-----HHTTT-----
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH-----HHhcc-----
Confidence            54322    223456899999999776 5699999999999999999999999875332211000     00000     


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ......+......+.+++..||+.+|++||+++|+++.
T Consensus       246 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          246 ---VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               00111112223468889999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-36  Score=336.17  Aligned_cols=267  Identities=22%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-------  582 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------  582 (835)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++.+.       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999984 58999999986543  23346778999999999999999999999873       


Q ss_pred             -CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          583 -GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       583 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                       +..++||||+++ +|...+..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999986 56666543  2345899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCc--cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc--------
Q 003264          662 MARMFCGDEL--QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL--------  729 (835)
Q Consensus       662 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~--------  729 (835)
                      +++.+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...        
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987643221  222344678999999999876 4689999999999999999999999976542211 000        


Q ss_pred             ccchhhhccccchhccCc--cccchhHH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          730 GHAWNLWKDNRAYELLSP--ALQHEASY-----QMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~--~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+.........+....  ........     .....+.+|+.+||+.||++||+++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000000000001100000  00001111     113457899999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.5e-37  Score=340.20  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=205.8

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhc-CCCceeeEe
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLM  576 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~  576 (835)
                      .......++|++.+.||+|+||.||+|++. +|+.||||++....        ....+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455678999999999999999999985 59999999986542        12245688999999999 899999999


Q ss_pred             eEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       577 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                      +++......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999853   346899999999999999999999998   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeecC------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccc
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG  730 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~  730 (835)
                      |+|||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||........  ..
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~  315 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LR  315 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HH
Confidence            99999998764332   2234678999999998863      3588999999999999999999999865331110  00


Q ss_pred             cchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          .+....    .  ..........+..+.+++.+||+.||++||++.|+++.
T Consensus       316 ----~i~~~~----~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 ----MIMEGQ----Y--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ----HHHHTC----C--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----HHHhCC----C--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                000000    0  00001111234568889999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-37  Score=336.06  Aligned_cols=258  Identities=19%  Similarity=0.268  Sum_probs=200.6

Q ss_pred             hcCCccccccccCCcccEEEEEe-cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEe--cCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE--QGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV  588 (835)
                      .++|++.++||+|+||.||+|+. .+++.||||++....   .+.+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            37899999999999999999987 458999999997543   467889999999997 9999999999998  6678999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~  667 (835)
                      |||+++++|.+++.      .+++..+..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999883      3789999999999999999999998   99999999999999777 89999999998764


Q ss_pred             CCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch--------hhhcc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW--------NLWKD  738 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~  738 (835)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.....        ..+..
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            332   2234578999999999877 67999999999999999999999998543322111110000        00000


Q ss_pred             c--------------cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 N--------------RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 ~--------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .              .....................+.+++.+||+.||++|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0              0000000011111122245678899999999999999999999973

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.4e-38  Score=347.66  Aligned_cols=254  Identities=10%  Similarity=0.065  Sum_probs=183.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhc--CCCceeeEe-------eEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL--QHRNLVRLM-------GCC  579 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~  579 (835)
                      ..+|++.+.||+|+||.||+|++. +++.||||++....   ....+.+++|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            356999999999999999999975 58999999997653   23456788886555555  699988755       444


Q ss_pred             Eec-----------------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 003264          580 VEQ-----------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR------VKIIEGIAQGLLYLHQYSRLR  636 (835)
Q Consensus       580 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~  636 (835)
                      ...                 ...++||||++ |+|.+++...  ...+.+..+      ..++.||++||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            433                 23799999999 8999999542  223455555      788899999999999998   


Q ss_pred             EEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhC
Q 003264          637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTS  714 (835)
Q Consensus       637 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG  714 (835)
                      |+||||||+||||+.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||+||||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999986532     1224556799999999987  6899999999999999999999


Q ss_pred             CCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          715 KRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       715 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +.||.............       ...................+..+.+++.+||+.||++||++.|+++
T Consensus       290 ~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKR-------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCCB-------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchhh-------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99998654221111110       0000000001111111233467888999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-37  Score=335.90  Aligned_cols=252  Identities=23%  Similarity=0.417  Sum_probs=199.1

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            4789999999999999999999864 889999999876666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++++|.+++..  ....+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++......  
T Consensus        98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999998843  2345899999999999999999999998   999999999999999999999999998643211  


Q ss_pred             cccccccccccceeCceee-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          672 QGNTKRVVGTYGYMSPEYA-----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ........|+..|+|||++     ....++.++||||||+++|||++|+.|+...+....  .   ..... ...     
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~-~~~-----  239 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L---LKIAK-SDP-----  239 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHHH-SCC-----
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H---HHHhc-cCC-----
Confidence            1112235689999999988     366789999999999999999999999875442211  0   00000 000     


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +..  ..+...+..+.+++.+||+.+|++||++.|+++
T Consensus       240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000  011223456788999999999999999999885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=343.87  Aligned_cols=275  Identities=24%  Similarity=0.393  Sum_probs=202.0

Q ss_pred             HHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       508 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      +.....++|++.+.||+|+||.||+|+...  .||||++....  ....+.+.+|+.++++++||||+++++++.+....
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            334456889999999999999999998754  59999986542  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||+++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|||+++.
T Consensus       105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999954  2346889999999999999999999998   99999999999998 78999999999876


Q ss_pred             ccCCC---ccccccccccccceeCceeecC---------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch
Q 003264          666 FCGDE---LQGNTKRVVGTYGYMSPEYALD---------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW  733 (835)
Q Consensus       666 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~  733 (835)
                      .....   .........|+..|+|||++..         ..++.++||||||+++|||++|+.||.....+...     .
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~  253 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----W  253 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----H
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----H
Confidence            53211   1122334568999999999864         45788999999999999999999998754422110     0


Q ss_pred             hhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCccccc
Q 003264          734 NLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSYA  804 (835)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~~  804 (835)
                      .. ...     ..+....   ...+..+.+++.+||+.+|++||++.+++++|+.+.........+..+|.
T Consensus       254 ~~-~~~-----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          254 QM-GTG-----MKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             HH-HTT-----CCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             Hh-ccC-----CCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence            00 000     0111110   01234577899999999999999999999999998766655555554443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6e-38  Score=337.99  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=187.3

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34579999999999999999999874 58899999986543 33457788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          589 YEYMPNKSLNFFLFD-----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      |||+++++|.+++..     ......+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999853     112456899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCc---cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc
Q 003264          664 RMFCGDEL---QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN  739 (835)
Q Consensus       664 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  739 (835)
                      ........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..............  .....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~  246 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPS  246 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCc
Confidence            87643221   112234578999999999876 5689999999999999999999999976543221100000  00000


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ......++...    ......+.+++.+||+.||++||++.|+++.
T Consensus       247 ~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          247 LETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000011111    1223567889999999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-38  Score=353.01  Aligned_cols=242  Identities=14%  Similarity=0.152  Sum_probs=188.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHH---HHHHhcCCCceeeEe-------eE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEM---MLIAKLQHRNLVRLM-------GC  578 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~  578 (835)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   .....+.+.+|+   .++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            478999999999999999999974 5899999998632   344567899999   555566899999998       66


Q ss_pred             EEecC-----------------eEEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 003264          579 CVEQG-----------------EKILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  637 (835)
Q Consensus       579 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  637 (835)
                      +.+.+                 ..++||||+ +|+|.+++....    ....+++..+..++.||++||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 689999985321    1123446888899999999999999998   9


Q ss_pred             EEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCC-----------CCCccccchhHHH
Q 003264          638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-----------LFSVKSDVFSFGV  706 (835)
Q Consensus       638 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGv  706 (835)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          707 LLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       707 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +||||++|+.||........  ....         ....         ...+..+.+++.+||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~--~~~~---------~~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG--SEWI---------FRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC--SGGG---------GSSC---------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc--hhhh---------hhhc---------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999875432211  0000         0000         112356788999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.3e-37  Score=329.29  Aligned_cols=252  Identities=22%  Similarity=0.239  Sum_probs=199.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC----hhhHHHHHHHHHHHHhcCCCceeeEeeEEE--ecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  585 (835)
                      .++|++.+.||+|+||.||+++.. +++.||||++....    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999985 48899999986542    234678999999999999999999999984  45588


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||++++ |.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 66665432 2346899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCCC--CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGL--FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ..............|+..|+|||++.+..  ++.++||||||+++|||++|+.|+...+....  .    ..+....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~i~~~~---  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--F----ENIGKGS---  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H----HHHHHCC---
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--H----HHHhcCC---
Confidence            65433333344567899999999987644  47899999999999999999999875432111  0    0000000   


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ....    ......+.+++.+|++.||++||+++|+++.
T Consensus       230 ---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ---YAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---CCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---CCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               0011    1234567789999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-37  Score=342.24  Aligned_cols=255  Identities=24%  Similarity=0.294  Sum_probs=201.8

Q ss_pred             hcCCccccccccCCcccEEEEEe----cCCcEEEEEEecCcC----hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      .++|++.+.||+|+||.||+++.    .+++.||||++....    ....+.+.+|+.++.++ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47899999999999999999987    368999999986432    23345677899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999853   345889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +.+..... .......||+.|+|||++.+  ..++.++|||||||+||||++|+.||........ ..........    
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~----  280 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK----  280 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH----
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhc----
Confidence            87543222 22334579999999999986  3578999999999999999999999875432211 0000000000    


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSMI  786 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  786 (835)
                         ..+.    .+......+.+++.+||+.||++||     +++|+++..
T Consensus       281 ---~~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 ---SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---cCCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               0111    1123345678899999999999999     999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-37  Score=338.25  Aligned_cols=261  Identities=25%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             ccHHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcC--CCceeeEeeEE
Q 003264          504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCC  579 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~  579 (835)
                      +.+..+....++|++.+.||+|+||.||+++..+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3444555667899999999999999999999988999999998643  3456678999999999997  59999999999


Q ss_pred             EecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecc
Q 003264          580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  659 (835)
Q Consensus       580 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  659 (835)
                      .+....++||| +.+++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEee
Confidence            99999999999 678899999853   346889999999999999999999998   99999999999996 48999999


Q ss_pred             cCccccccCCCccccccccccccceeCceeecC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-----------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL  728 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~  728 (835)
                      ||+++...............|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.........+
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  249 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence            999987654333333344578999999999865           478889999999999999999999986432211100


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                   ....++......+......+.+++.+||+.+|++||++.|+++.
T Consensus       250 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          250 -------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -------------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                         01111111111111123567889999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-37  Score=340.69  Aligned_cols=267  Identities=24%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChh-----hHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ...++|++.+.||+|+||.||+|++. +|+.||||++......     ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999985 4899999998653211     12467899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++ +|..++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 78887743  3346888999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCccccc--cccc----chhhhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--LLGH----AWNLWK  737 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~--~~~~----~~~~~~  737 (835)
                      .+....  .......+|+.|+|||++.+. .++.++|||||||++|||++|.+|+.........  +...    ....|.
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            764322  223345789999999998764 5899999999999999999999998754421110  0000    000000


Q ss_pred             cc-cchhccCc-ccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DN-RAYELLSP-ALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~-~~~~~~~~-~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .. ...+.... ...    ..........+.+++.+||+.||++||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00 00000000 000    01112334678899999999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=331.79  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=200.0

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..++|++.+.||+|+||.||+|+... |+.||||++....  ..+++.+|+.++.+++||||+++++++.+....++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45789999999999999999999864 8999999987543  34678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999842  2346899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..........     .. ...     ..+.. 
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~-~~~-----~~~~~-  245 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----MI-PTN-----PPPTF-  245 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HH-HHS-----CCCCC-
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HH-hcC-----CCccc-
Confidence              22234578999999999999999999999999999999999999987543211100     00 000     00011 


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             011223456888999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=333.74  Aligned_cols=265  Identities=23%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEE-----------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-----------  580 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----------  580 (835)
                      .++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4789999999999999999999865 8999999998777777788999999999999999999999873           


Q ss_pred             ---ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeE
Q 003264          581 ---EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  656 (835)
Q Consensus       581 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~k  656 (835)
                         +....++||||++ |+|.+++.    ...+++..+..++.||++||+|||+++   |+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999998 69999883    345889999999999999999999998   99999999999997 567999


Q ss_pred             ecccCccccccCCCc-cccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccccch
Q 003264          657 ISDFGMARMFCGDEL-QGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGHAW  733 (835)
Q Consensus       657 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~  733 (835)
                      |+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999987643211 122234567899999998866 6789999999999999999999999976542111 0000000


Q ss_pred             hhhccccchhc------------cCcccc-chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 NLWKDNRAYEL------------LSPALQ-HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ~~~~~~~~~~~------------~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .........++            ..+... .......+..+.+++.+||+.||++||+++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00000000000            000000 01112345678899999999999999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.6e-37  Score=333.51  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=196.8

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ  582 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  582 (835)
                      ..++|++.+.||+|+||.||+|+... ++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34789999999999999999999754 7899999986532        12234588999999999999999999998765


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISD  659 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~D  659 (835)
                      . .++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999998843   346899999999999999999999998   999999999999987665   99999


Q ss_pred             cCccccccCCCccccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|..||........ +..    ..
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~----~~  232 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QI  232 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHH----HH
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHH----HH
Confidence            99998753221   223456899999999874   56789999999999999999999999875432211 000    00


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ....      ...........+..+.+++.+||+.||++||++.|+++
T Consensus       233 ~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGK------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCc------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000      00111122234567889999999999999999999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-37  Score=341.96  Aligned_cols=270  Identities=22%  Similarity=0.256  Sum_probs=200.4

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC-----------hhhHHHHHHHHHHHHhcCCCcee
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-----------GQGLKEFKNEMMLIAKLQHRNLV  573 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~H~niv  573 (835)
                      ...++....++|++.+.||+|+||.||+|+..+++.||||++....           ....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567778889999999999999999999999889999999985431           12347899999999999999999


Q ss_pred             eEeeEEEec-----CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          574 RLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       574 ~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ++++++...     ...++||||++ |+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998653     36799999998 577777753  3346899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~  727 (835)
                      ++.++.+||+|||+++.....   .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-  242 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-  242 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999999999754322   22334578999999999877 6799999999999999999999999976442111 


Q ss_pred             ccccchhhh-----------ccccchhcc-------CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          728 LLGHAWNLW-----------KDNRAYELL-------SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       728 ~~~~~~~~~-----------~~~~~~~~~-------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ........           ......+..       ...............+.+++.+||+.||++||++.|+++.
T Consensus       243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             00000000           000000000       0000011122334568899999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-37  Score=338.83  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChh-----------------hHHHHHHHHHHHHhcCCCceeeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL  575 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l  575 (835)
                      .++|++.+.||+|+||.||+|+. +++.||||++......                 ..+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 8999999998643211                 12789999999999999999999


Q ss_pred             eeEEEecCeEEEEEEecCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEE
Q 003264          576 MGCCVEQGEKILIYEYMPNKSLNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL  648 (835)
Q Consensus       576 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NIL  648 (835)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||++||+|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 124678999999999999999999998 77   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCC-CCCc-cccchhHHHHHHHHHhCCCCCCCCCcccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSV-KSDVFSFGVLLLETLTSKRNTGVYDIESF  726 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlGvvl~elltG~~p~~~~~~~~~  726 (835)
                      ++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999875432    23446789999999999887 6666 99999999999999999999976443110


Q ss_pred             cccccchh---hhcc--ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          727 NLLGHAWN---LWKD--NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       727 ~~~~~~~~---~~~~--~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .......   .+..  ........+.............+.+++.+||+.||++||++.|+++.
T Consensus       261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             0000000   0000  00000000000011113345678899999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.6e-38  Score=335.14  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=187.0

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-h-hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-G-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.+.||+|+||.||+++.. +++.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999974 58899999997542 2 2233455555668888999999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      |||+++ +|.+++... .....+++..+..++.||+.||+|||++ +   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999984 777766331 2345689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceee----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYA----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+.........+..    .....   
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~---  230 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEP---  230 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHSC---
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----HhccC---
Confidence            4322   22334689999999996    5567899999999999999999999998753322111110    00000   


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .+..   .....+..+.+++.+|++.+|++||++.|+++
T Consensus       231 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               0111   11123456788999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-36  Score=338.40  Aligned_cols=261  Identities=23%  Similarity=0.252  Sum_probs=194.5

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999875 4889999998653  3445677899999999999999999999998665      


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++||||+++ +|.+++.     ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999985 6777763     23789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-cccc----chhhhc
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLGH----AWNLWK  737 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~~----~~~~~~  737 (835)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . +...    ....+.
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865322   122345789999999999999999999999999999999999999976542111 0 0000    000000


Q ss_pred             -----------------cccchhccCccc---cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 -----------------DNRAYELLSPAL---QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 -----------------~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                       ............   ...........+.+|+.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                             000000000000   112233446788999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.7e-37  Score=353.44  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.++||+|+||+||+++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3478999999999999999999985 5899999998643  233467889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc---CCCCeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~  665 (835)
                      |||+++|+|.+.+..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999888843   345899999999999999999999998   99999999999995   456799999999986


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........  ...   . .....    
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---i-~~~~~----  239 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LKR---V-ETGKY----  239 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH---H-HHTCC----
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---H-HhCCC----
Confidence            64322   2334579999999998875 599999999999999999999999975432211  100   0 00000    


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ..........+..+.+++.+||+.+|++|||+.|+++.
T Consensus       240 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 --AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00011112234567899999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.2e-37  Score=327.94  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999986 58999999986432   23456889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999843   245889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..   ......+++.|+|||.+.+..+ +.++||||||++++||++|+.|+........  .    .......      .
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~~~------~  228 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--F----KKIRGGV------F  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHHCC------C
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H----HHhhcCc------c
Confidence            22   1234568999999999988765 6899999999999999999999875332111  0    0000000      0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..    +......+.+++.+|++.+|++||++.|+++.
T Consensus       229 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            01    11223567889999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.7e-37  Score=353.45  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcCh-------------hhHHHHHHHHHHHHhcCCCceeeEee
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      ..++|++.++||+|+||+||+|+... ++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999864 78999999865321             33577899999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC---C
Q 003264          578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---N  654 (835)
Q Consensus       578 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~  654 (835)
                      ++.+....++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999988843   345899999999999999999999998   99999999999998776   6


Q ss_pred             eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          655 PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       655 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      +||+|||+++.+....   ......||+.|+|||++. ..++.++|||||||++|||++|..||........  ..    
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IK----  257 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----
Confidence            9999999998764332   233457999999999876 5699999999999999999999999976442211  00    


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+....      ...........+..+.+++.+||+.+|++|||++|+++.
T Consensus       258 ~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          258 KVEKGK------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHCC------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHcCC------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000      000111112335678899999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.1e-37  Score=354.47  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=198.4

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.++||+|+||+||+|+.. .+..||||++....  ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999986 58899999987542  33457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC---CCeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~  665 (835)
                      |||+++|+|.+.+..   ...+++..+..++.||++||+|||+++   |+||||||+|||++..   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999888743   345889999999999999999999998   9999999999999764   4599999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      +....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||........  ...   . .... ... 
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---i-~~~~-~~~-  256 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LRK---V-EKGK-YTF-  256 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH---H-HHTC-CCC-
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---H-HhCC-CCC-
Confidence            64332   233457999999999875 5799999999999999999999999976442211  000   0 0000 000 


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          ........+..+.+++.+||+.+|++|||+.|+++.
T Consensus       257 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 ----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                011112234567889999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.4e-37  Score=355.17  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ..++|++.++||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3468999999999999999999986 58999999986432   3456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---cCCCCeEecccCccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMAR  664 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~  664 (835)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999998854   345899999999999999999999998   9999999999999   567899999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .+....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+....  ...   . ..... . 
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---i-~~~~~-~-  245 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKK---V-EKGKY-T-  245 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH---H-HHCCC-C-
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HHH---H-HcCCC-C-
Confidence            764322   2344579999999998865 699999999999999999999999976442211  100   0 00000 0 


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          .........+..+.+++.+||+.+|++|||+.|+++.
T Consensus       246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                0011112344668899999999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-36  Score=327.71  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=203.2

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---------hhhHHHHHHHHHHHHhcC-CCceeeEeeEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCV  580 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~  580 (835)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....         ....+.+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999985 48899999986442         123467889999999995 999999999999


Q ss_pred             ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       581 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                      +....++||||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999843   346899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeec------CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYAL------DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      |++..+....   ......+++.|+|||++.      ...++.++||||||++++||++|+.|+........  ..   .
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~---~  240 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LR---M  240 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---H
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HH---H
Confidence            9998764322   223456899999999885      45688999999999999999999999865432111  00   0


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ... .. ..     .........+..+.+++.+|++.+|++||++.|+++
T Consensus       241 ~~~-~~-~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMS-GN-YQ-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHH-TC-CC-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Hhc-CC-cc-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            000 00 00     001111234566889999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-37  Score=346.22  Aligned_cols=262  Identities=20%  Similarity=0.267  Sum_probs=196.8

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe------EE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE------KI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~  586 (835)
                      ..+|++.+.||+|+||.||+|++..+..||+|++.....    ...+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999998877899998864322    12369999999999999999999976543      78


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeEecccCcccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM  665 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~  665 (835)
                      +||||++++.+............+++..+..++.||++||+|||+++   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999998765544322223456899999999999999999999998   99999999999999 799999999999987


Q ss_pred             ccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch-------hhhc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW-------NLWK  737 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~~~  737 (835)
                      +....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.... +.....       ..+.
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            64332   22345789999999998765 589999999999999999999999976542211 000000       0000


Q ss_pred             --cccchhccCccc-----cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 --DNRAYELLSPAL-----QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 --~~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        .....+..-+..     ...........+.+++.+||+.||++||++.|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence              000000000000     011112244578899999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=337.28  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=199.0

Q ss_pred             cHHHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe-
Q 003264          505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE-  581 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-  581 (835)
                      .+.++....++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444556789999999999999999999984 58999999986543 3446789999999999 89999999999987 


Q ss_pred             -----cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeE
Q 003264          582 -----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  656 (835)
Q Consensus       582 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  656 (835)
                           ....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 46789999999999999998543 2346889999999999999999999998   99999999999999999999


Q ss_pred             ecccCccccccCCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc
Q 003264          657 ISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH  731 (835)
Q Consensus       657 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~  731 (835)
                      |+|||++.......  .......|++.|+|||++.     +..++.++||||||+++|||++|+.|+.........    
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----  243 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----  243 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----
T ss_pred             EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----
Confidence            99999998653221  1223457899999999987     567899999999999999999999998654321110    


Q ss_pred             chhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       ... ...     ..+...   ....+..+.+++.+||+.+|++||++.|+++
T Consensus       244 -~~~-~~~-----~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 -FLI-PRN-----PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -HHH-HHS-----CCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHh-hcC-----ccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             000 000     001110   1122356788999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.8e-37  Score=338.52  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=201.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  585 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999975 57889999997543 34457889999999999999999999999765     368


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 588888842    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccc----
Q 003264          666 FCGDELQ-GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN----  739 (835)
Q Consensus       666 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----  739 (835)
                      ....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  ...........    
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED  255 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence            6433221 122445799999999987654 589999999999999999999999976542211  00000000000    


Q ss_pred             -----------cchhccCcccc--chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          740 -----------RAYELLSPALQ--HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       740 -----------~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                 .......+...  ..........+.+++.+||+.||++||++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       00000000000  01111234568899999999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.6e-37  Score=340.77  Aligned_cols=260  Identities=26%  Similarity=0.316  Sum_probs=184.6

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------C
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  583 (835)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999874 5889999998653  334567888999999999999999999998754      5


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6889888732    46899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccc-cccccc-----chhhh
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES-FNLLGH-----AWNLW  736 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~-----~~~~~  736 (835)
                      +....     ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...+... ......     ....+
T Consensus       180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86532     2334678999999999887 679999999999999999999999997654211 100000     00000


Q ss_pred             c---cccchhc---cCcccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 K---DNRAYEL---LSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~---~~~~~~~---~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .   .......   +.....   ..........+.+|+.+||+.||++||++.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0   0000000   000000   00111224567899999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.8e-37  Score=345.39  Aligned_cols=200  Identities=24%  Similarity=0.292  Sum_probs=172.9

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhc------CCCceeeEeeEEEecCe
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL------QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~  584 (835)
                      ...+|++.++||+|+||.||+|+... ++.||||++... ....+.+.+|+.++..+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            34689999999999999999998754 889999999753 34456778888888887      56799999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC--eEecccCc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGM  662 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGl  662 (835)
                      .++||||++ ++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 5888887543 2234899999999999999999999998   999999999999999987  99999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      ++....     ......||+.|+|||++.+..++.++|||||||+||||++|++||...+
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            976432     2234578999999999999999999999999999999999999997654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-37  Score=366.82  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=204.6

Q ss_pred             hhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCc---ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  586 (835)
                      ..++|+++++||+|+||.||+|+... ++.||||++++.   .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45789999999999999999999754 789999998753   223456788899999988 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      |||||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999853   346899999999999999999999998   999999999999999999999999999864


Q ss_pred             cCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+....  ..   .+.. .       
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~---~i~~-~-------  557 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---SIME-H-------  557 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHS-S-------
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HH---HHHh-C-------
Confidence            3222  234456899999999999999999999999999999999999999976442211  00   0100 0       


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTM-----SKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  784 (835)
                       ..  ..+......+.+|+..||+.||++||++     +||++
T Consensus       558 -~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 -NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             00  1112345668899999999999999998     77764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.8e-37  Score=342.44  Aligned_cols=261  Identities=21%  Similarity=0.237  Sum_probs=200.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC--------CCceeeEeeEEE---
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLMGCCV---  580 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~---  580 (835)
                      .++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999875 4889999999753 445677899999999995        788999999988   


Q ss_pred             -ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCC-----
Q 003264          581 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM-----  653 (835)
Q Consensus       581 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~-----  653 (835)
                       +....++||||+.+ +|.+.+... ....+++..+..++.||++||+|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             45688999999955 554444322 234589999999999999999999998 7   99999999999998775     


Q ss_pred             --------------------------------------------CeEecccCccccccCCCccccccccccccceeCcee
Q 003264          654 --------------------------------------------NPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY  689 (835)
Q Consensus       654 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  689 (835)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        8999999999875322     233578999999999


Q ss_pred             ecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc----cccchhh--------h----------cc-ccchhccC
Q 003264          690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL----LGHAWNL--------W----------KD-NRAYELLS  746 (835)
Q Consensus       690 ~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~----~~~~~~~--------~----------~~-~~~~~~~~  746 (835)
                      +.+..++.++|||||||+||||++|+.||..........    .......        +          .. .....+.+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999997654322110    0000000        0          00 00000000


Q ss_pred             ccc---------cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PAL---------QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ...         ....+......+.+|+.+||+.||++||+++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000         01124566778999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.8e-37  Score=339.16  Aligned_cols=271  Identities=19%  Similarity=0.234  Sum_probs=190.8

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe-
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-  584 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-  584 (835)
                      .......++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445567789999999999999999999985 48999999986532 233456778888999999999999999987544 


Q ss_pred             ------EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCcEEEecCCCCeEEEcC-CCCe
Q 003264          585 ------KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDS-DMNP  655 (835)
Q Consensus       585 ------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivHrDlkp~NILl~~-~~~~  655 (835)
                            .++||||++++.+..+.........+++..+..++.||+.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987543332221234456889999999999999999999  776   999999999999996 8999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch-
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW-  733 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  733 (835)
                      ||+|||+++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.... +..... 
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~  247 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRV  247 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHH
Confidence            999999998764332   22345689999999998765 489999999999999999999999976542211 000000 


Q ss_pred             ------hhh---c-cccchhccCcc------ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 ------NLW---K-DNRAYELLSPA------LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ------~~~---~-~~~~~~~~~~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                            ..+   . ...........      ............+.+++.+||+.||++||++.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  000   0 00000000000      0001111245678899999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.8e-37  Score=346.41  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------eEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------EKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~  586 (835)
                      .+|++.+.||+|+||.||+|++. +++.||||++....    +.+.+|+++|++++|||||++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            47999999999999999999985 48999999986532    22347999999999999999999986532      367


Q ss_pred             EEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCccc
Q 003264          587 LIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  664 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~  664 (835)
                      +||||+++ +|..++.. ......+++..+..++.||++||+|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 45444422 123456899999999999999999999988   9999999999999965 568999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch-------hhh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW-------NLW  736 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~~  736 (835)
                      .+....   ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||...+.... +.....       ..+
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence            764332   22345789999999998765 799999999999999999999999976442111 100000       000


Q ss_pred             c--cccchhccCccccc-----hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 K--DNRAYELLSPALQH-----EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~--~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .  .....+...+.+..     .........+.+|+.+||+.||++||++.|+++.
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0  00000111111110     0112234678899999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-36  Score=336.91  Aligned_cols=260  Identities=22%  Similarity=0.296  Sum_probs=197.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE---
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK---  585 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---  585 (835)
                      ..++|.+.+.||+|+||.||+|++. +|+.||||++...  .....+++.+|+.++++++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3478999999999999999999975 4889999999754  334467889999999999999999999999877654   


Q ss_pred             ---EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          586 ---ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       586 ---~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                         ++||||++ ++|.+++.     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 67877762     23899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-c-c---cc----
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-L-G---HA----  732 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~-~---~~----  732 (835)
                      ++....     ......||+.|+|||++.+ ..++.++||||||++++||++|+.||...+...... . .   ..    
T Consensus       191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            986532     2234578999999999887 689999999999999999999999997644221100 0 0   00    


Q ss_pred             hhhhccccc---hhccCccccc---hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          733 WNLWKDNRA---YELLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       733 ~~~~~~~~~---~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...+.....   ...+......   .........+.+|+.+||+.||++||++.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000000000   0000000000   1112235678899999999999999999999865

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-36  Score=334.84  Aligned_cols=265  Identities=24%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  585 (835)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.... .....++.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999985 48899999997543 34456788999999999999999999988764     678


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++||||++ ++|.+++..    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 588888843    45899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccc--------cccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccccccc-----
Q 003264          666 FCGDELQG--------NTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-----  731 (835)
Q Consensus       666 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~-----  731 (835)
                      ........        ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...+.........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            64322111        1223578999999998765 678999999999999999999999997654221100000     


Q ss_pred             -----chhhhccccchhc----cC--ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          732 -----AWNLWKDNRAYEL----LS--PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       732 -----~~~~~~~~~~~~~----~~--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           ...........+.    ..  ..............+.+++.+||+.||++||+++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 0000000000000    00  000001112345678899999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.7e-37  Score=363.85  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  584 (835)
                      ....++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.++++++||||+++++++. .+.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3445789999999999999999998743    457999998754 3445578999999999999999999999985 467


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++|+|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence            89999999999999999532  345889999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchh
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........  ..    .+....   
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~----~i~~~~---  609 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE---  609 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHHTC---
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----HHHcCC---
Confidence            7643322 12223456789999999999999999999999999999997 8999875432211  00    000000   


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        ..    ..+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       610 --~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          610 --RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              00    11123345688899999999999999999999999876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-37  Score=342.26  Aligned_cols=264  Identities=19%  Similarity=0.236  Sum_probs=195.2

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------  582 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  582 (835)
                      ....++|++.+.||+|+||.||+|++. +++.||||++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345689999999999999999999874 589999999865422    234799999999999999999998543      


Q ss_pred             --------------------------------CeEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 003264          583 --------------------------------GEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYL  629 (835)
Q Consensus       583 --------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL  629 (835)
                                                      ...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 4776666431 2345689999999999999999999


Q ss_pred             HhcCCCcEEEecCCCCeEEEc-CCCCeEecccCccccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHH
Q 003264          630 HQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVL  707 (835)
Q Consensus       630 H~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvv  707 (835)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+....   ......+|+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9988   99999999999998 68899999999998764332   22345689999999998775 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccccccccch-------hhh-------ccccchhccCccccchhHHHHHHHHHHHHHhccccCC
Q 003264          708 LLETLTSKRNTGVYDIESFNLLGHAW-------NLW-------KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKA  773 (835)
Q Consensus       708 l~elltG~~p~~~~~~~~~~~~~~~~-------~~~-------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP  773 (835)
                      +|||++|+.||........ +.....       ..+       .................+...+..+.+++.+||+.+|
T Consensus       232 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999976442211 000000       000       0000000000111111222244568899999999999


Q ss_pred             CCCCCHHHHHHH
Q 003264          774 ADRPTMSKVVSM  785 (835)
Q Consensus       774 ~~RPs~~evl~~  785 (835)
                      ++|||+.|+++.
T Consensus       311 ~~R~t~~e~l~h  322 (383)
T 3eb0_A          311 DLRINPYEAMAH  322 (383)
T ss_dssp             GGSCCHHHHHTS
T ss_pred             hhCCCHHHHhcC
Confidence            999999999853

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-36  Score=329.91  Aligned_cols=266  Identities=25%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             hhcCCccccccccCCcccEEEEEec--CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhc---CCCceeeEeeEEE----
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCV----  580 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~----  580 (835)
                      ..++|++.+.||+|+||.||+|+..  +++.||||++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999983  57899999986432  12223556777777766   8999999999987    


Q ss_pred             -ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecc
Q 003264          581 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  659 (835)
Q Consensus       581 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  659 (835)
                       .....++||||++ |+|.+++.... ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 69998885432 234889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-c-cccc----ch
Q 003264          660 FGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-N-LLGH----AW  733 (835)
Q Consensus       660 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~-~~~~----~~  733 (835)
                      ||+++.....   .......||..|+|||++.+..++.++||||||+++|||++|+.||........ . +...    ..
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9999865322   123345789999999999999999999999999999999999999976442211 0 0000    00


Q ss_pred             hhhccc-----cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          734 NLWKDN-----RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       734 ~~~~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..+...     .....................+.+++.+||+.||++||++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000     0000000000011122344667889999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-36  Score=328.63  Aligned_cols=262  Identities=21%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             hcCCccccccccCCcccEEEEEe--cCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc------eeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKL--LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+++.  .+++.||||++... ....+.+.+|+.++..++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999987  35889999999753 345677899999999997654      9999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------------  651 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------------  651 (835)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999888543 2235889999999999999999999998   999999999999987             


Q ss_pred             ------CCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc
Q 003264          652 ------DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  725 (835)
Q Consensus       652 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~  725 (835)
                            ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  67899999999986432     2234578999999999999999999999999999999999999997654321


Q ss_pred             c-ccccc-----chhhhcccc---------------------chhccCccc-cchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          726 F-NLLGH-----AWNLWKDNR---------------------AYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       726 ~-~~~~~-----~~~~~~~~~---------------------~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                      . .....     ....+....                     ..+...+.. ...........+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            1 00000     000000000                     000000000 0011224567789999999999999999


Q ss_pred             CHHHHHHH
Q 003264          778 TMSKVVSM  785 (835)
Q Consensus       778 s~~evl~~  785 (835)
                      ++.|+++.
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999854

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-36  Score=326.07  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe---------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE---------  581 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  581 (835)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3568999999999999999999975 589999999864 34456789999999999999999999999875         


Q ss_pred             ----cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          582 ----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       582 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                          ....++||||+++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                3567999999999999999953  2345778899999999999999999998   999999999999999999999


Q ss_pred             cccCccccccCCCc------------cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcc
Q 003264          658 SDFGMARMFCGDEL------------QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIE  724 (835)
Q Consensus       658 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~  724 (835)
                      +|||+++.......            ........|+..|+|||++.+. .++.++||||||+++|||++   |+......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            99999987542210            1122345789999999998764 78999999999999999998   43321100


Q ss_pred             cccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          725 SFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .....    .+..      .........+...+..+.+++.+||+.||++||++.|+++.
T Consensus       235 -~~~~~----~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 -VNILK----KLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -HHHHH----HHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -HHHHH----hccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence             00000    0000      01111122223344567889999999999999999999964

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-36  Score=329.96  Aligned_cols=255  Identities=26%  Similarity=0.370  Sum_probs=178.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHH-HHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999985 58899999997643 334455666666 677789999999999999999999999


Q ss_pred             EecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          590 EYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       590 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ||+++ +|.+++..  ......+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 77666632  11245689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceee----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYA----LDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........+..    ... .   
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~-~---  245 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----VVK-G---  245 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----CCC-S---
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----Hhc-C---
Confidence            4322   12234689999999998    4567899999999999999999999998753321111100    000 0   


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                        ..+.+...........+.+++.+||+.||++||++.|+++
T Consensus       246 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 --DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              0011111111123456888999999999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=340.97  Aligned_cols=204  Identities=27%  Similarity=0.432  Sum_probs=155.1

Q ss_pred             hcCCcc-ccccccCCcccEEEEEec---CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEE
Q 003264          513 TENFSM-QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKI  586 (835)
Q Consensus       513 ~~~~~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~  586 (835)
                      .+.|++ .++||+|+||.||+|+..   +++.||||++.....  .+.+.+|+.+|++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            355666 458999999999999965   478899999975432  3567899999999999999999999965  66899


Q ss_pred             EEEEecCCCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE----cCCCCeE
Q 003264          587 LIYEYMPNKSLNFFLFD------PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPK  656 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~k  656 (835)
                      +||||+++ +|.+++..      ......+++..+..++.||+.||+|||+++   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 66666631      112235899999999999999999999998   9999999999999    6788999


Q ss_pred             ecccCccccccCCCc-cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          657 ISDFGMARMFCGDEL-QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       657 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      |+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999999987643221 1223456789999999999874 58999999999999999999999997543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-36  Score=321.45  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             HhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999986 5899999998643  23456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC---CCeEecccCccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMAR  664 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~  664 (835)
                      |+||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999888743   245889999999999999999999998   9999999999999754   469999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ......   ......+++.|+|||.+.+ .++.++||||||+++|||++|+.|+........  ..    .+..... . 
T Consensus       173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~~-~-  240 (287)
T 2wei_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LK----RVETGKY-A-  240 (287)
T ss_dssp             TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCCC-C-
T ss_pred             eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcCCC-C-
Confidence            764322   1223458999999998765 489999999999999999999999875432211  00    0000000 0 


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          .........+..+.+++.+|++.+|++||++.|+++
T Consensus       241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                000111123456888999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-36  Score=339.64  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=187.7

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445567889999999998776667999999998643   245678899999987 8999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-------------CCe
Q 003264          593 PNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-------------MNP  655 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~  655 (835)
                      + |+|.+++.......    ...+..++.++.||+.||+|||+++   |+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999996532211    1234456789999999999999998   9999999999999754             489


Q ss_pred             EecccCccccccCCCcc--ccccccccccceeCceeecC-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCccc
Q 003264          656 KISDFGMARMFCGDELQ--GNTKRVVGTYGYMSPEYALD-------GLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIES  725 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~  725 (835)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221  12234679999999999865       678999999999999999999 899986433221


Q ss_pred             ccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..+..       ...  ..  +..........+..+.+++.+||+.||++||++.|+++
T Consensus       248 ~~i~~-------~~~--~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNIIR-------GIF--SL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHH-------TCC--CC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhc-------CCC--Cc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11110       000  00  01111122355678899999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.4e-36  Score=329.59  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe-----
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  584 (835)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++...  .....+++.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            368999999999999999999975 5899999999654  33446788999999999999999999999987654     


Q ss_pred             -EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          585 -KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       585 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 58877762     23899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh-------
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL-------  735 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-------  735 (835)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||...+....  .......       
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE  246 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            864321     234578999999999877 6789999999999999999999999976442110  0000000       


Q ss_pred             ----hcccc---chhccCcccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          736 ----WKDNR---AYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       736 ----~~~~~---~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                          +....   ....+.....   ..........+.+++.+|++.||++||++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                00000   0000000000   01112345678899999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-35  Score=330.61  Aligned_cols=204  Identities=25%  Similarity=0.318  Sum_probs=172.3

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CC-----ceeeEeeEEEec
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLMGCCVEQ  582 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~  582 (835)
                      ....++|++.+.||+|+||+||+|+.. +++.||||++... .....++..|+.++..++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            344689999999999999999999975 4789999999753 344567888999998884 55     499999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCCCeEeccc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDF  660 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DF  660 (835)
                      +..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++ ..+|+||||||+||||+  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 58988885432 24589999999999999999999952 12499999999999995  5788999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYD  722 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~  722 (835)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999876322     234578999999999999999999999999999999999999998654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.6e-36  Score=326.80  Aligned_cols=254  Identities=19%  Similarity=0.198  Sum_probs=174.2

Q ss_pred             hhcCCcccc-ccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeE
Q 003264          512 ATENFSMQC-KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       512 ~~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  585 (835)
                      ..++|.+.+ .||+|+||.||+|++. +++.||||++....    ....+....+..++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            347899965 6999999999999986 58999999986532    122223344567799999999999986    4458


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  662 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  662 (835)
                      ++||||+++|+|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999653 2346899999999999999999999998   999999999999976   45599999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ++.....    ......+|+.|+|||++.+..++.++||||||+++|||++|+.||............  .......   
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~---  248 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLG---  248 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhcc---
Confidence            9865322    223456899999999998889999999999999999999999998654322110000  0000000   


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         ............+..+.+++.+||+.||++||++.|+++.
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               0000111112234568889999999999999999999983

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-35  Score=328.66  Aligned_cols=262  Identities=20%  Similarity=0.280  Sum_probs=199.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-----------CCceeeEeeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCV  580 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  580 (835)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999974 5889999999753 344577889999999886           899999999998


Q ss_pred             ecC----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEc-----
Q 003264          581 EQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD-----  650 (835)
Q Consensus       581 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~-----  650 (835)
                      ..+    ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +   |+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            764    789999999 88999988543 234588999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-
Q 003264          651 -SDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-  728 (835)
Q Consensus       651 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-  728 (835)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... 
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             3447999999999865322     233578999999999999999999999999999999999999997544221100 


Q ss_pred             ---cccchhh--------h----------ccccchhccCc----------cccchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          729 ---LGHAWNL--------W----------KDNRAYELLSP----------ALQHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       729 ---~~~~~~~--------~----------~~~~~~~~~~~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                         .......        +          ........+..          ......+......+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence               0000000        0          00000000000          000123356778899999999999999999


Q ss_pred             CHHHHHHH
Q 003264          778 TMSKVVSM  785 (835)
Q Consensus       778 s~~evl~~  785 (835)
                      +++|+++.
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=327.30  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=190.7

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhc----CCCceeeEee
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKL----QHRNLVRLMG  577 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~  577 (835)
                      .....++|++.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445688999999999999999999874 588999999965432      1233466799999999    8999999999


Q ss_pred             EEEecCeEEEEEEe-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCe
Q 003264          578 CCVEQGEKILIYEY-MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNP  655 (835)
Q Consensus       578 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~  655 (835)
                      ++.+.+..++|+|| +++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999853   345899999999999999999999998   99999999999999 88999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFS-VKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++......    .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.....           
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------  244 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence            999999998764332    2345689999999998877664 589999999999999999999864210           


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .....       ..+    +......+.+++.+||+.+|++||+++|+++.
T Consensus       245 ~~~~~-------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 ILEAE-------LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHHTC-------CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             Hhhhc-------cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000       000    11233567889999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-35  Score=324.36  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=198.4

Q ss_pred             hcCCccccccccCCcccEEEEEecC-C-cEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc------eeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-G-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  584 (835)
                      .++|++.+.||+|+||.||+|+... + +.||||++... ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4789999999999999999999753 4 68999999753 345577889999999998766      9999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE---------------
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---------------  649 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---------------  649 (835)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 55565555332 2245899999999999999999999988   9999999999999               


Q ss_pred             ----cCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccc
Q 003264          650 ----DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES  725 (835)
Q Consensus       650 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~  725 (835)
                          +.++.+||+|||+++....     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                6788999999999986432     2234578999999999999999999999999999999999999998654221


Q ss_pred             c-cccccc-----hhhh---ccccc------------------hhccCcc-ccchhHHHHHHHHHHHHHhccccCCCCCC
Q 003264          726 F-NLLGHA-----WNLW---KDNRA------------------YELLSPA-LQHEASYQMLNRYITVALLCVQEKAADRP  777 (835)
Q Consensus       726 ~-~~~~~~-----~~~~---~~~~~------------------~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RP  777 (835)
                      . ......     ...+   .....                  .+...+. ............+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            1 000000     0000   00000                  0000000 00001123356788999999999999999


Q ss_pred             CHHHHHH
Q 003264          778 TMSKVVS  784 (835)
Q Consensus       778 s~~evl~  784 (835)
                      ++.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-36  Score=327.98  Aligned_cols=244  Identities=21%  Similarity=0.331  Sum_probs=198.4

Q ss_pred             HHhhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhcC--CCceeeEeeEEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLMGCCV  580 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~  580 (835)
                      ....++|++.+.||+|+||.||+|+.. +++.||||++.....      ...+.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344578999999999999999999864 588999999865421      12345678999999996  599999999999


Q ss_pred             ecCeEEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeEec
Q 003264          581 EQGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKIS  658 (835)
Q Consensus       581 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~  658 (835)
                      +.+..++|+|++.+ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 899999843   346889999999999999999999998   99999999999999 78999999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......           ..
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----------~~  257 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------IR  257 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------HH
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----------hc
Confidence            999998764322    233568999999999887765 67899999999999999999998642210           00


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..   ...    .    ......+.+++.+||+.+|++||+++|+++.
T Consensus       258 ~~---~~~----~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQ---VFF----R----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC---CCC----S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc---ccc----c----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   000    0    1123467889999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=333.36  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=187.2

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ...+|++.+.||+|+||+|+.....+++.||||++.....   ..+.+|+.+++++ +|||||++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3457999999999999997655556789999999965432   2356799999999 89999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-----CCCeEecccCcccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM  665 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~  665 (835)
                      |++ |+|.+++....  ....+..+..++.||++||+|||+++   |+||||||+||||+.     ...+||+|||+++.
T Consensus        99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            997 58999885432  23445567899999999999999998   999999999999953     33578999999987


Q ss_pred             ccCCCc-cccccccccccceeCceeec---CCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhcccc
Q 003264          666 FCGDEL-QGNTKRVVGTYGYMSPEYAL---DGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNR  740 (835)
Q Consensus       666 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  740 (835)
                      +..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..|+...........       ....
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~  245 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------LGAC  245 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------TTCC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------hccC
Confidence            643321 12234467999999999987   4567889999999999999999 8888864332211110       0000


Q ss_pred             chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          741 AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       741 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ......      ........+.+++.+||+.||++||++.|+++
T Consensus       246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            001111      11223455778999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=318.61  Aligned_cols=253  Identities=21%  Similarity=0.357  Sum_probs=180.0

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.....  ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3478999999999999999999985 589999999975432  2234455556678888999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      |||+ ++.+..+...  ....+++..+..++.||++||+|||+. +   |+||||||+|||++.++.+||+|||++..+.
T Consensus       103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 4555554421  234688999999999999999999985 7   9999999999999999999999999997654


Q ss_pred             CCCccccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ...   ......+++.|+|||++.     ...++.++||||||+++|||++|+.||........ ...   ......   
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~~~---  246 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLT---KVLQEE---  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHH---HHHHSC---
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHH---HHhccC---
Confidence            322   223456899999999984     45788999999999999999999999875332111 000   000000   


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .+.+..  ....+..+.+++.+||+.||++||++.|+++.
T Consensus       247 ---~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          247 ---PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               000100  01133567889999999999999999999863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-35  Score=345.70  Aligned_cols=262  Identities=25%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe------cCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  584 (835)
                      .++|++.++||+|+||.||+|++. +|+.||||++... .....+.+.+|+.++.+++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999999874 4889999998754 44556789999999999999999999998765      667


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCC---eEecccC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFG  661 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFG  661 (835)
                      .++||||+++|+|.+++........+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555556899999999999999999999988   999999999999997765   9999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccch-----hhh
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAW-----NLW  736 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~~  736 (835)
                      +++......   ......||+.|+|||.+.+..++.++||||||+++|||++|..||........ ......     ...
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CC
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhh
Confidence            998764332   22346789999999999999999999999999999999999999865321100 000000     000


Q ss_pred             ccccch--hccCc--cccchhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003264          737 KDNRAY--ELLSP--ALQHEASYQMLNRYITVALLCVQEKAADRPTMSK  781 (835)
Q Consensus       737 ~~~~~~--~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  781 (835)
                      ......  .....  .............+.+++..|++.||++||++.|
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000000  00000  0011223345677889999999999999999977

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-34  Score=347.75  Aligned_cols=238  Identities=20%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             hcCCccccccccCCcccEEEEEec--CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCe-----
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-----  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  584 (835)
                      .++|++.+.||+|+||.||+|++.  +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999985  5899999998654 34456778999999999999999999999998766     


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .+|||||+++++|.+++..     .+++..++.++.||++||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887632     5899999999999999999999998   9999999999999885 89999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .....      ....||+.|+|||++.+.. +.++|||||||+|+||++|..|+.......                  +
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~  284 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L  284 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------c
Confidence            75332      3457999999999887654 899999999999999999988765311100                  0


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITN  788 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~  788 (835)
                      .    ...........+.+++.+||+.||++|| +++++.+.|..
T Consensus       285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0    0111223346788999999999999999 46666666554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-34  Score=308.39  Aligned_cols=232  Identities=12%  Similarity=0.087  Sum_probs=185.6

Q ss_pred             hcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      .++|++.+.||+|+||.||+|++.. ++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3689999999999999999999865 8999999997542   34457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..    . ....++.+++.||++||+|||+++   |+||||||+|||++.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    2 355678899999999999999998   9999999999999999999998544       


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                                     |++|       ++.++||||||+++|||++|+.||............  .......       +.
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~~~-------~~  223 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERDTAGQ-------PI  223 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--CBCTTSC-------BC
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--HHHhccC-------CC
Confidence                           3333       688999999999999999999999865432210000  0000000       00


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      .........+..+.+++.+||+.||++| |+.|+++.|+....
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0011122344568899999999999999 99999999988643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-33  Score=304.20  Aligned_cols=232  Identities=18%  Similarity=0.209  Sum_probs=180.2

Q ss_pred             hcCCccc-cccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHH-HhcCCCceeeEeeEEEe----cCeE
Q 003264          513 TENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLI-AKLQHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       513 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~  585 (835)
                      .++|.+. +.||+|+||.||+++.. +++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3678887 78999999999999974 5889999998642     4567888888 55599999999999987    6788


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  662 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  662 (835)
                      ++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999643 2346899999999999999999999998   999999999999998   78999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      +....                        +..++.++||||||+++|||++|+.||...........  .....      
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~------  214 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRI------  214 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSS------
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHH------
Confidence            86532                        24567899999999999999999999865432211000  00000      


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ...............+..+.+++.+||+.||++||++.|+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000011111112345678899999999999999999999974

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-34  Score=323.32  Aligned_cols=242  Identities=15%  Similarity=0.170  Sum_probs=178.8

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCC-Cce--------------
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQH-RNL--------------  572 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~ni--------------  572 (835)
                      ...+|...++||+|+||.||+|++. +|+.||||++....   ....+.+++|+.++..++| +|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456888899999999999999964 58999999987432   2336789999999999977 221              


Q ss_pred             -ee------EeeEEEe-----cCeEEEEEEecCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003264          573 -VR------LMGCCVE-----QGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR  636 (835)
Q Consensus       573 -v~------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  636 (835)
                       +.      +..++..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence             11      1111111     12456666654 6889888731    123445788899999999999999999998   


Q ss_pred             EEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceee----------cCCCCCccccchhHHH
Q 003264          637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA----------LDGLFSVKSDVFSFGV  706 (835)
Q Consensus       637 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlGv  706 (835)
                      |+||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998864322     334567 999999999          5566889999999999


Q ss_pred             HHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003264          707 LLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       707 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  783 (835)
                      ++|||++|+.||........  ..            ..+..  ..    ..+..+.+++.+||+.+|++||++.|++
T Consensus       306 il~elltg~~Pf~~~~~~~~--~~------------~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG--SE------------WIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC--SG------------GGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHCCCCCCCcchhhh--HH------------HHHhh--cc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999975432211  00            00000  00    1235688899999999999999976654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-34  Score=316.30  Aligned_cols=242  Identities=16%  Similarity=0.148  Sum_probs=186.9

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcC---------CCceeeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL  575 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l  575 (835)
                      .++|++.++||+|+||+||+|+. +|+.||||++....        ....+.+.+|+.++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 78999999986542        234578899999999886         8888877


Q ss_pred             eeEEE------------------------------ecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 003264          576 MGCCV------------------------------EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG  625 (835)
Q Consensus       576 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  625 (835)
                      .+++.                              +....++||||+++|++.+.+.+    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77653                              26789999999999977666622    458999999999999999


Q ss_pred             HHHHH-hcCCCcEEEecCCCCeEEEcCCC--------------------CeEecccCccccccCCCccccccccccccce
Q 003264          626 LLYLH-QYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARMFCGDELQGNTKRVVGTYGY  684 (835)
Q Consensus       626 L~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  684 (835)
                      |+||| +++   |+||||||+||||+.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 888   99999999999999887                    8999999999876422       35799999


Q ss_pred             eCceeecCCCCCccccchhHHHH-HHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHH
Q 003264          685 MSPEYALDGLFSVKSDVFSFGVL-LLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYIT  763 (835)
Q Consensus       685 ~aPE~~~~~~~s~ksDVwSlGvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  763 (835)
                      +|||++.+.. +.++|||||+++ .+++++|..|+....... ...   ......    ...............+..+.+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-~~~---~~~~~~----~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-YLT---DKMLKQ----MTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-HHH---HHHHHT----CCCSSCCCSHHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-HHH---Hhhhhh----hccCcccchhhhhhcCHHHHH
Confidence            9999998766 899999998777 777888988874210000 000   000000    011111223345567888999


Q ss_pred             HHHhccccCCCCCCCHHHHH
Q 003264          764 VALLCVQEKAADRPTMSKVV  783 (835)
Q Consensus       764 li~~cl~~dP~~RPs~~evl  783 (835)
                      |+.+||+.+     |++|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999966     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.4e-28  Score=287.07  Aligned_cols=185  Identities=16%  Similarity=0.141  Sum_probs=130.7

Q ss_pred             ccccCCcccEEEEEe-cCCcEEEEEEecCc----------ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       521 ~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ..+.|++|.+..++. --|+.||||.+...          .+...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466777777766553 24888999998643          123457799999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||++|++|.++|.+.   ..++..   +|+.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999543   345443   58999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCC
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  717 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p  717 (835)
                      ..  ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  22345689999999998875 467789999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.1e-25  Score=254.33  Aligned_cols=185  Identities=18%  Similarity=0.181  Sum_probs=146.4

Q ss_pred             ccccccccCCcccEEEEEecCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ...++||+|+||.||+|+. .++.+++|+.....        ....+++.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 57889999864321        11245689999999999999999777777788888999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++++|.+++..           +..++.||++||+|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999998   999999999999998  999999999998744


Q ss_pred             CCccc-----cccccccccceeCceeecC--CCCCccccchhHHHHHHHHHhCCCCC
Q 003264          669 DELQG-----NTKRVVGTYGYMSPEYALD--GLFSVKSDVFSFGVLLLETLTSKRNT  718 (835)
Q Consensus       669 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvl~elltG~~p~  718 (835)
                      .....     ......||+.|||||++..  ..|+...|+|+..+-..+.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1235689999999999977  66888899999999999888776654

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.87  E-value=6.5e-22  Score=176.09  Aligned_cols=104  Identities=18%  Similarity=0.355  Sum_probs=92.8

Q ss_pred             CCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCC
Q 003264           26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD  105 (835)
Q Consensus        26 ~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~  105 (835)
                      |+|.+||.|.+|++|.|  |.|.|.|..+|+     |.++.   ..++||+|||+.|. ...+.|+|+.||||||+|+++
T Consensus         2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~~   70 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSSG   70 (105)
T ss_dssp             CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTTC
T ss_pred             CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCCc
Confidence            78999999999999998  889999999987     77765   56999999999994 456899999999999999999


Q ss_pred             ceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       106 ~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      .+||+|++.+......|+|+|||||||++.         .||||
T Consensus        71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S  105 (105)
T 4h3o_A           71 RSLWASHSTRGSGNYILILQDDGNVIIYGS---------DIWST  105 (105)
T ss_dssp             CEEEECCCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred             EEEEEecCCCCCCCEEEEEeCCCeEEEECC---------cEecC
Confidence            999999987666667889999999999964         69998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=3.2e-22  Score=212.78  Aligned_cols=164  Identities=17%  Similarity=0.134  Sum_probs=129.2

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcCh------------------hhHHHHHHHHHHHHhcC
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAKLQ  568 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~  568 (835)
                      ..+......|++.+.||+|+||.||+|+..+|+.||||.+.....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344555677888899999999999999997799999999864321                  13567899999999999


Q ss_pred             CCceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       569 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.||++||+|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              4 666665433 56699999999999988 411         234579999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecC----------CCCCccccchh
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD----------GLFSVKSDVFS  703 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~ksDVwS  703 (835)
                      ++ ++.+||+|||+++.               +..++|||++..          ..|...+|+|.
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99 99999999999974               345678887743          34455566654

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.86  E-value=3.6e-21  Score=175.41  Aligned_cols=108  Identities=16%  Similarity=0.334  Sum_probs=95.3

Q ss_pred             cccCCCCCCcccCCCCeEE--eCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEE
Q 003264           23 LATDTITPATLIGDGEKLV--SSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVL  100 (835)
Q Consensus        23 ~~~~~~~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l  100 (835)
                      ++.|+|.+||.|.+|++|+  |++|.|+|+|+.+|+     + +||++  +++||+||++.|  +.++.|+|+.||||||
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl   75 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV   75 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence            5679999999999999999  999999999999886     2 57875  899999999876  4468999999999999


Q ss_pred             ecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          101 LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       101 ~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      +|.++.++|+|++........++|+|+|||||++.         ++|||
T Consensus        76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~---------~~W~S  115 (119)
T 1b2p_A           76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWAT  115 (119)
T ss_dssp             ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred             EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc---------cEeCC
Confidence            99999999999987555566789999999999962         79998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.85  E-value=5.6e-21  Score=171.92  Aligned_cols=110  Identities=23%  Similarity=0.429  Sum_probs=96.1

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      +|+|.+||.|.+|++|+ ++|.|+|+|+.+|+     | ++|+  .+++||.||++.|  +..+.|+|+.||||||+|.+
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~   69 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS   69 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence            48999999999999999 99999999999887     3 6676  4799999999876  34678999999999999999


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCC
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPS  154 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PT  154 (835)
                      +.++|+|++........++|+|+|||||++.         ++||||+||.
T Consensus        70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~~~  110 (110)
T 3a0c_A           70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---------VVWATGSGPA  110 (110)
T ss_dssp             CCEEEECCCCCSSSCCEEEECTTSCEEEECS---------EEEECSCCC-
T ss_pred             CcEEEecCCCCCCCCEEEEEeCCccEEEECC---------CEecCCCcCC
Confidence            9999999987665566789999999999852         7999999983

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.83  E-value=3.3e-20  Score=168.54  Aligned_cols=110  Identities=18%  Similarity=0.307  Sum_probs=94.4

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      .|||.+||+|.+|++|+  +|.|+|+|+.+|+     +. +|+  ..++||+||++.|  +.++.|.|+.||||||+|.+
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~   69 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN   69 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence            48999999999999998  8999999998876     32 354  5799999999988  34689999999999999998


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCc
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD  155 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTD  155 (835)
                      +.++|+|++........++|+|+|||||++       .  ++||||.+++.
T Consensus        70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-------~--~~W~S~~~~~~  111 (115)
T 2dpf_A           70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG-------P--VLWSLGPNGCR  111 (115)
T ss_dssp             CCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S--EEECSSTTCBC
T ss_pred             ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-------C--CEEECCCCCCc
Confidence            999999998655455678999999999984       2  79999998764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.82  E-value=4.2e-20  Score=167.13  Aligned_cols=110  Identities=24%  Similarity=0.438  Sum_probs=94.2

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      +|||.+||.|.+|++|  ++|.|+|+|+.+|+     + ++|++  .++||+||++.+  +.++.|.|..||||||+| +
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~   67 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G   67 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence            4899999999999999  58999999999987     3 45664  799999999763  456789999999999999 8


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCC
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP  153 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~P  153 (835)
                      +.++|+|++........++|+++|||||++.      .+.++||||++.
T Consensus        68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~------~~~~~W~S~~~~  110 (112)
T 1xd5_A           68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNV  110 (112)
T ss_dssp             TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCC
T ss_pred             CEEEEECCccCCCCCEEEEEeCCCcEEEECC------CCceEEECCCcc
Confidence            8899999987655567789999999999974      457999999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.80  E-value=1.7e-19  Score=162.02  Aligned_cols=105  Identities=24%  Similarity=0.381  Sum_probs=89.8

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      .+||.|||.|.+|++|+  +|.|+|+|+.+|+     |.+ |..  .++||++|++.+  +..+.|.|+.||||||+|.+
T Consensus         1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~   68 (109)
T 3dzw_A            1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR   68 (109)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred             CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence            36899999999999997  7999999999887     433 543  699999999875  45689999999999999999


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeec
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF  150 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsF  150 (835)
                      +.++|+|++.+.....+|+|+||||||||+.         ++|||=
T Consensus        69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---------~~W~s~  105 (109)
T 3dzw_A           69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT---------ARWATG  105 (109)
T ss_dssp             SCEEEECCCCCSSSCEEEEECTTSCEEEEES---------CCCCCC
T ss_pred             CCEEEECCCCCCCCCEEEEEeCCCEEEEECC---------CEEeCC
Confidence            9999999987655556789999999999963         799983

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.77  E-value=1.2e-18  Score=156.45  Aligned_cols=106  Identities=18%  Similarity=0.295  Sum_probs=89.1

Q ss_pred             ccccCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEe
Q 003264           22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLL  101 (835)
Q Consensus        22 ~~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~  101 (835)
                      +.+.|||.|||.|.+|+.|+|  |.|.|.|..+|+     |.+ |..   ++||++|+..  .+..+.|.|+.||||||+
T Consensus         3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~--~~~~~~l~l~~dGNLvl~   69 (110)
T 3r0e_B            3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHG--NGEHCFLRLNHKGELIIK   69 (110)
T ss_dssp             CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTT--SSSSCEEEECTTSCEEEE
T ss_pred             ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcC--CCcCEEEEEeCCCcEEEE
Confidence            467899999999999999998  459998877776     555 543   5899999986  344679999999999999


Q ss_pred             cCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          102 NQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       102 ~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      |.++.++|+|++........|+|+||||||||+.         .+|+|
T Consensus        70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~---------~~W~t  108 (110)
T 3r0e_B           70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP---------AIFET  108 (110)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---------EEEES
T ss_pred             eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC---------CEecC
Confidence            9999999999986544557889999999999953         79997

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.75  E-value=8.8e-18  Score=151.69  Aligned_cols=109  Identities=15%  Similarity=0.268  Sum_probs=92.0

Q ss_pred             ccccCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEe
Q 003264           22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLL  101 (835)
Q Consensus        22 ~~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~  101 (835)
                      +.+.|+|.+||.|.+|+.|.+  |.|.|.|..+|+     |.++.. -..++||.+|+..+  +..+.|.|+.||||||+
T Consensus         3 ~~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~   72 (113)
T 3mez_B            3 PRVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT   72 (113)
T ss_dssp             CCCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred             cccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence            356799999999999999975  889999998887     666532 14789999999875  34689999999999999


Q ss_pred             cCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          102 NQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       102 ~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      |.++.++|+|++........|+|+||||||||+         ..+|+|
T Consensus        73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s  111 (113)
T 3mez_B           73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST  111 (113)
T ss_dssp             CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred             CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence            999999999998755455788999999999995         379997

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=3.1e-18  Score=179.73  Aligned_cols=138  Identities=16%  Similarity=0.180  Sum_probs=107.8

Q ss_pred             cCCccccccccCCcccEEEEEe-cCCcE--EEEEEecCcCh------------------------hhHHHHHHHHHHHHh
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKL-LNGQE--VAVKRLSSQSG------------------------QGLKEFKNEMMLIAK  566 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~  566 (835)
                      .-|++.+.||+|+||.||+|+. .+|+.  ||||+++....                        .....+.+|+..|.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999998 67888  99998754311                        112368899999999


Q ss_pred             cCCCce--eeEeeEEEecCeEEEEEEecCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEE
Q 003264          567 LQHRNL--VRLMGCCVEQGEKILIYEYMPN-K----SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSRLRII  638 (835)
Q Consensus       567 l~H~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iv  638 (835)
                      ++|+++  ..++..    ...+|||||+.+ |    +|.++...      .++..+..++.||+.+|.||| +.+   |+
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            988764  334432    356899999942 4    56555421      235577899999999999999 887   99


Q ss_pred             EecCCCCeEEEcCCCCeEecccCccccc
Q 003264          639 HRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       639 HrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      ||||||+|||++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999988  9999999999764

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.70  E-value=6e-17  Score=145.11  Aligned_cols=102  Identities=21%  Similarity=0.323  Sum_probs=86.4

Q ss_pred             ccCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecC
Q 003264           24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQ  103 (835)
Q Consensus        24 ~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~  103 (835)
                      |.|||.|||.|.+|+.|  .+|.|.|.|..+|+     |-+ |..     +|.+|+..+  +..+.|+|+.||||||+|.
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~   66 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKNG   66 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred             ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence            67999999999999999  57999999998887     333 431     799998864  4468999999999999999


Q ss_pred             CCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          104 TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       104 ~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      ++.++|+|++.+......|+|+|||||||++.         .+|+|
T Consensus        67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~---------~~W~s  103 (109)
T 3r0e_A           67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP---------SVFKI  103 (109)
T ss_dssp             TSCEEEECCCCCSSSCCEEEEETTTEEEEECS---------EEEEE
T ss_pred             CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec---------CEECC
Confidence            99999999987544456789999999999953         79997

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.67  E-value=2.2e-16  Score=142.59  Aligned_cols=97  Identities=23%  Similarity=0.412  Sum_probs=80.6

Q ss_pred             CCCcCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccc
Q 003264           81 SPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIG  160 (835)
Q Consensus        81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg  160 (835)
                      .|+.+...+|.|+.||||+|++. +.+||++++.+......|+|+++|||||++       .+.++||||+         
T Consensus        14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-------~~~~~W~S~~---------   76 (112)
T 1xd5_A           14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-------GSRAIWASNT---------   76 (112)
T ss_dssp             CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-------TTEEEEECCC---------
T ss_pred             CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-------CCEEEEECCc---------
Confidence            34555677899999999999987 789999998755455788999999999997       2469999993         


Q ss_pred             cccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEc-CCeEEEeecCCCC
Q 003264          161 MNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYN-GSVKLSCTGPWNG  218 (835)
Q Consensus       161 ~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~-~~~~~~~~g~w~g  218 (835)
                                            ||++|.|++.++++|.  ++++. +..+||++++|+|
T Consensus        77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                                  5567899999999997  55665 5789999999987

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.66  E-value=3.8e-16  Score=140.34  Aligned_cols=90  Identities=21%  Similarity=0.342  Sum_probs=75.8

Q ss_pred             CCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccc
Q 003264           85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMG  164 (835)
Q Consensus        85 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~  164 (835)
                      +...+|.|+.||||||++ .+.+||++++.+......++|+|+|||||++.      .+.++||||              
T Consensus        19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~------~~~~~W~S~--------------   77 (110)
T 3a0c_A           19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ------SNRVIWQTK--------------   77 (110)
T ss_dssp             TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECC--------------
T ss_pred             CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC------CCcEEEecC--------------
Confidence            446789999999999998 57999999987655567889999999999985      567999999              


Q ss_pred             cccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecCC
Q 003264          165 WDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (835)
Q Consensus       165 ~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~w  216 (835)
                                       ++|++|.|++.++++|.  ++++++  .||+++++
T Consensus        78 -----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           78 -----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             -----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             -----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                             35678999999999997  566765  79999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=2.4e-16  Score=172.04  Aligned_cols=144  Identities=13%  Similarity=0.143  Sum_probs=103.8

Q ss_pred             HHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcCh--------------hhHH--------HHHHHHHHHHh
Q 003264          509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------------QGLK--------EFKNEMMLIAK  566 (835)
Q Consensus       509 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~--------~~~~E~~~l~~  566 (835)
                      +.....-|++.+.||+|+||.||+|...+|+.||||+++....              ....        ...+|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            3333445999999999999999999998999999998753210              0011        12346667777


Q ss_pred             cCCCceeeEeeEEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCe
Q 003264          567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN  646 (835)
Q Consensus       567 l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  646 (835)
                      +.+.++.-..-+..  ...+|||||+++++|..+..         ......++.||+.+|.|||+.+   ||||||||.|
T Consensus       170 L~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N  235 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFN  235 (397)
T ss_dssp             HHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             HHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence            75544322111111  23379999999998876541         1234578899999999999988   9999999999


Q ss_pred             EEEcCCCC----------eEecccCccccc
Q 003264          647 ILLDSDMN----------PKISDFGMARMF  666 (835)
Q Consensus       647 ILl~~~~~----------~kl~DFGla~~~  666 (835)
                      |||++++.          +.|+||+-+...
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99987763          899999987643

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.60  E-value=4.9e-15  Score=134.80  Aligned_cols=87  Identities=25%  Similarity=0.310  Sum_probs=73.7

Q ss_pred             CceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccccc
Q 003264           87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (835)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~  166 (835)
                      ..+|.|+.||||+|++. +.+||++|+........++|+|+|||||++.      .++++||||                
T Consensus        31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~------~~~~lW~S~----------------   87 (119)
T 1b2p_A           31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN------ENVTVWQSP----------------   87 (119)
T ss_dssp             EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECS----------------
T ss_pred             CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC------CCcEEEcCC----------------
Confidence            35699999999999987 8999999987655567889999999999985      567999999                


Q ss_pred             cccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                     +||++|.|++.++++|.  ++++.  ..||++|+
T Consensus        88 ---------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 ---------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             ---------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             ---------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                           46778999999999997  55666  38999987

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.59  E-value=4.4e-15  Score=133.39  Aligned_cols=103  Identities=15%  Similarity=0.240  Sum_probs=83.9

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      .|+|.|||.|.+|+.|.  +|.|.|.|..+|+     |.+ |..  .. ||.+|+..+  +..+.|.|+.||||||+|.+
T Consensus         2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~   68 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN   68 (111)
T ss_dssp             TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred             cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence            58999999999999994  7999999998887     544 432  23 999999875  34689999999999999988


Q ss_pred             Cc-eEEeecCCC--CccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          105 DG-IIWSSNLSR--EVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       105 ~~-~~wst~~~~--~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      +. ++|+|++..  ......++|++|||||||+         ..+|+|
T Consensus        69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s  107 (111)
T 3mez_A           69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST  107 (111)
T ss_dssp             CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred             CCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence            76 599999642  2234678999999999995         379997

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.58  E-value=6.8e-15  Score=133.37  Aligned_cols=92  Identities=29%  Similarity=0.381  Sum_probs=76.9

Q ss_pred             CCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccccccccc
Q 003264           86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW  165 (835)
Q Consensus        86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~  165 (835)
                      ....|.|+.||||+|++ .+.+||++++........++|+++|||||++.      .+.++|||||+             
T Consensus        20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~------~~~~vW~S~~~-------------   79 (115)
T 2dpf_A           20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH------NNNDVWGSACW-------------   79 (115)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT------TCCEEEECCCC-------------
T ss_pred             CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC------CceEEEEcCCC-------------
Confidence            35679999999999998 57899999987554557889999999999985      46799999997             


Q ss_pred             ccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecCCCCc
Q 003264          166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGL  219 (835)
Q Consensus       166 ~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~w~g~  219 (835)
                                        |++|.|++.++++|.  ++++++  .||++++|...
T Consensus        80 ------------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           80 ------------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR  111 (115)
T ss_dssp             ------------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred             ------------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence                              356889999999997  566765  89999999754

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.31  E-value=6.8e-12  Score=112.97  Aligned_cols=95  Identities=20%  Similarity=0.313  Sum_probs=73.4

Q ss_pred             CCCCcCCCceEEEecCCceEEecC-CCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccc
Q 003264           80 NSPIVDSNAVLTIGNNGNLVLLNQ-TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLL  158 (835)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlL  158 (835)
                      +.|+.+...+|.|+.||||||++. .+.++|++++.+......++|+++|||||++.      .+.++|||=.+      
T Consensus        18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~------~~~~iW~S~t~------   85 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD------RLNTVFVSNTV------   85 (113)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECSCC------
T ss_pred             CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC------CCCEEEECCCc------
Confidence            456666678899999999999998 58999999987655567889999999999985      45689997221      


Q ss_pred             cccccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          159 IGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       159 pg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                               -..|.|.+.++.+|...+  |.  ...|.+|+
T Consensus        86 -------------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~  113 (113)
T 3mez_B           86 -------------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA  113 (113)
T ss_dssp             -------------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             -------------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence                                     013568899999987654  44  57898875

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.31  E-value=6.7e-12  Score=131.45  Aligned_cols=112  Identities=18%  Similarity=0.400  Sum_probs=85.2

Q ss_pred             ccCCCCCCcc----cCCCCeEEeCCCeEEEEeecCC--CCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCc
Q 003264           24 ATDTITPATL----IGDGEKLVSSSQIFELGFFSPG--KSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGN   97 (835)
Q Consensus        24 ~~~~~~~~~~----l~~~~~l~s~~g~f~lgf~~~~--~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~   97 (835)
                      .+|||.|||.    |..|+.|.|+ ..++.|+|...  ....  +-+ |.+ ..+++|.+++..+  +. ..|.|+.||+
T Consensus       135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGn--lvL-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~dGn  206 (276)
T 3m7h_A          135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGN--LVA-YGP-NGAATWNAGTQGK--GA-VRAVFQGDGN  206 (276)
T ss_dssp             TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSC--EEE-ECT-TSSEEEECCCTTT--TC-CEEEECTTSC
T ss_pred             cccccccccccccccccCcccccC-CCCCCceEEEeecCCce--EEE-EeC-CCeEEEECCCCCC--cc-EEEEEcCCCe
Confidence            4699999999    8899998654 45555555321  1112  333 322 3589999999876  22 7899999999


Q ss_pred             eEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCC
Q 003264           98 LVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (835)
Q Consensus        98 l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~  152 (835)
                      |+++|.++.++|++++.+. ...+|+|++||||||++.        +++|||||+
T Consensus       207 Lvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~--------~~~Wqsf~~  252 (276)
T 3m7h_A          207 LVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE--------KPVWARFGF  252 (276)
T ss_dssp             EEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE--------EEEEESSSC
T ss_pred             EEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC--------CCeEEccCc
Confidence            9999998899999998654 347889999999999962        489999997

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=1.4e-11  Score=129.00  Aligned_cols=147  Identities=18%  Similarity=0.088  Sum_probs=116.7

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ......|++...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+ +|..+.++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            445578999899999999999999764 689999998653222234688999999998 467888999999998899999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY------------------------------------  632 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------  632 (835)
                      |||++|.+|.+.+.        +......++.+++++|+.||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999987641        1223457889999999999982                                    


Q ss_pred             --------------------CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          633 --------------------SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       633 --------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                                          ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                114599999999999998765667999998753

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.22  E-value=3.7e-11  Score=107.75  Aligned_cols=94  Identities=18%  Similarity=0.233  Sum_probs=71.0

Q ss_pred             CCCcCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCc-eeEeecCCCCccccc
Q 003264           81 SPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS-YLWQSFDCPSDTLLI  159 (835)
Q Consensus        81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~-~~WqsFd~PTDTlLp  159 (835)
                      .++.+....|.|+.||||||++.++  +|++++.+.+....++|+++|||||++.      .+. ++|||.-+       
T Consensus        15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~------~~~~~vW~S~t~-------   79 (111)
T 3mez_A           15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA------NSNTPVWVYPRS-------   79 (111)
T ss_dssp             CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS------SCSSCSEEESSS-------
T ss_pred             CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC------CCCEEEEEeccc-------
Confidence            3445556789999999999999876  9999987655567889999999999985      333 59998621       


Q ss_pred             ccccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       160 g~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                            .....|.|.+.++.+|...+  |.  ..+|.++.
T Consensus        80 ----------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t  109 (111)
T 3mez_A           80 ----------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA  109 (111)
T ss_dssp             ----------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred             ----------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence                                  01134789999999987654  44  67888764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=9.7e-11  Score=122.11  Aligned_cols=140  Identities=17%  Similarity=0.180  Sum_probs=104.4

Q ss_pred             hhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc--eeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~  589 (835)
                      ....+.+....+.|..+.||++...+|+.++||+....   ....+.+|+.+++.+.+.+  +.+++++...++..++||
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            33456654444466679999998777888999997653   2245788999999985444  566888888888899999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------  633 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  633 (835)
                      ||+++.+|.  ...      .   ....++.++++.|+.||+..                                    
T Consensus        95 e~i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999998884  211      1   12367788888888888743                                    


Q ss_pred             -------------------CCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          634 -------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       634 -------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                                         ...++|+|++|.|||++.++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               12399999999999998776677999998754

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.12  E-value=2.4e-10  Score=102.26  Aligned_cols=88  Identities=20%  Similarity=0.329  Sum_probs=66.8

Q ss_pred             CCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccc
Q 003264           85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMG  164 (835)
Q Consensus        85 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~  164 (835)
                      +....|.|+.||||||++.  .++|++++.+.+....++|+++|||||++.      .+.++|||-.+-           
T Consensus        23 sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~------~~~~iW~S~t~~-----------   83 (110)
T 3r0e_B           23 AKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD------DFKTIWSSRSSS-----------   83 (110)
T ss_dssp             CSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT------TCCEEEECCCCC-----------
T ss_pred             eCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC------CCCEEEEcCCcC-----------
Confidence            3457899999999999987  589999987655556889999999999985      467899984210           


Q ss_pred             cccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          165 WDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       165 ~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                          ..|.|.+.++.+|...+  |+  ...|.+|.
T Consensus        84 --------------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~~  110 (110)
T 3r0e_B           84 --------------------KQGEYVLILQDDGFGVI--YG--PAIFETSS  110 (110)
T ss_dssp             --------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             --------------------CCCCEEEEEcCCccEEE--ec--CCEecCCC
Confidence                                13458889998887554  44  36787763

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.08  E-value=3.7e-10  Score=100.81  Aligned_cols=92  Identities=24%  Similarity=0.416  Sum_probs=70.2

Q ss_pred             CCCCcCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccc
Q 003264           80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLI  159 (835)
Q Consensus        80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLp  159 (835)
                      +.|+.+....|.|+.||||||+++    +|+|++.+.+....++|+++|||||++.      .+.++|+|-.        
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~------~~~~vWss~t--------   76 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG------DGSTVWKSGA--------   76 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECCC--------
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC------CCCEEEcCCC--------
Confidence            345555667899999999999985    7999987655567889999999999975      4578997521        


Q ss_pred             ccccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecCC
Q 003264          160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (835)
Q Consensus       160 g~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~w  216 (835)
                                             ....+.|.+.++++|...+  +.  .+.|.+++|
T Consensus        77 -----------------------~~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~  106 (109)
T 3r0e_A           77 -----------------------QSVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW  106 (109)
T ss_dssp             -----------------------CCSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred             -----------------------cCCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence                                   0023568899999986554  44  678999987

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.07  E-value=4.8e-10  Score=100.21  Aligned_cols=88  Identities=24%  Similarity=0.331  Sum_probs=66.3

Q ss_pred             CCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccccccccc
Q 003264           86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW  165 (835)
Q Consensus        86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~  165 (835)
                      ...+|.|+.||||||++. +.++|++++.+......+.|+++|||||++.      .+.++|||....            
T Consensus        19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~------~~~~~W~S~t~~------------   79 (109)
T 3dzw_A           19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP------RNNPIWASNTGG------------   79 (109)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT------TSCEEEECCCCC------------
T ss_pred             CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC------CCCEEEECCCCC------------
Confidence            356799999999999987 6899999987654557789999999999985      457899974211            


Q ss_pred             ccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       166 ~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                         ..+.|.+.++.+|...+  ++.  ..|.++.
T Consensus        80 -------------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~t  106 (109)
T 3dzw_A           80 -------------------ENGNYVCVLQKDRNVVI--YGT--ARWATGT  106 (109)
T ss_dssp             -------------------SSSCEEEEECTTSCEEE--EES--CCCCCCC
T ss_pred             -------------------CCCCEEEEEeCCCEEEE--ECC--CEEeCCC
Confidence                               12567888998886554  442  5676654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=4.6e-09  Score=115.20  Aligned_cols=142  Identities=14%  Similarity=0.239  Sum_probs=107.8

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEec--CcC-hhhHHHHHHHHHHHHhcC--CCceeeEeeEEEec---CeEEEEE
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLS--SQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQ---GEKILIY  589 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~  589 (835)
                      ..+.|+.|.++.||+.+.. +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578999999999999875 4678889875  322 123456788999999996  45688888888776   4589999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------  633 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  633 (835)
                      ||+++..+.+..     ...++..++..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875322     123677888899999999999999731                                    


Q ss_pred             -------------------CCcEEEecCCCCeEEEcCCCC--eEecccCcccc
Q 003264          634 -------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARM  665 (835)
Q Consensus       634 -------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~  665 (835)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999997753  68999998864

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.83  E-value=1.7e-08  Score=89.28  Aligned_cols=55  Identities=29%  Similarity=0.450  Sum_probs=45.3

Q ss_pred             ceEEEecCCceEEecCCCceEEeecCCCCc-cCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      -+|.|+.||||||++. +.+||++|+...+ ....+.|+++|||||+|.      .++++|+|
T Consensus        21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~------~~~~vWss   76 (105)
T 4h3o_A           21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS------SGRSLWAS   76 (105)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT------TCCEEEEC
T ss_pred             EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC------CcEEEEEe
Confidence            4699999999999975 5899999986443 345779999999999986      56789986

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.71  E-value=4.8e-09  Score=112.28  Aligned_cols=187  Identities=18%  Similarity=0.197  Sum_probs=121.5

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCc--eeeEeeEEEecC---eEEEEEEec
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRN--LVRLMGCCVEQG---EKILIYEYM  592 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lV~E~~  592 (835)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+.+|..+ .+..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    56889986432  4457789999999888 4332  344444433332   348899999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY----------------------------------------  632 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  632 (835)
                      ++.+|.....     ..++..++..++.++++.|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     2356777788888888888888861                                        


Q ss_pred             ---------------CCCcEEEecCCCCeEEEcC--CCCeEecccCccccccCCCc-ccccc-----------ccccccc
Q 003264          633 ---------------SRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGDEL-QGNTK-----------RVVGTYG  683 (835)
Q Consensus       633 ---------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~-~~~~~-----------~~~gt~~  683 (835)
                                     ....++|+|++|.||+++.  ...+.|+||+.+..-..... .....           ......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1246899999999999998  45678999999865321100 00000           0000001


Q ss_pred             eeC-ceeecCCCCCccccchhHHHHHHHHHhCCCCC
Q 003264          684 YMS-PEYALDGLFSVKSDVFSFGVLLLETLTSKRNT  718 (835)
Q Consensus       684 y~a-PE~~~~~~~s~ksDVwSlGvvl~elltG~~p~  718 (835)
                      ... |+....  .....+.|+++.++|++.+|+.++
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 221111  112358999999999999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=3.4e-06  Score=90.04  Aligned_cols=136  Identities=21%  Similarity=0.201  Sum_probs=97.1

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC---ceeeEeeEEE-ecCeEEEEEEecCC
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCV-EQGEKILIYEYMPN  594 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~E~~~~  594 (835)
                      .+.++.|....||+.    ++.++||+-.  .......+.+|+.+|..+.+.   .+.+.+.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356888888899987    5678888853  234457789999999999642   3556666664 34567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY------------------------------------------  632 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  632 (835)
                      ..|......     .++..+...++.++++.|+.||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            988763211     234555566666666666666642                                          


Q ss_pred             ---------------CCCcEEEecCCCCeEEEcC---CCCe-EecccCcccc
Q 003264          633 ---------------SRLRIIHRDLKASNILLDS---DMNP-KISDFGMARM  665 (835)
Q Consensus       633 ---------------~~~~ivHrDlkp~NILl~~---~~~~-kl~DFGla~~  665 (835)
                                     ....++|+|+++.|||++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999987   4554 8999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=3.4e-06  Score=88.12  Aligned_cols=141  Identities=17%  Similarity=0.170  Sum_probs=100.7

Q ss_pred             cCCccccccccCCcc-cEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFG-PVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg-~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ..|+. +.+..|..+ .||+..... +..++||+-...   ....+.+|+..|+.+. +--+.++++++.+.+..++|||
T Consensus        25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            34443 345556665 589887654 667899986532   3456788999998883 4447788899999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY--------------------------------------  632 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------  632 (835)
                      ++++.++.+....       .......+..++++.|+.||..                                      
T Consensus       101 ~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          101 AIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             CCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             eeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            9999887765421       1223345666677777777742                                      


Q ss_pred             -----------------CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          633 -----------------SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       633 -----------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                                       ....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             122489999999999999877778999998753

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.28  E-value=1e-06  Score=90.24  Aligned_cols=105  Identities=19%  Similarity=0.318  Sum_probs=76.2

Q ss_pred             ccCCCCCCc-------ccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCC
Q 003264           24 ATDTITPAT-------LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNG   96 (835)
Q Consensus        24 ~~~~~~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g   96 (835)
                      ..|+|.+||       .|..++.+.  .|.|.|.|.+.|+     +-+|..   ..++|.++....  ...+.++|..+|
T Consensus       124 g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~---~~~~W~s~~~~~--~~~~~~~L~~~G  191 (236)
T 1dlp_A          124 GNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAGK--GTGCRAVLQPNG  191 (236)
T ss_dssp             CCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCSS--CSSCEEEEETTT
T ss_pred             cceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcC---CEeEEeCCCcCC--CCceEEEECCCC
Confidence            357888888       555555554  6899999877663     445432   368898876543  235779999999


Q ss_pred             ceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264           97 NLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus        97 ~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      +|++++.++.++|.+.+........++|.++|||+++..         .+|+|
T Consensus       192 nl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~---------~~W~s  235 (236)
T 1dlp_A          192 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG---------ALWTT  235 (236)
T ss_dssp             EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC---------CCCBC
T ss_pred             cEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC---------CCccC
Confidence            999998888899999875443456779999999999842         68876

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.6e-06  Score=91.84  Aligned_cols=81  Identities=7%  Similarity=-0.006  Sum_probs=57.2

Q ss_pred             cccc-ccCCcccEEEEEec-------CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcC-C--CceeeEeeEEEec--
Q 003264          519 QCKL-GEGGFGPVYKGKLL-------NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQ--  582 (835)
Q Consensus       519 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--  582 (835)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.++..+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4577 88999999998764       26788999865432   101245678888888884 3  3567788777655  


Q ss_pred             -CeEEEEEEecCCCChhh
Q 003264          583 -GEKILIYEYMPNKSLNF  599 (835)
Q Consensus       583 -~~~~lV~E~~~~gsL~~  599 (835)
                       +..++||||+++..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.84  E-value=4.8e-05  Score=84.20  Aligned_cols=75  Identities=9%  Similarity=0.127  Sum_probs=50.4

Q ss_pred             ccccccCCcccEEEEEec-CCcEEEEEEecCcCh-------hhHHHHHHHHHHHHhcCC--C-ceeeEeeEEEecCeEEE
Q 003264          519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQH--R-NLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l  587 (835)
                      .+.||.|..+.||+++.. +++.++||.......       ...+++..|++++..+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999764 468899998653211       123456789999888742  3 34455543  4556789


Q ss_pred             EEEecCCC
Q 003264          588 IYEYMPNK  595 (835)
Q Consensus       588 V~E~~~~g  595 (835)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.81  E-value=4.5e-05  Score=82.28  Aligned_cols=140  Identities=16%  Similarity=0.169  Sum_probs=80.5

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-----CCceeeEe-e--EEEecCeEEEEEEe
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLM-G--CCVEQGEKILIYEY  591 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lV~E~  591 (835)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|+.++..|.     .|.++... |  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987554 5899998752    133444555555553     24443311 1  22346678999999


Q ss_pred             cCCCChhh-----------h---hc----CC--C-C----CCCCCHHHH-------------------------------
Q 003264          592 MPNKSLNF-----------F---LF----DP--S-R----THLLGWQTR-------------------------------  615 (835)
Q Consensus       592 ~~~gsL~~-----------~---l~----~~--~-~----~~~l~~~~~-------------------------------  615 (835)
                      +++..+..           .   ++    ..  . .    .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876530           0   11    00  0 0    011122211                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          616 VKIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       616 ~~i~~~ia~~L~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      ..+...+.+++++|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223445666663          124579999999999999888899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.75  E-value=0.00018  Score=76.56  Aligned_cols=139  Identities=20%  Similarity=0.116  Sum_probs=92.9

Q ss_pred             cccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC---CCceeeEeeEEEecCeEEEEEEecCC
Q 003264          518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ..+.|+.|....+|+... +++.++||+....   ....+..|+..|+.|.   ...+.+++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346799999999999986 4678889986532   3567889999998883   35688888888888889999999999


Q ss_pred             CChhh--------h---hcCCCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 003264          595 KSLNF--------F---LFDPSR-T------------------HLLGWQTRV---KIIE----------------GIAQG  625 (835)
Q Consensus       595 gsL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~~  625 (835)
                      ..+..        .   |+.... .                  -.-.|....   ++..                .+.+-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86521        1   111111 0                  011343221   1111                11111


Q ss_pred             -HHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          626 -LLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       626 -L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223422 2356899999999999999887 8999974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=7e-05  Score=78.96  Aligned_cols=81  Identities=16%  Similarity=0.223  Sum_probs=59.7

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-C--CceeeEeeEEEecCeEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~  589 (835)
                      .....-++.+|.|..+.||+.++.+|+.|+||+-..........|..|+..|+.|. .  --+.+++++    +..++||
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~   89 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM   89 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence            34566678899999999999999999999999876544444456788999998884 2  123444443    2347899


Q ss_pred             EecCCCCh
Q 003264          590 EYMPNKSL  597 (835)
Q Consensus       590 E~~~~gsL  597 (835)
                      ||++.+..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.42  E-value=0.00053  Score=76.38  Aligned_cols=80  Identities=9%  Similarity=-0.023  Sum_probs=47.2

Q ss_pred             CCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCC---CCCccccchhHHHHHHH
Q 003264          634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG---LFSVKSDVFSFGVLLLE  710 (835)
Q Consensus       634 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvl~e  710 (835)
                      ...++|+|+++.|||++.++ ++|+||+.+..-.... ........-...|++|+.....   .-....++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45799999999999998776 9999999887521100 0000000012345666544311   11123455677888888


Q ss_pred             HHhCC
Q 003264          711 TLTSK  715 (835)
Q Consensus       711 lltG~  715 (835)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.35  E-value=0.00093  Score=71.32  Aligned_cols=159  Identities=14%  Similarity=0.131  Sum_probs=87.8

Q ss_pred             ccHHHHHHhhcCCcc-----ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc--eeeEe
Q 003264          504 FSLASVSAATENFSM-----QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLM  576 (835)
Q Consensus       504 ~~~~~~~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~  576 (835)
                      .+..++.....+|.+     .+.|+.|....+|+....+| .+++|+.....  ..+++..|+.++..+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344445544455554     34567788899999987555 68899886521  1234556777777763212  23333


Q ss_pred             eE------EEecCeEEEEEEecCCCChhhh--------------hc----C--CCCCCC---CCHHHHHH----------
Q 003264          577 GC------CVEQGEKILIYEYMPNKSLNFF--------------LF----D--PSRTHL---LGWQTRVK----------  617 (835)
Q Consensus       577 ~~------~~~~~~~~lV~E~~~~gsL~~~--------------l~----~--~~~~~~---l~~~~~~~----------  617 (835)
                      ..      ....+..++++||+++..+...              ++    .  ......   ..|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      1234567899999998764210              01    0  000000   11222110          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          618 --IIEGIAQGLLYLHQY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       618 --i~~~ia~~L~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                        +...+.+.++.++..    .+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244455555532    235699999999999998876668999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.08  E-value=0.0013  Score=69.50  Aligned_cols=138  Identities=12%  Similarity=0.126  Sum_probs=75.9

Q ss_pred             ccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-eeEeeEEEecCeEEEEEEec-CCCC
Q 003264          519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYM-PNKS  596 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~-~~gs  596 (835)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.++..+...++ .+++++  +.+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            578999999999998     568889876432211 123567877777743222 455543  344457899999 6555


Q ss_pred             hhhh------------------hcCCCC--CCCCC-HHHHHHHHH--------------HHHHHHH----HHHh-cCCCc
Q 003264          597 LNFF------------------LFDPSR--THLLG-WQTRVKIIE--------------GIAQGLL----YLHQ-YSRLR  636 (835)
Q Consensus       597 L~~~------------------l~~~~~--~~~l~-~~~~~~i~~--------------~ia~~L~----yLH~-~~~~~  636 (835)
                      |...                  ++....  ..... +.....+..              .+.+.+.    .+.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4310                  011000  00001 111111100              0111111    1111 22346


Q ss_pred             EEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          637 IIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       637 ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5677889999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.06  E-value=0.002  Score=70.32  Aligned_cols=141  Identities=21%  Similarity=0.234  Sum_probs=83.5

Q ss_pred             cccccCCcccEEEEEec--------CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEE
Q 003264          520 CKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+    -+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888899999874        2478999986432 223456678999998884 3333566666543    29999


Q ss_pred             ecCCCChhhh-h----------------cCCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 003264          591 YMPNKSLNFF-L----------------FDPS--RTHLLG--WQTRVKIIEGIAQ-------------------GLLYLH  630 (835)
Q Consensus       591 ~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~yLH  630 (835)
                      |+++..|..- +                +...  ..+...  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665421 0                1110  011111  3444444433321                   223332


Q ss_pred             ----h-cCCCcEEEecCCCCeEEEcCC----CCeEecccCcccc
Q 003264          631 ----Q-YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  665 (835)
Q Consensus       631 ----~-~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~  665 (835)
                          . .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                2 123579999999999999876    7899999998854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0015  Score=72.82  Aligned_cols=73  Identities=16%  Similarity=0.234  Sum_probs=49.7

Q ss_pred             ccccccCCcccEEEEEecC--------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~  589 (835)
                      .+.|+.|....+|+....+        ++.+++|+.....  ..+.+.+|+.++..+...+ ..++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578888889999998753        5789999984321  1244557888888884333 3566665432    3899


Q ss_pred             EecCCCCh
Q 003264          590 EYMPNKSL  597 (835)
Q Consensus       590 E~~~~gsL  597 (835)
                      ||+++..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.98  E-value=0.0052  Score=65.60  Aligned_cols=142  Identities=15%  Similarity=0.160  Sum_probs=82.6

Q ss_pred             cccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCC--ceeeEeeE-----EEecCeEEEEEEec
Q 003264          520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGC-----CVEQGEKILIYEYM  592 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lV~E~~  592 (835)
                      +.|+ |....||+....+|+.+++|+..... ...+.+..|..++..+...  .+++++..     ....+..+++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3566 88889999887777789999986431 1345667788888777422  23444442     22345668899999


Q ss_pred             CCCChhh-----h---------hc----CC--CCCCCCCHHHH----HH---------------HHHHHHHHHHHHHhc-
Q 003264          593 PNKSLNF-----F---------LF----DP--SRTHLLGWQTR----VK---------------IIEGIAQGLLYLHQY-  632 (835)
Q Consensus       593 ~~gsL~~-----~---------l~----~~--~~~~~l~~~~~----~~---------------i~~~ia~~L~yLH~~-  632 (835)
                      ++..+..     +         ++    ..  .......+...    ..               +...+.+.++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421     0         00    00  00111121110    00               111111223333221 


Q ss_pred             ---CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          633 ---SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       633 ---~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                         ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               235689999999999999 4 899999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.94  E-value=0.0032  Score=67.55  Aligned_cols=141  Identities=13%  Similarity=0.132  Sum_probs=72.4

Q ss_pred             cccccCCccc-EEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC--CceeeEeeEEEecCeEEEEEEecCCCC
Q 003264          520 CKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       520 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      +.|+.|.... +|+....+++.+++|.......   +.+..|+.++..+..  -.+.+++.+..+.  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4565554443 6777654467788886543321   234456667666632  2345566653333  378999997766


Q ss_pred             hhhhhcC---------------------CCCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003264          597 LNFFLFD---------------------PSRT--HLLGWQTRV-------K-------------IIEGIAQGLLYLH---  630 (835)
Q Consensus       597 L~~~l~~---------------------~~~~--~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  630 (835)
                      +.+.+..                     ....  ..+......       .             ....+.+.++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            5433211                     0000  011111000       0             0011122222221   


Q ss_pred             hcCCCcEEEecCCCCeEEEcCC----CCeEecccCcccc
Q 003264          631 QYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM  665 (835)
Q Consensus       631 ~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~  665 (835)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1124579999999999999875    6799999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.91  E-value=0.0039  Score=69.94  Aligned_cols=74  Identities=14%  Similarity=0.109  Sum_probs=48.4

Q ss_pred             ccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-eeEeeEEEecCeEEEEEEecCCCC
Q 003264          519 QCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKS  596 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gs  596 (835)
                      .+.|+.|-...+|+....+ ++.+++|+......... ...+|+.++..|...++ .++++.+.  +  .+|+||+++..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578888889999998765 57889998754322211 12578889998854444 56776662  2  25999998855


Q ss_pred             h
Q 003264          597 L  597 (835)
Q Consensus       597 L  597 (835)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.59  E-value=0.0033  Score=68.50  Aligned_cols=74  Identities=12%  Similarity=0.112  Sum_probs=44.9

Q ss_pred             ccccccCCcccEEEEEecC---------CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILI  588 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV  588 (835)
                      .+.|+.|..-.+|+....+         ++.+++|+....... ......|+.++..+...+ +.++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567888888999998654         268889987543222 122367888888774333 34566543  2  3689


Q ss_pred             EEecCCCCh
Q 003264          589 YEYMPNKSL  597 (835)
Q Consensus       589 ~E~~~~gsL  597 (835)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.46  E-value=0.016  Score=62.29  Aligned_cols=68  Identities=12%  Similarity=0.103  Sum_probs=43.7

Q ss_pred             ccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC---CCceeeEeeE------EEecCeEEEEEEecC
Q 003264          523 GEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGC------CVEQGEKILIYEYMP  593 (835)
Q Consensus       523 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~------~~~~~~~~lV~E~~~  593 (835)
                      |.|....||+....+| .+++|+......      ..|+.++..|.   -|++++.+..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3444678999987667 899998765432      34555555552   1224444432      234567899999999


Q ss_pred             CCCh
Q 003264          594 NKSL  597 (835)
Q Consensus       594 ~gsL  597 (835)
                      +..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.00  E-value=0.011  Score=58.21  Aligned_cols=102  Identities=13%  Similarity=0.046  Sum_probs=64.9

Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccccc
Q 003264          596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT  675 (835)
Q Consensus       596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  675 (835)
                      +|.++|.  ....++++++++.++.|.+.+|.-+-.... + ..+=+.|..|+|..+|.+.+.+ ..+.           
T Consensus        34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            6777773  345789999999999999999876622110 1 1233457899999999988764 1110           


Q ss_pred             cccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCC
Q 003264          676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN  717 (835)
Q Consensus       676 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p  717 (835)
                         .....+.|||... ...+.+.=|||||++||..+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               1223566888653 3456788899999999998864433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.64  E-value=0.019  Score=63.55  Aligned_cols=74  Identities=12%  Similarity=0.107  Sum_probs=48.6

Q ss_pred             ccccccCCcccEEEEEecC--------CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEE
Q 003264          519 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++.|..|-...+|+....+        ++.+++|+........ ....+|..+++.+. +.-..++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3567778888999998753        5789999875433221 12357888888874 32244555433  2  37899


Q ss_pred             EecCCCCh
Q 003264          590 EYMPNKSL  597 (835)
Q Consensus       590 E~~~~gsL  597 (835)
                      ||+++..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.46  E-value=0.34  Score=53.14  Aligned_cols=30  Identities=27%  Similarity=0.388  Sum_probs=25.4

Q ss_pred             cEEEecCCCCeEEE------cCCCCeEecccCcccc
Q 003264          636 RIIHRDLKASNILL------DSDMNPKISDFGMARM  665 (835)
Q Consensus       636 ~ivHrDlkp~NILl------~~~~~~kl~DFGla~~  665 (835)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999998854

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=90.26  E-value=17  Score=36.87  Aligned_cols=66  Identities=11%  Similarity=0.210  Sum_probs=41.7

Q ss_pred             CCeeEEecCCCCC--C----cCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEec
Q 003264           70 PDTVVWVANRNSP--I----VDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK  135 (835)
Q Consensus        70 ~~~~vW~an~~~p--~----~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~  135 (835)
                      ..+++|...+..+  +    ..+++.+-++.++.+..+|.+|..+|.-.+........+..+.+||+++-+.
T Consensus        24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~   95 (276)
T 3no2_A           24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC   95 (276)
T ss_dssp             TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred             CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence            5678888876541  1    1233444456666677778889999998864221222356778888888753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.58  E-value=0.22  Score=55.79  Aligned_cols=62  Identities=11%  Similarity=0.109  Sum_probs=19.4

Q ss_pred             ccccccccCCcccEEEEEecC-CcEEEE------EEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 003264          517 SMQCKLGEGGFGPVYKGKLLN-GQEVAV------KRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE  581 (835)
Q Consensus       517 ~~~~~LG~G~fg~Vy~~~~~~-~~~vav------K~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  581 (835)
                      .+.++||   ||.||+|.+.. ..+|||      |..+..  ..+....|.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456777   99999999854 357888      766532  23334568889999999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	835
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-26
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-21
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-14
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	3e-14
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	4e-14
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	2e-07
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-12
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	3e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 8e-70
 Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 19/284 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
              ++  ++G G FG VYKGK      V +  +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
             MG      +  ++ ++    SL   L              + I    AQG+ YLH   
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL-- 691
              IIHRDLK++NI L  D+  KI DFG+A +          +++ G+  +M+PE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 692 -DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
               +S +SDV++FG++L E +T +         + N       +         LS    
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP 794
           +            +   C+++K  +RP   ++++ I     +LP
Sbjct: 237 N-----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 2e-66
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 25/275 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
              +   ++G G FG V+ G  LN  +VA+K +  +     ++F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L G C+EQ    L++E+M +  L    +  ++  L   +T + +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
              +IHRDL A N L+  +   K+SDFGM R    D+   ++        + SPE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 694 LFSVKSDVFSFGVLLLETLTSKR--NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
            +S KSDV+SFGVL+ E  +  +       + E    +   + L+K      L S  +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP----RLASTHVYQ 233

Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                       +   C +E+  DRP  S+++  +
Sbjct: 234 ------------IMNHCWKERPEDRPAFSRLLRQL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 8e-66
 Identities = 87/273 (31%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E   +  +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           RL      Q    +I EYM N SL  FL  PS   L      + +   IA+G+ ++ +  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E             + +PE    G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            F++KSDV+SFG+LL E +T  R         +  + +   +    R Y ++ P    E 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
            YQ       +  LC +E+  DRPT   + S++
Sbjct: 239 LYQ-------LMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-64
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 21/275 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           ++ +   +LG G FG V  GK     +VA+K +   S     EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L G C +Q    +I EYM N  L  +L +    H    Q  +++ + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
             + +HRDL A N L++     K+SDFG++R    DE   +         +  PE  +  
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            FS KSD+++FGVL+ E  +  +                +  + ++   E ++  L+   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 222

Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            +    +  T+   C  EKA +RPT   ++S I +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-62
 Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 29/291 (9%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
            +G+G FG V++GK   G+EVAVK  SS+  +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 581 EQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ----- 631
           +         L+ +Y  + SL  +L      + +  +  +K+    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGTYGYMSPEY 689
             +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 690 ALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-----NLLGHAWNLWKD 738
             D +         ++D+++ G++  E        G+++              +    + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 739 NRAYELLSPAL-QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
               + L P +     S + L     +   C     A R T  ++   ++ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 2e-62
 Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 21/285 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           E+  ++ KLG+G FG V+ G       VA+K L   +    + F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
           +L      +    ++ EYM   SL  FL   +  +L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDG 693
               +HRDL+A+NIL+  ++  K++DFG+AR+   +E             + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 694 LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEA 753
            F++KSDV+SFG+LL E  T  R                +    +    + +    +   
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPC 235

Query: 754 SYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQ 798
             +       +   C +++  +RPT   + + + +   +     Q
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-62
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQH 569
             ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             +V   G     GE  +  E+M   SL+  L    R   +  Q   K+   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
               + +I+HRD+K SNIL++S    K+ DFG++       +       VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
                +SV+SD++S G+ L+E    + 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 5e-62
 Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 574 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +L+G  VE+   + ++ EYM   SL  +L    R+ +LG    +K    + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
                +HRDL A N+L+  D   K+SDFG+ +     E             + +PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             FS KSDV+SFG+LL E  +  R                +           +    + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMD 220

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
           A          V   C    AA RP+  ++   +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 2e-61
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            + +M+ KLG G +G VY+G        VAVK L   + + ++EF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V+L+G C  +    +I E+M   +L  +L + +R   +     + +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132

Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
            +   IHRDL A N L+  +   K++DFG++R+  GD    +         + +PE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             FS+KSDV++FGVLL E  T   +               +     ++ YELL    + E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                  +   +   C Q   +DRP+ +++    
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 5e-61
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 36/300 (12%)

Query: 504 FSLASVSAATENFS---------MQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQ 549
           F+    + A   F+         ++  +G G FG V  G L         VA+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 550 SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL 609
           + +  ++F +E  ++ +  H N++ L G   +    ++I E+M N SL+ FL        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 610 LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669
                 V ++ GIA G+ YL        +HRDL A NIL++S++  K+SDFG++R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 670 ELQGNTKRVVG---TYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF 726
                    +G      + +PE      F+  SDV+S+G+++ E ++             
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                 +    +      +    +        +    + L C Q+    RP   ++V+ +
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-59
 Identities = 64/296 (21%), Positives = 116/296 (39%), Gaps = 26/296 (8%)

Query: 512 ATENFSMQ-CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
             +N  +   +LG G FG V +G         +VA+K L   + +   +E   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L +  +VRL+G C +    +L+ E      L+ FL        +      +++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGTYGYM 685
            YL +      +HRDL A N+LL +    KISDFG+++    D+     +        + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 745
           +PE      FS +SDV+S+GV + E L+  +                +   K       +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFI 225

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAF 801
               + E   +       +   C   K  DRP    V   +   + +L    +   
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-58
 Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 27/275 (9%)

Query: 521 KLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
            +G G FG VY G LL+        AVK L+  +  G + +F  E +++    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 576 MGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           +G C+  +G  +++  YM +  L    F  + TH    +  +     +A+G+      + 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGTYGYMSPEYALD 692
            + +HRDL A N +LD     K++DFG+AR     E      +        +M+ E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             F+ KSDV+SFGVLL E +T             N       L +  R   LL P    +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRR---LLQPEYCPD 261

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
             Y+       V L C   KA  RP+ S++VS I+
Sbjct: 262 PLYE-------VMLKCWHPKAEMRPSFSELVSRIS 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 2e-58
 Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 45/301 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGL-KEFKNEMMLIAK 566
            N      +GEG FG V++ +            VAVK L  ++   +  +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL----------------- 609
             + N+V+L+G C       L++EYM    LN FL   S   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 610 ----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
               L    ++ I   +A G+ YL +    + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES 725
               +             +M PE      ++ +SDV+++GV+L E  +            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------P 242

Query: 726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 785
           +  + H   ++       L  P                +  LC  +  ADRP+   +  +
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

Query: 786 I 786
           +
Sbjct: 296 L 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-58
 Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 521 KLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRL 575
           +LG G FG V KG        + VAVK L +++       E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
           +G C E    +L+ E      LN +L        +  +  ++++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGTYGYMSPEYALDGL 694
             +HRDL A N+LL +    KISDFG+++    DE     +        + +PE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 695 FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEAS 754
           FS KSDV+SFGVL+ E  +  +                +   K +    +L    +    
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMGCP 232

Query: 755 YQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                    +  LC      +RP  + V   + N
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 3e-58
 Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 22/274 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
           E++ +   LGEG +G V         + VAVK +   ++    +  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+  G   E   + L  EY     L   +        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
              + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 692 DGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ 750
              F +   DV+S G++L   L      G    +  +     ++ WK+ + Y      + 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 784
                 +L++        + E  + R T+  +  
Sbjct: 234 SAP-LALLHK-------ILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-58
 Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 39/299 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
              S    LG G FG V +              VAVK L   +     +   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---------------L 610
           L  H N+V L+G C   G  ++I EY     L  FL     + +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
             +  +     +A+G+ +L        IHRDL A NILL      KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 730
                        +M+PE   + +++ +SDV+S+G+ L E  +   +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE 789
               +  D++ Y+++    +  +          +   C       RPT  ++V +I  +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 7e-58
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
           E++ +   +G G +G   K +   +G+ +  K L   S +    +   +E+ L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 571 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLL 627
           N+VR     +++    L  + EY     L   +   ++    L  +  ++++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 628 YLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
             H+ S     ++HRDLK +N+ LD   N K+ DFG+AR+   D      K  VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 745
           SPE      ++ KSD++S G LL E          +   S   L       K  R     
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVV 783
           S  L              +    +  K   RP++ +++
Sbjct: 239 SDELNE------------IITRMLNLKDYHRPSVEEIL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-57
 Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 44/304 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
           EN      LG G FG V               +VAVK L  ++     +   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--------------------PS 605
           L  H N+V L+G C   G   LI+EY     L  +L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
             ++L ++  +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIES 725
              D              +M+PE   +G++++KSDV+S+G+LL E  +   N        
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265

Query: 726 FNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM 785
                    +  D   Y+L+    + +  +        +   C    +  RP+   + S 
Sbjct: 266 -----PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 786 ITNE 789
           +  +
Sbjct: 321 LGCQ 324

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
            + FS   ++G G FG VY  + + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H N ++  GC + +    L+ EY    + +           L       +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      +IHRD+KA NILL      K+ DFG A +             VGT  +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181

Query: 689 YAL---DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL 745
             L   +G +  K DV+S G+  +E            + + N +   +++ ++      L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPLFNMNAMSALYHIAQNE--SPAL 234

Query: 746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 784
                 E     ++        C+Q+   DRPT   ++ 
Sbjct: 235 QSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 3e-57
 Identities = 62/276 (22%), Positives = 123/276 (44%), Gaps = 26/276 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
            + + +  +LG+G FG VYK +        A K + ++S + L+++  E+ ++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L+     +    ++ E+    +++  + +  R   L       + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               +IIHRDLKA NIL   D + K++DFG++        + ++   +GT  +M+PE  +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 692 -----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
                D  +  K+DV+S G+ L+E    +     +++    +L         +    L  
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVL----LKIAKSEPPTLAQ 237

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           P+         L +       C+++    R T S++
Sbjct: 238 PSRWSSNFKDFLKK-------CLEKNVDARWTTSQL 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-57
 Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 26/279 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
             F     LG G FG VYKG  +   E     VA+K L  + S +  KE  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            + ++ RL+G C+      LI + MP   L  ++ +       G Q  +     IA+G+ 
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMN 125

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
           YL      R++HRDL A N+L+ +  + KI+DFG+A++   +E + + +       +M+ 
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E  L  +++ +SDV+S+GV + E +T                   ++    +    +L  
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228

Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             +             + + C    A  RP   +++   
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 5e-57
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 26/280 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSGQG-LKEFKNEMMLIAKL 567
              + Q  +G G FG VYKG L          VA+K L +   +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
            H N++RL G   +    ++I EYM N +     F   +         V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMS 686
           YL     +  +HRDL A NIL++S++  K+SDFG++R+   D     T         + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 687 PEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS 746
           PE      F+  SDV+SFG+++ E +T                   +    ++   + ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIN 227

Query: 747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
              +        +    + + C Q++ A RP  + +VS++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 4e-56
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 38/291 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLS-SQSGQGLKEFKNEMMLIAKL-Q 568
            +   Q  +GEG FG V K ++       + A+KR+    S    ++F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 615
           H N++ L+G C  +G   L  EY P+ +L  FL                S    L  Q  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
           +     +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 676 KRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL 735
                   +M+ E     +++  SDV+S+GVLL E ++                   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------TPYCG 229

Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
                 YE L    + E      +    +   C +EK  +RP+ ++++  +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 30/272 (11%)

Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
           ++G G F  VYKG       EVA   L  +  +    + FK E  ++  LQH N+VR   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 578 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
                 +     +L+ E M + +L  +L    R  ++  +        I +GL +LH  +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 634 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
              IIHRDLK  NI +     + KI D G+A +          K V+GT  +M+PE   +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE 752
             +    DV++FG+ +LE  TS+         +  +     +  K     ++  P ++  
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244

Query: 753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS 784
                      +   C+++   +R ++  +++
Sbjct: 245 -----------IIEGCIRQNKDERYSIKDLLN 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 2e-55
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 33/304 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLS-SQSGQGLKEFKNEMMLIAK 566
           E  +M  +LG+G FG VY+G             VA+K ++ + S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVKII 619
               ++VRL+G   +    ++I E M    L  +L        +            +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
             IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 680 GTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDN 739
               +MSPE   DG+F+  SDV+SFGV+L E  T                   +    + 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242

Query: 740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQS 799
           +    +      +      +    +  +C Q     RP+  +++S I  E    P  ++ 
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREV 300

Query: 800 AFSY 803
           +F Y
Sbjct: 301 SFYY 304

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-55
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 30/275 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
           E+F +   LG+G FG VY  +   +   +A+K L     +      + + E+ + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
            N++RL G   +     LI EY P  ++   L   S+      Q     I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H     R+IHRD+K  N+LL S    KI+DFG +              + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
               +   K D++S GVL  E L  K     ++  ++         +K     E   P  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQ------ETYKRISRVEFTFPDF 226

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS 784
             E +  +++R        ++   + RP + +V+ 
Sbjct: 227 VTEGARDLISR-------LLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-55
 Identities = 65/279 (23%), Positives = 122/279 (43%), Gaps = 23/279 (8%)

Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     +   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
           + + ++ N+V  +   +   E  ++ EY+   SL   + +              +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126

Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYG 683
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG       +  Q     +VGT  
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE 743
           +M+PE      +  K D++S G++ +E +      G     + N L   + +  +    E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI-----EGEPPYLNENPLRALYLIATNGT-PE 235

Query: 744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           L +P          LNR       C+      R +  ++
Sbjct: 236 LQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-54
 Identities = 74/283 (26%), Positives = 108/283 (38%), Gaps = 29/283 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAK 566
           ++  +  KLG+G FG V +G+          VAVK L        + + +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           L HRNL+RL G         ++ E  P  SL                T  +    +A+G+
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-NTKRVVGTYGYM 685
            YL      R IHRDL A N+LL +    KI DFG+ R    ++      +     + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK-DNRAYEL 744
           +PE      FS  SD + FGV L E  T  +       E +  L  +  L K D     L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-------EPWIGLNGSQILHKIDKEGERL 234

Query: 745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT 787
             P                V + C   K  DRPT   +   + 
Sbjct: 235 PRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-52
 Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 26/280 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 568
           E   +   +GEG FG V++G  ++       VA+K   + +   ++E F  E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H ++V+L+G   E     +I E      L    F   R + L   + +     ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           L      R +HRD+ A N+L+ S+   K+ DFG++R            +      +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA 748
                 F+  SDV+ FGV + E L                    +   K+N     +   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV--------------KPFQGVKNNDVIGRIENG 225

Query: 749 LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
            +            ++   C     + RP  +++ + ++ 
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-51
 Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 38/297 (12%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 565
           +   +   LG G FG V +            + VAVK L   +     +   +E+ +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 566 KLQHRNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHL-------------LG 611
              H N+V L+G C + G  +++  E+    +L+ +L       +             L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
            +  +     +A+G+ +L      + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH 731
                       +M+PE   D +++++SDV+SFGVLL E  +              +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245

Query: 732 AWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
                K+                           L C   + + RPT S++V  + N
Sbjct: 246 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-51
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 40/296 (13%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLI 564
           +   +   LGEG FG V   + +           +VAVK L S  + + L +  +EM ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------L 610
             + +H+N++ L+G C + G   +I EY    +L  +L       L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
             +  V     +A+G+ YL      + IHRDL A N+L+  D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLG 730
               T        +M+PE   D +++ +SDV+SFGVLL E  T                 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------------- 235

Query: 731 HAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMI 786
             +        ++LL    + +      N    +   C     + RPT  ++V  +
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-50
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 10/207 (4%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
           E+F     LGEG F  V   + L   +E A+K L          +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
              V+L     +  +      Y  N  L  ++                    I   L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
           H      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT  Y+SPE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
             +      SD+++ G ++ + +    
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (448), Expect = 1e-49
 Identities = 56/273 (20%), Positives = 110/273 (40%), Gaps = 25/273 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           +++ +  +LG G FG V++      G   A K + +      +  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           V L     +  E ++IYE+M    L   + D      +     V+ +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141

Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
                +H DLK  NI+  +  +   K+ DFG+       +   + K   GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
                   +D++S GVL    L+      G  D E+   +  + +   D+ A+  +S   
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSGISEDG 256

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           +       + +        +      R T+ + 
Sbjct: 257 KD-----FIRK-------LLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (436), Expect = 5e-48
 Identities = 62/315 (19%), Positives = 125/315 (39%), Gaps = 28/315 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           + L     ++ E +LI E++    L   +   +  + +     +  +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               I+H D+K  NI+ ++      KI DFG+A     DE+    K    T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNLWKDNRAYELLSPAL 749
                   +D+++ GVL    L+      G  D+E+   +    +   D  A+  +SP  
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWEFDEDAFSSVSPEA 259

Query: 750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNEHATLP-YPKQSAFSYARR 806
           +       +          +Q++   R T+   +    +  +H+ L      S ++  R+
Sbjct: 260 K-----DFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307

Query: 807 GEKISFLPSSRVSEA 821
             K  +        A
Sbjct: 308 KIKEKYADWPAPQPA 322

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (411), Expect = 5e-45
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
           ++F +   LG G FG V+  +   NG+  A+K L        + ++   +E ++++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             ++R+ G   +  +  +I +Y+        LF   R          K     A+  L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY--AAEVCLAL 117

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
                  II+RDLK  NILLD + + KI+DFG A+      +   T  + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
                ++   D +SFG+L+ E L    
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 15/213 (7%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
           ++ + +   LG GG   V+  + L   ++VAVK L    ++       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 569 HRNLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           H  +V +      +        ++ EY+   +L   +        +  +  +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGTYG 683
            L + H   +  IIHRD+K +NI++ +    K+ DFG+AR           T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 684 YMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR 716
           Y+SPE A       +SDV+S G +L E LT + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (410), Expect = 2e-44
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 18/210 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNE---MMLIAK 566
            +FS+   +G GGFG VY  +    G+  A+K L  +     QG     NE   + L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
                +V +        +   I + M    L++ L                    I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
            ++H      +++RDLK +NILLD   + +ISD G+A  F   +        VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 687 PEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
           PE    G+ +   +D FS G +L + L   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 4e-44
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 7/207 (3%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
              ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N++ +         + +   Y+    +   L+   +T  L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT-KRVVGTYGYMSPEY 689
                 ++HRDLK SN+LL++  + KI DFG+AR+   D          V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 690 ALDGLFSVKS-DVFSFGVLLLETLTSK 715
            L+     KS D++S G +L E L+++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 24/277 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           K+G G FG +Y G  +  G+EVA+K    ++     +   E  +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
             +G+  ++   +   SL       SR      +T + + + +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 640 RDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGN-----TKRVVGTYGYMSPEYAL 691
           RD+K  N L           I DFG+A+ +       +      K + GT  Y S    L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 692 DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH 751
               S + D+ S G +L+               +        +  K +   E+L      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246

Query: 752 EASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           E     LN        C   +  D+P  S +  +  N
Sbjct: 247 EF-ATYLNF-------CRSLRFDDKPDYSYLRQLFRN 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-43
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 12/206 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
           E + +   LG G FG V++     + +    K +  + G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           + L        E ++I+E++    +   +   +    L  +  V  +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
               I H D++  NI+  +  +   KI +FG AR     +   N + +     Y +PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR 716
              + S  +D++S G L+   L+   
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN 201

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-43
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 13/208 (6%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQ 568
           E+F +   LG+G FG V+  +     Q  A+K L         + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
           H  L  +      +     + EY+    L + +    +               I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           LH      I++RDLK  NILLD D + KI+DFGM +     + + NT    GT  Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 689 YALDGLFSVKSDVFSFGVLLLETLTSKR 716
             L   ++   D +SFGVLL E L  + 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (389), Expect = 2e-42
 Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 42/288 (14%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--------SSQSGQGLKE-FKNEMML 563
           EN+  +  LG G    V +       +E AVK +        S++  Q L+E    E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 564 IAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           + K+  H N+++L           L+++ M    L  +L   +    L  +   KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTY 682
            + +  LH   +L I+HRDLK  NILLD DMN K++DFG +      E     + V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173

Query: 683 GYMSPEYALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW 736
            Y++PE     +      +  + D++S GV++   L      G         +     + 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-----AGSPPFWHRKQMLMLRMIM 228

Query: 737 KDNRAYELLSPALQH--EASYQMLNRYITVALLCVQEKAADRPTMSKV 782
             N  Y+  SP      +    +++R        +  +   R T  + 
Sbjct: 229 SGN--YQFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 4e-42
 Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 26/275 (9%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
            + +  +  LG G F  V   +     + VA+K ++ ++ +G     +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V L       G   LI + +    L   + +         +   ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 631 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSP 687
                 I+HRDLK  N+L    D D    ISDFG+++M     +        GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

Query: 688 EYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP 747
           E      +S   D +S GV+    L      G       N       + K    ++    
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILL-----CGYPPFYDENDAKLFEQILKAEYEFDSPYW 233

Query: 748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
               +++   +          +++    R T  + 
Sbjct: 234 DDISDSAKDFIRH-------LMEKDPEKRFTCEQA 261

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (387), Expect = 5e-42
 Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 26/286 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
            ++ +  ++GEG FG +++G  LLN Q+VA+K    +S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
           +  +    ++G   ++   +   SL   L    R      +T     + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE- 119

Query: 633 SRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN-----TKRVVGTY 682
               +++RD+K  N L+    +       + DFGM + +     + +      K + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            YMS    L    S + D+ + G + +  L             +  L  A N  K  R  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--------WQGLKAATNKQKYERIG 229

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN 788
           E        E        +               P    +  + + 
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 5e-42
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           ENF    K+GEG +G VYK +  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+V+L+     + +  L++E++      F   D S    +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
            +   R++HRDLK  N+L++++   K++DFG+AR   G  ++  T  VV  +        
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR 716
               +S   D++S G +  E +T + 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-41
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 27/292 (9%)

Query: 512 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQG--LKEFKNE---MMLI 564
           A + +    ++GEG +G V+K + L   G+ VA+KR+  Q+G+         E   +  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN---FFLFDPSRTHLLGWQTRVKIIEG 621
              +H N+VRL   C            +  + ++       D      +  +T   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
           + +GL +LH     R++HRDLK  NIL+ S    K++DFG+AR++     Q     VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 682 YGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRN-TGVYDIESFNLLGHAWNL----- 735
             Y +PE  L   ++   D++S G +  E    K    G  D++    +     L     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 736 WKDNRAYELLSPALQHEASYQMLNRYITVALL-----CVQEKAADRPTMSKV 782
           W  + A    +   +     +     I          C+    A R +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQHRNLVR 574
            LGEG F  VYK +  N  Q VA+K++        K+        E+ L+ +L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
           L+     +    L++++M              + +L        +    QGL YLHQ+  
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD-G 693
             I+HRDLK +N+LLD +   K++DFG+A+ F            V T  Y +PE      
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176

Query: 694 LFSVKSDVFSFGVLLLETLTSK 715
           ++ V  D+++ G +L E L   
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 11/205 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
           E +    K+GEG +G VYK +   G+  A+K  RL  +          E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
           +V+L      +   +L++E++                 L   T    +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118

Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYAL 691
               R++HRDLK  N+L++ +   KI+DFG+AR F            + T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173

Query: 692 -DGLFSVKSDVFSFGVLLLETLTSK 715
               +S   D++S G +  E +   
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-39
 Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 32/280 (11%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL------SSQSGQGLKEFKNEMMLIAK 566
           + +    +LG G F  V K +    G + A K +      SS+ G   ++ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
           +QH N++ L      + + ILI E +    L  FL +      L  +   + ++ I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGTY 682
             ++    L+I H DLK  NI+L     P    KI DFG+A            K + GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 683 GYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY 742
            +++PE        +++D++S GV+    L     +G              N+   N  +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILL-----SGASPFLGDTKQETLANVSAVNYEF 235

Query: 743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKV 782
           E    +     +   + R        + +    R T+   
Sbjct: 236 EDEYFSNTSALAKDFIRR-------LLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-39
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 19/211 (9%)

Query: 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
           +++    +G G FG VY+ KL  +G+ VA+K++        +    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 574 RLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
           RL       GEK       L+ +Y+P                L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 628 YLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMS 686
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190

Query: 687 PEYALDGL-FSVKSDVFSFGVLLLETLTSKR 716
           PE       ++   DV+S G +L E L  + 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-38
 Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 12/207 (5%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
            +F     LG+G FG V   +    G+  A+K L  +   +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
             L  L            + EY     L F L   SR  +   +         A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118

Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEY 689
                  +++RD+K  N++LD D + KI+DFG+ +    D      K   GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 690 ALDGLFSVKSDVFSFGVLLLETLTSKR 716
             D  +    D +  GV++ E +  + 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 10/206 (4%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
           + +    K+GEG +G V+K K     + VA+K  RL             E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
           N+VRL        +  L++E+       +F          G      +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYA 690
                 ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  VV  +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 691 LDGLFSVKSDVFSFGVLLLETLTSKR 716
              L+S   D++S G +  E   + R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
             +    K+G+G FG V+K +    GQ+VA+K++   ++          E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 571 NLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
           N+V L+  C  +            L++++  +           +          ++++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 680
             GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F    +         V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 681 TYGYMSPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 716
           T  Y  PE  L +  +    D++  G ++ E  T   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-37
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 20/212 (9%)

Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE------FKNEMMLIAKLQ 568
           + +   LG GGFG VY G  + +   VA+K +         E         E++L+ K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 569 --HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
                ++RL+         +LI E        F     +    L  +        + + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123

Query: 627 LYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
            + H      ++HRD+K  NIL+D +    K+ DFG   +              GT  Y 
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176

Query: 686 SPEYAL-DGLFSVKSDVFSFGVLLLETLTSKR 716
            PE+          + V+S G+LL + +    
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 49/272 (18%), Positives = 97/272 (35%), Gaps = 33/272 (12%)

Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCC 579
           LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 580 ----VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
                 +   +++ E +    L   + D         +   +I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 636 RIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALD 692
            I HRD+K  N+L  S       K++DFG A+                T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 693 GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQH- 751
             +    D++S GV++   L        +       +            YE  +P     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 752 -EASYQMLNRYITVALLCVQEKAADRPTMSKV 782
            E    ++          ++ +   R T+++ 
Sbjct: 245 SEEVKMLIRN-------LLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 9e-36
 Identities = 55/244 (22%), Positives = 94/244 (38%), Gaps = 15/244 (6%)

Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
           + A + +E           + D +    + +  +A  + F     LG G FG V   K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63

Query: 536 LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
            +G   A+K L  Q     + ++   NE  ++  +    LV+L     +     ++ EY+
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123

Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
               +   L    R               I     YLH    L +I+RDLK  N+L+D  
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177

Query: 653 MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETL 712
              +++DFG A+        G T  + GT   ++PE  L   ++   D ++ GVL+ E  
Sbjct: 178 GYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 713 TSKR 716
               
Sbjct: 233 AGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-34
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
             +     +G G +G V        G +VA+K+L    QS    K    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 571 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           N++ L+             +  L+  +M             +   LG      ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     +        V T  Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 685 MSPEYALDGL-FSVKSDVFSFGVLLLETLTSK 715
            +PE  L+ + ++   D++S G ++ E +T K
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-34
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)

Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLS----SQSGQGLKEFKNEMMLIA 565
           ENF +   LG G +G V+  + +     G+  A+K L      Q  +  +  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 566 KLQHR-NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
            ++    LV L      + +  LI +Y+    L   L    R       T  ++   + +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGE 137

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
            +L L    +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 685 MSPEYALDGL--FSVKSDVFSFGVLLLETLTSKR 716
           M+P+    G        D +S GVL+ E LT   
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 4e-32
 Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRN 571
           +++ +  KLG G +  V++   + N ++V VK L        K+ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 572 LVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
           ++ L     +   +   L++E++ N               L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 630 HQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           H    + I+HRD+K  N+++D +    ++ D+G+A  +   +        V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 689 YALD-GLFSVKSDVFSFGVLLLETLTSKR 716
             +D  ++    D++S G +L   +  K 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-31
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQHR 570
           + +     +G G  G V      +  + VA+K+LS   Q+    K    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 571 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
           N++ L+     Q       +  L+ E M          +         +    ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGY 684
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR      +       V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 685 MSPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
            +PE  L   +    D++S G ++ E +  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-29
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 13/208 (6%)

Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 569
            E +     +G G +G V        G  VAVK+LS   QS    K    E+ L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 570 RNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
            N++ L+               Y+    +   L +  +   L       +I  I +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPE 688
           +H      IIHRDLK SN+ ++ D   KI DFG+AR              V T  Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 188

Query: 689 YALDGL-FSVKSDVFSFGVLLLETLTSK 715
             L+ + ++   D++S G ++ E LT +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 42/210 (20%), Positives = 80/210 (38%), Gaps = 18/210 (8%)

Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
           KLG G F  V+  K ++N   VA+K +        +  ++E+ L+ ++   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 580 VEQGEKILIY-------------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
                K+L +              +         L        +      +I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 627 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGTYGYM 685
            Y+H+  R  IIH D+K  N+L++  D    +    +A +        +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 686 SPEYALDGLFSVKSDVFSFGVLLLETLTSK 715
           SPE  L   +   +D++S   L+ E +T  
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  103 bits (257), Expect = 8e-26
 Identities = 30/154 (19%), Positives = 60/154 (38%), Gaps = 20/154 (12%)

Query: 521 KLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLK--------EFKNEMMLIAKLQHR 570
            +GEG    V+        E  VK  ++   S + +K         F    +  A+ + R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
            L +L G  V +     +Y +  N ++   L D    + +  +   ++++ I + +   +
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
                 I+H DL   N+L+  +    I DF  + 
Sbjct: 121 HR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 86.9 bits (215), Expect = 4e-21
 Identities = 24/117 (20%), Positives = 47/117 (40%), Gaps = 14/117 (11%)

Query: 34  IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIG 93
           + +GE L  + Q  ++  +     +   L ++      T VW +N             + 
Sbjct: 4   LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58

Query: 94  NNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF 150
           ++GN V+ +     +W+S+  R   N V  L + GN+V+          GS +W + 
Sbjct: 59  SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSDIWSTG 106

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 67.7 bits (165), Expect = 2e-14
 Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 21/126 (16%)

Query: 26  DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
           + +     +  GE L   S  F              L ++     D  +W  N       
Sbjct: 2   NILYSGETLSTGEFLNYGS--FVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49

Query: 86  SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
            +  L++  +GNLV+ N ++  IW+SN   +  N V  L    N+V+          G+ 
Sbjct: 50  RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY---------GTD 100

Query: 146 LWQSFD 151
            W +  
Sbjct: 101 RWATGT 106

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.3 bits (164), Expect = 3e-14
 Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 20/131 (15%)

Query: 20  LLSLATDTITPATLI-GDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
           + S   D   P  L   +  +++  + ++     +          + Y    +  +W  N
Sbjct: 4   IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATN 55

Query: 79  RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSS 138
                    AVL    +G LV++   +  +W S ++ +  + V  L    N+V+      
Sbjct: 56  TGGLGNGCRAVLQ--PDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY----- 108

Query: 139 NTSEGSYLWQS 149
               G  LW +
Sbjct: 109 ----GDALWAT 115

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.6 bits (165), Expect = 4e-14
 Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 10/99 (10%)

Query: 64  IWY-KQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVA 122
           I Y  Q  D      +    +  S   L++  + NLVL ++ D  +WS+N + +     A
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70

Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFD--CPSDTLLI 159
            L   G + +       T++   +W S +       + +
Sbjct: 71  VLQPNGRMDVL------TNQNIAVWTSGNSRSAGRYVFV 103

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 48.4 bits (115), Expect = 2e-07
 Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 2/63 (3%)

Query: 70  PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
            D  VW    N+    +     +  NG + +L   +  +W+S  SR     V  L    N
Sbjct: 52  RDDRVWS--TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109

Query: 130 LVL 132
           L +
Sbjct: 110 LAI 112

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 63.3 bits (153), Expect = 1e-12
 Identities = 25/131 (19%), Positives = 48/131 (36%), Gaps = 19/131 (14%)

Query: 25  TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
           +D +     +  G  L      +     +          + Y    +  VW +  N    
Sbjct: 1   SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYD--NNRAVWASGTNGKA- 49

Query: 85  DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
            S  VL + N+GNLV+ +     IW+SN +R+  N    L    N+V+ +      +  +
Sbjct: 50  -SGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSNN 101

Query: 145 YLWQSFDCPSD 155
            +W +     +
Sbjct: 102 AIWATHTNVGN 112

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 50.3 bits (120), Expect = 3e-08
 Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 16/124 (12%)

Query: 20  LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANR 79
           L  L+ +   P TL    + L  SS  F     S        L ++     D  VW +N 
Sbjct: 4   LFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASNT 52

Query: 80  NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FS 137
                 +     + ++G LV+L   + I WSS     + N V  L     + +     + 
Sbjct: 53  AG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWD 109

Query: 138 SNTS 141
           S TS
Sbjct: 110 SGTS 113

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	835
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.85
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.85
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.65
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.64
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.5
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.48
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.28
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.07
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.95
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.91
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.64
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.92
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.4
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.69
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.45
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.23
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	90.05
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	81.66

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=420.86  Aligned_cols=264  Identities=29%  Similarity=0.450  Sum_probs=207.3

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||+||+|+..  ..||||+++..  .....+.|++|+.+|++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  46999998644  45567889999999999999999999998754 56899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++...  ...+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999543  345899999999999999999999987   9999999999999999999999999998765444


Q ss_pred             ccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .........||+.|||||++..   ..|+.++|||||||+||||+||+.||........ +.    .....+    ...+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~----~~~~~~----~~~p  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----FMVGRG----YLSP  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH----HHHHHT----SCCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HH----HHHhcC----CCCC
Confidence            4444456789999999999864   3589999999999999999999999975432211 00    001100    0111


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCC
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLP  794 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~  794 (835)
                      .+ ...+..++..+.+++.+||+.+|++|||++||++.|+.+.+.+|
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11 11223345678899999999999999999999999998866655

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=413.90  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=205.7

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999985 58999999986543 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+++|+|.+++..   ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus        84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999999843   456899999999999999999999998   9999999999999999999999999999875544


Q ss_pred             ccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      ........+||+.|||||++.+..+ +.++|||||||+||||++|+.||............     .....        .
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~--------~  224 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKK--------T  224 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTC--------T
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCC--------C
Confidence            4444556789999999999988876 57899999999999999999999754422111110     00000        0


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ........+..+.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            01111223456778999999999999999999865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=414.38  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=199.8

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.++||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            579999999999999999999988899999999754 3445789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999854  3356889999999999999999999988   99999999999999999999999999987644322 2


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-CCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+. +|+.......  +...    ....  .+...|     
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~----i~~~--~~~~~p-----  224 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED----ISTG--FRLYKP-----  224 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHH----HHHT--CCCCCC-----
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHhc--CCCCCc-----
Confidence            233457899999999999999999999999999999999965 4444322111  1110    0000  111111     


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                        ..++..+.+++.+||+.||++||+|+||++.|+++
T Consensus       225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              22345678999999999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-49  Score=417.58  Aligned_cols=261  Identities=27%  Similarity=0.397  Sum_probs=213.2

Q ss_pred             HhhcCCccccccccCCcccEEEEEecC-CcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       511 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ...++|++.++||+|+||+||+|++.. ++.||||+++... ...++|++|+.+|++++|||||++++++.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            345789999999999999999999864 8899999997543 35678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++... ....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999998543 3456899999999999999999999988   999999999999999999999999999876443


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .. .......|++.|+|||++.+..++.++|||||||++|||++|..|+....... .+.    ....         ...
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~----~~i~---------~~~  233 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVY----ELLE---------KDY  233 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH----HHHH---------TTC
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHH----HHHh---------cCC
Confidence            22 22334568899999999999999999999999999999999777654322111 010    1111         111


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                      ....+..++..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111222345678899999999999999999999999987643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=409.83  Aligned_cols=249  Identities=22%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999974 58999999997665556788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++.+    ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999998743    35899999999999999999999998   9999999999999999999999999998764332  


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      .......||+.|||||++.+..++.++|||||||++|||++|+.||...+....  .   ....... .     +.+  .
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~---~~~~~~~-~-----~~~--~  237 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L---YLIATNG-T-----PEL--Q  237 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHHHHC-S-----CCC--S
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--H---HHHHhCC-C-----CCC--C
Confidence            223456799999999999999999999999999999999999999975432211  0   0000000 0     001  1


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .+...+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12234566889999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=411.57  Aligned_cols=256  Identities=31%  Similarity=0.440  Sum_probs=206.8

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46899999999999999999999888899999997543 345789999999999999999999998754 5679999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++... ....+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987432 2235899999999999999999999988   99999999999999999999999999998754332 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      .......||+.|||||++.++.++.++|||||||+||||+||..|+....... ....    .....     ..+    .
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----~i~~~-----~~~----~  230 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----NLERG-----YRM----V  230 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHTT-----CCC----C
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHhc-----CCC----C
Confidence            22334578999999999999999999999999999999999766543222111 0110    00000     111    1


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+...+..+.+|+.+||+.+|++||||+||+++|+..
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            1123345688899999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-48  Score=415.70  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=199.5

Q ss_pred             cCCccccccccCCcccEEEEEecC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.++||+|+||+||+|++.. +   ..||||++... .....++|.+|+.+|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            568888999999999999998753 2   36899998654 445667899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..  ....+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998854  3346899999999999999999999987   99999999999999999999999999987754


Q ss_pred             CCccc---cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          669 DELQG---NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       669 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      .....   ......||+.|||||.+.++.++.++|||||||+||||+| |+.||.......  +...    ...      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~----i~~------  248 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINA----IEQ------  248 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH----HHT------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHH----HHc------
Confidence            33221   1223467999999999999999999999999999999998 899987543221  1110    000      


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                         ......+..++..+.+|+.+||+.||++||+|+||++.|+.+
T Consensus       249 ---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         249 ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               011112223456788999999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=402.99  Aligned_cols=253  Identities=29%  Similarity=0.442  Sum_probs=212.1

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecC
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP  593 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  593 (835)
                      ++|++.++||+|+||+||+|++++++.||||+++... ...++|++|+.++++++|||||+++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999997643 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCccc
Q 003264          594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG  673 (835)
Q Consensus       594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  673 (835)
                      +|+|..++..  ....+++..+.+++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999999744  3456889999999999999999999988   999999999999999999999999999876544322 


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||........  ..   .+ ...  .....      
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~---~i-~~~--~~~~~------  222 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE---HI-AQG--LRLYR------  222 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH---HH-HTT--CCCCC------
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HH---HH-HhC--CCCCC------
Confidence            2334578999999999999999999999999999999998 7889876553321  11   01 110  11111      


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITN  788 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  788 (835)
                       +...+..+.+++.+||+.||++|||++|+++.|.+
T Consensus       223 -p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             12234578899999999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-48  Score=417.30  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=208.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC-C-----cEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN-G-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  584 (835)
                      .++|++.++||+|+||+||+|++.. +     ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999998743 2     36999998654 334456789999999998 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCC
Q 003264          585 KILIYEYMPNKSLNFFLFDPSR--------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA  644 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp  644 (835)
                      .++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965421                    235889999999999999999999988   99999999


Q ss_pred             CeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCc
Q 003264          645 SNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDI  723 (835)
Q Consensus       645 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~  723 (835)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||...+.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655444334445678999999999999999999999999999999998 8999875443


Q ss_pred             ccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 003264          724 ESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMIT  787 (835)
Q Consensus       724 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  787 (835)
                      ... +.    .....+         .+.+.+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~~-~~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN-FY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH-HH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH-HH----HHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211 10    111111         111122234467889999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-48  Score=403.39  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=205.7

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+.   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999985 4889999998643   2334677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999843   346899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                          ......||+.|||||++.+..++.++|||||||+||||++|+.||...+....  ..    .+....      .. 
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~------~~-  222 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YK----RISRVE------FT-  222 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHTTC------CC-
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC------CC-
Confidence                23446799999999999999999999999999999999999999975432211  10    000000      01 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .+...+..+.+++.+||+.||++|||++|+++
T Consensus       223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               11123456788999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=406.18  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             hcCCccccc-cccCCcccEEEEEec---CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCK-LGEGGFGPVYKGKLL---NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~-LG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|.+.+. ||+|+||+||+|.+.   ++..||||+++.. .....++|.+|+++|++++|||||++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356777774 999999999999764   3557999999765 34456889999999999999999999999864 56899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..  ....+++..+.+++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999999843  2346899999999999999999999988   9999999999999999999999999999875


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ..... .......||+.|||||++..+.++.++|||||||++|||+| |+.||........  ..    .+..+.     
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~----~i~~~~-----  229 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK-----  229 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTC-----
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcCC-----
Confidence            43322 22334568999999999999999999999999999999998 8999976442211  11    111111     


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          +...+..++..+.+|+.+||+.+|++||+|.+|++.|+..
T Consensus       230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1111223446788999999999999999999999999765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=407.88  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=195.6

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--cCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV  588 (835)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|++++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            68999999999999999999975 5899999998654  34456779999999999999999999999875  4568999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      |||+++|+|.+++.+. .....+++..++.++.||+.||+|||+++.  .+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998532 234568999999999999999999998652  3599999999999999999999999999988


Q ss_pred             ccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          666 FCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       666 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      +....  .......||+.|||||++.+..|+.++|||||||++|||++|++||...+....  ..    .+.....    
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~~----~i~~~~~----  231 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AG----KIREGKF----  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTCC----
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--HH----HHHcCCC----
Confidence            64322  223456899999999999999999999999999999999999999975442211  10    0111111    


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       +.    .+..++..+.+|+.+||+.||++|||++|+++
T Consensus       232 -~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             11    11233456889999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=406.16  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=201.2

Q ss_pred             cCCccccccccCCcccEEEEEecCC-----cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      +.|++.++||+|+||+||+|++...     ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688999999999999999987542     37999999754 34455679999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+.+++|.+++..  ....+++.++++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988743  3356899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ..... .......||+.|||||++.++.++.++|||||||+||||++|..|+....... .+..             .+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~-------------~i~  227 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMK-------------AIN  227 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH-------------HHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHH-------------HHh
Confidence            43322 22334568999999999999999999999999999999999766654322111 1111             011


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ...+...+..++..+.+|+.+||+.+|++||+|+||+++|+.+.
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            11111222234567889999999999999999999999998763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=406.88  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      +.|++++.||+|+||+||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            57999999999999999999975 58899999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++.+  ....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            99999998743  2346899999999999999999999998   9999999999999999999999999997653221  


Q ss_pred             ccccccccccceeCceeec-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          673 GNTKRVVGTYGYMSPEYAL-----DGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      .......||+.|||||++.     +..|+.++|||||||+||||++|+.||........  ..   .... ...     +
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~---~i~~-~~~-----~  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LL---KIAK-SEP-----P  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH---HHHH-SCC-----C
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HH---HHHc-CCC-----C
Confidence            1223467999999999984     45689999999999999999999999975442211  10   0000 100     1


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .+  ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11  112234567889999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=406.54  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=206.6

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      .++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            3689999999999999999999988889999999654 344578999999999999999999999985 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|..++... ....+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999999888542 2345899999999999999999999998   99999999999999999999999999987643332 


Q ss_pred             ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          673 GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       673 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      .......||+.|+|||++..+.++.++|||||||+||||++|..|+........ ....    +..+         ....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~----i~~~---------~~~~  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ----VERG---------YRMP  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHH----HHTT---------CCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHH----HHhc---------CCCC
Confidence            223345789999999999999999999999999999999997766543322111 1111    0101         1111


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCC
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYP  796 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p  796 (835)
                      .+...+..+.+++.+||+.||++||+|++|+++|+......+++
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            22234467889999999999999999999999998875554433

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=405.24  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             cccccCCcccEEEEEecC---CcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEecCC
Q 003264          520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN  594 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  594 (835)
                      ++||+|+||+||+|.+.+   ++.||||+++..  .....++|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   468999999653  33346789999999999999999999999854 567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc-c
Q 003264          595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ-G  673 (835)
Q Consensus       595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~  673 (835)
                      |+|.+++..   ...+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999853   346899999999999999999999988   999999999999999999999999999876543322 2


Q ss_pred             cccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCccccch
Q 003264          674 NTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHE  752 (835)
Q Consensus       674 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  752 (835)
                      ......||+.|||||.+.+..++.++|||||||++|||++ |+.||........  ..    .+..+.         +..
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~----~i~~~~---------~~~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TA----MLEKGE---------RMG  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTTC---------CCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HH----HHHcCC---------CCC
Confidence            2334678999999999999999999999999999999998 8999875442211  11    111111         111


Q ss_pred             hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          753 ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+..++..+.+|+.+||+.||++||++++|+++|+..
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            1223446788999999999999999999999988764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=410.97  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=205.7

Q ss_pred             hhcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ..++|+++++||+|+||+||+|++. +|+.||||+++.. .....+++.+|+.+|++++|||||++++++.+.++.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999975 5889999998754 3344578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      ||+++|+|.+++.+   ...+++..+..++.||++||.|||+. +   |+||||||+||||+.++++||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999953   34689999999999999999999974 6   99999999999999999999999999987643


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhh-----------hc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNL-----------WK  737 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~  737 (835)
                      .    ......||+.|||||++.+..|+.++||||+||++|||++|+.||...+.............           ..
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    22346899999999999999999999999999999999999999976543221111000000           00


Q ss_pred             cc-------------cchhc-------cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          738 DN-------------RAYEL-------LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       738 ~~-------------~~~~~-------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..             ...+.       ..+.+.   ....+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00             00000       000000   0112456889999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=405.65  Aligned_cols=249  Identities=23%  Similarity=0.301  Sum_probs=203.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++.+.||+|+||+||+|+.. +++.||||++...   .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999985 5899999998643   2334578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999884   3356899999999999999999999998   999999999999999999999999999987554


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      ..........||+.|||||++.+..++.++|||||||+||||++|+.||...+....  ..   .. ....      .. 
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i-~~~~------~~-  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQ---KI-IKLE------YD-  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-HTTC------CC-
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--HH---HH-HcCC------CC-
Confidence            444444556899999999999999999999999999999999999999975432211  10   00 0000      01 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               11223456789999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=394.21  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             CccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCeEEEE
Q 003264          516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI  588 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV  588 (835)
                      |++.++||+|+||+||+|++. +++.||||++...  .....+.|.+|+++|++++|||||++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            467778999999999999985 4889999998654  34456789999999999999999999999875    3457999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc-CCCCeEecccCcccccc
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFC  667 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~  667 (835)
                      |||+++|+|.+++.+   ...+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999843   356899999999999999999999875 4599999999999996 57899999999998643


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ..    ......||+.|||||++.+ .++.++|||||||++|||++|+.||........ +..    .....     .  
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~----~i~~~-----~--  229 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYR----RVTSG-----V--  229 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHH----HHTTT-----C--
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHH----HHHcC-----C--
Confidence            22    2345689999999998765 699999999999999999999999964332111 100    00000     0  


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                       .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       230 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 -KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             011112223445788999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-47  Score=405.90  Aligned_cols=266  Identities=26%  Similarity=0.406  Sum_probs=214.5

Q ss_pred             HHHHHHhhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeE
Q 003264          506 LASVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGC  578 (835)
Q Consensus       506 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~  578 (835)
                      +.+++...++|++.+.||+|+||+||+|+..      +++.||||+++... ....++|.+|+.+|++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3445556688999999999999999999864      35789999997653 3456789999999999999999999999


Q ss_pred             EEecCeEEEEEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 003264          579 CVEQGEKILIYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI  637 (835)
Q Consensus       579 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  637 (835)
                      +.+....++||||+++|+|.++++...                     ....+++..++.++.||++||+|||+++   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence            999999999999999999999985321                     1235889999999999999999999988   9


Q ss_pred             EEecCCCCeEEEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-C
Q 003264          638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-R  716 (835)
Q Consensus       638 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~  716 (835)
                      |||||||+||||+.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998775554444445567899999999999999999999999999999999996 5


Q ss_pred             CCCCCCcccccccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          717 NTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       717 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      |+...+....  ..    ....+..     +    ..+..++..+.+|+.+||+.+|++||||.||+++|+.+
T Consensus       242 p~~~~~~~e~--~~----~v~~~~~-----~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         242 PYYGMAHEEV--IY----YVRDGNI-----L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTTSCHHHH--HH----HHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCHHHH--HH----HHHcCCC-----C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            6654432211  11    0111111     1    11223345688999999999999999999999999876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.1e-46  Score=404.89  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=210.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.++||+|+||+||+|+.. +|+.||||++........+.+++|+.+|++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            368999999999999999999975 5899999999877767778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCCCeEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~  669 (835)
                      +++|+|.+++.+  ....+++..+..++.||+.||+|||+++   ||||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999853  2346899999999999999999999998   99999999999995  4678999999999876432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||...+....  ..   .....       ....
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~---~i~~~-------~~~~  244 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR---NVKSC-------DWNM  244 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHHT-------CCCS
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HH---HHHhC-------CCCC
Confidence            2   23456899999999999999999999999999999999999999975442211  10   00000       0011


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ........+..+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111122334567899999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-46  Score=400.12  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=191.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .+.|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999985 48899999987543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc---CCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~  667 (835)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+.   .++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999953   356899999999999999999999998   99999999999994   57899999999998654


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCc
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSP  747 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  747 (835)
                      ...   ......||+.|||||++.+..|+.++|||||||+||||++|+.||........  ..   ......       .
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i~~~~-------~  226 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FE---QILKAE-------Y  226 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH---HHHTTC-------C
T ss_pred             CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HH---HHhccC-------C
Confidence            322   23346799999999999999999999999999999999999999975432211  00   000100       0


Q ss_pred             cccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          748 ALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       748 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      ..........+..+.+++.+||+.||++|||++|+++.
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            01111122344668899999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-46  Score=401.71  Aligned_cols=245  Identities=31%  Similarity=0.469  Sum_probs=201.2

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      +.|+++++||+|+||+||+|+.. +++.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999975 58899999986543   344567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|..++.   ....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987763   2346899999999999999999999998   99999999999999999999999999986532 


Q ss_pred             CccccccccccccceeCceeecC---CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALD---GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||........  .   .......      .
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~---~~i~~~~------~  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQNE------S  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHHHSC------C
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--H---HHHHhCC------C
Confidence                 234579999999999864   4689999999999999999999999875432111  0   0000100      1


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      +...   +...+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111   1123456888999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-45  Score=401.64  Aligned_cols=256  Identities=21%  Similarity=0.260  Sum_probs=211.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM  592 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  592 (835)
                      ++|++++.||+|+||+||+|+.. +|+.||||++........+.+++|+.+|++++|||||++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            67999999999999999999974 58999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc--CCCCeEecccCccccccCCC
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~  670 (835)
                      ++|+|.+++..  ....+++.++..++.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+++.+....
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887743  3346899999999999999999999998   99999999999997  67899999999998865432


Q ss_pred             ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||...+....  ...   ... .      .....
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~---i~~-~------~~~~~  248 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQN---VKR-C------DWEFD  248 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH---HHH-C------CCCCC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---HHh-C------CCCCC
Confidence               23446789999999999999999999999999999999999999975442211  100   000 0      00111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                      .......+..+.+|+.+||+.||++|||++|+++.  +.+.
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            11122344567899999999999999999999874  5443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=402.17  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc----EEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .+|+++++||+|+||+||+|++.. |+    +||||++... .....++|.+|+.++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999998743 43    6899998654 345678899999999999999999999999865 5678


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ++||+.+|+|.+++..  ....+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999888754  3456899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      ............||+.|||||++.++.++.++|||||||+||||+| |.+|+........  .    .....+       
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~----~~i~~~-------  229 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S----SILEKG-------  229 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H----HHHHHT-------
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H----HHHHcC-------
Confidence            5554444455678999999999999999999999999999999998 7888875442221  1    111111       


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                        .+...+..++..+.+|+.+||+.+|++|||+.||++.|+.+.
T Consensus       230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence              111112234466888999999999999999999999987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=392.03  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=207.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC------hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999984 58999999986432      22467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC----CeEecccC
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  661 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG  661 (835)
                      +|||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999843   346899999999999999999999998   99999999999998776    49999999


Q ss_pred             ccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          662 MARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       662 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      +++......   ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+....  ..   ....    
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i~~----  230 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NVSA----  230 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHT----
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HH---HHHh----
Confidence            998764332   23345789999999999999999999999999999999999999975442211  00   0000    


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                         .............+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         231 ---VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0111122223344567889999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=397.56  Aligned_cols=263  Identities=27%  Similarity=0.395  Sum_probs=201.6

Q ss_pred             HHhhcCCccccccccCCcccEEEEEecC------CcEEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 003264          510 SAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE  581 (835)
Q Consensus       510 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  581 (835)
                      +...++|++.++||+|+||.||+|++..      ++.||||+++.. .....+++.+|...+.++ +|+|||.+++++.+
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            3345789999999999999999998632      468999999754 344566788888888887 78999999999876


Q ss_pred             cC-eEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeE
Q 003264          582 QG-EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  647 (835)
Q Consensus       582 ~~-~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  647 (835)
                      .+ ..++||||+++|+|.+++....             ....+++..+..++.||++||+|||+++   ||||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence            54 6899999999999999985432             1345889999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-CCCCCCCcccc
Q 003264          648 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESF  726 (835)
Q Consensus       648 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~  726 (835)
                      ||+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. +|+........
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998765554444455678999999999999999999999999999999999975 56654332211


Q ss_pred             cccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          727 NLLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                       +.    .....+.     .+    ..+...+..+.+++.+||+.||++|||++||++.|+.+
T Consensus       246 -~~----~~~~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 -FC----RRLKEGT-----RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             -HH----HHHHHTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HH----HHHhcCC-----CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             10    1111111     11    11122345688999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=390.50  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=198.3

Q ss_pred             hcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-CeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++..  ...+.|++|++++++++||||+++++++.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            36789999999999999999998 5789999999754  3457899999999999999999999999764 568999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +++|+|.+++... ....+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            9999999999542 2235899999999999999999999987   999999999999999999999999999865322  


Q ss_pred             cccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                         .....+|..|+|||++.+..++.++||||||+++|||+| |+.|+...+....  ...    ...         ..+
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~----i~~---------~~~  218 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR----VEK---------GYK  218 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH----HTT---------TCC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHH----HHc---------CCC
Confidence               233467899999999999999999999999999999998 6777765432211  110    111         111


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+.+...+..+.+|+.+||+.||++|||+.|++++|+.+
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            112223346788999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=390.63  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=197.0

Q ss_pred             hcCCccccccccCCcccEEEEEecC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL  587 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  587 (835)
                      .++|++.+.||+|+||.||+|++..    +..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3689999999999999999998743    357999998654 3445678999999999999999999999985 467899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC  667 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  667 (835)
                      ||||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999988743  3346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhccC
Q 003264          668 GDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYELLS  746 (835)
Q Consensus       668 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  746 (835)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |.+|+........  ...    ...+.     .
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~----i~~~~-----~  227 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR----IENGE-----R  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH----HHTTC-----C
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHH----HHcCC-----C
Confidence            3322 22334578999999999999999999999999999999998 8888875442211  110    01110     0


Q ss_pred             ccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          747 PALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       747 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          ...+..++..+.+|+.+||+.||++|||++||++.|+.+
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                111223446788999999999999999999999999765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=390.59  Aligned_cols=256  Identities=27%  Similarity=0.364  Sum_probs=197.8

Q ss_pred             cCCccccccccCCcccEEEEEecC--C--cEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ++|++.+.||+|+||+||+|++..  +  ..||||++...   .....++|.+|+.+|++++|||||++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            679999999999999999998643  2  37899998654   34456789999999999999999999999965 4678


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++..  +...+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988743  3446899999999999999999999988   999999999999999999999999999987


Q ss_pred             cCCCcc-ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccccccchhhhccccchhc
Q 003264          667 CGDELQ-GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNLLGHAWNLWKDNRAYEL  744 (835)
Q Consensus       667 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (835)
                      ...... .......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+....  .   .......     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~---~~i~~~~-----  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--L---HKIDKEG-----  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H---HHHHTSC-----
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--H---HHHHhCC-----
Confidence            544322 22334567889999999999999999999999999999998 8999875442211  1   1111111     


Q ss_pred             cCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          745 LSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       745 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          ...+.+...+..+.+++.+||+.||++|||+.||+++|++.
T Consensus       232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                11111223345688999999999999999999999999764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=393.67  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=210.5

Q ss_pred             hcCCccccccccCCcccEEEEEecC--------CcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEec
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ  582 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  582 (835)
                      .++|++.+.||+|+||.||+|+...        +..||||+++... .....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4789999999999999999998632        2479999997653 44567889999999988 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEE
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  649 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl  649 (835)
                      +..++||||+++|+|.+++.....             ...+++.++++++.||++||+|||+++   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965421             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHh-CCCCCCCCCcccccc
Q 003264          650 DSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLT-SKRNTGVYDIESFNL  728 (835)
Q Consensus       650 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~  728 (835)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |.+|+........  
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~--  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH--
Confidence            9999999999999998766555555666789999999999999999999999999999999998 6788765442211  


Q ss_pred             cccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          729 LGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                          ...+..+.         ....+...+..+.+|+.+||+.||++|||+.||+++|+.+
T Consensus       247 ----~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         247 ----FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             ----HHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                11111111         1111223445688999999999999999999999999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=395.32  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=212.4

Q ss_pred             hhcCCccccccccCCcccEEEEEec------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 003264          512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG  583 (835)
Q Consensus       512 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  583 (835)
                      ..++|++.++||+|+||.||+|++.      .++.||||+++... .....+|.+|+.+++++ +|||||++++++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3478999999999999999999852      35789999997643 44566799999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEE
Q 003264          584 EKILIYEYMPNKSLNFFLFDPS---------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  648 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL  648 (835)
                      ..++||||+++|+|.+++....               ....+++..+..++.||++||+|||+++   ++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999985432               2235889999999999999999999998   999999999999


Q ss_pred             EcCCCCeEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-CCCCCCCccccc
Q 003264          649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFN  727 (835)
Q Consensus       649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~  727 (835)
                      ++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++ +|+........ 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            9999999999999999876554444555678999999999999999999999999999999999954 54443322111 


Q ss_pred             ccccchhhhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          728 LLGHAWNLWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      +.             +++....+...+...+..+.+|+.+||+.||++||||+||+++|+..
T Consensus       257 ~~-------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 FY-------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HH-------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH-------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            00             11111111112223446788999999999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=388.21  Aligned_cols=271  Identities=24%  Similarity=0.310  Sum_probs=203.8

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----eEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~  589 (835)
                      ++|.+.++||+|+||.||+|++ +|+.||||++..... ....+..|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5688899999999999999997 689999999965422 1222334555666789999999999998765    579999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      ||+++|+|.+++.+    ..+++..+++++.|++.||+|||+.     +..+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    3589999999999999999999974     23469999999999999999999999999998


Q ss_pred             cccCCCc--cccccccccccceeCceeecCCC------CCccccchhHHHHHHHHHhCCCCCCCCCccccccccc-----
Q 003264          665 MFCGDEL--QGNTKRVVGTYGYMSPEYALDGL------FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGH-----  731 (835)
Q Consensus       665 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~-----  731 (835)
                      .......  ........||+.|||||++.+..      ++.++|||||||+||||+||..|+.............     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7754332  22334568999999999987643      5778999999999999999998876544322211110     


Q ss_pred             chhhhccccchhccCccccch-hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 003264          732 AWNLWKDNRAYELLSPALQHE-ASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEH  790 (835)
Q Consensus       732 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  790 (835)
                      ...............|.+... ...+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            000011111112223333222 23446677899999999999999999999999998763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=394.39  Aligned_cols=247  Identities=22%  Similarity=0.280  Sum_probs=206.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++++.||+|+||.||+|+.. +|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            67999999999999999999974 5899999999753   2335677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|.+++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999999875432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .  ......+||+.|||||++.+..|+.++|||||||++|||++|++||...+....  ..    .+....      .. 
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~i~~~~------~~-  223 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILMEE------IR-  223 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC------CC-
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH----HHhcCC------CC-
Confidence            2  233456899999999999999999999999999999999999999986543221  10    000010      01 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  784 (835)
                         .+...+..+.+|+.+||+.||++||+     ++|+++
T Consensus       224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               11223456788999999999999995     778876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=391.67  Aligned_cols=259  Identities=28%  Similarity=0.416  Sum_probs=212.6

Q ss_pred             hcCCccccccccCCcccEEEEEec------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  585 (835)
                      .++|++.++||+|+||+||+|++.      .++.||||+++.. .......|.+|+.++++++|||||++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478999999999999999999863      2578999999754 344556799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEec
Q 003264          586 ILIYEYMPNKSLNFFLFDP-------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  658 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~  658 (835)
                      ++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+||||+.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988432       22345788999999999999999999987   9999999999999999999999


Q ss_pred             ccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCC-CCCCCCCcccccccccchhhhc
Q 003264          659 DFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSK-RNTGVYDIESFNLLGHAWNLWK  737 (835)
Q Consensus       659 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~  737 (835)
                      |||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. +|+........  ..    ...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--~~----~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR----FVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH----HHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH
Confidence            999998875555444455567899999999999999999999999999999999985 66654332211  10    001


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNE  789 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  789 (835)
                      .+.         ..+.+..++..+.+++.+||+.+|++||||+||+++|+..
T Consensus       250 ~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111         1111223346788999999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=391.67  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=205.0

Q ss_pred             cCCccccccccCCcccEEEEEecC-Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.++||+|+||+||+|++.+ +.  .||||++... .....++|.+|+++|.++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            689999999999999999999854 33  5788988644 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCe
Q 003264          589 YEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  655 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  655 (835)
                      |||+++|+|.+++...             .....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23467899999999999999999999998   9999999999999999999


Q ss_pred             EecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCC-CCCCCCcccccccccchh
Q 003264          656 KISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKR-NTGVYDIESFNLLGHAWN  734 (835)
Q Consensus       656 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~  734 (835)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. |+...+...  +....  
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i--  239 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL--  239 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG--
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHH--
Confidence            99999999865322   12234568999999999999999999999999999999999765 565433221  11100  


Q ss_pred             hhccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          735 LWKDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       735 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                        ..+         .+...+...+..+.+|+.+||+.||++||+|+||++.|+.+..
T Consensus       240 --~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         240 --PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             --GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --Hhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              000         0111122344678899999999999999999999999988744

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.7e-45  Score=390.25  Aligned_cols=245  Identities=23%  Similarity=0.306  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++++.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999985 4899999998643   2334678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998884   3445788899999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....||+.|||||++.+..|+.++|||||||+||||++|+.||...+....  ..   .... ..      .. 
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~~-~~------~~-  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YE---KILN-AE------LR-  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHH-CC------CC-
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HH---HHHc-CC------CC-
Confidence                 3346899999999999999999999999999999999999999975432211  00   0000 00      01 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVSM  785 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  785 (835)
                         .+...+..+.+++.+||+.||++||     +++|+++.
T Consensus       220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               1112345678899999999999996     89999863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-44  Score=383.28  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----e
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----E  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~  584 (835)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++..   .....++|.+|+.++++++|||||++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            478999999999999999999974 5899999999754   2344567999999999999999999999998765    3


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+++++|.+++..   ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.++|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999988843   346899999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchh
Q 003264          665 MFCGDE-LQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYE  743 (835)
Q Consensus       665 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (835)
                      ...... .........||+.|||||++.+..++.++|||||||++|||++|++||...+....  .   ........   
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~---~~~~~~~~---  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--A---YQHVREDP---  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H---HHHHHCCC---
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--H---HHHHhcCC---
Confidence            654332 22234456899999999999999999999999999999999999999975432211  0   00111110   


Q ss_pred             ccCccccchhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhcc
Q 003264          744 LLSPALQHEASYQMLNRYITVALLCVQEKAADRP-TMSKVVSMITNE  789 (835)
Q Consensus       744 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  789 (835)
                          ..........+..+.+++.+|++.||++|| +++++++.|..+
T Consensus       232 ----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 ----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                001111123346788899999999999999 899999888654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=387.72  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=203.2

Q ss_pred             ccccccCCcccEEEEEecCC----cEEEEEEecCc-ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-CeEEEEEEec
Q 003264          519 QCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEYM  592 (835)
Q Consensus       519 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~~  592 (835)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+++|++++|||||+++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997542    25899999753 455678899999999999999999999998864 5889999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCcc
Q 003264          593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ  672 (835)
Q Consensus       593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  672 (835)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999854  3345778899999999999999999988   999999999999999999999999999876544322


Q ss_pred             --ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcccc
Q 003264          673 --GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPALQ  750 (835)
Q Consensus       673 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  750 (835)
                        .......||..|+|||.+....++.++||||||+++|||++|+.|+...... .....   ......   +...|   
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~---~i~~g~---~~~~p---  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---YLLQGR---RLLQP---  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHH---HHHTTC---CCCCC---
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHH---HHHcCC---CCCCc---
Confidence              2233457899999999999999999999999999999999988876542211 11111   111111   11111   


Q ss_pred             chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccC
Q 003264          751 HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHA  791 (835)
Q Consensus       751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  791 (835)
                          ...+..+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus       257 ----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         257 ----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                1234568889999999999999999999999988744

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-44  Score=390.33  Aligned_cols=244  Identities=21%  Similarity=0.246  Sum_probs=204.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  589 (835)
                      ++|++++.||+|+||.||+|++. +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999985 5899999998643   2234577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD  669 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  669 (835)
                      ||+.+|+|..++..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999843   346899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                           .....||+.|||||++.+..++.++|||||||+||||++|+.||...+...  +..   ... ...      .. 
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~---~i~-~~~------~~-  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYE---KIV-SGK------VR-  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HHH-HCC------CC-
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHH---HHh-cCC------CC-
Confidence                 234679999999999999999999999999999999999999997543211  110   000 000      01 


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRP-----TMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  784 (835)
                         .+...+..+.+++.+||+.||++|+     +++|+++
T Consensus       257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               1122345678899999999999994     8999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=380.99  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=206.1

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .++|++.+.||+|+||+||+|++. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999985 48899999997653 3346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC--CCeEecccCccccccCC
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGD  669 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~  669 (835)
                      +++|+|.+++..  ....+++.++..++.||++||+|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999943  2346899999999999999999999998   9999999999999854  58999999999876332


Q ss_pred             CccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCccc
Q 003264          670 ELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPAL  749 (835)
Q Consensus       670 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  749 (835)
                      .   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........  ..   .....       ....
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~---~i~~~-------~~~~  222 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE---NIMNA-------EYTF  222 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHHT-------CCCC
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHhC-------CCCC
Confidence            2   23446789999999999999999999999999999999999999975442211  00   00000       0011


Q ss_pred             cchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          750 QHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ........+..+.+|+.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11222234566889999999999999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-44  Score=376.41  Aligned_cols=250  Identities=23%  Similarity=0.278  Sum_probs=203.9

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---------hhhHHHHHHHHHHHHhcC-CCceeeEeeEEEec
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ  582 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  582 (835)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....         ....+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999974 58999999986542         112356889999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCc
Q 003264          583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  662 (835)
Q Consensus       583 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  662 (835)
                      +..+|||||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999953   446899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecC------CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhh
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALD------GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLW  736 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  736 (835)
                      ++.+....   ......||..|+|||++.+      ..++.++||||+||+||||++|+.||...+....  .    ..+
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~----~~i  227 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--L----RMI  227 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--H----HHH
Confidence            98764432   2234679999999998853      3578899999999999999999999986442211  0    000


Q ss_pred             ccccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          737 KDNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       737 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      ..+..      ..........++.+.+++.+||+.+|++||+++||++
T Consensus       228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00100      0111122234567889999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=388.87  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=202.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc---ChhhHHHHHHHHHHHH-hcCCCceeeEeeEEEecCeEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV  588 (835)
                      ++|++.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999985 4899999999643   2334566777777765 68999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccC
Q 003264          589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG  668 (835)
Q Consensus       589 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  668 (835)
                      |||+++|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999843   345889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhccCcc
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELLSPA  748 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (835)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..    .....      .+.
T Consensus       156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~----~i~~~------~~~  221 (320)
T d1xjda_         156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH----SIRMD------NPF  221 (320)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------CCC
T ss_pred             c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC------CCC
Confidence            2  2233446899999999999999999999999999999999999999975442211  10    00000      111


Q ss_pred             ccchhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003264          749 LQHEASYQMLNRYITVALLCVQEKAADRPTMS-KVVS  784 (835)
Q Consensus       749 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  784 (835)
                      .    +...+..+.+|+.+||+.||++||++. |+++
T Consensus       222 ~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1    112345688999999999999999996 7764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=379.85  Aligned_cols=269  Identities=21%  Similarity=0.282  Sum_probs=203.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.+|++++|||||++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999974 58999999996542  2345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      |+.++.+......  ....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9987655444322  3456899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCCCccccccc---------ccchhhhccc-
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLL---------GHAWNLWKDN-  739 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~---------~~~~~~~~~~-  739 (835)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+.......         ...+...... 
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              2333457999999999877765 57899999999999999999999975442211000         0000000000 


Q ss_pred             cchhccCcccc---chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          740 RAYELLSPALQ---HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       740 ~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                      ...........   .......+..+.+++.+||+.||++|||++|+++.  |+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00000000000   11112334678899999999999999999999985  5554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=382.76  Aligned_cols=253  Identities=18%  Similarity=0.203  Sum_probs=200.7

Q ss_pred             hcCCcccc-ccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhc-CCCceeeEeeEEEe----cCeE
Q 003264          513 TENFSMQC-KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGEK  585 (835)
Q Consensus       513 ~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~  585 (835)
                      .++|++.+ .||+|+||+||+|++. +++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36898875 5999999999999974 5899999998643     4567899987665 89999999999876    4578


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC---CCCeEecccCc
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  662 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  662 (835)
                      ++|||||++|+|.+++.+. ....+++.++..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999643 2346899999999999999999999998   999999999999975   56799999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      ++......   ......||+.|||||++.+..|+.++|||||||+||||++|+.||.........  .........    
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~~~i~~----  231 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRM----  231 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS----
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHHHHHhc----
Confidence            98764432   234467999999999999999999999999999999999999999754322110  000000000    


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        .............+..+.+|+.+||+.||++|||+.|+++.
T Consensus       232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              00111222334556788999999999999999999999883

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=379.90  Aligned_cols=260  Identities=23%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             cccccccCCcccEEEEEec-CCcEEEEEEecCcChh-----hHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          518 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       518 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      .+++||+|+||+||+|++. +|+.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999975 4899999998654221     234688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      ++++++..+..   ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99988776652   3456889999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc-----chhhhccc---c-
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH-----AWNLWKDN---R-  740 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~-----~~~~~~~~---~-  740 (835)
                        ......||+.|+|||++... .|+.++|||||||++|||++|..||........ .....     ....+...   . 
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence              22345799999999998654 689999999999999999999999875442211 00000     00000000   0 


Q ss_pred             --chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          741 --AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       741 --~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                        ....................+.+|+.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              000000000011111234578899999999999999999999873

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.7e-44  Score=389.79  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=198.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC---hhhHHHHH---HHHHHHHhcCCCceeeEeeEEEecCeEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFK---NEMMLIAKLQHRNLVRLMGCCVEQGEKI  586 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~  586 (835)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.   +|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999975 48999999986431   12223333   4466777778999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999843   346789999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccchhcc
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAYELL  745 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (835)
                      ....    .....||+.|||||++.. ..|+.++|||||||+||||++|+.||...........      ......   .
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~~~~~---~  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------DRMTLT---M  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH------HHHSSS---C
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhccc---C
Confidence            4332    334579999999999875 5689999999999999999999999976443221100      000000   0


Q ss_pred             CccccchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003264          746 SPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  784 (835)
Q Consensus       746 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  784 (835)
                      ..    ..+...+..+.+|+.+||+.||++||+     ++|+++
T Consensus       225 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            00    111123456889999999999999999     688875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.2e-43  Score=373.34  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcccEEEEEecCCcEEEEEEecCcC--hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY  591 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  591 (835)
                      ++|+++++||+|+||+||+|++.+|+.||||++....  ....+++.+|+.+|++++|||||++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999996542  33457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCCc
Q 003264          592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL  671 (835)
Q Consensus       592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  671 (835)
                      +.++.+..+..   ....+++..+..++.||++||+|||+.+   ||||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            99888877763   3466999999999999999999999988   9999999999999999999999999998764322 


Q ss_pred             cccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cc----------cccc--hhhhc
Q 003264          672 QGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NL----------LGHA--WNLWK  737 (835)
Q Consensus       672 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~----------~~~~--~~~~~  737 (835)
                       .......+++.|+|||.+.+. .++.++|||||||+++||++|+.||...+.... ..          ..+.  .....
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence             223345689999999998764 568999999999999999999999975432111 00          0000  00000


Q ss_pred             cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          738 DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       738 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                      .........+.............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000001111111112233456789999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=372.02  Aligned_cols=265  Identities=24%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             hcCCccccccccCCcccEEEEEec-C-CcEEEEEEecCcC--hhhHHHHHHHHHHHHhc---CCCceeeEeeEEEe----
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-N-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE----  581 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----  581 (835)
                      .++|+++++||+|+||+||+|++. + ++.||||++....  ......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 3 5679999986432  22233456777777665   79999999999864    


Q ss_pred             -cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEeccc
Q 003264          582 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  660 (835)
Q Consensus       582 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  660 (835)
                       ....+++|||++++.+.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             246799999999987765543  23456889999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-c----cchh
Q 003264          661 GMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-G----HAWN  734 (835)
Q Consensus       661 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-~----~~~~  734 (835)
                      |+++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.... ... .    ....
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            999864322   233456899999999999999999999999999999999999999976542211 000 0    0000


Q ss_pred             hhcc-----ccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          735 LWKD-----NRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       735 ~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .+..     ........+.............+.+|+.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000     00000000000111222334567889999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=369.66  Aligned_cols=240  Identities=21%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHhcC--CCceeeEeeEEEecCe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGE  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~  584 (835)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.....      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999975 589999999864311      12244678999999996  8999999999999999


Q ss_pred             EEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCC-CCeEecccCc
Q 003264          585 KILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM  662 (835)
Q Consensus       585 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGl  662 (835)
                      .++||||+.+ +++.+++.   ....+++..+..++.||++||+|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999986 57777763   2356899999999999999999999998   9999999999999854 7999999999


Q ss_pred             cccccCCCccccccccccccceeCceeecCCCC-CccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccc
Q 003264          663 ARMFCGDELQGNTKRVVGTYGYMSPEYALDGLF-SVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRA  741 (835)
Q Consensus       663 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  741 (835)
                      ++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+.           .....  
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~~~~--  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQ--  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHHCC--
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hhhcc--
Confidence            9865332    2334679999999999987765 5678999999999999999999864221           00000  


Q ss_pred             hhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          742 YELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       742 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       .    ....    ..+..+.+++.+||+.||++|||++|+++.
T Consensus       221 -~----~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 -V----FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -C----CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -c----CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             0    0111    123567889999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-41  Score=362.21  Aligned_cols=274  Identities=17%  Similarity=0.221  Sum_probs=212.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCC-CceeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||+||+|++. +|+.||||++....  ..+.+++|+++++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999975 58899999986543  22457789999999965 899999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcC-----CCCeEecccCcccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM  665 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~  665 (835)
                      |+ +++|.+++..  ....+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 6888888743  2346899999999999999999999998   999999999999974     57899999999988


Q ss_pred             ccCCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccc-cccchhhhccc
Q 003264          666 FCGDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNL-LGHAWNLWKDN  739 (835)
Q Consensus       666 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~  739 (835)
                      +......     .......||+.|||||++.+..++.++|||||||++|||++|+.||.......... ....   ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i---~~~~  232 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---GEKK  232 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH---HHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH---Hhcc
Confidence            6543211     22345679999999999999999999999999999999999999997544321110 0000   0000


Q ss_pred             cchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003264          740 RAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  803 (835)
Q Consensus       740 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  803 (835)
                         .   ..........++..+.+++..|++.+|++||+++.+.+.|+++...........|.|
T Consensus       233 ---~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw  290 (293)
T d1csna_         233 ---Q---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  290 (293)
T ss_dssp             ---H---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             ---C---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence               0   000011112234568889999999999999999999999887655555444444444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-41  Score=364.28  Aligned_cols=275  Identities=19%  Similarity=0.260  Sum_probs=203.3

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCeEEEEEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E  590 (835)
                      .++|++.++||+|+||.||+|++. +|+.||||++.....  .+++..|++++++++|+| |+.+..+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            367999999999999999999974 488999999865432  245788999999997665 5555666677888999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEc---CCCCeEecccCcccccc
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMFC  667 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~  667 (835)
                      |+.+ +|...+..  ....+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+.
T Consensus        84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9955 45444422  2346899999999999999999999998   99999999999985   45579999999999875


Q ss_pred             CCCcc-----ccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          668 GDELQ-----GNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       668 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||++|+.||..............  . ..   .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~--~-~~---~  231 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER--I-SE---K  231 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH--H-HH---H
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH--h-hc---c
Confidence            43321     223456899999999999999999999999999999999999999976543221111000  0 00   0


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccCCCCCCCCCcccc
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSMITNEHATLPYPKQSAFSY  803 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~~~~~~  803 (835)
                      ...  .........++..+.+++..|++.+|++||+++++.+.|+.............|.|
T Consensus       232 ~~~--~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw  290 (299)
T d1ckia_         232 KMS--TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  290 (299)
T ss_dssp             HHH--SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred             cCC--CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence            000  00011112344668889999999999999999999999887644333333334444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-41  Score=362.39  Aligned_cols=267  Identities=22%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEe--------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--------  581 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  581 (835)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999974 6899999998544  33345778999999999999999999999865        


Q ss_pred             cCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccC
Q 003264          582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  661 (835)
Q Consensus       582 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  661 (835)
                      ....++||||++++.+..+.   .....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34679999999988777655   23456888999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCcc--ccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-cccc-------
Q 003264          662 MARMFCGDELQ--GNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLG-------  730 (835)
Q Consensus       662 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~-------  730 (835)
                      +++.+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876543221  222345799999999998765 689999999999999999999999975442211 0000       


Q ss_pred             -cchhhhccccchhccCc--cccchh-----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          731 -HAWNLWKDNRAYELLSP--ALQHEA-----SYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       731 -~~~~~~~~~~~~~~~~~--~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                       ..+..............  ......     .......+.+|+.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             00000000000000000  000111     11223466789999999999999999999965

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=367.90  Aligned_cols=263  Identities=22%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC------
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------  583 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  583 (835)
                      .++|+++++||+|+||+||+|++. +|+.||||+++..  .....+.+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            478999999999999999999975 4899999999753  3345678899999999999999999999998665      


Q ss_pred             eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCcc
Q 003264          584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  663 (835)
Q Consensus       584 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  663 (835)
                      +.++||||+ +.+|..+..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            579999999 556777663    345899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCccccc-cccc--------ch
Q 003264          664 RMFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGH--------AW  733 (835)
Q Consensus       664 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~--------~~  733 (835)
                      +....     ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+..... ....        ..
T Consensus       169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            87532     23346789999999998764 5789999999999999999999999765422110 0000        00


Q ss_pred             hhhccc---c----chhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 003264          734 NLWKDN---R----AYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM--ITNE  789 (835)
Q Consensus       734 ~~~~~~---~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  789 (835)
                      ......   .    ..+.....+ ..........+.+|+.+||+.||++|||++|+++.  |+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            000000   0    000000000 01111234567889999999999999999999985  5554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-41  Score=364.97  Aligned_cols=266  Identities=21%  Similarity=0.259  Sum_probs=198.2

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHhcCCCceeeEeeEEEecC----eEE
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKI  586 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~  586 (835)
                      +++|+++++||+|+||+||+|++. +|+.||||++.... ....+++++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999874 68999999997543 445678999999999999999999999987653    345


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccc
Q 003264          587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF  666 (835)
Q Consensus       587 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  666 (835)
                      +++||+.+|+|.+++..    ..+++..+..++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677789999999842    35899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-ccccc-----hhhhcc
Q 003264          667 CGDELQ-GNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-LLGHA-----WNLWKD  738 (835)
Q Consensus       667 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~-----~~~~~~  738 (835)
                      ...... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||...+..... .....     ......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            443322 22345679999999999854 56789999999999999999999999754421110 00000     000000


Q ss_pred             -----ccchhccCcccc----chhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          739 -----NRAYELLSPALQ----HEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       739 -----~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                           ........+...    ..........+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000000000000    01111223568899999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-41  Score=368.04  Aligned_cols=261  Identities=21%  Similarity=0.256  Sum_probs=194.7

Q ss_pred             CCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------CeEEE
Q 003264          515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEKIL  587 (835)
Q Consensus       515 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l  587 (835)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+.+|++++||||+++++++...      .+.+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6889999999999999999985 489999999965432    234799999999999999999998653      24789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccc
Q 003264          588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF  666 (835)
Q Consensus       588 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~  666 (835)
                      ||||++++.+..+.........+++..+..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755544422234456899999999999999999999988   99999999999999775 8999999999876


Q ss_pred             cCCCccccccccccccceeCceeecC-CCCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccc-----ccchhhh---
Q 003264          667 CGDELQGNTKRVVGTYGYMSPEYALD-GLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLL-----GHAWNLW---  736 (835)
Q Consensus       667 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~-----~~~~~~~---  736 (835)
                      .....   .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...     ......+   
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            44332   234579999999998875 4789999999999999999999999976542211 000     0000000   


Q ss_pred             c----cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          737 K----DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       737 ~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                      .    .......................+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0    000000000000011112234567889999999999999999999963

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=353.67  Aligned_cols=263  Identities=20%  Similarity=0.242  Sum_probs=203.3

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEecCeEEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      ++|+++++||+|+||+||+|++. +++.||||+++..  .....+++++|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999975 5889999998644  33456889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccccccCCC
Q 003264          591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE  670 (835)
Q Consensus       591 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  670 (835)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888743   356789999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccceeCceeecCCC-CCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhc------------
Q 003264          671 LQGNTKRVVGTYGYMSPEYALDGL-FSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWK------------  737 (835)
Q Consensus       671 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~------------  737 (835)
                      .  ......++..|+|||.+.... ++.++|||||||+++||++|+.|+.........+. .......            
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH-HHHHHHCCCCTTTCTTGGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH-HHHhhcCCCChhhhhhhhh
Confidence            2  223346788999999887665 68999999999999999999999754332111000 0000000            


Q ss_pred             ---cccchhccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 ---DNRAYELLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ---~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .......................+.+|+.+|++.||.+|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000000000000111222334567889999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-40  Score=356.66  Aligned_cols=256  Identities=20%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEec--CeEEEEE
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIY  589 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~  589 (835)
                      ++|+++++||+|+||+||+|++. +++.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999984 58999999997543   467889999999995 99999999999854  5689999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCC-CeEecccCccccccC
Q 003264          590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCG  668 (835)
Q Consensus       590 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~  668 (835)
                      ||+++++|..+.      +.+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      34899999999999999999999998   99999999999998765 599999999987643


Q ss_pred             CCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccc--------hhhhc--
Q 003264          669 DELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHA--------WNLWK--  737 (835)
Q Consensus       669 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~--  737 (835)
                      ..   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+..............        .....  
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   23345789999999998765 579999999999999999999999875442211000000        00000  


Q ss_pred             ----cccchh--------ccCccccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003264          738 ----DNRAYE--------LLSPALQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVS  784 (835)
Q Consensus       738 ----~~~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  784 (835)
                          ......        .................+.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000000        00000111112233456789999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-40  Score=353.38  Aligned_cols=252  Identities=24%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             cCCccccccccCCcccEEEEEec----CCcEEEEEEecCc----ChhhHHHHHHHHHHHHhcCC-CceeeEeeEEEecCe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGE  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~  584 (835)
                      ++|++++.||+|+||+||+|+..    +|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999862    3789999998643    22345678899999999966 899999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+.+|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999843   345678899999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccccceeCceeecCC--CCCccccchhHHHHHHHHHhCCCCCCCCCcccccccccchhhhccccch
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDG--LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFNLLGHAWNLWKDNRAY  742 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  742 (835)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........     ..... . 
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-----i~~~~-~-  249 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-----ISRRI-L-  249 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-----HHHHH-H-
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHHhc-c-
Confidence            76433322 23346789999999998764  478899999999999999999999976543221100     00000 0 


Q ss_pred             hccCccccchhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003264          743 ELLSPALQHEASYQMLNRYITVALLCVQEKAADRPT-----MSKVVS  784 (835)
Q Consensus       743 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  784 (835)
                       ...+    ..+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       250 -~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         250 -KSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -HCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -cCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             0001    112234567889999999999999995     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-39  Score=357.11  Aligned_cols=261  Identities=25%  Similarity=0.286  Sum_probs=196.0

Q ss_pred             hcCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec-----Ce
Q 003264          513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE  584 (835)
Q Consensus       513 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  584 (835)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999974 5899999999754  334556789999999999999999999998643     34


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5777888899999999843    35899999999999999999999998   9999999999999999999999999997


Q ss_pred             cccCCCccccccccccccceeCceeecCC-CCCccccchhHHHHHHHHHhCCCCCCCCCcccc-ccccc-----chhhhc
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDG-LFSVKSDVFSFGVLLLETLTSKRNTGVYDIESF-NLLGH-----AWNLWK  737 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~-----~~~~~~  737 (835)
                      ...     .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.... .....     ......
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            542     223446789999999987765 468999999999999999999999976542211 00000     000000


Q ss_pred             ---cccch---hccCccccc---hhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 ---DNRAY---ELLSPALQH---EASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ---~~~~~---~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                         .....   .........   .........+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence               00000   000000000   0111234567899999999999999999999973

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=354.73  Aligned_cols=260  Identities=23%  Similarity=0.227  Sum_probs=193.5

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHhcCCCceeeEeeEEEec------Ce
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GE  584 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  584 (835)
                      ++|+++++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999986 4899999999754  344556789999999999999999999999643      68


Q ss_pred             EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       585 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .++||||+.++.+..+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999877665442      34789999999999999999999998   9999999999999999999999999988


Q ss_pred             cccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc--c----cccchhhhc-
Q 003264          665 MFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN--L----LGHAWNLWK-  737 (835)
Q Consensus       665 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~--~----~~~~~~~~~-  737 (835)
                      .....   .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.....  .    .......+. 
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            65332   2334457899999999999999999999999999999999999998754321110  0    000000000 


Q ss_pred             ----------------cccchhccCcc---ccchhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003264          738 ----------------DNRAYELLSPA---LQHEASYQMLNRYITVALLCVQEKAADRPTMSKVVSM  785 (835)
Q Consensus       738 ----------------~~~~~~~~~~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  785 (835)
                                      ...........   .........+..+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            00000111111   1122345567789999999999999999999999855

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-35  Score=324.73  Aligned_cols=263  Identities=19%  Similarity=0.226  Sum_probs=192.0

Q ss_pred             cCCccccccccCCcccEEEEEec-CCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-----------CCceeeEeeEEEe
Q 003264          514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCVE  581 (835)
Q Consensus       514 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  581 (835)
                      .+|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999974 58999999997543 34567788999988875           5789999998865


Q ss_pred             c--CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCC----
Q 003264          582 Q--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMN----  654 (835)
Q Consensus       582 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~----  654 (835)
                      .  ...+++++++..+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4567777777665543333333455668889999999999999999998 65   999999999999986654    


Q ss_pred             --eEecccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHHHHHhCCCCCCCCCccccc-----
Q 003264          655 --PKISDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLLETLTSKRNTGVYDIESFN-----  727 (835)
Q Consensus       655 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-----  727 (835)
                        +|++|||.+.....     ......||+.|+|||++....++.++||||+||+++||++|+.||...+.....     
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999976532     223467999999999999999999999999999999999999998754321110     


Q ss_pred             ccccc-------hhhhcc----------ccchhccCcc----------ccchhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 003264          728 LLGHA-------WNLWKD----------NRAYELLSPA----------LQHEASYQMLNRYITVALLCVQEKAADRPTMS  780 (835)
Q Consensus       728 ~~~~~-------~~~~~~----------~~~~~~~~~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  780 (835)
                      +....       ...+..          ......+...          ............+.+|+.+|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            00000       000000          0000000000          01122355677899999999999999999999


Q ss_pred             HHHHH
Q 003264          781 KVVSM  785 (835)
Q Consensus       781 evl~~  785 (835)
                      |+++.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99874

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.86  E-value=8.8e-22  Score=175.78  Aligned_cols=112  Identities=22%  Similarity=0.401  Sum_probs=96.9

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      +|||.|||.|.+|+.|+|  |.|.|+|+.+|+     |.|+.   ..++||.||++.|  ...+.|.|+.||+|+|++. 
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~-   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG-   67 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence            489999999999999985  999999999998     67765   5799999999987  3457899999999999986 


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCc
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD  155 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTD  155 (835)
                      +.++|++++........|+|+|+|||||++.      .++++|||+.+|++
T Consensus        68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVGN  112 (112)
T ss_dssp             TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCCC
T ss_pred             CCeEEEEeeccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccCC
Confidence            5678888877666667889999999999985      56799999999985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.9e-22  Score=199.39  Aligned_cols=171  Identities=17%  Similarity=0.160  Sum_probs=122.8

Q ss_pred             CccccccccCCcccEEEEEecCCcEEEEEEecCcC------------------hhhHHHHHHHHHHHHhcCCCceeeEee
Q 003264          516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS------------------GQGLKEFKNEMMLIAKLQHRNLVRLMG  577 (835)
Q Consensus       516 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~~  577 (835)
                      +.+.++||+|+||+||+|++.+|+.||||+++...                  ......+..|+..+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35678999999999999999889999999875311                  011234567889999999999998876


Q ss_pred             EEEecCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEecCCCCeEEEcCCCCeEe
Q 003264          578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  657 (835)
Q Consensus       578 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl  657 (835)
                      +.    ..+++|||+++..+..          ++......++.|++++|+|||+++   |+||||||+|||++++ .++|
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    2379999998876543          334556789999999999999998   9999999999999865 4899


Q ss_pred             cccCccccccCCCccccccccccccceeCceeecCCCCCccccchhHHHHHH
Q 003264          658 SDFGMARMFCGDELQGNTKRVVGTYGYMSPEYALDGLFSVKSDVFSFGVLLL  709 (835)
Q Consensus       658 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvl~  709 (835)
                      +|||+|..............   ....+ .| ...+.|+.++|+||..--++
T Consensus       144 iDFG~a~~~~~~~~~~~l~r---d~~~~-~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILER---DVRNI-IT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHH---HHHHH-HH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHH---HHHHH-HH-HHcCCCCCcccHHHHHHHHh
Confidence            99999976532211000000   00000 01 12467889999999765443

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.85  E-value=1.3e-21  Score=172.94  Aligned_cols=107  Identities=22%  Similarity=0.343  Sum_probs=94.8

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      +|+|.+||.|.+|+.|.  +|.|.|.|+.+|+     |.||.   ..++||.||++.|  +..+.|.|+.||+|+|++++
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~   68 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS   68 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence            47999999999999995  6999999999998     77765   5689999999987  44678999999999999999


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCC
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~  152 (835)
                      |.+||+|++.......+|+|+|||||||++.         .+||||+|
T Consensus        69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S~t~  107 (108)
T d1jpca_          69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT---------DRWATGTH  107 (108)
T ss_dssp             CCEEEECCCCCSCSCEEEEECTTSCEEEEEC---------CCCCCCCC
T ss_pred             ccceEEccccCCCCcEEEEEcCCCCEEEeCC---------CcccCCCC
Confidence            9999999987766667889999999999964         48999987

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.85  E-value=4.4e-21  Score=169.55  Aligned_cols=108  Identities=19%  Similarity=0.308  Sum_probs=93.5

Q ss_pred             cCCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCC
Q 003264           25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT  104 (835)
Q Consensus        25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (835)
                      .|+|.|||.|.+|+.|.+  |.|.|+|+.+|+     |.++.   ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus         1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred             CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence            378999999999999974  889999999887     65653   56899999999984 45788999999999999999


Q ss_pred             CceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCC
Q 003264          105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC  152 (835)
Q Consensus       105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~  152 (835)
                      |.+||+|+++.......|+|+|||||||++.         .+|||+-|
T Consensus        70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---------~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---------DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCCSSCCEEEECTTSCEEEECC---------EEEECCCC
T ss_pred             CcEEEEEeeECCCCCEEEEEeCCCcEEEECC---------CEecCCCc
Confidence            9999999987655667789999999999963         59999865

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.65  E-value=7.7e-17  Score=144.31  Aligned_cols=101  Identities=22%  Similarity=0.302  Sum_probs=86.5

Q ss_pred             EEEEeec-CCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCC
Q 003264           63 GIWYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTS  141 (835)
Q Consensus        63 ~iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~  141 (835)
                      .|||.++ .++.+|++|++.|+....-+|.|+.||||||++. +.++|++++.+.+....|.|+++|||||++.      
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~------   83 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN------   83 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET------
T ss_pred             eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC------
Confidence            6899887 5799999999999988888999999999999986 6789999988777778899999999999986      


Q ss_pred             CCceeEeecCCCCcccccccccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceE
Q 003264          142 EGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHL  201 (835)
Q Consensus       142 ~~~~~WqsFd~PTDTlLpg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~  201 (835)
                      .+++|||||.                               +.++|.|.+.|+++|..-+
T Consensus        84 ~~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl  112 (120)
T d1dlpa2          84 QNIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI  112 (120)
T ss_dssp             TTEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred             CCCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence            5789999973                               3457889999999987654

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.64  E-value=9.5e-16  Score=136.63  Aligned_cols=103  Identities=14%  Similarity=0.343  Sum_probs=83.9

Q ss_pred             CCCCCCcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCC
Q 003264           26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD  105 (835)
Q Consensus        26 ~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~  105 (835)
                      ++|.++|.|    .+.+..|.|.|.|..+|+     |.++ .  ..++||.||+..|  +..+.|.|+.||+|+|+|++|
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g   80 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNEN   80 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTC
T ss_pred             CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCC
Confidence            345555544    246679999999999998     6553 2  5789999999876  345789999999999999999


Q ss_pred             ceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecC
Q 003264          106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD  151 (835)
Q Consensus       106 ~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd  151 (835)
                      .+||++++.+.....+++|+|||||||+++         ++|||-.
T Consensus        81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~---------~~W~S~T  117 (119)
T d1b2pa_          81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWATQT  117 (119)
T ss_dssp             CEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEECCC
T ss_pred             cEEEECCCcCCCCceEEEEcCCCCEEEECC---------CEeccCC
Confidence            999999988766667789999999999964         6999964

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.50  E-value=4.4e-15  Score=131.25  Aligned_cols=109  Identities=24%  Similarity=0.288  Sum_probs=87.5

Q ss_pred             EEEeec-CCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCC
Q 003264           64 IWYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSE  142 (835)
Q Consensus        64 iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~  142 (835)
                      |||.-. ..+..|+.+.+.++.+...+|.|+.||||||++ ++.++|++++.+. ....|.|+++|||||++.      .
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~------~   74 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTA------Q   74 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCT------T
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEcc------C
Confidence            455433 457779999999998888899999999999998 4688999998754 456789999999999985      5


Q ss_pred             CceeEeecCCCCcccccccccccccccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          143 GSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       143 ~~~~WqsFd~PTDTlLpg~~l~~~~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                      +++||||+.                               +.++|.|.+.|+++|...  +|.  .++|.+|.
T Consensus        75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY~--~~~Wssgt  112 (115)
T d1dlpa1          75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IYG--PGLWDSGT  112 (115)
T ss_dssp             TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EEC--SEEEECSC
T ss_pred             CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--EeC--CCeecCCC
Confidence            678999863                               346899999999999854  453  37898876

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.48  E-value=3.2e-14  Score=125.63  Aligned_cols=98  Identities=22%  Similarity=0.341  Sum_probs=79.9

Q ss_pred             cccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEee
Q 003264           32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS  111 (835)
Q Consensus        32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst  111 (835)
                      |.|.+++.|  .+|.|.|.|..+|+     |.|+.   ..++||.+|...   ...+.+.|..||||||+|.++.+||++
T Consensus        15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS   81 (115)
T d1dlpa1          15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSS   81 (115)
T ss_dssp             SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred             ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEEc
Confidence            555555555  46779999999998     77754   567899999754   346789999999999999999999999


Q ss_pred             cCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecC
Q 003264          112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD  151 (835)
Q Consensus       112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd  151 (835)
                      ++.......+++|++|||||||+.         .+|+|-.
T Consensus        82 ~t~~~~g~y~l~Lq~DGNlvlY~~---------~~Wssgt  112 (115)
T d1dlpa1          82 GTKGSIGNYVLVLQPDRTVTIYGP---------GLWDSGT  112 (115)
T ss_dssp             CCCCCSSCCEEEECSSSCEEEECS---------EEEECSC
T ss_pred             CCCCCCCCEEEEECCCCcEEEeCC---------CeecCCC
Confidence            987766777789999999999953         6999853

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.28  E-value=3.3e-12  Score=113.73  Aligned_cols=98  Identities=20%  Similarity=0.322  Sum_probs=75.8

Q ss_pred             CcccCCCCeEEeCCCeEEEEeecCCCCCceEEEEEEeecCCeeEEecCCCCCCcCCCceEEEecCCceEEecCCCceEEe
Q 003264           31 ATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWS  110 (835)
Q Consensus        31 ~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws  110 (835)
                      .+.|.+++.|  ..|.|.|.|..+|+     |.|+.   ...+||.++...  .+..+.+.|..+|||||+|.++.++|+
T Consensus        23 ~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~   90 (120)
T d1dlpa2          23 PQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWT   90 (120)
T ss_dssp             CCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred             ccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence            3444455554  24668888888876     65543   467899998644  455678999999999999999999999


Q ss_pred             ecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEee
Q 003264          111 SNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS  149 (835)
Q Consensus       111 t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~Wqs  149 (835)
                      |++.......+++|++|||||||+.         .+|.|
T Consensus        91 S~t~~~~~~~~l~Lq~DGnlvlY~~---------~~W~t  120 (120)
T d1dlpa2          91 SGNSRSAGRYVFVLQPDRNLAIYGG---------ALWTT  120 (120)
T ss_dssp             CCCCCSSSCCEEEECSSSCEEEECC---------CCCBC
T ss_pred             eCCCCCCCcEEEEECCCCcEEEeCC---------CcccC
Confidence            9987766677789999999999953         58875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.07  E-value=2.4e-10  Score=99.62  Aligned_cols=85  Identities=25%  Similarity=0.375  Sum_probs=64.6

Q ss_pred             ceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCccccccccccccc
Q 003264           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL  167 (835)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~~  167 (835)
                      -+|.|+.||||||++. +.+||++++.+.+....+.|+++|||||++.      +++++|+|                  
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~------~g~~vWsS------------------   75 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP------SNKPIWAS------------------   75 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEEC------------------
T ss_pred             EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC------CccceEEc------------------
Confidence            3589999999999974 5789999998776677889999999999985      67889986                  


Q ss_pred             ccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeec
Q 003264          168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTG  214 (835)
Q Consensus       168 ~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g  214 (835)
                                   ....+++.|.+.|+++|..-+  +..  +.|.++
T Consensus        76 -------------~t~~~~~~~~l~L~ddGNlVl--y~~--~~W~S~  105 (108)
T d1jpca_          76 -------------NTGGQNGNYVCILQKDRNVVI--YGT--DRWATG  105 (108)
T ss_dssp             -------------CCCCSCSCEEEEECTTSCEEE--EEC--CCCCCC
T ss_pred             -------------cccCCCCcEEEEEcCCCCEEE--eCC--CcccCC
Confidence                         111235678889998886554  432  356554

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.95  E-value=1.7e-09  Score=95.57  Aligned_cols=85  Identities=25%  Similarity=0.308  Sum_probs=66.5

Q ss_pred             eEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccccccc
Q 003264           89 VLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLK  168 (835)
Q Consensus        89 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~~~  168 (835)
                      .|.|+.||||||++. +.++|++++.+......+.|+++|||||++.      .+.++|+|.-                 
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~------~g~~vWsS~t-----------------   88 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN------ENVTVWQSPV-----------------   88 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECSC-----------------
T ss_pred             EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC------CCcEEEECCC-----------------
Confidence            588999999999975 5689999988776677889999999999985      5678998521                 


Q ss_pred             cCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecC
Q 003264          169 TGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP  215 (835)
Q Consensus       169 tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~  215 (835)
                                    .-+.|.|.+.|+++|...+  |.  .+.|.++.
T Consensus        89 --------------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T  117 (119)
T d1b2pa_          89 --------------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT  117 (119)
T ss_dssp             --------------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred             --------------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence                          1135778999999987654  43  36787764

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.91  E-value=5.8e-09  Score=90.74  Aligned_cols=87  Identities=29%  Similarity=0.412  Sum_probs=64.7

Q ss_pred             ceEEEecCCceEEecCCCceEEeecCCCCc-cCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccccc
Q 003264           88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (835)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~  166 (835)
                      -.|.|+.||||||++ .+.+||++++...+ ....+.|+++|||||++.      .++++|+|=                
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~s~----------------   77 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA------EGRSLWASH----------------   77 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS------SSCEEEECC----------------
T ss_pred             EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC------CCcEEEEEe----------------
Confidence            458899999999986 56889999986543 346689999999999985      577899861                


Q ss_pred             cccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcCCeEEEeecCC
Q 003264          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW  216 (835)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~~~~~~~~g~w  216 (835)
                                     ...+.|.|.+.|+++|...  +++  ..+|.++.+
T Consensus        78 ---------------t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t~  108 (109)
T d1kj1a_          78 ---------------SVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGTY  108 (109)
T ss_dssp             ---------------CCCCSSCCEEEECTTSCEE--EEC--CEEEECCCC
T ss_pred             ---------------eECCCCCEEEEEeCCCcEE--EEC--CCEecCCCc
Confidence                           1113467889999998765  444  357877653

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.64  E-value=7.1e-08  Score=84.32  Aligned_cols=88  Identities=23%  Similarity=0.408  Sum_probs=65.7

Q ss_pred             CceEEEecCCceEEecCCCceEEeecCCCCccCceEEEecCCCeEEEeccCCCCCCCceeEeecCCCCcccccccccccc
Q 003264           87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD  166 (835)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~~WqsFd~PTDTlLpg~~l~~~  166 (835)
                      .-.|.|+.||||||++ .+.+||++++........+.|+.+|||||++.       ++.+|.|                 
T Consensus        20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-------~~~~w~s-----------------   74 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-------SRAIWAS-----------------   74 (112)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-------TEEEEEC-----------------
T ss_pred             CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-------CCeEEEE-----------------
Confidence            3569999999999986 56899999987666667789999999999974       4566654                 


Q ss_pred             cccCcceeeEeecCCCCCCCCceEEEeecCCcceEEEEcC-CeEEEeecC
Q 003264          167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNG-SVKLSCTGP  215 (835)
Q Consensus       167 ~~tg~~~~L~Sw~s~~dps~G~fs~~l~~~~~~~~~~~~~-~~~~~~~g~  215 (835)
                                    ...-..|.|.+.|+.+|..-+  ++. ..+.|.++.
T Consensus        75 --------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t  108 (112)
T d1xd5a_          75 --------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT  108 (112)
T ss_dssp             --------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred             --------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence                          112234678899999987654  443 456888765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.3e-07  Score=94.08  Aligned_cols=150  Identities=18%  Similarity=0.115  Sum_probs=106.0

Q ss_pred             HHHHHhhcCCccccccccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeE
Q 003264          507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEK  585 (835)
Q Consensus       507 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  585 (835)
                      .++....+.|+..+..+-++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45566667888877655555678999864 56678889886554444456778888888773 44467788888888899


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 003264          586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY---------------------------------  632 (835)
Q Consensus       586 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------  632 (835)
                      ++|||++++..+......        ......++.++++.++.||+.                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999999888655421        112233455566666666631                                 


Q ss_pred             -----------------------CCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          633 -----------------------SRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       633 -----------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                                             ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   112489999999999999876677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.92  E-value=2.7e-05  Score=77.83  Aligned_cols=131  Identities=18%  Similarity=0.175  Sum_probs=87.6

Q ss_pred             ccccCCc-ccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcC--CCceeeEeeEEEecCeEEEEEEecCCCCh
Q 003264          521 KLGEGGF-GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILIYEYMPNKSL  597 (835)
Q Consensus       521 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~E~~~~gsL  597 (835)
                      .+..|.. +.||+....++..+++|.-.....   ..+..|+..++.+.  .-.+.+++.+..+.+..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 678999887888899998755432   34567777777763  33466778888888899999999998766


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 003264          598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ----------------------------------------------  631 (835)
Q Consensus       598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------------------  631 (835)
                      .+..        ..   ....+.++++.|+-||+                                              
T Consensus        94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        01   01122233333333332                                              


Q ss_pred             ---------cCCCcEEEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          632 ---------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       632 ---------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                               .....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     1123489999999999999877678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.40  E-value=0.00017  Score=76.89  Aligned_cols=75  Identities=11%  Similarity=0.158  Sum_probs=49.5

Q ss_pred             cccccCCcccEEEEEecC-CcEEEEEEecCc-------ChhhHHHHHHHHHHHHhc-CC--CceeeEeeEEEecCeEEEE
Q 003264          520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAKL-QH--RNLVRLMGCCVEQGEKILI  588 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~l~~~~~~~~~~~lV  588 (835)
                      +.||.|....||+....+ ++.|+||.-...       .....++...|++.|..+ .+  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            578999999999998755 678999964321       112334556788888776 33  345555544  55667899


Q ss_pred             EEecCCCC
Q 003264          589 YEYMPNKS  596 (835)
Q Consensus       589 ~E~~~~gs  596 (835)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.69  E-value=0.002  Score=66.36  Aligned_cols=135  Identities=15%  Similarity=0.134  Sum_probs=79.0

Q ss_pred             ccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce--eeEe-----eEEEecCeEEEEEEecCCCChhhh
Q 003264          528 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM-----GCCVEQGEKILIYEYMPNKSLNFF  600 (835)
Q Consensus       528 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~~  600 (835)
                      -.||+++..+|+.|++|+.... ....+++..|...+..|....+  +..+     ......+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999999999999998654 2245667788888888743222  1111     123445678899999987543211


Q ss_pred             -----------h-------cC--CCCCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCcE
Q 003264          601 -----------L-------FD--PSRTHLLGW-------------------QTRVKIIEGIAQGLLYLHQ----YSRLRI  637 (835)
Q Consensus       601 -----------l-------~~--~~~~~~l~~-------------------~~~~~i~~~ia~~L~yLH~----~~~~~i  637 (835)
                                 +       ..  .......++                   .....+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                       0       00  001111111                   1111222223333333332    223568


Q ss_pred             EEecCCCCeEEEcCCCCeEecccCcccc
Q 003264          638 IHRDLKASNILLDSDMNPKISDFGMARM  665 (835)
Q Consensus       638 vHrDlkp~NILl~~~~~~kl~DFGla~~  665 (835)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  46899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.45  E-value=0.0039  Score=66.07  Aligned_cols=72  Identities=15%  Similarity=0.206  Sum_probs=49.3

Q ss_pred             cccccCCcccEEEEEecC--------CcEEEEEEecCcChhhHHHHHHHHHHHHhcC-CCceeeEeeEEEecCeEEEEEE
Q 003264          520 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE  590 (835)
Q Consensus       520 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  590 (835)
                      +.|+.|--=.+|++...+        .+.|.+++... .. ......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578888888999998654        34677777653 22 2334567898988884 4334567777643    68999


Q ss_pred             ecCCCCh
Q 003264          591 YMPNKSL  597 (835)
Q Consensus       591 ~~~~gsL  597 (835)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.23  E-value=0.11  Score=52.18  Aligned_cols=157  Identities=13%  Similarity=0.072  Sum_probs=82.6

Q ss_pred             cHHHHHHhhcCCccccc-----cccCCcccEEEEEecCCcEEEEEEecCcChhhHHHHHHHHHHHHhcCCCce-----ee
Q 003264          505 SLASVSAATENFSMQCK-----LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-----VR  574 (835)
Q Consensus       505 ~~~~~~~~~~~~~~~~~-----LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~  574 (835)
                      +..+++....+|.+.+.     |..|---+.|+.+..+| .+++|+.....  ..+++..|++++..|.+.++     +.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            44566666777876544     34565677899987665 48999986532  22344556777777643222     11


Q ss_pred             Ee---eEEEecCeEEEEEEecCCCChhhhh--------------------cCCCCCCCCC------------------HH
Q 003264          575 LM---GCCVEQGEKILIYEYMPNKSLNFFL--------------------FDPSRTHLLG------------------WQ  613 (835)
Q Consensus       575 l~---~~~~~~~~~~lV~E~~~~gsL~~~l--------------------~~~~~~~~l~------------------~~  613 (835)
                      ..   .+.........++.+..+.......                    +.........                  ..
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            10   1122344566777777664432110                    0000000000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCcEEEecCCCCeEEEcCCCCeEecccCccc
Q 003264          614 TRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  664 (835)
Q Consensus       614 ~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  664 (835)
                      .....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222222222221 123469999999999999988877899999885

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.05  E-value=0.06  Score=33.96  Aligned_cols=31  Identities=29%  Similarity=0.690  Sum_probs=24.8

Q ss_pred             CCCccccCCCCCccccCC-CCCccccccccccc
Q 003264          287 NFCQLYGYCGANSVCSVD-DTANCECLKGFKLK  318 (835)
Q Consensus       287 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~  318 (835)
                      |+|.+-..|| +|.|+.- ..-.|.|-.||+|.
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepg   33 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG   33 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence            7899999998 6889743 33479999999985

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.66  E-value=0.26  Score=33.10  Aligned_cols=31  Identities=26%  Similarity=0.698  Sum_probs=24.1

Q ss_pred             CCCCcc-ccCCCCCccccCC-CCCccccccccc
Q 003264          286 NNFCQL-YGYCGANSVCSVD-DTANCECLKGFK  316 (835)
Q Consensus       286 ~~~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~  316 (835)
                      .++|.. ...|..+|.|... ..-.|.|++||+
T Consensus         3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~   35 (42)
T d2vj3a1           3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT   35 (42)
T ss_dssp             CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred             CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence            467875 5789999999754 345899999995